Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Duncan Gallagher DIRECTOR ELECTIONS ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Dr. Jill Hoggard Green DIRECTOR ELECTIONS ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of Health Catalyst, Inc. for its fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 To approve, on an advisory, non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 To approve, on an advisory, non-binding basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR 1 S000004450 Health Catalyst, Inc. 42225T107 US42225T1079 07/09/2025 To approve, on an advisory, non-binding basis, the board initiating action to declassify the board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 187104.000000 0.000000 FOR 187104.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Jordan R. Asher DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Joshua Hausman DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Denise W. Warren DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Company Nominees: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Paula J. Poskon DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Frank J. Small DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Ivona Smith DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven L. Vick DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of Directors: Ortelius Nominees OPPOSED by the Company: Lori B. Wittman DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 WITHHOLD 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR 1 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 587328.000000 0.000000 FOR 587328.000000 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Steven J. Insoft DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Paula J. Poskon DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Frank J. Small DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Ivona Smith DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Steven L. Vick DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. ORTELIUS NOMINEES: Lori B. Wittman DIRECTOR ELECTIONS SECURITY HOLDER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY ORTELIUS: Joshua Hausman DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY ORTELIUS: Denise W. Warren DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Jordan R. Asher DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 The Company's advisory proposal to approve the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 587328.000000 0.000000 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 The Company's advisory proposal to approve the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 587328.000000 0.000000 1 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 07/11/2025 The Company's proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 587328.000000 0.000000 S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 07/11/2025 Election of Class I Director: David N. Gill DIRECTOR ELECTIONS ISSUER 96999.000000 0.000000 FOR 96999.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 07/11/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 96999.000000 0.000000 FOR 96999.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 07/11/2025 To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 96999.000000 0.000000 FOR 96999.000000 FOR S000004450 Y-mAbs Therapeutics, Inc. 984241109 US9842411095 07/11/2025 To approve, on a non-binding advisory vote basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 96999.000000 0.000000 FOR 96999.000000 FOR 1 S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Robert E. Abernathy DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Diane M. Bryant DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Charles J. Dockendorff DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Lloyd E. Johnson DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Mark W. Kroll DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Claire Pomeroy DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 Election of Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR 1 S000004450 Haemonetics Corporation 405024100 US4050241003 07/24/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 28, 2026. AUDIT-RELATED ISSUER 157009.000000 0.000000 FOR 157009.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To elect four nominees for director named below to hold office until the 2028 Annual General Meeting of Shareholders: Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To elect four nominees for director named below to hold office until the 2028 Annual General Meeting of Shareholders: Patrick G. Enright DIRECTOR ELECTIONS ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To elect four nominees for director named below to hold office until the 2028 Annual General Meeting of Shareholders: Seamus Mulligan DIRECTOR ELECTIONS ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To elect four nominees for director named below to hold office until the 2028 Annual General Meeting of Shareholders: Norbert G. Riedel, Ph.D. DIRECTOR ELECTIONS ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration. AUDIT-RELATED ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals pic's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals pic's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR 1 S000004450 Jazz Pharmaceuticals plc G50871105 IE00B4Q5ZN47 07/24/2025 To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders. pursuant to the statutory pre-emption right that would otherwise apply. CAPITAL STRUCTURE ISSUER 179946.000000 0.000000 FOR 179946.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Gregory J. Divis DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Dr. Eric J. Ende DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Geoffrey M. Glass DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Dr. Mark A. McCamish DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Linda S. Palczuk DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Peter J. Thornton DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 Election of Directors: Dr. Naseem S. Amin DIRECTOR ELECTIONS ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 07/29/2025 To ratify, on a non-binding advisory basis, the appointment of Deloitte & Touche LLP as the Company's independent registered public auditor and accounting firm for the fiscal year ending December 31, 2025, and to authorize, in a binding vote, the Audit Committee of the Board of Directors to set the independent registered public auditor and accounting firm remuneration AUDIT-RELATED ISSUER 272183.000000 0.000000 FOR 272183.000000 FOR S000004450 Alumis Inc. 022307102 US0223071020 07/30/2025 To elect the two Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 90157.000000 0.000000 FOR 90157.000000 FOR S000004450 Alumis Inc. 022307102 US0223071020 07/30/2025 To elect the two Class I directors named below to hold office until the Company's 2028 annual meeting of stockholders: Sapna Srivastava, Ph.D. DIRECTOR ELECTIONS ISSUER 90157.000000 0.000000 FOR 90157.000000 FOR S000004450 Alumis Inc. 022307102 US0223071020 07/30/2025 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 90157.000000 0.000000 FOR 90157.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Lynne M. Doughtie DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Julie L. Gerberding, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: James H. Hinton DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 AUDIT-RELATED ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR S000004450 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 392178.000000 0.000000 FOR 392178.000000 FOR 1 S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Dr. Esther M. Alegria DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Richard C. Breeden DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Daniel A. Carestio DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Christopher S. Holland DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Paul E. Martin DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Dr. Nirav R. Shah DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Election of Directors: Dr. Mohsen M. Sohi DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 Elect Director Richard M. Steeves *Withdrawn Resolution* DIRECTOR ELECTIONS ISSUER 307221.000000 0.000000 S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2026. AUDIT-RELATED ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting. AUDIT-RELATED ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish law. AUDIT-RELATED ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 12, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR 1 S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To approve a proposal renewing the Board of Director's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 STERIS plc G8473T100 IE00BFY8C754 07/31/2025 To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 307221.000000 0.000000 FOR 307221.000000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 08/01/2025 To approve the repricing of certain outstanding stock options that have been granted under the Company's 2019 Stock Option and Grant Plan and/or the 2022 Stock Option and Incentive Plan (the "Option Repricing Proposal"). COMPENSATION ISSUER 23245.000000 103600.000000 AGAINST 23245.000000 AGAINST S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 08/01/2025 To approve a proposal to adjourn the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of additional proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Repricing Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 23245.000000 103600.000000 AGAINST 23245.000000 AGAINST S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Ronald M. Lombardi DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: John E. Byom DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Celeste A. Clark DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: James C. D'Arecca DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Sheila A. Hopkins DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: John F. Kelly DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To elect seven directors to serve until the 2026 Annual Meeting of Stockholders: Dawn M. Zier DIRECTOR ELECTIONS ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR 1 S000004450 Prestige Consumer Healthcare Inc. 74112D101 US74112D1019 08/05/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2026. AUDIT-RELATED ISSUER 155088.000000 0.000000 FOR 155088.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Paul B. Bolno, M.D., MBA DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Mark H. N. Corrigan, M.D. DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Christian Henry DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 AGAINST 335909.000000 AGAINST S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Peter Kolchinsky, Ph.D. DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Adrian Rawcliffe DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Ken Takanashi DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Aik Na Tan DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Gregory L. Verdine, Ph.D. DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 The election of the nominees for director: Heidi L. Wagner, J.D. DIRECTOR ELECTIONS ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2026 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non-Employee Directors' Compensation" in the proxy statement. COMPENSATION ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement. COMPENSATION ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. CAPITAL STRUCTURE ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 335909.000000 0.000000 FOR 335909.000000 FOR 1 S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 335909.000000 0.000000 ONE YEAR 335909.000000 FOR S000004450 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 335909.000000 0.000000 ONE YEAR 335909.000000 FOR 1 S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Michael G. Combs DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Joanna C. Burkey DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Steven J. Hamerslag DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Alan R. Hoops DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: R. Judd Jessup DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To elect six directors, each to serve until the annual meeting of stockholders to be held in 2026 or until his or her successor has been duly elected and qualified: Jeffrey J. Michael DIRECTOR ELECTIONS ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To ratify the appointment of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026; and AUDIT-RELATED ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 CorVel Corporation 221006109 US2210061097 08/07/2025 To approve the 2025 Stock Incentive Plan. COMPENSATION ISSUER 96677.000000 0.000000 FOR 96677.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Roderick de Greef DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Joydeep Goswami DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Amy DuRoss DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Rachel Ellingson DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Timothy L. Moore DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Cathy Coste DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 Election of Directors: Tony Hunt DIRECTOR ELECTIONS ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR 1 S000004450 BioLife Solutions, Inc. 09062W204 US09062W2044 08/20/2025 To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 119670.000000 0.000000 FOR 119670.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: J. Sullivan DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: G. Owens DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: S. Ladiwala DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: J. Alltoft DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: S. Hall DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: T. Tripeny DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 Election of directors: M. Capone DIRECTOR ELECTIONS ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 To ratify the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2026. AUDIT-RELATED ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR 1 S000004450 Mesa Laboratories, Inc. 59064R109 US59064R1095 08/22/2025 To approve the Amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan. COMPENSATION ISSUER 17058.000000 0.000000 FOR 17058.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jacob Bauer DIRECTOR ELECTIONS ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas Hughes DIRECTOR ELECTIONS ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert Susman DIRECTOR ELECTIONS ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2026. AUDIT-RELATED ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR S000004450 Immunovant, Inc. 45258J102 US45258J1025 08/27/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 212274.000000 0.000000 FOR 212274.000000 FOR 1 S000004450 Doximity, Inc. 26622P107 US26622P1075 08/28/2025 To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Jeffrey Tangney DIRECTOR ELECTIONS ISSUER 374142.000000 0.000000 FOR 374142.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/28/2025 To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Kira Wampler DIRECTOR ELECTIONS ISSUER 374142.000000 0.000000 FOR 374142.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/28/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending March 31, 2026. AUDIT-RELATED ISSUER 374142.000000 0.000000 FOR 374142.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/28/2025 To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 374142.000000 0.000000 FOR 374142.000000 FOR S000004450 Doximity, Inc. 26622P107 US26622P1075 08/28/2025 To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 374142.000000 0.000000 FOR 374142.000000 FOR 1 S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 Election of Directors: Kapil Dhingra DIRECTOR ELECTIONS ISSUER 119650.000000 0.000000 WITHHOLD 119650.000000 AGAINST S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 Election of Directors: Christy Oliger DIRECTOR ELECTIONS ISSUER 119650.000000 0.000000 WITHHOLD 119650.000000 AGAINST S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 Election of Directors: Joseph Slattery DIRECTOR ELECTIONS ISSUER 119650.000000 0.000000 WITHHOLD 119650.000000 AGAINST S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 Election of Directors: Michael Goller DIRECTOR ELECTIONS ISSUER 119650.000000 0.000000 FOR 119650.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 Election of Directors: Philip Astley-Sparke DIRECTOR ELECTIONS ISSUER 119650.000000 0.000000 FOR 119650.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2026. AUDIT-RELATED ISSUER 119650.000000 0.000000 FOR 119650.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 119650.000000 0.000000 FOR 119650.000000 FOR S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 119650.000000 0.000000 FOR 119650.000000 FOR 1 S000004450 Replimune Group, Inc. 76029N106 US76029N1063 09/03/2025 To approve an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan (the "Plan Amendment"). COMPENSATION ISSUER 119650.000000 0.000000 AGAINST 119650.000000 AGAINST S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew Gline DIRECTOR ELECTIONS ISSUER 1104318.000000 0.000000 FOR 1104318.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Manchester DIRECTOR ELECTIONS ISSUER 1104318.000000 0.000000 FOR 1104318.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa Epperly DIRECTOR ELECTIONS ISSUER 1104318.000000 0.000000 FOR 1104318.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2026, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2026, and to authorize the Board of Directors, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2026. AUDIT-RELATED ISSUER 1104318.000000 0.000000 FOR 1104318.000000 FOR S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1104318.000000 0.000000 AGAINST 1104318.000000 AGAINST S000004450 Roivant Sciences Ltd. G76279101 BMG762791017 09/10/2025 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1104318.000000 0.000000 AGAINST 1104318.000000 AGAINST 1 S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Mitchel Sayare, Ph.D. DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Vipin K. Garg, Ph.D. DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: John M. Gill DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Philip L. Hodges DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Diane Jorkasky, M.D. DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Wayne Pisano DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Klaus O. Schafer, M.D., MPH DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Catherine Sohn, Pharm D DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Teri Lawver DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to elect the ten nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2026 Annual Meeting of Stockholders: Jerome Durso DIRECTOR ELECTIONS ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR 1 S000004450 Altimmune, Inc. 02155H200 US02155H2004 09/25/2025 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 36404.000000 201775.000000 FOR 36404.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Election of three director nominees to our Board to serve three-year terms expiring at the annual meeting of stockholders in 2028 or until their successors are duly elected and qualified: Myla Lai-Goldman, M.D. DIRECTOR ELECTIONS ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Election of three director nominees to our Board to serve three-year terms expiring at the annual meeting of stockholders in 2028 or until their successors are duly elected and qualified: Masoud Toloue, Ph.D. DIRECTOR ELECTIONS ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Election of three director nominees to our Board to serve three-year terms expiring at the annual meeting of stockholders in 2028 or until their successors are duly elected and qualified: David R. Walt, Ph.D. DIRECTOR ELECTIONS ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR 1 S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Ratification, on an advisory basis, of the appointment of KPMG, LLP as the Company's independent public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Approval of an amendment to our Charter to declassify our Board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Approval of an amendment to our Charter to eliminate the supermajority stockholder vote requirement to amend certain provisions of our Charter. CORPORATE GOVERNANCE ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 09/29/2025 Approval of an amendment to our Charter to eliminate the supermajority stockholder vote requirement for stockholders to amend our Bylaws. CORPORATE GOVERNANCE ISSUER 113698.000000 0.000000 FOR 113698.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 09/30/2025 To approve an amendment to the Pulse Biosciences, Inc. 2017 Equity Incentive Plan (the "Plan"), to increase the number of shares of the Company's common stock issuable under the Plan by 2,000,000 shares and to change the Plan's definition of "Consultant." COMPENSATION ISSUER 4770.000000 46300.000000 AGAINST 4770.000000 AGAINST S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 09/30/2025 Subject to approval of Proposal 1, to ratify the grant under the Plan of (i) options to acquire up to 500,000 shares of Common Stock granted to certain Company consultants, and (ii) options to acquire up to 600,000 shares of Common Stock granted to certain Company directors. COMPENSATION ISSUER 4770.000000 46300.000000 AGAINST 4770.000000 AGAINST S000004450 KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: Benjamin L. Palleiko DIRECTOR ELECTIONS ISSUER 99982.000000 0.000000 FOR 99982.000000 FOR S000004450 KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 The election of two Class I directors to hold office until the earliest of our 2028 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: Brian J.G. Pereira DIRECTOR ELECTIONS ISSUER 99982.000000 0.000000 FOR 99982.000000 FOR S000004450 KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 The ratification of the selection by the audit committee of our Board, of Deloitte & Touche LLP as our independent registered public accounting firm for our eight-month transition period ending December 31, 2025. AUDIT-RELATED ISSUER 99982.000000 0.000000 FOR 99982.000000 FOR S000004450 KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 99982.000000 0.000000 FOR 99982.000000 FOR S000004450 KalVista Pharmaceuticals, Inc. 483497103 US4834971032 10/01/2025 Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 99982.000000 0.000000 FOR 99982.000000 FOR 1 S000004450 ZimVie Inc. 98888T107 US98888T1079 10/10/2025 A proposal to adopt the Agreement and Plan of Merger, dated as of July 20, 2025 (the "merger agreement"), by and among ZimVie Inc. (the "Company"), Zamboni Parent Inc. ("Parent"), and Zamboni MergerCo Inc. ("MergerCo"), pursuant to which and subject to the terms and conditions thereof, MergerCo will be merged with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of Parent. EXTRAORDINARY TRANSACTIONS ISSUER 84655.000000 0.000000 FOR 84655.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 10/10/2025 A proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 84655.000000 0.000000 FOR 84655.000000 FOR S000004450 ZimVie Inc. 98888T107 US98888T1079 10/10/2025 A proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 84655.000000 0.000000 FOR 84655.000000 FOR 1 S000004450 ZimVie Inc. 98888T107 US98888T1079 10/10/2025 A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 84655.000000 0.000000 FOR 84655.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 10/13/2025 To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company's common stock in connection with the conversion of convertible senior unsecured promissory notes due 2031 held by several non-affiliated purchasers, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of common stock issued and outstanding prior to such issuance. CAPITAL STRUCTURE ISSUER 369660.000000 0.000000 FOR 369660.000000 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 10/13/2025 To approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of a number of shares of the Company's common stock in connection with the conversion of the Company's Series A Convertible Preferred Stock held by several non-affiliated holders, which could, under certain circumstances that may occur in the future, exceed 19.99% of the number of shares of common stock issued and outstanding prior to such issuance. CAPITAL STRUCTURE ISSUER 369660.000000 0.000000 FOR 369660.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): John P. Groetelaars DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): William R. Jellison DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Joon S. Lee, M.D. DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2026 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell DIRECTOR ELECTIONS ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR 1 S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; CAPITAL STRUCTURE ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares; CAPITAL STRUCTURE ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving an amendment to Article 177 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reserves; CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving a Capital Reduction to Create Distributable Reserves under Irish Law; and CAPITAL STRUCTURE ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Medtronic plc G5960L103 IE00BTN1Y115 10/16/2025 Approving amendments to the Company's Articles of Association, to update the advance notice provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3892081.000000 0.000000 FOR 3892081.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 Election of Directors: Thierry L. Bernard DIRECTOR ELECTIONS ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 Election of Directors: Mikhael Nassif DIRECTOR ELECTIONS ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 Election of Directors: Avi Pelossof DIRECTOR ELECTIONS ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 Election of Directors: Andrea F. Wainer DIRECTOR ELECTIONS ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR 1 S000004450 Neogen Corporation 640491106 US6404911066 10/23/2025 Ratification of Appointment of BDO USA P.C. as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 624467.000000 0.000000 FOR 624467.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 10/24/2025 That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to. EXTRAORDINARY TRANSACTIONS ISSUER 45374.000000 0.000000 FOR 45374.000000 FOR S000004450 Mural Oncology Plc G63365103 IE000LK2BOB4 10/24/2025 To approve any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme. CORPORATE GOVERNANCE ISSUER 45374.000000 0.000000 FOR 45374.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 10/24/2025 Ordinary resolution to approve the scheme of arrangement that is included in the proxy statement in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court and to authorize the directors of Mural to take all such action as they consider necessary or appropriate for carrying the Scheme into effect. EXTRAORDINARY TRANSACTIONS ISSUER 45374.000000 0.000000 FOR 45374.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 10/24/2025 Special resolution to approve the amendment to the articles of association of Mural as set forth in the proxy statement so that any shares in Mural that are issued on or after the Voting Record Time to persons other than Sub and/or its nominee(s) will either be subject to the terms of the Scheme or be immediately and automatically acquired by Sub and/or its nominee(s) for the Scheme Consideration. CORPORATE GOVERNANCE ISSUER 45374.000000 0.000000 FOR 45374.000000 FOR S000004450 Mural Oncology plc G63365103 IE000LK2BOB4 10/24/2025 Ordinary resolution to approve any motion by the Chair to adjourn the EGM, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the EGM to approve proposals 1 and/or 2. CORPORATE GOVERNANCE ISSUER 45374.000000 0.000000 FOR 45374.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 To set the number of Directors at nine. CORPORATE GOVERNANCE ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Julie L. Bushman DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Judith Klimovsky DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: John L. Higgins DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Kim Kelderman DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Alpna Seth DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Rupert Vessey DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Joseph D. Keegan DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Elections of Directors: Amy E. Herr DIRECTOR ELECTIONS ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR 1 S000004450 Bio-Techne Corporation 09073M104 US09073M1045 10/30/2025 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 472264.000000 0.000000 FOR 472264.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Open Meeting OTHER Formalities - This code is used to approve/acknowledge meeting procedures. This is a routine item that is required by law in some countries. ISSUER 447915.000000 0.000000 S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Approve Acquisition of the Entire Issued Share Capital of Beckley Psytech not Already Owned by ATAI EXTRAORDINARY TRANSACTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Approve Issuance of Ordinary Shares in Connection with the Acquisition EXTRAORDINARY TRANSACTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Elect Cosmo Feilding-Mellen as Non-Executive Director DIRECTOR ELECTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Elect Robert Hershberg as Non-Executive Director DIRECTOR ELECTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Change Company Name and Amend Articles of Association CORPORATE GOVERNANCE ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Approve Conversion of the Company EXTRAORDINARY TRANSACTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Amend Articles Re: Withdrawal Right CORPORATE GOVERNANCE ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Approve Shareholders Exercise Their Withdrawal Right under Dutch Law EXTRAORDINARY TRANSACTIONS ISSUER 447915.000000 0.000000 FOR 447915.000000 FOR S000004450 ATAI Life Sciences NV N0731H103 NL0015000DX5 11/04/2025 Close Meeting OTHER Formalities - This code is used to approve/acknowledge meeting procedures. This is a routine item that is required by law in some countries. ISSUER 447915.000000 0.000000 S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Election of Class III Directors: Jack C. Bendheim DIRECTOR ELECTIONS ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Election of Class III Directors: Alejandro Bernal DIRECTOR ELECTIONS ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Election of Class III Directors: E. Thomas Corcoran DIRECTOR ELECTIONS ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Approval, on an advisory basis, of the compensation paid to the named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Approval, on an advisory basis, of the compensation paid to the named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR 1 S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Approval, on an advisory basis, of the frequency of future advisory votes on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 61457.000000 0.000000 ONE YEAR 61457.000000 AGAINST S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Approval, on an advisory basis, of the frequency of future advisory votes on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 61457.000000 0.000000 ONE YEAR 61457.000000 AGAINST 1 S000004450 Phibro Animal Health Corporation 71742Q106 US71742Q1067 11/04/2025 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026. AUDIT-RELATED ISSUER 61457.000000 0.000000 FOR 61457.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Robert W. Azelby DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Michelle M. Brennan DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Sheri H. Edison DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: David C. Evans DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Patricia A. Hemingway Hall DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Akhil Johri DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Gregory B. Kenny DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Nancy Killefer DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Christine A. Mundkur DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Robert W. Musslewhite DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Sudhakar Ramakrishna DIRECTOR ELECTIONS ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR 1 S000004450 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2026 AUDIT-RELATED ISSUER 719176.000000 0.000000 FOR 719176.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/10/2025 Proposal to elect two Class I directors, for a term of three years: James C. Clemmer DIRECTOR ELECTIONS ISSUER 121409.000000 0.000000 FOR 121409.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/10/2025 Proposal to elect two Class I directors, for a term of three years: Michael E. Tarnoff, MD DIRECTOR ELECTIONS ISSUER 121409.000000 0.000000 FOR 121409.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/10/2025 To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2026. AUDIT-RELATED ISSUER 121409.000000 0.000000 FOR 121409.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/10/2025 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 121409.000000 0.000000 FOR 121409.000000 FOR S000004450 AngioDynamics, Inc. 03475V101 US03475V1017 11/10/2025 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 121409.000000 0.000000 FOR 121409.000000 FOR 1 S000004450 Moderna, Inc. 60770K107 US60770K1079 11/12/2025 To approve a one-time stock option exchange program for non-Executive Committee employees of Moderna, Inc. (the "Option Exchange Proposal") COMPENSATION ISSUER 1035819.000000 0.000000 FOR 1035819.000000 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 11/12/2025 To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 1035819.000000 0.000000 FOR 1035819.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/18/2025 Election of Director: John Herhalt DIRECTOR ELECTIONS ISSUER 79927.000000 3020716.000000 FOR 79927.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/18/2025 The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2026; AUDIT-RELATED ISSUER 79927.000000 3020716.000000 FOR 79927.000000 FOR S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/18/2025 Approval of the non-binding advisory resolution on the named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 79927.000000 3020716.000000 AGAINST 79927.000000 AGAINST S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/18/2025 Approval of the non-binding advisory resolution on the named executive officer compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 79927.000000 3020716.000000 AGAINST 79927.000000 AGAINST 1 S000004450 Tilray Brands, Inc. 88688T100 US88688T1007 11/18/2025 Approval of the governance changes to the Company's Fifth Amended and Restated Certificate of Incorporation (the "Charter") to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the "Governance Proposal"); and CORPORATE GOVERNANCE ISSUER 79927.000000 3020716.000000 FOR 79927.000000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 11/19/2025 To approve a reduction in the Company's capital to create distributable reserves. CAPITAL STRUCTURE ISSUER 128784.000000 0.000000 FOR 128784.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Carol Burt DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Christopher DelOrefice DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Jan De Witte DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Karen Drexler DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Michael Farrell DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Peter Farrell DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Harjit Gill DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: John Hernandez DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Nicole Mowad-Nassar DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Desney Tan DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: Ronald Taylor DIRECTOR ELECTIONS ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. AUDIT-RELATED ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR 1 S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Approve the amendment and restatement of our 2009 Incentive Award Plan. COMPENSATION ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 ResMed Inc. 761152107 US7611521078 11/19/2025 Approve the amendment and restatement of our 2018 Employee Stock Purchase Plan. COMPENSATION ISSUER 438015.000000 0.000000 FOR 438015.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 11/21/2025 A proposal to adopt the merger agreement, dated as of September 21, 2025, by and among Premier, Inc., Premium Merger Sub, Inc. and Premium Parent, LLC (the "merger agreement proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 246556.000000 0.000000 FOR 246556.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 11/21/2025 A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 246556.000000 0.000000 FOR 246556.000000 FOR S000004450 Premier, Inc. 74051N102 US74051N1028 11/21/2025 A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 246556.000000 0.000000 FOR 246556.000000 FOR 1 S000004450 Premier, Inc. 74051N102 US74051N1028 11/21/2025 A proposal to approve any adjournment of the special meeting, if necessary or appropriate, for the purpose of soliciting additional proxies if there are not sufficient votes at the special meeting to adopt the merger agreement (the adjournment proposal"). CORPORATE GOVERNANCE ISSUER 246556.000000 0.000000 FOR 246556.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 12/02/2025 To adopt the Agreement and Plan of Merger (as may be amended, modified or supplemented from time to time, the "Merger Agreement"), dated October 9, 2025, by and among Akero Therapeutics, Inc., a Delaware corporation ("Akero"), Novo Nordisk A/S, a Danish aktieselskab ("Parent"), and NN Invest Sub, Inc, a Delaware corporation and a direct or indirect wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement (the "CVR Agreement") to be entered into at or immediately prior to the effective time of the Merger by a direct or indirect wholly owned subsidiary of Parent designated in the CVR Agreement, a rights agent selected by Parent and reasonably acceptable to Akero and, solely with respect to Section 6.11 of the CVR Agreement, Parent, subject to changes permitted by the Merger Agreement, pursuant to which Merger Sub will merge with and into Akero (the "Merger"), and Akero will become a direct or indirect wholly owned subsidiary of Parent. EXTRAORDINARY TRANSACTIONS ISSUER 167490.000000 0.000000 FOR 167490.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 167490.000000 0.000000 FOR 167490.000000 FOR S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 167490.000000 0.000000 FOR 167490.000000 FOR 1 S000004450 Akero Therapeutics, Inc. 00973Y108 US00973Y1082 12/02/2025 To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 167490.000000 0.000000 FOR 167490.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Election of 13 director nominees, each to hold office until the 2026 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Approval of, on a non-binding advisory basis, the 2024 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Approval of, on a non-binding advisory basis, the 2024 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR 1 S000004450 Viatris Inc. 92556V106 US92556V1061 12/05/2025 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 3527160.000000 0.000000 FOR 3527160.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: Kevin C. Clark DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: Dwayne Allen DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: Venkat Bhamidipati DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: W. Larry Cash DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: Gale Fitzgerald DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: John A. Martins DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to elect seven directors for terms expiring at the 2026 annual meeting: Janice E. Nevin, M.D., MPH DIRECTOR ELECTIONS ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending december 31, 2025. AUDIT-RELATED ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to approve, on an advisory basis, compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 12/09/2025 Proposal to approve, on an advisory basis, compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 88581.000000 0.000000 FOR 88581.000000 FOR 1 S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Open Meeting OTHER Formalities - This code is used to approve/acknowledge meeting procedures. This is a routine item that is required by law in some countries. ISSUER 156114.000000 0.000000 S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Discussion of the Offer EXTRAORDINARY TRANSACTIONS ISSUER 156114.000000 0.000000 S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Back-End Transactions (1) To enter into a statutory merger under Dutch law pursuant to which Merus, as disappearing company, will merge with and into New Topco, as surviving company; and (2) to approve, within the meaning of Section 2:107a of the Dutch Civil Code and to the extent required by applicable law, such statutory merger and the subsequent cancellation of all class A shares in the capital of New Topco with repayment and distribution by New Topco of an amount per class A share so cancelled equal to the Offer Consideration, without interest and subject to any applicable withholding taxes EXTRAORDINARY TRANSACTIONS ISSUER 156114.000000 0.000000 FOR 156114.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 (1) to amend Merus' Articles of Association to increase Merus' authorized share capital in one or more tranches, and (2) to convert Merus N.V. into a private company with limited liability, promptly following the delisting of Merus' common shares from the Nasdaq Global Market and to amend Merus' Articles of Association accordingly CORPORATE GOVERNANCE ISSUER 156114.000000 0.000000 FOR 156114.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Effective upon the acceptance for payment by Purchaser for all Common Shares validly tendered and not properly withdrawn pursuant to the Offer prior to the Expiration Time, to provide full and final discharge to each member of the Merus Board for their acts of management or supervision, as applicable, up to and including the date of the EGM to the fullest extent permitted under applicable law CORPORATE GOVERNANCE ISSUER 156114.000000 0.000000 FOR 156114.000000 FOR S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Greg Mueller as non-executive director of Merus Opportunity for Merus Shareholders to make recommendations at the EGM to Merus' non-executive directors in respect of their nomination to appoint a non-executive director CORPORATE GOVERNANCE ISSUER 156114.000000 0.000000 FOR 156114.000000 NONE S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Greg Mueller as non-executive director of Merus DIRECTOR ELECTIONS ISSUER 156114.000000 0.000000 AGAINST 156114.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Anthony Pagano as non-executive director of Merus Opportunity for Merus Shareholders to make recommendations at the EGM to Merus' non-executive directors in respect of their nomination to appoint a non-executive director CORPORATE GOVERNANCE ISSUER 156114.000000 0.000000 FOR 156114.000000 NONE S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Anthony Pagano as non-executive director of Merus DIRECTOR ELECTIONS ISSUER 156114.000000 0.000000 AGAINST 156114.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Martine van Vugt, Ph.D., as non-executive director of Merus Opportunity for Merus Shareholders to make recommendations at the EGM to Merus' non-executive directors in respect of their nomination to appoint a non-executive director CORPORATE GOVERNANCE ISSUER 156114.000000 0.000000 FOR 156114.000000 NONE S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Appointment of Martine van Vugt, Ph.D., as non-executive director of Merus DIRECTOR ELECTIONS ISSUER 156114.000000 0.000000 AGAINST 156114.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Non-binding advisory proposal to approve certain compensation arrangements SECTION 14A SAY-ON-PAY VOTES ISSUER 156114.000000 0.000000 AGAINST 156114.000000 AGAINST S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Non-binding advisory proposal to approve certain compensation arrangements SECTION 14A SAY-ON-PAY VOTES ISSUER 156114.000000 0.000000 AGAINST 156114.000000 AGAINST 1 S000004450 Merus N.V. N5749R100 NL0011606264 12/09/2025 Close Meeting OTHER Formalities - This code is used to approve/acknowledge meeting procedures. This is a routine item that is required by law in some countries. ISSUER 156114.000000 0.000000 S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 Election of Directors: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17942.000000 42900.000000 FOR 17942.000000 FOR 1 S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 To vote, on an advisory basis, the frequency of future advisory stockholder votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17942.000000 42900.000000 ONE YEAR 17942.000000 AGAINST S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 12/09/2025 To vote, on an advisory basis, the frequency of future advisory stockholder votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17942.000000 42900.000000 ONE YEAR 17942.000000 AGAINST 1 S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Approve Scheme of Arrangement EXTRAORDINARY TRANSACTIONS ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Approve Reduction in Share Capital CAPITAL STRUCTURE ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Authorize Issue of Equity CAPITAL STRUCTURE ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Amend Articles of Association CORPORATE GOVERNANCE ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Approve Re-registration of the Company as a Private Company by the Name of Indivior Limited EXTRAORDINARY TRANSACTIONS ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Adopt New Articles of Association CORPORATE GOVERNANCE ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 Indivior PLC G4766E116 GB00BN4HT335 12/11/2025 Approve Scheme of Arrangement EXTRAORDINARY TRANSACTIONS ISSUER 265913.000000 0.000000 FOR 265913.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Taylor Leavitt DIRECTOR ELECTIONS ISSUER 140762.000000 0.000000 FOR 140762.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Jacqueline Millard DIRECTOR ELECTIONS ISSUER 140762.000000 0.000000 FOR 140762.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 140762.000000 0.000000 FOR 140762.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To approve, on an advisory (non binding) basis, the frequency of future advisory votes on the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 140762.000000 0.000000 ONE YEAR 140762.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To approve, on an advisory (non binding) basis, the frequency of future advisory votes on the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 140762.000000 0.000000 ONE YEAR 140762.000000 FOR 1 S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 140762.000000 0.000000 FOR 140762.000000 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 12/19/2025 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 140762.000000 0.000000 FOR 140762.000000 FOR 1 S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Election of Directors: Carlos Campoy DIRECTOR ELECTIONS ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Election of Directors: Alessandra Cesano DIRECTOR ELECTIONS ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Election of Directors: Robert E. Landry DIRECTOR ELECTIONS ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR 1 S000004450 Zymeworks Inc. 98985Y108 US98985Y1082 12/30/2025 Appointment of Auditors Ratification of the appointment of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2025 AUDIT-RELATED ISSUER 112751.000000 0.000000 FOR 112751.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 A proposal to adopt the Agreement and Plan of Merger, dated as of August 4, 2025, as may be amended from time to time (the "Merger Agreement"), by and among STAAR Surgical Company ("STAAR"), Alcon Research, LLC, a Delaware limited liability company ("Alcon"), and Rascasse Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Alcon. EXTRAORDINARY TRANSACTIONS ISSUER 104465.000000 0.000000 FOR 104465.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to STAAR's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 104465.000000 0.000000 FOR 104465.000000 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to STAAR's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 104465.000000 0.000000 FOR 104465.000000 FOR 1 S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 Company Proposal: A proposal to approve the Agreement and Plan of Merger, dated as of August 4, 2025 (as may be amended from time to time, the "Merger Agreement"), by and among the Company, Alcon Research, LLC, a Delaware limited liability company ("Alcon"), and Rascasse Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Alcon, and the other transactions contemplated by the Merger Agreement. EXTRAORDINARY TRANSACTIONS ISSUER 104465.000000 0.000000 S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 Company Proposal: A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger Agreement and the transactions contemplated thereby. SECTION 14A SAY-ON-PAY VOTES ISSUER 104465.000000 0.000000 S000004450 STAAR Surgical Company 852312305 US8523123052 01/06/2026 Company Proposal: A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Merger Agreement and the transactions contemplated thereby. SECTION 14A SAY-ON-PAY VOTES ISSUER 104465.000000 0.000000 1 S000004450 Vanguard World Fund 921910709 ZZZZ00019402 01/06/2026 For shareholders of Vanguard Health Care Index Fund: To approve changing the Fund's classification from diversified to non-diversified and the elimination of the related fundamental investment restriction. INVESTMENT COMPANY MATTERS ISSUER 0.000000 0.000000 S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 01/12/2026 Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel") to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect. EXTRAORDINARY TRANSACTIONS ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 01/12/2026 Special resolution to approve an amendment to the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes plc or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquired by Alkermes plc and/or its nominee(s) for the Scheme Consideration. CORPORATE GOVERNANCE ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 01/12/2026 Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. SECTION 14A SAY-ON-PAY VOTES ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 01/12/2026 Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. SECTION 14A SAY-ON-PAY VOTES ISSUER 265492.000000 0 FOR 265492.000000 FOR 2 S000004450 Avadel Pharmaceuticals plc G29687103 IE00BDGMC594 01/12/2026 Ordinary resolution to approve any motion by the Chair to adjourn the Extraordinary General Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to approve resolutions 1 and 2. CORPORATE GOVERNANCE ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Avadel Pharmaceuticals Plc G29687103 IE00BDGMC594 01/12/2026 That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to. EXTRAORDINARY TRANSACTIONS ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Avadel Pharmaceuticals Plc G29687103 IE00BDGMC594 01/12/2026 That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved. CORPORATE GOVERNANCE ISSUER 265492.000000 0 FOR 265492.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 01/21/2026 To adopt the Agreement and Plan of Merger, dated as of October 14, 2025 by and among BioCryst Pharmaceuticals, Inc. ("BioCryst"), Axel Merger Sub, Inc., a wholly owned subsidiary of BioCryst ("Merger Sub"), and Astria Therapeutics, Inc. ("Astria"), under which Merger Sub will merge with and into Astria, with Astria surviving and becoming a wholly owned subsidiary of BioCryst (the "Merger") (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 94429.000000 0 FOR 94429.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 01/21/2026 To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled "Golden Parachute Compensation" and its accompanying footnotes which is included in the section of the proxy statement entitled "The Merger-Interests of Astria's Directors and Executive Officers in the Merger," as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. SECTION 14A SAY-ON-PAY VOTES ISSUER 94429.000000 0 FOR 94429.000000 FOR S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 01/21/2026 To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled "Golden Parachute Compensation" and its accompanying footnotes which is included in the section of the proxy statement entitled "The Merger-Interests of Astria's Directors and Executive Officers in the Merger," as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. SECTION 14A SAY-ON-PAY VOTES ISSUER 94429.000000 0 FOR 94429.000000 FOR 2 S000004450 Astria Therapeutics, Inc. 04635X102 US04635X1028 01/21/2026 To approve one or more adjournments of the Special Meeting to a later date or dates if there are not sufficient votes for adoption of the Merger Proposal on the date on which the Special Meeting is held. CORPORATE GOVERNANCE ISSUER 94429.000000 0 FOR 94429.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Gregory J. Hayes DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Robert L. Huffines DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jacqueline Wright DIRECTOR ELECTIONS ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 873342.000000 0 FOR 873342.000000 FOR 2 S000004450 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 873342.000000 0 FOR 873342.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 01/27/2026 To approve the issuance of shares of common stock, par value $0.01 per share, of the Company (the "Waters Common Stock"), pursuant to the Agreement and Plan of Merger, dated as of July 13, 2025, by and among the Company, Becton, Dickinson and Company, Augusta SpinCo Corporation and Beta Merger Sub, Inc., as amended from time to time (the "Share Issuance Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 181087.000000 0 FOR 181087.000000 FOR S000004450 Waters Corporation 941848103 US9418481035 01/27/2026 To approve the adjournment of the Special Meeting, if necessary, (a) to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Share Issuance Proposal, (b) if there are insufficient shares of Waters Common Stock represented (either in person via the Internet or by proxy) to constitute a quorum necessary to conduct business at the Special Meeting or (c) to allow reasonable time for the filing or mailing of any supplemental or amended disclosures that the Company has determined, based on the advice of outside legal counsel, are reasonably likely to be required under applicable law and for such supplemental or amended disclosures to be disseminated and reviewed by the Company's shareholders prior to the Special Meeting. CORPORATE GOVERNANCE ISSUER 181087.000000 0 FOR 181087.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Frank E. Casal DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: William L. Cornog DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Robyn C. Davis DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Dipal Doshi DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Quentin Koffey DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Martin Madaus DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Alan J. Malus DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: John P. Marotta DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Erica J. McLaughlin DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 125327.000000 0 FOR 125327.000000 FOR 2 S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 To approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 2,750,000. COMPENSATION ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Azenta, Inc. 114340102 US1143401024 01/28/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 125327.000000 0 FOR 125327.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 02/05/2026 A proposal to adopt the Agreement and Plan of Merger, dated as of October 21, 2025 (as it may be amended or supplemented from time to time, the "merger agreement"), by and among Hologic, Inc. (the "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, and on the terms and subject to the conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of Parent. EXTRAORDINARY TRANSACTIONS ISSUER 677273.000000 0 FOR 677273.000000 FOR S000004450 Hologic, Inc. 436440101 US4364401012 02/05/2026 A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 677273.000000 0 AGAINST 677273.000000 AGAINST S000004450 Hologic, Inc. 436440101 US4364401012 02/05/2026 A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 677273.000000 0 AGAINST 677273.000000 AGAINST 2 S000004450 Hologic, Inc. 436440101 US4364401012 02/05/2026 A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to adopt the merger agreement. CORPORATE GOVERNANCE ISSUER 677273.000000 0 FOR 677273.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 Election of Class II Directors: Keith Crandell DIRECTOR ELECTIONS ISSUER 183172.000000 0 FOR 183172.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 Election of Class II Directors: Jan Johannessen DIRECTOR ELECTIONS ISSUER 183172.000000 0 FOR 183172.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 Election of Class II Directors: Trynka Shineman Blake DIRECTOR ELECTIONS ISSUER 183172.000000 0 FOR 183172.000000 FOR S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." SECTION 14A SAY-ON-PAY VOTES ISSUER 183172.000000 0 AGAINST 183172.000000 AGAINST S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation." SECTION 14A SAY-ON-PAY VOTES ISSUER 183172.000000 0 AGAINST 183172.000000 AGAINST 2 S000004450 Twist Bioscience Corporation 90184D100 US90184D1000 02/05/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 183172.000000 0 FOR 183172.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Carrie L. Anderson DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Robert (Bob) J. Hombach DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Devdatt (Dev) Kurdikar DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Milton M. Morris, Ph.D. DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Claire Pomeroy, M.D. DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Election of Directors: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 169632.000000 0 FOR 169632.000000 FOR 2 S000004450 Embecta Corp. 29082K105 US29082K1051 02/11/2026 Approval of an amendment to the Embecta 2022 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 169632.000000 0 FOR 169632.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Election of Directors: Dr. Daniel Weiner DIRECTOR ELECTIONS ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Election of Directors: Dr. Walter S. Woltosz DIRECTOR ELECTIONS ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Election of Directors: Dr. John K. Paglia DIRECTOR ELECTIONS ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Election of Directors: Sharlene Evans DIRECTOR ELECTIONS ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2026. AUDIT-RELATED ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended to increase the number of shares authorized for issuance thereunder from 2,500,000 shares to 3,450,000 shares of common stock of the Company. COMPENSATION ISSUER 52882.000000 0 FOR 52882.000000 FOR S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Advisory vote as to whether the advisory vote to approve named executive officer compensation should take place every 1, 2 or 3 years. SECTION 14A SAY-ON-PAY VOTES ISSUER 52882.000000 0 ONE YEAR 52882.000000 AGAINST S000004450 Simulations Plus, Inc. 829214105 US8292141053 02/12/2026 Advisory vote as to whether the advisory vote to approve named executive officer compensation should take place every 1, 2 or 3 years. SECTION 14A SAY-ON-PAY VOTES ISSUER 52882.000000 0 ONE YEAR 52882.000000 AGAINST 2 S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Kathleen L. Bardwell DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Jocelyn D. Chertoff, M.D. DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Timothy E. Guertin DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Jay K. Kunkel DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Sunny S. Sanyal DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To elect seven directors to serve until the 2027 Annual Meeting of Stockholders: Christine A. Tsingos DIRECTOR ELECTIONS ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To approve, on an advisory basis, our executive compensation as described in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To approve, on an advisory basis, our executive compensation as described in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 126033.000000 0 FOR 126033.000000 FOR 2 S000004450 Varex Imaging Corporation 92214X106 US92214X1063 02/12/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 126033.000000 0 FOR 126033.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 02/20/2026 Proposal to adopt the Agreement and Plan of Merger, dated as of November 19, 2025, as it may be amended from time to time (the "Merger Agreement"), by and among Exact Sciences Corporation, Abbott Laboratories and Badger Merger Sub I, Inc. (the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 571127.000000 0 FOR 571127.000000 FOR S000004450 Exact Sciences Corporation 30063P105 US30063P1057 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 571127.000000 0 AGAINST 571127.000000 AGAINST S000004450 Exact Sciences Corporation 30063P105 US30063P1057 02/20/2026 Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 571127.000000 0 AGAINST 571127.000000 AGAINST 2 S000004450 Exact Sciences Corporation 30063P105 US30063P1057 02/20/2026 Proposal to approve any adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 571127.000000 0 FOR 571127.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 02/26/2026 To adopt (i) the Agreement and Plan of Merger, dated as of October 25, 2025 (the "Merger Agreement"), among Novartis AG, a company limited by shares (Aktiengesellschaft) incorporated under the laws of Switzerland ("Novartis"), Ajax Acquisition Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis, and Avidity Biosciences, Inc., a Delaware corporation (the "Company"), and (ii) the Separation and Distribution Agreement, dated as of October 25, 2025 (the "Separation Agreement"), among the Company, Bryce Therapeutics, Inc., a newly formed Delaware corporation and wholly owned subsidiary of the Company, and which on December 8, 2025, changed its name to Atrium Therapeutics, Inc., and Novartis (with respect to certain sections therein). EXTRAORDINARY TRANSACTIONS ISSUER 330411.000000 0 FOR 330411.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 02/26/2026 To adjourn the Special Meeting, if necessary, desirable or appropriate or to solicit additional proxies if, at the time of the Special Meeting, there are an insufficient number of votes in favor of adopting the Merger Agreement and the Separation Agreement. CORPORATE GOVERNANCE ISSUER 330411.000000 0 FOR 330411.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 02/26/2026 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 330411.000000 0 FOR 330411.000000 FOR S000004450 Avidity Biosciences, Inc. 05370A108 US05370A1088 02/26/2026 To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement. SECTION 14A SAY-ON-PAY VOTES ISSUER 330411.000000 0 FOR 330411.000000 FOR 2 S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 03/03/2026 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated December 19, 2025, by and among Amicus Therapeutics, Inc., a Delaware corporation ("Amicus"), BioMarin Pharmaceutical Inc., a Delaware corporation ("BioMarin"), and Lynx Merger Sub 1, Inc., a Delaware corporation and wholly owned subsidiary of BioMarin ("Merger Sub"), pursuant to which Merger Sub will merge with and into Amicus (the "Merger"), and Amicus will become a direct or indirect wholly owned subsidiary of BioMarin. EXTRAORDINARY TRANSACTIONS ISSUER 836938.000000 0 FOR 836938.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 03/03/2026 To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 836938.000000 0 FOR 836938.000000 FOR S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 03/03/2026 To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 836938.000000 0 FOR 836938.000000 FOR 2 S000004450 Amicus Therapeutics, Inc. 03152W109 US03152W1099 03/03/2026 To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 836938.000000 0 FOR 836938.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 03/03/2026 To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated as of January 7, 2026, by and among Eli Lilly and Company, RYLS Merger Corporation ("merger sub"), and Ventyx Biosciences, Inc. (the "merger agreement"); EXTRAORDINARY TRANSACTIONS ISSUER 172783.000000 0 FOR 172783.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 03/03/2026 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Ventyx Biosciences, Inc. to its named executive officers in connection with the merger of merger sub with and into Ventyx Biosciences, Inc.; and SECTION 14A SAY-ON-PAY VOTES ISSUER 172783.000000 0 FOR 172783.000000 FOR S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 03/03/2026 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Ventyx Biosciences, Inc. to its named executive officers in connection with the merger of merger sub with and into Ventyx Biosciences, Inc.; and SECTION 14A SAY-ON-PAY VOTES ISSUER 172783.000000 0 FOR 172783.000000 FOR 2 S000004450 Ventyx Biosciences, Inc. 92332V107 US92332V1070 03/03/2026 To adjourn the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the special meeting. CORPORATE GOVERNANCE ISSUER 172783.000000 0 FOR 172783.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Werner Baumann DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Frank K. Clyburn DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Ellen G. Cooper DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: D. Mark Durcan DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Lon R. Greenberg DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Lorence H. Kim, M.D. DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Robert P. Mauch DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Redonda G. Miller, M.D. DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Dennis M. Nally DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Lori J. Ryerkerk DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Election of eleven directors: Lauren M. Tyler DIRECTOR ELECTIONS ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Advisory vote to approve the fiscal 2025 compensation of Cencora, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 555943.000000 0 FOR 555943.000000 FOR 2 S000004450 Cencora, Inc. 03073E105 US03073E1055 03/05/2026 Ratify the appointment of Ernst & Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 555943.000000 0 FOR 555943.000000 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 03/17/2026 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); and CAPITAL STRUCTURE ISSUER 931715.240560 0 FOR 931715.240560 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 03/17/2026 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal. CORPORATE GOVERNANCE ISSUER 931715.240560 0 FOR 931715.240560 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Judy Gawlik Brown DIRECTOR ELECTIONS ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Sue H. Rataj DIRECTOR ELECTIONS ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: George A. Scangos, Ph.D. DIRECTOR ELECTIONS ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Dow R. Wilson DIRECTOR ELECTIONS ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 856604.000000 0 FOR 856604.000000 FOR 2 S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. AUDIT-RELATED ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Agilent Technologies, Inc. 00846U101 US00846U1016 03/18/2026 To approve an amendment to Agilent's Third Amended and Restated Certificate of Incorporation to declassify the Board of Directors over a three-year period. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 856604.000000 0 FOR 856604.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Christopher Anzalone DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Mauro Ferrari DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Hongbo Lu DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Adeoye Olukotun DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Michael S. Perry DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: Victoria Vakiener DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Election of Directors: William Waddill DIRECTOR ELECTIONS ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 376006.000000 0 AGAINST 376006.000000 AGAINST S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Advisory Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 376006.000000 0 AGAINST 376006.000000 AGAINST 2 S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan. COMPENSATION ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 Arrowhead Pharmaceuticals, Inc. 04280A100 US04280A1007 03/19/2026 Ratification of the selection of KPMG LLP as independent auditors of the Company for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 376006.000000 0 FOR 376006.000000 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Election of Directors: Albert G. White III DIRECTOR ELECTIONS ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 594062.544740 0 FOR 594062.544740 FOR S000004450 The Cooper Companies, Inc. 216648501 US2166485019 04/07/2026 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 594062.544740 0 FOR 594062.544740 FOR 2 S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Jerome Durso DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: John M. Gill DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Philip L. Hodges DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Diane Jorkasky, M.D. DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Teri Lawver DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Wayne Pisano DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Mitchel Sayare, Ph.D. DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Klaus O. Schafer, M.D., MPH DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to elect the nine nominees named in the attached Proxy Statement as members of the Company's Board of Directors for terms expiring at the 2027 Annual Meeting of Stockholders: Catherine Sohn, Pharm D DIRECTOR ELECTIONS ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Hold an advisory vote on compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 309359.305140 0 FOR 309359.305140 FOR 2 S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock. CAPITAL STRUCTURE ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan. COMPENSATION ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Altimmune, Inc. 02155H200 US02155H2004 04/16/2026 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 309359.305140 0 FOR 309359.305140 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR 2 S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 357480.250000 0.000000 FOR 357480.250000 FOR S000004450 Humana Inc. 444859102 US4448591028 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. COMPENSATION SECURITY HOLDER 357480.250000 0.000000 AGAINST 357480.250000 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Gary D. Blackford DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): William P. Burke DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): James L. Cunniff DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Lisa Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Indrani L. Franchini DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Patrick J. O'Leary DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): David C. Pacitti DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Julie Shimer DIRECTOR ELECTIONS ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 139490.703940 0 FOR 139490.703940 FOR 2 S000004450 Avanos Medical, Inc. 05350V106 US05350V1061 04/21/2026 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. COMPENSATION ISSUER 139490.703940 0 FOR 139490.703940 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 55539.384500 0 FOR 55539.384500 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 55539.384500 0 FOR 55539.384500 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 55539.384500 0 FOR 55539.384500 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 55539.384500 0 FOR 55539.384500 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 55539.384500 0 FOR 55539.384500 FOR 2 S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 55539.384500 0 FOR 55539.384500 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 US0905722072 04/21/2026 Stockholder proposal regarding dual class capital structure. SHAREHOLDER RIGHTS AND DEFENSES CAPITAL STRUCTURE SECURITY HOLDER 55539.384500 0 FOR 55539.384500 AGAINST S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR 2 S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 712865.000000 0.000000 FOR 712865.000000 FOR S000004450 The Cigna Group 125523100 US1255231003 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent CORPORATE GOVERNANCE SECURITY HOLDER 712865.000000 0.000000 AGAINST 712865.000000 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 486801.466530 0 FOR 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 486801.466530 0 FOR 486801.466530 FOR 2 S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 486801.466530 0 AGAINST 486801.466530 FOR S000004450 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 486801.466530 0 AGAINST 486801.466530 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Ari Bousbib DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Carol J. Burt DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): John G. Danhakl DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): James A. Fasano DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 The election of each of the director nominees listed below (a through i): Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 505257.783670 0 FOR 505257.783670 FOR 2 S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 505257.783670 0 FOR 505257.783670 FOR S000004450 IQVIA Holdings Inc. 46266C105 US46266C1053 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 505257.783670 0 AGAINST 505257.783670 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: John G. Morikis DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 7060750.363830 0 FOR 7060750.363830 FOR 2 S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 7060750.363830 0 FOR 7060750.363830 FOR S000004450 Johnson & Johnson 478160104 US4781601046 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 7060750.363830 0 AGAINST 7060750.363830 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 16902018.895940 0 FOR 16902018.895940 FOR S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 16902018.895940 0 FOR 16902018.895940 FOR 2 S000004450 Pfizer Inc. 717081103 US7170811035 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 16902018.895940 0 AGAINST 16902018.895940 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Election of Class II directors: Parvinderjit S. Khanuja DIRECTOR ELECTIONS ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Election of Class II directors: Robert A. Ortenzio DIRECTOR ELECTIONS ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Election of Class II directors: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 332173.421000 0 FOR 332173.421000 FOR 2 S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Amendment to the Company's Amended and Restated Certificate of Incorporation to phase out the classified structure of the Board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. CORPORATE GOVERNANCE ISSUER 332173.421000 0 FOR 332173.421000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 332173.421000 0 AGAINST 332173.421000 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5174027.361300 0 FOR 5174027.361300 FOR 2 S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 5174027.361300 0 FOR 5174027.361300 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan DIRECTOR ELECTIONS ISSUER 388668.775040 0 FOR 388668.775040 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 388668.775040 0 FOR 388668.775040 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin DIRECTOR ELECTIONS ISSUER 388668.775040 0 FOR 388668.775040 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. AUDIT-RELATED ISSUER 388668.775040 0 FOR 388668.775040 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 388668.775040 0 FOR 388668.775040 FOR S000004450 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 388668.775040 0 FOR 388668.775040 FOR 2 S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To elect ten nominees for director for terms of one year each: Pascale Witz DIRECTOR ELECTIONS ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 338303.308600 0 FOR 338303.308600 FOR 2 S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To approve an amendment to Revvity's Amended and Restated By-Laws to Allow Shareholders Owning 25% of Our Stock to Call a Special Meeting. CORPORATE GOVERNANCE ISSUER 338303.308600 0 FOR 338303.308600 FOR S000004450 Revvity, Inc. 714046109 US7140461093 04/28/2026 To approve the shareholder proposal regarding Executives to Retain Significant Stock. COMPENSATION SECURITY HOLDER 338303.308600 0 AGAINST 338303.308600 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Election of the four Class III nominees named in the proxy statement to our Board of Directors: Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Election of the four Class III nominees named in the proxy statement to our Board of Directors: Michael S. Klein DIRECTOR ELECTIONS ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Election of the four Class III nominees named in the proxy statement to our Board of Directors: Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Election of the four Class III nominees named in the proxy statement to our Board of Directors: Dale A. White DIRECTOR ELECTIONS ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17134.229520 0 FOR 17134.229520 FOR S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17134.229520 0 FOR 17134.229520 FOR 2 S000004450 Claritev Corporation 62548M209 US62548M2098 04/29/2026 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 17134.229520 0 AGAINST 17134.229520 AGAINST S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal DIRECTOR ELECTIONS ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To elect four Class II directors to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa DIRECTOR ELECTIONS ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157764.095880 0 FOR 157764.095880 FOR 2 S000004450 Emergent BioSolutions Inc. 29089Q105 US29089Q1058 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 157764.095880 0 FOR 157764.095880 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Alan L. Rubino DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Heidi Hagen DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Paul K. Wotton DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 Election of Directors: Lisa Wright DIRECTOR ELECTIONS ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 150208.891800 0 FOR 150208.891800 FOR 2 S000004450 Vericel Corporation 92346J108 US92346J1088 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 150208.891800 0 FOR 150208.891800 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4412609.128560 0 FOR 4412609.128560 FOR 2 S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 4412609.128560 0 FOR 4412609.128560 FOR S000004450 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 4412609.128560 0 AGAINST 4412609.128560 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Vipin Gopal DIRECTOR ELECTIONS ISSUER 344366.121350 0 FOR 344366.121350 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: William K. Newton DIRECTOR ELECTIONS ISSUER 344366.121350 0 FOR 344366.121350 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins DIRECTOR ELECTIONS ISSUER 344366.121350 0 FOR 344366.121350 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 344366.121350 0 FOR 344366.121350 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 344366.121350 0 FOR 344366.121350 FOR 2 S000004450 Concentra Group Holdings Parent, Inc. 20603L102 US20603L1026 04/30/2026 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 344366.121350 0 FOR 344366.121350 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3692958.629640 0 FOR 3692958.629640 FOR 2 S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 3692958.629640 0 FOR 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 3692958.629640 0 AGAINST 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 3692958.629640 0 AGAINST 3692958.629640 FOR S000004450 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 3692958.629640 0 AGAINST 3692958.629640 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Gary L. Ellis DIRECTOR ELECTIONS ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Election of Class II Directors: Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 83446.618100 0 FOR 83446.618100 FOR 2 S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 83446.618100 0 ONE YEAR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 83446.618100 0 ONE YEAR 83446.618100 FOR 2 S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Inspire Medical Systems, Inc. 457730109 US4577301090 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 83446.618100 0 FOR 83446.618100 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1056978.284700 0 FOR 1056978.284700 FOR 2 S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 1056978.284700 0 FOR 1056978.284700 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors: Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors: Mr. Heinz Mausli DIRECTOR ELECTIONS ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors: Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The election of four Class II directors to our Board of Directors: Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 197083.205880 0 FOR 197083.205880 FOR 2 S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 197083.205880 0 ONE YEAR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 197083.205880 0 ONE YEAR 197083.205880 FOR 2 S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lantheus Holdings, Inc. 516544103 US5165441032 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 197083.205880 0 FOR 197083.205880 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Election of Directors: Samuel L. Barker, Ph.D. DIRECTOR ELECTIONS ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Election of Directors: Christopher J. Sobecki DIRECTOR ELECTIONS ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Election of Directors: Judith L. Swain, M.D. DIRECTOR ELECTIONS ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Ratification and approval of the Company's Seventh Amended and Restated Certificate of Incorporation CAPITAL STRUCTURE ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Approval of the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Approval of the Company's 2026 Non-Employee Directors' Equity Incentive Plan COMPENSATION ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 542454.354840 0 FOR 542454.354840 FOR 2 S000004450 Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 04/30/2026 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 542454.354840 0 FOR 542454.354840 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Donal O'Connor DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To elect, by separate resolutions, nine director nominees to serve until the 2027 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor; AUDIT-RELATED ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To provide advisory approval of the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To provide advisory approval of the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 408787.537500 0 FOR 408787.537500 FOR 2 S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan; COMPENSATION ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to issue shares under Irish law; and CAPITAL STRUCTURE ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 Perrigo Company plc G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 408787.537500 0 FOR 408787.537500 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Cary S. Grace DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: James H. Hinton DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Celia P. Huber DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Eric P. Palmer DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 Election of Directors: Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114746.311680 0 FOR 114746.311680 FOR 2 S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 114746.311680 0 FOR 114746.311680 FOR S000004450 AMN Healthcare Services, Inc. 001744101 US0017441017 05/01/2026 A shareholder proposal entitled: "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 114746.311680 0 AGAINST 114746.311680 FOR S000004450 Masimo Corporation 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo Corporation ("Masimo"), Danaher Corporation ("Danaher"), and Mobius Merger Sub, Inc., a wholly owned subsidiary of Danaher ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Masimo, with Masimo surviving the merger as a wholly owned subsidiary of Danaher (the "Merger" and such proposal, the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 135307.490400 0 FOR 135307.490400 FOR S000004450 Masimo Corporation 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 135307.490400 0 FOR 135307.490400 FOR S000004450 Masimo Corporation 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 135307.490400 0 FOR 135307.490400 FOR 2 S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2391584.839260 0 FOR 2391584.839260 FOR 2 S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 2391584.839260 0 FOR 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 2391584.839260 0 AGAINST 2391584.839260 FOR S000004450 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 2391584.839260 0 AGAINST 2391584.839260 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Elect five directors to serve until the 2027 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Elect five directors to serve until the 2027 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Elect five directors to serve until the 2027 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Elect five directors to serve until the 2027 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Elect five directors to serve until the 2027 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 210987.434690 0 FOR 210987.434690 FOR 2 S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 Innoviva, Inc. 45781M101 US45781M1018 05/04/2026 Approval of the 2026 Equity Incentive Plan. COMPENSATION ISSUER 210987.434690 0 FOR 210987.434690 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 213735.560000 0 FOR 213735.560000 FOR 2 S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 213735.560000 0 FOR 213735.560000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 US9553061055 05/04/2026 Shareholder proposal regarding an independent Board Chair policy. CORPORATE GOVERNANCE SECURITY HOLDER 213735.560000 0 AGAINST 213735.560000 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Andrew P. Hider DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 1528061.946120 0 FOR 1528061.946120 FOR 2 S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Baxter International Inc. 071813109 US0718131099 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size CORPORATE GOVERNANCE ISSUER 1528061.946120 0 FOR 1528061.946120 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 6053929.419180 0 FOR 6053929.419180 FOR 2 S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 6053929.419180 0 FOR 6053929.419180 FOR S000004450 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 6053929.419180 0 AGAINST 6053929.419180 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Steven Barg DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Mark Enyedy DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Birgit Girshick DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Paul Graves DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: George Llado DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Martin Mackay DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Election of Directors: Virginia Wilson DIRECTOR ELECTIONS ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 146329.577400 0 FOR 146329.577400 FOR 2 S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 2026 Long-Term Incentive Plan COMPENSATION ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Charles River Laboratories International, Inc. 159864107 US1598641074 05/05/2026 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 146329.577400 0 FOR 146329.577400 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1892212.632840 0 FOR 1892212.632840 FOR 2 S000004450 Danaher Corporation 235851102 US2358511028 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 1892212.632840 0 FOR 1892212.632840 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman DIRECTOR ELECTIONS ISSUER 59094.346660 0 FOR 59094.346660 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis DIRECTOR ELECTIONS ISSUER 59094.346660 0 FOR 59094.346660 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59094.346660 0 FOR 59094.346660 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59094.346660 0 FOR 59094.346660 FOR 2 S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59094.346660 0 ONE YEAR 59094.346660 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59094.346660 0 ONE YEAR 59094.346660 FOR 2 S000004450 Guardian Pharmacy Services, Inc. 40145W101 US40145W1018 05/05/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 59094.346660 0 FOR 59094.346660 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/05/2026 Election of Class I Directors: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 350026.909390 0 FOR 350026.909390 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/05/2026 Election of Class I Directors: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 350026.909390 0 FOR 350026.909390 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 350026.909390 0 FOR 350026.909390 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 350026.909390 0 FOR 350026.909390 FOR 2 S000004450 Halozyme Therapeutics, Inc. 40637H109 US40637H1095 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 350026.909390 0 FOR 350026.909390 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Patrice A. Harris, M.D., M.A. DIRECTOR ELECTIONS ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Election of Directors: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 260783.795230 0 FOR 260783.795230 FOR 2 S000004450 Acadia Healthcare Company, Inc. 00404A109 US00404A1097 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 260783.795230 0 FOR 260783.795230 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Jeff George DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: John Kiely DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Paul Meister DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Ted Nark DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Chintu Patel DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Chirag Patel DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Gautam Patel DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Election of Directors: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 468214.018620 0 FOR 468214.018620 FOR 2 S000004450 Amneal Pharmaceuticals, Inc. 03168L105 US03168L1052 05/06/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 468214.018620 0 FOR 468214.018620 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 903312.663740 0 FOR 903312.663740 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas Hussain DIRECTOR ELECTIONS ISSUER 903312.663740 0 FOR 903312.663740 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 903312.663740 0 FOR 903312.663740 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 903312.663740 0 FOR 903312.663740 FOR 2 S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 903312.663740 0 ONE YEAR 903312.663740 FOR S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 903312.663740 0 ONE YEAR 903312.663740 FOR 2 S000004450 Moderna, Inc. 60770K107 US60770K1079 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 903312.663740 0 FOR 903312.663740 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Francis S. Soistman DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR 2 S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Molina Healthcare, Inc. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. CORPORATE GOVERNANCE ISSUER 153015.596540 0.000000 FOR 153015.596540 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/06/2026 To approve and adopt the Merger Agreement; EXTRAORDINARY TRANSACTIONS ISSUER 110242.138270 0 FOR 110242.138270 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 110242.138270 0 FOR 110242.138270 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger; and SECTION 14A SAY-ON-PAY VOTES ISSUER 110242.138270 0 FOR 110242.138270 FOR 2 S000004450 Penumbra, Inc. 70975L107 US70975L1070 05/06/2026 To adjourn or postpone the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to the accompanying proxy statement/prospectus is timely provided to Penumbra Stockholders. CORPORATE GOVERNANCE ISSUER 110242.138270 0 FOR 110242.138270 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Election Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1023883.409240 0 FOR 1023883.409240 FOR S000004450 Stryker Corporation 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1023883.409240 0 FOR 1023883.409240 FOR 2 S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: William W. Burke DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Valerie L. Asbury DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Sheri L. Dodd DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Raymond O. Huggenberger DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Laura G. King DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Andrea A. Pearson DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: D. Brent Shafer DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: Carmen B. Volkart DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Elect nine directors: B. Vindell Washington DIRECTOR ELECTIONS ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 66029.903280 0 FOR 66029.903280 FOR 2 S000004450 Tactile Systems Technology, Inc. 87357P100 US87357P1003 05/06/2026 Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 66029.903280 0 FOR 66029.903280 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Simon Dingemans DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Gregory Lucier DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2024299.448720 0 FOR 2024299.448720 FOR 2 S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2024299.448720 0 ONE YEAR 2024299.448720 FOR S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2024299.448720 0 ONE YEAR 2024299.448720 FOR 2 S000004450 Avantor, Inc. 05352A100 US05352A1007 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 2024299.448720 0 FOR 2024299.448720 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1725697.779580 0 FOR 1725697.779580 FOR 2 S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 1725697.779580 0 FOR 1725697.779580 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Election of ten nominees to the Board of Directors to serve until our 2027 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 299364.456410 0 FOR 299364.456410 FOR S000004450 Encompass Health Corporation 29261A100 US29261A1007 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 299364.456410 0 FOR 299364.456410 FOR 2 S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 1355546.390570 0 FOR 1355546.390570 FOR 2 S000004450 GE Healthcare Technologies, Inc. 36266G107 US36266G1076 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026, AUDIT-RELATED ISSUER 1355546.390570 0 FOR 1355546.390570 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade DIRECTOR ELECTIONS ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026. AUDIT-RELATED ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 197113.954780 0 FOR 197113.954780 FOR 2 S000004450 Integra LifeSciences Holdings Corporation 457985208 US4579852082 05/07/2026 To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 197113.954780 0 FOR 197113.954780 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Pablo Perversi DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Brian Shepherd DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Election of Directors: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Ratification of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 60764.887400 0 FOR 60764.887400 FOR S000004450 Mettler-Toledo International Inc. 592688105 US5926881054 05/07/2026 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 60764.887400 0 FOR 60764.887400 FOR 2 S000004450 National HealthCare Corporation 635906100 US6359061008 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Emil E. Hassan DIRECTOR ELECTIONS ISSUER 39308.906540 0 FOR 39308.906540 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: Lisa Piercey, M.D. DIRECTOR ELECTIONS ISSUER 39308.906540 0 FOR 39308.906540 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified: William A. Adams DIRECTOR ELECTIONS ISSUER 39308.906540 0 FOR 39308.906540 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 39308.906540 0 FOR 39308.906540 FOR S000004450 National HealthCare Corporation 635906100 US6359061008 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 39308.906540 0 FOR 39308.906540 FOR 2 S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman, M.D. DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year; AUDIT-RELATED ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year; and SECTION 14A SAY-ON-PAY VOTES ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year; and SECTION 14A SAY-ON-PAY VOTES ISSUER 255147.273540 0 FOR 255147.273540 FOR 2 S000004450 Pediatrix Medical Group, Inc. 58502B106 US58502B1061 05/07/2026 Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan COMPENSATION ISSUER 255147.273540 0 FOR 255147.273540 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5258146.072240 0 FOR 5258146.072240 FOR 2 S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 5258146.072240 0 FOR 5258146.072240 FOR S000004450 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 5258146.072240 0 AGAINST 5258146.072240 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: Kevin C. Clark DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: Dwayne Allen DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: Venkat Bhamidipati DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: W. Larry Cash DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: Gale Fitzgerald DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to elect six directors for terms expiring at the 2027 annual meeting: Janice E. Nevin, M.D., MPH DIRECTOR ELECTIONS ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to approve, on a non-binding, advisory basis, the 2025 compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to approve, on a non-binding, advisory basis, the 2025 compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 87548.396300 0 FOR 87548.396300 FOR 2 S000004450 Cross Country Healthcare, Inc. 227483104 US2274831047 05/11/2026 Proposal to approve an amendment and restatement of the Cross Country Healthcare, Inc. 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 87548.396300 0 FOR 87548.396300 FOR S000004450 Zenas BioPharma, Inc. 98937L105 US98937L1052 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan DIRECTOR ELECTIONS ISSUER 47562.053490 0 FOR 47562.053490 FOR S000004450 Zenas BioPharma, Inc. 98937L105 US98937L1052 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick Enright DIRECTOR ELECTIONS ISSUER 47562.053490 0 FOR 47562.053490 FOR S000004450 Zenas BioPharma, Inc. 98937L105 US98937L1052 05/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 47562.053490 0 FOR 47562.053490 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: James W. Bullock DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Jon W. Salveson DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 ELECTION OF DIRECTORS: Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 118988.067600 0 FOR 118988.067600 FOR 2 S000004450 Artivion, Inc. 228903100 US2289031005 05/12/2026 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 118988.067600 0 FOR 118988.067600 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: H. James Dallas DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Monte E. Ford DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Sarah M. London DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ELECTION OF DIRECTORS: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. SECTION 14A SAY-ON-PAY VOTES ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR 2 S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026. AUDIT-RELATED ISSUER 1459296.321320 0.000000 FOR 1459296.321320 FOR S000004450 Centene Corporation 15135B101 US15135B1017 05/12/2026 STOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. CORPORATE GOVERNANCE SECURITY HOLDER 1459296.321320 0.000000 AGAINST 1459296.321320 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Kevin J. Hammons DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 377828.738900 0 FOR 377828.738900 FOR 2 S000004450 Community Health Systems, Inc. 203668108 US2036681086 05/12/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 377828.738900 0 FOR 377828.738900 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 05/12/2026 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 22, 2026, by and among Enhabit, Inc. ("Enhabit"), Anchor Parent, LLC, a Delaware limited liability company ("Parent"), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Enhabit, with Enhabit surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 128087.562810 0 FOR 128087.562810 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 128087.562810 0 FOR 128087.562810 FOR S000004450 Enhabit, Inc. 29332G102 US29332G1022 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 128087.562810 0 FOR 128087.562810 FOR 2 S000004450 Enhabit, Inc. 29332G102 US29332G1022 05/12/2026 Approval of the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes virtually or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 128087.562810 0 FOR 128087.562810 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One): Daniel M. Junius DIRECTOR ELECTIONS ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One): Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Election of Directors (Proposal One): Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 237112.011400 0 FOR 237112.011400 FOR 2 S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting (Proposal Five). CORPORATE GOVERNANCE ISSUER 237112.011400 0 FOR 237112.011400 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). CORPORATE GOVERNANCE SECURITY HOLDER 237112.011400 0 AGAINST 237112.011400 FOR S000004450 Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Election of Directors: Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 157491.979000 0 FOR 157491.979000 FOR S000004450 Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Election of Directors: Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 157491.979000 0 FOR 157491.979000 FOR S000004450 Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 157491.979000 0 FOR 157491.979000 FOR S000004450 Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 157491.979000 0 FOR 157491.979000 FOR S000004450 Personalis, Inc. 71535D106 US71535D1063 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 157491.979000 0 FOR 157491.979000 FOR 2 S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR 2 S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 330854.000000 0.000000 FOR 330854.000000 FOR S000004450 Elevance Health, Inc. 036752103 US0367521038 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 330854.000000 0.000000 AGAINST 330854.000000 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: Vivek Jain DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: David C. Greenberg DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: Donald M. Abbey DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: Laurie Hernandez DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 Election of Directors: Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 69783.566640 0 FOR 69783.566640 FOR 2 S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. CORPORATE GOVERNANCE ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. CORPORATE GOVERNANCE ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 69783.566640 0 FOR 69783.566640 FOR S000004450 ICU Medical, Inc. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. CORPORATE GOVERNANCE SECURITY HOLDER 69783.566640 0 AGAINST 69783.566640 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Dr. David Wheadon DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Joe Ciaffoni DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Dr. Keith Humphreys DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Tony Kingsley DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Daniel Ninivaggi DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Barbara Ryan DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Mark Stejbach DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 Election of Directors: Juliet Thompson DIRECTOR ELECTIONS ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314454.786000 0 FOR 314454.786000 FOR 2 S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314454.786000 0 ONE YEAR 314454.786000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314454.786000 0 ONE YEAR 314454.786000 FOR 2 S000004450 Indivior Pharmaceuticals, Inc. 45579U109 US45579U1097 05/13/2026 To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 314454.786000 0 FOR 314454.786000 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2026 Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 634972.467960 0 FOR 634972.467960 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2026 Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D. DIRECTOR ELECTIONS ISSUER 634972.467960 0 FOR 634972.467960 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 634972.467960 0 FOR 634972.467960 FOR S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 634972.467960 0 FOR 634972.467960 FOR 2 S000004450 Insmed Incorporated 457669307 US4576693075 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 634972.467960 0 FOR 634972.467960 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Martha G. Aronson (three (3) year term) DIRECTOR ELECTIONS ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) DIRECTOR ELECTIONS ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) DIRECTOR ELECTIONS ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Scott R. Ward (three (3) year term) DIRECTOR ELECTIONS ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 175992.230520 0 FOR 175992.230520 FOR 2 S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 Merit Medical Systems, Inc. 589889104 US5898891040 05/13/2026 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 175992.230520 0 FOR 175992.230520 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Mr. Barry M. Smith DIRECTOR ELECTIONS ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Ms. Swati B. Abbott DIRECTOR ELECTIONS ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTORS EACH FOR A THREE-YEAR TERM as follows: Ms. Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS II DIRECTOR FOR AN INITIAL ONE-YEAR TERM as follows: Ms. Marivic Uychiat Pison DIRECTOR ELECTIONS ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 Approval, on an advisory basis, of our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 171843.314700 0 FOR 171843.314700 FOR S000004450 The Ensign Group, Inc. 29358P101 US29358P1012 05/13/2026 Approval, on an advisory basis, of our named executive officers' compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 171843.314700 0 FOR 171843.314700 FOR 2 S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 753428.948000 0 FOR 753428.948000 FOR 2 S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 753428.948000 0 FOR 753428.948000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 753428.948000 0 AGAINST 753428.948000 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Non-binding advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Non-binding advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 183059.725200 0 FOR 183059.725200 FOR 2 S000004450 Accendra Health, Inc. 690732102 US6907321029 05/14/2026 Approval of the Accendera Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 183059.725200 0 FOR 183059.725200 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Richard E. Buller DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: David F. Dalvey DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Leo T. Furcht DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Lance G. Laing DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Polly A. Murphy DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Richard J. Nigon DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Charles R. Romp DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 Elect eight directors: Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 61690.206120 0 FOR 61690.206120 FOR 2 S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Celcuity Inc. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 61690.206120 0 FOR 61690.206120 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 To elect the three Class III directors named in our Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Arjun Bedi DIRECTOR ELECTIONS ISSUER 356921.297160 0 FOR 356921.297160 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 To elect the three Class III directors named in our Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Stephen McLean DIRECTOR ELECTIONS ISSUER 356921.297160 0 FOR 356921.297160 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 To elect the three Class III directors named in our Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Jon Resnick DIRECTOR ELECTIONS ISSUER 356921.297160 0 FOR 356921.297160 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 356921.297160 0 FOR 356921.297160 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. SECTION 14A SAY-ON-PAY VOTES ISSUER 356921.297160 0 FOR 356921.297160 FOR S000004450 Certara, Inc. 15687V109 US15687V1098 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. SECTION 14A SAY-ON-PAY VOTES ISSUER 356921.297160 0 FOR 356921.297160 FOR 2 S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Michael Donovan DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 93201.120000 0 FOR 93201.120000 FOR 2 S000004450 Collegium Pharmaceutical, Inc. 19459J104 US19459J1043 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 93201.120000 0 FOR 93201.120000 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR 2 S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 3769944.738400 0.000000 FOR 3769944.738400 FOR S000004450 CVS Health Corporation 126650100 US1266501006 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 3769944.738400 0.000000 AGAINST 3769944.738400 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 Election of Directors: Ming Hsieh DIRECTOR ELECTIONS ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 Election of Directors: Linda Dong DIRECTOR ELECTIONS ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 Election of Directors: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 Election of Directors: Regina Groves DIRECTOR ELECTIONS ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 58984.175880 0 FOR 58984.175880 FOR 2 S000004450 Fulgent Genetics, Inc. 359664109 US3596641098 05/14/2026 To approve the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 58984.175880 0 FOR 58984.175880 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Geno J. Germano DIRECTOR ELECTIONS ISSUER 127318.947140 0 FOR 127318.947140 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi DIRECTOR ELECTIONS ISSUER 127318.947140 0 WITHHOLD 127318.947140 AGAINST S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron Philip DIRECTOR ELECTIONS ISSUER 127318.947140 0 FOR 127318.947140 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Andreas Wicki, Ph.D. DIRECTOR ELECTIONS ISSUER 127318.947140 0 FOR 127318.947140 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 127318.947140 0 FOR 127318.947140 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 127318.947140 0 FOR 127318.947140 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 US4131971040 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 127318.947140 0 FOR 127318.947140 FOR 2 S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 136346.671000 0 FOR 136346.671000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. Selkoe DIRECTOR ELECTIONS ISSUER 136346.671000 0 FOR 136346.671000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2026 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 136346.671000 0 FOR 136346.671000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 136346.671000 0 FOR 136346.671000 FOR S000004450 Prothena Corporation plc G72800108 IE00B91XRN20 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 136346.671000 0 FOR 136346.671000 FOR 2 S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 158676.463000 0 FOR 158676.463000 FOR S000004450 Repligen Corporation 759916109 US7599161095 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 158676.463000 0 FOR 158676.463000 FOR 2 S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Election of Directors: Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 103045.316740 0 FOR 103045.316740 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Election of Directors: Brent J. Guerisoli DIRECTOR ELECTIONS ISSUER 103045.316740 0 FOR 103045.316740 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Election of Directors: John G. Nackel, Ph.D. DIRECTOR ELECTIONS ISSUER 103045.316740 0 FOR 103045.316740 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2026. AUDIT-RELATED ISSUER 103045.316740 0 FOR 103045.316740 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 103045.316740 0 FOR 103045.316740 FOR S000004450 The Pennant Group, Inc. 70805E109 US70805E1091 05/14/2026 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 103045.316740 0 FOR 103045.316740 FOR 2 S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Nominees: Emil D. Kakkis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Nominees: Shehnaaz Suliman, M.D. DIRECTOR ELECTIONS ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Nominees: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 257345.878580 0 FOR 257345.878580 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 257345.878580 0 FOR 257345.878580 FOR 2 S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 Election of Class III Directors: Krish S. Krishnan DIRECTOR ELECTIONS ISSUER 64629.111320 0 FOR 64629.111320 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 Election of Class III Directors: Christopher Mason DIRECTOR ELECTIONS ISSUER 64629.111320 0 FOR 64629.111320 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 64629.111320 0 FOR 64629.111320 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 64629.111320 0 FOR 64629.111320 FOR S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 64629.111320 0 FOR 64629.111320 FOR 2 S000004450 Krystal Biotech, Inc. 501147102 US5011471027 05/15/2026 Approval of the Company's Non-Employee Director Compensation Policy. COMPENSATION ISSUER 64629.111320 0 FOR 64629.111320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Election of Directors: Brian T. Carley DIRECTOR ELECTIONS ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Election of Directors: Femida H. Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Election of Directors: Robert O. Kraft DIRECTOR ELECTIONS ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Election of Directors: August J. Troendle DIRECTOR ELECTIONS ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Election of Directors: Dani S. Zander DIRECTOR ELECTIONS ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 66580.600320 0 FOR 66580.600320 FOR 2 S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 66580.600320 0 ONE YEAR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 66580.600320 0 ONE YEAR 66580.600320 FOR 2 S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. CORPORATE GOVERNANCE ISSUER 66580.600320 0 FOR 66580.600320 FOR S000004450 Medpace Holdings, Inc. 58506Q109 US58506Q1094 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 66580.600320 0 AGAINST 66580.600320 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 Election of Class III Directors: Arthur T. Sands, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 224684.827080 0 FOR 224684.827080 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 Election of Class III Directors: Roger Dansey, M.D. DIRECTOR ELECTIONS ISSUER 224684.827080 0 FOR 224684.827080 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 Election of Class III Directors: Paul M. Silva DIRECTOR ELECTIONS ISSUER 224684.827080 0 FOR 224684.827080 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026. AUDIT-RELATED ISSUER 224684.827080 0 FOR 224684.827080 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 224684.827080 0 FOR 224684.827080 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 US67080M1036 05/15/2026 To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 224684.827080 0 FOR 224684.827080 FOR 2 S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Charles Kummeth DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Paula Dowdy DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Ruth Fattori DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Amir Jafri DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Jack Kenny DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Brigid A. Makes DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Scott Mendel DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Kevin Rakin DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 536456.352240 0 FOR 536456.352240 FOR S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 536456.352240 0 AGAINST 536456.352240 AGAINST S000004450 Quantum-Si Incorporated 74765K105 US74765K1051 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 536456.352240 0 AGAINST 536456.352240 AGAINST 2 S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Election of Directors: Carlos Alban DIRECTOR ELECTIONS ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Election of Directors: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Election of Directors: Shirley Edwards DIRECTOR ELECTIONS ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Election of Directors: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 463129.961040 0 FOR 463129.961040 FOR 2 S000004450 Solventum Corporation 83444M101 US83444M1018 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 463129.961040 0 FOR 463129.961040 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Neena M. Patil DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Approval, on an advisory basis, of named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 131272.221120 0 FOR 131272.221120 FOR 2 S000004450 Teleflex Incorporated 879369106 US8793691069 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 131272.221120 0 FOR 131272.221120 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 3417188.650680 0 FOR 3417188.650680 FOR 2 S000004450 Viatris Inc. 92556V106 US92556V1061 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3417188.650680 0 FOR 3417188.650680 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Regina E. Groves DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Robert S. White DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Election of Directors: Maggie Yuen DIRECTOR ELECTIONS ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. COMPENSATION ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 148299.232070 0 FOR 148299.232070 FOR S000004450 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 148299.232070 0 FOR 148299.232070 FOR 2 S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 41968.520520 0 FOR 41968.520520 FOR S000004450 Chemed Corporation 16359R103 US16359R1032 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 41968.520520 0 FOR 41968.520520 FOR 2 S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: David Bronson DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: LaVerne H. Council DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: Charles M. Farkas DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: Mark Kaye DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: Kim Kelderman DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Election of seven directors to serve on the Company's Board of Directors: Barbara J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 92674.408200 0 FOR 92674.408200 FOR 2 S000004450 CONMED Corporation 207410101 US2074101013 05/18/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 92674.408200 0 FOR 92674.408200 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1598478.773640 0 FOR 1598478.773640 FOR 2 S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1598478.773640 0 FOR 1598478.773640 FOR S000004450 Amgen Inc. 031162100 US0311621009 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 1598478.773640 0 AGAINST 1598478.773640 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Damien McDonald DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Philip A. Okala DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Christine Ortiz DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Brady Shirley DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 Election of Directors: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 168414.533160 0 FOR 168414.533160 FOR 2 S000004450 Enovis Corporation 194014502 US1940145022 05/19/2026 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 168414.533160 0 FOR 168414.533160 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Wendy Carruthers DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Kieran Gallahue DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Scott Huennekens DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Vivek Jain DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Paul Keel DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: J. Andrew Pierce DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Daniel Raskas DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To elect the following nominees to serve as Directors, for a one-year term expiring at the 2027 annual meeting: Christine Tsingos DIRECTOR ELECTIONS ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 487527.694980 0 FOR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 487527.694980 0 FOR 487527.694980 FOR 2 S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 487527.694980 0 ONE YEAR 487527.694980 FOR S000004450 Envista Holdings Corporation 29415F104 US29415F1049 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 487527.694980 0 ONE YEAR 487527.694980 FOR 2 S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien DIRECTOR ELECTIONS ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser DIRECTOR ELECTIONS ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 152586.442120 0 FOR 152586.442120 FOR 2 S000004450 MacroGenics, Inc. 556099109 US5560991094 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 152586.442120 0 FOR 152586.442120 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer DIRECTOR ELECTIONS ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim DIRECTOR ELECTIONS ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick DIRECTOR ELECTIONS ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 132866.877010 0 FOR 132866.877010 FOR 2 S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates. CORPORATE GOVERNANCE ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Omnicell, Inc. 68213N109 US68213N1090 05/19/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 132866.877010 0 FOR 132866.877010 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta DIRECTOR ELECTIONS ISSUER 138747.221560 0 FOR 138747.221560 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder DIRECTOR ELECTIONS ISSUER 138747.221560 0 FOR 138747.221560 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse DIRECTOR ELECTIONS ISSUER 138747.221560 0 FOR 138747.221560 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 138747.221560 0 FOR 138747.221560 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 138747.221560 0 FOR 138747.221560 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 138747.221560 0 FOR 138747.221560 FOR 2 S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy Baynes DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Timothy Coughlin DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Eric Dube DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Gary Lyons DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: John Orwin DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Sandra Poole DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ron Squarer DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251924.722420 0 FOR 251924.722420 FOR 2 S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251924.722420 0 ONE YEAR 251924.722420 FOR S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251924.722420 0 ONE YEAR 251924.722420 FOR 2 S000004450 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 251924.722420 0 FOR 251924.722420 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Election of Directors: Lance A. Berry DIRECTOR ELECTIONS ISSUER 149711.035740 0 FOR 149711.035740 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Election of Directors: Elizabeth S. Hanna DIRECTOR ELECTIONS ISSUER 149711.035740 0 FOR 149711.035740 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Election of Directors: Jane E. Kiernan DIRECTOR ELECTIONS ISSUER 149711.035740 0 FOR 149711.035740 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149711.035740 0 FOR 149711.035740 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149711.035740 0 FOR 149711.035740 FOR 2 S000004450 Treace Medical Concepts, Inc. 89455T109 US89455T1097 05/19/2026 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 149711.035740 0 FOR 149711.035740 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Christopher J. Reading DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Regg E. Swanson DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Election of seven directors to serve until the next annual meeting of stockholders: Peter F. Minan DIRECTOR ELECTIONS ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 45288.020400 0 FOR 45288.020400 FOR 2 S000004450 U.S. Physical Therapy, Inc. 90337L108 US90337L1089 05/19/2026 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 45288.020400 0 FOR 45288.020400 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/19/2026 ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 318389.869200 0 FOR 318389.869200 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/19/2026 ELECTION OF DIRECTOR NOMINEES FOR CLASS II (term to expire in 2029): S. Kathryn Rouan, Ph.D. DIRECTOR ELECTIONS ISSUER 318389.869200 0 FOR 318389.869200 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/19/2026 TO RATIFY THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026. AUDIT-RELATED ISSUER 318389.869200 0 FOR 318389.869200 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 318389.869200 0 FOR 318389.869200 FOR S000004450 Viking Therapeutics, Inc. 92686J106 US92686J1060 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES ISSUER 318389.869200 0 FOR 318389.869200 FOR 2 S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Joseph Lacob DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Anne M. Myong DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 ELECTION OF DIRECTORS: Britt Vitalone DIRECTOR ELECTIONS ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 202396.415440 0 FOR 202396.415440 FOR 2 S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Align Technology, Inc. 016255101 US0162551016 05/20/2026 Ratification of Special Meeting Provision in our Bylaws CORPORATE GOVERNANCE ISSUER 202396.415440 0 FOR 202396.415440 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To elect as directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 465970.148740 0 FOR 465970.148740 FOR 2 S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 465970.148740 0 FOR 465970.148740 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To elect the following nominees as Class I directors of Alnylam: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 391770.217300 0 FOR 391770.217300 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 391770.217300 0 FOR 391770.217300 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 391770.217300 0 FOR 391770.217300 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 391770.217300 0 FOR 391770.217300 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 391770.217300 0 FOR 391770.217300 FOR 2 S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 391770.217300 0 FOR 391770.217300 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Mark Sotir DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Martin J. Bonick DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Peter Bulgarelli DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Peter Bynoe DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Suzanne Campion DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: William Goodyear DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Ellen Havdala DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Edmondo Robinson DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Rahul Sen DIRECTOR ELECTIONS ISSUER 84490.895610 0 WITHHOLD 84490.895610 AGAINST S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Election of Directors: Rob Webb DIRECTOR ELECTIONS ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 84490.895610 0 FOR 84490.895610 FOR 2 S000004450 Ardent Health, Inc. 03980N107 US03980N1072 05/20/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 84490.895610 0 FOR 84490.895610 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Susan M. Molineaux, Ph.D. DIRECTOR ELECTIONS ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Patricia S. Andrews DIRECTOR ELECTIONS ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To elect the three nominees for director named below to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders: Constantine Chinoporos DIRECTOR ELECTIONS ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement. COMPENSATION ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1422982.781330 0 FOR 1422982.781330 FOR 2 S000004450 Geron Corporation 374163103 US3741631036 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1422982.781330 0 FOR 1422982.781330 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Luciana Borio DIRECTOR ELECTIONS ISSUER 208661.169880 0 FOR 208661.169880 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Michael R. Minogue DIRECTOR ELECTIONS ISSUER 208661.169880 0 FOR 208661.169880 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 Election of Directors: Timothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 208661.169880 0 FOR 208661.169880 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 208661.169880 0 FOR 208661.169880 FOR S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 208661.169880 0 FOR 208661.169880 FOR 2 S000004450 Insulet Corporation 45784P101 US45784P1012 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 208661.169880 0 FOR 208661.169880 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Sheila Antrum DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: James F. Flanagan DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: James F. Hinrichs DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Aaron Kapito DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Payman Khales DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Filippo Passerini DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified: Donald J. Spence DIRECTOR ELECTIONS ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 104029.826400 0 FOR 104029.826400 FOR 2 S000004450 Integer Holdings Corporation 45826H109 US45826H1095 05/20/2026 To approve the Integer Holdings Corporation 2026 0mnibus Incentive Plan. COMPENSATION ISSUER 104029.826400 0 FOR 104029.826400 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: James S. Shannon, M.D., MRCP (UK) DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael E. Castagna, Pharm.D. DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Steven B. Binder DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Michael A. Friedman, M.D. DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Jennifer Grancio DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Anthony Hooper DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Sabrina Kay, Ed.D. DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected: Christine Mundkur DIRECTOR ELECTIONS ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in Mannkind's proxy statement for the Annual Meeting; SECTION 14A SAY-ON-PAY VOTES ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in Mannkind's proxy statement for the Annual Meeting; SECTION 14A SAY-ON-PAY VOTES ISSUER 864572.662060 0 FOR 864572.662060 FOR 2 S000004450 MannKind Corporation 56400P706 US56400P7069 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 864572.662060 0 FOR 864572.662060 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Eric K. Brandt DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Natasha Deckmann DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: R. Carter Pate DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: John C. Rademacher DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To elect nine nominees identified in the accompanying proxy statement to serve as directors: Norman L. Wright DIRECTOR ELECTIONS ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 470358.750400 0 FOR 470358.750400 FOR S000004450 Option Care Health, Inc. 68404L201 US68404L2016 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 470358.750400 0 FOR 470358.750400 FOR 2 S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy Cocozza DIRECTOR ELECTIONS ISSUER 292337.426440 0 FOR 292337.426440 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David King DIRECTOR ELECTIONS ISSUER 292337.426440 0 FOR 292337.426440 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To elect the three nominees listed in the accompanying proxy statement as Class I directors to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis Soistman DIRECTOR ELECTIONS ISSUER 292337.426440 0 FOR 292337.426440 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 292337.426440 0 FOR 292337.426440 FOR S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 292337.426440 0 FOR 292337.426440 FOR 2 S000004450 Privia Health Group, Inc. 74276R102 US74276R1023 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 292337.426440 0 FOR 292337.426440 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Robert B. Carter DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: James E. Davis DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Timothy L. Main DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Election of Directors: Timothy C. Wentworth DIRECTOR ELECTIONS ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 330141.297840 0 FOR 330141.297840 FOR 2 S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 330141.297840 0 FOR 330141.297840 FOR S000004450 Quest Diagnostics Incorporated 74834L100 US74834L1008 05/20/2026 Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 330141.297840 0 AGAINST 330141.297840 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Peter Fong, Ph.D. DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The ratification of the appointment of Eisner Amper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 240872.066600 0 FOR 240872.066600 FOR 2 S000004450 Rocket Pharmaceuticals, Inc. 77313F106 US77313F1066 05/20/2026 The approval of the proposed stock option exchange program; and COMPENSATION ISSUER 240872.066600 0 FOR 240872.066600 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 201104.346880 0 FOR 201104.346880 FOR 2 S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 US8753722037 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 201104.346880 0 FOR 201104.346880 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1114752.894360 0 AGAINST 1114752.894360 AGAINST S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1114752.894360 0 AGAINST 1114752.894360 AGAINST 2 S000004450 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 1114752.894360 0 FOR 1114752.894360 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Edward M. Basile DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: Merilee Raines DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 Election of Directors: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 96188.152200 0 FOR 96188.152200 FOR 2 S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. COMPENSATION ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 TransMedics Group, Inc. 89377M109 US89377M1099 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96188.152200 0 FOR 96188.152200 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Election of Director: Nina Chen-Langenmayr DIRECTOR ELECTIONS ISSUER 163946.509760 0 FOR 163946.509760 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 163946.509760 0 FOR 163946.509760 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 163946.509760 0 FOR 163946.509760 FOR 2 S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 163946.509760 0 FOR 163946.509760 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 163946.509760 0 AGAINST 163946.509760 FOR S000004450 Universal Health Services, Inc. 913903100 US9139031002 05/20/2026 Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 163946.509760 0 AGAINST 163946.509760 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Election of Directors: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1305665.079330 0 FOR 1305665.079330 FOR 2 S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1305665.079330 0 ONE YEAR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1305665.079330 0 ONE YEAR 1305665.079330 FOR 2 S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1305665.079330 0 FOR 1305665.079330 FOR S000004450 Zoetis Inc. 98978V103 US98978V1035 05/20/2026 Shareholder proposal to permit shareholder action by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 1305665.079330 0 AGAINST 1305665.079330 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 53525.026700 0 FOR 53525.026700 FOR 2 S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 53525.026700 0 ONE YEAR 53525.026700 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 53525.026700 0 ONE YEAR 53525.026700 FOR 2 S000004450 ANI Pharmaceuticals, Inc. 00182C103 US00182C1036 05/21/2026 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 53525.026700 0 FOR 53525.026700 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Election of Class II directors: Olivia Kirtley DIRECTOR ELECTIONS ISSUER 426569.386260 0 FOR 426569.386260 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Election of Class II directors: Max Lin DIRECTOR ELECTIONS ISSUER 426569.386260 0 FOR 426569.386260 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Election of Class II directors: Steve Miller DIRECTOR ELECTIONS ISSUER 426569.386260 0 FOR 426569.386260 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 426569.386260 0 FOR 426569.386260 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 426569.386260 0 FOR 426569.386260 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 US10950A1060 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 426569.386260 0 FOR 426569.386260 FOR 2 S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Election of four Class II directors to serve for a three-year term expiring in 2028: John J. (Jack) Phillips DIRECTOR ELECTIONS ISSUER 314633.022420 0 FOR 314633.022420 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Election of four Class II directors to serve for a three-year term expiring in 2028: Hermann F. Requardt, Ph.D. DIRECTOR ELECTIONS ISSUER 314633.022420 0 FOR 314633.022420 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Election of four Class II directors to serve for a three-year term expiring in 2028: Laura A. Francis DIRECTOR ELECTIONS ISSUER 314633.022420 0 FOR 314633.022420 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 314633.022420 0 FOR 314633.022420 FOR S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 314633.022420 0 FOR 314633.022420 FOR 2 S000004450 Bruker Corporation 116794108 US1167941087 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 314633.022420 0 FOR 314633.022420 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: Gregg Alton DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: David L. Mahoney DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: Kimberly Park DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 Election of Directors: James N. Wilson DIRECTOR ELECTIONS ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 280244.746080 0 FOR 280244.746080 FOR 2 S000004450 Corcept Therapeutics Incorporated 218352102 US2183521028 05/21/2026 To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. COMPENSATION ISSUER 280244.746080 0 FOR 280244.746080 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 103561.105260 0 FOR 103561.105260 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 103561.105260 0 FOR 103561.105260 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 103561.105260 0 FOR 103561.105260 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 103561.105260 0 FOR 103561.105260 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 103561.105260 0 FOR 103561.105260 FOR 2 S000004450 Dianthus Therapeutics, Inc. 252828108 US2528281080 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 103561.105260 0 FOR 103561.105260 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand DIRECTOR ELECTIONS ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herendeen DIRECTOR ELECTIONS ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Harrington DIRECTOR ELECTIONS ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDonald DIRECTOR ELECTIONS ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1474629.437270 0 FOR 1474629.437270 FOR S000004450 Elanco Animal Health Incorporated 28414H103 US28414H1032 05/21/2026 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1474629.437270 0 FOR 1474629.437270 FOR 2 S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Mohamad Ali DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Deborah Derby DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Carole T. Faig DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Max Lin DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Election of Incumbent Directors: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 314602.889240 0 FOR 314602.889240 FOR 2 S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 314602.889240 0 FOR 314602.889240 FOR S000004450 Henry Schein, Inc. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 314602.889240 0 FOR 314602.889240 AGAINST S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: David P. King DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Keith A. Meister DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Anna Richo DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 Election of Directors: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 452946.564180 0 FOR 452946.564180 FOR S000004450 Illumina, Inc. 452327109 US4523271090 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 452946.564180 0 FOR 452946.564180 FOR 2 S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Victor Bulto DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 245692.410700 0 FOR 245692.410700 FOR 2 S000004450 Labcorp Holdings Inc. 504922105 US5049221055 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 245692.410700 0 FOR 245692.410700 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 134755.861800 0 WITHHOLD 134755.861800 AGAINST S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 134755.861800 0 FOR 134755.861800 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 134755.861800 0 FOR 134755.861800 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 US6031701013 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 134755.861800 0 FOR 134755.861800 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: John P. Kenny DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 385219.177580 0 FOR 385219.177580 FOR 2 S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 NeoGenomics, Inc. 64049M209 US64049M2098 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 385219.177580 0 FOR 385219.177580 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2026 Election of Directors: Robert Bazemore DIRECTOR ELECTIONS ISSUER 657548.434900 0 FOR 657548.434900 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2026 Election of Directors: Robert Mashal, M.D. DIRECTOR ELECTIONS ISSUER 657548.434900 0 FOR 657548.434900 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 657548.434900 0 FOR 657548.434900 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 657548.434900 0 FOR 657548.434900 FOR S000004450 Nuvation Bio Inc. 67080N101 US67080N1019 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 657548.434900 0 FOR 657548.434900 FOR 2 S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Election of Directors: Lloyd Dean DIRECTOR ELECTIONS ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Election of Directors: Kevin Gordon DIRECTOR ELECTIONS ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 242173.164010 0 FOR 242173.164010 FOR 2 S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements CORPORATE GOVERNANCE ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Progyny, Inc. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations CORPORATE GOVERNANCE ISSUER 242173.164010 0 FOR 242173.164010 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Sean L. Cunningham DIRECTOR ELECTIONS ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Richard G. Kyle DIRECTOR ELECTIONS ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Vincent K. Petrella DIRECTOR ELECTIONS ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 632321.366940 0 FOR 632321.366940 FOR 2 S000004450 Sotera Health Company 83601L102 US83601L1026 05/21/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 632321.366940 0 FOR 632321.366940 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Susan R. Salka DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: Michael S. Smith DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Elect nine directors, each for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 524801.793670 0 FOR 524801.793670 FOR 2 S000004450 Teladoc Health, Inc. 87918A105 US87918A1051 05/21/2026 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 524801.793670 0 FOR 524801.793670 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Peter J. Barris DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric D. Belcher DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: David R. Epstein DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Wayne A.I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Nadja West, M.D. DIRECTOR ELECTIONS ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 275353.102240 0 FOR 275353.102240 FOR S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 275353.102240 0 ONE YEAR 275353.102240 AGAINST S000004450 Tempus AI, Inc. 88023B103 US88023B1035 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 275353.102240 0 ONE YEAR 275353.102240 AGAINST 2 S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 113612.804800 0 FOR 113612.804800 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: Patrick G. Enright DIRECTOR ELECTIONS ISSUER 113612.804800 0 WITHHOLD 113612.804800 AGAINST S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To elect the three Class II directors named below to hold office until the Company's 2029 annual meeting of stockholders: James R. Meyers DIRECTOR ELECTIONS ISSUER 113612.804800 0 FOR 113612.804800 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 113612.804800 0 FOR 113612.804800 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 113612.804800 0 FOR 113612.804800 FOR S000004450 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 113612.804800 0 FOR 113612.804800 FOR 2 S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 Election of Directors: Michael Bailey DIRECTOR ELECTIONS ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 Election of Directors: Brian Stuglik DIRECTOR ELECTIONS ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 Election of Directors: Karin Tollefson DIRECTOR ELECTIONS ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive Plan COMPENSATION ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase Plan COMPENSATION ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 127604.991800 0 FOR 127604.991800 FOR S000004450 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 127604.991800 0 FOR 127604.991800 FOR 2 S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 291751.669000 0 FOR 291751.669000 FOR S000004450 Waters Corporation 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 291751.669000 0 FOR 291751.669000 FOR 2 S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Owen Hughes DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Heather L. Franklin DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Natasha Hernday DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Barbara Kosacz DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Joseph M. Limber DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Election of Director Nominees: To be elected for terms expiring in 2027: Matthew D. Perry DIRECTOR ELECTIONS ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan. COMPENSATION ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Approval of the 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28578.111800 0 FOR 28578.111800 FOR S000004450 XOMA Royalty Corporation 98419J206 US98419J2069 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28578.111800 0 FOR 28578.111800 FOR 2 S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Filippo "Peter" Caldini DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Leslie Gillin DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Edward Schutter DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To elect six directors to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 629.827220 51600.000000 FOR 629.827220 FOR 2 S000004450 Establishment Labs Holdings Inc. G31249108 VGG312491084 05/22/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 629.827220 51600.000000 FOR 629.827220 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 587951.142100 0 FOR 587951.142100 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 587951.142100 0 FOR 587951.142100 FOR 2 S000004450 Zimmer Biomet Holdings, Inc. 98956P102 US98956P1021 05/22/2026 Shareholder Proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 587951.142100 0 AGAINST 587951.142100 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Lindsay Androski, JD, MBA, CFA DIRECTOR ELECTIONS ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Robert Alan Beardsley DIRECTOR ELECTIONS ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Joseph Bishop DIRECTOR ELECTIONS ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Matthew Gline DIRECTOR ELECTIONS ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To elect five (5) director nominees named in the Proxy Statement/Circular, each to serve until the 2027 Annual General and Special Meeting of Shareholders or until his or her qualified successor has been duly elected or appointed: Roger Sawhney, MD DIRECTOR ELECTIONS ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; COMPENSATION ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and SECTION 14A SAY-ON-PAY VOTES ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and SECTION 14A SAY-ON-PAY VOTES ISSUER 425193.034300 0 FOR 425193.034300 FOR 2 S000004450 Arbutus Biopharma Corporation 03879J100 CA03879J1003 05/26/2026 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 425193.034300 0 FOR 425193.034300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. AUDIT-RELATED ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. COMPENSATION ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 754475.901300 0 FOR 754475.901300 FOR S000004450 Exelixis, Inc. 30161Q104 US30161Q1040 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 754475.901300 0 FOR 754475.901300 FOR 2 S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To elect three nominees to the Board of Directors (3-year term expiring in 2029): Bernd Brust DIRECTOR ELECTIONS ISSUER 321239.032350 0 FOR 321239.032350 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To elect three nominees to the Board of Directors (3-year term expiring in 2029): Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 321239.032350 0 FOR 321239.032350 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To elect three nominees to the Board of Directors (3-year term expiring in 2029): Luke Marker DIRECTOR ELECTIONS ISSUER 321239.032350 0 FOR 321239.032350 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To ratify the appointment of Deloitte & Touche LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 321239.032350 0 FOR 321239.032350 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 321239.032350 0 FOR 321239.032350 FOR S000004450 Maravai Lifesciences Holdings, Inc. 56600D107 US56600D1072 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 321239.032350 0 FOR 321239.032350 FOR 2 S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7353259.055970 0 FOR 7353259.055970 FOR 2 S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 7353259.055970 0 FOR 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 7353259.055970 0 AGAINST 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 7353259.055970 0 AGAINST 7353259.055970 FOR S000004450 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 7353259.055970 0 AGAINST 7353259.055970 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBA DIRECTOR ELECTIONS ISSUER 348236.506800 0 FOR 348236.506800 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. DIRECTOR ELECTIONS ISSUER 348236.506800 0 FOR 348236.506800 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 348236.506800 0 FOR 348236.506800 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 348236.506800 0 FOR 348236.506800 FOR S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 348236.506800 0 FOR 348236.506800 FOR 2 S000004450 Vir Biotechnology, Inc. 92764N102 US92764N1028 05/26/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 348236.506800 0 FOR 348236.506800 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 344485.754100 0 FOR 344485.754100 FOR S000004450 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 344485.754100 0 FOR 344485.754100 FOR 2 S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1154259.227820 0 FOR 1154259.227820 FOR S000004450 DexCom, Inc. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1154259.227820 0 FOR 1154259.227820 FOR 2 S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: C. Noel Bairey Merz, M.D. DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Quentin Blackford DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Bruce Bodaken DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen Ling DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karen McGinnis DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Kevin O'Boyle DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jason Patten DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Abhijit Talwalkar DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To elect nine directors to serve until our 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brian Yoor DIRECTOR ELECTIONS ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To approve the adoption of our 2026 Equity Incentive Plan. COMPENSATION ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. CORPORATE GOVERNANCE ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 95283.600780 0 FOR 95283.600780 FOR S000004450 iRhythm Holdings, Inc. 450056106 US4500561067 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 95283.600780 0 FOR 95283.600780 FOR 2 S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns DIRECTOR ELECTIONS ISSUER 182317.751420 0 FOR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Matthew Fust DIRECTOR ELECTIONS ISSUER 182317.751420 0 FOR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: David Piacquad DIRECTOR ELECTIONS ISSUER 182317.751420 0 FOR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 182317.751420 0 FOR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182317.751420 0 FOR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182317.751420 0 FOR 182317.751420 FOR 2 S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182317.751420 0 ONE YEAR 182317.751420 FOR S000004450 Neumora Therapeutics, Inc. 640979100 US6409791000 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182317.751420 0 ONE YEAR 182317.751420 FOR 2 S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Kevin C. Gorman, Ph.D. DIRECTOR ELECTIONS ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Gary A. Lyons DIRECTOR ELECTIONS ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 The election of the Board of Directors' three nominees for Class III directors named below to the Board of Directors to serve for a term of three years: Johanna Mercier DIRECTOR ELECTIONS ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 295315.252200 0 FOR 295315.252200 FOR 2 S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 US64125C1099 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 295315.252200 0 FOR 295315.252200 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Lori A. Woods DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Heidi Henson DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Robert Froman Williamson, III DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Frank Morich, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 Election of Directors: Maya Martinez-Davis DIRECTOR ELECTIONS ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 285741.158310 0 FOR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 285741.158310 0 ONE YEAR 285741.158310 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 US46489V3024 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 285741.158310 0 ONE YEAR 285741.158310 FOR 2 S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 Election of Class I Directors for terms expiring in 2029: Mark McKenna DIRECTOR ELECTIONS ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 Election of Class I Directors for terms expiring in 2029: Cameron Turtle, D.Phil. DIRECTOR ELECTIONS ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 Election of Class I Directors for terms expiring in 2029: Laurie Stelzer DIRECTOR ELECTIONS ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 144764.503170 0 FOR 144764.503170 FOR 2 S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 US00773J2024 05/27/2026 To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. COMPENSATION ISSUER 144764.503170 0 FOR 144764.503170 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: James L. Bierman DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Roy Blunt DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Richard J. Mark DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Tammy Romo DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To elect the 12 directors named in the accompanying Proxy Statement, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected and qualified, whichever is later, or until the director's earlier resignation or removal: Nadja Y. West DIRECTOR ELECTIONS ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To vote, on an advisory basis, to approve the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To vote, on an advisory basis, to approve the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 259847.164610 0 FOR 259847.164610 FOR 2 S000004450 Tenet Healthcare Corporation 88033G407 US88033G4073 05/27/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 259847.164610 0 FOR 259847.164610 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Ellen Goldberg DIRECTOR ELECTIONS ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Miles D. Harrison DIRECTOR ELECTIONS ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Tiffany P. Olson DIRECTOR ELECTIONS ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 86105.788320 0 FOR 86105.788320 FOR 2 S000004450 Castle Biosciences, Inc. 14843C105 US14843C1053 05/28/2026 To approve our non-employee director compensation policy. COMPENSATION ISSUER 86105.788320 0 FOR 86105.788320 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 Election of Class I Directors: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 707091.425100 0 FOR 707091.425100 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 Election of Class I Directors: Sheldon L. Koenig DIRECTOR ELECTIONS ISSUER 707091.425100 0 FOR 707091.425100 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 707091.425100 0 FOR 707091.425100 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 707091.425100 0 FOR 707091.425100 FOR 2 S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 707091.425100 0 FOR 707091.425100 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 US29664W1053 05/28/2026 To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan. COMPENSATION ISSUER 707091.425100 0 FOR 707091.425100 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/28/2026 Election of Directors: Denice M. Torres DIRECTOR ELECTIONS ISSUER 170117.516750 0 FOR 170117.516750 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/28/2026 Election of Directors: Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 170117.516750 0 FOR 170117.516750 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 170117.516750 0 FOR 170117.516750 FOR S000004450 Glaukos Corporation 377322102 US3773221029 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 170117.516750 0 FOR 170117.516750 FOR 2 S000004450 Glaukos Corporation 377322102 US3773221029 05/28/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 170117.516750 0 FOR 170117.516750 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir DIRECTOR ELECTIONS ISSUER 69471.217080 0 FOR 69471.217080 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Jeffrey L. McLaren DIRECTOR ELECTIONS ISSUER 69471.217080 0 FOR 69471.217080 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick DIRECTOR ELECTIONS ISSUER 69471.217080 0 FOR 69471.217080 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 69471.217080 0 FOR 69471.217080 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 69471.217080 0 FOR 69471.217080 FOR S000004450 HealthStream, Inc. 42222N103 US42222N1037 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 69471.217080 0 FOR 69471.217080 FOR 2 S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable DIRECTOR ELECTIONS ISSUER 39571.511150 0 FOR 39571.511150 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS ISSUER 39571.511150 0 FOR 39571.511150 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More DIRECTOR ELECTIONS ISSUER 39571.511150 0 FOR 39571.511150 FOR S000004450 Tyra Biosciences, Inc. 90240B106 US90240B1061 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 39571.511150 0 FOR 39571.511150 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly DIRECTOR ELECTIONS ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan, M.D. DIRECTOR ELECTIONS ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu, Pharm.D., J.D. DIRECTOR ELECTIONS ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 350357.082000 0 FOR 350357.082000 FOR 2 S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Acadia Pharmaceuticals Inc. 004225108 US0042251084 05/29/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. COMPENSATION ISSUER 350357.082000 0 FOR 350357.082000 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To elect the three Class II director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Rodney D. Windley DIRECTOR ELECTIONS ISSUER 153998.872170 0 FOR 153998.872170 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To elect the three Class II director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Sam Weil DIRECTOR ELECTIONS ISSUER 153998.872170 0 FOR 153998.872170 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To elect the three Class II director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Steven E. Rodgers DIRECTOR ELECTIONS ISSUER 153998.872170 0 FOR 153998.872170 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. AUDIT-RELATED ISSUER 153998.872170 0 FOR 153998.872170 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 153998.872170 0 FOR 153998.872170 FOR S000004450 Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 153998.872170 0 FOR 153998.872170 FOR 2 S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. COMPENSATION ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 106707.390270 0 FOR 106707.390270 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 GB00BRXB0C07 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 106707.390270 0 FOR 106707.390270 FOR 2 S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 Election of three Class II Directors: Jean Bennett, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 Election of three Class II Directors: A.N. "Jerry" Karabelas, Ph.D. DIRECTOR ELECTIONS ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 Election of three Class II Directors: Daniel Tasse DIRECTOR ELECTIONS ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 125746.988400 0 FOR 125746.988400 FOR 2 S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our non-executive employees. COMPENSATION ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 REGENXBIO Inc. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our executive employees. COMPENSATION ISSUER 125746.988400 0 FOR 125746.988400 FOR S000004450 Talkspace, Inc. 87427V103 US87427V1035 05/29/2026 To adopt the Agreement and Plan of Merger, dated as of March 9, 2026, by and among Talkspace, Inc., a Delaware corporation (the "Company"), Universal Health Services, Inc., a Delaware corporation ("UHS"), UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of UHS ("Merger Sub"), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company continuing as the surviving corporation in the merger as an indirect wholly owned subsidiary of UHS. EXTRAORDINARY TRANSACTIONS ISSUER 412154.302440 0 FOR 412154.302440 FOR S000004450 Talkspace, Inc. 87427V103 US87427V1035 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 412154.302440 0 AGAINST 412154.302440 AGAINST S000004450 Talkspace, Inc. 87427V103 US87427V1035 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 412154.302440 0 AGAINST 412154.302440 AGAINST 2 S000004450 Talkspace, Inc. 87427V103 US87427V1035 05/29/2026 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 412154.302440 0 FOR 412154.302440 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: David Gaugh DIRECTOR ELECTIONS ISSUER 108009.361980 0 FOR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: William J. Peters DIRECTOR ELECTIONS ISSUER 108009.361980 0 FOR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi DIRECTOR ELECTIONS ISSUER 108009.361980 0 FOR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 108009.361980 0 FOR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 108009.361980 0 FOR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 108009.361980 0 FOR 108009.361980 FOR 2 S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 108009.361980 0 ONE YEAR 108009.361980 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 108009.361980 0 ONE YEAR 108009.361980 FOR 2 S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. Nolan DIRECTOR ELECTIONS ISSUER 402625.737840 0 FOR 402625.737840 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Laura Sepp-Lorenzino, Ph.D. DIRECTOR ELECTIONS ISSUER 402625.737840 0 FOR 402625.737840 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 402625.737840 0 FOR 402625.737840 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 402625.737840 0 FOR 402625.737840 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 402625.737840 0 FOR 402625.737840 FOR 2 S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 402625.737840 0 ONE YEAR 402625.737840 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 US8776191061 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 402625.737840 0 ONE YEAR 402625.737840 FOR 2 S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR 2 S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2679178.377360 0.000000 FOR 2679178.377360 FOR S000004450 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 2679178.377360 0.000000 AGAINST 2679178.377360 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 339731.700750 0 FOR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John Driscoll DIRECTOR ELECTIONS ISSUER 339731.700750 0 FOR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 339731.700750 0 FOR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: Lauren Young DIRECTOR ELECTIONS ISSUER 339731.700750 0 FOR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 339731.700750 0 FOR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 339731.700750 0 ONE YEAR 339731.700750 FOR S000004450 Waystar Holding Corp. 946784105 US9467841055 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 339731.700750 0 ONE YEAR 339731.700750 FOR 2 S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. Finger DIRECTOR ELECTIONS ISSUER 702182.093440 0 FOR 702182.093440 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene Salas DIRECTOR ELECTIONS ISSUER 702182.093440 0 FOR 702182.093440 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 702182.093440 0 FOR 702182.093440 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 702182.093440 0 FOR 702182.093440 FOR S000004450 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 702182.093440 0 FOR 702182.093440 FOR 2 S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Election of Class II Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 36727.019200 0 FOR 36727.019200 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Election of Class II Directors: Karen McLoughlin DIRECTOR ELECTIONS ISSUER 36727.019200 0 FOR 36727.019200 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Election of Class II Directors: Ronald Williams DIRECTOR ELECTIONS ISSUER 36727.019200 0 FOR 36727.019200 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 36727.019200 0 FOR 36727.019200 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36727.019200 0 FOR 36727.019200 FOR S000004450 agilon health, inc. 00857U206 US00857U2069 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36727.019200 0 FOR 36727.019200 FOR 2 S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Ian T. Clark DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 Election of Directors: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 540167.148010 0 FOR 540167.148010 FOR 2 S000004450 BioMarin Pharmaceutical Inc. 09061G101 US09061G1013 06/02/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 540167.148010 0 FOR 540167.148010 FOR S000004450 Ceribell, Inc. 15678C102 US15678C1027 06/02/2026 Election of Directors: Josef Parvizi, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 54022.448610 0 FOR 54022.448610 FOR S000004450 Ceribell, Inc. 15678C102 US15678C1027 06/02/2026 Election of Directors: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 54022.448610 0 FOR 54022.448610 FOR S000004450 Ceribell, Inc. 15678C102 US15678C1027 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 54022.448610 0 FOR 54022.448610 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The election of the two nominees for director named in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders: William M. Greenman DIRECTOR ELECTIONS ISSUER 576624.685280 0 FOR 576624.685280 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The election of the two nominees for director named in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders: Ann Lucena DIRECTOR ELECTIONS ISSUER 576624.685280 0 FOR 576624.685280 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 576624.685280 0 FOR 576624.685280 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 576624.685280 0 FOR 576624.685280 FOR S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 576624.685280 0 FOR 576624.685280 FOR 2 S000004450 Cerus Corporation 157085101 US1570851014 06/02/2026 The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 576624.685280 0 FOR 576624.685280 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Michael J. Barber DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: James D. Forbes DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Election of Directors: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 590548.308480 0 FOR 590548.308480 FOR 2 S000004450 DENTSPLY SIRONA Inc. 24906P109 US24906P1093 06/02/2026 Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 590548.308480 0 FOR 590548.308480 FOR S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 85764.301740 0 FOR 85764.301740 FOR S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement: Bassil I. Dahiyat, Ph.D. DIRECTOR ELECTIONS ISSUER 85764.301740 0 FOR 85764.301740 FOR S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement: Taiyin Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 85764.301740 0 FOR 85764.301740 FOR S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 85764.301740 0 FOR 85764.301740 FOR S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 85764.301740 0 FOR 85764.301740 FOR 2 S000004450 Kodiak Sciences Inc. 50015M109 US50015M1099 06/02/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 85764.301740 0 FOR 85764.301740 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2026 Election of Directors: David B. Roberts DIRECTOR ELECTIONS ISSUER 63743.310930 0 FOR 63743.310930 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2026 Election of Directors: John A. Roush DIRECTOR ELECTIONS ISSUER 63743.310930 0 FOR 63743.310930 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 63743.310930 0 FOR 63743.310930 FOR S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 63743.310930 0 FOR 63743.310930 FOR 2 S000004450 LeMaitre Vascular, Inc. 525558201 US5255582018 06/02/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 63743.310930 0 FOR 63743.310930 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/02/2026 Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: David Bourdon DIRECTOR ELECTIONS ISSUER 515707.841600 0 FOR 515707.841600 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/02/2026 Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D. DIRECTOR ELECTIONS ISSUER 515707.841600 0 FOR 515707.841600 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2026; AUDIT-RELATED ISSUER 515707.841600 0 FOR 515707.841600 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 515707.841600 0 FOR 515707.841600 FOR S000004450 LifeStance Health Group, Inc. 53228F101 US53228F1012 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 515707.841600 0 FOR 515707.841600 FOR 2 S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: John W. Smither until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Janneke van der Kamp until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132737.330820 0 FOR 132737.330820 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132737.330820 0 FOR 132737.330820 FOR 2 S000004450 Oruka Therapeutics, Inc. 687604108 US6876041087 06/02/2026 Election of Class II Directors for terms expiring in 2029: Lawrence Klein DIRECTOR ELECTIONS ISSUER 64263.192350 0 FOR 64263.192350 FOR S000004450 Oruka Therapeutics, Inc. 687604108 US6876041087 06/02/2026 Election of Class II Directors for terms expiring in 2029: Chris Martin DIRECTOR ELECTIONS ISSUER 64263.192350 0 FOR 64263.192350 FOR S000004450 Oruka Therapeutics, Inc. 687604108 US6876041087 06/02/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 64263.192350 0 FOR 64263.192350 FOR S000004450 Oruka Therapeutics, Inc. 687604108 US6876041087 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 64263.192350 0 FOR 64263.192350 FOR S000004450 Oruka Therapeutics, Inc. 687604108 US6876041087 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 64263.192350 0 FOR 64263.192350 FOR 2 S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Election of Four Class I Directors: Jessica Chutter DIRECTOR ELECTIONS ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Election of Four Class I Directors: Matthew B. Klein, M.D., M.S., F.A.C.S. DIRECTOR ELECTIONS ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Election of Four Class I Directors: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 213740.874480 0 FOR 213740.874480 FOR S000004450 PTC Therapeutics, Inc. 69366J200 US69366J2006 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 213740.874480 0 FOR 213740.874480 FOR 2 S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Howard G. Berger, M.D. DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: A. Gregory Sorensen, M.D. DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: David L. Swartz DIRECTOR ELECTIONS ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 194079.661620 0 FOR 194079.661620 FOR 2 S000004450 RadNet, Inc. 750491102 US7504911022 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 194079.661620 0 FOR 194079.661620 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 192683.960560 0 FOR 192683.960560 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. Moses DIRECTOR ELECTIONS ISSUER 192683.960560 0 FOR 192683.960560 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 192683.960560 0 FOR 192683.960560 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192683.960560 0 FOR 192683.960560 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192683.960560 0 FOR 192683.960560 FOR 2 S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192683.960560 0 ONE YEAR 192683.960560 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192683.960560 0 ONE YEAR 192683.960560 FOR 2 S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Election of Directors: Kevin Tang DIRECTOR ELECTIONS ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Election of Directors: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Election of Directors: Kathy Goetz DIRECTOR ELECTIONS ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Election of Directors: Craig Johnson DIRECTOR ELECTIONS ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Appointment of Auditors To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 330048.623040 0 FOR 330048.623040 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 CA05156V1022 06/03/2026 Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 330048.623040 0 FOR 330048.623040 FOR 2 S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Evans DIRECTOR ELECTIONS ISSUER 269743.528390 0 FOR 269743.528390 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 269743.528390 0 FOR 269743.528390 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw DIRECTOR ELECTIONS ISSUER 269743.528390 0 FOR 269743.528390 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 269743.528390 0 FOR 269743.528390 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 269743.528390 0 FOR 269743.528390 FOR S000004450 Beam Therapeutics Inc. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 269743.528390 0 FOR 269743.528390 FOR 2 S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: John A. Bartholdson DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Ajay Dhankhar DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Mary Kay Ladone DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Guido J. Neels DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Guy P. Nohra DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Susan M. Stalnecker DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To elect the following nominees to serve as directors until the 2027 annual meeting of stockholders of Bioventus Inc. (the "Company"), and until their respective successors have been duly elected and qualified: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Bioventus Inc. 09075A108 US09075A1088 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 118437.967830 0 FOR 118437.967830 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 ELECTION OF DIRECTORS: Jennifer Cook DIRECTOR ELECTIONS ISSUER 411668.332920 0 FOR 411668.332920 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 ELECTION OF DIRECTORS: David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 411668.332920 0 FOR 411668.332920 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 ELECTION OF DIRECTORS: Ryan Watts, Ph.D. DIRECTOR ELECTIONS ISSUER 411668.332920 0 FOR 411668.332920 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 411668.332920 0 FOR 411668.332920 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 411668.332920 0 FOR 411668.332920 FOR S000004450 Denali Therapeutics Inc. 24823R105 US24823R1059 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 411668.332920 0 FOR 411668.332920 FOR 2 S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 331704.123660 0 FOR 331704.123660 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 331704.123660 0 FOR 331704.123660 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 331704.123660 0 AGAINST 331704.123660 AGAINST S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 331704.123660 0 FOR 331704.123660 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 331704.123660 0 FOR 331704.123660 FOR S000004450 Globus Medical, Inc. 379577208 US3795772082 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 331704.123660 0 FOR 331704.123660 FOR 2 S000004450 Hinge Health, Inc. 433313103 US4333131039 06/03/2026 Election of Class I Directors: Teddie Wardi DIRECTOR ELECTIONS ISSUER 51873.191440 0 FOR 51873.191440 FOR S000004450 Hinge Health, Inc. 433313103 US4333131039 06/03/2026 Election of Class I Directors: Tyler Sloat DIRECTOR ELECTIONS ISSUER 51873.191440 0 FOR 51873.191440 FOR S000004450 Hinge Health, Inc. 433313103 US4333131039 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 51873.191440 0 FOR 51873.191440 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To elect the two (2) nominees for Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 48663.537000 0 FOR 48663.537000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To elect the two (2) nominees for Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Charles Newton DIRECTOR ELECTIONS ISSUER 48663.537000 0 FOR 48663.537000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 48663.537000 0 FOR 48663.537000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 48663.537000 0 FOR 48663.537000 FOR S000004450 Keros Therapeutics, Inc. 492327101 US4923271013 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 48663.537000 0 FOR 48663.537000 FOR 2 S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Frank Leonard DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 314099.934720 0 FOR 314099.934720 FOR 2 S000004450 NovoCure Limited G6674U108 JE00BYSS4X48 06/03/2026 The approval of our amended and restated 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 314099.934720 0 FOR 314099.934720 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To elect three (3) Class II Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029: John D. Bertrand DIRECTOR ELECTIONS ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To elect three (3) Class II Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029: Steven K. Boyd DIRECTOR ELECTIONS ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To elect three (3) Class II Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029: Robert W. McMahon DIRECTOR ELECTIONS ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's Independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 185051.584480 0 FOR 185051.584480 FOR 2 S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To approve an amendment and restatement of the Company's Stock Award Plan to Increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. COMPENSATION ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 OraSure Technologies, Inc. 68554V108 US68554V1089 06/03/2026 To approve an amendment to the Company's Certificate of Incorporation to declassify the Company's Board of Directors and add certain clarifying changes. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 185051.584480 0 FOR 185051.584480 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: William Ericson DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: Christian O. Henry DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 Election of Directors: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 759014.958780 0 FOR 759014.958780 FOR 2 S000004450 Pacific Biosciences of California, Inc. 69404D108 US69404D1081 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 759014.958780 0 FOR 759014.958780 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: G. Clare Kahn, Ph.D. DIRECTOR ELECTIONS ISSUER 118123.653970 0 FOR 118123.653970 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D. DIRECTOR ELECTIONS ISSUER 118123.653970 0 FOR 118123.653970 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 118123.653970 0 FOR 118123.653970 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 118123.653970 0 FOR 118123.653970 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118123.653970 0 FOR 118123.653970 FOR S000004450 Stoke Therapeutics, Inc. 86150R107 US86150R1077 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118123.653970 0 FOR 118123.653970 FOR 2 S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders: Michael Heffernan DIRECTOR ELECTIONS ISSUER 251626.021530 0 FOR 251626.021530 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 251626.021530 0 FOR 251626.021530 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251626.021530 0 FOR 251626.021530 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251626.021530 0 FOR 251626.021530 FOR 2 S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan. COMPENSATION ISSUER 251626.021530 0 FOR 251626.021530 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 US89532M1018 06/03/2026 Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 251626.021530 0 FOR 251626.021530 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov DIRECTOR ELECTIONS ISSUER 309108.613240 0 FOR 309108.613240 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 309108.613240 0 FOR 309108.613240 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 309108.613240 0 FOR 309108.613240 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 309108.613240 0 FOR 309108.613240 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 309108.613240 0 FOR 309108.613240 FOR S000004450 10x Genomics, Inc. 88025U109 US88025U1097 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 309108.613240 0 FOR 309108.613240 FOR 2 S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: Jody Bilney DIRECTOR ELECTIONS ISSUER 498783.486630 0 FOR 498783.486630 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 498783.486630 0 FOR 498783.486630 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Election of Directors: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 498783.486630 0 FOR 498783.486630 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 498783.486630 0 FOR 498783.486630 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 498783.486630 0 FOR 498783.486630 FOR S000004450 Alignment Healthcare, Inc. 01625V104 US01625V1044 06/04/2026 Approval, on an non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 498783.486630 0 FOR 498783.486630 FOR 2 S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/04/2026 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. DIRECTOR ELECTIONS ISSUER 194203.591120 0 FOR 194203.591120 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/04/2026 Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 194203.591120 0 FOR 194203.591120 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 194203.591120 0 FOR 194203.591120 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 194203.591120 0 FOR 194203.591120 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 US03237H1014 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 194203.591120 0 FOR 194203.591120 FOR 2 S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 126465.382540 0 FOR 126465.382540 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 126465.382540 0 FOR 126465.382540 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 126465.382540 0 FOR 126465.382540 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 126465.382540 0 FOR 126465.382540 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 126465.382540 0 FOR 126465.382540 FOR 2 S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 126465.382540 0 ONE YEAR 126465.382540 FOR S000004450 CG Oncology, Inc. 156944100 US1569441009 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 126465.382540 0 ONE YEAR 126465.382540 FOR 2 S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114898.848480 0 FOR 114898.848480 FOR S000004450 DaVita Inc. 23918K108 US23918K1088 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 114898.848480 0 FOR 114898.848480 FOR 2 S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To elect the three Class II directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Sastry Chilukuri DIRECTOR ELECTIONS ISSUER 111159.803850 0 FOR 111159.803850 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To elect the three Class II directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Chris Egan DIRECTOR ELECTIONS ISSUER 111159.803850 0 FOR 111159.803850 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To elect the three Class II directors of Definitive Healthcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Samuel A. Hamood DIRECTOR ELECTIONS ISSUER 111159.803850 0 FOR 111159.803850 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 111159.803850 0 FOR 111159.803850 FOR S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan (the "2021 Plan"), to increase the number of shares of Class A Common Stock, par value $0.001 per share that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. COMPENSATION ISSUER 111159.803850 0 AGAINST 111159.803850 AGAINST S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 111159.803850 0 AGAINST 111159.803850 AGAINST S000004450 Definitive Healthcare Corp. 24477E103 US24477E1038 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 111159.803850 0 AGAINST 111159.803850 AGAINST 2 S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Laura Brege DIRECTOR ELECTIONS ISSUER 157120.963740 0 FOR 157120.963740 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D. DIRECTOR ELECTIONS ISSUER 157120.963740 0 FOR 157120.963740 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Jonathan Root, M.D. DIRECTOR ELECTIONS ISSUER 157120.963740 0 FOR 157120.963740 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 157120.963740 0 FOR 157120.963740 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157120.963740 0 FOR 157120.963740 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 US28036F1057 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157120.963740 0 FOR 157120.963740 FOR 2 S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Shawn Guertin DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Jill Smith DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Election of Directors: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 278888.208300 0 FOR 278888.208300 FOR 2 S000004450 Evolent Health, Inc. 30050B101 US30050B1017 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, COMPENSATION ISSUER 278888.208300 0 FOR 278888.208300 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/04/2026 Election of Class II Directors: Russell Cox DIRECTOR ELECTIONS ISSUER 535348.356780 0 FOR 535348.356780 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/04/2026 Election of Class II Directors: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 535348.356780 0 FOR 535348.356780 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 535348.356780 0 FOR 535348.356780 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 535348.356780 0 FOR 535348.356780 FOR S000004450 Gossamer Bio, Inc. 38341P102 US38341P1021 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 535348.356780 0 FOR 535348.356780 FOR 2 S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 Election of Directors: Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 Election of Directors: Joan E. Herman DIRECTOR ELECTIONS ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 455529.843790 0 FOR 455529.843790 FOR 2 S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 US4622221004 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 455529.843790 0 FOR 455529.843790 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Election of three Class III directors for three-year terms: Diane Parks DIRECTOR ELECTIONS ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Election of three Class III directors for three-year terms: Mary T. Szela DIRECTOR ELECTIONS ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Election of three Class III directors for three-year terms: Michael J. Vasconcelles, M.D. DIRECTOR ELECTIONS ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 218065.948620 0 FOR 218065.948620 FOR 2 S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 218065.948620 0 ONE YEAR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 218065.948620 0 ONE YEAR 218065.948620 FOR 2 S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval of an amendment to our 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 218065.948620 0 FOR 218065.948620 FOR S000004450 MBX Biosciences, Inc. 55287L101 US55287L1017 06/04/2026 Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 65829.238160 0 FOR 65829.238160 FOR S000004450 MBX Biosciences, Inc. 55287L101 US55287L1017 06/04/2026 Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 65829.238160 0 FOR 65829.238160 FOR S000004450 MBX Biosciences, Inc. 55287L101 US55287L1017 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2026. AUDIT-RELATED ISSUER 65829.238160 0 FOR 65829.238160 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/04/2026 Election of the Class I director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified: Spike Loy DIRECTOR ELECTIONS ISSUER 93818.822760 0 FOR 93818.822760 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/04/2026 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 93818.822760 0 FOR 93818.822760 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 93818.822760 0 FOR 93818.822760 FOR S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 93818.822760 0 FOR 93818.822760 FOR 2 S000004450 MoonLake Immunotherapeutics 61559X104 KY61559X1045 06/04/2026 Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan. COMPENSATION ISSUER 93818.822760 0 FOR 93818.822760 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 271517.478640 0 FOR 271517.478640 FOR 2 S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Myriad Genetics, Inc. 62855J104 US62855J1043 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 271517.478640 0 FOR 271517.478640 FOR S000004450 Nektar Therapeutics 640268306 US6402683063 06/04/2026 Election of Directors: Howard W. Robin DIRECTOR ELECTIONS ISSUER 71501.838330 0 FOR 71501.838330 FOR S000004450 Nektar Therapeutics 640268306 US6402683063 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 71501.838330 0 FOR 71501.838330 FOR S000004450 Nektar Therapeutics 640268306 US6402683063 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 71501.838330 0 FOR 71501.838330 FOR S000004450 Nektar Therapeutics 640268306 US6402683063 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 71501.838330 0 FOR 71501.838330 FOR S000004450 Nektar Therapeutics 640268306 US6402683063 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 71501.838330 0 FOR 71501.838330 FOR 2 S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD DIRECTOR ELECTIONS ISSUER 51657.380970 0 WITHHOLD 51657.380970 AGAINST S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Kelly Fischer DIRECTOR ELECTIONS ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Harald Ruf DIRECTOR ELECTIONS ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 51657.380970 0 FOR 51657.380970 FOR 2 S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To approve an amendment to the 2024 Incentive Award Plan. COMPENSATION ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 OrthoPediatrics Corp. 68752L100 US68752L1008 06/04/2026 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 51657.380970 0 FOR 51657.380970 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop DIRECTOR ELECTIONS ISSUER 515242.225290 0 FOR 515242.225290 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert Nelsen DIRECTOR ELECTIONS ISSUER 515242.225290 0 FOR 515242.225290 FOR S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Alise S. Reicin, M.D. DIRECTOR ELECTIONS ISSUER 515242.225290 0 WITHHOLD 515242.225290 AGAINST S000004450 Sana Biotechnology, Inc. 799566104 US7995661045 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 515242.225290 0 FOR 515242.225290 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 293381.337920 0 FOR 293381.337920 FOR 2 S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 US8036071004 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 293381.337920 0 FOR 293381.337920 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000. CAPITAL STRUCTURE ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000. COMPENSATION ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 204327.630000 0 FOR 204327.630000 FOR S000004450 Savara Inc. 805111101 US8051111016 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 204327.630000 0 FOR 204327.630000 FOR 2 S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David Hallal DIRECTOR ELECTIONS ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Kristina Burow DIRECTOR ELECTIONS ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Michael Gilman DIRECTOR ELECTIONS ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie Peng DIRECTOR ELECTIONS ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 185064.390000 0 FOR 185064.390000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 185064.390000 0 FOR 185064.390000 FOR 2 S000004450 SI-BONE, Inc. 825704109 US8257041090 06/04/2026 Election of Directors: Jeffrey W. Dunn DIRECTOR ELECTIONS ISSUER 121022.169450 0 FOR 121022.169450 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/04/2026 Election of Directors: John G. Freund, M.D. DIRECTOR ELECTIONS ISSUER 121022.169450 0 FOR 121022.169450 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/04/2026 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 121022.169450 0 FOR 121022.169450 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 121022.169450 0 FOR 121022.169450 FOR S000004450 SI-BONE, Inc. 825704109 US8257041090 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 121022.169450 0 FOR 121022.169450 FOR 2 S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 Election of Class II Directors: Malte Peters, M.D. DIRECTOR ELECTIONS ISSUER 132812.242640 0 FOR 132812.242640 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 Election of Class II Directors: Kanishka Pothula DIRECTOR ELECTIONS ISSUER 132812.242640 0 FOR 132812.242640 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 Election of Class II Directors: Mace Rothenberg, M.D. DIRECTOR ELECTIONS ISSUER 132812.242640 0 FOR 132812.242640 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 132812.242640 0 FOR 132812.242640 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132812.242640 0 FOR 132812.242640 FOR S000004450 Tango Therapeutics, Inc. 87583X109 US87583X1090 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 132812.242640 0 FOR 132812.242640 FOR 2 S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Marc Kozin DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Joseph John Hassett DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To elect the seven directors identified as standing for election in the accompanying proxy statement, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected: Symeria Hudson DIRECTOR ELECTIONS ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 21689.595760 0 FOR 21689.595760 FOR 2 S000004450 UFP Technologies, Inc. 902673102 US9026731029 06/04/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21689.595760 0 FOR 21689.595760 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To elect three Class II Directors: Richard W. Dugan DIRECTOR ELECTIONS ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To elect three Class II Directors: Charles C. Duncan, Ph.D. DIRECTOR ELECTIONS ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To elect three Class II Directors: Anne Sempowski Ward DIRECTOR ELECTIONS ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 165151.434330 0 FOR 165151.434330 FOR 2 S000004450 Vanda Pharmaceuticals Inc. 921659108 US9216591084 06/04/2026 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to increase the aggregate number of shares authorized for issuance thereunder. COMPENSATION ISSUER 165151.434330 0 FOR 165151.434330 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 489074.966960 0 FOR 489074.966960 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 489074.966960 0 FOR 489074.966960 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 489074.966960 0 FOR 489074.966960 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 489074.966960 0 FOR 489074.966960 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 489074.966960 0 FOR 489074.966960 FOR 2 S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD DIRECTOR ELECTIONS ISSUER 337621.371080 0 FOR 337621.371080 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Katey Owen, PhD DIRECTOR ELECTIONS ISSUER 337621.371080 0 FOR 337621.371080 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 337621.371080 0 FOR 337621.371080 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 337621.371080 0 FOR 337621.371080 FOR 2 S000004450 Adaptive Biotechnologies Corporation 00650F109 US00650F1093 06/05/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026; and AUDIT-RELATED ISSUER 337621.371080 0 FOR 337621.371080 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui DIRECTOR ELECTIONS ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 78310.134160 0 FOR 78310.134160 FOR 2 S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 US03969T1097 06/05/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 78310.134160 0 FOR 78310.134160 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 324981.739600 0 FOR 324981.739600 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha Krishnamohan DIRECTOR ELECTIONS ISSUER 324981.739600 0 FOR 324981.739600 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin Watanabe DIRECTOR ELECTIONS ISSUER 324981.739600 0 FOR 324981.739600 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 324981.739600 0 FOR 324981.739600 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 324981.739600 0 FOR 324981.739600 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 US03969K1088 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 324981.739600 0 FOR 324981.739600 FOR 2 S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/05/2026 Election of Directors: Mark Saad DIRECTOR ELECTIONS ISSUER 103400.237840 0 FOR 103400.237840 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/05/2026 Election of Directors: Susan Mahony, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 103400.237840 0 FOR 103400.237840 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 103400.237840 0 FOR 103400.237840 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 103400.237840 0 FOR 103400.237840 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 US05464T1043 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 103400.237840 0 FOR 103400.237840 FOR 2 S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Linda Baddour DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Daniel Hancock DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Robert Hariri, MD, PhD DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Ramkumar Mandalam, PhD DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To elect six directors: Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026; AUDIT-RELATED ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; SECTION 14A SAY-ON-PAY VOTES ISSUER 140574.448170 0 FOR 140574.448170 FOR 2 S000004450 CryoPort, Inc. 229050307 US2290503075 06/05/2026 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; and COMPENSATION ISSUER 140574.448170 0 FOR 140574.448170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian Posner DIRECTOR ELECTIONS ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes DIRECTOR ELECTIONS ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 340471.042170 0 FOR 340471.042170 FOR 2 S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 US26818M1080 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 340471.042170 0 FOR 340471.042170 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Todd C. Davis DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Nancy R. Gray, Ph.D. DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Jason Haas DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: John W. Kozarich, Ph.D. DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: John L. LaMattina, Ph.D. DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Stephen L. Sabba, M.D. DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Election of Directors: Martine Zimmermann, Pharm.D. DIRECTOR ELECTIONS ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 58276.397000 0 FOR 58276.397000 FOR 2 S000004450 Ligand Pharmaceuticals Incorporated 53220K504 US53220K5048 06/05/2026 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 58276.397000 0 FOR 58276.397000 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/05/2026 To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: Michael Kelly DIRECTOR ELECTIONS ISSUER 266255.758080 0 FOR 266255.758080 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/05/2026 To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 266255.758080 0 FOR 266255.758080 FOR S000004450 Prime Medicine, Inc. 74168J101 US74168J1016 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 266255.758080 0 FOR 266255.758080 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 227594.635040 0 FOR 227594.635040 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Brent Turner DIRECTOR ELECTIONS ISSUER 227594.635040 0 FOR 227594.635040 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Election of Class II Directors: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 227594.635040 0 FOR 227594.635040 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 227594.635040 0 FOR 227594.635040 FOR S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 227594.635040 0 FOR 227594.635040 FOR 2 S000004450 Surgery Partners, Inc. 86881A100 US86881A1007 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 227594.635040 0 FOR 227594.635040 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Muery DIRECTOR ELECTIONS ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 493685.381760 0 FOR 493685.381760 FOR 2 S000004450 Incyte Corporation 45337C102 US45337C1027 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 493685.381760 0 FOR 493685.381760 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/09/2026 Election of one Class III Director: Todd C. Brady, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 152730.882450 0 FOR 152730.882450 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/09/2026 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 152730.882450 0 FOR 152730.882450 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 152730.882450 0 FOR 152730.882450 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 US01438T1060 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 152730.882450 0 FOR 152730.882450 FOR 2 S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Election of Class III Directors for terms expiring in 2029: Mark C. McKenna DIRECTOR ELECTIONS ISSUER 113270.857700 0 FOR 113270.857700 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Election of Class III Directors for terms expiring in 2029: Jennifer Fox DIRECTOR ELECTIONS ISSUER 113270.857700 0 FOR 113270.857700 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Election of Class III Directors for terms expiring in 2029: William (BJ) Jones, Jr. DIRECTOR ELECTIONS ISSUER 113270.857700 0 FOR 113270.857700 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 113270.857700 0 FOR 113270.857700 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 113270.857700 0 FOR 113270.857700 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 US03770N1019 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 113270.857700 0 FOR 113270.857700 FOR 2 S000004450 Bicara Therapeutics Inc. 055477103 US0554771032 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D. DIRECTOR ELECTIONS ISSUER 81906.495200 0 FOR 81906.495200 FOR S000004450 Bicara Therapeutics Inc. 055477103 US0554771032 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D. DIRECTOR ELECTIONS ISSUER 81906.495200 0 FOR 81906.495200 FOR S000004450 Bicara Therapeutics Inc. 055477103 US0554771032 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 81906.495200 0 FOR 81906.495200 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 433526.542680 0 FOR 433526.542680 FOR S000004450 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 433526.542680 0 FOR 433526.542680 FOR 2 S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris Cain DIRECTOR ELECTIONS ISSUER 247848.109710 0 FOR 247848.109710 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. Morris DIRECTOR ELECTIONS ISSUER 247848.109710 0 FOR 247848.109710 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd Shegog DIRECTOR ELECTIONS ISSUER 247848.109710 0 FOR 247848.109710 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 247848.109710 0 FOR 247848.109710 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 247848.109710 0 FOR 247848.109710 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 247848.109710 0 FOR 247848.109710 FOR 2 S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A. DIRECTOR ELECTIONS ISSUER 96600.902720 0 FOR 96600.902720 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D. DIRECTOR ELECTIONS ISSUER 96600.902720 0 WITHHOLD 96600.902720 AGAINST S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96600.902720 0 FOR 96600.902720 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 96600.902720 0 FOR 96600.902720 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 96600.902720 0 FOR 96600.902720 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 96600.902720 0 FOR 96600.902720 FOR 2 S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 96600.902720 0 ONE YEAR 96600.902720 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 96600.902720 0 ONE YEAR 96600.902720 FOR 2 S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Election of Directors: Anshul Thakral DIRECTOR ELECTIONS ISSUER 273070.193680 0 FOR 273070.193680 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Election of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 273070.193680 0 FOR 273070.193680 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Election of Directors: William J. Sharbaugh DIRECTOR ELECTIONS ISSUER 273070.193680 0 FOR 273070.193680 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2026. AUDIT-RELATED ISSUER 273070.193680 0 FOR 273070.193680 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 273070.193680 0 FOR 273070.193680 FOR S000004450 Fortrea Holdings Inc. 34965K107 US34965K1079 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 273070.193680 0 FOR 273070.193680 FOR 2 S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Election of three Class II directors to serve until the 2029 annual meeting of stockholders: John P. Bamforth DIRECTOR ELECTIONS ISSUER 36068.809320 439700.000000 WITHHOLD 36068.809320 AGAINST S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Kathleen Sebelius DIRECTOR ELECTIONS ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR 2 S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36068.809320 439700.000000 ONE YEAR 36068.809320 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36068.809320 439700.000000 ONE YEAR 36068.809320 FOR 2 S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR S000004450 Humacyte, Inc. 44486Q103 US44486Q1031 06/09/2026 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 350,000,000 shares to 550,000,000 shares. CAPITAL STRUCTURE ISSUER 36068.809320 439700.000000 FOR 36068.809320 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Richard Adcock DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Wesley Clark DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Christobel Selecky DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 Election of Directors: Bruce Wendel DIRECTOR ELECTIONS ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 ImmunityBio, Inc. 45256X103 US45256X1037 06/09/2026 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 325968.653910 707501.000000 FOR 325968.653910 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James Boylan DIRECTOR ELECTIONS ISSUER 278230.193700 0 FOR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Sandra Swain, M.D. DIRECTOR ELECTIONS ISSUER 278230.193700 0 FOR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Philip Wagenheim DIRECTOR ELECTIONS ISSUER 278230.193700 0 FOR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 278230.193700 0 FOR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 278230.193700 0 FOR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 278230.193700 0 FOR 278230.193700 FOR 2 S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 278230.193700 0 ONE YEAR 278230.193700 FOR S000004450 Immunome, Inc. 45257U108 US45257U1088 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 278230.193700 0 ONE YEAR 278230.193700 FOR 2 S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 324188.484480 0 FOR 324188.484480 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Brian Goff DIRECTOR ELECTIONS ISSUER 324188.484480 0 FOR 324188.484480 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 324188.484480 0 FOR 324188.484480 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 324188.484480 0 FOR 324188.484480 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 324188.484480 0 FOR 324188.484480 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 324188.484480 0 FOR 324188.484480 FOR 2 S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Robert Essner DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Deborah Leone DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Election of Directors: Shalini Sharp DIRECTOR ELECTIONS ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 766465.469200 0 FOR 766465.469200 FOR 2 S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Organon & Co. 68622V106 US68622V1061 06/09/2026 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 766465.469200 0 FOR 766465.469200 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Samit Hirawat DIRECTOR ELECTIONS ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: Tom Wiggans DIRECTOR ELECTIONS ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 120254.136080 0 WITHHOLD 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 120254.136080 0 WITHHOLD 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 120254.136080 0 WITHHOLD 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 120254.136080 0 FOR 120254.136080 FOR 2 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval of our Amended and Restated 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 120254.136080 0 FOR 120254.136080 FOR S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: DOMA Nominees: Oliver Benton "Ben" Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: DOMA Nominees: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: DOMA Nominees: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: Company Nominees Opposed by DOMA: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: Company Nominees Opposed by DOMA: Samit Hirawat DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are elected and qualified: Company Nominees Opposed by DOMA: Tom Wiggans DIRECTOR ELECTIONS ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Ratification of the appointment of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 2 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval of the Amended and Restated 2011 Stock Incentive Plan COMPENSATION ISSUER 0.000000 0 S000004450 Pacira Biosciences, Inc. 695127100 US6951271005 06/09/2026 Approval of the Amended and Restated 2014 Employee Stock Purchase Plan COMPENSATION ISSUER 0.000000 0 S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai DIRECTOR ELECTIONS ISSUER 164928.202320 0 FOR 164928.202320 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett DIRECTOR ELECTIONS ISSUER 164928.202320 0 FOR 164928.202320 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 164928.202320 0 FOR 164928.202320 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 164928.202320 0 FOR 164928.202320 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164928.202320 0 FOR 164928.202320 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 US74276L1052 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164928.202320 0 FOR 164928.202320 FOR 2 S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 Election of Directors: William P. Donnelly DIRECTOR ELECTIONS ISSUER 123218.624960 0 FOR 123218.624960 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 Election of Directors: Ivana Magovcevic-Liebisch, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 123218.624960 0 FOR 123218.624960 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 123218.624960 0 FOR 123218.624960 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 123218.624960 0 FOR 123218.624960 FOR 2 S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 To ratify, on an advisory basis, the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 123218.624960 0 FOR 123218.624960 FOR S000004450 Quanterix Corporation 74766Q101 US74766Q1013 06/09/2026 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan COMPENSATION ISSUER 123218.624960 0 AGAINST 123218.624960 AGAINST S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 359000.036520 0 FOR 359000.036520 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 359000.036520 0 FOR 359000.036520 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 359000.036520 0 FOR 359000.036520 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 359000.036520 0 FOR 359000.036520 FOR 2 S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 359000.036520 0 FOR 359000.036520 FOR S000004450 Relay Therapeutics, Inc. 75943R102 US75943R1023 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000; and CAPITAL STRUCTURE ISSUER 359000.036520 0 FOR 359000.036520 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Harold E. Ford, Jr. DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: General John M. Keane (Ret.) DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Gary J. Nabel DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Diem Nguyen DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 Election of Directors: Holly L. Phillips DIRECTOR ELECTIONS ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 127718.132440 0 FOR 127718.132440 FOR 2 S000004450 SIGA Technologies, Inc. 826917106 US8269171067 06/09/2026 To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. COMPENSATION ISSUER 127718.132440 0 FOR 127718.132440 FOR S000004450 Upstream Bio, Inc. 91678A107 US91678A1079 06/09/2026 To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS ISSUER 71597.370450 0 FOR 71597.370450 FOR S000004450 Upstream Bio, Inc. 91678A107 US91678A1079 06/09/2026 To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: Liam Ratcliffe, M.B.Ch.B., Ph.D. DIRECTOR ELECTIONS ISSUER 71597.370450 0 FOR 71597.370450 FOR S000004450 Upstream Bio, Inc. 91678A107 US91678A1079 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 71597.370450 0 FOR 71597.370450 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/10/2026 Election of Directors: Michael Earley DIRECTOR ELECTIONS ISSUER 54481.757530 0 FOR 54481.757530 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/10/2026 Election of Directors: Veronica Hill-Milbourne DIRECTOR ELECTIONS ISSUER 54481.757530 0 FOR 54481.757530 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 54481.757530 0 FOR 54481.757530 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54481.757530 0 FOR 54481.757530 FOR S000004450 Addus HomeCare Corporation 006739106 US0067391062 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 54481.757530 0 FOR 54481.757530 FOR 2 S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: Quentin Blackford DIRECTOR ELECTIONS ISSUER 353615.844540 0 WITHHOLD 353615.844540 AGAINST S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: David Demski DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To elect seven persons to our Board of Directors: Keith Valentine DIRECTOR ELECTIONS ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan; COMPENSATION ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan; and COMPENSATION ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 353615.844540 0 FOR 353615.844540 FOR S000004450 Alphatec Holdings, Inc. 02081G201 US02081G2012 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 353615.844540 0 FOR 353615.844540 FOR 2 S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Election of Directors: Daniel Curran, M.D. DIRECTOR ELECTIONS ISSUER 96312.946380 0 FOR 96312.946380 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Election of Directors: Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 96312.946380 0 FOR 96312.946380 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Election of Directors: Chris Takimoto, M.D., Ph.D., F.A.C.P. DIRECTOR ELECTIONS ISSUER 96312.946380 0 FOR 96312.946380 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 96312.946380 0 FOR 96312.946380 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 96312.946380 0 FOR 96312.946380 FOR 2 S000004450 ALX Oncology Holdings Inc. 00166B105 US00166B1052 06/10/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96312.946380 0 FOR 96312.946380 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Kenneth Sim, M.D. DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Thomas S. Lam, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: John Chiang DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Weili Dai DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Linda Dong DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: J. Lorraine Estradas, R.N., B.S.N., M.P.H. DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To elect nine directors to the Board of Directors, each to hold office until the 2027 annual meeting of stockholders of the Company: David G. Schmidt DIRECTOR ELECTIONS ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 132639.222800 0 FOR 132639.222800 FOR 2 S000004450 Astrana Health, Inc. 03763A207 US03763A2078 06/10/2026 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 132639.222800 0 FOR 132639.222800 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 ELECTION OF DIRECTORS: Demetrios L. Kouzoukas DIRECTOR ELECTIONS ISSUER 1258694.424260 0 FOR 1258694.424260 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 ELECTION OF DIRECTORS: Andrew Toy DIRECTOR ELECTIONS ISSUER 1258694.424260 0 FOR 1258694.424260 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 ELECTION OF DIRECTORS: Thomas L. Tran DIRECTOR ELECTIONS ISSUER 1258694.424260 0 FOR 1258694.424260 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1258694.424260 0 FOR 1258694.424260 FOR S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1258694.424260 0 FOR 1258694.424260 FOR 2 S000004450 Clover Health Investments, Corp. 18914F103 US18914F1030 06/10/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 1258694.424260 0 FOR 1258694.424260 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To elect our three Class II director nominees, Vera Imper, Ph.D., Glenn P. Muir, and Ming Yan, Ph.D., each to serve a three-year term expiring at our 2029 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or removal: Vera Imper, Ph.D. DIRECTOR ELECTIONS ISSUER 320148.505980 0 FOR 320148.505980 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To elect our three Class II director nominees, Vera Imper, Ph.D., Glenn P. Muir, and Ming Yan, Ph.D., each to serve a three-year term expiring at our 2029 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or removal: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 320148.505980 0 FOR 320148.505980 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To elect our three Class II director nominees, Vera Imper, Ph.D., Glenn P. Muir, and Ming Yan, Ph.D., each to serve a three-year term expiring at our 2029 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation, or removal: Ming Yan, Ph.D. DIRECTOR ELECTIONS ISSUER 320148.505980 0 FOR 320148.505980 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 320148.505980 0 FOR 320148.505980 FOR S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 320148.505980 0 FOR 320148.505980 FOR 2 S000004450 Cytek Biosciences, Inc. 23285D109 US23285D1090 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 320148.505980 0 FOR 320148.505980 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/10/2026 Election of Directors: Peter S. Kim, Ph.D. DIRECTOR ELECTIONS ISSUER 56423.237520 0 FOR 56423.237520 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/10/2026 Election of Directors: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 56423.237520 0 FOR 56423.237520 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 56423.237520 0 FOR 56423.237520 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. COMPENSATION ISSUER 56423.237520 0 AGAINST 56423.237520 AGAINST S000004450 Entrada Therapeutics, Inc. 29384C108 US29384C1080 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. COMPENSATION ISSUER 56423.237520 0 FOR 56423.237520 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Iain Dukes, D. Phil. DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Athena Countouriotis, M.D. DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Ryan Maynard DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To elect six directors named in the proxy statement accompanying this notice to serve until the 2027 Annual Meeting of Stockholders: Michael Weiser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 906973.725200 0 FOR 906973.725200 FOR 2 S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 906973.725200 0 ONE YEAR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 906973.725200 0 ONE YEAR 906973.725200 FOR 2 S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares; COMPENSATION ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares; and CAPITAL STRUCTURE ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. CORPORATE GOVERNANCE ISSUER 906973.725200 0 FOR 906973.725200 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/10/2026 Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham DIRECTOR ELECTIONS ISSUER 21508.257720 0 FOR 21508.257720 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/10/2026 Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers DIRECTOR ELECTIONS ISSUER 21508.257720 0 FOR 21508.257720 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/10/2026 Non-Binding advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 21508.257720 0 FOR 21508.257720 FOR S000004450 Korro Bio, Inc. 500946108 US5009461089 06/10/2026 Non-Binding advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 21508.257720 0 FOR 21508.257720 FOR 2 S000004450 Korro Bio, Inc. 500946108 US5009461089 06/10/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 21508.257720 0 FOR 21508.257720 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): J. Christopher Barry DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Francesco Bianchi DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): William Kozy DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Jette Nygaard-Andersen DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Susan Podlogar DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Brooke Story DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Peter Wilver DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Donald Zurbay DIRECTOR ELECTIONS ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 161518.705200 0 FOR 161518.705200 FOR 2 S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered, or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Special Resolution: Subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of pounds10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this power expires, make offers or agreements which would or might require equity securities to be allotted and/or treasury shares to be sold after its expiry and the directors may allot equity securities and/or sell treasury shares pursuant to such offers or agreement as if this power had not expired; and (B) this power replaces (except for any power conferred by resolution 4) all subsisting powers previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect, without prejudice to any allotment of equity securities already made, offered, or agreed to be made under such powers CAPITAL STRUCTURE ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of this proxy statement (the "Share Repurchase Contracts") and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in this proxy statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the Share Repurchase Contracts shall not exceed 10% of the total issued Ordinary Shares of the Company as at 5:00 pm Eastern Time on April 13, 2026 as adjusted on a proportionate basis to take into account any consolidation or division of shares from time to time; and (B) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the date that is fifteen (15) months after the date on which this resolution is passed, save that the Company may enter into any Share Repurchase Contract with any of the Approved Counterparties under this authority prior to its expiry and may purchase Ordinary Shares pursuant to any such Share Repurchase Contract. CAPITAL STRUCTURE ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the year ended December 31, 2025. COMPENSATION ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2025, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2026. AUDIT-RELATED ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 LivaNova Plc G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 161518.705200 0 FOR 161518.705200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Election of Class II Directors: Richard Klausner, M.D. DIRECTOR ELECTIONS ISSUER 22648.601200 0 FOR 22648.601200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Election of Class II Directors: Otis Brawley, M.D. DIRECTOR ELECTIONS ISSUER 22648.601200 0 FOR 22648.601200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Election of Class II Directors: William Rieflin DIRECTOR ELECTIONS ISSUER 22648.601200 0 FOR 22648.601200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 22648.601200 0 FOR 22648.601200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22648.601200 0 FOR 22648.601200 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 US55083R2031 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22648.601200 0 FOR 22648.601200 FOR 2 S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: K. Todd Newton DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: Tiffany Olson DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Election of Directors: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 350430.801630 0 FOR 350430.801630 FOR 2 S000004450 MiMedx Group, Inc. 602496101 US6024961012 06/10/2026 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 350430.801630 0 FOR 350430.801630 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Pravin U. Dugel, M.D. DIRECTOR ELECTIONS ISSUER 473843.341200 0 FOR 473843.341200 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Merilee Raines DIRECTOR ELECTIONS ISSUER 473843.341200 0 FOR 473843.341200 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 473843.341200 0 FOR 473843.341200 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 473843.341200 0 FOR 473843.341200 FOR 2 S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 473843.341200 0 ONE YEAR 473843.341200 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 473843.341200 0 ONE YEAR 473843.341200 FOR 2 S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. COMPENSATION ISSUER 473843.341200 0 FOR 473843.341200 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 US67576A1007 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 473843.341200 0 FOR 473843.341200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Wayne Burris DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Election of Directors: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 92889.994200 0 FOR 92889.994200 FOR 2 S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 Orthofix Medical Inc. 68752M108 US68752M1080 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. COMPENSATION ISSUER 92889.994200 0 FOR 92889.994200 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 06/10/2026 To elect Evelyn Dilsaver and Mark Hancock as Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 138484.361220 0 FOR 138484.361220 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 06/10/2026 To elect Evelyn Dilsaver and Mark Hancock as Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Mark Hancock DIRECTOR ELECTIONS ISSUER 138484.361220 0 FOR 138484.361220 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 138484.361220 0 FOR 138484.361220 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 138484.361220 0 FOR 138484.361220 FOR S000004450 PACS Group, Inc. 69380Q107 US69380Q1076 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 138484.361220 0 FOR 138484.361220 FOR 2 S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: George M. Jenkins DIRECTOR ELECTIONS ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. Davis DIRECTOR ELECTIONS ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: John Doux, M.D. DIRECTOR ELECTIONS ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28811.258430 0 FOR 28811.258430 FOR 2 S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28811.258430 0 ONE YEAR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 28811.258430 0 ONE YEAR 28811.258430 FOR 2 S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. COMPENSATION ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Palvella Therapeutics, Inc. 697947109 US6979471090 06/10/2026 Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 28811.258430 0 FOR 28811.258430 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 69784.845580 0 FOR 69784.845580 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 69784.845580 0 FOR 69784.845580 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 69784.845580 0 FOR 69784.845580 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 69784.845580 0 FOR 69784.845580 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 69784.845580 0 FOR 69784.845580 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 US74006W2070 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 69784.845580 0 FOR 69784.845580 FOR 2 S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/10/2026 To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: James Healy, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 84306.133600 0 FOR 84306.133600 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/10/2026 To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Robert J. Perez DIRECTOR ELECTIONS ISSUER 84306.133600 0 FOR 84306.133600 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/10/2026 To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Raymond Sanchez, M.D. DIRECTOR ELECTIONS ISSUER 84306.133600 0 FOR 84306.133600 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 US75383L1026 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 84306.133600 0 FOR 84306.133600 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Robert Booth DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Alessandra Cesano DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Yu (Michelle) Xia DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 ELECTION OF DIRECTORS: Jeff Huber DIRECTOR ELECTIONS ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 167407.469340 294300.000000 FOR 167407.469340 FOR S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167407.469340 294300.000000 AGAINST 167407.469340 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167407.469340 294300.000000 AGAINST 167407.469340 AGAINST 2 S000004450 Summit Therapeutics Inc. 86627T108 US86627T1088 06/10/2026 Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. COMPENSATION ISSUER 167407.469340 294300.000000 AGAINST 167407.469340 AGAINST S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 Election of Directors: Pierre Legault DIRECTOR ELECTIONS ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 Election of Directors: Michael A. Metzger DIRECTOR ELECTIONS ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 242050.196640 0 FOR 242050.196640 FOR 2 S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 242050.196640 0 FOR 242050.196640 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley DIRECTOR ELECTIONS ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 234449.962660 0 FOR 234449.962660 FOR 2 S000004450 Veracyte, Inc. 92337F107 US92337F1075 06/10/2026 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 234449.962660 0 FOR 234449.962660 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D. DIRECTOR ELECTIONS ISSUER 351343.553640 0 FOR 351343.553640 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Douglas Love, Esq. DIRECTOR ELECTIONS ISSUER 351343.553640 0 FOR 351343.553640 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 351343.553640 0 FOR 351343.553640 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 351343.553640 0 FOR 351343.553640 FOR S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 351343.553640 0 FOR 351343.553640 FOR 2 S000004450 Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 351343.553640 0 FOR 351343.553640 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Nicole Lambert DIRECTOR ELECTIONS ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 Election of Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 255226.611700 0 FOR 255226.611700 FOR S000004450 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 255226.611700 0 FOR 255226.611700 FOR 2 S000004450 Aura Biosciences, Inc. 05153U107 US05153U1079 06/11/2026 To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: David Johnson DIRECTOR ELECTIONS ISSUER 135592.444000 0 FOR 135592.444000 FOR S000004450 Aura Biosciences, Inc. 05153U107 US05153U1079 06/11/2026 To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Teresa Marie Bitetti DIRECTOR ELECTIONS ISSUER 135592.444000 0 FOR 135592.444000 FOR S000004450 Aura Biosciences, Inc. 05153U107 US05153U1079 06/11/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 135592.444000 0 FOR 135592.444000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Amy E. Mckee, M.D. DIRECTOR ELECTIONS ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 Election of Directors (each to serve until the 2029 Annual Meeting of Stockholders): Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 614595.215070 0 FOR 614595.215070 FOR 2 S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 US09058V1035 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 614595.215070 0 FOR 614595.215070 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Fred E. Cohen, M.D., D. Phil DIRECTOR ELECTIONS ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Election of Directors: John W. Hanna DIRECTOR ELECTIONS ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149092.649600 0 FOR 149092.649600 FOR 2 S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149092.649600 0 ONE YEAR 149092.649600 FOR S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 149092.649600 0 ONE YEAR 149092.649600 FOR 2 S000004450 CareDx, Inc. 14167L103 US14167L1035 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 149092.649600 0 FOR 149092.649600 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D. DIRECTOR ELECTIONS ISSUER 164431.335800 0 FOR 164431.335800 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D. DIRECTOR ELECTIONS ISSUER 164431.335800 0 FOR 164431.335800 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 164431.335800 0 FOR 164431.335800 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164431.335800 0 FOR 164431.335800 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 US2210151005 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164431.335800 0 FOR 164431.335800 FOR 2 S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Adsett DIRECTOR ELECTIONS ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders. AUDIT-RELATED ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Definium Therapeutics, Inc. 24477V105 CA24477V1058 06/11/2026 To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares. COMPENSATION ISSUER 238349.475400 0 FOR 238349.475400 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Election of Class II directors for a three-year term: Brady Stewart DIRECTOR ELECTIONS ISSUER 141693.742880 0 FOR 141693.742880 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Election of Class II directors for a three-year term: Vikram Malik DIRECTOR ELECTIONS ISSUER 141693.742880 0 FOR 141693.742880 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 141693.742880 0 FOR 141693.742880 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 141693.742880 0 FOR 141693.742880 FOR S000004450 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 141693.742880 0 FOR 141693.742880 FOR 2 S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To elect or re-elect three (3) Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Richard J. Barry DIRECTOR ELECTIONS ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To elect or re-elect three (3) Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Pierre Gravier DIRECTOR ELECTIONS ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To elect or re-elect three (3) Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Claude Nicaise, M.D. DIRECTOR ELECTIONS ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To approve Amendment No. 2 to the Company's 2018 Omnibus Incentive Plan, which, among other things, increases the authorized number of shares issuable thereunder by 4,000,000 shares (from 5,000,000 to 9,000,000 authorized shares). COMPENSATION ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 130427.713080 0 FOR 130427.713080 FOR S000004450 Filana Therapeutics, Inc. 14817C107 US14817C1071 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 130427.713080 0 FOR 130427.713080 FOR 2 S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Election of Directors: Ross Fubini DIRECTOR ELECTIONS ISSUER 102397.878700 0 FOR 102397.878700 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Election of Directors: Christian Henry DIRECTOR ELECTIONS ISSUER 102397.878700 0 AGAINST 102397.878700 AGAINST S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Election of Directors: Sri Kosuri DIRECTOR ELECTIONS ISSUER 102397.878700 0 FOR 102397.878700 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Election of Directors: Harry E. Sloan DIRECTOR ELECTIONS ISSUER 102397.878700 0 FOR 102397.878700 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 102397.878700 0 FOR 102397.878700 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 102397.878700 0 FOR 102397.878700 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 102397.878700 0 FOR 102397.878700 FOR 2 S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Tom Cusack DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage DIRECTOR ELECTIONS ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 410687.090480 0 FOR 410687.090480 FOR 2 S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. COMPENSATION ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To amend the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares. COMPENSATION ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Heron Therapeutics, Inc. 427746102 US4277461020 06/11/2026 To ratify, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 410687.090480 0 FOR 410687.090480 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Andrew Dudum DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Kofi Amoo-Gottfried DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Delos Cosgrove, M.D. DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Anja Manuel DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Christopher Payne DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Andrea Perez DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: Kare Schultz DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Election of Directors: David Wells DIRECTOR ELECTIONS ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR S000004450 Hims & Hers Health, Inc. 433000106 US4330001060 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 192056.168340 398400.000000 FOR 192056.168340 FOR 2 S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Natasha Hernday DIRECTOR ELECTIONS ISSUER 115715.902310 0 FOR 115715.902310 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Eric Dobmeier DIRECTOR ELECTIONS ISSUER 115715.902310 0 FOR 115715.902310 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 115715.902310 0 FOR 115715.902310 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 115715.902310 0 FOR 115715.902310 FOR S000004450 Janux Therapeutics, Inc. 47103J105 US47103J1051 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 115715.902310 0 FOR 115715.902310 FOR 2 S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Charles N. Mills DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Jacob D. Best DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: James M. Boyle DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Richard A. Galanti DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Patrick J. Healy DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Andrew J. Mills DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Elect Directors: Stephen H. Wise DIRECTOR ELECTIONS ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Advisory Vote to Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Advisory Vote to Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 682726.687920 0 FOR 682726.687920 FOR 2 S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 682726.687920 0 ONE YEAR 682726.687920 FOR S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 682726.687920 0 ONE YEAR 682726.687920 FOR 2 S000004450 Medline Inc. 58507V107 US58507V1070 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 682726.687920 0 FOR 682726.687920 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/11/2026 Election of Directors: Ellen Hukkelhoven, Ph.D. DIRECTOR ELECTIONS ISSUER 128753.557800 0 FOR 128753.557800 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/11/2026 Election of Directors: Nicole Seligman DIRECTOR ELECTIONS ISSUER 128753.557800 0 FOR 128753.557800 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/11/2026 Election of Directors: Debra Yu, M.D. DIRECTOR ELECTIONS ISSUER 128753.557800 0 FOR 128753.557800 FOR S000004450 MeiraGTx Holdings Plc G59665102 KYG596651029 06/11/2026 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 128753.557800 0 FOR 128753.557800 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. DIRECTOR ELECTIONS ISSUER 91499.748300 0 FOR 91499.748300 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. DIRECTOR ELECTIONS ISSUER 91499.748300 0 FOR 91499.748300 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. DIRECTOR ELECTIONS ISSUER 91499.748300 0 FOR 91499.748300 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 US61225M1027 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 91499.748300 0 FOR 91499.748300 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Rowan Chapman DIRECTOR ELECTIONS ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Herm Rosenman DIRECTOR ELECTIONS ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class II Nominees: Jonathan Sheena DIRECTOR ELECTIONS ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To elect three directors named in the proxy statement accompanying this notice to serve as Class II directors until the annual meeting of stockholders held in 2029 and until their successors are duly elected and qualified, and to elect one director named in the proxy statement accompanying this notice to serve as a Class I director until the annual meeting of stockholders held in 2028 and until his successor is duly elected and qualified. Class I Nominee: Eric H. Rubin DIRECTOR ELECTIONS ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 388732.122780 0 FOR 388732.122780 FOR 2 S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 388732.122780 0 ONE YEAR 388732.122780 FOR S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 388732.122780 0 ONE YEAR 388732.122780 FOR 2 S000004450 Natera, Inc. 632307104 US6323071042 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 388732.122780 0 FOR 388732.122780 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 The election of Kirsten Castillo and Satish Chandran, Ph.D. as Class III Directors to hold office until the 2029 Annual Meeting: Kirsten Castillo DIRECTOR ELECTIONS ISSUER 920153.907120 0 FOR 920153.907120 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 The election of Kirsten Castillo and Satish Chandran, Ph.D. as Class III Directors to hold office until the 2029 Annual Meeting: Satish Chandran, Ph.D. DIRECTOR ELECTIONS ISSUER 920153.907120 0 FOR 920153.907120 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 920153.907120 0 FOR 920153.907120 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920153.907120 0 FOR 920153.907120 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920153.907120 0 FOR 920153.907120 FOR 2 S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920153.907120 0 ONE YEAR 920153.907120 FOR S000004450 Ocugen, Inc. 67577C105 US67577C1053 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920153.907120 0 ONE YEAR 920153.907120 FOR 2 S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To elect three class III directors named in the proxy statement to our Board of Directors: Bernard Coulie, M.D., Ph.D., M.B.A. DIRECTOR ELECTIONS ISSUER 151345.963800 0 FOR 151345.963800 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To elect three class III directors named in the proxy statement to our Board of Directors: Gayle Crowell DIRECTOR ELECTIONS ISSUER 151345.963800 0 FOR 151345.963800 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To elect three class III directors named in the proxy statement to our Board of Directors: Steve Krognes, M.B.A. DIRECTOR ELECTIONS ISSUER 151345.963800 0 FOR 151345.963800 FOR S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 151345.963800 0 AGAINST 151345.963800 AGAINST S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 151345.963800 0 AGAINST 151345.963800 AGAINST 2 S000004450 Pliant Therapeutics, Inc. 729139105 US7291391057 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 151345.963800 0 FOR 151345.963800 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Maria Sainz DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 Election of Directors: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 Pulse Biosciences, Inc. 74587B101 US74587B1017 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 13659.291860 46700.000000 FOR 13659.291860 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Laurence Charney DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Yann Echelard DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Daniel Hume DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Sagar Lonial, MD DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 Election of Directors: Michael S. Weiss DIRECTOR ELECTIONS ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 446681.784640 0 FOR 446681.784640 FOR S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 446681.784640 0 AGAINST 446681.784640 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 446681.784640 0 AGAINST 446681.784640 AGAINST 2 S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 Election of Class I Directors: Robert S. Epstein, M.D., M.S. DIRECTOR ELECTIONS ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 Election of Class I Directors: Karin Jooss, Ph.D. DIRECTOR ELECTIONS ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 Election of Class I Directors: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 289244.856920 0 FOR 289244.856920 FOR 2 S000004450 Fate Therapeutics, Inc. 31189P102 US31189P1021 06/12/2026 To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 289244.856920 0 FOR 289244.856920 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 US52635N1037 06/12/2026 To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Evert Schimmelpennink DIRECTOR ELECTIONS ISSUER 419.218080 34600.000000 FOR 419.218080 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 US52635N1037 06/12/2026 To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Jeff George DIRECTOR ELECTIONS ISSUER 419.218080 34600.000000 FOR 419.218080 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 US52635N1037 06/12/2026 To elect three Class II directors to hold office until our 2029 annual meeting of stockholders, each until their respective successors are elected and qualified: Shelley Thunen DIRECTOR ELECTIONS ISSUER 419.218080 34600.000000 FOR 419.218080 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 US52635N1037 06/12/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 419.218080 34600.000000 FOR 419.218080 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 305560.776320 0 FOR 305560.776320 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 305560.776320 0 FOR 305560.776320 FOR 2 S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah Gray DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. Mitchell DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O'Connor DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. Pakianathan DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Elect the following directors to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E Winningham DIRECTOR ELECTIONS ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111942.584700 0 FOR 111942.584700 FOR S000004450 Theravance Biopharma, Inc. G8807B106 KYG8807B1068 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111942.584700 0 FOR 111942.584700 FOR 2 S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 111450.855820 0 FOR 111450.855820 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey DIRECTOR ELECTIONS ISSUER 111450.855820 0 FOR 111450.855820 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert DIRECTOR ELECTIONS ISSUER 111450.855820 0 FOR 111450.855820 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 111450.855820 0 FOR 111450.855820 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 111450.855820 0 FOR 111450.855820 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 US6047491013 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 111450.855820 0 FOR 111450.855820 FOR 2 S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Robert Ades DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Jon Giacomin DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Michele Korfin DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 186264.587100 0 WITHHOLD 186264.587100 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Election of Directors: Gilberto Quintero DIRECTOR ELECTIONS ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 186264.587100 0 FOR 186264.587100 FOR 2 S000004450 Organogenesis Holdings Inc. 68621F102 US68621F1021 06/15/2026 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 186264.587100 0 FOR 186264.587100 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D. DIRECTOR ELECTIONS ISSUER 348720.090160 0 FOR 348720.090160 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D. DIRECTOR ELECTIONS ISSUER 348720.090160 0 FOR 348720.090160 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A. DIRECTOR ELECTIONS ISSUER 348720.090160 0 FOR 348720.090160 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 348720.090160 0 FOR 348720.090160 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 348720.090160 0 FOR 348720.090160 FOR S000004450 Vaxcyte, Inc. 92243G108 US92243G1085 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 348720.090160 0 FOR 348720.090160 FOR 2 S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Robert Bazemore DIRECTOR ELECTIONS ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To elect three Class III directors to hold office until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation or removal: Richard Rodgers DIRECTOR ELECTIONS ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES ISSUER 717756.734240 0 FOR 717756.734240 FOR 2 S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years; SECTION 14A SAY-ON-PAY VOTES ISSUER 717756.734240 0 ONE YEAR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years; SECTION 14A SAY-ON-PAY VOTES ISSUER 717756.734240 0 ONE YEAR 717756.734240 FOR 2 S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. COMPENSATION ISSUER 717756.734240 0 FOR 717756.734240 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Nadim Ahmed DIRECTOR ELECTIONS ISSUER 87011.803000 0 FOR 87011.803000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Stephen Webster DIRECTOR ELECTIONS ISSUER 87011.803000 0 FOR 87011.803000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 87011.803000 0 FOR 87011.803000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 87011.803000 0 FOR 87011.803000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 87011.803000 0 FOR 87011.803000 FOR 2 S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 Election of Directors: Class II Nominees: Vina Leite DIRECTOR ELECTIONS ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 Election of Directors: Class II Nominees: James M. Travers DIRECTOR ELECTIONS ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 256095.066720 0 FOR 256095.066720 FOR 2 S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve a series of six alternative amendments to the Company's Second Amended and Restated Certificate of Incorporation to effect (i) a reverse stock split of the Company's common stock at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 (each, a "Reverse Stock Split"), with such ratio and the time of the Reverse Stock Split as determined in the sole discretion of the Company's Board of Directors at a later date, and (ii) a proportionate reduction in the number of authorized shares of the Company's common stock and preferred stock by a corresponding ratio. CAPITAL STRUCTURE ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 DocGo Inc. 256086109 US2560861096 06/16/2026 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 256095.066720 0 FOR 256095.066720 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Election of Directors: Wendy Barnes DIRECTOR ELECTIONS ISSUER 254650.936400 0 FOR 254650.936400 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Election of Directors: Ronald E. Bruehlman DIRECTOR ELECTIONS ISSUER 254650.936400 0 FOR 254650.936400 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Election of Directors: Gregory Mondre DIRECTOR ELECTIONS ISSUER 254650.936400 0 FOR 254650.936400 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 254650.936400 0 FOR 254650.936400 FOR S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 254650.936400 0 AGAINST 254650.936400 AGAINST S000004450 GoodRx Holdings, Inc. 38246G108 US38246G1085 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 254650.936400 0 AGAINST 254650.936400 AGAINST 2 S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 233895.989880 0 FOR 233895.989880 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. DIRECTOR ELECTIONS ISSUER 233895.989880 0 FOR 233895.989880 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. DIRECTOR ELECTIONS ISSUER 233895.989880 0 FOR 233895.989880 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 233895.989880 0 FOR 233895.989880 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES ISSUER 233895.989880 0 FOR 233895.989880 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 US45166A1025 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES ISSUER 233895.989880 0 FOR 233895.989880 FOR 2 S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Mark Currie, Ph.D. DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Alexander Denner, Ph.D. DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jon Duane DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Marla Kessler DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Thomas McCourt DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Julie McHugh DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Election of Directors. To elect eight director nominees numbered 01 through 08 to serve for a one-year term extending until the 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jay Shepard DIRECTOR ELECTIONS ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 430476.275040 0 FOR 430476.275040 FOR 2 S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. COMPENSATION ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 US46333X1081 06/16/2026 Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 430476.275040 0 FOR 430476.275040 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 Election of Directors: David Johnson DIRECTOR ELECTIONS ISSUER 180683.525800 0 FOR 180683.525800 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 Election of Directors: Katie Rielly-Gauvin DIRECTOR ELECTIONS ISSUER 180683.525800 0 FOR 180683.525800 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 Election of Directors: Ramandeep Singh DIRECTOR ELECTIONS ISSUER 180683.525800 0 FOR 180683.525800 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. AUDIT-RELATED ISSUER 180683.525800 0 FOR 180683.525800 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180683.525800 0 FOR 180683.525800 FOR S000004450 Liquidia Corporation 53635D202 US53635D2027 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180683.525800 0 FOR 180683.525800 FOR 2 S000004450 Nuvalent, Inc. 670703107 US6707031075 06/16/2026 Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 118454.100880 0 FOR 118454.100880 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/16/2026 Election of the following nominees as Class II directors: Ron Squarer DIRECTOR ELECTIONS ISSUER 118454.100880 0 FOR 118454.100880 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118454.100880 0 FOR 118454.100880 FOR S000004450 Nuvalent, Inc. 670703107 US6707031075 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 118454.100880 0 FOR 118454.100880 FOR 2 S000004450 Nuvalent, Inc. 670703107 US6707031075 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 118454.100880 0 FOR 118454.100880 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Brian J. Blaser DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Kenneth F. Buechler, Ph.D. DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: John R. Chiminski DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Edward L. Michael DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Mary Lake Polan, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Kenneth J. Widder, M.D. DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Election of Directors: To be elected for terms expiring in 2027: Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 201399.122720 0 FOR 201399.122720 FOR 2 S000004450 QuidelOrtho Corporation 219798105 US2197981051 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 201399.122720 0 FOR 201399.122720 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: William J. Link, Ph.D. DIRECTOR ELECTIONS ISSUER 102476.598840 0 FOR 102476.598840 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Robert Warner DIRECTOR ELECTIONS ISSUER 102476.598840 0 FOR 102476.598840 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 102476.598840 0 FOR 102476.598840 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 102476.598840 0 FOR 102476.598840 FOR S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 102476.598840 0 FOR 102476.598840 FOR 2 S000004450 RxSight, Inc. 78349D107 US78349D1072 06/16/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 102476.598840 0 FOR 102476.598840 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Raymond J. Deshaies DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Election of the nine nominees to the Board named in this Proxy Statement to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. Simpson DIRECTOR ELECTIONS ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 147248.935810 0 FOR 147248.935810 FOR S000004450 Xencor, Inc. 98401F105 US98401F1057 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 147248.935810 0 FOR 147248.935810 FOR 2 S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/16/2026 Election of each of the Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: David Johnson DIRECTOR ELECTIONS ISSUER 148755.260360 0 FOR 148755.260360 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/16/2026 Election of each of the Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Jan Skvarka, Ph.D. DIRECTOR ELECTIONS ISSUER 148755.260360 0 FOR 148755.260360 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/16/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 148755.260360 0 FOR 148755.260360 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 148755.260360 0 FOR 148755.260360 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 148755.260360 0 FOR 148755.260360 FOR 2 S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Nancy Miller-Rich DIRECTOR ELECTIONS ISSUER 126271.882660 0 FOR 126271.882660 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 126271.882660 0 FOR 126271.882660 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Election of three Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Shawn Cline Tomasello, MBA DIRECTOR ELECTIONS ISSUER 126271.882660 0 FOR 126271.882660 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 126271.882660 0 FOR 126271.882660 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 126271.882660 0 FOR 126271.882660 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 US35104E1001 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 126271.882660 0 FOR 126271.882660 FOR 2 S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Adrian Adams DIRECTOR ELECTIONS ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Michael Rogers DIRECTOR ELECTIONS ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: LeAnne M. Zumwalt DIRECTOR ELECTIONS ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Approval of an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and to increase the number of authorized shares of common stock from 350,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 742398.082060 0 FOR 742398.082060 FOR 2 S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 742398.082060 0 ONE YEAR 742398.082060 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 742398.082060 0 ONE YEAR 742398.082060 FOR 2 S000004450 Akebia Therapeutics, Inc. 00972D105 US00972D1054 06/17/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 742398.082060 0 FOR 742398.082060 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 ELECTION OF DIRECTORS: Elizabeth Garofalo, M.D. DIRECTOR ELECTIONS ISSUER 216001.759280 0 FOR 216001.759280 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 ELECTION OF DIRECTORS: Errol De Souza, Ph.D. DIRECTOR ELECTIONS ISSUER 216001.759280 0 FOR 216001.759280 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 ELECTION OF DIRECTORS: Kristine Yaffe, M.D. DIRECTOR ELECTIONS ISSUER 216001.759280 0 FOR 216001.759280 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 216001.759280 0 FOR 216001.759280 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 216001.759280 0 FOR 216001.759280 FOR S000004450 Alector, Inc. 014442107 US0144421072 06/17/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 216001.759280 0 FOR 216001.759280 FOR 2 S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Matthew P. Young DIRECTOR ELECTIONS ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares; CAPITAL STRUCTURE ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan; COMPENSATION ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan; COMPENSATION ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES ISSUER 476455.777940 0 FOR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES ISSUER 476455.777940 0 FOR 476455.777940 FOR 2 S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 476455.777940 0 ONE YEAR 476455.777940 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 476455.777940 0 ONE YEAR 476455.777940 FOR 2 S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 06/17/2026 Election of two Class I Directors, each to serve until the 2029 annual meeting of stockholders: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 287864.950020 0 FOR 287864.950020 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 06/17/2026 Election of two Class I Directors, each to serve until the 2029 annual meeting of stockholders: Elliott Levy, M.D. DIRECTOR ELECTIONS ISSUER 287864.950020 0 FOR 287864.950020 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 287864.950020 0 FOR 287864.950020 FOR S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 287864.950020 0 FOR 287864.950020 FOR 2 S000004450 Editas Medicine, Inc. 28106W103 US28106W1036 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 287864.950020 0 FOR 287864.950020 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Election of Class II Directors: Ian Clark DIRECTOR ELECTIONS ISSUER 331864.689000 0 FOR 331864.689000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Election of Class II Directors: Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 331864.689000 0 FOR 331864.689000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 331864.689000 0 FOR 331864.689000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 331864.689000 0 FOR 331864.689000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 331864.689000 0 FOR 331864.689000 FOR 2 S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 331864.689000 0 ONE YEAR 331864.689000 FOR S000004450 Guardant Health, Inc. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 331864.689000 0 ONE YEAR 331864.689000 FOR 2 S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: Julian Baker DIRECTOR ELECTIONS ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: Daniel Brennan DIRECTOR ELECTIONS ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Re-election of Class I directors: James Daly DIRECTOR ELECTIONS ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 43642.630010 0 FOR 43642.630010 FOR 2 S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 43642.630010 0 FOR 43642.630010 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/17/2026 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class II directors: Patrick J. Balthrop DIRECTOR ELECTIONS ISSUER 298127.513040 0 FOR 298127.513040 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/17/2026 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class II directors: Cynthia Collins DIRECTOR ELECTIONS ISSUER 298127.513040 0 FOR 298127.513040 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/17/2026 To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class II directors: Stanley C. Erck DIRECTOR ELECTIONS ISSUER 298127.513040 0 FOR 298127.513040 FOR S000004450 MaxCyte, Inc. 57777K106 US57777K1060 06/17/2026 To ratify the Audit Committee's selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 298127.513040 0 FOR 298127.513040 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Sean Bohen, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott Garland DIRECTOR ELECTIONS ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi Larson DIRECTOR ELECTIONS ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew Rappaport DIRECTOR ELECTIONS ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 111186.598090 0 FOR 111186.598090 FOR 2 S000004450 Olema Pharmaceuticals, Inc. 68062P106 US68062P1066 06/17/2026 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 111186.598090 0 FOR 111186.598090 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2026 Election of Directors: Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 254079.413990 0 FOR 254079.413990 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2026 Election of Directors: Jennifer Cochran, Ph.D. DIRECTOR ELECTIONS ISSUER 254079.413990 0 FOR 254079.413990 FOR S000004450 OmniAb, Inc. 68218J103 US68218J1034 06/17/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm AUDIT-RELATED ISSUER 254079.413990 0 FOR 254079.413990 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D. DIRECTOR ELECTIONS ISSUER 147821.512280 0 FOR 147821.512280 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 147821.512280 0 FOR 147821.512280 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 147821.512280 0 FOR 147821.512280 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 147821.512280 0 FOR 147821.512280 FOR 2 S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 147821.512280 0 FOR 147821.512280 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 147821.512280 0 FOR 147821.512280 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Election of Directors: Najat Khan, Ph.D. DIRECTOR ELECTIONS ISSUER 52482.112200 1272095.000000 FOR 52482.112200 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Election of Directors: Franziska Michor, Ph.D. DIRECTOR ELECTIONS ISSUER 52482.112200 1272095.000000 FOR 52482.112200 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 52482.112200 1272095.000000 FOR 52482.112200 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 52482.112200 1272095.000000 FOR 52482.112200 FOR 2 S000004450 Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52482.112200 1272095.000000 FOR 52482.112200 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 Election of Directors: Michael Egholm, Ph.D. DIRECTOR ELECTIONS ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 Election of Directors: Thomas Carey DIRECTOR ELECTIONS ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 Election of Directors: Eli Casdin DIRECTOR ELECTIONS ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 730815.405780 0 FOR 730815.405780 FOR 2 S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Standard BioTools Inc. 34385P108 US34385P1084 06/17/2026 To approve an amendment to our Amended and Restated 2017 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares. COMPENSATION ISSUER 730815.405780 0 FOR 730815.405780 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew J. Wallach DIRECTOR ELECTIONS ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 Veeva Systems Inc. 922475108 US9224751084 06/17/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 461738.043800 0 FOR 461738.043800 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Gregory Belinfanti DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Terence Connors DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Brad Coppens DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Suzanne Foster DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Ted Lundberg DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Kenneth Samet DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Dr. Susan Weaver DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: David Williams III DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Election of Directors - To elect the nine director nominees to our board of directors, each to serve as a director for a term of one year expiring at the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified. The following persons have been nominated as directors: Dale Wolf DIRECTOR ELECTIONS ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 279552.210620 0 FOR 279552.210620 FOR S000004450 AdaptHealth Corp. 00653Q102 US00653Q1022 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 279552.210620 0 FOR 279552.210620 FOR 2 S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian Goff DIRECTOR ELECTIONS ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia Smith DIRECTOR ELECTIONS ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 164026.888200 0 FOR 164026.888200 FOR 2 S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. COMPENSATION ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 164026.888200 0 FOR 164026.888200 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 Election of Directors: Deborah Messemer DIRECTOR ELECTIONS ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 Election of Directors: Vicki Sato, Ph.D. DIRECTOR ELECTIONS ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 Election of Directors: Owen Witte, M.D. DIRECTOR ELECTIONS ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 734636.373460 0 FOR 734636.373460 FOR 2 S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 734636.373460 0 ONE YEAR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 734636.373460 0 ONE YEAR 734636.373460 FOR 2 S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Allogene Therapeutics, Inc. 019770106 US0197701065 06/18/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 734636.373460 0 FOR 734636.373460 FOR S000004450 Arrivent BioPharma, Inc. 04272N102 US04272N1028 06/18/2026 Election of Directors: James Healy, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 61827.675840 0 WITHHOLD 61827.675840 AGAINST S000004450 Arrivent BioPharma, Inc. 04272N102 US04272N1028 06/18/2026 Election of Directors: John Hohneker, M.D. DIRECTOR ELECTIONS ISSUER 61827.675840 0 FOR 61827.675840 FOR S000004450 Arrivent BioPharma, Inc. 04272N102 US04272N1028 06/18/2026 Election of Directors: Stuart Lutzker, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 61827.675840 0 FOR 61827.675840 FOR S000004450 Arrivent BioPharma, Inc. 04272N102 US04272N1028 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 61827.675840 0 FOR 61827.675840 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Election of Class III Directors: Jerome Adams, MD, MPH DIRECTOR ELECTIONS ISSUER 151597.412320 0 FOR 151597.412320 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Election of Class III Directors: Howard Berman, PhD DIRECTOR ELECTIONS ISSUER 151597.412320 0 FOR 151597.412320 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Election of Class III Directors: Barbara Duncan DIRECTOR ELECTIONS ISSUER 151597.412320 0 FOR 151597.412320 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 151597.412320 0 FOR 151597.412320 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 151597.412320 0 FOR 151597.412320 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 US04683R1068 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 151597.412320 0 FOR 151597.412320 FOR 2 S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Joseph DeVivo DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Larry Robbins DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Caroll H. Neubauer DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To elect seven directors to serve one-year terms expiring in 2027: Erica Schwartz, M.D., J.D., M.P.H. DIRECTOR ELECTIONS ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 597053.741760 0 FOR 597053.741760 FOR S000004450 Butterfly Network, Inc. 124155102 US1241551027 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 597053.741760 0 FOR 597053.741760 FOR 2 S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 264009.255020 0 FOR 264009.255020 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 264009.255020 0 FOR 264009.255020 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 264009.255020 0 FOR 264009.255020 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 264009.255020 0 FOR 264009.255020 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES ISSUER 264009.255020 0 FOR 264009.255020 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES ISSUER 264009.255020 0 FOR 264009.255020 FOR 2 S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 71670.261520 0 FOR 71670.261520 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 71670.261520 0 FOR 71670.261520 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 71670.261520 0 FOR 71670.261520 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 71670.261520 0 FOR 71670.261520 FOR S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 71670.261520 0 FOR 71670.261520 FOR 2 S000004450 Disc Medicine, Inc. 254604101 US2546041011 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 71670.261520 0 FOR 71670.261520 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Goran Ando, M.D. DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Jay S. Duker, M.D. DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: John B. Landis, Ph.D. DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Wendy DiCicco DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Karen Zaderej DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Stuart Duty DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 Election of Directors: Reginald Sanders, M.D. DIRECTOR ELECTIONS ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares. COMPENSATION ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 219318.276240 0 FOR 219318.276240 FOR 2 S000004450 EyePoint, Inc. 30233G209 US30233G2093 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 219318.276240 0 FOR 219318.276240 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Election of Director: Katherine Stueland DIRECTOR ELECTIONS ISSUER 59892.058680 0 FOR 59892.058680 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 59892.058680 0 FOR 59892.058680 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59892.058680 0 FOR 59892.058680 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59892.058680 0 FOR 59892.058680 FOR 2 S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 59892.058680 0 ONE YEAR 59892.058680 FOR S000004450 GeneDx Holdings Corp. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 59892.058680 0 ONE YEAR 59892.058680 FOR 2 S000004450 GRAIL, Inc. 384747101 US3847471014 06/18/2026 Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: Sarah Krevans DIRECTOR ELECTIONS ISSUER 103249.583320 0 FOR 103249.583320 FOR S000004450 GRAIL, Inc. 384747101 US3847471014 06/18/2026 Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: Steven Mizell DIRECTOR ELECTIONS ISSUER 103249.583320 0 FOR 103249.583320 FOR S000004450 GRAIL, Inc. 384747101 US3847471014 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 103249.583320 0 FOR 103249.583320 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 Election of Directors: Mark L. Baum DIRECTOR ELECTIONS ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 Election of Directors: Adrienne L. Graves DIRECTOR ELECTIONS ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 Election of Directors: Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 Election of Directors: Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 93242.186520 0 FOR 93242.186520 FOR 2 S000004450 Harrow, Inc. 415858109 US4158581094 06/18/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 93242.186520 0 FOR 93242.186520 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D. DIRECTOR ELECTIONS ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 406512.510580 0 FOR 406512.510580 FOR 2 S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares. COMPENSATION ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock. COMPENSATION ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Novavax, Inc. 670002401 US6700024010 06/18/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 406512.510580 0 FOR 406512.510580 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Election of Directors: Thomas J. Cable DIRECTOR ELECTIONS ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Election of Directors: Peter A. Demopulos, M.D. DIRECTOR ELECTIONS ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Election of Directors: Diana T. Perkinson, M.D. DIRECTOR ELECTIONS ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Approval of advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Approval of advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 208821.488150 0 FOR 208821.488150 FOR 2 S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 Omeros Corporation 682143102 US6821431029 06/18/2026 Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 208821.488150 0 FOR 208821.488150 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To approve the Company's 2026 Equity Incentive Plan; COMPENSATION ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 1245647.986380 0 FOR 1245647.986380 FOR 2 S000004450 OPKO Health, Inc. 68375N103 US68375N1037 06/18/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 1245647.986380 0 FOR 1245647.986380 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Jacob M. Chacko, M.D. DIRECTOR ELECTIONS ISSUER 128773.533480 0 FOR 128773.533480 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Mardi C. Dier DIRECTOR ELECTIONS ISSUER 128773.533480 0 FOR 128773.533480 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 128773.533480 0 FOR 128773.533480 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 128773.533480 0 AGAINST 128773.533480 AGAINST S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 128773.533480 0 FOR 128773.533480 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 128773.533480 0 FOR 128773.533480 FOR 2 S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 128773.533480 0 ONE YEAR 128773.533480 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 128773.533480 0 ONE YEAR 128773.533480 FOR 2 S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arani Bose, M.D. DIRECTOR ELECTIONS ISSUER 109893.876560 0 FOR 109893.876560 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Bridget O'Rourke DIRECTOR ELECTIONS ISSUER 109893.876560 0 FOR 109893.876560 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To elect the nominees for Class II director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Surbhi Sarna DIRECTOR ELECTIONS ISSUER 109893.876560 0 FOR 109893.876560 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 109893.876560 0 FOR 109893.876560 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 109893.876560 0 FOR 109893.876560 FOR S000004450 Penumbra, Inc. 70975L107 US70975L1070 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 109893.876560 0 FOR 109893.876560 FOR 2 S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS ISSUER 521170.697050 0 AGAINST 521170.697050 AGAINST S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 521170.697050 0 FOR 521170.697050 FOR 2 S000004450 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 521170.697050 0 FOR 521170.697050 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis Borisy DIRECTOR ELECTIONS ISSUER 477844.863850 0 FOR 477844.863850 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 477844.863850 0 FOR 477844.863850 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 477844.863850 0 FOR 477844.863850 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 477844.863850 0 FOR 477844.863850 FOR S000004450 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 477844.863850 0 FOR 477844.863850 FOR 2 S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Neal C. Bradsher DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Wei Jiang DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Richard T. LeBuhn DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Louis E. Silverman DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Christopher M. Wang DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Election of Directors: Lilian Y. Zhou DIRECTOR ELECTIONS ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Approve an amendment to the Company's Amended and Restated Omnibus Equity Incentive Plan, as amended. COMPENSATION ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Ratify the appointment of the Company's independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 96831.495680 0 FOR 96831.495680 FOR S000004450 STAAR Surgical Company 852312305 US8523123052 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 96831.495680 0 FOR 96831.495680 FOR 2 S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson DIRECTOR ELECTIONS ISSUER 168891.681700 0 FOR 168891.681700 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III DIRECTOR ELECTIONS ISSUER 168891.681700 0 FOR 168891.681700 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 168891.681700 0 FOR 168891.681700 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 168891.681700 0 FOR 168891.681700 FOR 2 S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 168891.681700 0 FOR 168891.681700 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 US8684591089 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. COMPENSATION ISSUER 168891.681700 0 FOR 168891.681700 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: James C. Momtazee DIRECTOR ELECTIONS ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: Frank P. McCormick, Ph.D. DIRECTOR ELECTIONS ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly elected and qualified: Hannah A. Valantine, M.D. DIRECTOR ELECTIONS ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 426972.543650 0 FOR 426972.543650 FOR 2 S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 426972.543650 0 ONE YEAR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 426972.543650 0 ONE YEAR 426972.543650 FOR 2 S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 426972.543650 0 FOR 426972.543650 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Joshua Hausman DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Nikolas W. Stengle DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Denise W. Warren DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Election of Directors: C. Christian Winkle DIRECTOR ELECTIONS ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 666899.445380 0 FOR 666899.445380 FOR 2 S000004450 Brookdale Senior Living Inc. 112463104 US1124631045 06/22/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 666899.445380 0 FOR 666899.445380 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Election of Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Richard A. Friesner DIRECTOR ELECTIONS ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Election of Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rosana Kapeller-Libermann DIRECTOR ELECTIONS ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Election of Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Gary Sender DIRECTOR ELECTIONS ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 192799.604240 0 FOR 192799.604240 FOR 2 S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 Schrodinger, Inc. 80810D103 US80810D1037 06/22/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 192799.604240 0 FOR 192799.604240 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Stuart Holden, M.D. DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Leana S. Wen, M.D., M.Sc. DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman DIRECTOR ELECTIONS ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law. CORPORATE GOVERNANCE ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company's Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors' and officers' Insurance. COMPENSATION ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000 shares. COMPENSATION ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 115102.672300 0 FOR 115102.672300 FOR 2 S000004450 UroGen Pharma Ltd. M96088105 IL0011407140 06/22/2026 To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2027 annual meeting of shareholders. AUDIT-RELATED ISSUER 115102.672300 0 FOR 115102.672300 FOR S000004450 Wave Life Sciences Ltd. 94352A104 US94352A1043 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. EXTRAORDINARY TRANSACTIONS ISSUER 325587.066420 0 FOR 325587.066420 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Michael Dale DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Amy Wendell DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: William Burke DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: John H. Johnson DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Alan M. Levine DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Paul Thomas DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Joseph Tyndall MD DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 Election of Directors: Kathy Weiler DIRECTOR ELECTIONS ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 135318.601120 0 FOR 135318.601120 FOR S000004450 Axogen, Inc. 05463X106 US05463X1063 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 135318.601120 0 FOR 135318.601120 FOR 2 S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Janet Dillione DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Gregory Duncan DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Alan W. Dunton DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Myron Kaplan DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Steven Lefkowitz DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Robert Stewart DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 Election of Directors: Joseph Todisco DIRECTOR ELECTIONS ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR 2 S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve the ratification of the Certificate of Designation Amendments (as defined in the Proxy Statement). CAPITAL STRUCTURE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve amendments to our Charter to make technical changes. CORPORATE GOVERNANCE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the extent permitted by Delaware law and provided that no changes are made to the terms of common stock. CORPORATE GOVERNANCE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to designate the exclusive forums in which certain claims relating to the Company may be brought. SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to limit certain officers' personal liability for monetary damages for breaches of the duty of care, as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 CorMedix Inc. 21900C308 US21900C3088 06/23/2026 To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. CORPORATE GOVERNANCE ISSUER 97860.624020 121997.000000 FOR 97860.624020 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 Election of Directors: Roger Susi DIRECTOR ELECTIONS ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 Election of Directors: Monty Allen DIRECTOR ELECTIONS ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 Election of Directors: Joe Kiani DIRECTOR ELECTIONS ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 Election of Directors: Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 Election of Directors: James Hawkins DIRECTOR ELECTIONS ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026; and AUDIT-RELATED ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 24431.979080 0 FOR 24431.979080 FOR S000004450 IRadimed Corporation 46266A109 US46266A1097 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 24431.979080 0 FOR 24431.979080 FOR 2 S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 17594.897760 144300.000000 FOR 17594.897760 FOR 2 S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17594.897760 144300.000000 ONE YEAR 17594.897760 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 US82835W1080 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17594.897760 144300.000000 ONE YEAR 17594.897760 FOR 2 S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 Election of two Class II directors: Leslie V. Norwalk, Esq. DIRECTOR ELECTIONS ISSUER 159900.797760 0 FOR 159900.797760 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 Election of two Class II directors: Randy Teel, Ph.D. DIRECTOR ELECTIONS ISSUER 159900.797760 0 FOR 159900.797760 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159900.797760 0 FOR 159900.797760 FOR S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 159900.797760 0 FOR 159900.797760 FOR 2 S000004450 Arvinas, Inc. 04335A105 US04335A1051 06/24/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 159900.797760 0 FOR 159900.797760 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks DIRECTOR ELECTIONS ISSUER 110814.095040 0 FOR 110814.095040 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz DIRECTOR ELECTIONS ISSUER 110814.095040 0 FOR 110814.095040 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill DIRECTOR ELECTIONS ISSUER 110814.095040 0 FOR 110814.095040 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 110814.095040 0 FOR 110814.095040 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 110814.095040 0 FOR 110814.095040 FOR 2 S000004450 Fulcrum Therapeutics, Inc. 359616109 US3596161097 06/24/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 110814.095040 0 FOR 110814.095040 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Bruce Booth, D.Phil. DIRECTOR ELECTIONS ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Nello Mainolfi, Ph.D. DIRECTOR ELECTIONS ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFA DIRECTOR ELECTIONS ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 140626.690380 0 FOR 140626.690380 FOR 2 S000004450 Kymera Therapeutics, Inc. 501575104 US5015751044 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 140626.690380 0 FOR 140626.690380 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To elect two Class I directors to serve until our 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Chaim Indig DIRECTOR ELECTIONS ISSUER 175202.090300 0 FOR 175202.090300 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To elect two Class I directors to serve until our 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Jon Kessler DIRECTOR ELECTIONS ISSUER 175202.090300 0 FOR 175202.090300 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 175202.090300 0 FOR 175202.090300 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 175202.090300 0 FOR 175202.090300 FOR S000004450 Phreesia, Inc. 71944F106 US71944F1066 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 175202.090300 0 FOR 175202.090300 FOR 2 S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr DIRECTOR ELECTIONS ISSUER 166671.614340 0 FOR 166671.614340 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David P. Meeker, M.D. DIRECTOR ELECTIONS ISSUER 166671.614340 0 FOR 166671.614340 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 166671.614340 0 FOR 166671.614340 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 166671.614340 0 FOR 166671.614340 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 166671.614340 0 FOR 166671.614340 FOR 2 S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 Election of Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 197077.968780 0 FOR 197077.968780 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 US15117B2025 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 197077.968780 0 FOR 197077.968780 FOR 2 S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251184.392220 0 FOR 251184.392220 FOR 2 S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 HealthEquity, Inc. 42226A107 US42226A1079 06/25/2026 To approve the Amended and Restated Health Equity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 251184.392220 0 FOR 251184.392220 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno DIRECTOR ELECTIONS ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg DIRECTOR ELECTIONS ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison DIRECTOR ELECTIONS ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 93566.619960 0 FOR 93566.619960 FOR 2 S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 US87650L1035 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 93566.619960 0 FOR 93566.619960 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 501099.312120 0 FOR 501099.312120 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 501099.312120 0 FOR 501099.312120 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 501099.312120 0 FOR 501099.312120 FOR S000004450 Erasca, Inc. 29479A108 US29479A1088 06/26/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 501099.312120 0 FOR 501099.312120 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 06/26/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub") and the Company, and approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 327836.533660 0 FOR 327836.533660 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 327836.533660 0 FOR 327836.533660 FOR S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 327836.533660 0 FOR 327836.533660 FOR 2 S000004450 Select Medical Holdings Corporation 81619Q105 US81619Q1058 06/26/2026 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 327836.533660 0 FOR 327836.533660 FOR S000004450 Septerna, Inc. 81734D104 US81734D1046 06/26/2026 To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Shalini Sharp DIRECTOR ELECTIONS ISSUER 32610.102000 0 FOR 32610.102000 FOR S000004450 Septerna, Inc. 81734D104 US81734D1046 06/26/2026 To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Jake Simson DIRECTOR ELECTIONS ISSUER 32610.102000 0 FOR 32610.102000 FOR S000004450 Septerna, Inc. 81734D104 US81734D1046 06/26/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 32610.102000 0 FOR 32610.102000 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 120253.179580 0 FOR 120253.179580 FOR 2 S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 120253.179580 0 FOR 120253.179580 FOR S000004450 Alumis Inc. 022307102 US0223071020 06/30/2026 To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: James B. Tananbaum, M.D. DIRECTOR ELECTIONS ISSUER 189994.168110 0 FOR 189994.168110 FOR S000004450 Alumis Inc. 022307102 US0223071020 06/30/2026 To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Lynn Tetrault, J.D. DIRECTOR ELECTIONS ISSUER 189994.168110 0 FOR 189994.168110 FOR S000004450 Alumis Inc. 022307102 US0223071020 06/30/2026 To elect the three Class II director nominees named below to serve until the Company's 2029 annual meeting of stockholders: Zhengbin (Bing) Yao, Ph.D. DIRECTOR ELECTIONS ISSUER 189994.168110 0 WITHHOLD 189994.168110 AGAINST S000004450 Alumis Inc. 022307102 US0223071020 06/30/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 189994.168110 0 FOR 189994.168110 FOR S000004450 AGILON HEALTH, INC. 00857U107 US00857U1079 03/17/2026 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"). CAPITAL STRUCTURE ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 64.000000 FOR S000004450 AGILON HEALTH, INC. 00857U107 US00857U1079 03/17/2026 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal. CORPORATE GOVERNANCE ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 64.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 27.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Election of Director: Albert G. White III DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 US2166485019 04/07/2026 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 26.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Jerome Durso DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR John M. Gill DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Philip L. Hodges DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Diane Jorkasky, M.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Teri Lawver DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Wayne Pisano DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Mitchel Sayare, Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR K. O. Schafer MD MPH DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 DIRECTOR Catherine Sohn, Pharm D DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 26.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock. CAPITAL STRUCTURE ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 27.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 29.000000 FOR S000004450 ALTIMMUNE INC. 02155H200 US02155H2004 04/16/2026 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 27.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 30.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 26.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 31.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Karen W. Katz DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 31.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: James A. Rechtin DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Election of Director: Gordon Smith DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 The ratification of the appointment of Pricewater-houseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 30.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 30.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 31.000000 FOR S000004450 HUMANA INC. 444859102 US4448591028 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 14.000000 AGAINST AGAINST 17.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: Gary D. Blackford (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: William P. Burke (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: James L. Cunniff (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: Dr. Lisa Egbuonu-Davis (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: Indrani L. Franchini (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: Patrick J. O'Leary (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: David C. Pacitti (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Election of Director: Dr. Julie Shimer (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 8.000000 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 US05350V1061 04/21/2026 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. COMPENSATION ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Election of Director: Melinda Litherland DIRECTOR ELECTIONS ISSUER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Election of Director: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 US0905722072 04/21/2026 Stockholder proposal regarding dual class capital structure. CAPITAL STRUCTURE SECURITY HOLDER 3.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 3.000000 AGAINST AGAINST 0.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: David M. Cordani DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 54.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Eric J. Foss DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 53.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Neesha Hathi DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: George Kurian DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 54.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 54.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Election of Director: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 54.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Advisory approval of executive compensation COMPENSATION ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 52.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 51.000000 FOR S000004450 THE CIGNA GROUP 125523100 US1255231003 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent CORPORATE GOVERNANCE SECURITY HOLDER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 27.000000 AGAINST AGAINST 29.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 28.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: William R. Frist DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 30.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Election of Director: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 29.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 31.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 6.000000 AGAINST AGAINST 28.000000 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 11.000000 AGAINST AGAINST 22.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: Ari Bousbib DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 33.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: Carol J. Burt DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 33.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: John G. Danhakl DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: James A. Fasano DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 33.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 33.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 34.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Election of Director: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 28.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 31.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 22.000000 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 US46266C1053 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 9.000000 AGAINST AGAINST 26.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 491.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 499.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 493.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Joaquin Duato DIRECTOR ELECTIONS ISSUER 499.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 25.000000 AGAINST FOR 473.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 485.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 493.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Hubert Joly DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 22.000000 AGAINST FOR 475.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 499.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 491.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: John G. Morikis DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 494.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 495.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 480.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Nadja Y. West DIRECTOR ELECTIONS ISSUER 498.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 492.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Election of Director: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 499.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 481.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation COMPENSATION ISSUER 498.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 26.000000 AGAINST FOR 469.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 499.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 40.000000 AGAINST FOR 458.000000 FOR S000004450 JOHNSON & JOHNSON 478160104 US4781601046 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 499.000000 0.000000 ABSTAIN 3.000000 AGAINST FOR 120.000000 AGAINST AGAINST 376.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 1536.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 45.000000 AGAINST FOR 1486.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Albert Bourla DIRECTOR ELECTIONS ISSUER 1534.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 119.000000 AGAINST FOR 1411.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 1535.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 62.000000 AGAINST FOR 1468.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 1536.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 63.000000 AGAINST FOR 1467.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 1535.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 266.000000 AGAINST FOR 1263.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 1534.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 55.000000 AGAINST FOR 1475.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Dan R. Littman DIRECTOR ELECTIONS ISSUER 1534.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 71.000000 AGAINST FOR 1459.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 1536.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 104.000000 AGAINST FOR 1427.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 1535.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 114.000000 AGAINST FOR 1417.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: James Quincey DIRECTOR ELECTIONS ISSUER 1536.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 40.000000 AGAINST FOR 1491.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: James C. Smith DIRECTOR ELECTIONS ISSUER 1536.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 111.000000 AGAINST FOR 1420.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Election of Director: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 1535.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 33.000000 AGAINST FOR 1497.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Ratify the selection of KPMG LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 1535.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 128.000000 AGAINST FOR 1404.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 1535.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 134.000000 AGAINST FOR 1391.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 2026 advisory approval of executive compensation COMPENSATION ISSUER 1534.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 172.000000 AGAINST FOR 1348.000000 FOR S000004450 PFIZER INC. 717081103 US7170811035 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 1536.000000 0.000000 ABSTAIN 13.000000 AGAINST FOR 407.000000 AGAINST AGAINST 1116.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Election of Class II Director: Parvinderjit S. Khanuja DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Election of Class II Director: Robert A. Ortenzio DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Election of Class II Director: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Amendment to the Company's Amended and Restated Certificate of Incorporation to phase out the classified structure of the Board. CORPORATE GOVERNANCE ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. CORPORATE GOVERNANCE ISSUER 29.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 24.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 04/23/2026 Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. CORPORATE GOVERNANCE ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 7.000000 AGAINST AGAINST 23.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: N. Ahuja DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 467.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 467.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: S. E. Blount DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 462.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: R. B. Ford DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 25.000000 AGAINST FOR 443.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: P. Gonzalez DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 466.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 464.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: D. W. McDew DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 466.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: N. McKinstry DIRECTOR ELECTIONS ISSUER 470.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 24.000000 AGAINST FOR 445.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 470.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 457.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: M. F. Roman DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 461.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: D. J. Starks DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 20.000000 AGAINST FOR 448.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Election of Director: J. G. Stratton DIRECTOR ELECTIONS ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 461.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 457.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation COMPENSATION ISSUER 469.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 39.000000 AGAINST FOR 428.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 19.000000 AGAINST FOR 449.000000 FOR S000004450 ABBOTT LABORATORIES 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 469.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 466.000000 FOR S000004450 BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 30.000000 FOR S000004450 BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 30.000000 FOR S000004450 BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 30.000000 FOR S000004450 BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 BIOHAVEN LTD G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 28.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 27.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 Election of Director for term of one year: Pascale Witz DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 28.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 To approve an amendment to Revvity's Amended and Restated By-Laws to Allow Shareholders Owning 25% of Our Stock to Call a Special Meeting. CORPORATE GOVERNANCE ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 REVVITY, INC. 714046109 US7140461093 04/28/2026 To approve the shareholder proposal regarding Executives to Retain Significant Stock. CORPORATE GOVERNANCE SECURITY HOLDER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 13.000000 AGAINST AGAINST 17.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 DIRECTOR Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 DIRECTOR Michael S. Klein DIRECTOR ELECTIONS ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 DIRECTOR Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 DIRECTOR Dale A. White DIRECTOR ELECTIONS ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 Advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 CLARITEV CORPORATION 62548M209 US62548M2098 04/29/2026 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 1.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. COMPENSATION ISSUER 18.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 11.000000 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 US29089Q1058 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 10.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Alan L. Rubino DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Heidi Hagen DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Kevin F. McLaughlin DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Paul K. Wotton DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 DIRECTOR Lisa Wright DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. COMPENSATION ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 12.000000 FOR S000004450 VERICEL CORPORATION 92346J108 US92346J1088 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 15.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: David C. Habiger DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 61.000000 AGAINST FOR 428.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 489.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 18.000000 AGAINST FOR 470.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 37.000000 AGAINST FOR 452.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 489.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 486.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Susan E. Morano DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 478.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 489.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 486.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 36.000000 AGAINST FOR 452.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 488.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: David S. Wichmann DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 486.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Election of Director: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 20.000000 AGAINST FOR 469.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 489.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 43.000000 AGAINST FOR 445.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 490.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 45.000000 AGAINST FOR 443.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 488.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 8.000000 AGAINST FOR 481.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 490.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 59.000000 AGAINST FOR 430.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 490.000000 0.000000 ABSTAIN 39.000000 AGAINST AGAINST 9.000000 AGAINST FOR 442.000000 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 US1011371077 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 490.000000 0.000000 ABSTAIN 2.000000 AGAINST FOR 195.000000 AGAINST AGAINST 293.000000 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 US20603L1026 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: Vipin Gopal DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 US20603L1026 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: William K. Newton DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 30.000000 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 US20603L1026 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 25.000000 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 US20603L1026 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 30.000000 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 US20603L1026 04/30/2026 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 409.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 401.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 410.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 403.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 411.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 398.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 409.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 395.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 410.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 404.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 409.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 394.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 410.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 19.000000 AGAINST FOR 389.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 410.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 404.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 410.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 16.000000 AGAINST FOR 393.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 410.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 32.000000 AGAINST FOR 378.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. COMPENSATION ISSUER 410.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 31.000000 AGAINST FOR 378.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 410.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 20.000000 AGAINST FOR 389.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 410.000000 0.000000 ABSTAIN 1.000000 AGAINST FOR 111.000000 AGAINST AGAINST 298.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 410.000000 0.000000 ABSTAIN 6.000000 AGAINST FOR 45.000000 AGAINST AGAINST 359.000000 FOR S000004450 GILEAD SCIENCES, INC. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. ENVIRONMENT OR CLIMATE SECURITY HOLDER 409.000000 0.000000 ABSTAIN 2.000000 AGAINST FOR 2.000000 AGAINST AGAINST 405.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 DIRECTOR Gary L. Ellis DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 DIRECTOR Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 DIRECTOR Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. CORPORATE GOVERNANCE ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 4.000000 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 US4577301090 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 93.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Lewis Chew DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 Election of Director: David J. Rosa DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 90.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 US46120E6023 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 88.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 Election Of Class II Director: Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 Election Of Class II Director: Mr. Heinz Mausli DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 Election Of Class II Director: Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 Election Of Class II Director: Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 21.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 20.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. CORPORATE GOVERNANCE ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 US5165441032 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 DIRECTOR Samuel L. Barker, Ph.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 DIRECTOR Christopher J. Sobecki DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 DIRECTOR Judith L. Swain, M.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 Ratification and approval of the Company's Seventh Amended and Restated Certificate of Incorporation CAPITAL STRUCTURE ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 58.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 Approval of the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 56.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 Approval of the Company's 2026 Non-Employee Directors' Equity Incentive Plan COMPENSATION ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 56.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers COMPENSATION ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 56.000000 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 US5288723027 04/30/2026 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 60.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 33.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 32.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Donal O'Connor DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To provide advisory approval of the Company's executive compensation. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERRIGO COMPANY PLC G97822103 IE00BGH1M568 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Cary S. Grace DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: James H. Hinton DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Celia P. Huber DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Eric P. Palmer DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 Election of Director: Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 9.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 8.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 US0017441017 05/01/2026 A shareholder proposal entitled: "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 2.000000 AGAINST AGAINST 8.000000 FOR S000004450 MASIMO CORPORATION 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo Corporation ("Masimo"), Danaher Corporation ("Danaher"), and Mobius Merger Sub, Inc., a wholly owned subsidiary of Danaher ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Masimo, with Masimo surviving the merger as a wholly owned subsidiary of Danaher (the "Merger" and such proposal, the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 MASIMO CORPORATION 574795100 US5747951003 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of Director to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 217.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 216.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of Director to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 217.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 204.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of Director to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 217.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 212.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Election of Director to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 217.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 207.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. COMPENSATION ISSUER 217.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 10.000000 AGAINST FOR 206.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 216.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 202.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. CORPORATE GOVERNANCE ISSUER 217.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 214.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 218.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 214.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 218.000000 0.000000 ABSTAIN 1.000000 AGAINST FOR 89.000000 AGAINST AGAINST 128.000000 FOR S000004450 ELI LILLY AND COMPANY 532457108 US5324571083 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 217.000000 0.000000 ABSTAIN 2.000000 AGAINST FOR 39.000000 AGAINST AGAINST 176.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 15.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 22.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 21.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 22.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 22.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 INNOVIVA, INC. 45781M101 US45781M1018 05/04/2026 Approval of the 2026 Equity Incentive Plan. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 22.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: William F. Feehery DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Robert F. Friel DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Eric M. Green DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Election of Director: Paolo Pucci DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 17.000000 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 US9553061055 05/04/2026 Shareholder proposal regarding an independent Board Chair policy. CORPORATE GOVERNANCE SECURITY HOLDER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 9.000000 AGAINST AGAINST 10.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 169.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 168.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Andrew P. Hider DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 169.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 169.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 169.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 169.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 166.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Brent Shafer DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 168.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 168.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Election of Director: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 169.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 COMPENSATION ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 155.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 165.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 170.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 33.000000 AGAINST FOR 137.000000 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 US0718131099 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size CORPORATE GOVERNANCE ISSUER 170.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 164.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 22.000000 AGAINST FOR 650.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 8.000000 AGAINST FOR 664.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 29.000000 AGAINST FOR 643.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 661.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 661.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 665.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Paula A. Price DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 660.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Derica W. Rice DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 16.000000 AGAINST FOR 656.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 672.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 654.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 8.000000 AGAINST FOR 664.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Election of Director: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 668.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers COMPENSATION ISSUER 673.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 32.000000 AGAINST FOR 638.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 673.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 29.000000 AGAINST FOR 642.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 673.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 26.000000 AGAINST FOR 646.000000 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 US1101221083 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 673.000000 0.000000 ABSTAIN 3.000000 AGAINST FOR 177.000000 AGAINST AGAINST 493.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Steven Barg DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 14.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Mark Enyedy DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: James C. Foster DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Birgit Girshick DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Paul Graves DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: George Llado DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Martin Mackay DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Election of Director: Virginia Wilson DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 2026 Long-Term Incentive Plan COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 US1598641074 05/05/2026 Ratification of Pricewaterhousecoopers LLC as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 208.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 202.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 32.000000 AGAINST FOR 177.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 209.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 44.000000 AGAINST FOR 166.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 206.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 205.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 47.000000 AGAINST FOR 163.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 200.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 39.000000 AGAINST FOR 171.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 195.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 198.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. COMPENSATION ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 199.000000 FOR S000004450 DANAHER CORPORATION 235851102 US2358511028 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 210.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 194.000000 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 US40145W1018 05/05/2026 Election of Class II Director to hold office until the Annual Meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 US40145W1018 05/05/2026 Election of Class II Director to hold office until the Annual Meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 US40145W1018 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 6.000000 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 US40145W1018 05/05/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 Election of Class I Director: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 36.000000 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 Election of Class I Director: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. COMPENSATION ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 36.000000 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 US40637H1095 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Election of Director: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 26.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Election of Director: Patrice A. Harris, M.D., M.A. DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Election of Director: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 24.000000 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 US00404A1097 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Deb Autor DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 47.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 46.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Jeff George DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 47.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: John Kiely DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 44.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Paul Meister DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 44.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Ted Nark DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 51.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Chintu Patel DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Chirag Patel DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Gautam Patel DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Election of Director: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 47.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 51.000000 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 US03168L1052 05/06/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 MODERNA, INC. 60770K107 US60770K1079 05/06/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 99.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 79.000000 FOR S000004450 MODERNA, INC. 60770K107 US60770K1079 05/06/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas Hussain DIRECTOR ELECTIONS ISSUER 100.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 98.000000 FOR S000004450 MODERNA, INC. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 100.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 38.000000 AGAINST FOR 62.000000 FOR S000004450 MODERNA, INC. 60770K107 US60770K1079 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 100.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 100.000000 FOR S000004450 MODERNA, INC. 60770K107 US60770K1079 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 100.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 99.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 15.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Francis S. Soistman DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 9.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 13.000000 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 US60855R1005 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. CORPORATE GOVERNANCE ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 05/06/2026 To approve and adopt the Merger Agreement. EXTRAORDINARY TRANSACTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 05/06/2026 To adjourn or postpone the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to the accompanying proxy statement/prospectus is timely provided to Penumbra Stockholders. CORPORATE GOVERNANCE ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 14.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 110.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 109.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Kevin A. Lobo (Chair of the Board and Chief Executive Officer) DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 107.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 93.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Sherilyn S. McCoy (Lead Independent Director) DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 112.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 111.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 106.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 111.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 109.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Election of Director: Rajeev Suri DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 111.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 102.000000 FOR S000004450 STRYKER CORPORATION 863667101 US8636671013 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. COMPENSATION ISSUER 114.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 8.000000 AGAINST FOR 105.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR William W. Burke DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Valerie L. Asbury DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Sheri L. Dodd DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Raymond O. Huggenberger DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Laura G. King DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Andrea A. Pearson DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR D. Brent Shafer DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR Carmen B. Volkart DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 DIRECTOR B. Vindell Washington DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 US87357P1003 05/06/2026 Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. CORPORATE GOVERNANCE ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Simon Dingemans DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 1.000000 AGAINST FOR 217.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 4.000000 AGAINST FOR 213.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Gregory Lucier DIRECTOR ELECTIONS ISSUER 224.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 5.000000 AGAINST FOR 212.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 215.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Joseph Massaro DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 215.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 224.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 1.000000 AGAINST FOR 216.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Mala Murthy DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 216.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Michael Severino DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 214.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Election of Director: Gregory Summe DIRECTOR ELECTIONS ISSUER 225.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 28.000000 AGAINST FOR 190.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Advisory Approval of Named Executive Officer Compensation COMPENSATION ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 219.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 224.000000 0.000000 2.0 0.000000 AGAINST 3.0 5.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 219.000000 FOR S000004450 AVANTOR, INC. 05352A100 US05352A1007 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 225.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 222.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 188.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 191.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 191.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 184.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 185.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 192.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 16.000000 AGAINST FOR 175.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 191.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 181.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 191.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 191.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 191.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 178.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Election of Director: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 191.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 185.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation COMPENSATION ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 18.000000 AGAINST FOR 174.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 171.000000 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 US28176E1082 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 192.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 185.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 US29261A1007 05/07/2026 An advisory vote to approve executive compensation. COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 149.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 149.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 145.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 149.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 149.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 149.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 141.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Anne T. Madden DIRECTOR ELECTIONS ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 149.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: William J. Stromberg DIRECTOR ELECTIONS ISSUER 149.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 148.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Election of Director: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 149.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. COMPENSATION ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 145.000000 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 US36266G1076 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 150.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 150.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 19.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 US4579852082 05/07/2026 To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Pablo Perversi DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 5.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Brian Shepherd DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Election of Director: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Ratification of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 US5926881054 05/07/2026 Advisory Vote to Approve Executive Compensation COMPENSATION ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 5.000000 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 US6359061008 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: Emil E. Hassan DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 US6359061008 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: Lisa Piercey, M.D. DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 US6359061008 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: William A. Adams DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 US6359061008 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman, M.D. DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 19.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year. COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 US58502B1061 05/07/2026 Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Director: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 584.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 30.000000 AGAINST FOR 553.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Director: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 585.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 10.000000 AGAINST FOR 574.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Director: Robert A. Michael DIRECTOR ELECTIONS ISSUER 585.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 36.000000 AGAINST FOR 548.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Director: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 585.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 35.000000 AGAINST FOR 549.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 586.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 10.000000 AGAINST FOR 575.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation COMPENSATION ISSUER 585.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 26.000000 AGAINST FOR 554.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 585.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 577.000000 FOR S000004450 ABBVIE INC. 00287Y109 US00287Y1091 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 585.000000 0.000000 ABSTAIN 3.000000 AGAINST FOR 231.000000 AGAINST AGAINST 351.000000 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 US98937L1052 05/11/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 US98937L1052 05/11/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick Enright DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 US98937L1052 05/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR James W. Bullock DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Jon W. Salveson DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 DIRECTOR Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 13.000000 FOR S000004450 ARTIVION, INC. 228903100 US2289031005 05/12/2026 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 161.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 22.000000 AGAINST FOR 135.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 160.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 161.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 155.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: H. James Dallas DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 158.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 150.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Monte E. Ford DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 160.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Sarah M. London DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 160.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 151.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 Election of Director: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 152.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. COMPENSATION ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 148.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026. AUDIT-RELATED ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 152.000000 FOR S000004450 CENTENE CORPORATION 15135B101 US15135B1017 05/12/2026 STOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. CORPORATE GOVERNANCE SECURITY HOLDER 161.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 30.000000 AGAINST AGAINST 131.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 43.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: John A. Clerico DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Michael Dinkins DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: James S. Ely III DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: John A. Fry DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 44.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Kevin J. Hammons DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 44.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 44.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 44.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Election of Director: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 43.000000 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 US2036681086 05/12/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 ENHABIT, INC. 29332G102 US29332G1022 05/12/2026 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 22, 2026, by and among Enhabit, Inc. ("Enhabit"), Anchor Parent, LLC, a Delaware limited liability company ("Parent"), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Enhabit, with Enhabit surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 ENHABIT, INC. 29332G102 US29332G1022 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 32.000000 FOR S000004450 ENHABIT, INC. 29332G102 US29332G1022 05/12/2026 Approval of the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes virtually or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Director: Daniel M. Junius DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 26.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Director: Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 26.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Election of Director: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 25.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 26.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). CORPORATE GOVERNANCE ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to have IDEXX Call a Special Meeting (Proposal Five). CORPORATE GOVERNANCE ISSUER 28.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 US45168D1046 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). CORPORATE GOVERNANCE SECURITY HOLDER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 11.000000 AGAINST AGAINST 17.000000 FOR S000004450 PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Election of Director: Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Election of Director: Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 PERSONALIS, INC. 71535D106 US71535D1063 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Director: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 70.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Director: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 69.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Election of Director: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 69.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 68.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 64.000000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 US0367521038 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 6.000000 AGAINST AGAINST 65.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR Vivek Jain DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR David C. Greenberg DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR Elisha W. Finney DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR Donald M. Abbey DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR Laurie Hernandez DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 DIRECTOR Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. CORPORATE GOVERNANCE ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. CORPORATE GOVERNANCE ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ICU MEDICAL, INC. 44930G107 US44930G1076 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. CORPORATE GOVERNANCE SECURITY HOLDER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 3.000000 AGAINST AGAINST 5.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Dr. David Wheadon DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 37.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Joe Ciaffoni DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Dr. Keith Humphreys DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Tony Kingsley DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Daniel Ninivaggi DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 35.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Barbara Ryan DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Mark Stejbach DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 Election of Director: Juliet Thompson DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 39.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 37.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 38.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 37.000000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 US45579U1097 05/13/2026 To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 37.000000 FOR S000004450 INSMED INCORPORATED 457669307 US4576693075 05/13/2026 DIRECTOR E. McKee Anderson DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 INSMED INCORPORATED 457669307 US4576693075 05/13/2026 DIRECTOR C. Desjardins, Ph.D. DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 INSMED INCORPORATED 457669307 US4576693075 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 61.000000 FOR S000004450 INSMED INCORPORATED 457669307 US4576693075 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 68.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Election of Director: Martha G. Aronson (three (3) year term) DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Election of Director: Lonny J. Carpenter (three (3) year term) DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Election of Director: Lynne N. Ward (one (1) year term) DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Election of Director: Scott R. Ward (three (3) year term) DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 US5898891040 05/13/2026 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Mr. Barry M. Smith DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Swati B. Abbott DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 ELECTION OF CLASS II DIRECTOR FOR AN INITIAL ONE-YEAR TERM: Ms. Marivic Uychiat Pison DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 US29358P1012 05/13/2026 Approval, on an advisory basis, of our named executive officers' compensation. COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 90.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Lloyd Carney DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 87.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Alan Garber DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 90.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Michel Lagarde DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 90.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 90.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Diana McKenzie DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Bruce Sachs DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 86.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 90.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Election of Director: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 77.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 87.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 86.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 89.000000 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 US92532F1003 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 52.000000 AGAINST AGAINST 39.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 21.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 21.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Non-binding advisory vote to approve the compensation of the Company's named executive officers. COMPENSATION ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 20.000000 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 US6907321029 05/14/2026 Approval of the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 21.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Richard E. Buller DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR David F. Dalvey DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Leo T. Furcht DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Lance G. Laing DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Polly A. Murphy DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Richard J. Nigon DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Charles R. Romp DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 DIRECTOR Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve, on an advisory basis, named executive officer compensation. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 5.000000 FOR S000004450 CELCUITY INC. 15102K100 US15102K1007 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 6.000000 FOR S000004450 CERTARA, INC. 15687V109 US15687V1098 05/14/2026 DIRECTOR Arjun Bedi DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 CERTARA, INC. 15687V109 US15687V1098 05/14/2026 DIRECTOR Stephen McLean DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 CERTARA, INC. 15687V109 US15687V1098 05/14/2026 DIRECTOR Jon Resnick DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 CERTARA, INC. 15687V109 US15687V1098 05/14/2026 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 CERTARA, INC. 15687V109 US15687V1098 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. COMPENSATION ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 42.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 13.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Michael Donovan DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 US19459J1043 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 450.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 458.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 453.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: C. David Brown II DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 32.000000 AGAINST FOR 424.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 439.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 458.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 445.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: John E. Gallina DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 451.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: J. David Joyner DIRECTOR ELECTIONS ISSUER 456.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 29.000000 AGAINST FOR 427.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 439.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 39.000000 AGAINST FOR 417.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 450.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 452.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 458.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 18.000000 AGAINST FOR 439.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Election of Director: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 449.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 456.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 446.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. COMPENSATION ISSUER 457.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 25.000000 AGAINST FOR 430.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 457.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 13.000000 AGAINST FOR 443.000000 FOR S000004450 CVS HEALTH CORPORATION 126650100 US1266501006 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 457.000000 0.000000 ABSTAIN 2.000000 AGAINST FOR 187.000000 AGAINST AGAINST 268.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 Election of Director: Ming Hsieh DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 Election of Director: Linda Dong DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 Election of Director: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 Election of Director: Regina Groves DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 6.000000 FOR S000004450 FULGENT GENETICS, INC. 359664109 US3596641098 05/14/2026 To approve the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 6.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 DIRECTOR Geno J. Germano DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 DIRECTOR Troy Ignelzi DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 DIRECTOR Ron Philip DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 DIRECTOR Andreas Wicki, Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 US4131971040 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 11.000000 FOR S000004450 PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 05/14/2026 Election of Director to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 8.000000 FOR S000004450 PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 05/14/2026 Election of Director to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. Selkoe DIRECTOR ELECTIONS ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 9.000000 FOR S000004450 PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 05/14/2026 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 PROTHENA CORPORATION PLC G72800108 IE00B91XRN20 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. COMPENSATION ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 15.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 15.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 14.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Election of Director: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REPLIGEN CORPORATION 759916109 US7599161095 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 US70805E1091 05/14/2026 Election of Director: Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 9.000000 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 US70805E1091 05/14/2026 Election OF Director: Brent J. Guerisoli DIRECTOR ELECTIONS ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 10.000000 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 US70805E1091 05/14/2026 Election OF Director: John G. Nackel, Ph.D. DIRECTOR ELECTIONS ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 9.000000 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 US70805E1091 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for 2026. AUDIT-RELATED ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 US70805E1091 05/14/2026 Advisory approval of the Company's named executive officer compensation. COMPENSATION ISSUER 12.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 9.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Election of Director: Emil D. Kakkis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Election of Director: Shehnaaz Suliman, M.D. DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Election of Director: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 23.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 DIRECTOR Krish S. Krishnan DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 DIRECTOR Christopher Mason DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 US5011471027 05/15/2026 Approval of the Company's Non-Employee Director Compensation Policy. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 6.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 DIRECTOR Brian T. Carley DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 DIRECTOR Femida H Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 DIRECTOR Robert O. Kraft DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 DIRECTOR August J. Troendle DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 DIRECTOR Dani S. Zander DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 7.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. CORPORATE GOVERNANCE ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 US58506Q1094 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 3.000000 AGAINST AGAINST 5.000000 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 US67080M1036 05/15/2026 DIRECTOR Arthur T. Sands, M.D. DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 US67080M1036 05/15/2026 DIRECTOR Roger Dansey, M.D. DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 US67080M1036 05/15/2026 DIRECTOR Paul M. Silva DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 US67080M1036 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026. AUDIT-RELATED ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 US67080M1036 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 24.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Charles Kummeth DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Paula Dowdy DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Ruth Fattori DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Amir Jafri DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jack Kenny DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 48.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Brigid A. Makes DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Scott Mendel DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Kevin Rakin DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 59.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 64.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 US74765K1051 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement COMPENSATION ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 45.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Director: Carlos Alban DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 43.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Director: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 44.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Director: Shirley Edwards DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 44.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Election of Director: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 44.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Advisory vote to approve executive compensation COMPENSATION ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 40.000000 FOR S000004450 SOLVENTUM CORPORATION 83444M101 US83444M1018 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Neena M. Patil DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Election of Director: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Approval, on an advisory basis, of named executive officer compensation. COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 TELEFLEX INCORPORATED 879369106 US8793691069 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 402.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 412.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 30.000000 AGAINST FOR 376.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 413.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 414.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 404.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 414.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 412.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 408.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 414.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 412.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 414.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 33.000000 AGAINST FOR 381.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 413.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 406.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 413.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 415.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 413.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. COMPENSATION ISSUER 415.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 403.000000 FOR S000004450 VIATRIS INC. 92556V106 US92556V1061 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 414.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 403.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Regina E. Groves DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Karen N. Prange DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Robert S. White DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Election of Director: Maggie Yuen DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ATRICURE, INC. 04963C209 US04963C2098 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Ron DeLyons DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Election of Director: George J. Walsh III DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 CHEMED CORPORATION 16359R103 US16359R1032 05/18/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 2.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR David Bronson DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR LaVerne H. Council DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR Charles M. Farkas DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR Mark Kaye DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR Kim Kelderman DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 DIRECTOR B. J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 12.000000 FOR S000004450 CONMED CORPORATION 207410101 US2074101013 05/18/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 12.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 193.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 192.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 184.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 193.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 191.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 193.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 186.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 185.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 190.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 193.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 192.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 189.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 193.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 191.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 193.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 190.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 191.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Advisory vote to approve our executive compensation. COMPENSATION ISSUER 194.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 188.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 194.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 182.000000 FOR S000004450 AMGEN INC. 031162100 US0311621009 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 194.000000 0.000000 ABSTAIN 1.000000 AGAINST FOR 32.000000 AGAINST AGAINST 161.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Damien McDonald DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Philip A. Okala DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Christine Ortiz DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Brady Shirley DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 Election of Director: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ENOVIS CORPORATION 194014502 US1940145022 05/19/2026 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Wendy Carruthers DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Kieran Gallahue DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Scott Huennekens DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Vivek Jain DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Paul Keel DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR J. Andrew Pierce DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Daniel Raskas DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 DIRECTOR Christine Tsingos DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 62.000000 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 US29415F1049 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 64.000000 0.000000 2.0 0.000000 AGAINST 3.0 5.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 59.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MACROGENICS, INC. 556099109 US5560991094 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 22.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates. CORPORATE GOVERNANCE ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 OMNICELL, INC. 68213N109 US68213N1090 05/19/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 US71722W1071 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 US71722W1071 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 US71722W1071 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 US71722W1071 05/19/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 US71722W1071 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). COMPENSATION ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 17.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Roy Baynes DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Timothy Coughlin DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Eric Dube DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Gary Lyons DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR John Orwin DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Sandra Poole DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Ron Squarer DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 DIRECTOR Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 31.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 32.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 32.000000 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 US89422G1076 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 US89455T1097 05/19/2026 DIRECTOR Lance A. Berry DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 US89455T1097 05/19/2026 DIRECTOR Elizabeth S. Hanna DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 US89455T1097 05/19/2026 DIRECTOR Jane E. Kiernan DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 US89455T1097 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 18.000000 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 US89455T1097 05/19/2026 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Christopher J. Reading DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Dr. B. A. Harris Jr. DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Regg E. Swanson DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 DIRECTOR Peter F. Minan DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 Advisory vote to approve the named executive officer compensation. COMPENSATION ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 US90337L1089 05/19/2026 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 DIRECTOR J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 DIRECTOR S. Kathryn Rouan, Ph D DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 TO RATIFY THE SELECTION OF CBIZ CPAS P C AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026 AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 US92686J1060 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS COMPENSATION ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 27.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Joseph Lacob DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Anne M. Myong DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Election of Director: Britt Vitalone DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 23.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 US0162551016 05/20/2026 Ratification of Special Meeting Provision in our Bylaws CORPORATE GOVERNANCE ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 19.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 49.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 49.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 49.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. COMPENSATION ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 46.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 ALKERMES PLC G01767105 IE00B56GVS15 05/20/2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 US02043Q1076 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 52.000000 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 US02043Q1076 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 US02043Q1076 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 48.000000 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 US02043Q1076 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. COMPENSATION ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 52.000000 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 US02043Q1076 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 52.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Mark Sotir DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Martin J. Bonick DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Peter Bulgarelli DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Peter Bynoe DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Suzanne Campion DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR William Goodyear DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Ellen Havdala DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Edmondo Robinson DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Rahul Sen DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 1.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 DIRECTOR Rob Webb DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ARDENT HEALTH, INC. 03980N107 US03980N1072 05/20/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 10.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 DIRECTOR Susan M. Molineaux, PhD DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 20.000000 AGAINST AGAINST 0.000000 AGAINST FOR 181.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 DIRECTOR Patricia S. Andrews DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 198.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 DIRECTOR Constantine Chinoporos DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 198.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement. COMPENSATION ISSUER 200.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 189.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. COMPENSATION ISSUER 201.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 9.000000 AGAINST FOR 191.000000 FOR S000004450 GERON CORPORATION 374163103 US3741631036 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 200.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 196.000000 FOR S000004450 INSULET CORPORATION 45784P101 US45784P1012 05/20/2026 DIRECTOR Luciana Borio DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 INSULET CORPORATION 45784P101 US45784P1012 05/20/2026 DIRECTOR Michael R. Minogue DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 INSULET CORPORATION 45784P101 US45784P1012 05/20/2026 DIRECTOR Timothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 INSULET CORPORATION 45784P101 US45784P1012 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. COMPENSATION ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 25.000000 FOR S000004450 INSULET CORPORATION 45784P101 US45784P1012 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Sheila Antrum DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: James F. Flanagan DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: James F. Hinrichs DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Aaron Kapito DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Payman Khales DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Filippo Passerini DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Donald J. Spence DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 US45826H1095 05/20/2026 To approve the Integer Holdings Corporation 2026 Omnibus Incentive Plan. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 14.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR J.S. Shannon, MD, MRCP DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR M.E. Castagna, Pharm.D. DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Steven B. Binder DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 105.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 102.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Michael A. Friedman, MD DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 103.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Jennifer Grancio DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 103.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Anthony Hooper DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 105.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Sabrina Kay, Ed.D. DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 DIRECTOR Christine Mundkur DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting. COMPENSATION ISSUER 113.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 101.000000 FOR S000004450 MANNKIND CORPORATION 56400P706 US56400P7069 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 113.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 109.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Eric K. Brandt DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Natasha Deckmann DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Harry Jansen Kraemer Jr DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR R. Carter Pate DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR John C. Rademacher DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 DIRECTOR Norman L. Wright DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 US68404L2016 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. COMPENSATION ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 65.000000 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy Cocozza DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David King DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis Soistman DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). COMPENSATION ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 37.000000 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 US74276R1023 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Robert B. Carter DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: James E. Davis DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 41.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 38.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Timothy L. Main DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 40.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 41.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 39.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 38.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Election of Director: Timothy C. Wentworth DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. COMPENSATION ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 40.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 40.000000 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 US74834L1008 05/20/2026 Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 11.000000 AGAINST AGAINST 32.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Peter Fong, Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 The ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 US77313F1066 05/20/2026 The approval of the proposed stock option exchange program. CAPITAL STRUCTURE ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 25.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 23.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 22.000000 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 US8753722037 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Marc N. Casper DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 136.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 136.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 145.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: C. Martin Harris DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 132.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Tyler Jacks DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 141.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 141.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 145.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 143.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 144.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Debora L. Spar DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 146.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 135.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Election of Director: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 132.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 145.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 92.000000 AGAINST FOR 53.000000 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 US8835561023 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 130.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: James R. Tobin DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Edward M. Basile DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 12.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: Merilee Raines DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 Election of Director: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 9.000000 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 US89377M1099 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 US9139031002 05/20/2026 Election of Director: Nina Chen-Langenmayr DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 US9139031002 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 20.000000 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 US9139031002 05/20/2026 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 US9139031002 05/20/2026 Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 13.000000 AGAINST AGAINST 8.000000 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 US9139031002 05/20/2026 Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 4.000000 AGAINST AGAINST 17.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 190.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 192.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 184.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 189.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 188.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 196.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 188.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Gregory Norden DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 183.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 195.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Willie M. Reed DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 190.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Mark Stetter DIRECTOR ELECTIONS ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 196.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Election of Director: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 196.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve our executive compensation. COMPENSATION ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 29.000000 AGAINST FOR 169.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 197.000000 0.000000 2.0 0.000000 AGAINST 3.0 2.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 195.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 198.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 192.000000 FOR S000004450 ZOETIS INC. 98978V103 US98978V1035 05/20/2026 Shareholder proposal to permit shareholder action by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 198.000000 0.000000 ABSTAIN 3.000000 AGAINST FOR 89.000000 AGAINST AGAINST 106.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 Election of Director: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 7.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 7.000000 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 US00182C1036 05/21/2026 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II Director: Olivia Kirtley DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II Director: Max Lin DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Election of Class II Director: Steve Miller DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 US10950A1060 05/21/2026 Advisory vote on executive compensation COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 BRUKER CORPORATION 116794108 US1167941087 05/21/2026 DIRECTOR John J. (Jack) Phillips DIRECTOR ELECTIONS ISSUER 47.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 46.000000 FOR S000004450 BRUKER CORPORATION 116794108 US1167941087 05/21/2026 DIRECTOR Hermann F. Requardt PhD DIRECTOR ELECTIONS ISSUER 47.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 BRUKER CORPORATION 116794108 US1167941087 05/21/2026 DIRECTOR Laura A. Francis DIRECTOR ELECTIONS ISSUER 47.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. COMPENSATION ISSUER 47.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 45.000000 FOR S000004450 BRUKER CORPORATION 116794108 US1167941087 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 47.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: Gregg Alton DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 71.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: David L. Mahoney DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 26.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 70.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: Kimberly Park DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 Election of Director: James N. Wilson DIRECTOR ELECTIONS ISSUER 71.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 70.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 66.000000 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 US2183521028 05/21/2026 To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. COMPENSATION ISSUER 71.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 23.000000 AGAINST FOR 48.000000 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 14.000000 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 US2528281080 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of Class I Nominee: Kapila Anand DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 43.000000 AGAINST FOR 166.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of Class I Nominee: Paul Herendeen DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 197.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of Class II Nominee: Michael Harrington DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 44.000000 AGAINST FOR 165.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of Class II Nominee: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 197.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Election of Class II Nominee: Kirk McDonald DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 197.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 208.000000 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 US28414H1032 05/21/2026 Advisory vote on the compensation of the company's named executive officers. COMPENSATION ISSUER 209.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 38.000000 AGAINST FOR 171.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Mohamad Ali DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 39.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Deborah Derby DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Carole T. Faig DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 39.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Max Lin DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 30.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Election of Incumbent Director: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. COMPENSATION ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 HENRY SCHEIN, INC. 806407102 US8064071025 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 25.000000 AGAINST AGAINST 16.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 62.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: David P. King DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Keith A. Meister DIRECTOR ELECTIONS ISSUER 63.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 62.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Anna Richo DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 60.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 Election of Director: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 63.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 60.000000 FOR S000004450 ILLUMINA, INC. 452327109 US4523271090 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 60.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Victor Bulto DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 24.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 32.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Election of Director: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 LABCORP HOLDINGS INC. 504922105 US5049221055 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 US6031701013 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 US6031701013 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 US6031701013 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 US6031701013 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 47.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: John P. Kenny DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: David B. Perez DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Felicia Williams DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Election of Director: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. COMPENSATION ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 43.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NEOGENOMICS, INC. 64049M209 US64049M2098 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NUVATION BIO INC. 67080N101 US67080N1019 05/21/2026 DIRECTOR Robert Bazemore DIRECTOR ELECTIONS ISSUER 93.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 NUVATION BIO INC. 67080N101 US67080N1019 05/21/2026 DIRECTOR Robert Mashal, M.D. DIRECTOR ELECTIONS ISSUER 93.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 86.000000 FOR S000004450 NUVATION BIO INC. 67080N101 US67080N1019 05/21/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 93.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 93.000000 FOR S000004450 NUVATION BIO INC. 67080N101 US67080N1019 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 93.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 92.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Director: Lloyd Dean DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Director: Kevin Gordon DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Election of Director: Cheryl Scott DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 34.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements CORPORATE GOVERNANCE ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 PROGYNY, INC. 74340E103 US74340E1038 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations CORPORATE GOVERNANCE ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Sean L. Cunningham DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 83.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Richard G. Kyle DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Vincent K. Petrella DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 92.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 93.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 US83601L1026 05/21/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 70.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 68.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 6.000000 AGAINST FOR 67.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 68.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Susan R. Salka DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 70.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 68.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 71.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: Michael S. Smith DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 70.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Election of Director for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 61.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. COMPENSATION ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 68.000000 FOR S000004450 TELADOC HEALTH, INC. 87918A105 US87918A1051 05/21/2026 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Peter J. Barris DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Eric D. Belcher DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR David R. Epstein DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Wayne A.I. Frederick MD DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 DIRECTOR Nadja West, M.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 41.000000 0.000000 1.0 21.000000 AGAINST 2.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 3.0 20.000000 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 DIRECTOR Michael M Morrissey PhD DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 DIRECTOR Patrick G. Enright DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 DIRECTOR James R. Meyers DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 US92337R1014 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 DIRECTOR Michael Bailey DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 DIRECTOR Brian Stuglik DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 DIRECTOR Karin Tollefson DIRECTOR ELECTIONS ISSUER 18.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive Plan. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase Plan. COMPENSATION ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 VERASTEM, INC. 92337C203 US92337C2035 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. COMPENSATION ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 17.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 39.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 38.000000 FOR S000004450 WATERS CORPORATION 941848103 US9418481035 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. COMPENSATION ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 36.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Owen Hughes DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Heather L. Franklin DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Natasha Hernday DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Barbara Kosacz DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Joseph M. Limber DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 DIRECTOR Matthew D. Perry DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan. COMPENSATION ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 Approval of the 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 XOMA ROYALTY CORP. 98419J206 US98419J2069 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Filippo "Peter" Caldini DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Leslie Gillin DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Edward Schutter DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 Election of Director to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 VGG312491084 05/22/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 81.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 81.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 81.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Syed Jafry DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 82.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 82.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 82.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Election of Director: Ivan Tornos DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). COMPENSATION ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 US98956P1021 05/22/2026 Shareholder Proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 15.000000 AGAINST AGAINST 68.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 DIRECTOR L Androski JD, MBA CFA DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 DIRECTOR Robert Alan Beardsley DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 DIRECTOR Joseph Bishop DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 DIRECTOR Matthew Gline DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 DIRECTOR Roger Sawhney, MD DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 58.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and COMPENSATION ISSUER 63.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 57.000000 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 CA03879J1003 05/26/2026 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 62.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 99.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 111.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr. DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 109.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 113.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 112.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 111.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. AUDIT-RELATED ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 111.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. COMPENSATION ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 109.000000 FOR S000004450 EXELIXIS, INC. 30161Q104 US30161Q1040 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. COMPENSATION ISSUER 114.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 24.000000 AGAINST FOR 90.000000 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 US56600D1072 05/26/2026 Election of Director for 3-year term expiring in 2029: Bernd Brust DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 US56600D1072 05/26/2026 Election of Director for 3-year term expiring in 2029: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 US56600D1072 05/26/2026 Election of Director for 3-year term expiring in 2029: Luke Marker DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 US56600D1072 05/26/2026 To ratify the appointment of Deloitte & Touche LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 US56600D1072 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. COMPENSATION ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 46.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 1113.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 1111.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 24.000000 AGAINST FOR 1091.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Robert M. Davis DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 65.000000 AGAINST FOR 1046.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 63.000000 AGAINST FOR 1052.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 13.000000 AGAINST FOR 1102.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 1111.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 1113.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 1104.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 1117.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 121.000000 AGAINST FOR 994.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 1112.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 14.000000 AGAINST FOR 1101.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Election of Director: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 1116.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 14.000000 AGAINST FOR 1100.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 1117.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 60.000000 AGAINST FOR 1046.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 73.000000 AGAINST FOR 1043.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. ENVIRONMENT OR CLIMATE SECURITY HOLDER 1118.000000 0.000000 ABSTAIN 14.000000 AGAINST FOR 13.000000 AGAINST AGAINST 1091.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. ENVIRONMENT OR CLIMATE SECURITY HOLDER 1118.000000 0.000000 ABSTAIN 14.000000 AGAINST FOR 13.000000 AGAINST AGAINST 1091.000000 FOR S000004450 MERCK & CO., INC. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 1118.000000 0.000000 ABSTAIN 15.000000 AGAINST FOR 130.000000 AGAINST AGAINST 973.000000 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBA DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 23.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 53.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 45.000000 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 US92764N1028 05/26/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Director for term expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Director for term expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 Election of Class I Director for term expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 50.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 174.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 166.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 172.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 174.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 24.000000 AGAINST FOR 150.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 168.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 175.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 172.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 174.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 174.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 167.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 174.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 174.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 174.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 171.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 175.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 175.000000 FOR S000004450 DEXCOM, INC. 252131107 US2521311074 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. COMPENSATION ISSUER 174.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 18.000000 AGAINST FOR 156.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR C. Noel Bairey Merz, MD DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Quentin Blackford DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Bruce Bodaken DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Karen Ling DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Karen McGinnis DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Kevin O'Boyle DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Jason Patten DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Abhijit Talwalkar DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 DIRECTOR Brian Yoor DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 To approve the adoption of our 2026 Equity Incentive Plan. COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. CORPORATE GOVERNANCE ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 US4500561067 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Matthew Fust DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: David Piacquad DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 Advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 US6409791000 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 29.000000 0.000000 2.0 0.000000 AGAINST 3.0 4.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 25.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 DIRECTOR Kevin C. Gorman, Ph.D. DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 DIRECTOR Gary A. Lyons DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 DIRECTOR Johanna Mercier DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 42.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares. COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 40.000000 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 US64125C1099 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 41.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR Lori A. Woods DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR Heidi Henson DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR R. F. Williamson, III DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR Frank Morich, M.D Ph.D DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 46.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 DIRECTOR Maya Martinez-Davis DIRECTOR ELECTIONS ISSUER 46.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 46.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 46.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 46.000000 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 US46489V3024 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 46.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 46.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 DIRECTOR Mark McKenna DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 DIRECTOR Cameron Turtle, D.Phil. DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 DIRECTOR Laurie Stelzer DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 21.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 US00773J2024 05/27/2026 To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 41.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 41.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: James L. Bierman DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Roy Blunt DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Richard J. Mark DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Tammy Romo DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 41.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 Election of Director: Nadja Y. West DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. COMPENSATION ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 35.000000 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 US88033G4073 05/27/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 DIRECTOR Ellen Goldberg DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 DIRECTOR Miles D. Harrison DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 DIRECTOR Tiffany P. Olson DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 12.000000 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 US14843C1053 05/28/2026 To approve our non-employee director compensation policy. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 12.000000 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 US29664W1053 05/28/2026 Election of Class I Director: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 107.000000 0.000000 ABSTAIN 24.000000 AGAINST AGAINST 0.000000 AGAINST FOR 83.000000 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 US29664W1053 05/28/2026 Election of Class I Director: Sheldon L. Koenig DIRECTOR ELECTIONS ISSUER 107.000000 0.000000 ABSTAIN 20.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 US29664W1053 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. COMPENSATION ISSUER 108.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 33.000000 AGAINST FOR 74.000000 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 US29664W1053 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 107.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 102.000000 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 US29664W1053 05/28/2026 To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan. COMPENSATION ISSUER 106.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 85.000000 FOR S000004450 GLAUKOS CORPORATION 377322102 US3773221029 05/28/2026 DIRECTOR Denice M. Torres DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 GLAUKOS CORPORATION 377322102 US3773221029 05/28/2026 DIRECTOR Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 GLAUKOS CORPORATION 377322102 US3773221029 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 25.000000 FOR S000004450 GLAUKOS CORPORATION 377322102 US3773221029 05/28/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 27.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 HEALTHSTREAM, INC. 42222N103 US42222N1037 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 HEALTHSTREAM, INC. 42222N103 US42222N1037 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Jeffrey L. McLaren DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 HEALTHSTREAM, INC. 42222N103 US42222N1037 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 HEALTHSTREAM, INC. 42222N103 US42222N1037 05/28/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 HEALTHSTREAM, INC. 42222N103 US42222N1037 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 9.000000 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 US90240B1061 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 US90240B1061 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 US90240B1061 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 US90240B1061 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: James M. Daly DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 94.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: Edmund P. Harrigan, M.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 82.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: Adora Ndu, Pharm.D., J.D. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 86.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 US0042251084 05/29/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 89.000000 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 US05356F1057 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Rodney D. Windley DIRECTOR ELECTIONS ISSUER 24.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 US05356F1057 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Sam Weil DIRECTOR ELECTIONS ISSUER 24.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 US05356F1057 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Steven E. Rodgers DIRECTOR ELECTIONS ISSUER 24.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 US05356F1057 05/29/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. AUDIT-RELATED ISSUER 24.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 US05356F1057 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. COMPENSATION ISSUER 24.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 20.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 11.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 GB00BRXB0C07 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 DIRECTOR Jean Bennett, M.D., PhD DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 DIRECTOR A.N. Karabelas, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 DIRECTOR Daniel Tasse DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 17.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our non-executive employees. CAPITAL STRUCTURE ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 14.000000 FOR S000004450 REGENXBIO INC. 75901B107 US75901B1070 05/29/2026 To approve a stock option exchange for our executive employees. CAPITAL STRUCTURE ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 7.000000 FOR S000004450 TALKSPACE, INC. 87427V103 US87427V1035 05/29/2026 Talkspace, Inc. ("Talkspace") entered into an Agreement and Plan of Merger with Universal Health Services, Inc. ("UHS") and UHS Merger Subsidiary, Inc., an indirect wholly owned subsidiary of UHS ("Merger Sub"), under which Merger Sub will merge with and into Talkspace, with Talkspace surviving the merger as an indirect wholly owned subsidiary of UHS. EXTRAORDINARY TRANSACTIONS ISSUER 113.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 113.000000 FOR S000004450 TALKSPACE, INC. 87427V103 US87427V1035 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. COMPENSATION ISSUER 113.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 72.000000 AGAINST FOR 40.000000 FOR S000004450 TALKSPACE, INC. 87427V103 US87427V1035 05/29/2026 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 113.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 109.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: David Gaugh DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: William J. Peters DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 12.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 11.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 16.000000 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 US03209R1032 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 17.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 16.000000 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 US8776191061 06/01/2026 DIRECTOR Sean P. Nolan DIRECTOR ELECTIONS ISSUER 102.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 84.000000 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 US8776191061 06/01/2026 DIRECTOR L. Sepp-Lorenzino Ph.D DIRECTOR ELECTIONS ISSUER 102.000000 0.000000 ABSTAIN 27.000000 AGAINST AGAINST 0.000000 AGAINST FOR 75.000000 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 US8776191061 06/01/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 102.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 102.000000 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 US8776191061 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 102.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 18.000000 AGAINST FOR 84.000000 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 US8776191061 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 101.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 101.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Charles Baker DIRECTOR ELECTIONS ISSUER 434.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 44.000000 AGAINST FOR 389.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Timothy Flynn DIRECTOR ELECTIONS ISSUER 433.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 18.000000 AGAINST FOR 415.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Paul Garcia DIRECTOR ELECTIONS ISSUER 434.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 422.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Kristen Gil DIRECTOR ELECTIONS ISSUER 433.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 430.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 434.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 422.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 434.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 17.000000 AGAINST FOR 415.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: F. William McNabb III DIRECTOR ELECTIONS ISSUER 433.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 423.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 433.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 424.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Election of Director: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 434.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 428.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. COMPENSATION ISSUER 434.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 80.000000 AGAINST FOR 353.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 433.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 24.000000 AGAINST FOR 409.000000 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 US91324P1021 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 434.000000 0.000000 ABSTAIN 2.000000 AGAINST FOR 78.000000 AGAINST AGAINST 354.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 DIRECTOR Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 DIRECTOR John Driscoll DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 DIRECTOR Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 53.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 DIRECTOR Lauren Young DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 WAYSTAR HOLDING CORP 946784105 US9467841055 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 54.000000 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 US0008991046 06/02/2026 Election of Class I Director for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. Finger DIRECTOR ELECTIONS ISSUER 178.000000 0.000000 ABSTAIN 23.000000 AGAINST AGAINST 0.000000 AGAINST FOR 155.000000 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 US0008991046 06/02/2026 Election of Class I Director for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene Salas DIRECTOR ELECTIONS ISSUER 178.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 172.000000 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 US0008991046 06/02/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 177.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 177.000000 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 US0008991046 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 177.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 174.000000 FOR S000004450 AGILON HEALTH, INC. 00857U206 US00857U2069 06/02/2026 Election of Class II Director: Diana Mckenzie DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AGILON HEALTH, INC. 00857U206 US00857U2069 06/02/2026 Election of Class II Director: Karen McLoughlin DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 7.000000 FOR S000004450 AGILON HEALTH, INC. 00857U206 US00857U2069 06/02/2026 Election of Class II Director: Ronald Williams DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AGILON HEALTH, INC. 00857U206 US00857U2069 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 AGILON HEALTH, INC. 00857U206 US00857U2069 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 9.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 81.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 86.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 86.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Ian T. Clark DIRECTOR ELECTIONS ISSUER 86.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 76.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 86.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Willard Dere DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 85.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 85.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Alexander Hardy DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 86.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Maykin Ho DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 85.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 86.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 85.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 Election of Director: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 86.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 83.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 84.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 76.000000 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 US09061G1013 06/02/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 86.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 84.000000 FOR S000004450 CERIBELL INC 15678C102 US15678C1027 06/02/2026 Election of Director: Josef Parvizi, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CERIBELL INC 15678C102 US15678C1027 06/02/2026 Election of Director: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 CERIBELL INC 15678C102 US15678C1027 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 CERUS CORPORATION 157085101 US1570851014 06/02/2026 DIRECTOR William M. Greenman DIRECTOR ELECTIONS ISSUER 152.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 144.000000 FOR S000004450 CERUS CORPORATION 157085101 US1570851014 06/02/2026 DIRECTOR Ann Lucena DIRECTOR ELECTIONS ISSUER 152.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 145.000000 FOR S000004450 CERUS CORPORATION 157085101 US1570851014 06/02/2026 Equity Plan Proposal: The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 152.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 40.000000 AGAINST FOR 112.000000 FOR S000004450 CERUS CORPORATION 157085101 US1570851014 06/02/2026 Advisory Votes on Executive Compensation: The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 152.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 12.000000 AGAINST FOR 139.000000 FOR S000004450 CERUS CORPORATION 157085101 US1570851014 06/02/2026 Independent Registered Public Accounting Firm: The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 152.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 150.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Michael J. Barber DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: James D. Forbes DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 81.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 93.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 94.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Election of Director: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 29.000000 AGAINST FOR 66.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. COMPENSATION ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 90.000000 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 US24906P1093 06/02/2026 Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 82.000000 FOR S000004450 KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Election of Class II Director: Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Election of Class II Director: Bassil I. Dahiyat, Ph.D. DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Election of Class II Director: Taiyin Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 KODIAK SCIENCES INC. 50015M109 US50015M1099 06/02/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 US5255582018 06/02/2026 Election of Director: David B. Roberts DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 US5255582018 06/02/2026 Election of Director: John A. Roush DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 US5255582018 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 US5255582018 06/02/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 US53228F1012 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: David Bourdon DIRECTOR ELECTIONS ISSUER 136.000000 0.000000 ABSTAIN 80.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 US53228F1012 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D. DIRECTOR ELECTIONS ISSUER 136.000000 0.000000 ABSTAIN 30.000000 AGAINST AGAINST 0.000000 AGAINST FOR 106.000000 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 US53228F1012 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2026. AUDIT-RELATED ISSUER 136.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 136.000000 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 US53228F1012 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 136.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 131.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Re-appointment of non-executive director of the Company until the annual general meeting 2030: John W. Smither DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Re-appointment of non-executive director of the Company until the annual general meeting 2030: Janneke van der Kamp DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 NL00150012L7 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 US6876041087 06/02/2026 DIRECTOR Lawrence Klein DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 US6876041087 06/02/2026 DIRECTOR Chris Martin DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 US6876041087 06/02/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 US6876041087 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 DIRECTOR Jessica Chutter DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 DIRECTOR M.B. Klein, MD MS, FACS DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 DIRECTOR Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 53.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 DIRECTOR J.B. Zeldis, M.D., PhD DIRECTOR ELECTIONS ISSUER 56.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 53.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 US69366J2006 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. COMPENSATION ISSUER 56.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 55.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR Howard G. Berger, M.D. DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR A. Gregory Sorensen M.D DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 DIRECTOR David L. Swartz DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 29.000000 FOR S000004450 RADNET, INC. 750491102 US7504911022 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 30.000000 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 US92790C1045 06/02/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 US92790C1045 06/02/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Jennifer K. Moses DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 US92790C1045 06/02/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 30.000000 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 31.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 31.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Election of Director: Kevin Tang DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Election of Director: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 86.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Election of Director: Kathy Goetz DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Election of Director: Craig Johnson DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Election of Director: Tina S. Nova DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Appointment of Auditors: To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 90.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 CA05156V1022 06/03/2026 Advisory Resolution on Executive Compensation: To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. COMPENSATION ISSUER 90.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 84.000000 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Evans DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 38.000000 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 39.000000 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 42.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR William A. Hawkins DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR John A. Bartholdson DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Ajay Dhankhar DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Mary Kay Ladone DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Guido J. Neels DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Guy P. Nohra DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Susan M. Stalnecker DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 DIRECTOR Martin P. Sutter DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 BIOVENTUS INC. 09075A108 US09075A1088 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 DIRECTOR Jennifer Cook DIRECTOR ELECTIONS ISSUER 104.000000 0.000000 ABSTAIN 34.000000 AGAINST AGAINST 0.000000 AGAINST FOR 70.000000 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 DIRECTOR David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 104.000000 0.000000 ABSTAIN 28.000000 AGAINST AGAINST 0.000000 AGAINST FOR 76.000000 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 DIRECTOR Ryan Watts, Ph.D. DIRECTOR ELECTIONS ISSUER 104.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 101.000000 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 104.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 US24823R1059 06/03/2026 Advisory vote on executive compensation. COMPENSATION ISSUER 104.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 100.000000 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 90.000000 0.000000 ABSTAIN 26.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 90.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 74.000000 AGAINST FOR 16.000000 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 90.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 90.000000 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 US3795772082 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). COMPENSATION ISSUER 90.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 86.000000 FOR S000004450 HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 DIRECTOR Teddie Wardi DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 DIRECTOR Tyler Sloat DIRECTOR ELECTIONS ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 HINGE HEALTH, INC. 433313103 US4333131039 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 13.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 US4923271013 06/03/2026 Election of Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 US4923271013 06/03/2026 Election of Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Charles Newton DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 US4923271013 06/03/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 US4923271013 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Asaf Danziger DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: William Doyle DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: David Hung DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Frank Leonard DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Martin Madden DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Allyson Ocean DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Timothy Scannell DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: Kristin Stafford DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 Election of Director: William Vernon DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 49.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 A non-binding advisory vote to approve executive compensation. COMPENSATION ISSUER 49.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 45.000000 FOR S000004450 NOVOCURE LIMITED G6674U108 JE00BYSS4X48 06/03/2026 The approval of our amended and restated 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 25.000000 AGAINST FOR 25.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: John D. Bertrand DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 45.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: Steven K. Boyd DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 45.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: Robert W. McMahon DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 45.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 46.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 42.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. COMPENSATION ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 44.000000 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 US68554V1089 06/03/2026 To approve an amendment to the Company's Certificate of Incorporation to declassify the Company's Board of Directors and add certain clarifying changes. CORPORATE GOVERNANCE ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 46.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: William Ericson DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 115.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 118.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: Christian O. Henry DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 117.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: John F. Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 117.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 117.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Director: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 118.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 121.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 122.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 18.000000 AGAINST FOR 103.000000 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 123.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 18.000000 AGAINST FOR 104.000000 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 DIRECTOR G. Clare Kahn, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 DIRECTOR Adrian Krainer, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 DIRECTOR Julie Anne Smith DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 US86150R1077 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 13.000000 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 US89532M1018 06/03/2026 Election of Class I Director to serve until the 2029 Annual Meeting of Stockholders: Michael Heffernan DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 US89532M1018 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 US89532M1018 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 39.000000 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 US89532M1018 06/03/2026 Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 39.000000 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 US89532M1018 06/03/2026 Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 38.000000 FOR S000004450 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov DIRECTOR ELECTIONS ISSUER 78.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 14.000000 AGAINST FOR 63.000000 FOR S000004450 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 78.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 15.000000 AGAINST FOR 62.000000 FOR S000004450 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 78.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 20.000000 AGAINST FOR 57.000000 FOR S000004450 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 78.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 78.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 76.000000 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Director: Jody Bilney DIRECTOR ELECTIONS ISSUER 80.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Director: David Hodgson DIRECTOR ELECTIONS ISSUER 80.000000 0.000000 ABSTAIN 30.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Election of Director: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 80.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 80.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 80.000000 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 US01625V1044 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers COMPENSATION ISSUER 80.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 79.000000 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 US03237H1014 06/04/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 US03237H1014 06/04/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 51.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 US03237H1014 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 US03237H1014 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 51.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 43.000000 FOR S000004450 CG ONCOLOGY, INC. 156944100 US1569441009 06/04/2026 Election of Class II to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 CG ONCOLOGY, INC. 156944100 US1569441009 06/04/2026 Election of Class II to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 20.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 CG ONCOLOGY, INC. 156944100 US1569441009 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 CG ONCOLOGY, INC. 156944100 US1569441009 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 19.000000 FOR S000004450 CG ONCOLOGY, INC. 156944100 US1569441009 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 20.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 20.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 Election of Director: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 28.000000 FOR S000004450 DAVITA INC. 23918K108 US23918K1088 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Sastry Chilukuri DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Chris Egan DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Samuel A. Hamood DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan (the "2021 Plan"), to increase the number of shares of Class A Common Stock, par value $0.001 per share that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 26.000000 AGAINST FOR 4.000000 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 US24477E1038 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 10.000000 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 06/04/2026 DIRECTOR Laura Brege DIRECTOR ELECTIONS ISSUER 39.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 06/04/2026 DIRECTOR Badreddin Edris, Ph.D. DIRECTOR ELECTIONS ISSUER 39.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 06/04/2026 DIRECTOR Jonathan Root, M.D. DIRECTOR ELECTIONS ISSUER 39.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 06/04/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 39.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 US28036F1057 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 37.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Seth Blackley DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Russell Glass DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Peter Grua DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Shawn Guertin DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Richard Jelinek DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Kim Keck DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Jill Smith DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Election of Director: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 70.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 66.000000 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 US30050B1017 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 54.000000 FOR S000004450 GOSSAMER BIO, INC. 38341P102 US38341P1021 06/04/2026 Election of Class II Director: Russell Cox DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 37.000000 AGAINST AGAINST 0.000000 AGAINST FOR 109.000000 FOR S000004450 GOSSAMER BIO, INC. 38341P102 US38341P1021 06/04/2026 Election of Class II Director: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 146.000000 0.000000 ABSTAIN 34.000000 AGAINST AGAINST 0.000000 AGAINST FOR 112.000000 FOR S000004450 GOSSAMER BIO, INC. 38341P102 US38341P1021 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 146.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 146.000000 FOR S000004450 GOSSAMER BIO, INC. 38341P102 US38341P1021 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 145.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 137.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 Election of Director: Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 59.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 Election of Director: Joan E. Herman DIRECTOR ELECTIONS ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 70.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To make an advisory vote on executive compensation. COMPENSATION ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 71.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 53.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 73.000000 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 US4622221004 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 71.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Election of Class III Director for three-year term: Diane Parks DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Election of Class III Director for three-year term: Mary T. Szela DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Election of Class III Director for three-year term: Michael J. Vasconcelles, M.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 35.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 5.000000 AGAINST 1.0 29.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 30.000000 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 US50127T1097 06/04/2026 Approval of an amendment to our 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 MBX BIOSCIENCES 55287L101 US55287L1017 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 MBX BIOSCIENCES 55287L101 US55287L1017 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 17.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 MBX BIOSCIENCES 55287L101 US55287L1017 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 17.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 KY61559X1045 06/04/2026 Election of Class I Director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified: Spike Loy DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 KY61559X1045 06/04/2026 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 KY61559X1045 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 KY61559X1045 06/04/2026 Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 67.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 67.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 67.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 67.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 67.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 64.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 67.000000 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 US62855J1043 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 68.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 65.000000 FOR S000004450 NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 Election of Director: Howard W. Robin DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 8.000000 FOR S000004450 NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 8.000000 FOR S000004450 NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 NEKTAR THERAPEUTICS 640268306 US6402683063 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 2.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Kelly Fischer DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Harald Ruf DIRECTOR ELECTIONS ISSUER 8.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 6.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 To approve an amendment to the 2024 Incentive Award Plan. COMPENSATION ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 US68752L1008 06/04/2026 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 8.000000 FOR S000004450 SANA BIOTECHNOLOGY, INC. 799566104 US7995661045 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Hans E. Bishop DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 33.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 SANA BIOTECHNOLOGY, INC. 799566104 US7995661045 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Robert Nelsen DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 80.000000 FOR S000004450 SANA BIOTECHNOLOGY, INC. 799566104 US7995661045 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Alise S. Reicin, M.D. DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 73.000000 FOR S000004450 SANA BIOTECHNOLOGY, INC. 799566104 US7995661045 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 82.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 73.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 61.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 69.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Michael Chambers DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 72.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 69.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation COMPENSATION ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 28.000000 AGAINST FOR 46.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 73.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 68.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 73.000000 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 US8036071004 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 71.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 31.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000. CAPITAL STRUCTURE ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000. COMPENSATION ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 SAVARA INC. 805111101 US8051111016 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. COMPENSATION ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 DIRECTOR David Hallal DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 DIRECTOR Kristina Burow DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 DIRECTOR Michael Gilman DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 DIRECTOR Katie Peng DIRECTOR ELECTIONS ISSUER 48.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 US80706P1030 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 48.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 27.000000 FOR S000004450 SI-BONE, INC. 825704109 US8257041090 06/04/2026 Election of Director: Jeffrey W. Dunn DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 SI-BONE, INC. 825704109 US8257041090 06/04/2026 Election of Director: John G. Freund, M.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 SI-BONE, INC. 825704109 US8257041090 06/04/2026 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 SI-BONE, INC. 825704109 US8257041090 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 Election of Class II Director: Malte Peters, M.D. DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 Election of Class II Director: Kanishka Pothula DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 Election of Class II Director: Mace Rothenberg, M.D. DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 US87583X1090 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Marc Kozin DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Joseph John Hassett DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 DIRECTOR Symeria Hudson DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. COMPENSATION ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 US9026731029 06/04/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 Election of Class II Director: Richard W. Dugan DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 39.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 Election of Class II Director: Charles C. Duncan DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 42.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 Election of Class II Director: Anne Sempowski Ward DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 39.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 41.000000 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 US9216591084 06/04/2026 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to increase the aggregate number of shares authorized for issuance thereunder. COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 36.000000 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 Election of Class II Director to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 134.000000 0.000000 ABSTAIN 39.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 Election of Class II Director to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 134.000000 0.000000 ABSTAIN 55.000000 AGAINST AGAINST 0.000000 AGAINST FOR 79.000000 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 134.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 132.000000 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 US98422E1038 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 134.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 126.000000 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 US00650F1093 06/05/2026 Election of Class I Director for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD DIRECTOR ELECTIONS ISSUER 54.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 US00650F1093 06/05/2026 Election of Class I Director for a three-year term expiring at the 2029 annual meeting of shareholders: Katey Owen, PhD DIRECTOR ELECTIONS ISSUER 54.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 US00650F1093 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. COMPENSATION ISSUER 53.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 51.000000 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 US00650F1093 06/05/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 54.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. Peter Farrell DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Joseph E. Payne DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR James Barlow DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. Edward W. Holmes DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. Magda Marquet DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. Jing L. Marantz DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. John Markels DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 DIRECTOR Dr. Moncef Slaoui DIRECTOR ELECTIONS ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. COMPENSATION ISSUER 20.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 US03969T1097 06/05/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 21.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 82.000000 0.000000 ABSTAIN 28.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha Krishnamohan DIRECTOR ELECTIONS ISSUER 82.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin Watanabe DIRECTOR ELECTIONS ISSUER 82.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 82.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 82.000000 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 US03969K1088 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 82.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 79.000000 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 DIRECTOR Mark Saad DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 DIRECTOR Susan Mahony, PhD., MBA DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 US05464T1043 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 27.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Linda Baddour DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Daniel Hancock DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Robert Hariri, MD, PhD DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Ramkumar Mandalam, PhD DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 DIRECTOR Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026. AUDIT-RELATED ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 21.000000 FOR S000004450 CRYOPORT, INC. 229050307 US2290503075 06/05/2026 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000. COMPENSATION ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 14.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian Posner DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. COMPENSATION ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 50.000000 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 US26818M1080 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR Todd C. Davis DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR Nancy R. Gray, Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR Jason Haas DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR John W. Kozarich, Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR John L. LaMattina,Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR Stephen L. Sabba, M.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 DIRECTOR M. Zimmermann Pharm.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 US53220K5048 06/05/2026 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 14.000000 FOR S000004450 PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 DIRECTOR Michael Kelly DIRECTOR ELECTIONS ISSUER 67.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 DIRECTOR David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 67.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 67.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 67.000000 FOR S000004450 SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Director: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 57.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Director: Brent Turner DIRECTOR ELECTIONS ISSUER 57.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Election of Class II Director: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 57.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. COMPENSATION ISSUER 57.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 56.000000 FOR S000004450 SURGERY PARTNERS INC. 86881A100 US86881A1007 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 57.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 27.000000 AGAINST FOR 108.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 134.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 124.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 133.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 129.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 129.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 133.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 133.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Meury DIRECTOR ELECTIONS ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 133.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 123.000000 FOR S000004450 INCYTE CORPORATION 45337C102 US45337C1027 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 135.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 126.000000 FOR S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 US01438T1060 06/09/2026 Election of Class III Director: Todd C. Brady, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 US01438T1060 06/09/2026 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 US01438T1060 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. COMPENSATION ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 33.000000 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 DIRECTOR Mark C. McKenna DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 DIRECTOR Jennifer Fox DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 DIRECTOR William (BJ) Jones, Jr. DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 US03770N1019 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D. DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D. DIRECTOR ELECTIONS ISSUER 22.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 US0554771032 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 22.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 22.000000 AGAINST FOR 96.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 23.000000 AGAINST FOR 95.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 97.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 117.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 22.000000 AGAINST FOR 95.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 117.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 117.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 117.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 32.000000 AGAINST FOR 86.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 22.000000 AGAINST FOR 96.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 117.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 111.000000 FOR S000004450 BIOGEN INC. 09062X103 US09062X1037 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. COMPENSATION ISSUER 117.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 110.000000 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 DIRECTOR Dr. Chris Cain DIRECTOR ELECTIONS ISSUER 67.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 DIRECTOR Arlene M. Morris DIRECTOR ELECTIONS ISSUER 67.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 56.000000 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 DIRECTOR Todd Shegog DIRECTOR ELECTIONS ISSUER 67.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 67.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 67.000000 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 67.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 64.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 Election of Class III Director named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A. DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 Election of Class III Director named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D. DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 25.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 US29337E1029 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 25.000000 0.000000 2.0 1.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 24.000000 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 US34965K1079 06/09/2026 Election of Director: Anshul Thakral DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 71.000000 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 US34965K1079 06/09/2026 Election of Director: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 7.000000 AGAINST FOR 66.000000 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 US34965K1079 06/09/2026 Election of Director: William J. Sharbaugh DIRECTOR ELECTIONS ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 71.000000 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 US34965K1079 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 US34965K1079 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. COMPENSATION ISSUER 74.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 70.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 DIRECTOR John P. Bamforth DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 DIRECTOR Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 DIRECTOR Kathleen Sebelius DIRECTOR ELECTIONS ISSUER 9.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. COMPENSATION ISSUER 9.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 4.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 9.000000 0.000000 2.0 2.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 7.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 HUMACYTE, INC. 44486Q103 US44486Q1031 06/09/2026 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 350,000,000 shares to 550,000,000 shares. CAPITAL STRUCTURE ISSUER 9.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 7.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Richard Adcock DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Wesley Clark DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 84.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 71.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Christobel Selecky DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 Election of Director: Bruce Wendel DIRECTOR ELECTIONS ISSUER 89.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 88.000000 FOR S000004450 IMMUNITYBIO, INC. 45256X103 US45256X1037 06/09/2026 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 89.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 88.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James Boylan DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 25.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 76.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Philip Wagenheim DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 76.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 76.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 75.000000 FOR S000004450 IMMUNOME INC. 45257U108 US45257U1088 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 76.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 76.000000 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 85.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 82.000000 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Brian Goff DIRECTOR ELECTIONS ISSUER 85.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 20.000000 AGAINST FOR 65.000000 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 85.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 24.000000 AGAINST FOR 61.000000 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 84.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 84.000000 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 85.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 64.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 10.000000 AGAINST FOR 198.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Robert Essner DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 9.000000 AGAINST FOR 198.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 201.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 201.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 202.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Deborah Leone DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 202.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 7.000000 AGAINST FOR 201.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 209.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 201.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 5.000000 AGAINST FOR 203.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Election of Director: Shalini Sharp DIRECTOR ELECTIONS ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 7.000000 AGAINST FOR 201.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. COMPENSATION ISSUER 210.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 10.000000 AGAINST FOR 197.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 211.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 11.000000 AGAINST FOR 197.000000 FOR S000004450 ORGANON & CO. 68622V106 US68622V1061 06/09/2026 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 210.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 3.000000 AGAINST FOR 205.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Company Nominee: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Company Nominee: Samit Hirawat DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Company Nominee: Thomas Wiggans DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 COMPANY NOMINEE OPPOSED BY DOMA: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 COMPANY NOMINEE OPPOSED BY DOMA: Samit Hirawat DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 COMPANY NOMINEE OPPOSED BY DOMA: Tom Wiggans DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Ratification of the appointment of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR FOR 0.000000 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 US6951271005 06/09/2026 Approval of our Amended and Restated 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 AGAINST AGAINST 0.000000 FOR FOR 0.000000 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 US74276L1052 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 17.000000 AGAINST FOR 26.000000 FOR S000004450 QUANTERIX CORPORATION 74766Q101 US74766Q1013 06/09/2026 Election of Director: William P. Donnelly DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 30.000000 FOR S000004450 QUANTERIX CORPORATION 74766Q101 US74766Q1013 06/09/2026 Election of Director: Ivana Magovcevic-Liebisch, Ph.D., J.D DIRECTOR ELECTIONS ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 29.000000 FOR S000004450 QUANTERIX CORPORATION 74766Q101 US74766Q1013 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 4.000000 AGAINST FOR 27.000000 FOR S000004450 QUANTERIX CORPORATION 74766Q101 US74766Q1013 06/09/2026 To ratify, on an advisory basis, the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 QUANTERIX CORPORATION 74766Q101 US74766Q1013 06/09/2026 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan COMPENSATION ISSUER 33.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 25.000000 AGAINST FOR 8.000000 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 Election of class III Director to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 98.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 Election of class III Director to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 98.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 98.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 97.000000 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 98.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 98.000000 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 US75943R1023 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000. CAPITAL STRUCTURE ISSUER 98.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 98.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Harold E. Ford, Jr. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Gen John M. Keane(Ret.) DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Gary J. Nabel DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Diem Nguyen DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 DIRECTOR Holly L. Phillips DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 33.000000 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 US8269171067 06/09/2026 To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 27.000000 FOR S000004450 UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 DIRECTOR H. E. Fleming Jr., M.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 DIRECTOR L. Ratcliffe,MBChB, PhD DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 UPSTREAM BIO, INC. 91678A107 US91678A1079 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 US0067391062 06/10/2026 DIRECTOR Michael Earley DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 US0067391062 06/10/2026 DIRECTOR Veronica Hill-Milbourne DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 US0067391062 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 US0067391062 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 13.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 24.000000 AGAINST AGAINST 0.000000 AGAINST FOR 73.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: Quentin Blackford DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 34.000000 AGAINST AGAINST 0.000000 AGAINST FOR 63.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: David Demski DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 90.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 Election of Director: Keith Valentine DIRECTOR ELECTIONS ISSUER 97.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 86.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 97.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 97.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 97.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 27.000000 AGAINST FOR 70.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 97.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 97.000000 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 US02081G2012 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 97.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 88.000000 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 US00166B1052 06/10/2026 DIRECTOR Daniel Curran, M.D. DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 US00166B1052 06/10/2026 DIRECTOR Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 US00166B1052 06/10/2026 DIRECTOR C. Takimoto MD PhD FACP DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 US00166B1052 06/10/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 21.000000 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 US00166B1052 06/10/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Kenneth Sim, M.D. DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Thomas S Lam M.D, M.P.H DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR John Chiang DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Weili Dai DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Linda Dong DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR J. Lorraine Estradas DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 DIRECTOR David G. Schmidt DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. COMPENSATION ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 35.000000 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 US03763A2078 06/10/2026 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 US18914F1030 06/10/2026 DIRECTOR Demetrios L. Kouzoukas DIRECTOR ELECTIONS ISSUER 345.000000 0.000000 ABSTAIN 42.000000 AGAINST AGAINST 0.000000 AGAINST FOR 303.000000 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 US18914F1030 06/10/2026 DIRECTOR Andrew Toy DIRECTOR ELECTIONS ISSUER 345.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 333.000000 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 US18914F1030 06/10/2026 DIRECTOR Thomas L. Tran DIRECTOR ELECTIONS ISSUER 345.000000 0.000000 ABSTAIN 58.000000 AGAINST AGAINST 0.000000 AGAINST FOR 287.000000 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 US18914F1030 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. COMPENSATION ISSUER 346.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 36.000000 AGAINST FOR 304.000000 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 US18914F1030 06/10/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 345.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 342.000000 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 US23285D1090 06/10/2026 DIRECTOR Vera Imper, Ph.D. DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 US23285D1090 06/10/2026 DIRECTOR Glenn P. Muir DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 79.000000 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 US23285D1090 06/10/2026 DIRECTOR Ming Yan, Ph.D. DIRECTOR ELECTIONS ISSUER 87.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 75.000000 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 US23285D1090 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. COMPENSATION ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 86.000000 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 US23285D1090 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 87.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 87.000000 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 US29384C1080 06/10/2026 Election of Director: Peter S. Kim, Ph.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 US29384C1080 06/10/2026 Election of Director: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 15.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 US29384C1080 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 US29384C1080 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 9.000000 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 US29384C1080 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. COMPENSATION ISSUER 15.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 11.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR Iain Dukes, D. Phil. DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 227.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR Athena Countouriotis MD DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 19.000000 AGAINST AGAINST 0.000000 AGAINST FOR 229.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR Ryan Maynard DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 19.000000 AGAINST AGAINST 0.000000 AGAINST FOR 229.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 226.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR F. G. Vogt, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 25.000000 AGAINST AGAINST 0.000000 AGAINST FOR 223.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 DIRECTOR Michael Weiser, MD, PhD DIRECTOR ELECTIONS ISSUER 248.000000 0.000000 ABSTAIN 20.000000 AGAINST AGAINST 0.000000 AGAINST FOR 228.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. COMPENSATION ISSUER 248.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 50.000000 AGAINST FOR 194.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 248.000000 0.000000 2.0 5.000000 AGAINST 3.0 5.000000 AGAINST ABSTAIN 6.000000 AGAINST 1.0 232.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 247.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 2.000000 AGAINST FOR 242.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares. COMPENSATION ISSUER 249.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 27.000000 AGAINST FOR 219.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares. CAPITAL STRUCTURE ISSUER 248.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 38.000000 AGAINST FOR 207.000000 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 US4622601007 06/10/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. CORPORATE GOVERNANCE ISSUER 247.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 39.000000 AGAINST FOR 205.000000 FOR S000004450 KORRO BIO, INC. 500946108 US5009461089 06/10/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 KORRO BIO, INC. 500946108 US5009461089 06/10/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 KORRO BIO, INC. 500946108 US5009461089 06/10/2026 Non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 KORRO BIO, INC. 500946108 US5009461089 06/10/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: J. Christopher Barry DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Francesco Bianchi DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: William Kozy DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Jette Nygaard-Andersen DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Susan Podlogar DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Brooke Story DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Peter Wilver DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Election of Director: Donald Zurbay DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Special Resolution: Subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 43.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of this proxy statement (the "Share Repurchase Contracts") and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in this proxy statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the share ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the year ended December 31, 2025. COMPENSATION ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 43.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2025, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2026. AUDIT-RELATED ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIVANOVA PLC G5509L101 GB00BYMT0J19 06/10/2026 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 US55083R2031 06/10/2026 Election of Class II Director: Richard Klausner, M.D. DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 US55083R2031 06/10/2026 Election of Class II Director: Otis Brawley, M.D. DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 US55083R2031 06/10/2026 Election of Class II Director: William Rieflin DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 US55083R2031 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 US55083R2031 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. COMPENSATION ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: James L. Bierman DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 90.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 93.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: K. Todd Newton DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 91.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: Tiffany Olson DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 94.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Election of Director: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 91.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Advisory approval of executive compensation. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 4.000000 AGAINST FOR 89.000000 FOR S000004450 MIMEDX GROUP, INC. 602496101 US6024961012 06/10/2026 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 DIRECTOR Pravin U. Dugel, M.D. DIRECTOR ELECTIONS ISSUER 129.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 118.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 DIRECTOR Merilee Raines DIRECTOR ELECTIONS ISSUER 129.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 113.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To approve an advisory vote on named executive officer compensation. COMPENSATION ISSUER 130.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 32.000000 AGAINST FOR 97.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 130.000000 0.000000 2.0 1.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 1.000000 AGAINST 1.0 127.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. COMPENSATION ISSUER 129.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 124.000000 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 US67576A1007 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 129.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 128.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Wayne Burris DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Election of Director: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 US68752M1080 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 24.000000 FOR S000004450 PACS GROUP, INC. 69380Q107 US69380Q1076 06/10/2026 DIRECTOR Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 PACS GROUP, INC. 69380Q107 US69380Q1076 06/10/2026 DIRECTOR Mark Hancock DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 PACS GROUP, INC. 69380Q107 US69380Q1076 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 PACS GROUP, INC. 69380Q107 US69380Q1076 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 25.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Election of Class III Director to serve will expire in 2029: George M. Jenkins DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Election of Class III Director to serve will expire in 2029: Todd C. Davis DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Election of Class III Director to serve will expire in 2029: John Doux, M.D. DIRECTOR ELECTIONS ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 7.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 7.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. COMPENSATION ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 5.000000 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 US6979471090 06/10/2026 Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 7.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 5.000000 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 US74006W2070 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 US74006W2070 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 US74006W2070 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 US74006W2070 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 US74006W2070 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. COMPENSATION ISSUER 18.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 US75383L1026 06/10/2026 DIRECTOR James Healy, M.D., PhD DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 US75383L1026 06/10/2026 DIRECTOR Robert J. Perez DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 US75383L1026 06/10/2026 DIRECTOR Raymond Sanchez, M.D. DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 US75383L1026 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Robert W. Duggan DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Robert Booth DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Alessandra Cesano DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Yu (Michelle) Xia DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 DIRECTOR Jeff Huber DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 43.000000 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 US86627T1088 06/10/2026 Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 43.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 Election of Director: Pierre Legault DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 25.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 Election of Director: Michael A. Metzger DIRECTOR ELECTIONS ISSUER 66.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. COMPENSATION ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 62.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 30.000000 AGAINST FOR 36.000000 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 US87164F1057 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 66.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 62.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein DIRECTOR ELECTIONS ISSUER 63.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 59.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 62.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 63.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 62.000000 FOR S000004450 VERACYTE, INC. 92337F107 US92337F1075 06/10/2026 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 19.000000 AGAINST FOR 45.000000 FOR S000004450 ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 DIRECTOR Bettina M. Cockroft, MD DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 19.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 DIRECTOR Douglas Love, Esq. DIRECTOR ELECTIONS ISSUER 96.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 96.000000 FOR S000004450 ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 95.000000 FOR S000004450 ANNEXON, INC. 03589W102 US03589W1027 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 96.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 93.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 Election of Director: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 Election of Director: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 53.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 Election of Director: Nicole Lambert DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 Election of Director: Johanna Mercier DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 65.000000 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 61.000000 FOR S000004450 AURA BIOSCIENCES, INC. 05153U107 US05153U1079 06/11/2026 DIRECTOR David Johnson DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 AURA BIOSCIENCES, INC. 05153U107 US05153U1079 06/11/2026 DIRECTOR Teresa Marie Bitetti DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AURA BIOSCIENCES, INC. 05153U107 US05153U1079 06/11/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 DIRECTOR Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 168.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 162.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 DIRECTOR Amy E. McKee, M.D. DIRECTOR ELECTIONS ISSUER 168.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 164.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 DIRECTOR Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 168.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 159.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 168.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 162.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. COMPENSATION ISSUER 169.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 50.000000 AGAINST FOR 118.000000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 US09058V1035 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 168.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 56.000000 AGAINST FOR 112.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 DIRECTOR F. E. Cohen MD, D. Phil DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 DIRECTOR R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 DIRECTOR Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 DIRECTOR Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 DIRECTOR John W. Hanna DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 38.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 40.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 39.000000 FOR S000004450 CAREDX, INC. 14167L103 US14167L1035 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 27.000000 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 US2210151005 06/11/2026 Election of Class I Director with term to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 US2210151005 06/11/2026 Election of Class I Director with term to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 US2210151005 06/11/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 US2210151005 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 43.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Roger Adsett DIRECTOR ELECTIONS ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders. AUDIT-RELATED ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 65.000000 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 CA24477V1058 06/11/2026 To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares. COMPENSATION ISSUER 65.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 60.000000 FOR S000004450 EVOLUS, INC. 30052C107 US30052C1071 06/11/2026 DIRECTOR Brady Stewart DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 EVOLUS, INC. 30052C107 US30052C1071 06/11/2026 DIRECTOR Vikram Malik DIRECTOR ELECTIONS ISSUER 38.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 20.000000 FOR S000004450 EVOLUS, INC. 30052C107 US30052C1071 06/11/2026 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 38.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 EVOLUS, INC. 30052C107 US30052C1071 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Richard J. Barry DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Pierre Gravier DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Claude Nicaise, M.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 To approve Amendment No. 2 to the Company's 2018 Omnibus Incentive Plan, which, among other things, increases the authorized number of shares issuable thereunder by 4,000,000 shares (from 5,000,000 to 9,000,000 authorized shares). COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 31.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 34.000000 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 US14817C1071 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 27.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Election of Class A Director: Ross Fubini DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 8.000000 AGAINST FOR 16.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Election of Class A Director: Christian Henry DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 14.000000 AGAINST FOR 10.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Election of Class A Director: Sri Kosuri DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 9.000000 AGAINST FOR 16.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Election of Class A Director: Harry E. Sloan DIRECTOR ELECTIONS ISSUER 27.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 11.000000 AGAINST FOR 13.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 US37611X2099 06/11/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 13.000000 AGAINST FOR 11.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard DIRECTOR ELECTIONS ISSUER 111.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 9.000000 AGAINST FOR 102.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Tom Cusack DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 105.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 104.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson DIRECTOR ELECTIONS ISSUER 111.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 103.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 105.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 105.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage DIRECTOR ELECTIONS ISSUER 112.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 99.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 111.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 109.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025. COMPENSATION ISSUER 113.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 29.000000 AGAINST FOR 78.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. COMPENSATION ISSUER 112.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 25.000000 AGAINST FOR 81.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 To amend the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares. COMPENSATION ISSUER 112.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 15.000000 AGAINST FOR 93.000000 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 US4277461020 06/11/2026 To ratify, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan. CORPORATE GOVERNANCE ISSUER 111.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 104.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Andrew Dudum DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Kofi Amoo-Gottfried DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Deb Autor DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Delos Cosgrove, M.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Anja Manuel DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Christopher Payne DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Andrea Perez DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR Kare Schultz DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 DIRECTOR David Wells DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 US4330001060 06/11/2026 Advisory approval of the Company's executive compensation. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 40.000000 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 Election of Class II Director to serve for three-year term until the 2029 Annual Meeting of Stockholders: Natasha Hernday DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 Election of Class II Director to serve for three-year term until the 2029 Annual Meeting of Stockholders: Eric Dobmeier DIRECTOR ELECTIONS ISSUER 31.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 31.000000 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 US47103J1051 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 31.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 27.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Charles N. Mills DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 183.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 181.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Jacob D. Best DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 178.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 184.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR James M. Boyle DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 184.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Richard A. Galanti DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 181.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Patrick J. Healy DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 184.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Andrew J. Mills DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 184.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 31.000000 AGAINST AGAINST 0.000000 AGAINST FOR 156.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 182.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 181.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 DIRECTOR Stephen H. Wise DIRECTOR ELECTIONS ISSUER 187.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 181.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote to Approve Our Executive Compensation. COMPENSATION ISSUER 187.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 183.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 187.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 187.000000 FOR S000004450 MEDLINE INC. 58507V107 US58507V1070 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 187.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 187.000000 FOR S000004450 MEIRAGTX HOLDINGS PLC G59665102 KYG596651029 06/11/2026 DIRECTOR Ellen Hukkelhoven DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 MEIRAGTX HOLDINGS PLC G59665102 KYG596651029 06/11/2026 DIRECTOR Nicole Seligman DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 MEIRAGTX HOLDINGS PLC G59665102 KYG596651029 06/11/2026 DIRECTOR Debra Yu, M.D. DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 MEIRAGTX HOLDINGS PLC G59665102 KYG596651029 06/11/2026 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 US61225M1027 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 US61225M1027 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 US61225M1027 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 US61225M1027 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 DIRECTOR Rowan Chapman* DIRECTOR ELECTIONS ISSUER 106.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 92.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 DIRECTOR Herm Rosenman* DIRECTOR ELECTIONS ISSUER 106.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 90.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 DIRECTOR Jonathan Sheena* DIRECTOR ELECTIONS ISSUER 106.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 92.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 DIRECTOR Eric H. Rubin# DIRECTOR ELECTIONS ISSUER 106.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 104.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 106.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 105.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 106.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 104.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 106.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 105.000000 FOR S000004450 NATERA, INC. 632307104 US6323071042 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 106.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 24.000000 AGAINST FOR 82.000000 FOR S000004450 OCUGEN, INC. 67577C105 US67577C1053 06/11/2026 DIRECTOR Kirsten Castillo DIRECTOR ELECTIONS ISSUER 252.000000 0.000000 ABSTAIN 30.000000 AGAINST AGAINST 0.000000 AGAINST FOR 222.000000 FOR S000004450 OCUGEN, INC. 67577C105 US67577C1053 06/11/2026 DIRECTOR Satish Chandran, Ph.D. DIRECTOR ELECTIONS ISSUER 252.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 245.000000 FOR S000004450 OCUGEN, INC. 67577C105 US67577C1053 06/11/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 252.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 1.000000 AGAINST FOR 245.000000 FOR S000004450 OCUGEN, INC. 67577C105 US67577C1053 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. COMPENSATION ISSUER 252.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 51.000000 AGAINST FOR 196.000000 FOR S000004450 OCUGEN, INC. 67577C105 US67577C1053 06/11/2026 Approval, on a non-binding advisory basis, of the preferred frequency with which future advisory votes on the compensation of Ocugen's named executive officers should be held. SECTION 14A SAY-ON-PAY VOTES ISSUER 253.000000 0.000000 2.0 5.000000 AGAINST 3.0 13.000000 AGAINST ABSTAIN 8.000000 AGAINST 1.0 227.000000 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 Election of class III Director: Bernard Coulie, M.D., Ph.D., M.B.A. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 Election of class III Director: Gayle Crowell DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 Election of class III Director: Steve Krognes, M.B.A. DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. COMPENSATION ISSUER 41.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 21.000000 AGAINST FOR 19.000000 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 US7291391057 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Maria Sainz DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 Election of Director: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 US74587B1017 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Laurence Charney DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 24.000000 AGAINST AGAINST 0.000000 AGAINST FOR 98.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Yann Echelard DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 31.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 30.000000 AGAINST AGAINST 0.000000 AGAINST FOR 92.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Daniel Hume DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 31.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Sagar Lonial, MD DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 47.000000 AGAINST AGAINST 0.000000 AGAINST FOR 75.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 DIRECTOR Michael S. Weiss DIRECTOR ELECTIONS ISSUER 122.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 105.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 122.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 121.000000 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 US88322Q1085 06/11/2026 An advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 122.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 66.000000 AGAINST FOR 55.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 Election of Class I Director: Robert S. Epstein, M.D., M.S. DIRECTOR ELECTIONS ISSUER 79.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 Election of Class I Director: Karin Jooss, Ph.D. DIRECTOR ELECTIONS ISSUER 79.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 Election of Class I Director: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 79.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 79.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 79.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 79.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 79.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 77.000000 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 US31189P1021 06/12/2026 To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 79.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 18.000000 AGAINST FOR 61.000000 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 US52635N1037 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Evert Schimmelpennink DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 US52635N1037 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Jeff George DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 US52635N1037 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Shelley Thunen DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 US52635N1037 06/12/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Director: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 29.000000 AGAINST FOR 54.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Director: Christine A. Poon DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 23.000000 AGAINST FOR 60.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Director: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 79.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Director: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 21.000000 AGAINST FOR 62.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Election of Director: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 80.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 77.000000 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. COMPENSATION ISSUER 83.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 77.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah Gray DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. Mitchell DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O'Connor DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. Pakianathan DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E Winningham DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 KYG8807B1068 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 21.000000 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 US6047491013 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Robert Ades DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Jon Giacomin DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 26.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Michele Korfin DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 31.000000 AGAINST AGAINST 0.000000 AGAINST FOR 27.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 DIRECTOR Gilberto Quintero DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. COMPENSATION ISSUER 58.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 43.000000 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 US68621F1021 06/15/2026 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 58.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 DIRECTOR Olivier Brandicourt MD DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 84.000000 FOR S000004450 VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 DIRECTOR Halley Gilbert, J.D. DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 11.000000 AGAINST AGAINST 0.000000 AGAINST FOR 84.000000 FOR S000004450 VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 DIRECTOR Grant E. Pickering MBA DIRECTOR ELECTIONS ISSUER 95.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 94.000000 FOR S000004450 VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 95.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 95.000000 FOR S000004450 VAXCYTE, INC. 92243G108 US92243G1085 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 94.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 93.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 DIRECTOR Robert Bazemore DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 190.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 DIRECTOR Muna Bhanji, R.Ph DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 38.000000 AGAINST AGAINST 0.000000 AGAINST FOR 159.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 DIRECTOR Richard Rodgers DIRECTOR ELECTIONS ISSUER 197.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 188.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). COMPENSATION ISSUER 197.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 14.000000 AGAINST FOR 182.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years. SECTION 14A SAY-ON-PAY VOTES ISSUER 197.000000 0.000000 2.0 1.000000 AGAINST 3.0 5.000000 AGAINST ABSTAIN 3.000000 AGAINST 1.0 188.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 197.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 194.000000 FOR S000004450 ARDELYX, INC 039697107 US0396971071 06/16/2026 To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. COMPENSATION ISSUER 197.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 85.000000 AGAINST FOR 111.000000 FOR S000004450 CULLINAN THERAPEUTICS, INC. 230031106 US2300311063 06/16/2026 DIRECTOR Nadim Ahmed DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CULLINAN THERAPEUTICS, INC. 230031106 US2300311063 06/16/2026 DIRECTOR Stephen Webster DIRECTOR ELECTIONS ISSUER 23.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 17.000000 FOR S000004450 CULLINAN THERAPEUTICS, INC. 230031106 US2300311063 06/16/2026 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 CULLINAN THERAPEUTICS, INC. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. COMPENSATION ISSUER 23.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 DIRECTOR Vina Leite DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 32.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 DIRECTOR James M. Travers DIRECTOR ELECTIONS ISSUER 70.000000 0.000000 ABSTAIN 31.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. COMPENSATION ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 16.000000 AGAINST FOR 54.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 Shareholders are asked to approve six possible amendments to the Company's charter to allow a reverse stock split of common stock at one of these ratios: 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1- for-9, or 1-for-10. The Board would choose the final ratio and timing, and the amendment would also reduce authorized common and preferred shares proportionally. CAPITAL STRUCTURE ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 66.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 70.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 14.000000 AGAINST FOR 55.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 69.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 8.000000 AGAINST FOR 60.000000 FOR S000004450 DOCGO INC. 256086109 US2560861096 06/16/2026 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 70.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 67.000000 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 US38246G1085 06/16/2026 DIRECTOR Wendy Barnes DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 9.000000 AGAINST AGAINST 0.000000 AGAINST FOR 60.000000 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 US38246G1085 06/16/2026 DIRECTOR Ronald E. Bruehlman DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 US38246G1085 06/16/2026 DIRECTOR Gregory Mondre DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 US38246G1085 06/16/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 69.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 69.000000 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 US38246G1085 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 69.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 30.000000 AGAINST FOR 35.000000 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 49.000000 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. DIRECTOR ELECTIONS ISSUER 64.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 64.000000 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 US45166A1025 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. COMPENSATION ISSUER 64.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 61.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Mark Currie, Ph.D. DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 115.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Alexander Denner, Ph.D. DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 112.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Jon Duane DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 114.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Marla Kessler DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 115.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Thomas McCourt DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 115.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Julie McHugh DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 112.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 114.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 DIRECTOR Jay Shepard DIRECTOR ELECTIONS ISSUER 118.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 115.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. COMPENSATION ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 113.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. COMPENSATION ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 113.000000 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 US46333X1081 06/16/2026 Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 118.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 115.000000 FOR S000004450 LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 Election of Director: David Johnson DIRECTOR ELECTIONS ISSUER 49.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 49.000000 FOR S000004450 LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 Election of Director: Katie Rielly-Gauvin DIRECTOR ELECTIONS ISSUER 49.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 Election of Director: Ramandeep Singh DIRECTOR ELECTIONS ISSUER 49.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. AUDIT-RELATED ISSUER 49.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 49.000000 FOR S000004450 LIQUIDIA CORPORATION 53635D202 US53635D2027 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 49.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 48.000000 FOR S000004450 NUVALENT, INC. 670703107 US6707031075 06/16/2026 Election of Class II Director: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 NUVALENT, INC. 670703107 US6707031075 06/16/2026 Election of Class II Director: Ron Squarer DIRECTOR ELECTIONS ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 NUVALENT, INC. 670703107 US6707031075 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. COMPENSATION ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 31.000000 FOR S000004450 NUVALENT, INC. 670703107 US6707031075 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 32.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Brian J. Blaser DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR K. F. Buechler, Ph.D. DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR John R. Chiminski DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Edward L. Michael DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR M.L. Polan, MD PhD MPH DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Kenneth J. Widder, M.D. DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 DIRECTOR Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. COMPENSATION ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 53.000000 FOR S000004450 QUIDELORTHO CORPORATION 219798105 US2197981051 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 RXSIGHT, INC. 78349D107 US78349D1072 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: William J. Link, Ph.D. DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 RXSIGHT, INC. 78349D107 US78349D1072 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Robert Warner DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 10.000000 AGAINST AGAINST 0.000000 AGAINST FOR 18.000000 FOR S000004450 RXSIGHT, INC. 78349D107 US78349D1072 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 13.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 RXSIGHT, INC. 78349D107 US78349D1072 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. COMPENSATION ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 25.000000 FOR S000004450 RXSIGHT, INC. 78349D107 US78349D1072 06/16/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Raymond J. Deshaies DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. Simpson DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 36.000000 FOR S000004450 XENCOR, INC. 98401F105 US98401F1057 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 39.000000 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 US98943L1070 06/16/2026 DIRECTOR David Johnson DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 US98943L1070 06/16/2026 DIRECTOR Jan Skvarka, Ph.D. DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 US98943L1070 06/16/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 US98943L1070 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 14.000000 AGAINST FOR 26.000000 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Nancy Miller-Rich DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Shawn Cline Tomasello, MBA DIRECTOR ELECTIONS ISSUER 34.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 US35104E1001 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 33.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 DIRECTOR Adrian Adams DIRECTOR ELECTIONS ISSUER 203.000000 0.000000 ABSTAIN 56.000000 AGAINST AGAINST 0.000000 AGAINST FOR 147.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 DIRECTOR Michael Rogers DIRECTOR ELECTIONS ISSUER 203.000000 0.000000 ABSTAIN 56.000000 AGAINST AGAINST 0.000000 AGAINST FOR 147.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 DIRECTOR LeAnne M. Zumwalt DIRECTOR ELECTIONS ISSUER 203.000000 0.000000 ABSTAIN 62.000000 AGAINST AGAINST 0.000000 AGAINST FOR 141.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 Approval of an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and to increase the number of authorized shares of common stock from 350,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 203.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 82.000000 AGAINST FOR 121.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. COMPENSATION ISSUER 204.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 69.000000 AGAINST FOR 131.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 202.000000 0.000000 2.0 3.000000 AGAINST 3.0 29.000000 AGAINST ABSTAIN 11.000000 AGAINST 1.0 159.000000 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 US00972D1054 06/17/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 202.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 14.000000 AGAINST FOR 186.000000 FOR S000004450 ALECTOR, INC. 014442107 US0144421072 06/17/2026 DIRECTOR E. Garofalo, M.D. DIRECTOR ELECTIONS ISSUER 59.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 ALECTOR, INC. 014442107 US0144421072 06/17/2026 DIRECTOR Errol De Souza, Ph.D. DIRECTOR ELECTIONS ISSUER 59.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 ALECTOR, INC. 014442107 US0144421072 06/17/2026 DIRECTOR Kristine Yaffe, M.D. DIRECTOR ELECTIONS ISSUER 59.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 ALECTOR, INC. 014442107 US0144421072 06/17/2026 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 59.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 ALECTOR, INC. 014442107 US0144421072 06/17/2026 Advisory vote on executive compensation. COMPENSATION ISSUER 59.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 57.000000 FOR S000004450 BIOLIFE SOLUTIONS, INC. 09062W204 US09062W2044 06/17/2026 DIRECTOR Meeting Cancelled DIRECTOR ELECTIONS ISSUER 0.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 0.000000 FOR S000004450 BIOLIFE SOLUTIONS, INC. 09062W204 US09062W2044 06/17/2026 As per the Issuer, this meeting is no longer taking place. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0.000000 1.0 0.000000 AGAINST 2.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 3.0 0.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 Election of Director with term to expire at the 2029 Annual Meeting of Stockholders: Matthew P. Young DIRECTOR ELECTIONS ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 128.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 Election of Director with term to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 15.000000 AGAINST FOR 115.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 130.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares. CAPITAL STRUCTURE ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 128.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 129.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 128.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 129.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. COMPENSATION ISSUER 130.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 128.000000 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 US23284F1057 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 129.000000 0.000000 2.0 1.000000 AGAINST 3.0 2.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 126.000000 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 US28106W1036 06/17/2026 DIRECTOR Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 79.000000 0.000000 ABSTAIN 21.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 US28106W1036 06/17/2026 DIRECTOR Elliott Levy, M.D. DIRECTOR ELECTIONS ISSUER 79.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 77.000000 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 US28106W1036 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 78.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 67.000000 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 US28106W1036 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 78.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 78.000000 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Election of Class II Director: Ian Clark DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 34.000000 AGAINST AGAINST 0.000000 AGAINST FOR 57.000000 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Election of Class II Director: Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 91.000000 0.000000 ABSTAIN 25.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 91.000000 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. COMPENSATION ISSUER 91.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 89.000000 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 US40131M1099 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 91.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 91.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I director: Julian Baker DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I director: Daniel Brennan DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Re-election of Class I director: James Daly DIRECTOR ELECTIONS ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 US5588681057 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 11.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 11.000000 FOR S000004450 MAXCYTE, INC. 57777K106 US57777K1060 06/17/2026 DIRECTOR Patrick J. Balthrop DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 15.000000 AGAINST AGAINST 0.000000 AGAINST FOR 66.000000 FOR S000004450 MAXCYTE, INC. 57777K106 US57777K1060 06/17/2026 DIRECTOR Cynthia Collins DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 79.000000 FOR S000004450 MAXCYTE, INC. 57777K106 US57777K1060 06/17/2026 DIRECTOR Stanley C. Erck DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 67.000000 FOR S000004450 MAXCYTE, INC. 57777K106 US57777K1060 06/17/2026 To ratify the Audit Committee's selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 DIRECTOR Sean Bohen, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 DIRECTOR Scott Garland DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 DIRECTOR Yi Larson DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 DIRECTOR Andrew Rappaport DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 US68062P1066 06/17/2026 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 OMNIAB, INC. 68218J103 US68218J1034 06/17/2026 Election of Director: Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 67.000000 FOR S000004450 OMNIAB, INC. 68218J103 US68218J1034 06/17/2026 Election of Director: Jennifer Cochran, Ph.D. DIRECTOR ELECTIONS ISSUER 69.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 47.000000 FOR S000004450 OMNIAB, INC. 68218J103 US68218J1034 06/17/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm AUDIT-RELATED ISSUER 69.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 69.000000 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 DIRECTOR Dinesh V. Patel, Ph.D. DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 DIRECTOR L.T. Williams, MD, PhD DIRECTOR ELECTIONS ISSUER 40.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 39.000000 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 40.000000 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 US74366E1029 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 40.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 34.000000 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 DIRECTOR Najat Khan, Ph.D. DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 DIRECTOR Franziska Michor, Ph.D. DIRECTOR ELECTIONS ISSUER 14.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 13.000000 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. COMPENSATION ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 12.000000 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 14.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 14.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 DIRECTOR Michael Egholm, Ph.D. DIRECTOR ELECTIONS ISSUER 200.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 193.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 DIRECTOR Thomas Carey DIRECTOR ELECTIONS ISSUER 200.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 186.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 DIRECTOR Eli Casdin DIRECTOR ELECTIONS ISSUER 200.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 192.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 200.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 28.000000 AGAINST FOR 168.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 200.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 198.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 201.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 12.000000 AGAINST FOR 185.000000 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 US34385P1084 06/17/2026 To approve an amendment to our Amended and Restated 2017 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares. COMPENSATION ISSUER 200.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 194.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 124.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 34.000000 AGAINST FOR 92.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 125.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 124.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 127.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 20.000000 AGAINST FOR 106.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 124.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 123.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 43.000000 AGAINST FOR 83.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 118.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew J. Wallach DIRECTOR ELECTIONS ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 49.000000 AGAINST FOR 77.000000 FOR S000004450 VEEVA SYSTEMS INC. 922475108 US9224751084 06/17/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 126.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 123.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Gregory Belinfanti DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Terence Connors DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Brad Coppens DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 75.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Suzanne Foster DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Ted Lundberg DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 71.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Kenneth Samet DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 76.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Dr. Susan Weaver DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR David Williams III DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 DIRECTOR Dale Wolf DIRECTOR ELECTIONS ISSUER 76.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 74.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 76.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 75.000000 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 US00653Q1022 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. COMPENSATION ISSUER 77.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 75.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 39.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian Goff DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia Smith DIRECTOR ELECTIONS ISSUER 45.000000 0.000000 ABSTAIN 16.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 1.000000 AGAINST FOR 42.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. COMPENSATION ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 42.000000 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 US00847X1046 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 Election of Director: Deborah Messemer DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 33.000000 AGAINST AGAINST 0.000000 AGAINST FOR 168.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 Election of Director: Vicki Sato, Ph.D. DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 33.000000 AGAINST AGAINST 0.000000 AGAINST FOR 168.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 Election of Director: Owen Witte, M.D. DIRECTOR ELECTIONS ISSUER 201.000000 0.000000 ABSTAIN 48.000000 AGAINST AGAINST 0.000000 AGAINST FOR 153.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 201.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 13.000000 AGAINST FOR 184.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 201.000000 0.000000 2.0 0.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 4.000000 AGAINST 1.0 196.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE ISSUER 201.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 193.000000 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 US0197701065 06/18/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 200.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 200.000000 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 US04272N1028 06/18/2026 DIRECTOR James Healy, MD, PhD DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 US04272N1028 06/18/2026 DIRECTOR John Hohneker, M.D. DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 15.000000 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 US04272N1028 06/18/2026 DIRECTOR Stuart Lutzker, MD, PhD DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 US04272N1028 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 DIRECTOR Jerome Adams, MD, MPH DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 18.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 DIRECTOR Howard Berman, PhD DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 DIRECTOR Barbara Duncan DIRECTOR ELECTIONS ISSUER 41.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 41.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 40.000000 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 US04683R1068 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. COMPENSATION ISSUER 41.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 38.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Joseph DeVivo DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 159.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 161.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Larry Robbins DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 160.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Caroll H. Neubauer DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 161.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 162.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 160.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 2.000000 AGAINST FOR 160.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 Election of Director to serve one-year term expiring in 2027: Erica Schwartz, M.D., J.D., M.P.H. DIRECTOR ELECTIONS ISSUER 163.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 160.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 163.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 162.000000 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 US1241551027 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 163.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 145.000000 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 72.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 72.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 67.000000 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 72.000000 0.000000 ABSTAIN 17.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 72.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 72.000000 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 US22663K1079 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission COMPENSATION ISSUER 72.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 1.000000 AGAINST FOR 69.000000 FOR S000004450 DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 Election of Class III Director: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 Election of Class III Director: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 Election of Class III Director: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 DISC MEDICINE, INC. 254604101 US2546041011 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 19.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Goran Ando, M.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Jay S. Duker, M.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR John B. Landis, Ph.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Wendy DiCicco DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 58.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Karen Zaderej DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Stuart Duty DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Fred Hassan DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 DIRECTOR Reginald Sanders, M.D. DIRECTOR ELECTIONS ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 59.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares. COMPENSATION ISSUER 59.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 46.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 60.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 56.000000 FOR S000004450 EYEPOINT, INC. 30233G209 US30233G2093 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 60.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 60.000000 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 DIRECTOR Katherine Stueland DIRECTOR ELECTIONS ISSUER 16.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 12.000000 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 16.000000 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 16.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 15.000000 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 US81663L2007 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 16.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 16.000000 FOR S000004450 GRAIL, INC. 384747101 US3847471014 06/18/2026 DIRECTOR Sarah Krevans DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 GRAIL, INC. 384747101 US3847471014 06/18/2026 DIRECTOR Steven Mizell DIRECTOR ELECTIONS ISSUER 28.000000 0.000000 ABSTAIN 6.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 GRAIL, INC. 384747101 US3847471014 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 28.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 DIRECTOR Mark L. Baum DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 22.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 DIRECTOR Adrienne L. Graves DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 DIRECTOR Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 DIRECTOR Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 25.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. COMPENSATION ISSUER 25.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 21.000000 FOR S000004450 HARROW INC. 415858109 US4158581094 06/18/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 23.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 111.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 49.000000 AGAINST FOR 61.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D. DIRECTOR ELECTIONS ISSUER 111.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 51.000000 AGAINST FOR 58.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 111.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 50.000000 AGAINST FOR 59.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. COMPENSATION ISSUER 111.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 63.000000 AGAINST FOR 47.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares. COMPENSATION ISSUER 111.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 59.000000 AGAINST FOR 51.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock. COMPENSATION ISSUER 111.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 61.000000 AGAINST FOR 47.000000 FOR S000004450 NOVAVAX, INC. 670002401 US6700024010 06/18/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 111.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 36.000000 AGAINST FOR 72.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Election of Director: Thomas J. Cable DIRECTOR ELECTIONS ISSUER 57.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 22.000000 AGAINST FOR 34.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Election of Director: Peter A. Demopulos, M.D. DIRECTOR ELECTIONS ISSUER 58.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 13.000000 AGAINST FOR 44.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Election of Director: Diana T. Perkinson, M.D. DIRECTOR ELECTIONS ISSUER 57.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 17.000000 AGAINST FOR 39.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Approval of advisory resolution on executive compensation. COMPENSATION ISSUER 57.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 14.000000 AGAINST FOR 42.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 57.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 25.000000 AGAINST FOR 31.000000 FOR S000004450 OMEROS CORPORATION 682143102 US6821431029 06/18/2026 Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 58.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 9.000000 AGAINST FOR 48.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 342.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 77.000000 AGAINST FOR 264.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 78.000000 AGAINST FOR 262.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 82.000000 AGAINST FOR 257.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 103.000000 AGAINST FOR 237.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 84.000000 AGAINST FOR 256.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 74.000000 AGAINST FOR 266.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 75.000000 AGAINST FOR 265.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 126.000000 AGAINST FOR 214.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 75.000000 AGAINST FOR 265.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D. DIRECTOR ELECTIONS ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 18.000000 AGAINST FOR 322.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 342.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 88.000000 AGAINST FOR 253.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 To approve the Company's 2026 Equity Incentive Plan; COMPENSATION ISSUER 341.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 40.000000 AGAINST FOR 300.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers; COMPENSATION ISSUER 342.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 27.000000 AGAINST FOR 314.000000 FOR S000004450 OPKO HEALTH, INC. 68375N103 US68375N1037 06/18/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 341.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 9.000000 AGAINST FOR 330.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 Election of Class III Director to serve until the 2029 annual meeting of stockholders: Jacob M. Chacko, M.D DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 Election of Class III Director to serve until the 2029 annual meeting of stockholders: Mardi C. Dier DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 32.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 11.000000 AGAINST FOR 23.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, executive compensation. COMPENSATION ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 US68622P1093 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 35.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 35.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 06/18/2026 DIRECTOR Arani Bose, M.D. DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 25.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 06/18/2026 DIRECTOR Bridget O'Rourke DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 06/18/2026 DIRECTOR Surbhi Sarna DIRECTOR ELECTIONS ISSUER 30.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 PENUMBRA, INC. 70975L107 US70975L1070 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 30.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 29.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Randal Kirk DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 137.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 14.000000 AGAINST FOR 127.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Steven Frank DIRECTOR ELECTIONS ISSUER 144.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 6.000000 AGAINST FOR 136.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Vinita Gupta DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 58.000000 AGAINST FOR 83.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Fred Hassan DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 137.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 137.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 144.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 5.000000 AGAINST FOR 137.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 143.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 141.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Election of Director: James Turley DIRECTOR ELECTIONS ISSUER 142.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 5.000000 AGAINST FOR 136.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 143.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 143.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. COMPENSATION ISSUER 143.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 139.000000 FOR S000004450 PRECIGEN, INC. 74017N105 US74017N1054 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 143.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 137.000000 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 DIRECTOR Alexis Borisy DIRECTOR ELECTIONS ISSUER 131.000000 0.000000 ABSTAIN 22.000000 AGAINST AGAINST 0.000000 AGAINST FOR 109.000000 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 DIRECTOR Mark A Goldsmith MD PhD DIRECTOR ELECTIONS ISSUER 131.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 128.000000 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 131.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 131.000000 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). COMPENSATION ISSUER 131.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 128.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Neal C. Bradsher DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Wei Jiang DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Richard T. LeBuhn DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Louis E. Silverman DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Christopher M. Wang DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 DIRECTOR Lilian Y. Zhou DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 Approve an amendment to the Company's Amended and Restated Omnibus Equity Incentive Plan, as amended. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 Ratify the appointment of the Company's independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 26.000000 FOR S000004450 STAAR SURGICAL COMPANY 852312305 US8523123052 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson DIRECTOR ELECTIONS ISSUER 53.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III DIRECTOR ELECTIONS ISSUER 53.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 48.000000 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. COMPENSATION ISSUER 53.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 52.000000 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 53.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 53.000000 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 US8684591089 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. COMPENSATION ISSUER 53.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 47.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 DIRECTOR James C. Momtazee DIRECTOR ELECTIONS ISSUER 117.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 113.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 DIRECTOR Frank P. McCormick, PhD DIRECTOR ELECTIONS ISSUER 117.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 110.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 DIRECTOR Hannah A. Valantine, MD DIRECTOR ELECTIONS ISSUER 117.000000 0.000000 ABSTAIN 24.000000 AGAINST AGAINST 0.000000 AGAINST FOR 93.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 3.000000 AGAINST FOR 113.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 116.000000 0.000000 2.0 4.000000 AGAINST 3.0 1.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 111.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 117.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 117.000000 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 US10806X1028 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 117.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 22.000000 AGAINST FOR 94.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 176.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 182.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 180.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Joshua Hausman DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 182.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 182.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Nikolas W. Stengle DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 182.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Denise W. Warren DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 181.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 180.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Election of Director: C. Christian Winkle DIRECTOR ELECTIONS ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 182.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Advisory approval of named executive officer compensation COMPENSATION ISSUER 183.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 4.000000 AGAINST FOR 178.000000 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 US1124631045 06/22/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 183.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 180.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Richard A. Friesner DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 40.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Rosana Kapeller-Libermann DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 13.000000 AGAINST FOR 39.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Gary Sender DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 40.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Approval of an advisory vote on executive compensation. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 51.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 12.000000 AGAINST FOR 40.000000 FOR S000004450 SCHRODINGER, INC. 80810D103 US80810D1037 06/22/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 7.000000 AGAINST FOR 29.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 33.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 33.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Stuart Holden, M.D. DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 34.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 35.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Leana S. Wen, M.D., M.Sc. DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 34.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 35.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law. CORPORATE GOVERNANCE ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 11.000000 AGAINST FOR 25.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company's Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors' and officers' insurance. COMPENSATION ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 33.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000 shares. COMPENSATION ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 33.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. COMPENSATION ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 31.000000 FOR S000004450 UROGEN PHARMA LTD M96088105 IL0011407140 06/22/2026 To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2027 annual meeting of shareholders. AUDIT-RELATED ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 WAVE LIFE SCIENCES LTD. Y95308105 SG9999014716 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. CORPORATE GOVERNANCE ISSUER 102.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 102.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Michael Dale DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Amy Wendell DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR William Burke DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR John H. Johnson DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Alan M. Levine DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Paul Thomas DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Joseph Tyndall MD DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 36.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 DIRECTOR Kathy Weiler DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 4.000000 AGAINST AGAINST 0.000000 AGAINST FOR 33.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 AXOGEN, INC. 05463X106 US05463X1063 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Janet Dillione DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Gregory Duncan DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Alan W. Dunton DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Myron Kaplan DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Steven Lefkowitz DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Robert Stewart DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 DIRECTOR Joseph Todisco DIRECTOR ELECTIONS ISSUER 26.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. COMPENSATION ISSUER 26.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 4.000000 AGAINST FOR 20.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 25.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve the ratification of the Certificate of Designation Amendments (as defined in the Proxy Statement). CAPITAL STRUCTURE ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve amendments to our Charter to make technical changes. CORPORATE GOVERNANCE ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the extent permitted by Delaware law and provided that no changes are made to the terms of common stock. CORPORATE GOVERNANCE ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 20.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to designate the exclusive forums in which certain claims relating to the Company may be brought. CORPORATE GOVERNANCE ISSUER 26.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 23.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve an amendment to our Charter to limit certain officers' personal liability for monetary damages for breaches of the duty of care, as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 6.000000 AGAINST FOR 19.000000 FOR S000004450 CORMEDIX INC. 21900C308 US21900C3088 06/23/2026 To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. CORPORATE GOVERNANCE ISSUER 25.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 5.000000 AGAINST FOR 20.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 DIRECTOR Roger Susi DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 DIRECTOR Monty Allen DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 DIRECTOR Joe Kiani DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 DIRECTOR Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 DIRECTOR James Hawkins DIRECTOR ELECTIONS ISSUER 6.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 IRADIMED CORPORATION 46266A109 US46266A1097 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. COMPENSATION ISSUER 6.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 6.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 3.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 5.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 4.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 5.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 5.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 4.000000 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 US82835W1080 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5.000000 0.000000 2.0 0.000000 AGAINST 3.0 0.000000 AGAINST ABSTAIN 0.000000 AGAINST 1.0 5.000000 FOR S000004450 ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 DIRECTOR Leslie V. Norwalk, Esq. DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 38.000000 FOR S000004450 ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 DIRECTOR Randy Teel, Ph.D. DIRECTOR ELECTIONS ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 48.000000 FOR S000004450 ARVINAS, INC. 04335A105 US04335A1051 06/24/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 50.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 50.000000 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 US3596161097 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 30.000000 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 US3596161097 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 US3596161097 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill DIRECTOR ELECTIONS ISSUER 35.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 US3596161097 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 34.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 34.000000 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 US3596161097 06/24/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 35.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 35.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 DIRECTOR Bruce Booth, D.Phil. DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 DIRECTOR Nello Mainolfi, Ph.D. DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 DIRECTOR John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 42.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 DIRECTOR Elena Ridloff, CFA DIRECTOR ELECTIONS ISSUER 44.000000 0.000000 ABSTAIN 3.000000 AGAINST AGAINST 0.000000 AGAINST FOR 41.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 43.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 43.000000 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 US5015751044 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 44.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 44.000000 FOR S000004450 PHREESIA, INC. 71944F106 US71944F1066 06/24/2026 DIRECTOR Chaim Indig DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 PHREESIA, INC. 71944F106 US71944F1066 06/24/2026 DIRECTOR Jon Kessler DIRECTOR ELECTIONS ISSUER 55.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 PHREESIA, INC. 71944F106 US71944F1066 06/24/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 55.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 55.000000 FOR S000004450 PHREESIA, INC. 71944F106 US71944F1066 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 54.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 53.000000 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 US76243J1051 06/24/2026 DIRECTOR David W.J. McGirr DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 7.000000 AGAINST AGAINST 0.000000 AGAINST FOR 45.000000 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 US76243J1051 06/24/2026 DIRECTOR David P. Meeker, M.D. DIRECTOR ELECTIONS ISSUER 52.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 51.000000 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 US76243J1051 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 52.000000 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 US76243J1051 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. COMPENSATION ISSUER 52.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 8.000000 AGAINST FOR 44.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 61.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: James J. Marino DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 Election of Director: Denice Torres DIRECTOR ELECTIONS ISSUER 61.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 US15117B2025 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 63.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 1.000000 AGAINST FOR 61.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 79.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 80.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. COMPENSATION ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 79.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 81.000000 FOR S000004450 HEALTHEQUITY, INC. 42226A107 US42226A1079 06/25/2026 To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 81.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 79.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 5.000000 AGAINST AGAINST 0.000000 AGAINST FOR 24.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 29.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 28.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. COMPENSATION ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 US87650L1035 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 29.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 29.000000 FOR S000004450 ERASCA, INC. 29479A108 US29479A1088 06/26/2026 Election of Class II Director to serve as for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 158.000000 0.000000 ABSTAIN 14.000000 AGAINST AGAINST 0.000000 AGAINST FOR 144.000000 FOR S000004450 ERASCA, INC. 29479A108 US29479A1088 06/26/2026 Election of Class II Director to serve as for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 158.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 146.000000 FOR S000004450 ERASCA, INC. 29479A108 US29479A1088 06/26/2026 Election of Class II Director to serve as for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 158.000000 0.000000 ABSTAIN 12.000000 AGAINST AGAINST 0.000000 AGAINST FOR 146.000000 FOR S000004450 ERASCA, INC. 29479A108 US29479A1088 06/26/2026 To ratify the appointment of KPMG LLP as our indpendent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 158.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 158.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 06/26/2026 To vote on the proposal to adopt the Agreement and Plan of Merger, dated as of March 2, 2026 (as amended from time to time, the "Merger Agreement"), by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub") and the Company, and approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 107.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 2.000000 AGAINST FOR 103.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). COMPENSATION ISSUER 107.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 71.000000 AGAINST FOR 34.000000 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 US81619Q1058 06/26/2026 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 107.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 8.000000 AGAINST FOR 97.000000 FOR S000004450 SEPTERNA, INC. 81734D104 US81734D1046 06/26/2026 Election of Director: Shalini Sharp, M.B.A. DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 SEPTERNA, INC. 81734D104 US81734D1046 06/26/2026 Election of Director: Jake Simson, Ph.D. DIRECTOR ELECTIONS ISSUER 10.000000 0.000000 ABSTAIN 1.000000 AGAINST AGAINST 0.000000 AGAINST FOR 9.000000 FOR S000004450 SEPTERNA, INC. 81734D104 US81734D1046 06/26/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 10.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Christopher Causey DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 4.000000 AGAINST FOR 33.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Richard Giltner DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 34.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Jan Malcolm DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Linda Maxwell DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Nilda Mesa DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Judy Olian DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Christopher Patusky DIRECTOR ELECTIONS ISSUER 36.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 33.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Louis Sullivan DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 3.000000 AGAINST FOR 34.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Tommy Thompson DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Election of Director: Kevin Tracey DIRECTOR ELECTIONS ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 37.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Advisory resolution to approve executive compensation. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 1.000000 AGAINST FOR 36.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 10.000000 AGAINST FOR 27.000000 FOR S000004450 UNITED THERAPEUTICS CORPORATION 91307C102 US91307C1027 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 37.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 2.000000 AGAINST FOR 35.000000 FOR S000004450 ALUMIS INC 022307102 US0223071020 06/30/2026 DIRECTOR James B. Tananbaum DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 2.000000 AGAINST AGAINST 0.000000 AGAINST FOR 60.000000 FOR S000004450 ALUMIS INC 022307102 US0223071020 06/30/2026 DIRECTOR Lynn Tetrault, J.D. DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 ALUMIS INC 022307102 US0223071020 06/30/2026 DIRECTOR Zhengbin Yao, Ph.D. DIRECTOR ELECTIONS ISSUER 62.000000 0.000000 ABSTAIN 8.000000 AGAINST AGAINST 0.000000 AGAINST FOR 54.000000 FOR S000004450 ALUMIS INC 022307102 US0223071020 06/30/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 62.000000 0.000000 ABSTAIN 0.000000 AGAINST AGAINST 0.000000 AGAINST FOR 62.000000 FOR S000004450 AGILON HEALTH, INC. 00857U107 03/17/2026 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"). CAPITAL STRUCTURE ISSUER 2914.195300 0.000000 FOR 2914.195300 FOR S000004450 AGILON HEALTH, INC. 00857U107 03/17/2026 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal. CORPORATE GOVERNANCE ISSUER 2914.195300 0.000000 FOR 2914.195300 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Election of Director: Albert G. White III DIRECTOR ELECTIONS ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 1285.435550 0.000000 FOR 1285.435550 FOR S000004450 THE COOPER COMPANIES, INC. 216648501 04/07/2026 Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. COMPENSATION ISSUER 1285.435550 0.000000 AGAINST 1285.435550 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Jerome Durso DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect John M. Gill DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 WITHHOLD 1323.706590 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Philip L. Hodges DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 WITHHOLD 1323.706590 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Diane Jorkasky DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Teri Lawver DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Wayne Pisano DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 WITHHOLD 1323.706590 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Mitchel B. Sayare DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 WITHHOLD 1323.706590 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Klaus O. Schafer DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 WITHHOLD 1323.706590 AGAINST S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Elect Catherine Angell Sohn DIRECTOR ELECTIONS ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. COMPENSATION ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock. CAPITAL STRUCTURE ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan COMPENSATION ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 ALTIMMUNE INC. 02155H200 04/16/2026 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 1323.706590 0.000000 FOR 1323.706590 FOR S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Karen W. Katz DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 AGAINST 1238.230000 AGAINST S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: James A. Rechtin DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 Election of Director: Gordon Smith DIRECTOR ELECTIONS ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 The ratification of the appointment of Pricewater-houseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. COMPENSATION ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 1238.230000 0.000000 FOR 1238.230000 FOR S000004450 HUMANA INC. 444859102 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. COMPENSATION SECURITY HOLDER 1238.230000 0.000000 FOR 1238.230000 AGAINST S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: Gary D. Blackford (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 WITHHOLD 440.544370 AGAINST S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: William P. Burke (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: James L. Cunniff (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: Dr. Lisa Egbuonu-Davis (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: Indrani L. Franchini (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: Patrick J. O'Leary (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 WITHHOLD 440.544370 AGAINST S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: David C. Pacitti (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Election of Director: Dr. Julie Shimer (to serve until the 2027 Annual Meeting) DIRECTOR ELECTIONS ISSUER 440.544370 0.000000 WITHHOLD 440.544370 AGAINST S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 440.544370 0.000000 AGAINST 440.544370 AGAINST S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 AVANOS MEDICAL,INC. 05350V106 04/21/2026 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. COMPENSATION ISSUER 440.544370 0.000000 FOR 440.544370 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Election of Director: Melinda Litherland DIRECTOR ELECTIONS ISSUER 183.844000 0.000000 FOR 183.844000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Election of Director: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 183.844000 0.000000 FOR 183.844000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 183.844000 0.000000 FOR 183.844000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 183.844000 0.000000 FOR 183.844000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 183.844000 0.000000 FOR 183.844000 FOR S000004450 BIO-RAD LABORATORIES, INC. 090572207 04/21/2026 Stockholder proposal regarding dual class capital structure. CORPORATE GOVERNANCE SECURITY HOLDER 183.844000 0.000000 FOR 183.844000 AGAINST S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: David M. Cordani DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Eric J. Foss DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Neesha Hathi DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: George Kurian DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Mark B. McClellan, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Philip O. Ozuah, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Election of Director: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Advisory approval of executive compensation COMPENSATION ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 2625.922080 0.000000 FOR 2625.922080 FOR S000004450 THE CIGNA GROUP 125523100 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent CORPORATE GOVERNANCE SECURITY HOLDER 2625.922080 0.000000 FOR 2625.922080 AGAINST S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: William R. Frist DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Election of Director: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 1611.388560 0.000000 FOR 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 1611.388560 0.000000 AGAINST 1611.388560 FOR S000004450 HCA HEALTHCARE, INC. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 1611.388560 0.000000 FOR 1611.388560 AGAINST S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: Ari Bousbib DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: Carol J. Burt DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: John G. Danhakl DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: James A. Fasano DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Election of Director: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). COMPENSATION ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 1672.481840 0.000000 FOR 1672.481840 FOR S000004450 IQVIA HOLDINGS INC. 46266C105 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 1672.481840 0.000000 AGAINST 1672.481840 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Joaquin Duato DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Hubert Joly DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: John G. Morikis DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Nadja Y. West DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Election of Director: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation COMPENSATION ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 23372.653520 0.000000 FOR 23372.653520 FOR S000004450 JOHNSON & JOHNSON 478160104 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 23372.653520 0.000000 AGAINST 23372.653520 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Albert Bourla DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 AGAINST 56805.194610 AGAINST S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 AGAINST 56805.194610 AGAINST S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Dan R. Littman DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 AGAINST 56805.194610 AGAINST S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: James Quincey DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 AGAINST 56805.194610 AGAINST S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: James C. Smith DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Election of Director: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Ratify the selection of KPMG LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 56805.194610 0.000000 AGAINST 56805.194610 AGAINST S000004450 PFIZER INC. 717081103 04/23/2026 2026 advisory approval of executive compensation COMPENSATION ISSUER 56805.194610 0.000000 FOR 56805.194610 FOR S000004450 PFIZER INC. 717081103 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 56805.194610 0.000000 AGAINST 56805.194610 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Election of Class II Director: Parvinderjit S. Khanuja DIRECTOR ELECTIONS ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Election of Class II Director: Robert A. Ortenzio DIRECTOR ELECTIONS ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Election of Class II Director: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. COMPENSATION ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Amendment to the Company's Amended and Restated Certificate of Incorporation to phase out the classified structure of the Board. CORPORATE GOVERNANCE ISSUER 1150.572920 0.000000 FOR 1150.572920 FOR S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. CORPORATE GOVERNANCE ISSUER 1150.572920 0.000000 AGAINST 1150.572920 AGAINST S000004450 SELECT MEDICAL HOLDINGS CORPORATION 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. CORPORATE GOVERNANCE ISSUER 1150.572920 0.000000 FOR 1150.572920 AGAINST S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: N. Ahuja DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: S. E. Blount DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: R. B. Ford DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: P. Gonzalez DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: D. W. McDew DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: N. McKinstry DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: M. F. Roman DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: D. J. Starks DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Election of Director: J. G. Stratton DIRECTOR ELECTIONS ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation COMPENSATION ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 ABBOTT LABORATORIES 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 17389.143450 0.000000 FOR 17389.143450 FOR S000004450 BIOHAVEN LTD G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan DIRECTOR ELECTIONS ISSUER 1346.491090 0.000000 AGAINST 1346.491090 AGAINST S000004450 BIOHAVEN LTD G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1346.491090 0.000000 AGAINST 1346.491090 AGAINST S000004450 BIOHAVEN LTD G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin DIRECTOR ELECTIONS ISSUER 1346.491090 0.000000 AGAINST 1346.491090 AGAINST S000004450 BIOHAVEN LTD G1110E107 04/28/2026 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. AUDIT-RELATED ISSUER 1346.491090 0.000000 FOR 1346.491090 FOR S000004450 BIOHAVEN LTD G1110E107 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. COMPENSATION ISSUER 1346.491090 0.000000 AGAINST 1346.491090 AGAINST S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 AGAINST 1171.982980 AGAINST S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 Election of Director for term of one year: Pascale Witz DIRECTOR ELECTIONS ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. COMPENSATION ISSUER 1171.982980 0.000000 AGAINST 1171.982980 AGAINST S000004450 REVVITY, INC. 714046109 04/28/2026 To approve an amendment to Revvity's Amended and Restated By-Laws to Allow Shareholders Owning 25% of Our Stock to Call a Special Meeting. CORPORATE GOVERNANCE ISSUER 1171.982980 0.000000 FOR 1171.982980 FOR S000004450 REVVITY, INC. 714046109 04/28/2026 To approve the shareholder proposal regarding Executives to Retain Significant Stock. CORPORATE GOVERNANCE SECURITY HOLDER 1171.982980 0.000000 FOR 1171.982980 AGAINST S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Elect Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 68.941560 0.000000 WITHHOLD 68.941560 AGAINST S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Elect Michael S. Klein DIRECTOR ELECTIONS ISSUER 68.941560 0.000000 WITHHOLD 68.941560 AGAINST S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Elect Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 68.941560 0.000000 WITHHOLD 68.941560 AGAINST S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Elect Dale A. White DIRECTOR ELECTIONS ISSUER 68.941560 0.000000 WITHHOLD 68.941560 AGAINST S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 68.941560 0.000000 FOR 68.941560 FOR S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 68.941560 0.000000 FOR 68.941560 FOR S000004450 CLARITEV CORPORATION 62548M209 04/29/2026 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 68.941560 0.000000 AGAINST 68.941560 AGAINST S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal DIRECTOR ELECTIONS ISSUER 634.782140 0.000000 WITHHOLD 634.782140 AGAINST S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 634.782140 0.000000 FOR 634.782140 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 634.782140 0.000000 WITHHOLD 634.782140 AGAINST S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa DIRECTOR ELECTIONS ISSUER 634.782140 0.000000 FOR 634.782140 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 634.782140 0.000000 FOR 634.782140 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. COMPENSATION ISSUER 634.782140 0.000000 FOR 634.782140 FOR S000004450 EMERGENT BIOSOLUTIONS INC. 29089Q105 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 634.782140 0.000000 AGAINST 634.782140 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 WITHHOLD 604.382900 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Alan L. Rubino DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 WITHHOLD 604.382900 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Heidi Hagen DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 WITHHOLD 604.382900 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Kevin McLaughlin DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 FOR 604.382900 FOR S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Paul Kevin Wotton DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 FOR 604.382900 FOR S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 WITHHOLD 604.382900 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 Elect Lisa Wright DIRECTOR ELECTIONS ISSUER 604.382900 0.000000 FOR 604.382900 FOR S000004450 VERICEL CORPORATION 92346J108 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. COMPENSATION ISSUER 604.382900 0.000000 AGAINST 604.382900 AGAINST S000004450 VERICEL CORPORATION 92346J108 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 604.382900 0.000000 FOR 604.382900 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: David C. Habiger DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Susan E. Morano DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: David S. Wichmann DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Election of Director: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 17754.644680 0.000000 FOR 17754.644680 FOR S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 17754.644680 0.000000 AGAINST 17754.644680 AGAINST S000004450 BOSTON SCIENTIFIC CORPORATION 101137107 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 17754.644680 0.000000 FOR 17754.644680 AGAINST S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: Vipin Gopal DIRECTOR ELECTIONS ISSUER 1193.046610 0.000000 AGAINST 1193.046610 AGAINST S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: William K. Newton DIRECTOR ELECTIONS ISSUER 1193.046610 0.000000 AGAINST 1193.046610 AGAINST S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 04/30/2026 Election of Class II Director for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins DIRECTOR ELECTIONS ISSUER 1193.046610 0.000000 AGAINST 1193.046610 AGAINST S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 1193.046610 0.000000 FOR 1193.046610 FOR S000004450 CONCENTRA GROUP HOLDINGS PARENT INC 20603L102 04/30/2026 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1193.046610 0.000000 FOR 1193.046610 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 Election of Director to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. COMPENSATION ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 14859.047420 0.000000 FOR 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 14859.047420 0.000000 AGAINST 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 14859.047420 0.000000 AGAINST 14859.047420 FOR S000004450 GILEAD SCIENCES, INC. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 14859.047420 0.000000 AGAINST 14859.047420 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Elect Gary L. Ellis DIRECTOR ELECTIONS ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Elect Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Elect Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 289.083830 0.000000 1.0 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. CORPORATE GOVERNANCE ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 289.083830 0.000000 AGAINST 289.083830 AGAINST S000004450 INSPIRE MEDICAL SYSTEMS, INC. 457730109 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 289.083830 0.000000 FOR 289.083830 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Lewis Chew DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 Election of Director: David J. Rosa DIRECTOR ELECTIONS ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 INTUITIVE SURGICAL, INC. 46120E602 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 3661.686210 0.000000 FOR 3661.686210 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 Election Of Class II Director: Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 Election Of Class II Director: Mr. Heinz Mausli DIRECTOR ELECTIONS ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 Election Of Class II Director: Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 Election Of Class II Director: Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). COMPENSATION ISSUER 792.987140 0.000000 AGAINST 792.987140 AGAINST S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 792.987140 0.000000 1.0 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. CORPORATE GOVERNANCE ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LANTHEUS HOLDINGS, INC. 516544103 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 792.987140 0.000000 FOR 792.987140 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Elect Samuel L. Barker DIRECTOR ELECTIONS ISSUER 2182.628020 0.000000 WITHHOLD 2182.628020 AGAINST S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Elect Christopher J. Sobecki DIRECTOR ELECTIONS ISSUER 2182.628020 0.000000 WITHHOLD 2182.628020 AGAINST S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Elect Judith L. Swain DIRECTOR ELECTIONS ISSUER 2182.628020 0.000000 WITHHOLD 2182.628020 AGAINST S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Ratification and approval of the Company's Seventh Amended and Restated Certificate of Incorporation CAPITAL STRUCTURE ISSUER 2182.628020 0.000000 AGAINST 2182.628020 AGAINST S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Approval of the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 2182.628020 0.000000 AGAINST 2182.628020 AGAINST S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Approval of the Company's 2026 Non-Employee Directors' Equity Incentive Plan COMPENSATION ISSUER 2182.628020 0.000000 FOR 2182.628020 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers COMPENSATION ISSUER 2182.628020 0.000000 FOR 2182.628020 FOR S000004450 LEXICON PHARMACEUTICALS, INC. 528872302 04/30/2026 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2182.628020 0.000000 FOR 2182.628020 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Donal O'Connor DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. AUDIT-RELATED ISSUER 1416.161250 0.000000 AGAINST 1416.161250 AGAINST S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 To provide advisory approval of the Company's executive compensation. COMPENSATION ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 To renew the Board's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 PERRIGO COMPANY PLC G97822103 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 1416.161250 0.000000 FOR 1416.161250 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Cary S. Grace DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: James H. Hinton DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Celia P. Huber DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Eric P. Palmer DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 Election of Director: Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. COMPENSATION ISSUER 397.523280 0.000000 AGAINST 397.523280 AGAINST S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 397.523280 0.000000 FOR 397.523280 FOR S000004450 AMN HEALTHCARE SERVICES, INC. 001744101 05/01/2026 A shareholder proposal entitled: "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 397.523280 0.000000 AGAINST 397.523280 FOR S000004450 MASIMO CORPORATION 574795100 05/01/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo Corporation ("Masimo"), Danaher Corporation ("Danaher"), and Mobius Merger Sub, Inc., a wholly owned subsidiary of Danaher ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Masimo, with Masimo surviving the merger as a wholly owned subsidiary of Danaher (the "Merger" and such proposal, the "Merger Agreement Proposal"). CORPORATE GOVERNANCE ISSUER 633.161760 0.000000 FOR 633.161760 FOR S000004450 MASIMO CORPORATION 574795100 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). COMPENSATION ISSUER 633.161760 0.000000 AGAINST 633.161760 AGAINST S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Election of Director to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Election of Director to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Election of Director to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Election of Director to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. COMPENSATION ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 8037.764190 0.000000 FOR 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 8037.764190 0.000000 AGAINST 8037.764190 FOR S000004450 ELI LILLY AND COMPANY 532457108 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 8037.764190 0.000000 AGAINST 8037.764190 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. COMPENSATION ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 896.284200 0.000000 FOR 896.284200 FOR S000004450 INNOVIVA, INC. 45781M101 05/04/2026 Approval of the 2026 Equity Incentive Plan. COMPENSATION ISSUER 896.284200 0.000000 AGAINST 896.284200 AGAINST S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: William F. Feehery DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Robert F. Friel DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Eric M. Green DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 AGAINST 740.331200 AGAINST S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Election of Director: Paolo Pucci DIRECTOR ELECTIONS ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 740.331200 0.000000 AGAINST 740.331200 AGAINST S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 740.331200 0.000000 FOR 740.331200 FOR S000004450 WEST PHARMACEUTICAL SERVICES, INC. 955306105 05/04/2026 Shareholder proposal regarding an independent Board Chair policy. CORPORATE GOVERNANCE SECURITY HOLDER 740.331200 0.000000 AGAINST 740.331200 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 COMPENSATION ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size CORPORATE GOVERNANCE ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Andrew P. Hider DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Brent Shafer DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Election of Director: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 6538.370220 0.000000 AGAINST 6538.370220 AGAINST S000004450 BAXTER INTERNATIONAL INC. 071813109 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 6538.370220 0.000000 FOR 6538.370220 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 FOR 25842.444440 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 FOR 25842.444440 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Paula A. Price DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Derica W. Rice DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Election of Director: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 25842.444440 0.000000 AGAINST 25842.444440 AGAINST S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers COMPENSATION ISSUER 25842.444440 0.000000 FOR 25842.444440 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 25842.444440 0.000000 FOR 25842.444440 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 25842.444440 0.000000 FOR 25842.444440 FOR S000004450 BRISTOL-MYERS SQUIBB COMPANY 110122108 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 25842.444440 0.000000 AGAINST 25842.444440 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Steven Barg DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Mark Enyedy DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: James C. Foster DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Birgit Girshick DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Paul Graves DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: George Llado DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Martin Mackay DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 AGAINST 615.688320 AGAINST S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Election of Director: Virginia Wilson DIRECTOR ELECTIONS ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Advisory Approval of 2025 Executive Officer Compensation COMPENSATION ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 2026 Long-Term Incentive Plan COMPENSATION ISSUER 615.688320 0.000000 AGAINST 615.688320 AGAINST S000004450 CHARLES RIVER LABORATORIES INTL., INC. 159864107 05/05/2026 Ratification of Pricewaterhousecoopers LLC as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 615.688320 0.000000 FOR 615.688320 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 Election of Director to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. COMPENSATION ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 DANAHER CORPORATION 235851102 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 7613.537020 0.000000 FOR 7613.537020 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 05/05/2026 Election of Class II Director to hold office until the Annual Meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman DIRECTOR ELECTIONS ISSUER 252.856710 0.000000 FOR 252.856710 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 05/05/2026 Election of Class II Director to hold office until the Annual Meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis DIRECTOR ELECTIONS ISSUER 252.856710 0.000000 FOR 252.856710 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 252.856710 0.000000 FOR 252.856710 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 252.856710 0.000000 1.0 252.856710 FOR S000004450 GUARDIAN PHARMACY SERVICES INC. 40145W101 05/05/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 252.856710 0.000000 FOR 252.856710 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 05/05/2026 Election of Class I Director: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 1486.930200 0.000000 FOR 1486.930200 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 05/05/2026 Election of Class I Director: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 1486.930200 0.000000 FOR 1486.930200 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1486.930200 0.000000 FOR 1486.930200 FOR S000004450 HALOZYME THERAPEUTICS, INC. 40637H109 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1486.930200 0.000000 FOR 1486.930200 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Election of Director: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 1107.821400 0.000000 AGAINST 1107.821400 AGAINST S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Election of Director: Patrice A. Harris, M.D., M.A. DIRECTOR ELECTIONS ISSUER 1107.821400 0.000000 FOR 1107.821400 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Election of Director: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 1107.821400 0.000000 FOR 1107.821400 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 1107.821400 0.000000 FOR 1107.821400 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. COMPENSATION ISSUER 1107.821400 0.000000 FOR 1107.821400 FOR S000004450 ACADIA HEALTHCARE COMPANY, INC. 00404A109 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1107.821400 0.000000 FOR 1107.821400 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Deb Autor DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 FOR 1998.667960 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Jeff George DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: John Kiely DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Paul Meister DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Ted Nark DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Chintu Patel DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Chirag Patel DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Gautam Patel DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Election of Director: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 1998.667960 0.000000 AGAINST 1998.667960 AGAINST S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 1998.667960 0.000000 FOR 1998.667960 FOR S000004450 AMNEAL PHARMACEUTICALS, INC. 03168L105 05/06/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 1998.667960 0.000000 FOR 1998.667960 FOR S000004450 MODERNA, INC. 60770K107 05/06/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 3837.313200 0.000000 FOR 3837.313200 FOR S000004450 MODERNA, INC. 60770K107 05/06/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas Hussain DIRECTOR ELECTIONS ISSUER 3837.313200 0.000000 FOR 3837.313200 FOR S000004450 MODERNA, INC. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 3837.313200 0.000000 AGAINST 3837.313200 AGAINST S000004450 MODERNA, INC. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3837.313200 0.000000 1.0 3837.313200 FOR S000004450 MODERNA, INC. 60770K107 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3837.313200 0.000000 FOR 3837.313200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 AGAINST 650.017200 AGAINST S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Francis S. Soistman DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 Election of Director to hold office until the 2027 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 650.017200 0.000000 AGAINST 650.017200 AGAINST S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 MOLINA HEALTHCARE, INC. 60855R100 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. CORPORATE GOVERNANCE ISSUER 650.017200 0.000000 FOR 650.017200 FOR S000004450 PENUMBRA, INC. 70975L107 05/06/2026 To approve and adopt the Merger Agreement. CORPORATE GOVERNANCE ISSUER 512.432190 0.000000 FOR 512.432190 FOR S000004450 PENUMBRA, INC. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. COMPENSATION ISSUER 512.432190 0.000000 AGAINST 512.432190 AGAINST S000004450 PENUMBRA, INC. 70975L107 05/06/2026 To adjourn or postpone the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to the accompanying proxy statement/prospectus is timely provided to Penumbra Stockholders. CORPORATE GOVERNANCE ISSUER 512.432190 0.000000 FOR 512.432190 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Kevin A. Lobo (Chair of the Board and Chief Executive Officer) DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Sherilyn S. McCoy (Lead Independent Director) DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Election of Director: Rajeev Suri DIRECTOR ELECTIONS ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 STRYKER CORPORATION 863667101 05/06/2026 Advisory Vote to Approve Named Executive Officer Compensation. COMPENSATION ISSUER 4349.503200 0.000000 FOR 4349.503200 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: William W. Burke DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Valerie L. Asbury DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Sheri L. Dodd DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 ABSTAIN 281.862240 AGAINST S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Raymond O. Huggenberger DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Laura G. King DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Andrea A. Pearson DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: D. Brent Shafer DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: Carmen B. Volkart DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Elect Directors: B. Vindell Washington DIRECTOR ELECTIONS ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. COMPENSATION ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 TACTILE SYSTEMS TECHNOLOGY, INC. 87357P100 05/06/2026 Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. CORPORATE GOVERNANCE ISSUER 281.862240 0.000000 FOR 281.862240 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Simon Dingemans DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 AGAINST 8661.703320 AGAINST S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 AGAINST 8661.703320 AGAINST S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Gregory Lucier DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 AGAINST 8661.703320 AGAINST S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Joseph Massaro DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Mala Murthy DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 AGAINST 8661.703320 AGAINST S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Michael Severino DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Election of Director: Gregory Summe DIRECTOR ELECTIONS ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Advisory Approval of Named Executive Officer Compensation COMPENSATION ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8661.703320 0.000000 1.0 8661.703320 FOR S000004450 AVANTOR, INC. 05352A100 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 8661.703320 0.000000 FOR 8661.703320 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Election of Director: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation COMPENSATION ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 EDWARDS LIFESCIENCES CORPORATION 28176E108 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 7348.445540 0.000000 FOR 7348.445540 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Joan E. Herman DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Election of Director to serve until our 2027 Annual Meeting of Stockholders: Terrance Williams DIRECTOR ELECTIONS ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 ENCOMPASS HEALTH CORPORATION 29261A100 05/07/2026 An advisory vote to approve executive compensation. COMPENSATION ISSUER 1271.713800 0.000000 FOR 1271.713800 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Anne T. Madden DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: William J. Stromberg DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Election of Director: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. COMPENSATION ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5758.422600 0.000000 FOR 5758.422600 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 FOR 843.423930 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 FOR 843.423930 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade DIRECTOR ELECTIONS ISSUER 843.423930 0.000000 AGAINST 843.423930 AGAINST S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026. AUDIT-RELATED ISSUER 843.423930 0.000000 FOR 843.423930 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 843.423930 0.000000 FOR 843.423930 FOR S000004450 INTEGRA LIFESCIENCES HOLDINGS CORP. 457985208 05/07/2026 To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 843.423930 0.000000 FOR 843.423930 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Pablo Perversi DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Brian Shepherd DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Election of Director: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Ratification of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 METTLER-TOLEDO INTERNATIONAL INC. 592688105 05/07/2026 Advisory Vote to Approve Executive Compensation COMPENSATION ISSUER 258.132000 0.000000 FOR 258.132000 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: Emil E. Hassan DIRECTOR ELECTIONS ISSUER 168.197490 0.000000 FOR 168.197490 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: Lisa Piercey, M.D. DIRECTOR ELECTIONS ISSUER 168.197490 0.000000 FOR 168.197490 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 05/07/2026 Re-election of Director to hold office for a three (3) year term and until their successors have been duly elected and qualified: William A. Adams DIRECTOR ELECTIONS ISSUER 168.197490 0.000000 FOR 168.197490 FOR S000004450 NATIONAL HEALTHCARE CORPORATION 635906100 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 168.197490 0.000000 FOR 168.197490 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 FOR 1083.877200 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman, M.D. DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 FOR 1083.877200 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Election of Director each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 1083.877200 0.000000 FOR 1083.877200 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 1083.877200 0.000000 FOR 1083.877200 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year. COMPENSATION ISSUER 1083.877200 0.000000 FOR 1083.877200 FOR S000004450 PEDIATRIX MEDICAL GROUP, INC. 58502B106 05/07/2026 Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan COMPENSATION ISSUER 1083.877200 0.000000 AGAINST 1083.877200 AGAINST S000004450 ABBVIE INC. 00287Y109 05/08/2026 Election of Class II Director: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Election of Class II Director: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Election of Class II Director: Robert A. Michael DIRECTOR ELECTIONS ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Election of Class II Director: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation COMPENSATION ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 22336.843200 0.000000 FOR 22336.843200 FOR S000004450 ABBVIE INC. 00287Y109 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 22336.843200 0.000000 AGAINST 22336.843200 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 05/11/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan DIRECTOR ELECTIONS ISSUER 203.028420 0.000000 FOR 203.028420 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 05/11/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick Enright DIRECTOR ELECTIONS ISSUER 203.028420 0.000000 FOR 203.028420 FOR S000004450 ZENAS BIOPHARMA, INC. 98937L105 05/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 203.028420 0.000000 FOR 203.028420 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: James W. Bullock DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Jon W. Salveson DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 Elect Directors: Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. COMPENSATION ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 ARTIVION, INC. 228903100 05/12/2026 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 500.647680 0.000000 FOR 500.647680 FOR S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: H. James Dallas DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 FOR 6244.131420 FOR S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Monte E. Ford DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Sarah M. London DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 Election of Director: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 6244.131420 0.000000 FOR 6244.131420 FOR S000004450 CENTENE CORPORATION 15135B101 05/12/2026 ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. COMPENSATION ISSUER 6244.131420 0.000000 AGAINST 6244.131420 AGAINST S000004450 CENTENE CORPORATION 15135B101 05/12/2026 RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026. AUDIT-RELATED ISSUER 6244.131420 0.000000 FOR 6244.131420 FOR S000004450 CENTENE CORPORATION 15135B101 05/12/2026 STOCKHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN. CORPORATE GOVERNANCE SECURITY HOLDER 6244.131420 0.000000 AGAINST 6244.131420 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 FOR 1589.731520 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: John A. Clerico DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Michael Dinkins DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: James S. Ely III DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: John A. Fry DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Kevin J. Hammons DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 FOR 1589.731520 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 FOR 1589.731520 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Election of Director: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. COMPENSATION ISSUER 1589.731520 0.000000 FOR 1589.731520 FOR S000004450 COMMUNITY HEALTH SYSTEMS, INC. 203668108 05/12/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1589.731520 0.000000 AGAINST 1589.731520 AGAINST S000004450 ENHABIT, INC. 29332G102 05/12/2026 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 22, 2026, by and among Enhabit, Inc. ("Enhabit"), Anchor Parent, LLC, a Delaware limited liability company ("Parent"), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Enhabit, with Enhabit surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). CORPORATE GOVERNANCE ISSUER 680.355010 0.000000 FOR 680.355010 FOR S000004450 ENHABIT, INC. 29332G102 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. COMPENSATION ISSUER 680.355010 0.000000 AGAINST 680.355010 AGAINST S000004450 ENHABIT, INC. 29332G102 05/12/2026 Approval of the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes virtually or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 680.355010 0.000000 FOR 680.355010 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Election of Director: Daniel M. Junius DIRECTOR ELECTIONS ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Election of Director: Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Election of Director: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). COMPENSATION ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 997.659520 0.000000 FOR 997.659520 FOR S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to have IDEXX Call a Special Meeting (Proposal Five). CORPORATE GOVERNANCE ISSUER 997.659520 0.000000 AGAINST 997.659520 AGAINST S000004450 IDEXX LABORATORIES, INC. 45168D104 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). CORPORATE GOVERNANCE SECURITY HOLDER 997.659520 0.000000 FOR 997.659520 AGAINST S000004450 PERSONALIS, INC. 71535D106 05/12/2026 Election of Director: Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 691.579000 0.000000 WITHHOLD 691.579000 AGAINST S000004450 PERSONALIS, INC. 71535D106 05/12/2026 Election of Director: Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 691.579000 0.000000 WITHHOLD 691.579000 AGAINST S000004450 PERSONALIS, INC. 71535D106 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 691.579000 0.000000 FOR 691.579000 FOR S000004450 PERSONALIS, INC. 71535D106 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 691.579000 0.000000 FOR 691.579000 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Election of Director: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 2765.121390 0.000000 FOR 2765.121390 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Election of Director: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 2765.121390 0.000000 FOR 2765.121390 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Election of Director: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 2765.121390 0.000000 FOR 2765.121390 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). COMPENSATION ISSUER 2765.121390 0.000000 FOR 2765.121390 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 2765.121390 0.000000 FOR 2765.121390 FOR S000004450 ELEVANCE HEALTH, INC. 036752103 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 2765.121390 0.000000 AGAINST 2765.121390 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: Vivek Jain DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: David C. Greenberg DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 ABSTAIN 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: Donald M. Abbey DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 ABSTAIN 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: Laurie Hernandez DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 ABSTAIN 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 Elect Directors: Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 312.202280 0.000000 ABSTAIN 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 312.202280 0.000000 AGAINST 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. CORPORATE GOVERNANCE ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. CORPORATE GOVERNANCE ISSUER 312.202280 0.000000 AGAINST 312.202280 AGAINST S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 312.202280 0.000000 FOR 312.202280 FOR S000004450 ICU MEDICAL, INC. 44930G107 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. CORPORATE GOVERNANCE SECURITY HOLDER 312.202280 0.000000 FOR 312.202280 AGAINST S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Dr. David Wheadon DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Joe Ciaffoni DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Dr. Keith Humphreys DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Tony Kingsley DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Daniel Ninivaggi DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Barbara Ryan DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Mark Stejbach DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 Election of Director: Juliet Thompson DIRECTOR ELECTIONS ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1396.898000 0.000000 1.0 1396.898000 FOR S000004450 INDIVIOR PHARMACEUTICALS, INC. 45579U109 05/13/2026 To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1396.898000 0.000000 FOR 1396.898000 FOR S000004450 INSMED INCORPORATED 457669307 05/13/2026 Elect Directors: E. McKee Anderson DIRECTOR ELECTIONS ISSUER 2554.885380 0.000000 FOR 2554.885380 FOR S000004450 INSMED INCORPORATED 457669307 05/13/2026 Elect Directors: C. Desjardins, Ph.D. DIRECTOR ELECTIONS ISSUER 2554.885380 0.000000 FOR 2554.885380 FOR S000004450 INSMED INCORPORATED 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. COMPENSATION ISSUER 2554.885380 0.000000 FOR 2554.885380 FOR S000004450 INSMED INCORPORATED 457669307 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2554.885380 0.000000 FOR 2554.885380 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Election of Director: Martha G. Aronson (three (3) year term) DIRECTOR ELECTIONS ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Election of Director: Lonny J. Carpenter (three (3) year term) DIRECTOR ELECTIONS ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Election of Director: Lynne N. Ward (one (1) year term) DIRECTOR ELECTIONS ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Election of Director: Scott R. Ward (three (3) year term) DIRECTOR ELECTIONS ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. COMPENSATION ISSUER 787.365540 0.000000 AGAINST 787.365540 AGAINST S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 MERIT MEDICAL SYSTEMS, INC. 589889104 05/13/2026 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 787.365540 0.000000 FOR 787.365540 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Mr. Barry M. Smith DIRECTOR ELECTIONS ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Swati B. Abbott DIRECTOR ELECTIONS ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 ELECTION OF CLASS II DIRECTOR FOR AN INITIAL ONE-YEAR TERM: Ms. Marivic Uychiat Pison DIRECTOR ELECTIONS ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 THE ENSIGN GROUP, INC. 29358P101 05/13/2026 Approval, on an advisory basis, of our named executive officers' compensation. COMPENSATION ISSUER 763.377100 0.000000 FOR 763.377100 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Lloyd Carney DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Alan Garber DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Michel Lagarde DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Diana McKenzie DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Bruce Sachs DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Election of Director: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 3170.086400 0.000000 FOR 3170.086400 FOR S000004450 VERTEX PHARMACEUTICALS INCORPORATED 92532F100 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 3170.086400 0.000000 FOR 3170.086400 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Election of Director for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 813.203600 0.000000 FOR 813.203600 FOR S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Non-binding advisory vote to approve the compensation of the Company's named executive officers. COMPENSATION ISSUER 813.203600 0.000000 AGAINST 813.203600 AGAINST S000004450 ACCENDRA HEALTH, INC. 690732102 05/14/2026 Approval of the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 813.203600 0.000000 FOR 813.203600 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Richard E. Buller DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: David F. Dalvey DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Leo T. Furcht DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Lance G. Laing DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Polly A. Murphy DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Richard J. Nigon DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Charles R. Romp DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 Elect Directors: Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 To approve, on an advisory basis, named executive officer compensation. COMPENSATION ISSUER 270.894120 0.000000 FOR 270.894120 FOR S000004450 CELCUITY INC. 15102K100 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 270.894120 0.000000 AGAINST 270.894120 AGAINST S000004450 CELCUITY INC. 15102K100 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 270.894120 0.000000 AGAINST 270.894120 AGAINST S000004450 CERTARA, INC. 15687V109 05/14/2026 Elect Directors: Arjun Bedi DIRECTOR ELECTIONS ISSUER 1596.817820 0.000000 FOR 1596.817820 FOR S000004450 CERTARA, INC. 15687V109 05/14/2026 Elect Directors: Stephen McLean DIRECTOR ELECTIONS ISSUER 1596.817820 0.000000 FOR 1596.817820 FOR S000004450 CERTARA, INC. 15687V109 05/14/2026 Elect Directors: Jon Resnick DIRECTOR ELECTIONS ISSUER 1596.817820 0.000000 FOR 1596.817820 FOR S000004450 CERTARA, INC. 15687V109 05/14/2026 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1596.817820 0.000000 FOR 1596.817820 FOR S000004450 CERTARA, INC. 15687V109 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. COMPENSATION ISSUER 1596.817820 0.000000 FOR 1596.817820 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Michael Donovan DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Election of Director to hold office until the 2027 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers COMPENSATION ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 COLLEGIUM PHARMACEUTICAL, INC. 19459J104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 436.128000 0.000000 FOR 436.128000 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: C. David Brown II DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 AGAINST 15862.213120 AGAINST S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: John E. Gallina DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: J. David Joyner DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Election of Director: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. COMPENSATION ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 15862.213120 0.000000 FOR 15862.213120 FOR S000004450 CVS HEALTH CORPORATION 126650100 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 15862.213120 0.000000 FOR 15862.213120 AGAINST S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 Election of Director: Ming Hsieh DIRECTOR ELECTIONS ISSUER 263.887260 0.000000 FOR 263.887260 FOR S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 Election of Director: Linda Dong DIRECTOR ELECTIONS ISSUER 263.887260 0.000000 FOR 263.887260 FOR S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 Election of Director: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 263.887260 0.000000 WITHHOLD 263.887260 AGAINST S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 Election of Director: Regina Groves DIRECTOR ELECTIONS ISSUER 263.887260 0.000000 FOR 263.887260 FOR S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 263.887260 0.000000 FOR 263.887260 FOR S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 To approve, on an advisory basis, compensation awarded to the Company's named executive officers (Say-on-Pay). COMPENSATION ISSUER 263.887260 0.000000 FOR 263.887260 FOR S000004450 FULGENT GENETICS, INC. 359664109 05/14/2026 To approve the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 263.887260 0.000000 AGAINST 263.887260 AGAINST S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Elect Directors: Geno J. Germano DIRECTOR ELECTIONS ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Elect Directors: Troy Ignelzi DIRECTOR ELECTIONS ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Elect Directors: Ron Philip DIRECTOR ELECTIONS ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Elect Directors: Andreas Wicki, Ph.D. DIRECTOR ELECTIONS ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 HARMONY BIOSCIENCES HOLDINGS, INC. 413197104 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. COMPENSATION ISSUER 559.083140 0.000000 FOR 559.083140 FOR S000004450 PROTHENA CORPORATION PLC G72800108 05/14/2026 Election of Director to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 472.345300 0.000000 AGAINST 472.345300 AGAINST S000004450 PROTHENA CORPORATION PLC G72800108 05/14/2026 Election of Director to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. Selkoe DIRECTOR ELECTIONS ISSUER 472.345300 0.000000 AGAINST 472.345300 AGAINST S000004450 PROTHENA CORPORATION PLC G72800108 05/14/2026 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 472.345300 0.000000 FOR 472.345300 FOR S000004450 PROTHENA CORPORATION PLC G72800108 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. COMPENSATION ISSUER 472.345300 0.000000 FOR 472.345300 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 AGAINST 667.638400 AGAINST S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Election of Director: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 REPLIGEN CORPORATION 759916109 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. COMPENSATION ISSUER 667.638400 0.000000 FOR 667.638400 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 05/14/2026 Election of Director: Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 452.492740 0.000000 AGAINST 452.492740 AGAINST S000004450 THE PENNANT GROUP, INC. 70805E109 05/14/2026 Election OF Director: Brent J. Guerisoli DIRECTOR ELECTIONS ISSUER 452.492740 0.000000 FOR 452.492740 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 05/14/2026 Election OF Director: John G. Nackel, Ph.D. DIRECTOR ELECTIONS ISSUER 452.492740 0.000000 AGAINST 452.492740 AGAINST S000004450 THE PENNANT GROUP, INC. 70805E109 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for 2026. AUDIT-RELATED ISSUER 452.492740 0.000000 FOR 452.492740 FOR S000004450 THE PENNANT GROUP, INC. 70805E109 05/14/2026 Advisory approval of the Company's named executive officer compensation. COMPENSATION ISSUER 452.492740 0.000000 FOR 452.492740 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Election of Director: Emil D. Kakkis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1174.940690 0.000000 WITHHOLD 1174.940690 AGAINST S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Election of Director: Shehnaaz Suliman, M.D. DIRECTOR ELECTIONS ISSUER 1174.940690 0.000000 WITHHOLD 1174.940690 AGAINST S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Election of Director: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 1174.940690 0.000000 FOR 1174.940690 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 1174.940690 0.000000 AGAINST 1174.940690 AGAINST S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1174.940690 0.000000 FOR 1174.940690 FOR S000004450 ULTRAGENYX PHARMACEUTICAL INC. 90400D108 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 1174.940690 0.000000 AGAINST 1174.940690 AGAINST S000004450 KRYSTAL BIOTECH, INC. 501147102 05/15/2026 Elect Directors: Krish S. Krishnan DIRECTOR ELECTIONS ISSUER 295.071260 0.000000 FOR 295.071260 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 05/15/2026 Elect Directors: Christopher Mason DIRECTOR ELECTIONS ISSUER 295.071260 0.000000 FOR 295.071260 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 05/15/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 295.071260 0.000000 FOR 295.071260 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. COMPENSATION ISSUER 295.071260 0.000000 FOR 295.071260 FOR S000004450 KRYSTAL BIOTECH, INC. 501147102 05/15/2026 Approval of the Company's Non-Employee Director Compensation Policy. COMPENSATION ISSUER 295.071260 0.000000 FOR 295.071260 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Elect Directors: Brian T. Carley DIRECTOR ELECTIONS ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Elect Directors: Femida H Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Elect Directors: Robert O. Kraft DIRECTOR ELECTIONS ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Elect Directors: August J. Troendle DIRECTOR ELECTIONS ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Elect Directors: Dani S. Zander DIRECTOR ELECTIONS ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. COMPENSATION ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 297.872640 0.000000 1.0 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 297.872640 0.000000 FOR 297.872640 FOR S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. CORPORATE GOVERNANCE ISSUER 297.872640 0.000000 AGAINST 297.872640 AGAINST S000004450 MEDPACE HOLDINGS, INC. 58506Q109 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 297.872640 0.000000 FOR 297.872640 AGAINST S000004450 NURIX THERAPEUTICS, INC. 67080M103 05/15/2026 Elect Directors: Arthur T. Sands, M.D. DIRECTOR ELECTIONS ISSUER 1005.209660 0.000000 ABSTAIN 1005.209660 AGAINST S000004450 NURIX THERAPEUTICS, INC. 67080M103 05/15/2026 Elect Directors: Roger Dansey, M.D. DIRECTOR ELECTIONS ISSUER 1005.209660 0.000000 FOR 1005.209660 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 05/15/2026 Elect Directors: Paul M. Silva DIRECTOR ELECTIONS ISSUER 1005.209660 0.000000 ABSTAIN 1005.209660 AGAINST S000004450 NURIX THERAPEUTICS, INC. 67080M103 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026. AUDIT-RELATED ISSUER 1005.209660 0.000000 FOR 1005.209660 FOR S000004450 NURIX THERAPEUTICS, INC. 67080M103 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 1005.209660 0.000000 FOR 1005.209660 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Charles Kummeth DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 AGAINST 2400.033480 AGAINST S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Paula Dowdy DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Ruth Fattori DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 AGAINST 2400.033480 AGAINST S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Amir Jafri DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jack Kenny DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Brigid A. Makes DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 AGAINST 2400.033480 AGAINST S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Scott Mendel DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Kevin Rakin DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 AGAINST 2400.033480 AGAINST S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 Election of Director to serve one-year term expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 2400.033480 0.000000 AGAINST 2400.033480 AGAINST S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 QUANTUM-SI INCORPORATED 74765K105 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement COMPENSATION ISSUER 2400.033480 0.000000 FOR 2400.033480 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Election of Director: Carlos AlbAin DIRECTOR ELECTIONS ISSUER 2071.981080 0.000000 FOR 2071.981080 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Election of Director: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 2071.981080 0.000000 FOR 2071.981080 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Election of Director: Shirley Edwards DIRECTOR ELECTIONS ISSUER 2071.981080 0.000000 FOR 2071.981080 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Election of Director: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 2071.981080 0.000000 FOR 2071.981080 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Advisory vote to approve executive compensation COMPENSATION ISSUER 2071.981080 0.000000 FOR 2071.981080 FOR S000004450 SOLVENTUM CORPORATION 83444M101 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2071.981080 0.000000 AGAINST 2071.981080 AGAINST S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 AGAINST 587.294240 AGAINST S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 AGAINST 587.294240 AGAINST S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 FOR 587.294240 FOR S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Neena M. Patil DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 FOR 587.294240 FOR S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 AGAINST 587.294240 AGAINST S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 FOR 587.294240 FOR S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Election of Director: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 587.294240 0.000000 FOR 587.294240 FOR S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Approval, on an advisory basis, of named executive officer compensation. COMPENSATION ISSUER 587.294240 0.000000 FOR 587.294240 FOR S000004450 TELEFLEX INCORPORATED 879369106 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 587.294240 0.000000 AGAINST 587.294240 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Election of Director to hold office until the 2027 annual meeting of shareholders: RogA(c)rio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. COMPENSATION ISSUER 15288.041860 0.000000 FOR 15288.041860 FOR S000004450 VIATRIS INC. 92556V106 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 15288.041860 0.000000 AGAINST 15288.041860 AGAINST S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Regina E. Groves DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Karen N. Prange DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 AGAINST 689.330790 AGAINST S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Robert S. White DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Election of Director: Maggie Yuen DIRECTOR ELECTIONS ISSUER 689.330790 0.000000 AGAINST 689.330790 AGAINST S000004450 ATRICURE, INC. 04963C209 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. CAPITAL STRUCTURE ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 ATRICURE, INC. 04963C209 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. COMPENSATION ISSUER 689.330790 0.000000 FOR 689.330790 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Ron DeLyons DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Election of Director: George J. Walsh III DIRECTOR ELECTIONS ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 191.611860 0.000000 FOR 191.611860 FOR S000004450 CHEMED CORPORATION 16359R103 05/18/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 191.611860 0.000000 AGAINST 191.611860 AGAINST S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 FOR 423.123690 FOR S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: David Bronson DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 ABSTAIN 423.123690 AGAINST S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: LaVerne H. Council DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 ABSTAIN 423.123690 AGAINST S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: Charles M. Farkas DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 ABSTAIN 423.123690 AGAINST S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: Mark Kaye DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 FOR 423.123690 FOR S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: Kim Kelderman DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 FOR 423.123690 FOR S000004450 CONMED CORPORATION 207410101 05/18/2026 Elect Directors: B. J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 423.123690 0.000000 ABSTAIN 423.123690 AGAINST S000004450 CONMED CORPORATION 207410101 05/18/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 423.123690 0.000000 FOR 423.123690 FOR S000004450 CONMED CORPORATION 207410101 05/18/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 423.123690 0.000000 FOR 423.123690 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Advisory vote to approve our executive compensation. COMPENSATION ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7151.378780 0.000000 FOR 7151.378780 FOR S000004450 AMGEN INC. 031162100 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 7151.378780 0.000000 AGAINST 7151.378780 FOR S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Damien McDonald DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 FOR 788.051880 FOR S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Philip A. Okala DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Christine Ortiz DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Brady Shirley DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 Election of Director: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 788.051880 0.000000 AGAINST 788.051880 AGAINST S000004450 ENOVIS CORPORATION 194014502 05/19/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 788.051880 0.000000 FOR 788.051880 FOR S000004450 ENOVIS CORPORATION 194014502 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. COMPENSATION ISSUER 788.051880 0.000000 FOR 788.051880 FOR S000004450 ENOVIS CORPORATION 194014502 05/19/2026 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 788.051880 0.000000 FOR 788.051880 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Wendy Carruthers DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Kieran Gallahue DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Scott Huennekens DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 ABSTAIN 2225.860890 AGAINST S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Vivek Jain DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Paul Keel DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: J. Andrew Pierce DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Daniel Raskas DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 ABSTAIN 2225.860890 AGAINST S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 Elect Directors: Christine Tsingos DIRECTOR ELECTIONS ISSUER 2225.860890 0.000000 ABSTAIN 2225.860890 AGAINST S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. COMPENSATION ISSUER 2225.860890 0.000000 FOR 2225.860890 FOR S000004450 ENVISTA HOLDINGS CORPORATION 29415F104 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2225.860890 0.000000 1.0 2225.860890 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 709.301880 0.000000 FOR 709.301880 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien DIRECTOR ELECTIONS ISSUER 709.301880 0.000000 FOR 709.301880 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser DIRECTOR ELECTIONS ISSUER 709.301880 0.000000 FOR 709.301880 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 709.301880 0.000000 FOR 709.301880 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. COMPENSATION ISSUER 709.301880 0.000000 FOR 709.301880 FOR S000004450 MACROGENICS, INC. 556099109 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 709.301880 0.000000 AGAINST 709.301880 AGAINST S000004450 OMNICELL, INC. 68213N109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer DIRECTOR ELECTIONS ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 OMNICELL, INC. 68213N109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim DIRECTOR ELECTIONS ISSUER 617.634990 0.000000 WITHHOLD 617.634990 AGAINST S000004450 OMNICELL, INC. 68213N109 05/19/2026 Election of Class I Director to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick DIRECTOR ELECTIONS ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 OMNICELL, INC. 68213N109 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 OMNICELL, INC. 68213N109 05/19/2026 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 OMNICELL, INC. 68213N109 05/19/2026 Proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates. CORPORATE GOVERNANCE ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 OMNICELL, INC. 68213N109 05/19/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 617.634990 0.000000 FOR 617.634990 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta DIRECTOR ELECTIONS ISSUER 633.465580 0.000000 FOR 633.465580 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder DIRECTOR ELECTIONS ISSUER 633.465580 0.000000 FOR 633.465580 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse DIRECTOR ELECTIONS ISSUER 633.465580 0.000000 FOR 633.465580 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 05/19/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 633.465580 0.000000 FOR 633.465580 FOR S000004450 PHATHOM PHARMACEUTICALS, INC. 71722W107 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). COMPENSATION ISSUER 633.465580 0.000000 FOR 633.465580 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Roy Baynes DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Timothy Coughlin DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Eric Dube DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Gary Lyons DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: John Orwin DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Sandra Poole DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Ron Squarer DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 Elect Directors: Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 1150.189810 0.000000 AGAINST 1150.189810 AGAINST S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1150.189810 0.000000 1.0 1150.189810 FOR S000004450 TRAVERE THERAPEUTICS, INC. 89422G107 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1150.189810 0.000000 FOR 1150.189810 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 05/19/2026 Elect Directors: Lance A. Berry DIRECTOR ELECTIONS ISSUER 683.522070 0.000000 ABSTAIN 683.522070 AGAINST S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 05/19/2026 Elect Directors: Elizabeth S. Hanna DIRECTOR ELECTIONS ISSUER 683.522070 0.000000 ABSTAIN 683.522070 AGAINST S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 05/19/2026 Elect Directors: Jane E. Kiernan DIRECTOR ELECTIONS ISSUER 683.522070 0.000000 ABSTAIN 683.522070 AGAINST S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 683.522070 0.000000 FOR 683.522070 FOR S000004450 TREACE MEDICAL CONCEPTS, INC. 89455T109 05/19/2026 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 683.522070 0.000000 FOR 683.522070 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Christopher J. Reading DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Dr. B. A. Harris Jr. DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Regg E. Swanson DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Elect Directors: Peter F. Minan DIRECTOR ELECTIONS ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Advisory vote to approve the named executive officer compensation. COMPENSATION ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 U.S. PHYSICAL THERAPY, INC. 90337L108 05/19/2026 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 208.626600 0.000000 FOR 208.626600 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 05/19/2026 Elect Directors: J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 1424.433400 0.000000 FOR 1424.433400 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 05/19/2026 Elect Directors: S. Kathryn Rouan, Ph D DIRECTOR ELECTIONS ISSUER 1424.433400 0.000000 FOR 1424.433400 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 05/19/2026 TO RATIFY THE SELECTION OF CBIZ CPAS P C AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2026 AUDIT-RELATED ISSUER 1424.433400 0.000000 FOR 1424.433400 FOR S000004450 VIKING THERAPEUTICS INC 92686J106 05/19/2026 TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS COMPENSATION ISSUER 1424.433400 0.000000 AGAINST 1424.433400 AGAINST S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 AGAINST 924.062920 AGAINST S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Joseph Lacob DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Anne M. Myong DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 AGAINST 924.062920 AGAINST S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Election of Director: Britt Vitalone DIRECTOR ELECTIONS ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers COMPENSATION ISSUER 924.062920 0.000000 AGAINST 924.062920 AGAINST S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALIGN TECHNOLOGY, INC. 016255101 05/20/2026 Ratification of Special Meeting Provision in our Bylaws CORPORATE GOVERNANCE ISSUER 924.062920 0.000000 FOR 924.062920 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 AGAINST 1993.823190 AGAINST S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 AGAINST 1993.823190 AGAINST S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 AGAINST 1993.823190 AGAINST S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 AGAINST 1993.823190 AGAINST S000004450 ALKERMES PLC G01767105 05/20/2026 Election of Director to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 1993.823190 0.000000 AGAINST 1993.823190 AGAINST S000004450 ALKERMES PLC G01767105 05/20/2026 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALKERMES PLC G01767105 05/20/2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 1993.823190 0.000000 FOR 1993.823190 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 1804.752950 0.000000 FOR 1804.752950 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 1804.752950 0.000000 FOR 1804.752950 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 05/20/2026 Election of Class I Director of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1804.752950 0.000000 FOR 1804.752950 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. COMPENSATION ISSUER 1804.752950 0.000000 FOR 1804.752950 FOR S000004450 ALNYLAM PHARMACEUTICALS, INC. 02043Q107 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1804.752950 0.000000 FOR 1804.752950 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Mark Sotir DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Martin J. Bonick DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Peter Bulgarelli DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Peter Bynoe DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Suzanne Campion DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Robert A. DeMichiei DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: William Goodyear DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Ellen Havdala DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Edmondo Robinson DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Rahul Sen DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 ABSTAIN 392.734170 AGAINST S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Elect Directors: Rob Webb DIRECTOR ELECTIONS ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. COMPENSATION ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 ARDENT HEALTH, INC. 03980N107 05/20/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 392.734170 0.000000 FOR 392.734170 FOR S000004450 GERON CORPORATION 374163103 05/20/2026 Elect Directors: Susan M. Molineaux, PhD DIRECTOR ELECTIONS ISSUER 6614.369010 0.000000 ABSTAIN 6614.369010 AGAINST S000004450 GERON CORPORATION 374163103 05/20/2026 Elect Directors: Patricia S. Andrews DIRECTOR ELECTIONS ISSUER 6614.369010 0.000000 FOR 6614.369010 FOR S000004450 GERON CORPORATION 374163103 05/20/2026 Elect Directors: Constantine Chinoporos DIRECTOR ELECTIONS ISSUER 6614.369010 0.000000 FOR 6614.369010 FOR S000004450 GERON CORPORATION 374163103 05/20/2026 To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement. COMPENSATION ISSUER 6614.369010 0.000000 AGAINST 6614.369010 AGAINST S000004450 GERON CORPORATION 374163103 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. COMPENSATION ISSUER 6614.369010 0.000000 AGAINST 6614.369010 AGAINST S000004450 GERON CORPORATION 374163103 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6614.369010 0.000000 FOR 6614.369010 FOR S000004450 INSULET CORPORATION 45784P101 05/20/2026 Elect Directors: Luciana Borio DIRECTOR ELECTIONS ISSUER 952.665340 0.000000 FOR 952.665340 FOR S000004450 INSULET CORPORATION 45784P101 05/20/2026 Elect Directors: Michael R. Minogue DIRECTOR ELECTIONS ISSUER 952.665340 0.000000 FOR 952.665340 FOR S000004450 INSULET CORPORATION 45784P101 05/20/2026 Elect Directors: Timothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 952.665340 0.000000 FOR 952.665340 FOR S000004450 INSULET CORPORATION 45784P101 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. COMPENSATION ISSUER 952.665340 0.000000 FOR 952.665340 FOR S000004450 INSULET CORPORATION 45784P101 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 952.665340 0.000000 FOR 952.665340 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Sheila Antrum DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Michael J. Coyle DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: James F. Flanagan DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: James F. Hinrichs DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Aaron Kapito DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Payman Khales DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Filippo Passerini DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 Election of Director for a one-year term or until their successors have been duly elected and qualified: Donald J. Spence DIRECTOR ELECTIONS ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. COMPENSATION ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 INTEGER HOLDINGS CORPORATION 45826H109 05/20/2026 To approve the Integer Holdings Corporation 2026 Omnibus Incentive Plan. COMPENSATION ISSUER 486.800160 0.000000 FOR 486.800160 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: J.S. Shannon, MD, MRCP DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 ABSTAIN 3947.300830 AGAINST S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: M.E. Castagna, Pharm.D. DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Steven B. Binder DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 ABSTAIN 3947.300830 AGAINST S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Michael A. Friedman, MD DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 ABSTAIN 3947.300830 AGAINST S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Jennifer Grancio DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Anthony Hooper DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Sabrina Kay, Ed.D. DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 Elect Directors: Christine Mundkur DIRECTOR ELECTIONS ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting. COMPENSATION ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 MANNKIND CORPORATION 56400P706 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3947.300830 0.000000 FOR 3947.300830 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Eric K. Brandt DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Natasha Deckmann DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Harry Jansen Kraemer Jr DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: R. Carter Pate DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 ABSTAIN 2147.517680 AGAINST S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: John C. Rademacher DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 Elect Directors: Norman L. Wright DIRECTOR ELECTIONS ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 OPTION CARE HEALTH, INC. 68404L201 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. COMPENSATION ISSUER 2147.517680 0.000000 FOR 2147.517680 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy Cocozza DIRECTOR ELECTIONS ISSUER 1334.698420 0.000000 FOR 1334.698420 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David King DIRECTOR ELECTIONS ISSUER 1334.698420 0.000000 FOR 1334.698420 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis Soistman DIRECTOR ELECTIONS ISSUER 1334.698420 0.000000 FOR 1334.698420 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). COMPENSATION ISSUER 1334.698420 0.000000 FOR 1334.698420 FOR S000004450 PRIVIA HEALTH GROUP, INC. 74276R102 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1334.698420 0.000000 FOR 1334.698420 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Robert B. Carter DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: James E. Davis DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Tracey C. Doi DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Timothy L. Main DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Denise M. Morrison DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Election of Director: Timothy C. Wentworth DIRECTOR ELECTIONS ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. COMPENSATION ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1507.296120 0.000000 FOR 1507.296120 FOR S000004450 QUEST DIAGNOSTICS INCORPORATED 74834L100 05/20/2026 Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 1507.296120 0.000000 AGAINST 1507.296120 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Peter Fong, Ph.D. DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 FOR 1099.749970 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 WITHHOLD 1099.749970 AGAINST S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 FOR 1099.749970 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 WITHHOLD 1099.749970 AGAINST S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 WITHHOLD 1099.749970 AGAINST S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 WITHHOLD 1099.749970 AGAINST S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 Election of Director to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 1099.749970 0.000000 WITHHOLD 1099.749970 AGAINST S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 The ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1099.749970 0.000000 FOR 1099.749970 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 1099.749970 0.000000 FOR 1099.749970 FOR S000004450 ROCKET PHARMACEUTICALS, INC. 77313F106 05/20/2026 The approval of the proposed stock option exchange program. COMPENSATION ISSUER 1099.749970 0.000000 AGAINST 1099.749970 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 FOR 918.163840 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 Election of Director for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 918.163840 0.000000 FOR 918.163840 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 918.163840 0.000000 AGAINST 918.163840 AGAINST S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 918.163840 0.000000 FOR 918.163840 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 918.163840 0.000000 FOR 918.163840 FOR S000004450 TANDEM DIABETES CARE, INC. 875372203 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 918.163840 0.000000 FOR 918.163840 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Marc N. Casper DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: C. Martin Harris DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Tyler Jacks DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Debora L. Spar DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Election of Director: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 5089.525980 0.000000 FOR 5089.525980 FOR S000004450 THERMO FISHER SCIENTIFIC INC. 883556102 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 5089.525980 0.000000 AGAINST 5089.525980 AGAINST S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: James R. Tobin DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Edward M. Basile DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: Merilee Raines DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 Election of Director: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. COMPENSATION ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. COMPENSATION ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 TRANSMEDICS GROUP, INC. 89377M109 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 443.106300 0.000000 FOR 443.106300 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 05/20/2026 Election of Director: Nina Chen-Langenmayr DIRECTOR ELECTIONS ISSUER 748.515680 0.000000 FOR 748.515680 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. COMPENSATION ISSUER 748.515680 0.000000 FOR 748.515680 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 05/20/2026 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 748.515680 0.000000 FOR 748.515680 FOR S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 05/20/2026 Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 748.515680 0.000000 FOR 748.515680 AGAINST S000004450 UNIVERSAL HEALTH SERVICES, INC. 913903100 05/20/2026 Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 748.515680 0.000000 AGAINST 748.515680 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 AGAINST 6069.416670 AGAINST S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Gregory Norden DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Willie M. Reed DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Mark Stetter DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Election of Director: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Advisory vote to approve our executive compensation. COMPENSATION ISSUER 6069.416670 0.000000 AGAINST 6069.416670 AGAINST S000004450 ZOETIS INC. 98978V103 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6069.416670 0.000000 1.0 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 6069.416670 0.000000 FOR 6069.416670 FOR S000004450 ZOETIS INC. 98978V103 05/20/2026 Shareholder proposal to permit shareholder action by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 6069.416670 0.000000 FOR 6069.416670 AGAINST S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 Election of Director: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. COMPENSATION ISSUER 244.374350 0.000000 FOR 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 244.374350 0.000000 1.0 244.374350 FOR S000004450 ANI PHARMACEUTICALS, INC. 00182C103 05/21/2026 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 244.374350 0.000000 AGAINST 244.374350 AGAINST S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 05/21/2026 Election of Class II Director: Olivia Kirtley DIRECTOR ELECTIONS ISSUER 1996.020180 0.000000 FOR 1996.020180 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 05/21/2026 Election of Class II Director: Max Lin DIRECTOR ELECTIONS ISSUER 1996.020180 0.000000 FOR 1996.020180 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 05/21/2026 Election of Class II Director: Steve Miller DIRECTOR ELECTIONS ISSUER 1996.020180 0.000000 FOR 1996.020180 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 1996.020180 0.000000 FOR 1996.020180 FOR S000004450 BRIGHTSPRING HEALTH SERVICES, INC. 10950A106 05/21/2026 Advisory vote on executive compensation COMPENSATION ISSUER 1996.020180 0.000000 FOR 1996.020180 FOR S000004450 BRUKER CORPORATION 116794108 05/21/2026 Elect Directors: John J. (Jack) Phillips DIRECTOR ELECTIONS ISSUER 1482.043350 0.000000 FOR 1482.043350 FOR S000004450 BRUKER CORPORATION 116794108 05/21/2026 Elect Directors: Hermann F. Requardt PhD DIRECTOR ELECTIONS ISSUER 1482.043350 0.000000 FOR 1482.043350 FOR S000004450 BRUKER CORPORATION 116794108 05/21/2026 Elect Directors: Laura A. Francis DIRECTOR ELECTIONS ISSUER 1482.043350 0.000000 FOR 1482.043350 FOR S000004450 BRUKER CORPORATION 116794108 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. COMPENSATION ISSUER 1482.043350 0.000000 FOR 1482.043350 FOR S000004450 BRUKER CORPORATION 116794108 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1482.043350 0.000000 AGAINST 1482.043350 AGAINST S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: Gregg Alton DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: David L. Mahoney DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: Kimberly Park DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 Election of Director: James N. Wilson DIRECTOR ELECTIONS ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1467.875520 0.000000 FOR 1467.875520 FOR S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 1467.875520 0.000000 AGAINST 1467.875520 AGAINST S000004450 CORCEPT THERAPEUTICS INCORPORATED 218352102 05/21/2026 To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. COMPENSATION ISSUER 1467.875520 0.000000 AGAINST 1467.875520 AGAINST S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 484.587180 0.000000 FOR 484.587180 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 484.587180 0.000000 WITHHOLD 484.587180 AGAINST S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 05/21/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 484.587180 0.000000 WITHHOLD 484.587180 AGAINST S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and COMPENSATION ISSUER 484.587180 0.000000 FOR 484.587180 FOR S000004450 DIANTHUS THERAPEUTICS, INC. 252828108 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 484.587180 0.000000 FOR 484.587180 FOR S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Election of Class I Nominee: Kapila Anand DIRECTOR ELECTIONS ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Election of Class I Nominee: Paul Herendeen DIRECTOR ELECTIONS ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Election of Class II Nominee: Michael Harrington DIRECTOR ELECTIONS ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Election of Class II Nominee: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Election of Class II Nominee: Kirk McDonald DIRECTOR ELECTIONS ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 6854.435190 0.000000 AGAINST 6854.435190 AGAINST S000004450 ELANCO ANIMAL HEALTH INCORPORATED 28414H103 05/21/2026 Advisory vote on the compensation of the company's named executive officers. COMPENSATION ISSUER 6854.435190 0.000000 FOR 6854.435190 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Mohamad Ali DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Deborah Derby DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Carole T. Faig DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Max Lin DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Election of Incumbent Director: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. COMPENSATION ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 1436.353820 0.000000 FOR 1436.353820 FOR S000004450 HENRY SCHEIN, INC. 806407102 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. CORPORATE GOVERNANCE SECURITY HOLDER 1436.353820 0.000000 FOR 1436.353820 AGAINST S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 AGAINST 2105.405460 AGAINST S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: David P. King DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Keith A. Meister DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Anna Richo DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Philip W. Schiller DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 AGAINST 2105.405460 AGAINST S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 AGAINST 2105.405460 AGAINST S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 Election of Director: Scott B. Ullem DIRECTOR ELECTIONS ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 ILLUMINA, INC. 452327109 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 2105.405460 0.000000 FOR 2105.405460 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Victor Bulto DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Election of Director: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 LABCORP HOLDINGS INC. 504922105 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1142.037900 0.000000 FOR 1142.037900 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 620.774700 0.000000 FOR 620.774700 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 620.774700 0.000000 FOR 620.774700 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 05/21/2026 Election of Class III Director for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 620.774700 0.000000 FOR 620.774700 FOR S000004450 MINERALYS THERAPEUTICS, INC. 603170101 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 620.774700 0.000000 FOR 620.774700 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 AGAINST 1758.760190 AGAINST S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 AGAINST 1758.760190 AGAINST S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: John P. Kenny DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: David B. Perez DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 AGAINST 1758.760190 AGAINST S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Felicia Williams DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Election of Director: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. COMPENSATION ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 1758.760190 0.000000 AGAINST 1758.760190 AGAINST S000004450 NEOGENOMICS, INC. 64049M209 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 1758.760190 0.000000 FOR 1758.760190 FOR S000004450 NUVATION BIO INC. 67080N101 05/21/2026 Elect Directors: Robert Bazemore DIRECTOR ELECTIONS ISSUER 3029.103350 0.000000 ABSTAIN 3029.103350 AGAINST S000004450 NUVATION BIO INC. 67080N101 05/21/2026 Elect Directors: Robert Mashal, M.D. DIRECTOR ELECTIONS ISSUER 3029.103350 0.000000 FOR 3029.103350 FOR S000004450 NUVATION BIO INC. 67080N101 05/21/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3029.103350 0.000000 FOR 3029.103350 FOR S000004450 NUVATION BIO INC. 67080N101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 3029.103350 0.000000 FOR 3029.103350 FOR S000004450 PROGYNY, INC. 74340E103 05/21/2026 Election of Director: Lloyd Dean DIRECTOR ELECTIONS ISSUER 1125.747990 0.000000 WITHHOLD 1125.747990 AGAINST S000004450 PROGYNY, INC. 74340E103 05/21/2026 Election of Director: Kevin Gordon DIRECTOR ELECTIONS ISSUER 1125.747990 0.000000 WITHHOLD 1125.747990 AGAINST S000004450 PROGYNY, INC. 74340E103 05/21/2026 Election of Director: Cheryl Scott DIRECTOR ELECTIONS ISSUER 1125.747990 0.000000 WITHHOLD 1125.747990 AGAINST S000004450 PROGYNY, INC. 74340E103 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1125.747990 0.000000 FOR 1125.747990 FOR S000004450 PROGYNY, INC. 74340E103 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers COMPENSATION ISSUER 1125.747990 0.000000 FOR 1125.747990 FOR S000004450 PROGYNY, INC. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements CORPORATE GOVERNANCE ISSUER 1125.747990 0.000000 FOR 1125.747990 FOR S000004450 PROGYNY, INC. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations CORPORATE GOVERNANCE ISSUER 1125.747990 0.000000 FOR 1125.747990 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Sean L. Cunningham DIRECTOR ELECTIONS ISSUER 2978.478450 0.000000 WITHHOLD 2978.478450 AGAINST S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Richard G. Kyle DIRECTOR ELECTIONS ISSUER 2978.478450 0.000000 FOR 2978.478450 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Vincent K. Petrella DIRECTOR ELECTIONS ISSUER 2978.478450 0.000000 WITHHOLD 2978.478450 AGAINST S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 2978.478450 0.000000 FOR 2978.478450 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 2978.478450 0.000000 FOR 2978.478450 FOR S000004450 SOTERA HEALTH COMPANY 83601L102 05/21/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2978.478450 0.000000 FOR 2978.478450 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 AGAINST 2439.405990 AGAINST S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 AGAINST 2439.405990 AGAINST S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Susan R. Salka DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 AGAINST 2439.405990 AGAINST S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 AGAINST 2439.405990 AGAINST S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: Michael S. Smith DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Election of Director for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. COMPENSATION ISSUER 2439.405990 0.000000 AGAINST 2439.405990 AGAINST S000004450 TELADOC HEALTH, INC. 87918A105 05/21/2026 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2439.405990 0.000000 FOR 2439.405990 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Peter J. Barris DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Eric D. Belcher DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: David R. Epstein DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Wayne A.I. Frederick MD DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 Elect Directors: Nadja West, M.D. DIRECTOR ELECTIONS ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1279.985760 0.000000 FOR 1279.985760 FOR S000004450 TEMPUS AI, INC. 88023B103 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1279.985760 0.000000 1.0 1279.985760 AGAINST S000004450 VERA THERAPEUTICS, INC. 92337R101 05/21/2026 Elect Directors: Michael M Morrissey PhD DIRECTOR ELECTIONS ISSUER 518.722160 0.000000 FOR 518.722160 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 05/21/2026 Elect Directors: Patrick G. Enright DIRECTOR ELECTIONS ISSUER 518.722160 0.000000 FOR 518.722160 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 05/21/2026 Elect Directors: James R. Meyers DIRECTOR ELECTIONS ISSUER 518.722160 0.000000 FOR 518.722160 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 518.722160 0.000000 FOR 518.722160 FOR S000004450 VERA THERAPEUTICS, INC. 92337R101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 518.722160 0.000000 FOR 518.722160 FOR S000004450 VERASTEM, INC. 92337C203 05/21/2026 Elect Directors: Michael Bailey DIRECTOR ELECTIONS ISSUER 582.606310 0.000000 FOR 582.606310 FOR S000004450 VERASTEM, INC. 92337C203 05/21/2026 Elect Directors: Brian Stuglik DIRECTOR ELECTIONS ISSUER 582.606310 0.000000 ABSTAIN 582.606310 AGAINST S000004450 VERASTEM, INC. 92337C203 05/21/2026 Elect Directors: Karin Tollefson DIRECTOR ELECTIONS ISSUER 582.606310 0.000000 FOR 582.606310 FOR S000004450 VERASTEM, INC. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive Plan. COMPENSATION ISSUER 582.606310 0.000000 AGAINST 582.606310 AGAINST S000004450 VERASTEM, INC. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 582.606310 0.000000 FOR 582.606310 FOR S000004450 VERASTEM, INC. 92337C203 05/21/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 582.606310 0.000000 FOR 582.606310 FOR S000004450 VERASTEM, INC. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. COMPENSATION ISSUER 582.606310 0.000000 FOR 582.606310 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 Election of Director to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 WATERS CORPORATION 941848103 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. COMPENSATION ISSUER 1332.051050 0.000000 FOR 1332.051050 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Owen Hughes DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 ABSTAIN 131.649700 AGAINST S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Heather L. Franklin DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 ABSTAIN 131.649700 AGAINST S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Natasha Hernday DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Barbara Kosacz DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Joseph M. Limber DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 ABSTAIN 131.649700 AGAINST S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Elect Directors: Matthew D. Perry DIRECTOR ELECTIONS ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan. COMPENSATION ISSUER 131.649700 0.000000 AGAINST 131.649700 AGAINST S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Approval of the 2026 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 XOMA ROYALTY CORP. 98419J206 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 131.649700 0.000000 FOR 131.649700 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Filippo "Peter" Caldini DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Leslie Gillin DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Edward Schutter DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 Election of Director to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/22/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2.947560 0.000000 FOR 2.947560 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Syed Jafry DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 FOR 2708.492150 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 FOR 2708.492150 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Election of Director: Ivan Tornos DIRECTOR ELECTIONS ISSUER 2708.492150 0.000000 FOR 2708.492150 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 2708.492150 0.000000 FOR 2708.492150 FOR S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). COMPENSATION ISSUER 2708.492150 0.000000 AGAINST 2708.492150 AGAINST S000004450 ZIMMER BIOMET HOLDINGS, INC. 98956P102 05/22/2026 Shareholder Proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 2708.492150 0.000000 AGAINST 2708.492150 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 Elect Directors: L Androski JD, MBA CFA DIRECTOR ELECTIONS ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 Elect Directors: Robert Alan Beardsley DIRECTOR ELECTIONS ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 Elect Directors: Joseph Bishop DIRECTOR ELECTIONS ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 Elect Directors: Matthew Gline DIRECTOR ELECTIONS ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 Elect Directors: Roger Sawhney, MD DIRECTOR ELECTIONS ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan; COMPENSATION ISSUER 1989.579900 0.000000 AGAINST 1989.579900 AGAINST S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular; and COMPENSATION ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 ARBUTUS BIOPHARMA CORPORATION 03879J100 05/26/2026 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1989.579900 0.000000 FOR 1989.579900 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver, Jr. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. AUDIT-RELATED ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. COMPENSATION ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 EXELIXIS, INC. 30161Q104 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. COMPENSATION ISSUER 3530.516220 0.000000 FOR 3530.516220 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Bernd Brust DIRECTOR ELECTIONS ISSUER 1493.287650 0.000000 FOR 1493.287650 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 1493.287650 0.000000 WITHHOLD 1493.287650 AGAINST S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Luke Marker DIRECTOR ELECTIONS ISSUER 1493.287650 0.000000 WITHHOLD 1493.287650 AGAINST S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 05/26/2026 To ratify the appointment of Deloitte & Touche LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1493.287650 0.000000 FOR 1493.287650 FOR S000004450 MARAVAI LIFESCIENCES HOLDINGS, INC. 56600D107 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. COMPENSATION ISSUER 1493.287650 0.000000 AGAINST 1493.287650 AGAINST S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Robert M. Davis DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Election of Director: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 34181.808030 0.000000 FOR 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 34181.808030 0.000000 AGAINST 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 34181.808030 0.000000 AGAINST 34181.808030 FOR S000004450 MERCK & CO., INC. 58933Y105 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 34181.808030 0.000000 AGAINST 34181.808030 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBA DIRECTOR ELECTIONS ISSUER 1629.547920 0.000000 WITHHOLD 1629.547920 AGAINST S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. DIRECTOR ELECTIONS ISSUER 1629.547920 0.000000 WITHHOLD 1629.547920 AGAINST S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 05/26/2026 Election of Director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1629.547920 0.000000 WITHHOLD 1629.547920 AGAINST S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1629.547920 0.000000 FOR 1629.547920 FOR S000004450 VIR BIOTECHNOLOGY, INC. 92764N102 05/26/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1629.547920 0.000000 FOR 1629.547920 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 Election of Class I Director for term expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 Election of Class I Director for term expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 Election of Class I Director for term expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. CAPITAL STRUCTURE ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 CYTOKINETICS, INCORPORATED 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 1611.996540 0.000000 FOR 1611.996540 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: RenA(c)e GalAi DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 Election of Director to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5437.007850 0.000000 FOR 5437.007850 FOR S000004450 DEXCOM, INC. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. COMPENSATION ISSUER 5437.007850 0.000000 AGAINST 5437.007850 AGAINST S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: C. Noel Bairey Merz, MD DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Quentin Blackford DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 ABSTAIN 448.822650 AGAINST S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Bruce Bodaken DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Karen Ling DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 ABSTAIN 448.822650 AGAINST S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Karen McGinnis DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Kevin O'Boyle DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Jason Patten DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Abhijit Talwalkar DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 Elect Directors: Brian Yoor DIRECTOR ELECTIONS ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 To approve the adoption of our 2026 Equity Incentive Plan. COMPENSATION ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. CORPORATE GOVERNANCE ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 IRHYTHM HOLDINGS, INC. 450056106 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. COMPENSATION ISSUER 448.822650 0.000000 FOR 448.822650 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns DIRECTOR ELECTIONS ISSUER 855.188780 0.000000 FOR 855.188780 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Matthew Fust DIRECTOR ELECTIONS ISSUER 855.188780 0.000000 FOR 855.188780 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 Election of Class III director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: David Piacquad DIRECTOR ELECTIONS ISSUER 855.188780 0.000000 FOR 855.188780 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 855.188780 0.000000 FOR 855.188780 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 Advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 855.188780 0.000000 FOR 855.188780 FOR S000004450 NEUMORA THERAPEUTICS, INC. 640979100 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 855.188780 0.000000 1.0 855.188780 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 Elect Directors: Kevin C. Gorman, Ph.D. DIRECTOR ELECTIONS ISSUER 1381.906680 0.000000 FOR 1381.906680 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 Elect Directors: Gary A. Lyons DIRECTOR ELECTIONS ISSUER 1381.906680 0.000000 FOR 1381.906680 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 Elect Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 1381.906680 0.000000 FOR 1381.906680 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 1381.906680 0.000000 FOR 1381.906680 FOR S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares. COMPENSATION ISSUER 1381.906680 0.000000 AGAINST 1381.906680 AGAINST S000004450 NEUROCRINE BIOSCIENCES, INC. 64125C109 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1381.906680 0.000000 FOR 1381.906680 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: Lori A. Woods DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 ABSTAIN 1337.254380 AGAINST S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: Heidi Henson DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: R. F. Williamson, III DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: Frank Morich, M.D Ph.D DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 Elect Directors: Maya Martinez-Davis DIRECTOR ELECTIONS ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1337.254380 0.000000 FOR 1337.254380 FOR S000004450 PERSPECTIVE THERAPEUTICS, INC. 46489V302 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1337.254380 0.000000 1.0 1337.254380 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 Elect Directors: Mark McKenna DIRECTOR ELECTIONS ISSUER 677.490660 0.000000 FOR 677.490660 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 Elect Directors: Cameron Turtle, D.Phil. DIRECTOR ELECTIONS ISSUER 677.490660 0.000000 FOR 677.490660 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 Elect Directors: Laurie Stelzer DIRECTOR ELECTIONS ISSUER 677.490660 0.000000 FOR 677.490660 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 677.490660 0.000000 FOR 677.490660 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 677.490660 0.000000 FOR 677.490660 FOR S000004450 SPYRE THERAPEUTICS INC. 00773J202 05/27/2026 To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. CAPITAL STRUCTURE ISSUER 677.490660 0.000000 AGAINST 677.490660 AGAINST S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: James L. Bierman DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Roy Blunt DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Richard J. Mark DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Tammy Romo DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 Election of Director: Nadja Y. West DIRECTOR ELECTIONS ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. COMPENSATION ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 TENET HEALTHCARE CORPORATION 88033G407 05/27/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1216.071780 0.000000 FOR 1216.071780 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 Elect Directors: Ellen Goldberg DIRECTOR ELECTIONS ISSUER 405.591600 0.000000 ABSTAIN 405.591600 AGAINST S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 Elect Directors: Miles D. Harrison DIRECTOR ELECTIONS ISSUER 405.591600 0.000000 FOR 405.591600 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 Elect Directors: Tiffany P. Olson DIRECTOR ELECTIONS ISSUER 405.591600 0.000000 ABSTAIN 405.591600 AGAINST S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 405.591600 0.000000 FOR 405.591600 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 405.591600 0.000000 FOR 405.591600 FOR S000004450 CASTLE BIOSCIENCES INC. 14843C105 05/28/2026 To approve our non-employee director compensation policy. COMPENSATION ISSUER 405.591600 0.000000 FOR 405.591600 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 05/28/2026 Election of Class I Director: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 3308.783940 0.000000 WITHHOLD 3308.783940 AGAINST S000004450 ESPERION THERAPEUTICS, INC. 29664W105 05/28/2026 Election of Class I Director: Sheldon L. Koenig DIRECTOR ELECTIONS ISSUER 3308.783940 0.000000 WITHHOLD 3308.783940 AGAINST S000004450 ESPERION THERAPEUTICS, INC. 29664W105 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. COMPENSATION ISSUER 3308.783940 0.000000 FOR 3308.783940 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3308.783940 0.000000 FOR 3308.783940 FOR S000004450 ESPERION THERAPEUTICS, INC. 29664W105 05/28/2026 To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan. COMPENSATION ISSUER 3308.783940 0.000000 AGAINST 3308.783940 AGAINST S000004450 GLAUKOS CORPORATION 377322102 05/28/2026 Elect Directors: Denice M. Torres DIRECTOR ELECTIONS ISSUER 796.141500 0.000000 FOR 796.141500 FOR S000004450 GLAUKOS CORPORATION 377322102 05/28/2026 Elect Directors: Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 796.141500 0.000000 FOR 796.141500 FOR S000004450 GLAUKOS CORPORATION 377322102 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 796.141500 0.000000 AGAINST 796.141500 AGAINST S000004450 GLAUKOS CORPORATION 377322102 05/28/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 796.141500 0.000000 FOR 796.141500 FOR S000004450 HEALTHSTREAM, INC. 42222N103 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir DIRECTOR ELECTIONS ISSUER 325.072440 0.000000 FOR 325.072440 FOR S000004450 HEALTHSTREAM, INC. 42222N103 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Jeffrey L. McLaren DIRECTOR ELECTIONS ISSUER 325.072440 0.000000 FOR 325.072440 FOR S000004450 HEALTHSTREAM, INC. 42222N103 05/28/2026 Election of Class II Director to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick DIRECTOR ELECTIONS ISSUER 325.072440 0.000000 FOR 325.072440 FOR S000004450 HEALTHSTREAM, INC. 42222N103 05/28/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 325.072440 0.000000 FOR 325.072440 FOR S000004450 HEALTHSTREAM, INC. 42222N103 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. COMPENSATION ISSUER 325.072440 0.000000 FOR 325.072440 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable DIRECTOR ELECTIONS ISSUER 185.192700 0.000000 FOR 185.192700 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS ISSUER 185.192700 0.000000 FOR 185.192700 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 05/28/2026 Election of Class II Director for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More DIRECTOR ELECTIONS ISSUER 185.192700 0.000000 FOR 185.192700 FOR S000004450 TYRA BIOSCIENCES, INC. 90240B106 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 185.192700 0.000000 FOR 185.192700 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: James M. Daly DIRECTOR ELECTIONS ISSUER 1858.450500 0.000000 WITHHOLD 1858.450500 AGAINST S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: Edmund P. Harrigan, M.D. DIRECTOR ELECTIONS ISSUER 1858.450500 0.000000 WITHHOLD 1858.450500 AGAINST S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 Election of Class I Director to hold office until the Company's 2029 Annual Meeting of Stockholders: Adora Ndu, Pharm.D., J.D. DIRECTOR ELECTIONS ISSUER 1858.450500 0.000000 FOR 1858.450500 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 1858.450500 0.000000 FOR 1858.450500 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1858.450500 0.000000 FOR 1858.450500 FOR S000004450 ACADIA PHARMACEUTICALS INC. 004225108 05/29/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. COMPENSATION ISSUER 1858.450500 0.000000 AGAINST 1858.450500 AGAINST S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Rodney D. Windley DIRECTOR ELECTIONS ISSUER 722.340190 0.000000 FOR 722.340190 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Sam Weil DIRECTOR ELECTIONS ISSUER 722.340190 0.000000 FOR 722.340190 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Steven E. Rodgers DIRECTOR ELECTIONS ISSUER 722.340190 0.000000 FOR 722.340190 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 05/29/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. AUDIT-RELATED ISSUER 722.340190 0.000000 FOR 722.340190 FOR S000004450 AVEANNA HEALTHCARE HOLDINGS INC. 05356F105 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. COMPENSATION ISSUER 722.340190 0.000000 FOR 722.340190 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 Election of Class II Director to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025. OTHER SOCIAL ISSUES ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. COMPENSATION ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 KINIKSA PHARMACEUTICAL INTERNATIONAL PLC G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. COMPENSATION ISSUER 500.516890 0.000000 FOR 500.516890 FOR S000004450 REGENXBIO INC. 75901B107 05/29/2026 Elect Directors: Jean Bennett, M.D., PhD DIRECTOR ELECTIONS ISSUER 592.317000 0.000000 ABSTAIN 592.317000 AGAINST S000004450 REGENXBIO INC. 75901B107 05/29/2026 Elect Directors: A.N. Karabelas, Ph.D. DIRECTOR ELECTIONS ISSUER 592.317000 0.000000 ABSTAIN 592.317000 AGAINST S000004450 REGENXBIO INC. 75901B107 05/29/2026 Elect Directors: Daniel TassA(c) DIRECTOR ELECTIONS ISSUER 592.317000 0.000000 ABSTAIN 592.317000 AGAINST S000004450 REGENXBIO INC. 75901B107 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 592.317000 0.000000 FOR 592.317000 FOR S000004450 REGENXBIO INC. 75901B107 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. COMPENSATION ISSUER 592.317000 0.000000 FOR 592.317000 FOR S000004450 REGENXBIO INC. 75901B107 05/29/2026 To approve a stock option exchange for our non-executive employees. COMPENSATION ISSUER 592.317000 0.000000 AGAINST 592.317000 AGAINST S000004450 REGENXBIO INC. 75901B107 05/29/2026 To approve a stock option exchange for our executive employees. COMPENSATION ISSUER 592.317000 0.000000 AGAINST 592.317000 AGAINST S000004450 TALKSPACE, INC. 87427V103 05/29/2026 Talkspace, Inc. ("Talkspace") entered into an Agreement and Plan of Merger with Universal Health Services, Inc. ("UHS") and UHS Merger Subsidiary, Inc., an indirect wholly owned subsidiary of UHS ("Merger Sub"), under which Merger Sub will merge with and into Talkspace, with Talkspace surviving the merger as an indirect wholly owned subsidiary of UHS. CORPORATE GOVERNANCE ISSUER 2189.215240 0.000000 FOR 2189.215240 FOR S000004450 TALKSPACE, INC. 87427V103 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. COMPENSATION ISSUER 2189.215240 0.000000 AGAINST 2189.215240 AGAINST S000004450 TALKSPACE, INC. 87427V103 05/29/2026 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 2189.215240 0.000000 FOR 2189.215240 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: David Gaugh DIRECTOR ELECTIONS ISSUER 506.623860 0.000000 FOR 506.623860 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: William J. Peters DIRECTOR ELECTIONS ISSUER 506.623860 0.000000 FOR 506.623860 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 Election of Class I Director to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi DIRECTOR ELECTIONS ISSUER 506.623860 0.000000 FOR 506.623860 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 506.623860 0.000000 FOR 506.623860 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 506.623860 0.000000 FOR 506.623860 FOR S000004450 AMPHASTAR PHARMACEUTICALS INC. 03209R103 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 506.623860 0.000000 ONE YEAR 506.623860 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 06/01/2026 Elect Sean P. Nolan DIRECTOR ELECTIONS ISSUER 2063.217900 0.000000 WITHHOLD 2063.217900 AGAINST S000004450 TAYSHA GENE THERAPIES, INC. 877619106 06/01/2026 Elect Laura Sepp-Lorenzino DIRECTOR ELECTIONS ISSUER 2063.217900 0.000000 WITHHOLD 2063.217900 AGAINST S000004450 TAYSHA GENE THERAPIES, INC. 877619106 06/01/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2063.217900 0.000000 FOR 2063.217900 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 2063.217900 0.000000 FOR 2063.217900 FOR S000004450 TAYSHA GENE THERAPIES, INC. 877619106 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2063.217900 0.000000 ONE YEAR 2063.217900 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Charles Baker DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Timothy Flynn DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Paul Garcia DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Kristen Gil DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 AGAINST 12538.421280 AGAINST S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: F. William McNabb III DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Election of Director: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. COMPENSATION ISSUER 12538.421280 0.000000 AGAINST 12538.421280 AGAINST S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 12538.421280 0.000000 FOR 12538.421280 FOR S000004450 UNITEDHEALTH GROUP INCORPORATED 91324P102 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 12538.421280 0.000000 AGAINST 12538.421280 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Elect Robert A. Demichiei DIRECTOR ELECTIONS ISSUER 1593.530250 0.000000 FOR 1593.530250 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Elect John P. Driscoll DIRECTOR ELECTIONS ISSUER 1593.530250 0.000000 FOR 1593.530250 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Elect Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 1593.530250 0.000000 FOR 1593.530250 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Elect Lauren Young DIRECTOR ELECTIONS ISSUER 1593.530250 0.000000 FOR 1593.530250 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1593.530250 0.000000 FOR 1593.530250 FOR S000004450 WAYSTAR HOLDING CORP 946784105 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1593.530250 0.000000 ONE YEAR 1593.530250 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 06/02/2026 Election of Class I Director for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Alison C. Finger DIRECTOR ELECTIONS ISSUER 3598.266400 0.000000 FOR 3598.266400 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 06/02/2026 Election of Class I Director for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eduardo Rene Salas DIRECTOR ELECTIONS ISSUER 3598.266400 0.000000 FOR 3598.266400 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 06/02/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3598.266400 0.000000 FOR 3598.266400 FOR S000004450 ADMA BIOLOGICS, INC. 000899104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 3598.266400 0.000000 FOR 3598.266400 FOR S000004450 AGILON HEALTH, INC. 00857U206 06/02/2026 Election of Class II Director: Diana Mckenzie DIRECTOR ELECTIONS ISSUER 2914.195300 0.000000 FOR 2914.195300 FOR S000004450 AGILON HEALTH, INC. 00857U206 06/02/2026 Election of Class II Director: Karen McLoughlin DIRECTOR ELECTIONS ISSUER 2914.195300 0.000000 AGAINST 2914.195300 AGAINST S000004450 AGILON HEALTH, INC. 00857U206 06/02/2026 Election of Class II Director: Ronald Williams DIRECTOR ELECTIONS ISSUER 2914.195300 0.000000 AGAINST 2914.195300 AGAINST S000004450 AGILON HEALTH, INC. 00857U206 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2914.195300 0.000000 FOR 2914.195300 FOR S000004450 AGILON HEALTH, INC. 00857U206 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 2914.195300 0.000000 FOR 2914.195300 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Ian T. Clark DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Willard Dere DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Alexander Hardy DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Maykin Ho DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 Election of Director: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 2533.735090 0.000000 AGAINST 2533.735090 AGAINST S000004450 BIOMARIN PHARMACEUTICAL INC. 09061G101 06/02/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 2533.735090 0.000000 FOR 2533.735090 FOR S000004450 CERIBELL INC 15678C102 06/02/2026 Election of Director: Josef Parvizi, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 253.395270 0.000000 FOR 253.395270 FOR S000004450 CERIBELL INC 15678C102 06/02/2026 Election of Director: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 253.395270 0.000000 FOR 253.395270 FOR S000004450 CERIBELL INC 15678C102 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 253.395270 0.000000 FOR 253.395270 FOR S000004450 CERUS CORPORATION 157085101 06/02/2026 Elect William M. Greenman DIRECTOR ELECTIONS ISSUER 3026.424940 0.000000 WITHHOLD 3026.424940 AGAINST S000004450 CERUS CORPORATION 157085101 06/02/2026 Elect Ann Lucena DIRECTOR ELECTIONS ISSUER 3026.424940 0.000000 WITHHOLD 3026.424940 AGAINST S000004450 CERUS CORPORATION 157085101 06/02/2026 Equity Plan Proposal: The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 3026.424940 0.000000 AGAINST 3026.424940 AGAINST S000004450 CERUS CORPORATION 157085101 06/02/2026 Advisory Votes on Executive Compensation: The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 3026.424940 0.000000 FOR 3026.424940 FOR S000004450 CERUS CORPORATION 157085101 06/02/2026 Independent Registered Public Accounting Firm: The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3026.424940 0.000000 FOR 3026.424940 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Michael J. Barber DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: James D. Forbes DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Election of Director: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 2769.999360 0.000000 FOR 2769.999360 FOR S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. COMPENSATION ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 DENTSPLY SIRONA INC. 24906P109 06/02/2026 Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 2769.999360 0.000000 AGAINST 2769.999360 AGAINST S000004450 KODIAK SCIENCES INC. 50015M109 06/02/2026 Election of Class II Director: Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 402.282180 0.000000 FOR 402.282180 FOR S000004450 KODIAK SCIENCES INC. 50015M109 06/02/2026 Election of Class II Director: Bassil I. Dahiyat, Ph.D. DIRECTOR ELECTIONS ISSUER 402.282180 0.000000 WITHHOLD 402.282180 AGAINST S000004450 KODIAK SCIENCES INC. 50015M109 06/02/2026 Election of Class II Director: Taiyin Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 402.282180 0.000000 FOR 402.282180 FOR S000004450 KODIAK SCIENCES INC. 50015M109 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 402.282180 0.000000 FOR 402.282180 FOR S000004450 KODIAK SCIENCES INC. 50015M109 06/02/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 402.282180 0.000000 FOR 402.282180 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 06/02/2026 Election of Director: David B. Roberts DIRECTOR ELECTIONS ISSUER 298.991510 0.000000 FOR 298.991510 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 06/02/2026 Election of Director: John A. Roush DIRECTOR ELECTIONS ISSUER 298.991510 0.000000 FOR 298.991510 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. COMPENSATION ISSUER 298.991510 0.000000 FOR 298.991510 FOR S000004450 LEMAITRE VASCULAR, INC. 525558201 06/02/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 298.991510 0.000000 FOR 298.991510 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: David Bourdon DIRECTOR ELECTIONS ISSUER 2706.701800 0.000000 FOR 2706.701800 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D. DIRECTOR ELECTIONS ISSUER 2706.701800 0.000000 WITHHOLD 2706.701800 AGAINST S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2026. AUDIT-RELATED ISSUER 2706.701800 0.000000 FOR 2706.701800 FOR S000004450 LIFESTANCE HEALTH GROUP, INC 53228F101 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 2706.701800 0.000000 FOR 2706.701800 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Re-appointment of non-executive director of the Company until the annual general meeting 2030: John W. Smither DIRECTOR ELECTIONS ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Re-appointment of non-executive director of the Company until the annual general meeting 2030: Janneke van der Kamp DIRECTOR ELECTIONS ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CORPORATE GOVERNANCE ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. COMPENSATION ISSUER 808.111140 0.000000 FOR 808.111140 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 06/02/2026 Elect Lawrence Klein DIRECTOR ELECTIONS ISSUER 301.436150 0.000000 FOR 301.436150 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 06/02/2026 Elect Chris Martin DIRECTOR ELECTIONS ISSUER 301.436150 0.000000 FOR 301.436150 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 06/02/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 301.436150 0.000000 FOR 301.436150 FOR S000004450 ORUKA THERAPEUTICS, INC. 687604108 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 301.436150 0.000000 FOR 301.436150 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Elect Jessica Chutter DIRECTOR ELECTIONS ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Elect Matthew B. Klein DIRECTOR ELECTIONS ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Elect Stephanie S. Okey DIRECTOR ELECTIONS ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Elect Jerome B. Zeldis DIRECTOR ELECTIONS ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 PTC THERAPEUTICS, INC. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. COMPENSATION ISSUER 1121.822790 0.000000 FOR 1121.822790 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect Howard G. Berger DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect A. Gregory Sorensen DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 Elect David L. Swartz DIRECTOR ELECTIONS ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 RADNET, INC. 750491102 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 910.341340 0.000000 FOR 910.341340 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 06/02/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 903.813040 0.000000 FOR 903.813040 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 06/02/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Jennifer K. Moses DIRECTOR ELECTIONS ISSUER 903.813040 0.000000 FOR 903.813040 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 06/02/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 903.813040 0.000000 FOR 903.813040 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 903.813040 0.000000 FOR 903.813040 FOR S000004450 VIRIDIAN THERAPEUTICS, INC. 92790C104 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 903.813040 0.000000 ONE YEAR 903.813040 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Election of Director: Kevin Tang DIRECTOR ELECTIONS ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Election of Director: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Election of Director: Kathy Goetz DIRECTOR ELECTIONS ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Election of Director: Craig Johnson DIRECTOR ELECTIONS ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Election of Director: Tina S. Nova DIRECTOR ELECTIONS ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Appointment of Auditors: To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 AURINIA PHARMACEUTICALS INC. 05156V102 06/03/2026 Advisory Resolution on Executive Compensation: To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. COMPENSATION ISSUER 1750.725360 0.000000 FOR 1750.725360 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Evans DIRECTOR ELECTIONS ISSUER 1265.272510 0.000000 AGAINST 1265.272510 AGAINST S000004450 BEAM THERAPEUTICS INC. 07373V105 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 1265.272510 0.000000 AGAINST 1265.272510 AGAINST S000004450 BEAM THERAPEUTICS INC. 07373V105 06/03/2026 Election of Class III Director for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw DIRECTOR ELECTIONS ISSUER 1265.272510 0.000000 FOR 1265.272510 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1265.272510 0.000000 FOR 1265.272510 FOR S000004450 BEAM THERAPEUTICS INC. 07373V105 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1265.272510 0.000000 FOR 1265.272510 FOR S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect William A. Hawkins DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect John A. Bartholdson DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 FOR 555.539810 FOR S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 FOR 555.539810 FOR S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Ajay Dhankar DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 FOR 555.539810 FOR S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Mary Kay Ladone DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Guido J. Neels DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Guy P. Nohra DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Susan M. Stalnecker DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 Elect Martin P. Sutter DIRECTOR ELECTIONS ISSUER 555.539810 0.000000 WITHHOLD 555.539810 AGAINST S000004450 BIOVENTUS INC. 09075A108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 555.539810 0.000000 FOR 555.539810 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 06/03/2026 Elect Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 2156.250480 0.000000 FOR 2156.250480 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 06/03/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 2156.250480 0.000000 FOR 2156.250480 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 06/03/2026 Elect Ryan J. Watts DIRECTOR ELECTIONS ISSUER 2156.250480 0.000000 FOR 2156.250480 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2156.250480 0.000000 FOR 2156.250480 FOR S000004450 DENALI THERAPEUTICS INC. 24823R105 06/03/2026 Advisory vote on executive compensation. COMPENSATION ISSUER 2156.250480 0.000000 FOR 2156.250480 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 06/03/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 1761.892860 0.000000 FOR 1761.892860 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 06/03/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 1761.892860 0.000000 FOR 1761.892860 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 1761.892860 0.000000 FOR 1761.892860 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1761.892860 0.000000 FOR 1761.892860 FOR S000004450 GLOBUS MEDICAL, INC. 379577208 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). COMPENSATION ISSUER 1761.892860 0.000000 FOR 1761.892860 FOR S000004450 HINGE HEALTH, INC. 433313103 06/03/2026 Elect Teddie Wardi DIRECTOR ELECTIONS ISSUER 272.257370 0.000000 FOR 272.257370 FOR S000004450 HINGE HEALTH, INC. 433313103 06/03/2026 Elect Tyler Sloat DIRECTOR ELECTIONS ISSUER 272.257370 0.000000 FOR 272.257370 FOR S000004450 HINGE HEALTH, INC. 433313103 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 272.257370 0.000000 FOR 272.257370 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 06/03/2026 Election of Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 228.259000 0.000000 FOR 228.259000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 06/03/2026 Election of Class III director named below to hold office until the 2029 Annual Meeting of Stockholders: Charles Newton DIRECTOR ELECTIONS ISSUER 228.259000 0.000000 FOR 228.259000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 06/03/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 228.259000 0.000000 FOR 228.259000 FOR S000004450 KEROS THERAPEUTICS, INC. 492327101 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. COMPENSATION ISSUER 228.259000 0.000000 FOR 228.259000 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Asaf Danziger DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: William Doyle DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: David Hung DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Frank Leonard DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 FOR 1473.303040 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Martin Madden DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 FOR 1473.303040 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Allyson Ocean DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 FOR 1473.303040 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Timothy Scannell DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: Kristin Stafford DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 FOR 1473.303040 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 Election of Director: William Vernon DIRECTOR ELECTIONS ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1473.303040 0.000000 FOR 1473.303040 FOR S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 A non-binding advisory vote to approve executive compensation. COMPENSATION ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 NOVOCURE LIMITED G6674U108 06/03/2026 The approval of our amended and restated 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 1473.303040 0.000000 AGAINST 1473.303040 AGAINST S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: John D. Bertrand DIRECTOR ELECTIONS ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: Steven K. Boyd DIRECTOR ELECTIONS ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 Election of Class II Director to serve for a term expiring at the Company's Annual Meeting of Stockholders in 2029: Robert W. McMahon DIRECTOR ELECTIONS ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. CAPITAL STRUCTURE ISSUER 868.906500 0.000000 AGAINST 868.906500 AGAINST S000004450 ORASURE TECHNOLOGIES, INC. 68554V108 06/03/2026 To approve an amendment to the Company's Certificate of Incorporation to declassify the Company's Board of Directors and add certain clarifying changes. CORPORATE GOVERNANCE ISSUER 868.906500 0.000000 FOR 868.906500 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: William Ericson DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 AGAINST 3560.201460 AGAINST S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 FOR 3560.201460 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: Christian O. Henry DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 AGAINST 3560.201460 AGAINST S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: John F. Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 AGAINST 3560.201460 AGAINST S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 AGAINST 3560.201460 AGAINST S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 Election of Director: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 3560.201460 0.000000 FOR 3560.201460 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3560.201460 0.000000 FOR 3560.201460 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 3560.201460 0.000000 FOR 3560.201460 FOR S000004450 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 3560.201460 0.000000 AGAINST 3560.201460 AGAINST S000004450 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 Elect Clare Kahn DIRECTOR ELECTIONS ISSUER 554.076730 0.000000 FOR 554.076730 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 Elect Adrian R. Krainer DIRECTOR ELECTIONS ISSUER 554.076730 0.000000 FOR 554.076730 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 Elect Julie Anne Smith DIRECTOR ELECTIONS ISSUER 554.076730 0.000000 FOR 554.076730 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 554.076730 0.000000 FOR 554.076730 FOR S000004450 STOKE THERAPEUTICS, INC. 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 554.076730 0.000000 FOR 554.076730 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 06/03/2026 Election of Class I Director to serve until the 2029 Annual Meeting of Stockholders: Michael Heffernan DIRECTOR ELECTIONS ISSUER 1180.265710 0.000000 FOR 1180.265710 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1180.265710 0.000000 FOR 1180.265710 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. COMPENSATION ISSUER 1180.265710 0.000000 FOR 1180.265710 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 06/03/2026 Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan. COMPENSATION ISSUER 1180.265710 0.000000 FOR 1180.265710 FOR S000004450 TREVI THERAPEUTICS INC 89532M101 06/03/2026 Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 1180.265710 0.000000 AGAINST 1180.265710 AGAINST S000004450 10X GENOMICS, INC. 88025U109 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov DIRECTOR ELECTIONS ISSUER 1583.998150 0.000000 AGAINST 1583.998150 AGAINST S000004450 10X GENOMICS, INC. 88025U109 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 1583.998150 0.000000 AGAINST 1583.998150 AGAINST S000004450 10X GENOMICS, INC. 88025U109 06/04/2026 Election of Class I Director to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 1583.998150 0.000000 AGAINST 1583.998150 AGAINST S000004450 10X GENOMICS, INC. 88025U109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1583.998150 0.000000 FOR 1583.998150 FOR S000004450 10X GENOMICS, INC. 88025U109 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1583.998150 0.000000 FOR 1583.998150 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 06/04/2026 Election of Director: Jody Bilney DIRECTOR ELECTIONS ISSUER 2339.571410 0.000000 FOR 2339.571410 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 06/04/2026 Election of Director: David Hodgson DIRECTOR ELECTIONS ISSUER 2339.571410 0.000000 FOR 2339.571410 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 06/04/2026 Election of Director: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 2339.571410 0.000000 FOR 2339.571410 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 2339.571410 0.000000 FOR 2339.571410 FOR S000004450 ALIGNMENT HEALTHCARE INC 01625V104 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers COMPENSATION ISSUER 2339.571410 0.000000 FOR 2339.571410 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 06/04/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. DIRECTOR ELECTIONS ISSUER 1019.281010 0.000000 WITHHOLD 1019.281010 AGAINST S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 06/04/2026 Election of Class II Director to serve until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 1019.281010 0.000000 WITHHOLD 1019.281010 AGAINST S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1019.281010 0.000000 FOR 1019.281010 FOR S000004450 AMYLYX PHARMACEUTICALS, INC. 03237H101 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1019.281010 0.000000 FOR 1019.281010 FOR S000004450 CG ONCOLOGY, INC. 156944100 06/04/2026 Election of Class II to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 593.204860 0.000000 FOR 593.204860 FOR S000004450 CG ONCOLOGY, INC. 156944100 06/04/2026 Election of Class II to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 593.204860 0.000000 FOR 593.204860 FOR S000004450 CG ONCOLOGY, INC. 156944100 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 593.204860 0.000000 FOR 593.204860 FOR S000004450 CG ONCOLOGY, INC. 156944100 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. COMPENSATION ISSUER 593.204860 0.000000 FOR 593.204860 FOR S000004450 CG ONCOLOGY, INC. 156944100 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 593.204860 0.000000 ONE YEAR 593.204860 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 Election of Director: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 601.821120 0.000000 FOR 601.821120 FOR S000004450 DAVITA INC. 23918K108 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 601.821120 0.000000 AGAINST 601.821120 AGAINST S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Sastry Chilukuri DIRECTOR ELECTIONS ISSUER 590.440850 0.000000 WITHHOLD 590.440850 AGAINST S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Chris Egan DIRECTOR ELECTIONS ISSUER 590.440850 0.000000 WITHHOLD 590.440850 AGAINST S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 Election of Class II Director to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Samuel A. Hamood DIRECTOR ELECTIONS ISSUER 590.440850 0.000000 WITHHOLD 590.440850 AGAINST S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 590.440850 0.000000 FOR 590.440850 FOR S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan (the "2021 Plan"), to increase the number of shares of Class A Common Stock, par value $0.001 per share that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. COMPENSATION ISSUER 590.440850 0.000000 AGAINST 590.440850 AGAINST S000004450 DEFINITIVE HEALTHCARE CORP. 24477E103 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. COMPENSATION ISSUER 590.440850 0.000000 FOR 590.440850 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 06/04/2026 Elect Laura A. Brege DIRECTOR ELECTIONS ISSUER 822.973560 0.000000 FOR 822.973560 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 06/04/2026 Elect Badreddin Edris DIRECTOR ELECTIONS ISSUER 822.973560 0.000000 FOR 822.973560 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 06/04/2026 Elect Jonathan Root DIRECTOR ELECTIONS ISSUER 822.973560 0.000000 FOR 822.973560 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 06/04/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 822.973560 0.000000 FOR 822.973560 FOR S000004450 EDGEWISE THERAPEUTICS INC 28036F105 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 822.973560 0.000000 FOR 822.973560 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Seth Blackley DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Russell Glass DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Peter Grua DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Shawn Guertin DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Richard Jelinek DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Kim Keck DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Jill Smith DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Election of Director: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. COMPENSATION ISSUER 1460.770200 0.000000 AGAINST 1460.770200 AGAINST S000004450 EVOLENT HEALTH, INC. 30050B101 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 1460.770200 0.000000 FOR 1460.770200 FOR S000004450 GOSSAMER BIO, INC. 38341P102 06/04/2026 Election of Class II Director: Russell Cox DIRECTOR ELECTIONS ISSUER 2846.150310 0.000000 WITHHOLD 2846.150310 AGAINST S000004450 GOSSAMER BIO, INC. 38341P102 06/04/2026 Election of Class II Director: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 2846.150310 0.000000 WITHHOLD 2846.150310 AGAINST S000004450 GOSSAMER BIO, INC. 38341P102 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2846.150310 0.000000 FOR 2846.150310 FOR S000004450 GOSSAMER BIO, INC. 38341P102 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 2846.150310 0.000000 FOR 2846.150310 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 Election of Director: Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 Election of Director: Joan E. Herman DIRECTOR ELECTIONS ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 To make an advisory vote on executive compensation. COMPENSATION ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 IONIS PHARMACEUTICALS, INC. 462222100 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 2136.731110 0.000000 FOR 2136.731110 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Election of Class III Director for three-year term: Diane Parks DIRECTOR ELECTIONS ISSUER 1022.850340 0.000000 WITHHOLD 1022.850340 AGAINST S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Election of Class III Director for three-year term: Mary T. Szela DIRECTOR ELECTIONS ISSUER 1022.850340 0.000000 WITHHOLD 1022.850340 AGAINST S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Election of Class III Director for three-year term: Michael J. Vasconcelles, M.D. DIRECTOR ELECTIONS ISSUER 1022.850340 0.000000 FOR 1022.850340 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1022.850340 0.000000 FOR 1022.850340 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. COMPENSATION ISSUER 1022.850340 0.000000 FOR 1022.850340 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1022.850340 0.000000 ONE YEAR 1022.850340 FOR S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 1022.850340 0.000000 AGAINST 1022.850340 AGAINST S000004450 KURA ONCOLOGY, INC. 50127T109 06/04/2026 Approval of an amendment to our 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 1022.850340 0.000000 FOR 1022.850340 FOR S000004450 MBX BIOSCIENCES 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 345.505930 0.000000 FOR 345.505930 FOR S000004450 MBX BIOSCIENCES 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 345.505930 0.000000 FOR 345.505930 FOR S000004450 MBX BIOSCIENCES 55287L101 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 345.505930 0.000000 FOR 345.505930 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Election of Class I Director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified: Spike Loy DIRECTOR ELECTIONS ISSUER 491.407440 0.000000 FOR 491.407440 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 491.407440 0.000000 FOR 491.407440 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 491.407440 0.000000 FOR 491.407440 FOR S000004450 MOONLAKE IMMUNOTHERAPEUTICS 61559X104 06/04/2026 Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan. COMPENSATION ISSUER 491.407440 0.000000 FOR 491.407440 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1391.365900 0.000000 AGAINST 1391.365900 AGAINST S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 1391.365900 0.000000 AGAINST 1391.365900 AGAINST S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 1391.365900 0.000000 AGAINST 1391.365900 AGAINST S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1391.365900 0.000000 FOR 1391.365900 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 1391.365900 0.000000 FOR 1391.365900 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 1391.365900 0.000000 FOR 1391.365900 FOR S000004450 MYRIAD GENETICS, INC. 62855J104 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 1391.365900 0.000000 AGAINST 1391.365900 AGAINST S000004450 NEKTAR THERAPEUTICS 640268306 06/04/2026 Election of Director: Howard W. Robin DIRECTOR ELECTIONS ISSUER 335.383310 0.000000 AGAINST 335.383310 AGAINST S000004450 NEKTAR THERAPEUTICS 640268306 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 335.383310 0.000000 AGAINST 335.383310 AGAINST S000004450 NEKTAR THERAPEUTICS 640268306 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 335.383310 0.000000 FOR 335.383310 FOR S000004450 NEKTAR THERAPEUTICS 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). COMPENSATION ISSUER 335.383310 0.000000 FOR 335.383310 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD DIRECTOR ELECTIONS ISSUER 242.301790 0.000000 WITHHOLD 242.301790 AGAINST S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Kelly Fischer DIRECTOR ELECTIONS ISSUER 242.301790 0.000000 WITHHOLD 242.301790 AGAINST S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 242.301790 0.000000 WITHHOLD 242.301790 AGAINST S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Harald Ruf DIRECTOR ELECTIONS ISSUER 242.301790 0.000000 WITHHOLD 242.301790 AGAINST S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. COMPENSATION ISSUER 242.301790 0.000000 FOR 242.301790 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 To approve an amendment to the 2024 Incentive Award Plan. COMPENSATION ISSUER 242.301790 0.000000 FOR 242.301790 FOR S000004450 ORTHOPEDIATRICS CORP. 68752L100 06/04/2026 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 242.301790 0.000000 FOR 242.301790 FOR S000004450 SANA BIOTECHNOLOGY, INC. 799566104 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Hans E. Bishop DIRECTOR ELECTIONS ISSUER 2416.772030 0.000000 WITHHOLD 2416.772030 AGAINST S000004450 SANA BIOTECHNOLOGY, INC. 799566104 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Robert Nelsen DIRECTOR ELECTIONS ISSUER 2416.772030 0.000000 WITHHOLD 2416.772030 AGAINST S000004450 SANA BIOTECHNOLOGY, INC. 799566104 06/04/2026 Election of Class II Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Alise S. Reicin, M.D. DIRECTOR ELECTIONS ISSUER 2416.772030 0.000000 WITHHOLD 2416.772030 AGAINST S000004450 SANA BIOTECHNOLOGY, INC. 799566104 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2416.772030 0.000000 FOR 2416.772030 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 1503.405200 0.000000 AGAINST 1503.405200 AGAINST S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1503.405200 0.000000 AGAINST 1503.405200 AGAINST S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 1503.405200 0.000000 AGAINST 1503.405200 AGAINST S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Michael Chambers DIRECTOR ELECTIONS ISSUER 1503.405200 0.000000 AGAINST 1503.405200 AGAINST S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Election of Class I Director to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 1503.405200 0.000000 FOR 1503.405200 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation COMPENSATION ISSUER 1503.405200 0.000000 FOR 1503.405200 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 1503.405200 0.000000 AGAINST 1503.405200 AGAINST S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 1503.405200 0.000000 FOR 1503.405200 FOR S000004450 SAREPTA THERAPEUTICS, INC. 803607100 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 1503.405200 0.000000 FOR 1503.405200 FOR S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 Election of Director to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000. CAPITAL STRUCTURE ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000. COMPENSATION ISSUER 958.410000 0.000000 AGAINST 958.410000 AGAINST S000004450 SAVARA INC. 805111101 06/04/2026 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 958.410000 0.000000 FOR 958.410000 FOR S000004450 SAVARA INC. 805111101 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. COMPENSATION ISSUER 958.410000 0.000000 FOR 958.410000 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 Elect David Hallal DIRECTOR ELECTIONS ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 Elect Kristina M. Burow DIRECTOR ELECTIONS ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 Elect Michael Gilman DIRECTOR ELECTIONS ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 Elect Katie Peng DIRECTOR ELECTIONS ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SCHOLAR ROCK HOLDING CORPORATION 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 971.313750 0.000000 FOR 971.313750 FOR S000004450 SI-BONE, INC. 825704109 06/04/2026 Election of Director: Jeffrey W. Dunn DIRECTOR ELECTIONS ISSUER 567.661150 0.000000 WITHHOLD 567.661150 AGAINST S000004450 SI-BONE, INC. 825704109 06/04/2026 Election of Director: John G. Freund, M.D. DIRECTOR ELECTIONS ISSUER 567.661150 0.000000 WITHHOLD 567.661150 AGAINST S000004450 SI-BONE, INC. 825704109 06/04/2026 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 567.661150 0.000000 FOR 567.661150 FOR S000004450 SI-BONE, INC. 825704109 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". COMPENSATION ISSUER 567.661150 0.000000 FOR 567.661150 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 06/04/2026 Election of Class II Director: Malte Peters, M.D. DIRECTOR ELECTIONS ISSUER 622.975760 0.000000 WITHHOLD 622.975760 AGAINST S000004450 TANGO THERAPEUTICS, INC. 87583X109 06/04/2026 Election of Class II Director: Kanishka Pothula DIRECTOR ELECTIONS ISSUER 622.975760 0.000000 FOR 622.975760 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 06/04/2026 Election of Class II Director: Mace Rothenberg, M.D. DIRECTOR ELECTIONS ISSUER 622.975760 0.000000 WITHHOLD 622.975760 AGAINST S000004450 TANGO THERAPEUTICS, INC. 87583X109 06/04/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 622.975760 0.000000 FOR 622.975760 FOR S000004450 TANGO THERAPEUTICS, INC. 87583X109 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 622.975760 0.000000 FOR 622.975760 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Marc Kozin DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Joseph John Hassett DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 Elect Symeria Hudson DIRECTOR ELECTIONS ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. COMPENSATION ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 UFP TECHNOLOGIES, INC. 902673102 06/04/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 113.838230 0.000000 FOR 113.838230 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 Election of Class II Director: Richard W. Dugan DIRECTOR ELECTIONS ISSUER 874.545390 0.000000 AGAINST 874.545390 AGAINST S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 Election of Class II Director: Charles C. Duncan DIRECTOR ELECTIONS ISSUER 874.545390 0.000000 FOR 874.545390 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 Election of Class II Director: Anne Sempowski Ward DIRECTOR ELECTIONS ISSUER 874.545390 0.000000 AGAINST 874.545390 AGAINST S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 874.545390 0.000000 FOR 874.545390 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. COMPENSATION ISSUER 874.545390 0.000000 FOR 874.545390 FOR S000004450 VANDA PHARMACEUTICALS INC. 921659108 06/04/2026 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to increase the aggregate number of shares authorized for issuance thereunder. COMPENSATION ISSUER 874.545390 0.000000 AGAINST 874.545390 AGAINST S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 06/04/2026 Election of Class II Director to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 2594.272140 0.000000 FOR 2594.272140 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 06/04/2026 Election of Class II Director to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 2594.272140 0.000000 FOR 2594.272140 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2594.272140 0.000000 FOR 2594.272140 FOR S000004450 XERIS BIOPHARMA HOLDINGS, INC. 98422E103 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 2594.272140 0.000000 FOR 2594.272140 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 06/05/2026 Election of Class I Director for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD DIRECTOR ELECTIONS ISSUER 1583.663720 0.000000 WITHHOLD 1583.663720 AGAINST S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 06/05/2026 Election of Class I Director for a three-year term expiring at the 2029 annual meeting of shareholders: Katey Owen, PhD DIRECTOR ELECTIONS ISSUER 1583.663720 0.000000 WITHHOLD 1583.663720 AGAINST S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. COMPENSATION ISSUER 1583.663720 0.000000 FOR 1583.663720 FOR S000004450 ADAPTIVE BIOTECHNOLOGIES CORPORATION 00650F109 06/05/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1583.663720 0.000000 FOR 1583.663720 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Peter C. Farrell DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Joseph E. Payne DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect James Barlow DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Edward W. Holmes DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 FOR 415.391940 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Magda Marquet DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Jing L. Marantz DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect John H. Markels DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 WITHHOLD 415.391940 AGAINST S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Elect Moncef Slaoui DIRECTOR ELECTIONS ISSUER 415.391940 0.000000 FOR 415.391940 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. COMPENSATION ISSUER 415.391940 0.000000 FOR 415.391940 FOR S000004450 ARCTURUS THERAPEUTICS, HOLDINGS INC. 03969T109 06/05/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 415.391940 0.000000 FOR 415.391940 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 1665.338500 0.000000 FOR 1665.338500 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha Krishnamohan DIRECTOR ELECTIONS ISSUER 1665.338500 0.000000 FOR 1665.338500 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 06/05/2026 Election of Class III director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin Watanabe DIRECTOR ELECTIONS ISSUER 1665.338500 0.000000 FOR 1665.338500 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 06/05/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1665.338500 0.000000 FOR 1665.338500 FOR S000004450 ARCUTIS BIOTHERAPEUTICS, INC. 03969K108 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1665.338500 0.000000 FOR 1665.338500 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 06/05/2026 Elect Mark E. Saad DIRECTOR ELECTIONS ISSUER 548.481060 0.000000 FOR 548.481060 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 06/05/2026 Elect Susan Mahony DIRECTOR ELECTIONS ISSUER 548.481060 0.000000 FOR 548.481060 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 548.481060 0.000000 FOR 548.481060 FOR S000004450 AXSOME THERAPEUTICS, INC. 05464T104 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. COMPENSATION ISSUER 548.481060 0.000000 FOR 548.481060 FOR S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Linda Baddour DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 WITHHOLD 659.372190 AGAINST S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Daniel M. Hancock DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 WITHHOLD 659.372190 AGAINST S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Robert J. Hariri DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 FOR 659.372190 FOR S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 WITHHOLD 659.372190 AGAINST S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Ramkumar Mandalam DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 FOR 659.372190 FOR S000004450 CRYOPORT, INC. 229050307 06/05/2026 Elect Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 659.372190 0.000000 WITHHOLD 659.372190 AGAINST S000004450 CRYOPORT, INC. 229050307 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026. AUDIT-RELATED ISSUER 659.372190 0.000000 FOR 659.372190 FOR S000004450 CRYOPORT, INC. 229050307 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 659.372190 0.000000 FOR 659.372190 FOR S000004450 CRYOPORT, INC. 229050307 06/05/2026 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000. COMPENSATION ISSUER 659.372190 0.000000 AGAINST 659.372190 AGAINST S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian Posner DIRECTOR ELECTIONS ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 Election of Class III director, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes DIRECTOR ELECTIONS ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. COMPENSATION ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 DYNE THERAPEUTICS, INC. 26818M108 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1597.030530 0.000000 FOR 1597.030530 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Todd C. Davis DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Nancy Ryan Gray DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Jason Haas DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect John W. Kozarich DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect John L. LaMattina DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Stephen L. Sabba DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Elect Martine Zimmermann DIRECTOR ELECTIONS ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers COMPENSATION ISSUER 309.180600 0.000000 FOR 309.180600 FOR S000004450 LIGAND PHARMACEUTICALS INCORPORATED 53220K504 06/05/2026 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 309.180600 0.000000 AGAINST 309.180600 AGAINST S000004450 PRIME MEDICINE, INC. 74168J101 06/05/2026 Elect Michael A. Kelly DIRECTOR ELECTIONS ISSUER 1394.603520 0.000000 WITHHOLD 1394.603520 AGAINST S000004450 PRIME MEDICINE, INC. 74168J101 06/05/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 1394.603520 0.000000 WITHHOLD 1394.603520 AGAINST S000004450 PRIME MEDICINE, INC. 74168J101 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1394.603520 0.000000 FOR 1394.603520 FOR S000004450 SURGERY PARTNERS INC. 86881A100 06/05/2026 Election of Class II Director: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 1166.287400 0.000000 WITHHOLD 1166.287400 AGAINST S000004450 SURGERY PARTNERS INC. 86881A100 06/05/2026 Election of Class II Director: Brent Turner DIRECTOR ELECTIONS ISSUER 1166.287400 0.000000 WITHHOLD 1166.287400 AGAINST S000004450 SURGERY PARTNERS INC. 86881A100 06/05/2026 Election of Class II Director: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 1166.287400 0.000000 FOR 1166.287400 FOR S000004450 SURGERY PARTNERS INC. 86881A100 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. COMPENSATION ISSUER 1166.287400 0.000000 FOR 1166.287400 FOR S000004450 SURGERY PARTNERS INC. 86881A100 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1166.287400 0.000000 FOR 1166.287400 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 AGAINST 2618.727840 AGAINST S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Election of Director to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Meury DIRECTOR ELECTIONS ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 INCYTE CORPORATION 45337C102 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2618.727840 0.000000 FOR 2618.727840 FOR S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 06/09/2026 Election of Class III Director: Todd C. Brady, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 811.251450 0.000000 WITHHOLD 811.251450 AGAINST S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 06/09/2026 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 811.251450 0.000000 FOR 811.251450 FOR S000004450 ALDEYRA THERAPEUTICS, INC. 01438T106 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. COMPENSATION ISSUER 811.251450 0.000000 FOR 811.251450 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 06/09/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 599.749150 0.000000 FOR 599.749150 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 06/09/2026 Elect Jennifer Fox DIRECTOR ELECTIONS ISSUER 599.749150 0.000000 FOR 599.749150 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 06/09/2026 Elect William Jones, Jr. DIRECTOR ELECTIONS ISSUER 599.749150 0.000000 FOR 599.749150 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 599.749150 0.000000 FOR 599.749150 FOR S000004450 APOGEE THERAPEUTICS, INC. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 599.749150 0.000000 FOR 599.749150 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 06/09/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D. DIRECTOR ELECTIONS ISSUER 433.680400 0.000000 FOR 433.680400 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 06/09/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D. DIRECTOR ELECTIONS ISSUER 433.680400 0.000000 FOR 433.680400 FOR S000004450 BICARA THERAPEUTICS INC. 055477103 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 433.680400 0.000000 FOR 433.680400 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 AGAINST 2305.054510 AGAINST S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 AGAINST 2305.054510 AGAINST S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 AGAINST 2305.054510 AGAINST S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Election of Director to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 2305.054510 0.000000 AGAINST 2305.054510 AGAINST S000004450 BIOGEN INC. 09062X103 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 BIOGEN INC. 09062X103 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. COMPENSATION ISSUER 2305.054510 0.000000 FOR 2305.054510 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Elect Chris Cain DIRECTOR ELECTIONS ISSUER 1316.479910 0.000000 FOR 1316.479910 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Elect Arlene M. Morris DIRECTOR ELECTIONS ISSUER 1316.479910 0.000000 FOR 1316.479910 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Elect Todd Shegog DIRECTOR ELECTIONS ISSUER 1316.479910 0.000000 FOR 1316.479910 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1316.479910 0.000000 FOR 1316.479910 FOR S000004450 COGENT BIOSCIENCES, INC. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 1316.479910 0.000000 FOR 1316.479910 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 Election of Class III Director named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Richard Fair, M.B.A. DIRECTOR ELECTIONS ISSUER 507.011560 0.000000 FOR 507.011560 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 Election of Class III Director named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D. DIRECTOR ELECTIONS ISSUER 507.011560 0.000000 FOR 507.011560 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 507.011560 0.000000 FOR 507.011560 FOR S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 507.011560 0.000000 AGAINST 507.011560 AGAINST S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. COMPENSATION ISSUER 507.011560 0.000000 AGAINST 507.011560 AGAINST S000004450 ENLIVEN THERAPEUTICS, INC. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 507.011560 0.000000 ONE YEAR 507.011560 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 06/09/2026 Election of Director: Anshul Thakral DIRECTOR ELECTIONS ISSUER 1445.858360 0.000000 FOR 1445.858360 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 06/09/2026 Election of Director: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 1445.858360 0.000000 FOR 1445.858360 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 06/09/2026 Election of Director: William J. Sharbaugh DIRECTOR ELECTIONS ISSUER 1445.858360 0.000000 FOR 1445.858360 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1445.858360 0.000000 FOR 1445.858360 FOR S000004450 FORTREA HOLDINGS INC. 34965K107 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. COMPENSATION ISSUER 1445.858360 0.000000 AGAINST 1445.858360 AGAINST S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Elect John P. Bamforth DIRECTOR ELECTIONS ISSUER 199.560960 0.000000 WITHHOLD 199.560960 AGAINST S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Elect Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 199.560960 0.000000 FOR 199.560960 FOR S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Elect Kathleen G. Sebelius DIRECTOR ELECTIONS ISSUER 199.560960 0.000000 WITHHOLD 199.560960 AGAINST S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. COMPENSATION ISSUER 199.560960 0.000000 FOR 199.560960 FOR S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 199.560960 0.000000 ONE YEAR 199.560960 FOR S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 199.560960 0.000000 FOR 199.560960 FOR S000004450 HUMACYTE, INC. 44486Q103 06/09/2026 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 350,000,000 shares to 550,000,000 shares. CAPITAL STRUCTURE ISSUER 199.560960 0.000000 FOR 199.560960 FOR S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 FOR 1731.428110 FOR S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Richard Adcock DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Wesley Clark DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Christobel Selecky DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 WITHHOLD 1731.428110 AGAINST S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 Election of Director: Bruce Wendel DIRECTOR ELECTIONS ISSUER 1731.428110 0.000000 FOR 1731.428110 FOR S000004450 IMMUNITYBIO, INC. 45256X103 06/09/2026 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1731.428110 0.000000 FOR 1731.428110 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James Boylan DIRECTOR ELECTIONS ISSUER 1476.127260 0.000000 FOR 1476.127260 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 1476.127260 0.000000 FOR 1476.127260 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: Philip Wagenheim DIRECTOR ELECTIONS ISSUER 1476.127260 0.000000 FOR 1476.127260 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1476.127260 0.000000 FOR 1476.127260 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1476.127260 0.000000 FOR 1476.127260 FOR S000004450 IMMUNOME INC. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1476.127260 0.000000 ONE YEAR 1476.127260 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 1701.509040 0.000000 AGAINST 1701.509040 AGAINST S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Brian Goff DIRECTOR ELECTIONS ISSUER 1701.509040 0.000000 FOR 1701.509040 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 06/09/2026 Election of class I Director to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 1701.509040 0.000000 AGAINST 1701.509040 AGAINST S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1701.509040 0.000000 FOR 1701.509040 FOR S000004450 INTELLIA THERAPEUTICS, INC. 45826J105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 1701.509040 0.000000 FOR 1701.509040 FOR S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Robert Essner DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Deborah Leone DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 FOR 4065.675300 FOR S000004450 ORGANON & CO. 68622V106 06/09/2026 Election of Director: Shalini Sharp DIRECTOR ELECTIONS ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. COMPENSATION ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 ORGANON & CO. 68622V106 06/09/2026 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 4065.675300 0.000000 AGAINST 4065.675300 AGAINST S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Company Nominee: Christopher J. Christie CORPORATE GOVERNANCE ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Company Nominee: Samit Hirawat CORPORATE GOVERNANCE ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Company Nominee: Thomas Wiggans CORPORATE GOVERNANCE ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 DOMA Nominees Opposed by the Company: Oliver Benton Curtis III DIRECTOR ELECTIONS ISSUER 659.164660 0.000000 WITHHOLD 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 DOMA Nominees Opposed by the Company: Eric de Armas DIRECTOR ELECTIONS ISSUER 659.164660 0.000000 WITHHOLD 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 DOMA Nominees Opposed by the Company: Christopher Dennis DIRECTOR ELECTIONS ISSUER 659.164660 0.000000 WITHHOLD 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 659.164660 0.000000 AGAINST 659.164660 AGAINST S000004450 PACIRA BIOSCIENCES, INC. 695127100 06/09/2026 Approval of our Amended and Restated 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 659.164660 0.000000 FOR 659.164660 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai DIRECTOR ELECTIONS ISSUER 865.628610 0.000000 FOR 865.628610 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett DIRECTOR ELECTIONS ISSUER 865.628610 0.000000 FOR 865.628610 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 06/09/2026 Election of Class II Director to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 865.628610 0.000000 FOR 865.628610 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 865.628610 0.000000 FOR 865.628610 FOR S000004450 PROCEPT BIOROBOTICS CORPORATION 74276L105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 865.628610 0.000000 AGAINST 865.628610 AGAINST S000004450 QUANTERIX CORPORATION 74766Q101 06/09/2026 Election of Director: William P. Donnelly DIRECTOR ELECTIONS ISSUER 653.606640 0.000000 FOR 653.606640 FOR S000004450 QUANTERIX CORPORATION 74766Q101 06/09/2026 Election of Director: Ivana Magovcevic-Liebisch, Ph.D., J.D DIRECTOR ELECTIONS ISSUER 653.606640 0.000000 FOR 653.606640 FOR S000004450 QUANTERIX CORPORATION 74766Q101 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers COMPENSATION ISSUER 653.606640 0.000000 FOR 653.606640 FOR S000004450 QUANTERIX CORPORATION 74766Q101 06/09/2026 To ratify, on an advisory basis, the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 653.606640 0.000000 FOR 653.606640 FOR S000004450 QUANTERIX CORPORATION 74766Q101 06/09/2026 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan COMPENSATION ISSUER 653.606640 0.000000 AGAINST 653.606640 AGAINST S000004450 RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 Election of class III Director to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 1686.313860 0.000000 WITHHOLD 1686.313860 AGAINST S000004450 RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 Election of class III Director to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 1686.313860 0.000000 FOR 1686.313860 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers. COMPENSATION ISSUER 1686.313860 0.000000 FOR 1686.313860 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1686.313860 0.000000 FOR 1686.313860 FOR S000004450 RELAY THERAPEUTICS, INC. 75943R102 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000. CAPITAL STRUCTURE ISSUER 1686.313860 0.000000 FOR 1686.313860 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Harold Ford, Jr. DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect John M. Keane DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 WITHHOLD 676.320520 AGAINST S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Gary J. Nabel DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Diem Nguyen DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 Elect Holly L. Phillips DIRECTOR ELECTIONS ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. COMPENSATION ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 SIGA TECHNOLOGIES, INC. 826917106 06/09/2026 To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. COMPENSATION ISSUER 676.320520 0.000000 FOR 676.320520 FOR S000004450 UPSTREAM BIO, INC. 91678A107 06/09/2026 Elect H. Edward Fleming, Jr. DIRECTOR ELECTIONS ISSUER 380.299450 0.000000 FOR 380.299450 FOR S000004450 UPSTREAM BIO, INC. 91678A107 06/09/2026 Elect Liam Ratcliffe DIRECTOR ELECTIONS ISSUER 380.299450 0.000000 FOR 380.299450 FOR S000004450 UPSTREAM BIO, INC. 91678A107 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 380.299450 0.000000 FOR 380.299450 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 06/10/2026 Elect Michael Earley DIRECTOR ELECTIONS ISSUER 301.435840 0.000000 FOR 301.435840 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 06/10/2026 Elect Veronica Hill-Milbourne DIRECTOR ELECTIONS ISSUER 301.435840 0.000000 FOR 301.435840 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 301.435840 0.000000 FOR 301.435840 FOR S000004450 ADDUS HOMECARE CORPORATION 006739106 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. COMPENSATION ISSUER 301.435840 0.000000 AGAINST 301.435840 AGAINST S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 WITHHOLD 1872.333330 AGAINST S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: Quentin Blackford DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: David Demski DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 Election of Director: Keith Valentine DIRECTOR ELECTIONS ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 1872.333330 0.000000 AGAINST 1872.333330 AGAINST S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALPHATEC HOLDINGS, INC. 02081G201 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 1872.333330 0.000000 FOR 1872.333330 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 06/10/2026 Elect Daniel Curran DIRECTOR ELECTIONS ISSUER 509.960010 0.000000 FOR 509.960010 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 06/10/2026 Elect Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 509.960010 0.000000 WITHHOLD 509.960010 AGAINST S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 06/10/2026 Elect Chris Takimoto DIRECTOR ELECTIONS ISSUER 509.960010 0.000000 FOR 509.960010 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 06/10/2026 Advisory vote to approve named executive officer compensation. COMPENSATION ISSUER 509.960010 0.000000 FOR 509.960010 FOR S000004450 ALX ONCOLOGY HOLDINGS INC. 00166B105 06/10/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 509.960010 0.000000 FOR 509.960010 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Kenneth Sim DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Thomas S. Lam DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect John Chiang DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Weili Dai DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Linda Dong DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect J. Lorraine Estradas DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 Elect David G. Schmidt DIRECTOR ELECTIONS ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. COMPENSATION ISSUER 703.577700 0.000000 AGAINST 703.577700 AGAINST S000004450 ASTRANA HEALTH, INC. 03763A207 06/10/2026 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 703.577700 0.000000 FOR 703.577700 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 06/10/2026 Elect Demetrios L. Kouzoukas DIRECTOR ELECTIONS ISSUER 6664.564270 0.000000 WITHHOLD 6664.564270 AGAINST S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 06/10/2026 Elect Andrew Toy DIRECTOR ELECTIONS ISSUER 6664.564270 0.000000 WITHHOLD 6664.564270 AGAINST S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 06/10/2026 Elect Thomas L. Tran DIRECTOR ELECTIONS ISSUER 6664.564270 0.000000 FOR 6664.564270 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. COMPENSATION ISSUER 6664.564270 0.000000 FOR 6664.564270 FOR S000004450 CLOVER HEALTH INVESTMENTS, CORP. 18914F103 06/10/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 6664.564270 0.000000 FOR 6664.564270 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 06/10/2026 Elect Vera Imper DIRECTOR ELECTIONS ISSUER 1700.513580 0.000000 WITHHOLD 1700.513580 AGAINST S000004450 CYTEK BIOSCIENCES, INC. 23285D109 06/10/2026 Elect Glenn P. Muir DIRECTOR ELECTIONS ISSUER 1700.513580 0.000000 FOR 1700.513580 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 06/10/2026 Elect Ming Yan DIRECTOR ELECTIONS ISSUER 1700.513580 0.000000 WITHHOLD 1700.513580 AGAINST S000004450 CYTEK BIOSCIENCES, INC. 23285D109 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. COMPENSATION ISSUER 1700.513580 0.000000 FOR 1700.513580 FOR S000004450 CYTEK BIOSCIENCES, INC. 23285D109 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1700.513580 0.000000 FOR 1700.513580 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 06/10/2026 Election of Director: Peter S. Kim, Ph.D. DIRECTOR ELECTIONS ISSUER 299.699920 0.000000 WITHHOLD 299.699920 AGAINST S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 06/10/2026 Election of Director: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 299.699920 0.000000 FOR 299.699920 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 299.699920 0.000000 FOR 299.699920 FOR S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. COMPENSATION ISSUER 299.699920 0.000000 AGAINST 299.699920 AGAINST S000004450 ENTRADA THERAPEUTICS, INC. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. COMPENSATION ISSUER 299.699920 0.000000 AGAINST 299.699920 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Iain D. Dukes DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 WITHHOLD 4802.265400 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Athena Countouriotis DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 WITHHOLD 4802.265400 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Ryan Maynard DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 WITHHOLD 4802.265400 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 WITHHOLD 4802.265400 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Frederick G. Vogt DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 Elect Michael Weiser DIRECTOR ELECTIONS ISSUER 4802.265400 0.000000 WITHHOLD 4802.265400 AGAINST S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. COMPENSATION ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4802.265400 0.000000 ONE YEAR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares. COMPENSATION ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares. CAPITAL STRUCTURE ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 IOVANCE BIOTHERAPEUTICS, INC. 462260100 06/10/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. CORPORATE GOVERNANCE ISSUER 4802.265400 0.000000 FOR 4802.265400 FOR S000004450 KORRO BIO, INC. 500946108 06/10/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham DIRECTOR ELECTIONS ISSUER 114.244120 0.000000 FOR 114.244120 FOR S000004450 KORRO BIO, INC. 500946108 06/10/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers DIRECTOR ELECTIONS ISSUER 114.244120 0.000000 FOR 114.244120 FOR S000004450 KORRO BIO, INC. 500946108 06/10/2026 Non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 114.244120 0.000000 FOR 114.244120 FOR S000004450 KORRO BIO, INC. 500946108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 114.244120 0.000000 FOR 114.244120 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: J. Christopher Barry DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Francesco Bianchi DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: William Kozy DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Jette Nygaard-Andersen DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Susan Podlogar DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Brooke Story DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Peter Wilver DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 AGAINST 857.929200 AGAINST S000004450 LIVANOVA PLC G5509L101 06/10/2026 Election of Director: Donald Zurbay DIRECTOR ELECTIONS ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). COMPENSATION ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Special Resolution: Subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of this proxy statement (the "Share Repurchase Contracts") and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in this proxy statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the share ... (due to space limits, see proxy material for full proposal). CAPITAL STRUCTURE ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the year ended December 31, 2025. COMPENSATION ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2025, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2026. AUDIT-RELATED ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LIVANOVA PLC G5509L101 06/10/2026 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 857.929200 0.000000 FOR 857.929200 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Election of Class II Director: Richard Klausner, M.D. DIRECTOR ELECTIONS ISSUER 120.138300 0.000000 WITHHOLD 120.138300 AGAINST S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Election of Class II Director: Otis Brawley, M.D. DIRECTOR ELECTIONS ISSUER 120.138300 0.000000 WITHHOLD 120.138300 AGAINST S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Election of Class II Director: William Rieflin DIRECTOR ELECTIONS ISSUER 120.138300 0.000000 WITHHOLD 120.138300 AGAINST S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 120.138300 0.000000 FOR 120.138300 FOR S000004450 LYELL IMMUNOPHARMA, INC. 55083R203 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers. COMPENSATION ISSUER 120.138300 0.000000 FOR 120.138300 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: James L. Bierman DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 AGAINST 1861.362230 AGAINST S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: K. Todd Newton DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: Tiffany Olson DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Election of Director: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 1861.362230 0.000000 AGAINST 1861.362230 AGAINST S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Advisory approval of executive compensation. COMPENSATION ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 MIMEDX GROUP, INC. 602496101 06/10/2026 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1861.362230 0.000000 FOR 1861.362230 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 Elect Pravin U. Dugel DIRECTOR ELECTIONS ISSUER 2516.885200 0.000000 FOR 2516.885200 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 Elect Merilee Raines DIRECTOR ELECTIONS ISSUER 2516.885200 0.000000 WITHHOLD 2516.885200 AGAINST S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 To approve an advisory vote on named executive officer compensation. COMPENSATION ISSUER 2516.885200 0.000000 FOR 2516.885200 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2516.885200 0.000000 ONE YEAR 2516.885200 FOR S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. COMPENSATION ISSUER 2516.885200 0.000000 AGAINST 2516.885200 AGAINST S000004450 OCULAR THERAPEUTIX, INC. 67576A100 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2516.885200 0.000000 FOR 2516.885200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Wayne Burris DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 AGAINST 493.398200 AGAINST S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 AGAINST 493.398200 AGAINST S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Election of Director: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 493.398200 0.000000 AGAINST 493.398200 AGAINST S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. COMPENSATION ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 ORTHOFIX MEDICAL INC. 68752M108 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. COMPENSATION ISSUER 493.398200 0.000000 FOR 493.398200 FOR S000004450 PACS GROUP, INC. 69380Q107 06/10/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 733.250190 0.000000 FOR 733.250190 FOR S000004450 PACS GROUP, INC. 69380Q107 06/10/2026 Elect Mark Hancock DIRECTOR ELECTIONS ISSUER 733.250190 0.000000 FOR 733.250190 FOR S000004450 PACS GROUP, INC. 69380Q107 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 733.250190 0.000000 FOR 733.250190 FOR S000004450 PACS GROUP, INC. 69380Q107 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. COMPENSATION ISSUER 733.250190 0.000000 FOR 733.250190 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Election of Class III Director to serve will expire in 2029: George M. Jenkins DIRECTOR ELECTIONS ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Election of Class III Director to serve will expire in 2029: Todd C. Davis DIRECTOR ELECTIONS ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Election of Class III Director to serve will expire in 2029: John Doux, M.D. DIRECTOR ELECTIONS ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153.035030 0.000000 ONE YEAR 153.035030 FOR S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. COMPENSATION ISSUER 153.035030 0.000000 AGAINST 153.035030 AGAINST S000004450 PALVELLA THERAPEUTICS, INC 697947109 06/10/2026 Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 153.035030 0.000000 FOR 153.035030 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 370.508890 0.000000 WITHHOLD 370.508890 AGAINST S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 370.508890 0.000000 WITHHOLD 370.508890 AGAINST S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 370.508890 0.000000 WITHHOLD 370.508890 AGAINST S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 370.508890 0.000000 FOR 370.508890 FOR S000004450 PRAXIS PRECISION MEDICINES, INC. 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. COMPENSATION ISSUER 370.508890 0.000000 FOR 370.508890 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 06/10/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 447.197400 0.000000 FOR 447.197400 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 06/10/2026 Elect Robert J. Perez DIRECTOR ELECTIONS ISSUER 447.197400 0.000000 FOR 447.197400 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 06/10/2026 Elect Raymond Sanchez DIRECTOR ELECTIONS ISSUER 447.197400 0.000000 FOR 447.197400 FOR S000004450 RAPPORT THERAPEUTICS, INC. 75383L102 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 447.197400 0.000000 FOR 447.197400 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Robert W. Duggan DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Robert T. Booth DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Alessandra Cesano DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Yu Xia DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Elect Jeffrey T. Huber DIRECTOR ELECTIONS ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. COMPENSATION ISSUER 886.392930 0.000000 FOR 886.392930 FOR S000004450 SUMMIT THERAPEUTICS INC. 86627T108 06/10/2026 Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. COMPENSATION ISSUER 886.392930 0.000000 AGAINST 886.392930 AGAINST S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 Election of Director: Pierre Legault DIRECTOR ELECTIONS ISSUER 1286.977480 0.000000 FOR 1286.977480 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 Election of Director: Michael A. Metzger DIRECTOR ELECTIONS ISSUER 1286.977480 0.000000 FOR 1286.977480 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. COMPENSATION ISSUER 1286.977480 0.000000 FOR 1286.977480 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1286.977480 0.000000 FOR 1286.977480 FOR S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 1286.977480 0.000000 AGAINST 1286.977480 AGAINST S000004450 SYNDAX PHARMACEUTICALS, INC 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 1286.977480 0.000000 FOR 1286.977480 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 AGAINST 1241.371070 AGAINST S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley DIRECTOR ELECTIONS ISSUER 1241.371070 0.000000 AGAINST 1241.371070 AGAINST S000004450 VERACYTE, INC. 92337F107 06/10/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. COMPENSATION ISSUER 1241.371070 0.000000 FOR 1241.371070 FOR S000004450 VERACYTE, INC. 92337F107 06/10/2026 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 1241.371070 0.000000 AGAINST 1241.371070 AGAINST S000004450 ANNEXON, INC. 03589W102 06/11/2026 Elect Bettina M. Cockroft DIRECTOR ELECTIONS ISSUER 1866.210440 0.000000 WITHHOLD 1866.210440 AGAINST S000004450 ANNEXON, INC. 03589W102 06/11/2026 Elect Douglas E. Love DIRECTOR ELECTIONS ISSUER 1866.210440 0.000000 WITHHOLD 1866.210440 AGAINST S000004450 ANNEXON, INC. 03589W102 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1866.210440 0.000000 FOR 1866.210440 FOR S000004450 ANNEXON, INC. 03589W102 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 1866.210440 0.000000 FOR 1866.210440 FOR S000004450 ANNEXON, INC. 03589W102 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 1866.210440 0.000000 FOR 1866.210440 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 Election of Director: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1354.083660 0.000000 WITHHOLD 1354.083660 AGAINST S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 Election of Director: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 1354.083660 0.000000 FOR 1354.083660 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 Election of Director: Nicole Lambert DIRECTOR ELECTIONS ISSUER 1354.083660 0.000000 FOR 1354.083660 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 Election of Director: Johanna Mercier DIRECTOR ELECTIONS ISSUER 1354.083660 0.000000 WITHHOLD 1354.083660 AGAINST S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1354.083660 0.000000 FOR 1354.083660 FOR S000004450 ARCUS BIOSCIENCES, INC. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 1354.083660 0.000000 FOR 1354.083660 FOR S000004450 AURA BIOSCIENCES, INC. 05153U107 06/11/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 717.938000 0.000000 WITHHOLD 717.938000 AGAINST S000004450 AURA BIOSCIENCES, INC. 05153U107 06/11/2026 Elect Teresa Marie Bitetti DIRECTOR ELECTIONS ISSUER 717.938000 0.000000 FOR 717.938000 FOR S000004450 AURA BIOSCIENCES, INC. 05153U107 06/11/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 717.938000 0.000000 FOR 717.938000 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 Elect Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 3264.508470 0.000000 FOR 3264.508470 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 Elect Amy E. McKee DIRECTOR ELECTIONS ISSUER 3264.508470 0.000000 FOR 3264.508470 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 Elect Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 3264.508470 0.000000 WITHHOLD 3264.508470 AGAINST S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 3264.508470 0.000000 FOR 3264.508470 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. COMPENSATION ISSUER 3264.508470 0.000000 FOR 3264.508470 FOR S000004450 BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 3264.508470 0.000000 AGAINST 3264.508470 AGAINST S000004450 CAREDX, INC. 14167L103 06/11/2026 Elect Fred E. Cohen DIRECTOR ELECTIONS ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Elect R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Elect Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Elect Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Elect John W. Hanna DIRECTOR ELECTIONS ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. COMPENSATION ISSUER 789.419200 0.000000 FOR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 789.419200 0.000000 ONE YEAR 789.419200 FOR S000004450 CAREDX, INC. 14167L103 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 789.419200 0.000000 AGAINST 789.419200 AGAINST S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 06/11/2026 Election of Class I Director with term to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D DIRECTOR ELECTIONS ISSUER 872.376840 0.000000 WITHHOLD 872.376840 AGAINST S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 06/11/2026 Election of Class I Director with term to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D DIRECTOR ELECTIONS ISSUER 872.376840 0.000000 FOR 872.376840 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 06/11/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 872.376840 0.000000 FOR 872.376840 FOR S000004450 CORVUS PHARMACEUTICALS, INC. 221015100 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 872.376840 0.000000 FOR 872.376840 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 WITHHOLD 1262.018300 AGAINST S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 WITHHOLD 1262.018300 AGAINST S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 WITHHOLD 1262.018300 AGAINST S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 FOR 1262.018300 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 WITHHOLD 1262.018300 AGAINST S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 WITHHOLD 1262.018300 AGAINST S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 Election of Director to hold office until the 2027 annual general meeting of shareholders: Roger Adsett DIRECTOR ELECTIONS ISSUER 1262.018300 0.000000 FOR 1262.018300 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders. AUDIT-RELATED ISSUER 1262.018300 0.000000 FOR 1262.018300 FOR S000004450 DEFINIUM THERAPEUTICS, INC. 24477V105 06/11/2026 To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares. COMPENSATION ISSUER 1262.018300 0.000000 AGAINST 1262.018300 AGAINST S000004450 EVOLUS, INC. 30052C107 06/11/2026 Elect Brady Stewart DIRECTOR ELECTIONS ISSUER 751.606920 0.000000 FOR 751.606920 FOR S000004450 EVOLUS, INC. 30052C107 06/11/2026 Elect Vikram Malik DIRECTOR ELECTIONS ISSUER 751.606920 0.000000 WITHHOLD 751.606920 AGAINST S000004450 EVOLUS, INC. 30052C107 06/11/2026 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 751.606920 0.000000 AGAINST 751.606920 AGAINST S000004450 EVOLUS, INC. 30052C107 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. COMPENSATION ISSUER 751.606920 0.000000 FOR 751.606920 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Richard J. Barry DIRECTOR ELECTIONS ISSUER 693.482310 0.000000 WITHHOLD 693.482310 AGAINST S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Pierre Gravier DIRECTOR ELECTIONS ISSUER 693.482310 0.000000 FOR 693.482310 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 Election of Class II Director to serve for three-year term and until their successors are duly elected and qualified: Claude Nicaise, M.D. DIRECTOR ELECTIONS ISSUER 693.482310 0.000000 FOR 693.482310 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 To approve Amendment No. 2 to the Company's 2018 Omnibus Incentive Plan, which, among other things, increases the authorized number of shares issuable thereunder by 4,000,000 shares (from 5,000,000 to 9,000,000 authorized shares). COMPENSATION ISSUER 693.482310 0.000000 AGAINST 693.482310 AGAINST S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 693.482310 0.000000 FOR 693.482310 FOR S000004450 FILANA THERAPEUTICS, INC. 14817C107 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. COMPENSATION ISSUER 693.482310 0.000000 FOR 693.482310 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Election of Class A Director: Ross Fubini DIRECTOR ELECTIONS ISSUER 542.178650 0.000000 FOR 542.178650 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Election of Class A Director: Christian Henry DIRECTOR ELECTIONS ISSUER 542.178650 0.000000 AGAINST 542.178650 AGAINST S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Election of Class A Director: Sri Kosuri DIRECTOR ELECTIONS ISSUER 542.178650 0.000000 FOR 542.178650 FOR S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Election of Class A Director: Harry E. Sloan DIRECTOR ELECTIONS ISSUER 542.178650 0.000000 AGAINST 542.178650 AGAINST S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 542.178650 0.000000 AGAINST 542.178650 AGAINST S000004450 GINKGO BIOWORKS HOLDINGS, INC. 37611X209 06/11/2026 Advisory vote to approve executive compensation. COMPENSATION ISSUER 542.178650 0.000000 FOR 542.178650 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Tom Cusack DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 AGAINST 2178.467820 AGAINST S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 AGAINST 2178.467820 AGAINST S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage DIRECTOR ELECTIONS ISSUER 2178.467820 0.000000 AGAINST 2178.467820 AGAINST S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers during the fiscal year ended December 31, 2025. COMPENSATION ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. COMPENSATION ISSUER 2178.467820 0.000000 AGAINST 2178.467820 AGAINST S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 To amend the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares. COMPENSATION ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HERON THERAPEUTICS, INC. 427746102 06/11/2026 To ratify, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan. CORPORATE GOVERNANCE ISSUER 2178.467820 0.000000 FOR 2178.467820 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Andrew Dudum DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Kofi Amoo-Gottfried DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Deborah M. Autor DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Delos Cosgrove DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Anja L. Manuel DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Christopher D. Payne DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Andrea Perez DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect Kare Schultz DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Elect David B. Wells DIRECTOR ELECTIONS ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 HIMS & HERS HEALTH, INC. 433000106 06/11/2026 Advisory approval of the Company's executive compensation. COMPENSATION ISSUER 1016.903430 0.000000 FOR 1016.903430 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 06/11/2026 Election of Class II Director to serve for three-year term until the 2029 Annual Meeting of Stockholders: Natasha Hernday DIRECTOR ELECTIONS ISSUER 612.763730 0.000000 FOR 612.763730 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 06/11/2026 Election of Class II Director to serve for three-year term until the 2029 Annual Meeting of Stockholders: Eric Dobmeier DIRECTOR ELECTIONS ISSUER 612.763730 0.000000 FOR 612.763730 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 06/11/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 612.763730 0.000000 FOR 612.763730 FOR S000004450 JANUX THERAPEUTICS, INC. 47103J105 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 612.763730 0.000000 AGAINST 612.763730 AGAINST S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Charles N. Mills DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Jacob Best DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect James M. Boyle DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Richard A. Galanti DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Patrick J. Healy DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Andrew J. Mills DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Elect Stephen H. Wise DIRECTOR ELECTIONS ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Advisory Vote to Approve Our Executive Compensation. COMPENSATION ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3626.398320 0.000000 ONE YEAR 3626.398320 FOR S000004450 MEDLINE INC. 58507V107 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 3626.398320 0.000000 FOR 3626.398320 FOR S000004450 MEIRAGTX HOLDINGS PLC G59665102 06/11/2026 Elect Ellen Hukkelhoven DIRECTOR ELECTIONS ISSUER 684.580850 0.000000 WITHHOLD 684.580850 AGAINST S000004450 MEIRAGTX HOLDINGS PLC G59665102 06/11/2026 Elect Nicole Seligman DIRECTOR ELECTIONS ISSUER 684.580850 0.000000 WITHHOLD 684.580850 AGAINST S000004450 MEIRAGTX HOLDINGS PLC G59665102 06/11/2026 Elect Debra YU DIRECTOR ELECTIONS ISSUER 684.580850 0.000000 WITHHOLD 684.580850 AGAINST S000004450 MEIRAGTX HOLDINGS PLC G59665102 06/11/2026 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 684.580850 0.000000 FOR 684.580850 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. DIRECTOR ELECTIONS ISSUER 485.444340 0.000000 WITHHOLD 485.444340 AGAINST S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. DIRECTOR ELECTIONS ISSUER 485.444340 0.000000 WITHHOLD 485.444340 AGAINST S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 06/11/2026 Election of Class II Director to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. DIRECTOR ELECTIONS ISSUER 485.444340 0.000000 FOR 485.444340 FOR S000004450 MONTE ROSA THERAPEUTICS, INC. 61225M102 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 485.444340 0.000000 FOR 485.444340 FOR S000004450 NATERA, INC. 632307104 06/11/2026 Elect Rowan Chapman DIRECTOR ELECTIONS ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 Elect Herm Rosenman DIRECTOR ELECTIONS ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 Elect Jonathan Sheena DIRECTOR ELECTIONS ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 Elect Eric H. Rubin DIRECTOR ELECTIONS ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 2058.267810 0.000000 FOR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2058.267810 0.000000 ONE YEAR 2058.267810 FOR S000004450 NATERA, INC. 632307104 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 2058.267810 0.000000 AGAINST 2058.267810 AGAINST S000004450 OCUGEN, INC. 67577C105 06/11/2026 Elect Kirsten Castillo DIRECTOR ELECTIONS ISSUER 4892.445340 0.000000 FOR 4892.445340 FOR S000004450 OCUGEN, INC. 67577C105 06/11/2026 Elect Satish Chandran DIRECTOR ELECTIONS ISSUER 4892.445340 0.000000 FOR 4892.445340 FOR S000004450 OCUGEN, INC. 67577C105 06/11/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 4892.445340 0.000000 FOR 4892.445340 FOR S000004450 OCUGEN, INC. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. COMPENSATION ISSUER 4892.445340 0.000000 FOR 4892.445340 FOR S000004450 OCUGEN, INC. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the preferred frequency with which future advisory votes on the compensation of Ocugen's named executive officers should be held. SECTION 14A SAY-ON-PAY VOTES ISSUER 4892.445340 0.000000 ONE YEAR 4892.445340 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 06/11/2026 Election of class III Director: Bernard Coulie, M.D., Ph.D., M.B.A. DIRECTOR ELECTIONS ISSUER 801.350100 0.000000 WITHHOLD 801.350100 AGAINST S000004450 PLIANT THERAPEUTICS, INC. 729139105 06/11/2026 Election of class III Director: Gayle Crowell DIRECTOR ELECTIONS ISSUER 801.350100 0.000000 WITHHOLD 801.350100 AGAINST S000004450 PLIANT THERAPEUTICS, INC. 729139105 06/11/2026 Election of class III Director: Steve Krognes, M.B.A. DIRECTOR ELECTIONS ISSUER 801.350100 0.000000 FOR 801.350100 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. COMPENSATION ISSUER 801.350100 0.000000 FOR 801.350100 FOR S000004450 PLIANT THERAPEUTICS, INC. 729139105 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 801.350100 0.000000 FOR 801.350100 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Maria Sainz DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 Election of Director: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 PULSE BIOSCIENCES, INC. 74587B101 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 63.042420 0.000000 FOR 63.042420 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Laurence N. Charney DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Yann Echelard DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Daniel Hume DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Sagar Lonial DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 Elect Michael S. Weiss DIRECTOR ELECTIONS ISSUER 2369.399760 0.000000 WITHHOLD 2369.399760 AGAINST S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 TG THERAPEUTICS, INC. 88322Q108 06/11/2026 An advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 2369.399760 0.000000 FOR 2369.399760 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 Election of Class I Director: Robert S. Epstein, M.D., M.S. DIRECTOR ELECTIONS ISSUER 1531.500340 0.000000 WITHHOLD 1531.500340 AGAINST S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 Election of Class I Director: Karin Jooss, Ph.D. DIRECTOR ELECTIONS ISSUER 1531.500340 0.000000 WITHHOLD 1531.500340 AGAINST S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 Election of Class I Director: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 1531.500340 0.000000 FOR 1531.500340 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1531.500340 0.000000 FOR 1531.500340 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 1531.500340 0.000000 FOR 1531.500340 FOR S000004450 FATE THERAPEUTICS, INC. 31189P102 06/12/2026 To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 1531.500340 0.000000 AGAINST 1531.500340 AGAINST S000004450 LENZ THERAPEUTICS, INC. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Evert Schimmelpennink DIRECTOR ELECTIONS ISSUER 2.223720 0.000000 FOR 2.223720 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Jeff George DIRECTOR ELECTIONS ISSUER 2.223720 0.000000 FOR 2.223720 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Shelley Thunen DIRECTOR ELECTIONS ISSUER 2.223720 0.000000 FOR 2.223720 FOR S000004450 LENZ THERAPEUTICS, INC. 52635N103 06/12/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2.223720 0.000000 FOR 2.223720 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Election of Director: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Election of Director: Christine A. Poon DIRECTOR ELECTIONS ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Election of Director: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Election of Director: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Election of Director: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 REGENERON PHARMACEUTICALS, INC. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. COMPENSATION ISSUER 1620.830880 0.000000 FOR 1620.830880 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 AGAINST 594.598700 AGAINST S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah Gray DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 FOR 594.598700 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. Mitchell DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 AGAINST 594.598700 AGAINST S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O'Connor DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 AGAINST 594.598700 AGAINST S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. Pakianathan DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 AGAINST 594.598700 AGAINST S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E Winningham DIRECTOR ELECTIONS ISSUER 594.598700 0.000000 AGAINST 594.598700 AGAINST S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 594.598700 0.000000 FOR 594.598700 FOR S000004450 THERAVANCE BIOPHARMA, INC. G8807B106 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. COMPENSATION ISSUER 594.598700 0.000000 FOR 594.598700 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 592.522390 0.000000 FOR 592.522390 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey DIRECTOR ELECTIONS ISSUER 592.522390 0.000000 FOR 592.522390 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 Election of Class I Director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert DIRECTOR ELECTIONS ISSUER 592.522390 0.000000 FOR 592.522390 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 592.522390 0.000000 FOR 592.522390 FOR S000004450 MIRUM PHARMACEUTICALS, INC. 604749101 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 592.522390 0.000000 FOR 592.522390 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Robert Ades DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 FOR 1104.909540 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Jon Giacomin DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Michele Korfin DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Elect Gilberto Quintero DIRECTOR ELECTIONS ISSUER 1104.909540 0.000000 WITHHOLD 1104.909540 AGAINST S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. COMPENSATION ISSUER 1104.909540 0.000000 FOR 1104.909540 FOR S000004450 ORGANOGENESIS HOLDINGS INC 68621F102 06/15/2026 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 1104.909540 0.000000 FOR 1104.909540 FOR S000004450 VAXCYTE, INC. 92243G108 06/15/2026 Elect Olivier Brandicourt DIRECTOR ELECTIONS ISSUER 1853.951320 0.000000 FOR 1853.951320 FOR S000004450 VAXCYTE, INC. 92243G108 06/15/2026 Elect Halley E. Gilbert DIRECTOR ELECTIONS ISSUER 1853.951320 0.000000 FOR 1853.951320 FOR S000004450 VAXCYTE, INC. 92243G108 06/15/2026 Elect Grant E. Pickering DIRECTOR ELECTIONS ISSUER 1853.951320 0.000000 FOR 1853.951320 FOR S000004450 VAXCYTE, INC. 92243G108 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1853.951320 0.000000 FOR 1853.951320 FOR S000004450 VAXCYTE, INC. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 1853.951320 0.000000 AGAINST 1853.951320 AGAINST S000004450 ARDELYX, INC 039697107 06/16/2026 Elect Robert B. Bazemore Jr. DIRECTOR ELECTIONS ISSUER 3934.333480 0.000000 WITHHOLD 3934.333480 AGAINST S000004450 ARDELYX, INC 039697107 06/16/2026 Elect Muna Bhanji DIRECTOR ELECTIONS ISSUER 3934.333480 0.000000 FOR 3934.333480 FOR S000004450 ARDELYX, INC 039697107 06/16/2026 Elect Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 3934.333480 0.000000 WITHHOLD 3934.333480 AGAINST S000004450 ARDELYX, INC 039697107 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). COMPENSATION ISSUER 3934.333480 0.000000 FOR 3934.333480 FOR S000004450 ARDELYX, INC 039697107 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years. SECTION 14A SAY-ON-PAY VOTES ISSUER 3934.333480 0.000000 ONE YEAR 3934.333480 FOR S000004450 ARDELYX, INC 039697107 06/16/2026 To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3934.333480 0.000000 FOR 3934.333480 FOR S000004450 ARDELYX, INC 039697107 06/16/2026 To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. COMPENSATION ISSUER 3934.333480 0.000000 AGAINST 3934.333480 AGAINST S000004450 CULLINAN THERAPEUTICS, INC. 230031106 06/16/2026 Elect Nadim Ahmed DIRECTOR ELECTIONS ISSUER 462.593500 0.000000 WITHHOLD 462.593500 AGAINST S000004450 CULLINAN THERAPEUTICS, INC. 230031106 06/16/2026 Elect Stephen W. Webster DIRECTOR ELECTIONS ISSUER 462.593500 0.000000 WITHHOLD 462.593500 AGAINST S000004450 CULLINAN THERAPEUTICS, INC. 230031106 06/16/2026 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 462.593500 0.000000 FOR 462.593500 FOR S000004450 CULLINAN THERAPEUTICS, INC. 230031106 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. COMPENSATION ISSUER 462.593500 0.000000 FOR 462.593500 FOR S000004450 DOCGO INC. 256086109 06/16/2026 Elect Vina M. Leite DIRECTOR ELECTIONS ISSUER 1361.515440 0.000000 WITHHOLD 1361.515440 AGAINST S000004450 DOCGO INC. 256086109 06/16/2026 Elect James M. Travers DIRECTOR ELECTIONS ISSUER 1361.515440 0.000000 WITHHOLD 1361.515440 AGAINST S000004450 DOCGO INC. 256086109 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. COMPENSATION ISSUER 1361.515440 0.000000 FOR 1361.515440 FOR S000004450 DOCGO INC. 256086109 06/16/2026 Shareholders are asked to approve six possible amendments to the Company's charter to allow a reverse stock split of common stock at one of these ratios: 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1- for-9, or 1-for-10. The Board would choose the final ratio and timing, and the amendment would also reduce authorized common and preferred shares proportionally. CAPITAL STRUCTURE ISSUER 1361.515440 0.000000 FOR 1361.515440 FOR S000004450 DOCGO INC. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 1361.515440 0.000000 FOR 1361.515440 FOR S000004450 DOCGO INC. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 1361.515440 0.000000 FOR 1361.515440 FOR S000004450 DOCGO INC. 256086109 06/16/2026 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1361.515440 0.000000 FOR 1361.515440 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 06/16/2026 Elect Wendy Barnes DIRECTOR ELECTIONS ISSUER 1353.837800 0.000000 FOR 1353.837800 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 06/16/2026 Elect Ronald E. Bruehlman DIRECTOR ELECTIONS ISSUER 1353.837800 0.000000 FOR 1353.837800 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 06/16/2026 Elect Gregory K. Mondre DIRECTOR ELECTIONS ISSUER 1353.837800 0.000000 WITHHOLD 1353.837800 AGAINST S000004450 GOODRX HOLDINGS, INC. 38246G108 06/16/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1353.837800 0.000000 FOR 1353.837800 FOR S000004450 GOODRX HOLDINGS, INC. 38246G108 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 1353.837800 0.000000 AGAINST 1353.837800 AGAINST S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 1243.495260 0.000000 FOR 1243.495260 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. DIRECTOR ELECTIONS ISSUER 1243.495260 0.000000 FOR 1243.495260 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 06/16/2026 Election of Class I Director to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. DIRECTOR ELECTIONS ISSUER 1243.495260 0.000000 FOR 1243.495260 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 06/16/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1243.495260 0.000000 FOR 1243.495260 FOR S000004450 IDEAYA BIOSCIENCES, INC. 45166A102 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. COMPENSATION ISSUER 1243.495260 0.000000 FOR 1243.495260 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Mark G. Currie DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Alexander J. Denner DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Jon R. Duane DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Marla L. Kessler DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Thomas A. McCourt DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Julie H. McHugh DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Elect Jay P. Shepard DIRECTOR ELECTIONS ISSUER 2288.836280 0.000000 WITHHOLD 2288.836280 AGAINST S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. COMPENSATION ISSUER 2288.836280 0.000000 FOR 2288.836280 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. COMPENSATION ISSUER 2288.836280 0.000000 FOR 2288.836280 FOR S000004450 IRONWOOD PHARMACEUTICALS, INC. 46333X108 06/16/2026 Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 2288.836280 0.000000 FOR 2288.836280 FOR S000004450 LIQUIDIA CORPORATION 53635D202 06/16/2026 Election of Director: David Johnson DIRECTOR ELECTIONS ISSUER 960.594100 0.000000 FOR 960.594100 FOR S000004450 LIQUIDIA CORPORATION 53635D202 06/16/2026 Election of Director: Katie Rielly-Gauvin DIRECTOR ELECTIONS ISSUER 960.594100 0.000000 FOR 960.594100 FOR S000004450 LIQUIDIA CORPORATION 53635D202 06/16/2026 Election of Director: Ramandeep Singh DIRECTOR ELECTIONS ISSUER 960.594100 0.000000 FOR 960.594100 FOR S000004450 LIQUIDIA CORPORATION 53635D202 06/16/2026 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. AUDIT-RELATED ISSUER 960.594100 0.000000 FOR 960.594100 FOR S000004450 LIQUIDIA CORPORATION 53635D202 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 960.594100 0.000000 FOR 960.594100 FOR S000004450 NUVALENT, INC. 670703107 06/16/2026 Election of Class II Director: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 629.754760 0.000000 FOR 629.754760 FOR S000004450 NUVALENT, INC. 670703107 06/16/2026 Election of Class II Director: Ron Squarer DIRECTOR ELECTIONS ISSUER 629.754760 0.000000 FOR 629.754760 FOR S000004450 NUVALENT, INC. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. COMPENSATION ISSUER 629.754760 0.000000 FOR 629.754760 FOR S000004450 NUVALENT, INC. 670703107 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 629.754760 0.000000 FOR 629.754760 FOR S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Brian Blaser DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 FOR 1070.727440 FOR S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Kenneth F. Buechler DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect John R. Chiminski DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 FOR 1070.727440 FOR S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 FOR 1070.727440 FOR S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Edward L. Michael DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Mary Lake Polan DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Kenneth J. Widder DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Elect Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 1070.727440 0.000000 WITHHOLD 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. COMPENSATION ISSUER 1070.727440 0.000000 AGAINST 1070.727440 AGAINST S000004450 QUIDELORTHO CORPORATION 219798105 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 1070.727440 0.000000 FOR 1070.727440 FOR S000004450 RXSIGHT, INC. 78349D107 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: William J. Link, Ph.D. DIRECTOR ELECTIONS ISSUER 544.866630 0.000000 FOR 544.866630 FOR S000004450 RXSIGHT, INC. 78349D107 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Robert Warner DIRECTOR ELECTIONS ISSUER 544.866630 0.000000 FOR 544.866630 FOR S000004450 RXSIGHT, INC. 78349D107 06/16/2026 Election of Class II Director to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 544.866630 0.000000 FOR 544.866630 FOR S000004450 RXSIGHT, INC. 78349D107 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. COMPENSATION ISSUER 544.866630 0.000000 FOR 544.866630 FOR S000004450 RXSIGHT, INC. 78349D107 06/16/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 544.866630 0.000000 FOR 544.866630 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Raymond J. Deshaies DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 WITHHOLD 779.744230 AGAINST S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 WITHHOLD 779.744230 AGAINST S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. Barbara Klencke DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Dr. A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 WITHHOLD 779.744230 AGAINST S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 WITHHOLD 779.744230 AGAINST S000004450 XENCOR, INC. 98401F105 06/16/2026 Election of Director to serve until the next annual meeting and until their successors are duly elected and qualified: Mr. Todd E. Simpson DIRECTOR ELECTIONS ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 XENCOR, INC. 98401F105 06/16/2026 Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 779.744230 0.000000 AGAINST 779.744230 AGAINST S000004450 XENCOR, INC. 98401F105 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. COMPENSATION ISSUER 779.744230 0.000000 FOR 779.744230 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 06/16/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 790.849220 0.000000 WITHHOLD 790.849220 AGAINST S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 06/16/2026 Elect Jan Skvarka DIRECTOR ELECTIONS ISSUER 790.849220 0.000000 WITHHOLD 790.849220 AGAINST S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 06/16/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 790.849220 0.000000 FOR 790.849220 FOR S000004450 ZENTALIS PHARMACEUTICALS, INC. 98943L107 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 790.849220 0.000000 FOR 790.849220 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Nancy Miller-Rich DIRECTOR ELECTIONS ISSUER 671.317570 0.000000 WITHHOLD 671.317570 AGAINST S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 671.317570 0.000000 WITHHOLD 671.317570 AGAINST S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Election of Class III Director to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Shawn Cline Tomasello, MBA DIRECTOR ELECTIONS ISSUER 671.317570 0.000000 WITHHOLD 671.317570 AGAINST S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 671.317570 0.000000 FOR 671.317570 FOR S000004450 4D MOLECULAR THERAPEUTICS, INC. 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). COMPENSATION ISSUER 671.317570 0.000000 FOR 671.317570 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Elect Adrian Adams DIRECTOR ELECTIONS ISSUER 3946.918870 0.000000 WITHHOLD 3946.918870 AGAINST S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Elect Michael Rogers DIRECTOR ELECTIONS ISSUER 3946.918870 0.000000 WITHHOLD 3946.918870 AGAINST S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Elect LeAnne M. Zumwalt DIRECTOR ELECTIONS ISSUER 3946.918870 0.000000 WITHHOLD 3946.918870 AGAINST S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Approval of an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and to increase the number of authorized shares of common stock from 350,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 3946.918870 0.000000 FOR 3946.918870 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. COMPENSATION ISSUER 3946.918870 0.000000 FOR 3946.918870 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3946.918870 0.000000 ONE YEAR 3946.918870 FOR S000004450 AKEBIA THERAPEUTICS, INC. 00972D105 06/17/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3946.918870 0.000000 FOR 3946.918870 FOR S000004450 ALECTOR, INC. 014442107 06/17/2026 Elect Elizabeth A. Garofalo DIRECTOR ELECTIONS ISSUER 1148.361560 0.000000 WITHHOLD 1148.361560 AGAINST S000004450 ALECTOR, INC. 014442107 06/17/2026 Elect Errol B. De Souza DIRECTOR ELECTIONS ISSUER 1148.361560 0.000000 FOR 1148.361560 FOR S000004450 ALECTOR, INC. 014442107 06/17/2026 Elect Kristine Yaffe DIRECTOR ELECTIONS ISSUER 1148.361560 0.000000 WITHHOLD 1148.361560 AGAINST S000004450 ALECTOR, INC. 014442107 06/17/2026 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1148.361560 0.000000 FOR 1148.361560 FOR S000004450 ALECTOR, INC. 014442107 06/17/2026 Advisory vote on executive compensation. COMPENSATION ISSUER 1148.361560 0.000000 FOR 1148.361560 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 Election of Director with term to expire at the 2029 Annual Meeting of Stockholders: Matthew P. Young DIRECTOR ELECTIONS ISSUER 2533.051130 0.000000 AGAINST 2533.051130 AGAINST S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 Election of Director with term to expire at the 2029 Annual Meeting of Stockholders: Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 2533.051130 0.000000 AGAINST 2533.051130 AGAINST S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2533.051130 0.000000 FOR 2533.051130 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares. CAPITAL STRUCTURE ISSUER 2533.051130 0.000000 AGAINST 2533.051130 AGAINST S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 2533.051130 0.000000 AGAINST 2533.051130 AGAINST S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 2533.051130 0.000000 FOR 2533.051130 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. COMPENSATION ISSUER 2533.051130 0.000000 FOR 2533.051130 FOR S000004450 CYTOMX THERAPEUTICS, INC. 23284F105 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2533.051130 0.000000 ONE YEAR 2533.051130 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 06/17/2026 Elect Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 1530.418290 0.000000 WITHHOLD 1530.418290 AGAINST S000004450 EDITAS MEDICINE, INC. 28106W103 06/17/2026 Elect Elliott Levy DIRECTOR ELECTIONS ISSUER 1530.418290 0.000000 FOR 1530.418290 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 1530.418290 0.000000 FOR 1530.418290 FOR S000004450 EDITAS MEDICINE, INC. 28106W103 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1530.418290 0.000000 FOR 1530.418290 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 06/17/2026 Election of Class II Director: Ian Clark DIRECTOR ELECTIONS ISSUER 1764.340500 0.000000 FOR 1764.340500 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 06/17/2026 Election of Class II Director: Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 1764.340500 0.000000 FOR 1764.340500 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1764.340500 0.000000 FOR 1764.340500 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. COMPENSATION ISSUER 1764.340500 0.000000 FOR 1764.340500 FOR S000004450 GUARDANT HEALTH, INC. 40131M109 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1764.340500 0.000000 ONE YEAR 1764.340500 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Re-election of Class I director: Julian Baker DIRECTOR ELECTIONS ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Re-election of Class I director: Daniel Brennan DIRECTOR ELECTIONS ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Re-election of Class I director: James Daly DIRECTOR ELECTIONS ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Advisory vote to approve executive compensation COMPENSATION ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MADRIGAL PHARMACEUTICALS INC. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 241.465280 0.000000 FOR 241.465280 FOR S000004450 MAXCYTE, INC. 57777K106 06/17/2026 Elect Patrick J. Balthrop, Sr. DIRECTOR ELECTIONS ISSUER 1585.139780 0.000000 WITHHOLD 1585.139780 AGAINST S000004450 MAXCYTE, INC. 57777K106 06/17/2026 Elect Cynthia Collins DIRECTOR ELECTIONS ISSUER 1585.139780 0.000000 FOR 1585.139780 FOR S000004450 MAXCYTE, INC. 57777K106 06/17/2026 Elect Stanley C. Erck DIRECTOR ELECTIONS ISSUER 1585.139780 0.000000 WITHHOLD 1585.139780 AGAINST S000004450 MAXCYTE, INC. 57777K106 06/17/2026 To ratify the Audit Committee's selection of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1585.139780 0.000000 FOR 1585.139780 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Elect Sean P. Bohen DIRECTOR ELECTIONS ISSUER 615.171520 0.000000 WITHHOLD 615.171520 AGAINST S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Elect Scott Garland DIRECTOR ELECTIONS ISSUER 615.171520 0.000000 FOR 615.171520 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Elect Yi Larson DIRECTOR ELECTIONS ISSUER 615.171520 0.000000 WITHHOLD 615.171520 AGAINST S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Elect Andrew S. Rappaport DIRECTOR ELECTIONS ISSUER 615.171520 0.000000 WITHHOLD 615.171520 AGAINST S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. COMPENSATION ISSUER 615.171520 0.000000 FOR 615.171520 FOR S000004450 OLEMA PHARMACEUTICALS, INC. 68062P106 06/17/2026 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 615.171520 0.000000 FOR 615.171520 FOR S000004450 OMNIAB, INC. 68218J103 06/17/2026 Election of Director: Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 1405.766720 0.000000 WITHHOLD 1405.766720 AGAINST S000004450 OMNIAB, INC. 68218J103 06/17/2026 Election of Director: Jennifer Cochran, Ph.D. DIRECTOR ELECTIONS ISSUER 1405.766720 0.000000 WITHHOLD 1405.766720 AGAINST S000004450 OMNIAB, INC. 68218J103 06/17/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm AUDIT-RELATED ISSUER 1405.766720 0.000000 FOR 1405.766720 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 06/17/2026 Elect Dinesh V. Patel DIRECTOR ELECTIONS ISSUER 810.273310 0.000000 FOR 810.273310 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 06/17/2026 Elect Lewis T. Williams DIRECTOR ELECTIONS ISSUER 810.273310 0.000000 FOR 810.273310 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 810.273310 0.000000 FOR 810.273310 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 810.273310 0.000000 FOR 810.273310 FOR S000004450 PROTAGONIST THERAPEUTICS, INC. 74366E102 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 810.273310 0.000000 AGAINST 810.273310 AGAINST S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 06/17/2026 Elect Najat Khan DIRECTOR ELECTIONS ISSUER 279.046650 0.000000 FOR 279.046650 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 06/17/2026 Elect Franziska Michor DIRECTOR ELECTIONS ISSUER 279.046650 0.000000 FOR 279.046650 FOR S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. COMPENSATION ISSUER 279.046650 0.000000 AGAINST 279.046650 AGAINST S000004450 RECURSION PHARMACEUTICALS, INC. 75629V104 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 279.046650 0.000000 FOR 279.046650 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 Elect Michael Egholm DIRECTOR ELECTIONS ISSUER 4118.652060 0.000000 WITHHOLD 4118.652060 AGAINST S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 Elect Thomas Carey DIRECTOR ELECTIONS ISSUER 4118.652060 0.000000 FOR 4118.652060 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 Elect Eli Casdin DIRECTOR ELECTIONS ISSUER 4118.652060 0.000000 WITHHOLD 4118.652060 AGAINST S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4118.652060 0.000000 FOR 4118.652060 FOR S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4118.652060 0.000000 AGAINST 4118.652060 AGAINST S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 4118.652060 0.000000 AGAINST 4118.652060 AGAINST S000004450 STANDARD BIOTOOLS INC. 34385P108 06/17/2026 To approve an amendment to our Amended and Restated 2017 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares. COMPENSATION ISSUER 4118.652060 0.000000 FOR 4118.652060 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 Election of Director to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew J. Wallach DIRECTOR ELECTIONS ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 VEEVA SYSTEMS INC. 922475108 06/17/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 2454.805100 0.000000 FOR 2454.805100 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Gregory Belinfanti DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Terence J. Connors DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Bradley J. Coppens DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Suzanne M. Foster DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 FOR 1575.470740 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Ted Lundberg DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Kenneth A. Samet DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 FOR 1575.470740 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Susan T. Weaver DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect David Williams III DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Elect Dale B. Wolf DIRECTOR ELECTIONS ISSUER 1575.470740 0.000000 WITHHOLD 1575.470740 AGAINST S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1575.470740 0.000000 FOR 1575.470740 FOR S000004450 ADAPTHEALTH CORP. 00653Q102 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. COMPENSATION ISSUER 1575.470740 0.000000 FOR 1575.470740 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 872.128650 0.000000 FOR 872.128650 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian Goff DIRECTOR ELECTIONS ISSUER 872.128650 0.000000 FOR 872.128650 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia Smith DIRECTOR ELECTIONS ISSUER 872.128650 0.000000 FOR 872.128650 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. COMPENSATION ISSUER 872.128650 0.000000 FOR 872.128650 FOR S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. COMPENSATION ISSUER 872.128650 0.000000 AGAINST 872.128650 AGAINST S000004450 AGIOS PHARMACEUTICALS, INC. 00847X104 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 872.128650 0.000000 FOR 872.128650 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 Election of Director: Deborah Messemer DIRECTOR ELECTIONS ISSUER 3905.654170 0.000000 WITHHOLD 3905.654170 AGAINST S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 Election of Director: Vicki Sato, Ph.D. DIRECTOR ELECTIONS ISSUER 3905.654170 0.000000 WITHHOLD 3905.654170 AGAINST S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 Election of Director: Owen Witte, M.D. DIRECTOR ELECTIONS ISSUER 3905.654170 0.000000 WITHHOLD 3905.654170 AGAINST S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 3905.654170 0.000000 FOR 3905.654170 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3905.654170 0.000000 ONE YEAR 3905.654170 FOR S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE ISSUER 3905.654170 0.000000 AGAINST 3905.654170 AGAINST S000004450 ALLOGENE THERAPEUTICS, INC. 019770106 06/18/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3905.654170 0.000000 FOR 3905.654170 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 06/18/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 328.736880 0.000000 FOR 328.736880 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 06/18/2026 Elect John A. Hohneker DIRECTOR ELECTIONS ISSUER 328.736880 0.000000 FOR 328.736880 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 06/18/2026 Elect Stuart Lutzker DIRECTOR ELECTIONS ISSUER 328.736880 0.000000 FOR 328.736880 FOR S000004450 ARRIVENT BIOPHARMA, INC. 04272N102 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 328.736880 0.000000 FOR 328.736880 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 06/18/2026 Elect Jerome M. Adams DIRECTOR ELECTIONS ISSUER 854.356640 0.000000 WITHHOLD 854.356640 AGAINST S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 06/18/2026 Elect Howard H. Berman DIRECTOR ELECTIONS ISSUER 854.356640 0.000000 FOR 854.356640 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 06/18/2026 Elect Barbara G. Duncan DIRECTOR ELECTIONS ISSUER 854.356640 0.000000 WITHHOLD 854.356640 AGAINST S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 06/18/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 854.356640 0.000000 FOR 854.356640 FOR S000004450 ATEA PHARMACEUTICALS, INC. 04683R106 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. COMPENSATION ISSUER 854.356640 0.000000 FOR 854.356640 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Joseph DeVivo DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 FOR 3174.526320 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Larry Robbins DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Caroll H. Neubauer DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 Election of Director to serve one-year term expiring in 2027: Erica Schwartz, M.D., J.D., M.P.H. DIRECTOR ELECTIONS ISSUER 3174.526320 0.000000 AGAINST 3174.526320 AGAINST S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3174.526320 0.000000 FOR 3174.526320 FOR S000004450 BUTTERFLY NETWORK, INC. 124155102 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 3174.526320 0.000000 FOR 3174.526320 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 1403.590790 0.000000 FOR 1403.590790 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 1403.590790 0.000000 FOR 1403.590790 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 06/18/2026 Election of Class II Director for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 1403.590790 0.000000 FOR 1403.590790 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1403.590790 0.000000 FOR 1403.590790 FOR S000004450 CRINETICS PHARMACEUTICALS, INC. 22663K107 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission COMPENSATION ISSUER 1403.590790 0.000000 AGAINST 1403.590790 AGAINST S000004450 DISC MEDICINE, INC. 254604101 06/18/2026 Election of Class III Director: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 392.855540 0.000000 WITHHOLD 392.855540 AGAINST S000004450 DISC MEDICINE, INC. 254604101 06/18/2026 Election of Class III Director: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 392.855540 0.000000 WITHHOLD 392.855540 AGAINST S000004450 DISC MEDICINE, INC. 254604101 06/18/2026 Election of Class III Director: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 392.855540 0.000000 WITHHOLD 392.855540 AGAINST S000004450 DISC MEDICINE, INC. 254604101 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. COMPENSATION ISSUER 392.855540 0.000000 FOR 392.855540 FOR S000004450 DISC MEDICINE, INC. 254604101 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 392.855540 0.000000 FOR 392.855540 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Goran A. Ando DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Jay S. Duker DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect John B. Landis DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Wendy F. DiCicco DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 WITHHOLD 1166.112180 AGAINST S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Karen Zaderej DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Stuart Duty DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Fred Hassan DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 Elect Reginald J. Sanders DIRECTOR ELECTIONS ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares. COMPENSATION ISSUER 1166.112180 0.000000 AGAINST 1166.112180 AGAINST S000004450 EYEPOINT, INC. 30233G209 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 EYEPOINT, INC. 30233G209 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1166.112180 0.000000 FOR 1166.112180 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 06/18/2026 Elect Katherine Stueland DIRECTOR ELECTIONS ISSUER 318.412860 0.000000 FOR 318.412860 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 318.412860 0.000000 FOR 318.412860 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 318.412860 0.000000 FOR 318.412860 FOR S000004450 GENEDX HOLDINGS CORP. 81663L200 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 318.412860 0.000000 ONE YEAR 318.412860 FOR S000004450 GRAIL, INC. 384747101 06/18/2026 Elect Sarah Krevans DIRECTOR ELECTIONS ISSUER 565.955390 0.000000 FOR 565.955390 FOR S000004450 GRAIL, INC. 384747101 06/18/2026 Elect Steven C. Mizell DIRECTOR ELECTIONS ISSUER 565.955390 0.000000 FOR 565.955390 FOR S000004450 GRAIL, INC. 384747101 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 565.955390 0.000000 FOR 565.955390 FOR S000004450 HARROW INC. 415858109 06/18/2026 Elect Mark L. Baum DIRECTOR ELECTIONS ISSUER 495.767390 0.000000 WITHHOLD 495.767390 AGAINST S000004450 HARROW INC. 415858109 06/18/2026 Elect Adrienne Graves DIRECTOR ELECTIONS ISSUER 495.767390 0.000000 FOR 495.767390 FOR S000004450 HARROW INC. 415858109 06/18/2026 Elect Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 495.767390 0.000000 FOR 495.767390 FOR S000004450 HARROW INC. 415858109 06/18/2026 Elect Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 495.767390 0.000000 FOR 495.767390 FOR S000004450 HARROW INC. 415858109 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. COMPENSATION ISSUER 495.767390 0.000000 FOR 495.767390 FOR S000004450 HARROW INC. 415858109 06/18/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 495.767390 0.000000 FOR 495.767390 FOR S000004450 NOVAVAX, INC. 670002401 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 2249.146240 0.000000 FOR 2249.146240 FOR S000004450 NOVAVAX, INC. 670002401 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D. DIRECTOR ELECTIONS ISSUER 2249.146240 0.000000 FOR 2249.146240 FOR S000004450 NOVAVAX, INC. 670002401 06/18/2026 Election of Class I director to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 2249.146240 0.000000 AGAINST 2249.146240 AGAINST S000004450 NOVAVAX, INC. 670002401 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. COMPENSATION ISSUER 2249.146240 0.000000 FOR 2249.146240 FOR S000004450 NOVAVAX, INC. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares. COMPENSATION ISSUER 2249.146240 0.000000 AGAINST 2249.146240 AGAINST S000004450 NOVAVAX, INC. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock. COMPENSATION ISSUER 2249.146240 0.000000 AGAINST 2249.146240 AGAINST S000004450 NOVAVAX, INC. 670002401 06/18/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2249.146240 0.000000 FOR 2249.146240 FOR S000004450 OMEROS CORPORATION 682143102 06/18/2026 Election of Director: Thomas J. Cable DIRECTOR ELECTIONS ISSUER 1105.796450 0.000000 FOR 1105.796450 FOR S000004450 OMEROS CORPORATION 682143102 06/18/2026 Election of Director: Peter A. Demopulos, M.D. DIRECTOR ELECTIONS ISSUER 1105.796450 0.000000 FOR 1105.796450 FOR S000004450 OMEROS CORPORATION 682143102 06/18/2026 Election of Director: Diana T. Perkinson, M.D. DIRECTOR ELECTIONS ISSUER 1105.796450 0.000000 FOR 1105.796450 FOR S000004450 OMEROS CORPORATION 682143102 06/18/2026 Approval of advisory resolution on executive compensation. COMPENSATION ISSUER 1105.796450 0.000000 FOR 1105.796450 FOR S000004450 OMEROS CORPORATION 682143102 06/18/2026 Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 1105.796450 0.000000 AGAINST 1105.796450 AGAINST S000004450 OMEROS CORPORATION 682143102 06/18/2026 Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1105.796450 0.000000 FOR 1105.796450 FOR S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 FOR 6622.419510 FOR S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 6622.419510 0.000000 AGAINST 6622.419510 AGAINST S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 To approve the Company's 2026 Equity Incentive Plan; COMPENSATION ISSUER 6622.419510 0.000000 FOR 6622.419510 FOR S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers; COMPENSATION ISSUER 6622.419510 0.000000 FOR 6622.419510 FOR S000004450 OPKO HEALTH, INC. 68375N103 06/18/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 6622.419510 0.000000 FOR 6622.419510 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 Election of Class III Director to serve until the 2029 annual meeting of stockholders: Jacob M. Chacko, M.D DIRECTOR ELECTIONS ISSUER 684.617460 0.000000 WITHHOLD 684.617460 AGAINST S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 Election of Class III Director to serve until the 2029 annual meeting of stockholders: Mardi C. Dier DIRECTOR ELECTIONS ISSUER 684.617460 0.000000 WITHHOLD 684.617460 AGAINST S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 684.617460 0.000000 FOR 684.617460 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 684.617460 0.000000 AGAINST 684.617460 AGAINST S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 To approve, on an advisory basis, executive compensation. COMPENSATION ISSUER 684.617460 0.000000 FOR 684.617460 FOR S000004450 ORIC PHARMACEUTICALS, INC. 68622P109 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 684.617460 0.000000 ONE YEAR 684.617460 FOR S000004450 PENUMBRA, INC. 70975L107 06/18/2026 Elect Arani Bose DIRECTOR ELECTIONS ISSUER 361.530000 0.000000 FOR 361.530000 FOR S000004450 PENUMBRA, INC. 70975L107 06/18/2026 Elect Bridget O'Rourke DIRECTOR ELECTIONS ISSUER 361.530000 0.000000 FOR 361.530000 FOR S000004450 PENUMBRA, INC. 70975L107 06/18/2026 Elect Surbhi Sarna DIRECTOR ELECTIONS ISSUER 361.530000 0.000000 FOR 361.530000 FOR S000004450 PENUMBRA, INC. 70975L107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 361.530000 0.000000 FOR 361.530000 FOR S000004450 PENUMBRA, INC. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. COMPENSATION ISSUER 361.530000 0.000000 FOR 361.530000 FOR S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Randal Kirk DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Steven Frank DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Vinita Gupta DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Fred Hassan DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 FOR 2759.815150 FOR S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Election of Director: James Turley DIRECTOR ELECTIONS ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2759.815150 0.000000 FOR 2759.815150 FOR S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. COMPENSATION ISSUER 2759.815150 0.000000 FOR 2759.815150 FOR S000004450 PRECIGEN, INC. 74017N105 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 2759.815150 0.000000 AGAINST 2759.815150 AGAINST S000004450 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 Elect Alexis A. Borisy DIRECTOR ELECTIONS ISSUER 2643.812800 0.000000 FOR 2643.812800 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 Elect Mark A. Goldsmith DIRECTOR ELECTIONS ISSUER 2643.812800 0.000000 FOR 2643.812800 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2643.812800 0.000000 FOR 2643.812800 FOR S000004450 REVOLUTION MEDICINES, INC. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). COMPENSATION ISSUER 2643.812800 0.000000 FOR 2643.812800 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Neal C. Bradsher DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Wei Jiang DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Richard T. LeBuhn DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Louis E. Silverman DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Christopher M. Wang DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Elect Lilian Zhou DIRECTOR ELECTIONS ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Approve an amendment to the Company's Amended and Restated Omnibus Equity Incentive Plan, as amended. COMPENSATION ISSUER 207.166980 0.000000 AGAINST 207.166980 AGAINST S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Ratify the appointment of the Company's independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 STAAR SURGICAL COMPANY 852312305 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). COMPENSATION ISSUER 207.166980 0.000000 FOR 207.166980 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 06/18/2026 Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson DIRECTOR ELECTIONS ISSUER 1003.657820 0.000000 FOR 1003.657820 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 06/18/2026 Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III DIRECTOR ELECTIONS ISSUER 1003.657820 0.000000 FOR 1003.657820 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. COMPENSATION ISSUER 1003.657820 0.000000 FOR 1003.657820 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1003.657820 0.000000 FOR 1003.657820 FOR S000004450 SUPERNUS PHARMACEUTICALS, INC. 868459108 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. COMPENSATION ISSUER 1003.657820 0.000000 AGAINST 1003.657820 AGAINST S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 Elect James C. Momtazee DIRECTOR ELECTIONS ISSUER 2362.347200 0.000000 FOR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 Elect Frank McCormick DIRECTOR ELECTIONS ISSUER 2362.347200 0.000000 FOR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 Elect Hannah A. Valantine DIRECTOR ELECTIONS ISSUER 2362.347200 0.000000 FOR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. COMPENSATION ISSUER 2362.347200 0.000000 FOR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2362.347200 0.000000 ONE YEAR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2362.347200 0.000000 FOR 2362.347200 FOR S000004450 BRIDGEBIO PHARMA, INC. 10806X102 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 2362.347200 0.000000 AGAINST 2362.347200 AGAINST S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Joshua Hausman DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Nikolas W. Stengle DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Denise W. Warren DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 AGAINST 3758.441260 AGAINST S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Election of Director: C. Christian Winkle DIRECTOR ELECTIONS ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Advisory approval of named executive officer compensation COMPENSATION ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 BROOKDALE SENIOR LIVING INC. 112463104 06/22/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 3758.441260 0.000000 FOR 3758.441260 FOR S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Richard A. Friesner DIRECTOR ELECTIONS ISSUER 1066.718720 0.000000 AGAINST 1066.718720 AGAINST S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Rosana Kapeller-Libermann DIRECTOR ELECTIONS ISSUER 1066.718720 0.000000 AGAINST 1066.718720 AGAINST S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Election of Class III Director to serve until the 2029 Annual Meeting of Stockholders: Gary Sender DIRECTOR ELECTIONS ISSUER 1066.718720 0.000000 AGAINST 1066.718720 AGAINST S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Approval of an advisory vote on executive compensation. COMPENSATION ISSUER 1066.718720 0.000000 FOR 1066.718720 FOR S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 1066.718720 0.000000 AGAINST 1066.718720 AGAINST S000004450 SCHRODINGER, INC. 80810D103 06/22/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1066.718720 0.000000 FOR 1066.718720 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Stuart Holden, M.D. DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Leana S. Wen, M.D., M.Sc. DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 Election of Director to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman DIRECTOR ELECTIONS ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law. CORPORATE GOVERNANCE ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 To approve an amendment to the Company's Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors' and officers' insurance. COMPENSATION ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000 shares. COMPENSATION ISSUER 684.010580 0.000000 AGAINST 684.010580 AGAINST S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. COMPENSATION ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 UROGEN PHARMA LTD M96088105 06/22/2026 To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2027 annual meeting of shareholders. AUDIT-RELATED ISSUER 684.010580 0.000000 FOR 684.010580 FOR S000004450 WAVE LIFE SCIENCES LTD. Y95308105 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. CAPITAL STRUCTURE ISSUER 1917.520780 0.000000 FOR 1917.520780 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Michael D. Dale DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Amy M. Wendell DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect William Burke DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect John H. Johnson DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Alan Levine DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Paul G. Thomas DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Joseph Tyndall DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 Elect Kathy Weiler DIRECTOR ELECTIONS ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 AXOGEN, INC. 05463X106 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. COMPENSATION ISSUER 762.614240 0.000000 FOR 762.614240 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Janet M. Dillione DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 WITHHOLD 551.512540 AGAINST S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Gregory Duncan DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Alan W. Dunton DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Myron Kaplan DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 WITHHOLD 551.512540 AGAINST S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Steven Lefkowitz DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Robert A. Stewart DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 Elect Joseph Todisco DIRECTOR ELECTIONS ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. COMPENSATION ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve the ratification of the Certificate of Designation Amendments (as defined in the Proxy Statement). CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve amendments to our Charter to make technical changes. CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the extent permitted by Delaware law and provided that no changes are made to the terms of common stock. CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve an amendment to our Charter to designate the exclusive forums in which certain claims relating to the Company may be brought. CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve an amendment to our Charter to limit certain officers' personal liability for monetary damages for breaches of the duty of care, as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 CORMEDIX INC. 21900C308 06/23/2026 To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. CORPORATE GOVERNANCE ISSUER 551.512540 0.000000 FOR 551.512540 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Roger Susi DIRECTOR ELECTIONS ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Monty Allen DIRECTOR ELECTIONS ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Joe Kiani DIRECTOR ELECTIONS ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect James B. Hawkins DIRECTOR ELECTIONS ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. COMPENSATION ISSUER 137.691160 0.000000 FOR 137.691160 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 103.623840 0.000000 WITHHOLD 103.623840 AGAINST S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 103.623840 0.000000 WITHHOLD 103.623840 AGAINST S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 Election of Class III Director to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 103.623840 0.000000 FOR 103.623840 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 103.623840 0.000000 FOR 103.623840 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. COMPENSATION ISSUER 103.623840 0.000000 FOR 103.623840 FOR S000004450 ARS PHARMACEUTICALS, INC. 82835W108 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 103.623840 0.000000 ONE YEAR 103.623840 FOR S000004450 ARVINAS, INC. 04335A105 06/24/2026 Elect Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 941.723840 0.000000 WITHHOLD 941.723840 AGAINST S000004450 ARVINAS, INC. 04335A105 06/24/2026 Elect Randy Teel DIRECTOR ELECTIONS ISSUER 941.723840 0.000000 FOR 941.723840 FOR S000004450 ARVINAS, INC. 04335A105 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. COMPENSATION ISSUER 941.723840 0.000000 FOR 941.723840 FOR S000004450 ARVINAS, INC. 04335A105 06/24/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 941.723840 0.000000 FOR 941.723840 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks DIRECTOR ELECTIONS ISSUER 652.631360 0.000000 FOR 652.631360 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz DIRECTOR ELECTIONS ISSUER 652.631360 0.000000 WITHHOLD 652.631360 AGAINST S000004450 FULCRUM THERAPEUTICS INC 359616109 06/24/2026 Election of Class I Director to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill DIRECTOR ELECTIONS ISSUER 652.631360 0.000000 FOR 652.631360 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers. COMPENSATION ISSUER 652.631360 0.000000 FOR 652.631360 FOR S000004450 FULCRUM THERAPEUTICS INC 359616109 06/24/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 652.631360 0.000000 FOR 652.631360 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 Elect Bruce Booth DIRECTOR ELECTIONS ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 Elect Nello Mainolfi DIRECTOR ELECTIONS ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 Elect John M. Maraganore DIRECTOR ELECTIONS ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 Elect Elena Ridloff DIRECTOR ELECTIONS ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. COMPENSATION ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 KYMERA THERAPEUTICS, INC. 501575104 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 828.210420 0.000000 FOR 828.210420 FOR S000004450 PHREESIA, INC. 71944F106 06/24/2026 Elect Chaim Indig DIRECTOR ELECTIONS ISSUER 1059.275900 0.000000 WITHHOLD 1059.275900 AGAINST S000004450 PHREESIA, INC. 71944F106 06/24/2026 Elect Jon Kessler DIRECTOR ELECTIONS ISSUER 1059.275900 0.000000 FOR 1059.275900 FOR S000004450 PHREESIA, INC. 71944F106 06/24/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 1059.275900 0.000000 FOR 1059.275900 FOR S000004450 PHREESIA, INC. 71944F106 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. COMPENSATION ISSUER 1059.275900 0.000000 FOR 1059.275900 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 06/24/2026 Elect David W.J. McGirr DIRECTOR ELECTIONS ISSUER 981.600060 0.000000 FOR 981.600060 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 06/24/2026 Elect David P. Meeker DIRECTOR ELECTIONS ISSUER 981.600060 0.000000 FOR 981.600060 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 981.600060 0.000000 FOR 981.600060 FOR S000004450 RHYTHM PHARMACEUTICALS, INC. 76243J105 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. COMPENSATION ISSUER 981.600060 0.000000 FOR 981.600060 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 FOR 1160.676020 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: James J. Marino DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 Election of Director: Denice Torres DIRECTOR ELECTIONS ISSUER 1160.676020 0.000000 FOR 1160.676020 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1160.676020 0.000000 FOR 1160.676020 FOR S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 1160.676020 0.000000 AGAINST 1160.676020 AGAINST S000004450 CELLDEX THERAPEUTICS, INC. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. COMPENSATION ISSUER 1160.676020 0.000000 FOR 1160.676020 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Election of Director to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. COMPENSATION ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 HEALTHEQUITY, INC. 42226A107 06/25/2026 To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 1526.707640 0.000000 FOR 1526.707640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno DIRECTOR ELECTIONS ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg DIRECTOR ELECTIONS ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison DIRECTOR ELECTIONS ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 Election of Class III director, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. COMPENSATION ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 TARSUS PHARMACEUTICALS, INC. 87650L103 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 551.053640 0.000000 FOR 551.053640 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 2951.187080 0.000000 WITHHOLD 2951.187080 AGAINST S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 2951.187080 0.000000 WITHHOLD 2951.187080 AGAINST S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 2951.187080 0.000000 WITHHOLD 2951.187080 AGAINST S000004450 Erasca, Inc. 29479A108 06/26/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2951.187080 0.000000 FOR 2951.187080 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub") and the Company, and approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 2016.395820 0.000000 FOR 2016.395820 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 2016.395820 0.000000 FOR 2016.395820 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 2016.395820 0.000000 FOR 2016.395820 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Shalini Sharp, M.B.A. DIRECTOR ELECTIONS ISSUER 193.789200 0.000000 FOR 193.789200 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Jake Simson, Ph.D. DIRECTOR ELECTIONS ISSUER 193.789200 0.000000 FOR 193.789200 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 193.789200 0.000000 FOR 193.789200 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 713.334120 0.000000 FOR 713.334120 FOR S000004450 ALUMIS INC 022307102 06/30/2026 Elect James B. Tananbaum DIRECTOR ELECTIONS ISSUER 1156.693470 0.000000 FOR 1156.693470 FOR S000004450 ALUMIS INC 022307102 06/30/2026 Elect Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 1156.693470 0.000000 FOR 1156.693470 FOR S000004450 ALUMIS INC 022307102 06/30/2026 Elect Zhengbin Yao DIRECTOR ELECTIONS ISSUER 1156.693470 0.000000 FOR 1156.693470 FOR S000004450 ALUMIS INC 022307102 06/30/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1156.693470 0.000000 FOR 1156.693470 FOR S000004450 agilon health, inc. 00857U107 03/17/2026 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); and CAPITAL STRUCTURE ISSUER 3515.840000 0.000000 FOR 3515.840000 FOR S000004450 agilon health, inc. 00857U107 03/17/2026 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal. CORPORATE GOVERNANCE ISSUER 3515.840000 0.000000 FOR 3515.840000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Albert G. White III DIRECTOR ELECTIONS ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1578.400000 0.000000 FOR 1578.400000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Jerome Durso DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect John M. Gill DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Philip L. Hodges DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Diane Jorkasky DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Teri Lawver DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Wayne Pisano DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Mitchel B. Sayare DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Klaus O. Schafer DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Catherine Angell Sohn DIRECTOR ELECTIONS ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock. CAPITAL STRUCTURE ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan COMPENSATION ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 1505.210000 0.000000 FOR 1505.210000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Frank A. D Amelio DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 1480.100000 0.000000 FOR 1480.100000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. COMPENSATION SECURITY HOLDER 1480.100000 0.000000 AGAINST 1480.100000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Gary D. Blackford DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): William P. Burke DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): James L. Cunniff DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Lisa Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Indrani L. Franchini DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Patrick J. O'Leary DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): David C. Pacitti DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Julie Shimer DIRECTOR ELECTIONS ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. COMPENSATION ISSUER 526.400000 0.000000 FOR 526.400000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 209.070000 0.000000 FOR 209.070000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 209.070000 0.000000 FOR 209.070000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 209.070000 0.000000 FOR 209.070000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 209.070000 0.000000 FOR 209.070000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 209.070000 0.000000 FOR 209.070000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Stockholder proposal regarding dual class capital structure. CAPITAL STRUCTURE SECURITY HOLDER 209.070000 0.000000 AGAINST 209.070000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Philip O. Ozuah DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 2986.190000 0.000000 FOR 2986.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 2986.190000 0.000000 AGAINST 2986.190000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 To ratify the appointment of Ernst & Young LLP as our Independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1832.460000 0.000000 FOR 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 1832.460000 0.000000 AGAINST 1832.460000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1832.460000 0.000000 AGAINST 1832.460000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Ari Bousbib DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Carol J. Burt DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: John G. Danhakl DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: James A. Fasano DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 1901.940000 0.000000 FOR 1901.940000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 1901.940000 0.000000 AGAINST 1901.940000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: John G. Morikis DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 26579.270000 0.000000 FOR 26579.270000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 26579.270000 0.000000 AGAINST 26579.270000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 63116.880000 0.000000 FOR 63116.880000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 63116.880000 0.000000 AGAINST 63116.880000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Parvinderjit S. Khanuja DIRECTOR ELECTIONS ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Robert A. Ortenzio DIRECTOR ELECTIONS ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Amendment to the Company's Amended and Restated Certificate of Incorporation to phase out the classified structure of the Board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1375.320000 0.000000 FOR 1375.320000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1375.320000 0.000000 AGAINST 1375.320000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. G. O Grady DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 19321.270000 0.000000 FOR 19321.270000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan DIRECTOR ELECTIONS ISSUER 1672.320000 0.000000 FOR 1672.320000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1672.320000 0.000000 FOR 1672.320000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin DIRECTOR ELECTIONS ISSUER 1672.320000 0.000000 FOR 1672.320000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. AUDIT-RELATED ISSUER 1672.320000 0.000000 FOR 1672.320000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1672.320000 0.000000 FOR 1672.320000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Pascale Witz DIRECTOR ELECTIONS ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To approve an amendment to Revvity's Amended and Restated By-Laws to Allow Shareholders Owning 25% of Our Stock to Call a Special Meeting. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1448.750000 0.000000 FOR 1448.750000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To approve the shareholder proposal regarding Executives to Retain Significant Stock. COMPENSATION SECURITY HOLDER 1448.750000 0.000000 AGAINST 1448.750000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Michael S. Klein DIRECTOR ELECTIONS ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Dale A. White DIRECTOR ELECTIONS ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 78.120000 0.000000 FOR 78.120000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal DIRECTOR ELECTIONS ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa DIRECTOR ELECTIONS ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 719.310000 0.000000 FOR 719.310000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Alan L. Rubino DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Heidi Hagen DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Kevin McLaughlin DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Paul Kevin Wotton DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Lisa Wright DIRECTOR ELECTIONS ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 684.870000 0.000000 FOR 684.870000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Susan E Morano DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Catherine R. Smith DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 20118.960000 0.000000 FOR 20118.960000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 20118.960000 0.000000 AGAINST 20118.960000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Vipin Gopal DIRECTOR ELECTIONS ISSUER 1488.700000 0.000000 FOR 1488.700000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: William Newton DIRECTOR ELECTIONS ISSUER 1488.700000 0.000000 FOR 1488.700000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins DIRECTOR ELECTIONS ISSUER 1488.700000 0.000000 FOR 1488.700000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1488.700000 0.000000 FOR 1488.700000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1488.700000 0.000000 FOR 1488.700000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jacqueline K. Barton, Ph.D DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jeffrey A. Bluestone, Ph.D DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Ted W. Love, M.D DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Harish Manwani DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 16837.760000 0.000000 FOR 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 16837.760000 0.000000 AGAINST 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 16837.760000 0.000000 AGAINST 16837.760000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 16837.760000 0.000000 AGAINST 16837.760000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Gary L. Ellis DIRECTOR ELECTIONS ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 357.350000 0.000000 ONE YEAR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 357.350000 0.000000 FOR 357.350000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 4526.400000 0.000000 FOR 4526.400000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Mr. Heinz Mausli DIRECTOR ELECTIONS ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 898.590000 0.000000 ONE YEAR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 898.590000 0.000000 FOR 898.590000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Samuel L. Barker DIRECTOR ELECTIONS ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Christopher J. Sobecki DIRECTOR ELECTIONS ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Judith L. Swain DIRECTOR ELECTIONS ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Ratification and approval of the Company's Seventh Amended and Restated Certificate of Incorporation CAPITAL STRUCTURE ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Approval of the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Approval of the Company's 2026 Non-Employee Directors Equity Incentive Plan COMPENSATION ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2473.280000 0.000000 FOR 2473.280000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Donal O Connor DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. AUDIT-RELATED ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To provide advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To renew the Board's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 1750.590000 0.000000 FOR 1750.590000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Cary S. Grace DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: James H. Hinton DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Celia P. Huber DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Eric P. Palmer DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of directors Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 493.720000 0.000000 FOR 493.720000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 A shareholder proposal entitled: "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 493.720000 0.000000 AGAINST 493.720000 FOR S000004450 Masimo Corporation 574795100 05/01/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo Corporation ("Masimo"), Danaher Corporation ("Danaher"), and Mobius Merger Sub, Inc., a wholly owned subsidiary of Danaher ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Masimo, with Masimo surviving the merger as a wholly owned subsidiary of Danaher (the "Merger" and such proposal, the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 767.470000 0.000000 FOR 767.470000 FOR S000004450 Masimo Corporation 574795100 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 767.470000 0.000000 FOR 767.470000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 8930.850000 0.000000 FOR 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 8930.850000 0.000000 AGAINST 8930.850000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 8930.850000 0.000000 AGAINST 8930.850000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Approval of the 2026 Equity Incentive Plan. COMPENSATION ISSUER 1011.520000 0.000000 FOR 1011.520000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 884.940000 0.000000 FOR 884.940000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Shareholder proposal regarding an independent Board Chair policy. CORPORATE GOVERNANCE SECURITY HOLDER 884.940000 0.000000 AGAINST 884.940000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Andrew P. Hider DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size CORPORATE GOVERNANCE ISSUER 7434.880000 0.000000 FOR 7434.880000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 29455.490000 0.000000 FOR 29455.490000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 29455.490000 0.000000 AGAINST 29455.490000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Steven Barg DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Mark Enyedy DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Birgit Girshick DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Paul Graves DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: George Llado DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Martin Mackay DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Virginia Wilson DIRECTOR ELECTIONS ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Advisory approval of 2025 executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 708.930000 0.000000 FOR 708.930000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 8627.400000 0.000000 FOR 8627.400000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman DIRECTOR ELECTIONS ISSUER 287.530000 0.000000 FOR 287.530000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis DIRECTOR ELECTIONS ISSUER 287.530000 0.000000 FOR 287.530000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 287.530000 0.000000 FOR 287.530000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 287.530000 0.000000 ONE YEAR 287.530000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 287.530000 0.000000 FOR 287.530000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 Election of Class I Directors: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 1678.110000 0.000000 FOR 1678.110000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 Election of Class I Directors: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 1678.110000 0.000000 FOR 1678.110000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1678.110000 0.000000 FOR 1678.110000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1678.110000 0.000000 FOR 1678.110000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Patrice A. Harris DIRECTOR ELECTIONS ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1250.260000 0.000000 FOR 1250.260000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Jeff George DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: John Kiely DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Paul Meister DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Ted Nark DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Chintu Patel DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Chirag Patel DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Gautam Patel DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 2278.100000 0.000000 FOR 2278.100000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 4330.680000 0.000000 FOR 4330.680000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Abbas Hussain DIRECTOR ELECTIONS ISSUER 4330.680000 0.000000 FOR 4330.680000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4330.680000 0.000000 FOR 4330.680000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4330.680000 0.000000 ONE YEAR 4330.680000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4330.680000 0.000000 FOR 4330.680000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Steven J. Orlando DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Ronna E. Romney DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Francis S. Soistman DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Dale B. Wolf DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 733.590000 0.000000 FOR 733.590000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To approve and adopt the Merger Agreement. EXTRAORDINARY TRANSACTIONS ISSUER 612.910000 0.000000 FOR 612.910000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 612.910000 0.000000 FOR 612.910000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To adjourn or postpone the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to the accompanying proxy statement/prospectus is timely provided to Penumbra Stockholders. CORPORATE GOVERNANCE ISSUER 612.910000 0.000000 FOR 612.910000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Ratification of appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4908.730000 0.000000 FOR 4908.730000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect William W. Burke DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Valerie Asbury DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Sheri Dodd DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Raymond Huggenberger DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Laura G. King DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Andrea A. Pearson DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Brent Shafer DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Carmen Volkart DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect B. Vindell Washington DIRECTOR ELECTIONS ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. CORPORATE GOVERNANCE ISSUER 321.270000 0.000000 FOR 321.270000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Simon Dingemans DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Lucier DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 9849.360000 0.000000 ONE YEAR 9849.360000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 9849.360000 0.000000 FOR 9849.360000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 8291.000000 0.000000 FOR 8291.000000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Joan E. Herman DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Terrance Williams DIRECTOR ELECTIONS ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1435.220000 0.000000 FOR 1435.220000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6498.790000 0.000000 FOR 6498.790000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade DIRECTOR ELECTIONS ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026. AUDIT-RELATED ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 959.070000 0.000000 FOR 959.070000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Pablo Perversi DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Brian Shepherd DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Ratification of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 291.320000 0.000000 FOR 291.320000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; Emil E. Hassan DIRECTOR ELECTIONS ISSUER 191.260000 0.000000 FOR 191.260000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; Lisa Piercey, M.D. DIRECTOR ELECTIONS ISSUER 191.260000 0.000000 FOR 191.260000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; William A. Adams DIRECTOR ELECTIONS ISSUER 191.260000 0.000000 FOR 191.260000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 191.260000 0.000000 FOR 191.260000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year AUDIT-RELATED ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year SECTION 14A SAY-ON-PAY VOTES ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan COMPENSATION ISSUER 1223.230000 0.000000 FOR 1223.230000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Say on pay - an advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting SHAREHOLDER RIGHTS AND DEFENSES ISSUER 25208.720000 0.000000 FOR 25208.720000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Stockholder proposal - to adopt a policy to require an independent chair CORPORATE GOVERNANCE SECURITY HOLDER 25208.720000 0.000000 AGAINST 25208.720000 FOR S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan DIRECTOR ELECTIONS ISSUER 231.410000 0.000000 FOR 231.410000 FOR S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick G. Enright DIRECTOR ELECTIONS ISSUER 231.410000 0.000000 FOR 231.410000 FOR S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 231.410000 0.000000 FOR 231.410000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect James W. Bullock DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Jon W. Salveson DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 576.470000 0.000000 FOR 576.470000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: H. James Dallas DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Monte E. Ford DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Sarah M. London DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 7100.300000 0.000000 FOR 7100.300000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Stockholder proposal regarding an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 7100.300000 0.000000 AGAINST 7100.300000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Kevin J. Hammons DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1830.480000 0.000000 FOR 1830.480000 FOR S000004450 Enhabit, Inc. 29332G102 05/12/2026 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 22, 2026, by and among Enhabit, Inc. ("Enhabit"), Anchor Parent, LLC, a Delaware limited liability company ("Parent"), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Enhabit, with Enhabit surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 935.330000 0.000000 FOR 935.330000 FOR S000004450 Enhabit, Inc. 29332G102 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 935.330000 0.000000 FOR 935.330000 FOR S000004450 Enhabit, Inc. 29332G102 05/12/2026 Approval of the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes virtually or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 935.330000 0.000000 FOR 935.330000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Daniel M. Junius DIRECTOR ELECTIONS ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting (Proposal Five). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1148.750000 0.000000 FOR 1148.750000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1148.750000 0.000000 AGAINST 1148.750000 FOR S000004450 Personalis, Inc. 71535D106 05/12/2026 Election of Directors: Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 785.600000 0.000000 FOR 785.600000 FOR S000004450 Personalis, Inc. 71535D106 05/12/2026 Election of Directors: Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 785.600000 0.000000 FOR 785.600000 FOR S000004450 Personalis, Inc. 71535D106 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 785.600000 0.000000 FOR 785.600000 FOR S000004450 Personalis, Inc. 71535D106 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 785.600000 0.000000 FOR 785.600000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 3144.260000 0.000000 FOR 3144.260000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 3144.260000 0.000000 FOR 3144.260000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 3144.260000 0.000000 FOR 3144.260000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 3144.260000 0.000000 FOR 3144.260000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 3144.260000 0.000000 FOR 3144.260000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 3144.260000 0.000000 AGAINST 3144.260000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Mr. Barry M. Smith DIRECTOR ELECTIONS ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Swati B. Abbott DIRECTOR ELECTIONS ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS II DIRECTOR FOR AN INITIAL ONE-YEAR TERM: Ms. Marivic Uychiat Pison DIRECTOR ELECTIONS ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 Approval, on an advisory basis, of our named executive officers compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 862.490000 0.000000 FOR 862.490000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Vivek Jain DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect David C. Greenberg DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Elisha W. Finney DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Donald M. Abbey DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Laurie Hernandez DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt astockholder right to call special meetings at an ownership threshold of 25%. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 367.300000 0.000000 FOR 367.300000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 367.300000 0.000000 AGAINST 367.300000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Dr. David Wheadon DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Joe Ciaffoni DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Dr. Keith Humphreys DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Tony Kingsley DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Daniel Ninivaggi DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Barbara Ryan DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Mark Stejbach DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Juliet Thompson DIRECTOR ELECTIONS ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1578.270000 0.000000 ONE YEAR 1578.270000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1578.270000 0.000000 FOR 1578.270000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 Elect Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 2895.110000 0.000000 FOR 2895.110000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 Elect Clarissa Desjardins DIRECTOR ELECTIONS ISSUER 2895.110000 0.000000 FOR 2895.110000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2895.110000 0.000000 FOR 2895.110000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2895.110000 0.000000 FOR 2895.110000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Martha G. Aronson (three (3) year term) DIRECTOR ELECTIONS ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) DIRECTOR ELECTIONS ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) DIRECTOR ELECTIONS ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Scott R. Ward (three (3) year term) DIRECTOR ELECTIONS ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 926.310000 0.000000 FOR 926.310000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Lloyd A. Carney DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 3650.170000 0.000000 FOR 3650.170000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 3650.170000 0.000000 AGAINST 3650.170000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Non-Binding advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Approval of the Accenda Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 918.790000 0.000000 FOR 918.790000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Richard E. Buller DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect David F. Dalvey DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Leo T. Furcht DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Lance G. Laing DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Polly A. Murphy DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Richard J. Nigon DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Charles Romp DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 307.720000 0.000000 FOR 307.720000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Arjun Bedi DIRECTOR ELECTIONS ISSUER 1878.610000 0.000000 FOR 1878.610000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Stephen M. McLean DIRECTOR ELECTIONS ISSUER 1878.610000 0.000000 FOR 1878.610000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Jon Resnick DIRECTOR ELECTIONS ISSUER 1878.610000 0.000000 FOR 1878.610000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1878.610000 0.000000 FOR 1878.610000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. SECTION 14A SAY-ON-PAY VOTES ISSUER 1878.610000 0.000000 FOR 1878.610000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 528.640000 0.000000 FOR 528.640000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 18264.420000 0.000000 FOR 18264.420000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 18264.420000 0.000000 AGAINST 18264.420000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Ming Hsieh DIRECTOR ELECTIONS ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Linda Dong DIRECTOR ELECTIONS ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Regina Groves DIRECTOR ELECTIONS ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To approve the Fulgent Genetics, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 310.460000 0.000000 FOR 310.460000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Geno Germano DIRECTOR ELECTIONS ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Troy Ignelzi DIRECTOR ELECTIONS ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Ron Philip DIRECTOR ELECTIONS ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Andreas Wicki DIRECTOR ELECTIONS ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 635.090000 0.000000 FOR 635.090000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company. Shane M. Cooke DIRECTOR ELECTIONS ISSUER 583.890000 0.000000 FOR 583.890000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company. Dennis J. Selkoe DIRECTOR ELECTIONS ISSUER 583.890000 0.000000 FOR 583.890000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 583.890000 0.000000 FOR 583.890000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 583.890000 0.000000 FOR 583.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 768.750000 0.000000 FOR 768.750000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 514.010000 0.000000 FOR 514.010000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: Brent J. Guerisoli DIRECTOR ELECTIONS ISSUER 514.010000 0.000000 FOR 514.010000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: John G. Nackel, Ph.D. DIRECTOR ELECTIONS ISSUER 514.010000 0.000000 FOR 514.010000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2026. AUDIT-RELATED ISSUER 514.010000 0.000000 FOR 514.010000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 514.010000 0.000000 FOR 514.010000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Emil D. Kakkis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Shehnaaz Suliman, M.D. DIRECTOR ELECTIONS ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1362.510000 0.000000 FOR 1362.510000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Elect Krish S. Krishnan DIRECTOR ELECTIONS ISSUER 342.180000 0.000000 FOR 342.180000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Elect Christopher Mason DIRECTOR ELECTIONS ISSUER 342.180000 0.000000 FOR 342.180000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 342.180000 0.000000 FOR 342.180000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 342.180000 0.000000 FOR 342.180000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the Company's Non-Employee Director Compensation Policy. COMPENSATION ISSUER 342.180000 0.000000 FOR 342.180000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Brian T. Carley DIRECTOR ELECTIONS ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Femida H. Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Robert O. Kraft DIRECTOR ELECTIONS ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect August J. Troendle DIRECTOR ELECTIONS ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Dani S. Zander DIRECTOR ELECTIONS ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 350.440000 0.000000 ONE YEAR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 350.440000 0.000000 FOR 350.440000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 350.440000 0.000000 AGAINST 350.440000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Arthur T. Sands DIRECTOR ELECTIONS ISSUER 1182.600000 0.000000 FOR 1182.600000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Roger D. Dansey DIRECTOR ELECTIONS ISSUER 1182.600000 0.000000 FOR 1182.600000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Paul M. Silva DIRECTOR ELECTIONS ISSUER 1182.600000 0.000000 FOR 1182.600000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026. AUDIT-RELATED ISSUER 1182.600000 0.000000 FOR 1182.600000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1182.600000 0.000000 FOR 1182.600000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Charles Kummeth DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Paula Dowdy DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Ruth Fattori DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Amir Jafri DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jack Kenny DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Brigid A. Makes DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Scott Mendel DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Kevin Rakin DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 2823.570000 0.000000 FOR 2823.570000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Carlos Alban DIRECTOR ELECTIONS ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Shirley Edwards DIRECTOR ELECTIONS ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2437.620000 0.000000 FOR 2437.620000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Neena M. Patil DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Approval, on an advisory basis, of Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 690.930000 0.000000 FOR 690.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 17985.930000 0.000000 FOR 17985.930000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Regina E. Groves DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Robert S. White DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Maggie Yuen DIRECTOR ELECTIONS ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. COMPENSATION ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 824.490000 0.000000 FOR 824.490000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 222.200000 0.000000 FOR 222.200000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect David Bronson DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect LaVerne Council DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Charles M. Farkas DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Mark Kaye DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Kim Kelderman DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Barbara J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 491.610000 0.000000 FOR 491.610000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8413.390000 0.000000 FOR 8413.390000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 8413.390000 0.000000 AGAINST 8413.390000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Damien McDonald DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Philip A. Okala DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Christine Ortiz DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Brady Shirley DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 950.100000 0.000000 FOR 950.100000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Wendy Carruthers DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Vivek Jain DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Paul Keel DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect J. Andrew Pierce DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Daniel A. Raskas DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Christine A. Tsingos DIRECTOR ELECTIONS ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2581.210000 0.000000 FOR 2581.210000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2581.210000 0.000000 ONE YEAR 2581.210000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien DIRECTOR ELECTIONS ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser DIRECTOR ELECTIONS ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst &Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 856.110000 0.000000 FOR 856.110000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer DIRECTOR ELECTIONS ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim DIRECTOR ELECTIONS ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick DIRECTOR ELECTIONS ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates. CORPORATE GOVERNANCE ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 745.470000 0.000000 FOR 745.470000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta DIRECTOR ELECTIONS ISSUER 734.600000 0.000000 FOR 734.600000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder DIRECTOR ELECTIONS ISSUER 734.600000 0.000000 FOR 734.600000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse DIRECTOR ELECTIONS ISSUER 734.600000 0.000000 FOR 734.600000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 734.600000 0.000000 FOR 734.600000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 734.600000 0.000000 FOR 734.600000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Roy D. Baynes DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Timothy Coughlin DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Eric Dube DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Gary Lyons DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect John Orwin DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Sandra Poole DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Ron Squarer DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1333.810000 0.000000 ONE YEAR 1333.810000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1333.810000 0.000000 FOR 1333.810000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Lance Berry DIRECTOR ELECTIONS ISSUER 792.640000 0.000000 FOR 792.640000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Elizabeth Hanna DIRECTOR ELECTIONS ISSUER 792.640000 0.000000 FOR 792.640000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Jane E. Kiernan DIRECTOR ELECTIONS ISSUER 792.640000 0.000000 FOR 792.640000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 792.640000 0.000000 FOR 792.640000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31. 2026. AUDIT-RELATED ISSUER 792.640000 0.000000 FOR 792.640000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Christopher J. Reading DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Bernard A. Harris, Jr. DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Reginald E. Swanson DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Peter F. Minan DIRECTOR ELECTIONS ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 242.560000 0.000000 FOR 242.560000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 Elect J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 1675.800000 0.000000 FOR 1675.800000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 Elect S. Kathy Rouan DIRECTOR ELECTIONS ISSUER 1675.800000 0.000000 FOR 1675.800000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 To ratify the selection of CBIZ CPAS P.C. as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1675.800000 0.000000 FOR 1675.800000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1675.800000 0.000000 FOR 1675.800000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Joseph Lacob DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Anne M. Myong DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Britt Vitalone DIRECTOR ELECTIONS ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Ratification Of Appointment Of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Ratification of Special Meeting Provision in our Bylaws SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1071.590000 0.000000 FOR 1071.590000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Companys 2027 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 2267.210000 0.000000 FOR 2267.210000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 2098.270000 0.000000 FOR 2098.270000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 2098.270000 0.000000 FOR 2098.270000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2098.270000 0.000000 FOR 2098.270000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2098.270000 0.000000 FOR 2098.270000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2098.270000 0.000000 FOR 2098.270000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Mark Sotir DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Martin J. Bonick DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Peter Bulgarelli DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Peter C.B. Bynoe DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Suzanne Campion DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Robert A. Demichiei DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect William M. Goodyear DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Ellen Havdala DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Edmondo Robinson DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Rahul Sen DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Robert Webb DIRECTOR ELECTIONS ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 469.740000 0.000000 FOR 469.740000 FOR S000004450 Geron Corporation 374163103 05/20/2026 Elect Susan M. Molineaux DIRECTOR ELECTIONS ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Geron Corporation 374163103 05/20/2026 Elect Patricia S. Andrews DIRECTOR ELECTIONS ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Geron Corporation 374163103 05/20/2026 Elect Constantine Chinoporos DIRECTOR ELECTIONS ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement. COMPENSATION ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7911.300000 0.000000 FOR 7911.300000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 Elect Luciana Borio DIRECTOR ELECTIONS ISSUER 1104.750000 0.000000 FOR 1104.750000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 Elect Michael R. Minogue DIRECTOR ELECTIONS ISSUER 1104.750000 0.000000 FOR 1104.750000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 Elect TImothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 1104.750000 0.000000 FOR 1104.750000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1104.750000 0.000000 FOR 1104.750000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1104.750000 0.000000 FOR 1104.750000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Sheila Antrum DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Michael J. Coyle DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Flanagan DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Hinrichs DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Aaron Kapito DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Payman Khales DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Filippo Passerini DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Donald J. Spence DIRECTOR ELECTIONS ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To approve the Integer Holdings Corporation 2026 Omnibus Incentive Plan. COMPENSATION ISSUER 590.060000 0.000000 FOR 590.060000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect James S. Shannon DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Michael E. Castagna DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Steven B. Binder DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Michael A. Friedman DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Jennifer Grancio DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Anthony Hooper DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Sabrina Kay DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Christine Mundkur DIRECTOR ELECTIONS ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4577.470000 0.000000 FOR 4577.470000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Eric K. Brandt DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Natasha Deckmann DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect R. Carter Pate DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect John C. Rademacher DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Norman L. Wright DIRECTOR ELECTIONS ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2495.120000 0.000000 FOR 2495.120000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy Cocozza DIRECTOR ELECTIONS ISSUER 1547.780000 0.000000 FOR 1547.780000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David King DIRECTOR ELECTIONS ISSUER 1547.780000 0.000000 FOR 1547.780000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis Soistman DIRECTOR ELECTIONS ISSUER 1547.780000 0.000000 FOR 1547.780000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1547.780000 0.000000 FOR 1547.780000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1547.780000 0.000000 FOR 1547.780000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Robert B. Carter DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors James E. Davis DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Tracey C. Doi DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy L. Main DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Denise M. Morrison DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy M. Ring DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy C. Wentworth DIRECTOR ELECTIONS ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1747.930000 0.000000 FOR 1747.930000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 1747.930000 0.000000 AGAINST 1747.930000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Peter Fong, Ph.D. DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Carsten Boess DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; David P. Southwell DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The ratification of the appointment of Eisner Amper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The approval of the proposed stock option exchange program COMPENSATION ISSUER 1277.760000 0.000000 FOR 1277.760000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1064.740000 0.000000 FOR 1064.740000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 5902.040000 0.000000 FOR 5902.040000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Edward M. Basile DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Merilee Raines DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. COMPENSATION ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 515.170000 0.000000 FOR 515.170000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Election of Director: Nina Chen-Langenmayr DIRECTOR ELECTIONS ISSUER 868.010000 0.000000 FOR 868.010000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 868.010000 0.000000 FOR 868.010000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 868.010000 0.000000 FOR 868.010000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 868.010000 0.000000 AGAINST 868.010000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 868.010000 0.000000 AGAINST 868.010000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7325.610000 0.000000 ONE YEAR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 7325.610000 0.000000 FOR 7325.610000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Shareholder proposal to permit shareholder action by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 7325.610000 0.000000 AGAINST 7325.610000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 283.390000 0.000000 ONE YEAR 283.390000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 283.390000 0.000000 FOR 283.390000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Olivia F. Kirtley DIRECTOR ELECTIONS ISSUER 2406.460000 0.000000 FOR 2406.460000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Max C. Lin DIRECTOR ELECTIONS ISSUER 2406.460000 0.000000 FOR 2406.460000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Steve Miller DIRECTOR ELECTIONS ISSUER 2406.460000 0.000000 FOR 2406.460000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 2406.460000 0.000000 FOR 2406.460000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 2406.460000 0.000000 FOR 2406.460000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Jack Phillips DIRECTOR ELECTIONS ISSUER 1810.320000 0.000000 FOR 1810.320000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Hermann F. Requardt DIRECTOR ELECTIONS ISSUER 1810.320000 0.000000 FOR 1810.320000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Laura A. Francis DIRECTOR ELECTIONS ISSUER 1810.320000 0.000000 FOR 1810.320000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1810.320000 0.000000 FOR 1810.320000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1810.320000 0.000000 FOR 1810.320000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Gregg Alton DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: David L. Mahoney DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Kimberly Park DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: James N. Wilson DIRECTOR ELECTIONS ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. COMPENSATION ISSUER 1937.250000 0.000000 FOR 1937.250000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 584.230000 0.000000 FOR 584.230000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 584.230000 0.000000 FOR 584.230000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 584.230000 0.000000 FOR 584.230000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 584.230000 0.000000 FOR 584.230000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 584.230000 0.000000 FOR 584.230000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kapila Anand DIRECTOR ELECTIONS ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Paul Herendeen DIRECTOR ELECTIONS ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Michael Harrington DIRECTOR ELECTIONS ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kirk McDonald DIRECTOR ELECTIONS ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8198.440000 0.000000 FOR 8198.440000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Mohamad Ali DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Deborah Derby DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Carole T. Faig DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Max Lin DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 1665.660000 0.000000 FOR 1665.660000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1665.660000 0.000000 AGAINST 1665.660000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. David P. King DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Keith A. Meister DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Anna Richo DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Philip W. Schiller DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Susan E. Siegel DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Scott B. Ullem DIRECTOR ELECTIONS ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2518.230000 0.000000 FOR 2518.230000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Victor Bulto DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1365.970000 0.000000 FOR 1365.970000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 721.740000 0.000000 FOR 721.740000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 721.740000 0.000000 FOR 721.740000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 721.740000 0.000000 FOR 721.740000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 721.740000 0.000000 FOR 721.740000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: John P. Kenny DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 2039.540000 0.000000 FOR 2039.540000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Elect Robert B. Bazemore Jr. DIRECTOR ELECTIONS ISSUER 3521.750000 0.000000 FOR 3521.750000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Elect Robert Mashal DIRECTOR ELECTIONS ISSUER 3521.750000 0.000000 FOR 3521.750000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3521.750000 0.000000 FOR 3521.750000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3521.750000 0.000000 FOR 3521.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Lloyd Dean DIRECTOR ELECTIONS ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Kevin Gordon DIRECTOR ELECTIONS ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1358.750000 0.000000 FOR 1358.750000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Sean L. Cunningham DIRECTOR ELECTIONS ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Richard G. Kyle DIRECTOR ELECTIONS ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Vincent K. Petrella DIRECTOR ELECTIONS ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3638.230000 0.000000 FOR 3638.230000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Susan R. Salka DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Michael S. Smith DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2917.720000 0.000000 FOR 2917.720000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Peter Barris DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Eric D. Belcher DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect David R. Epstein DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Wayne A.I. Frederick DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Scott Gottlieb DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Nadja Y. West DIRECTOR ELECTIONS ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1544.910000 0.000000 FOR 1544.910000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1544.910000 0.000000 THREE YEARS 1544.910000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect Michael M. Morrissey DIRECTOR ELECTIONS ISSUER 602.680000 0.000000 FOR 602.680000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect Patrick G. Enright DIRECTOR ELECTIONS ISSUER 602.680000 0.000000 FOR 602.680000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect James R. Meyers DIRECTOR ELECTIONS ISSUER 602.680000 0.000000 FOR 602.680000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 602.680000 0.000000 FOR 602.680000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 602.680000 0.000000 FOR 602.680000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Michael P. Bailey DIRECTOR ELECTIONS ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Brian Stuglik DIRECTOR ELECTIONS ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Karin Tollefson DIRECTOR ELECTIONS ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive Plan. COMPENSATION ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase Plan. COMPENSATION ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 676.910000 0.000000 FOR 676.910000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1547.660000 0.000000 FOR 1547.660000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Owen Hughes DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Heather L. Franklin DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Natasha A. Hernday DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Barbara Kosacz DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Joseph M. Limber DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Matthew D. Perry DIRECTOR ELECTIONS ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan. COMPENSATION ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of the 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153.060000 0.000000 FOR 153.060000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Filippo "Peter" Caldini DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Leslie Gillin DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Edward Schutter DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3.620000 51600.000000 FOR 3.620000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation " Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 3148.990000 0.000000 FOR 3148.990000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Shareholder proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 3148.990000 0.000000 AGAINST 3148.990000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Lindsay Androski DIRECTOR ELECTIONS ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Robert A. Beardsley DIRECTOR ELECTIONS ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Joseph Bishop DIRECTOR ELECTIONS ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Matthew Gline DIRECTOR ELECTIONS ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Roger Sawhney DIRECTOR ELECTIONS ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan. COMPENSATION ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2398.690000 0.000000 FOR 2398.690000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver Jr. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. AUDIT-RELATED ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. COMPENSATION ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4279.410000 0.000000 FOR 4279.410000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Bernd Brust DIRECTOR ELECTIONS ISSUER 1802.360000 0.000000 FOR 1802.360000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 1802.360000 0.000000 FOR 1802.360000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Luke Marker DIRECTOR ELECTIONS ISSUER 1802.360000 0.000000 FOR 1802.360000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 To ratify the appointment of Deloitte & Touche LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1802.360000 0.000000 FOR 1802.360000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1802.360000 0.000000 FOR 1802.360000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Patrick F. Russo DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 41256.470000 0.000000 FOR 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 41256.470000 0.000000 AGAINST 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 41256.470000 0.000000 AGAINST 41256.470000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 41256.470000 0.000000 AGAINST 41256.470000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBA DIRECTOR ELECTIONS ISSUER 1975.210000 0.000000 FOR 1975.210000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. DIRECTOR ELECTIONS ISSUER 1975.210000 0.000000 FOR 1975.210000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1975.210000 0.000000 FOR 1975.210000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1975.210000 0.000000 FOR 1975.210000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1975.210000 0.000000 FOR 1975.210000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1953.940000 0.000000 FOR 1953.940000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 6641.330000 0.000000 FOR 6641.330000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Cathleen Noel Bairey Merz DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Quentin Blackford DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Bruce G. Bodaken DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Karen L. Ling DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Kevin C. O'Boyle DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Jason Patten DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Abhijit Y. Talwalkar DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Brian Yoor DIRECTOR ELECTIONS ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve the adoption of our 2026 Equity Incentive Plan. COMPENSATION ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. CORPORATE GOVERNANCE ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 548.240000 0.000000 FOR 548.240000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns DIRECTOR ELECTIONS ISSUER 1063.910000 0.000000 FOR 1063.910000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Matthew Fust DIRECTOR ELECTIONS ISSUER 1063.910000 0.000000 FOR 1063.910000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: David Piacquad DIRECTOR ELECTIONS ISSUER 1063.910000 0.000000 FOR 1063.910000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Emst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1063.910000 0.000000 FOR 1063.910000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1063.910000 0.000000 FOR 1063.910000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1063.910000 0.000000 ONE YEAR 1063.910000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Gary Lyons DIRECTOR ELECTIONS ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Johanna Mercier DIRECTOR ELECTIONS ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1675.040000 0.000000 FOR 1675.040000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Lori A. Woods DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Heidi Henson DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Robert Froman Williamson III DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Frank Morich DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Maya Martinez-Davis DIRECTOR ELECTIONS ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1644.070000 0.000000 FOR 1644.070000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1644.070000 0.000000 ONE YEAR 1644.070000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Cameron Turtle DIRECTOR ELECTIONS ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Laurie D. Stelzer DIRECTOR ELECTIONS ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. COMPENSATION ISSUER 832.930000 0.000000 FOR 832.930000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Roy Blunt DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Richard J. Mark DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Tammy Romo DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1495.080000 0.000000 FOR 1495.080000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Ellen Goldberg DIRECTOR ELECTIONS ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Miles D. Harrison DIRECTOR ELECTIONS ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Tiffany P. Olson DIRECTOR ELECTIONS ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To approve our non-employee director compensation policy. COMPENSATION ISSUER 495.430000 0.000000 FOR 495.430000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 Election of Class I Directors: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 4010.650000 0.000000 FOR 4010.650000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 Election of Class I Directors: Sheldon L. Koenig DIRECTOR ELECTIONS ISSUER 4010.650000 0.000000 FOR 4010.650000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4010.650000 0.000000 FOR 4010.650000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4010.650000 0.000000 FOR 4010.650000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan. COMPENSATION ISSUER 4010.650000 0.000000 FOR 4010.650000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Elect Denice M. Torres DIRECTOR ELECTIONS ISSUER 978.810000 0.000000 FOR 978.810000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Elect Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 978.810000 0.000000 FOR 978.810000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 978.810000 0.000000 FOR 978.810000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 978.810000 0.000000 FOR 978.810000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir DIRECTOR ELECTIONS ISSUER 391.920000 0.000000 FOR 391.920000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Jeffrey L. McLaren DIRECTOR ELECTIONS ISSUER 391.920000 0.000000 FOR 391.920000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick DIRECTOR ELECTIONS ISSUER 391.920000 0.000000 FOR 391.920000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 391.920000 0.000000 FOR 391.920000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 391.920000 0.000000 FOR 391.920000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable DIRECTOR ELECTIONS ISSUER 227.680000 0.000000 FOR 227.680000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS ISSUER 227.680000 0.000000 FOR 227.680000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More DIRECTOR ELECTIONS ISSUER 227.680000 0.000000 FOR 227.680000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 227.680000 0.000000 FOR 227.680000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly DIRECTOR ELECTIONS ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu DIRECTOR ELECTIONS ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. COMPENSATION ISSUER 2759.190000 0.000000 FOR 2759.190000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Rodney D. Windley DIRECTOR ELECTIONS ISSUER 895.510000 0.000000 FOR 895.510000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Sam Weil DIRECTOR ELECTIONS ISSUER 895.510000 0.000000 FOR 895.510000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Steven E. Rodgers DIRECTOR ELECTIONS ISSUER 895.510000 0.000000 FOR 895.510000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. AUDIT-RELATED ISSUER 895.510000 0.000000 FOR 895.510000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 895.510000 0.000000 FOR 895.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. COMPENSATION ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 620.510000 0.000000 FOR 620.510000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Jean Bennett DIRECTOR ELECTIONS ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Argeris N. Karabelas DIRECTOR ELECTIONS ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Daniel Tasse DIRECTOR ELECTIONS ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To approve a stock option exchange for our non-executive employees. COMPENSATION ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To approve a stock option exchange for our executive employees. COMPENSATION ISSUER 723.520000 0.000000 FOR 723.520000 FOR S000004450 Talkspace, Inc. 87427V103 05/29/2026 To adopt the Agreement and Plan of Merger, dated as of March 9, 2026, by and among Talkspace, Inc., a Delaware corporation (the "Company"), Universal Health Services, Inc., a Delaware corporation ("UHS"), UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of UHS ("Merger Sub"), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company continuing as the surviving corporation in the merger as an indirect wholly owned subsidiary of UHS. EXTRAORDINARY TRANSACTIONS ISSUER 3009.650000 0.000000 FOR 3009.650000 FOR S000004450 Talkspace, Inc. 87427V103 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 3009.650000 0.000000 FOR 3009.650000 FOR S000004450 Talkspace, Inc. 87427V103 05/29/2026 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 3009.650000 0.000000 FOR 3009.650000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: David Gaugh DIRECTOR ELECTIONS ISSUER 628.080000 0.000000 FOR 628.080000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: William J. Peters DIRECTOR ELECTIONS ISSUER 628.080000 0.000000 FOR 628.080000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi DIRECTOR ELECTIONS ISSUER 628.080000 0.000000 FOR 628.080000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 628.080000 0.000000 FOR 628.080000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 628.080000 0.000000 FOR 628.080000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 628.080000 0.000000 ONE YEAR 628.080000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 Elect Sean P. Nolan DIRECTOR ELECTIONS ISSUER 2704.650000 0.000000 FOR 2704.650000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 Elect Laura Sepp-Lorenzino DIRECTOR ELECTIONS ISSUER 2704.650000 0.000000 FOR 2704.650000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2704.650000 0.000000 FOR 2704.650000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2704.650000 0.000000 FOR 2704.650000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2704.650000 0.000000 ONE YEAR 2704.650000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Charles Baker DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Timothy Flynn DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Paul Garcia DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Kristen Gil DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Stephen Hemsley DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. F. William McNabb III DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 15415.200000 0.000000 FOR 15415.200000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 15415.200000 0.000000 AGAINST 15415.200000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Robert A. Demichiei DIRECTOR ELECTIONS ISSUER 1975.560000 0.000000 FOR 1975.560000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect John P. Driscoll DIRECTOR ELECTIONS ISSUER 1975.560000 0.000000 FOR 1975.560000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 1975.560000 0.000000 FOR 1975.560000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Lauren Young DIRECTOR ELECTIONS ISSUER 1975.560000 0.000000 FOR 1975.560000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1975.560000 0.000000 FOR 1975.560000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1975.560000 0.000000 ONE YEAR 1975.560000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Alison C. Finger DIRECTOR ELECTIONS ISSUER 4716.940000 0.000000 FOR 4716.940000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Eduardo Rene Salas DIRECTOR ELECTIONS ISSUER 4716.940000 0.000000 FOR 4716.940000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4716.940000 0.000000 FOR 4716.940000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4716.940000 0.000000 FOR 4716.940000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Diana Mckenzie DIRECTOR ELECTIONS ISSUER 294.520000 0.000000 FOR 294.520000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Karen McLoughlin DIRECTOR ELECTIONS ISSUER 294.520000 0.000000 FOR 294.520000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Ronald Williams DIRECTOR ELECTIONS ISSUER 294.520000 0.000000 FOR 294.520000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 294.520000 0.000000 FOR 294.520000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 294.520000 0.000000 FOR 294.520000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Ian T. Clark DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 3152.120000 0.000000 FOR 3152.120000 FOR S000004450 CeriBell, Inc. 15678C102 06/02/2026 Election of Directors: Josef Parvizi, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 314.140000 0.000000 FOR 314.140000 FOR S000004450 CeriBell, Inc. 15678C102 06/02/2026 Election of Directors: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 314.140000 0.000000 FOR 314.140000 FOR S000004450 CeriBell, Inc. 15678C102 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 314.140000 0.000000 FOR 314.140000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 Elect William M. Greenman DIRECTOR ELECTIONS ISSUER 4021.570000 0.000000 FOR 4021.570000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 Elect Ann Lucena DIRECTOR ELECTIONS ISSUER 4021.570000 0.000000 FOR 4021.570000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 4021.570000 0.000000 FOR 4021.570000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4021.570000 0.000000 FOR 4021.570000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The ratification of the selection by the Audit Committee of the Board of Directors of Emst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4021.570000 0.000000 FOR 4021.570000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Michael J. Barber DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: James D. Forbes DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 3434.080000 0.000000 FOR 3434.080000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 498.730000 0.000000 FOR 498.730000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Bassil I. Dahiyat, Ph.D. DIRECTOR ELECTIONS ISSUER 498.730000 0.000000 FOR 498.730000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Taiyin Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 498.730000 0.000000 FOR 498.730000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 498.730000 0.000000 FOR 498.730000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 498.730000 0.000000 FOR 498.730000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 Election of Director: David B. Roberts DIRECTOR ELECTIONS ISSUER 370.670000 0.000000 FOR 370.670000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 Election of Director: John A. Roush DIRECTOR ELECTIONS ISSUER 370.670000 0.000000 FOR 370.670000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 370.670000 0.000000 FOR 370.670000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 370.670000 0.000000 FOR 370.670000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: David Bourdon DIRECTOR ELECTIONS ISSUER 3596.720000 0.000000 FOR 3596.720000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D. DIRECTOR ELECTIONS ISSUER 3596.720000 0.000000 FOR 3596.720000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP ('PwC') as our independent registered public accounting firm for the year ended December 31, 2026. AUDIT-RELATED ISSUER 3596.720000 0.000000 FOR 3596.720000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3596.720000 0.000000 FOR 3596.720000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. John W. Smither until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. Janneke van der Kamp until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1333.320000 0.000000 FOR 1333.320000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 Elect Lawrence Klein DIRECTOR ELECTIONS ISSUER 375.000000 0.000000 FOR 375.000000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 Elect Chris Martin DIRECTOR ELECTIONS ISSUER 375.000000 0.000000 FOR 375.000000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 375.000000 0.000000 FOR 375.000000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 375.000000 0.000000 FOR 375.000000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jessica Chutter DIRECTOR ELECTIONS ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Matthew B. Klein DIRECTOR ELECTIONS ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Stephanie S. Okey DIRECTOR ELECTIONS ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jerome B. Zeldis DIRECTOR ELECTIONS ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1490.700000 0.000000 FOR 1490.700000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Howard G. Berger DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect A. Gregory Sorensen DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect David L. Swartz DIRECTOR ELECTIONS ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 1128.590000 0.000000 FOR 1128.590000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 1124.400000 0.000000 FOR 1124.400000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. Moses DIRECTOR ELECTIONS ISSUER 1124.400000 0.000000 FOR 1124.400000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1124.400000 0.000000 FOR 1124.400000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1124.400000 0.000000 FOR 1124.400000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1124.400000 0.000000 ONE YEAR 1124.400000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Kevin Tang DIRECTOR ELECTIONS ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Kathy Goetz DIRECTOR ELECTIONS ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Craig Johnson DIRECTOR ELECTIONS ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Advisory Resolution on Executive Compensation: To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 2599.260000 0.000000 FOR 2599.260000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Evans DIRECTOR ELECTIONS ISSUER 1574.080000 0.000000 FOR 1574.080000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 1574.080000 0.000000 FOR 1574.080000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw DIRECTOR ELECTIONS ISSUER 1574.080000 0.000000 FOR 1574.080000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1574.080000 0.000000 FOR 1574.080000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1574.080000 0.000000 FOR 1574.080000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect William A. Hawkins DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect John A. Bartholdson DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Ajay Dhankar DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Mary Kay Ladone DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Guido J. Neels DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Guy P. Nohra DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Susan M. Stalnecker DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Martin P. Sutter DIRECTOR ELECTIONS ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 688.730000 0.000000 FOR 688.730000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 2845.750000 0.000000 FOR 2845.750000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 2845.750000 0.000000 FOR 2845.750000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect Ryan J. Watts DIRECTOR ELECTIONS ISSUER 2845.750000 0.000000 FOR 2845.750000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2845.750000 0.000000 FOR 2845.750000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2845.750000 0.000000 FOR 2845.750000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 2422.180000 0.000000 FOR 2422.180000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 2422.180000 0.000000 FOR 2422.180000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 2422.180000 0.000000 FOR 2422.180000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2422.180000 0.000000 FOR 2422.180000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 2422.180000 0.000000 FOR 2422.180000 FOR S000004450 Hinge Health, Inc. 433313103 06/03/2026 Elect Teddie Wardi DIRECTOR ELECTIONS ISSUER 361.780000 0.000000 FOR 361.780000 FOR S000004450 Hinge Health, Inc. 433313103 06/03/2026 Elect Tyler Sloat DIRECTOR ELECTIONS ISSUER 361.780000 0.000000 FOR 361.780000 FOR S000004450 Hinge Health, Inc. 433313103 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 361.780000 0.000000 FOR 361.780000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To elect the two (2) nominees for Class IIl director named below to hold office until the 2029 Annual Meeting of Stockholders. Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 282.980000 0.000000 FOR 282.980000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To elect the two (2) nominees for Class IIl director named below to hold office until the 2029 Annual Meeting of Stockholders. Charles Newton DIRECTOR ELECTIONS ISSUER 282.980000 0.000000 FOR 282.980000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 282.980000 0.000000 FOR 282.980000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 282.980000 0.000000 FOR 282.980000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Frank Leonard DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 The approval of our amended and restated 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 1826.510000 0.000000 FOR 1826.510000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. John D. Bertrand DIRECTOR ELECTIONS ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. Steven K. Boyd DIRECTOR ELECTIONS ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. Robert W. McMahon DIRECTOR ELECTIONS ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. COMPENSATION ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve an amendment to the Company's Certificate of Incorporation to declassify the Company's Board of Directors and add certain clarifying changes. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1290.610000 0.000000 FOR 1290.610000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: William Ericson DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Christian O. Henry DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: John F. Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 4413.730000 0.000000 FOR 4413.730000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Clare Kahn DIRECTOR ELECTIONS ISSUER 689.300000 0.000000 FOR 689.300000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Adrian R. Krainer DIRECTOR ELECTIONS ISSUER 689.300000 0.000000 FOR 689.300000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Julie Anne Smith DIRECTOR ELECTIONS ISSUER 689.300000 0.000000 FOR 689.300000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 689.300000 0.000000 FOR 689.300000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 689.300000 0.000000 FOR 689.300000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders. Nominee: Michael Heffernan DIRECTOR ELECTIONS ISSUER 1463.220000 0.000000 FOR 1463.220000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1463.220000 0.000000 FOR 1463.220000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1463.220000 0.000000 FOR 1463.220000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan. COMPENSATION ISSUER 1463.220000 0.000000 FOR 1463.220000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 1463.220000 0.000000 FOR 1463.220000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov DIRECTOR ELECTIONS ISSUER 2076.450000 0.000000 FOR 2076.450000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 2076.450000 0.000000 FOR 2076.450000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 2076.450000 0.000000 FOR 2076.450000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2076.450000 0.000000 FOR 2076.450000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2076.450000 0.000000 FOR 2076.450000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jody Bilney DIRECTOR ELECTIONS ISSUER 2900.460000 0.000000 FOR 2900.460000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 2900.460000 0.000000 FOR 2900.460000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 2900.460000 0.000000 FOR 2900.460000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 2900.460000 0.000000 FOR 2900.460000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2900.460000 0.000000 FOR 2900.460000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. DIRECTOR ELECTIONS ISSUER 1354.440000 0.000000 FOR 1354.440000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 1354.440000 0.000000 FOR 1354.440000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1354.440000 0.000000 FOR 1354.440000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1354.440000 0.000000 FOR 1354.440000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 737.980000 0.000000 FOR 737.980000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 737.980000 0.000000 FOR 737.980000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 737.980000 0.000000 FOR 737.980000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 737.980000 0.000000 FOR 737.980000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 737.980000 0.000000 ONE YEAR 737.980000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 To ratify the appolntment of KPMG LLP as our Independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 794.260000 0.000000 FOR 794.260000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Sastry Chilukuri DIRECTOR ELECTIONS ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Chris Egan DIRECTOR ELECTIONS ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Samuel A. Hamood DIRECTOR ELECTIONS ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan (the "2021 Plan"), to increase the number of shares of Class A Common Stock, par value $0.001 per share that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. COMPENSATION ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 811.720000 0.000000 FOR 811.720000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Laura A. Brege DIRECTOR ELECTIONS ISSUER 1086.130000 0.000000 FOR 1086.130000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Badreddin Edris DIRECTOR ELECTIONS ISSUER 1086.130000 0.000000 FOR 1086.130000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Jonathan Root DIRECTOR ELECTIONS ISSUER 1086.130000 0.000000 FOR 1086.130000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1086.130000 0.000000 FOR 1086.130000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1086.130000 0.000000 FOR 1086.130000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Shawn Guertin DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Jill Smith DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 1927.880000 0.000000 FOR 1927.880000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Election of Class II Directors: Russell Cox DIRECTOR ELECTIONS ISSUER 4342.690000 0.000000 FOR 4342.690000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Election of Class II Directors: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 4342.690000 0.000000 FOR 4342.690000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4342.690000 0.000000 FOR 4342.690000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4342.690000 0.000000 FOR 4342.690000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Joan E. Herman DIRECTOR ELECTIONS ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 2658.220000 0.000000 FOR 2658.220000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Diane Parks DIRECTOR ELECTIONS ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Mary T. Szela DIRECTOR ELECTIONS ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Michael J. Vasconcelles, M.D. DIRECTOR ELECTIONS ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1268.070000 0.000000 ONE YEAR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval of an amendment to our 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 1268.070000 0.000000 FOR 1268.070000 FOR S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 459.120000 0.000000 FOR 459.120000 FOR S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 459.120000 0.000000 FOR 459.120000 FOR S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 459.120000 0.000000 FOR 459.120000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Election of the Class I director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified. Spike Loy DIRECTOR ELECTIONS ISSUER 648.540000 0.000000 FOR 648.540000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 648.540000 0.000000 FOR 648.540000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 648.540000 0.000000 FOR 648.540000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan. COMPENSATION ISSUER 648.540000 0.000000 FOR 648.540000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 1823.930000 0.000000 FOR 1823.930000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 Election of Director: Howard W. Robin DIRECTOR ELECTIONS ISSUER 415.790000 0.000000 FOR 415.790000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 415.790000 0.000000 FOR 415.790000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 415.790000 0.000000 FOR 415.790000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 415.790000 0.000000 FOR 415.790000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD DIRECTOR ELECTIONS ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Kelly Fischer DIRECTOR ELECTIONS ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Harald Ruf DIRECTOR ELECTIONS ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve an amendment to the 2024 Incentive Award Plan. COMPENSATION ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 300.390000 0.000000 FOR 300.390000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Hans E. Bishop DIRECTOR ELECTIONS ISSUER 2996.170000 0.000000 FOR 2996.170000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Robert Nelsen DIRECTOR ELECTIONS ISSUER 2996.170000 0.000000 FOR 2996.170000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Alise S. Reicin, M.D. DIRECTOR ELECTIONS ISSUER 2996.170000 0.000000 FOR 2996.170000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2996.170000 0.000000 FOR 2996.170000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 1970.800000 0.000000 FOR 1970.800000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000. CAPITAL STRUCTURE ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000. COMPENSATION ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 1188.180000 0.000000 FOR 1188.180000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect David Hallal DIRECTOR ELECTIONS ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Kristina M. Burow DIRECTOR ELECTIONS ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Michael Gilman DIRECTOR ELECTIONS ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Katie Peng DIRECTOR ELECTIONS ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1290.700000 0.000000 FOR 1290.700000 FOR S000004450 SI-BONE, Inc. 825704109 06/04/2026 Election of Directors: Jeffrey W. Dunn DIRECTOR ELECTIONS ISSUER 703.750000 0.000000 FOR 703.750000 FOR S000004450 SI-BONE, Inc. 825704109 06/04/2026 Election of Directors: John G. Freund, M.D. DIRECTOR ELECTIONS ISSUER 703.750000 0.000000 FOR 703.750000 FOR S000004450 SI-BONE, Inc. 825704109 06/04/2026 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 703.750000 0.000000 FOR 703.750000 FOR S000004450 SI-BONE, Inc. 825704109 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 703.750000 0.000000 FOR 703.750000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Malte Peters, M.D. DIRECTOR ELECTIONS ISSUER 775.020000 0.000000 FOR 775.020000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Kanishka Pothula DIRECTOR ELECTIONS ISSUER 775.020000 0.000000 FOR 775.020000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Mace Rothenberg, M.D. DIRECTOR ELECTIONS ISSUER 775.020000 0.000000 FOR 775.020000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 775.020000 0.000000 FOR 775.020000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 775.020000 0.000000 FOR 775.020000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Marc Kozin DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Joseph John Hassett DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Symeria Hudson DIRECTOR ELECTIONS ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 151.270000 0.000000 FOR 151.270000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Richard W. Dugan DIRECTOR ELECTIONS ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Charles C. Duncan DIRECTOR ELECTIONS ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Anne Sempowski Ward DIRECTOR ELECTIONS ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to increase the aggregate number of shares authorized for issuance thereunder. COMPENSATION ISSUER 1331.120000 0.000000 FOR 1331.120000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 3851.650000 0.000000 FOR 3851.650000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 3851.650000 0.000000 FOR 3851.650000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3851.650000 0.000000 FOR 3851.650000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3851.650000 0.000000 FOR 3851.650000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Robert Hershberg, PhD, MD DIRECTOR ELECTIONS ISSUER 1970.170000 0.000000 FOR 1970.170000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Katey Owen, PhD DIRECTOR ELECTIONS ISSUER 1970.170000 0.000000 FOR 1970.170000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1970.170000 0.000000 FOR 1970.170000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1970.170000 0.000000 FOR 1970.170000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Peter C. Farrell DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Joseph E. Payne DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect James Barlow DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Edward W. Holmes DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Magda Marquet DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Jing L. Marantz DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect John H. Markels DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Moncef Slaoui DIRECTOR ELECTIONS ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 616.720000 0.000000 FOR 616.720000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 2183.080000 0.000000 FOR 2183.080000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha Krishnamohan DIRECTOR ELECTIONS ISSUER 2183.080000 0.000000 FOR 2183.080000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin Watanabe DIRECTOR ELECTIONS ISSUER 2183.080000 0.000000 FOR 2183.080000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2183.080000 0.000000 FOR 2183.080000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2183.080000 0.000000 FOR 2183.080000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 Elect Mark E. Saad DIRECTOR ELECTIONS ISSUER 814.320000 0.000000 FOR 814.320000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 Elect Susan Mahony DIRECTOR ELECTIONS ISSUER 814.320000 0.000000 FOR 814.320000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 814.320000 0.000000 FOR 814.320000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 814.320000 0.000000 FOR 814.320000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Linda Baddour DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Daniel M. Hancock DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Robert J. Hariri DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Ramkumar Mandalam DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026. AUDIT-RELATED ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; and COMPENSATION ISSUER 817.450000 0.000000 FOR 817.450000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian Posner DIRECTOR ELECTIONS ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes DIRECTOR ELECTIONS ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1986.800000 0.000000 FOR 1986.800000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Todd C. Davis DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Nancy Ryan Gray DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Jason Haas DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect John W. Kozarich DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect John L. LaMattina DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Stephen L. Sabba DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Martine Zimmermann DIRECTOR ELECTIONS ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 467.320000 0.000000 FOR 467.320000 FOR S000004450 Prime Medicine Inc 74168J101 06/05/2026 Elect Michael A. Kelly DIRECTOR ELECTIONS ISSUER 1840.550000 0.000000 FOR 1840.550000 FOR S000004450 Prime Medicine Inc 74168J101 06/05/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 1840.550000 0.000000 FOR 1840.550000 FOR S000004450 Prime Medicine Inc 74168J101 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1840.550000 0.000000 FOR 1840.550000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 1528.880000 0.000000 FOR 1528.880000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Brent Turner DIRECTOR ELECTIONS ISSUER 1528.880000 0.000000 FOR 1528.880000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 1528.880000 0.000000 FOR 1528.880000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1528.880000 0.000000 FOR 1528.880000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1528.880000 0.000000 FOR 1528.880000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Meury DIRECTOR ELECTIONS ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3887.960000 0.000000 FOR 3887.960000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 Election of Class III Director: Todd C. Brady, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1115.280000 0.000000 FOR 1115.280000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1115.280000 0.000000 FOR 1115.280000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1115.280000 0.000000 FOR 1115.280000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 904.800000 0.000000 FOR 904.800000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Jennifer Fox DIRECTOR ELECTIONS ISSUER 904.800000 0.000000 FOR 904.800000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect William Jones, Jr. DIRECTOR ELECTIONS ISSUER 904.800000 0.000000 FOR 904.800000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 904.800000 0.000000 FOR 904.800000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 904.800000 0.000000 FOR 904.800000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher J. Bowden DIRECTOR ELECTIONS ISSUER 654.270000 0.000000 FOR 654.270000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng DIRECTOR ELECTIONS ISSUER 654.270000 0.000000 FOR 654.270000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 654.270000 0.000000 FOR 654.270000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd B. Minor DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3565.560000 0.000000 FOR 3565.560000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Chris Cain DIRECTOR ELECTIONS ISSUER 1809.850000 0.000000 FOR 1809.850000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Arlene M. Morris DIRECTOR ELECTIONS ISSUER 1809.850000 0.000000 FOR 1809.850000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Todd Shegog DIRECTOR ELECTIONS ISSUER 1809.850000 0.000000 FOR 1809.850000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1809.850000 0.000000 FOR 1809.850000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1809.850000 0.000000 FOR 1809.850000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 Election of Directors: Richard A. Fair DIRECTOR ELECTIONS ISSUER 673.730000 0.000000 FOR 673.730000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Lori Kunkel, M.D. DIRECTOR ELECTIONS ISSUER 673.730000 0.000000 FOR 673.730000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 673.730000 0.000000 FOR 673.730000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 673.730000 0.000000 FOR 673.730000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 673.730000 0.000000 FOR 673.730000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 673.730000 0.000000 ONE YEAR 673.730000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: Anshul Thakral DIRECTOR ELECTIONS ISSUER 2181.280000 0.000000 FOR 2181.280000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 2181.280000 0.000000 FOR 2181.280000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: William J. Sharbaugh DIRECTOR ELECTIONS ISSUER 2181.280000 0.000000 FOR 2181.280000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2181.280000 0.000000 FOR 2181.280000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2181.280000 0.000000 FOR 2181.280000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect John P. Bamforth DIRECTOR ELECTIONS ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect Kathleen G. Sebelius DIRECTOR ELECTIONS ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 303.380000 439700.000000 ONE YEAR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 350,000,000 shares to 550,000,000 shares. CAPITAL STRUCTURE ISSUER 303.380000 439700.000000 FOR 303.380000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Richard Adcock DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Wesley Clark DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Christobel Selecky DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Bruce Wendel DIRECTOR ELECTIONS ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2380.300000 707501.000000 FOR 2380.300000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. James Boylan DIRECTOR ELECTIONS ISSUER 2231.160000 0.000000 FOR 2231.160000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 2231.160000 0.000000 FOR 2231.160000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Philip Wagenheim DIRECTOR ELECTIONS ISSUER 2231.160000 0.000000 FOR 2231.160000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2231.160000 0.000000 FOR 2231.160000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2231.160000 0.000000 FOR 2231.160000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2231.160000 0.000000 ONE YEAR 2231.160000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 2261.000000 0.000000 FOR 2261.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Brian Goff DIRECTOR ELECTIONS ISSUER 2261.000000 0.000000 FOR 2261.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 2261.000000 0.000000 FOR 2261.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2261.000000 0.000000 FOR 2261.000000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2261.000000 0.000000 FOR 2261.000000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Robert Essner DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Deborah Leone DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Shalini Sharp DIRECTOR ELECTIONS ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 6036.200000 0.000000 FOR 6036.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Oliver Benton "Ben" Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Samit Hirawat DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Tom Wiggans DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Ratification of the appointment of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of the Amended and Restated 2011 Stock Incentive Plan COMPENSATION ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of the Amended and Restated 2014 Employee Stock Purchase Plan COMPENSATION ISSUER 1006.480000 0.000000 Takenoaction 1006.480000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Samit Hirawat DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Thomas Wiggans DIRECTOR ELECTIONS ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Oliver Benton Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 WITHHOLD 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 WITHHOLD 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 1006.480000 0.000000 WITHHOLD 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of our Amended and Restated 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 1006.480000 0.000000 FOR 1006.480000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai DIRECTOR ELECTIONS ISSUER 1150.260000 0.000000 FOR 1150.260000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett DIRECTOR ELECTIONS ISSUER 1150.260000 0.000000 FOR 1150.260000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 1150.260000 0.000000 FOR 1150.260000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1150.260000 0.000000 FOR 1150.260000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1150.260000 0.000000 FOR 1150.260000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 Election of Directors: William P. Donnelly DIRECTOR ELECTIONS ISSUER 970.390000 0.000000 FOR 970.390000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 Election of Directors: Ivana Magovcevic-Liebisch, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 970.390000 0.000000 FOR 970.390000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 970.390000 0.000000 FOR 970.390000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To ratify, on an advisory basis, the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 970.390000 0.000000 FOR 970.390000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 970.390000 0.000000 FOR 970.390000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director'searlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 2621.500000 0.000000 FOR 2621.500000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director'searlier death, resignation or removal: Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 2621.500000 0.000000 FOR 2621.500000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2621.500000 0.000000 FOR 2621.500000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2621.500000 0.000000 FOR 2621.500000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000. CAPITAL STRUCTURE ISSUER 2621.500000 0.000000 FOR 2621.500000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Harold Ford, Jr. DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect John M. Keane DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Gary J. Nabel DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Diem Nguyen DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Holly L. Phillips DIRECTOR ELECTIONS ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. COMPENSATION ISSUER 1029.410000 0.000000 FOR 1029.410000 FOR S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 Elect H. Edward Fleming, Jr. DIRECTOR ELECTIONS ISSUER 522.820000 0.000000 FOR 522.820000 FOR S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 Elect Liam Ratcliffe DIRECTOR ELECTIONS ISSUER 522.820000 0.000000 FOR 522.820000 FOR S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 522.820000 0.000000 FOR 522.820000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 Elect Michael Earley DIRECTOR ELECTIONS ISSUER 458.250000 0.000000 FOR 458.250000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 Elect Veronica Hill-Milbourne DIRECTOR ELECTIONS ISSUER 458.250000 0.000000 FOR 458.250000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 458.250000 0.000000 FOR 458.250000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 458.250000 0.000000 FOR 458.250000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Quentin Blackford DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: David Demski DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Keith Valentine DIRECTOR ELECTIONS ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan COMPENSATION ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2824.670000 0.000000 FOR 2824.670000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Daniel Curran DIRECTOR ELECTIONS ISSUER 769.340000 0.000000 FOR 769.340000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 769.340000 0.000000 FOR 769.340000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Chris Takimoto DIRECTOR ELECTIONS ISSUER 769.340000 0.000000 FOR 769.340000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 769.340000 0.000000 FOR 769.340000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 769.340000 0.000000 FOR 769.340000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Kenneth Sim DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Thomas S. Lam DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect John Chiang DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Weili Dai DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Linda Dong DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect J. Lorraine Estradas DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect David G. Schmidt DIRECTOR ELECTIONS ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 1044.580000 0.000000 FOR 1044.580000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Demetrios L. Kouzoukas DIRECTOR ELECTIONS ISSUER 10054.410000 0.000000 FOR 10054.410000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Andrew Toy DIRECTOR ELECTIONS ISSUER 10054.410000 0.000000 FOR 10054.410000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Thomas L. Tran DIRECTOR ELECTIONS ISSUER 10054.410000 0.000000 FOR 10054.410000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 10054.410000 0.000000 FOR 10054.410000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 10054.410000 0.000000 FOR 10054.410000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Vera Imper DIRECTOR ELECTIONS ISSUER 2337.800000 0.000000 FOR 2337.800000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Glenn P. Muir DIRECTOR ELECTIONS ISSUER 2337.800000 0.000000 FOR 2337.800000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Ming Yan DIRECTOR ELECTIONS ISSUER 2337.800000 0.000000 FOR 2337.800000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2337.800000 0.000000 FOR 2337.800000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2337.800000 0.000000 FOR 2337.800000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Election of Directors: Peter S. Kim, Ph.D. DIRECTOR ELECTIONS ISSUER 412.020000 0.000000 FOR 412.020000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Election of Directors: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 412.020000 0.000000 FOR 412.020000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 412.020000 0.000000 FOR 412.020000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. COMPENSATION ISSUER 412.020000 0.000000 FOR 412.020000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. COMPENSATION ISSUER 412.020000 0.000000 FOR 412.020000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Iain D. Dukes DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Athena Countouriotis DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Ryan Maynard DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Frederick G. Vogt DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Michael Weiser DIRECTOR ELECTIONS ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the frequency of future votes on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 7244.880000 0.000000 ONE YEAR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares COMPENSATION ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares CAPITAL STRUCTURE ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. CORPORATE GOVERNANCE ISSUER 7244.880000 0.000000 FOR 7244.880000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Election of Class I director, nominated by our board of directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham DIRECTOR ELECTIONS ISSUER 157.060000 0.000000 FOR 157.060000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Election of Class I director, nominated by our board of directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers DIRECTOR ELECTIONS ISSUER 157.060000 0.000000 FOR 157.060000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 157.060000 0.000000 FOR 157.060000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 157.060000 0.000000 FOR 157.060000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): J. Christopher Barry DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Francesco Bianchi DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): William Kozy DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Jette Nygaard-Andersen DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Susan Podlogar DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Brooke Story DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Peter Wilver DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Donald Zurbay DIRECTOR ELECTIONS ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of PS10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered, or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Special Resolution: Subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of PS10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this power replaces (except for any power conferred by resolution 4) all subsisting authorities previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered, or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of this proxy statement (the "Share Repurchase Contracts") and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in this proxy statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the Share Repurchase Contracts shall not exceed 10% of the total issued Ordinary Shares of the Company as at 5:00 pm Eastern Time on April 13, 2026 as adjusted on a proportionate basis to take into account any consolidation or division of shares from time to time; and (B) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the Company may enter into any Share Repurchase Contract with any of the Approved Counterparties under this authority prior to its expiry and may purchase Ordinary Shares pursuant to any such Share Repurchase Contract. CAPITAL STRUCTURE ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the year ended December 31, 2025. COMPENSATION ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2025, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2026. CORPORATE GOVERNANCE ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 1179.450000 0.000000 FOR 1179.450000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: Richard Klausner, M.D. DIRECTOR ELECTIONS ISSUER 178.370000 0.000000 FOR 178.370000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: Otis Brawley, M.D. DIRECTOR ELECTIONS ISSUER 178.370000 0.000000 FOR 178.370000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: William Rieflin DIRECTOR ELECTIONS ISSUER 178.370000 0.000000 FOR 178.370000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 178.370000 0.000000 FOR 178.370000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 178.370000 0.000000 FOR 178.370000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: K. Todd Newton DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Tiffany Olson DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2558.930000 0.000000 FOR 2558.930000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 Elect Pravin U. Dugel DIRECTOR ELECTIONS ISSUER 3460.120000 0.000000 FOR 3460.120000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 Elect Merilee Raines DIRECTOR ELECTIONS ISSUER 3460.120000 0.000000 FOR 3460.120000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3460.120000 0.000000 FOR 3460.120000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3460.120000 0.000000 ONE YEAR 3460.120000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. COMPENSATION ISSUER 3460.120000 0.000000 FOR 3460.120000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3460.120000 0.000000 FOR 3460.120000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Wayne C. Burris DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. COMPENSATION ISSUER 678.300000 0.000000 FOR 678.300000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 1106.210000 0.000000 FOR 1106.210000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 Elect Mark Hancock DIRECTOR ELECTIONS ISSUER 1106.210000 0.000000 FOR 1106.210000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1106.210000 0.000000 FOR 1106.210000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1106.210000 0.000000 FOR 1106.210000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: George M. Jenkins DIRECTOR ELECTIONS ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. Davis DIRECTOR ELECTIONS ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: John Doux, M.D. DIRECTOR ELECTIONS ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 210.390000 0.000000 ONE YEAR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. COMPENSATION ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 210.390000 0.000000 FOR 210.390000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 557.440000 0.000000 FOR 557.440000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 557.440000 0.000000 FOR 557.440000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 557.440000 0.000000 FOR 557.440000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 557.440000 0.000000 FOR 557.440000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 557.440000 0.000000 FOR 557.440000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 663.940000 0.000000 FOR 663.940000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect Robert J. Perez DIRECTOR ELECTIONS ISSUER 663.940000 0.000000 FOR 663.940000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect Raymond Sanchez DIRECTOR ELECTIONS ISSUER 663.940000 0.000000 FOR 663.940000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 663.940000 0.000000 FOR 663.940000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Robert W. Duggan DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Robert T. Booth DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Alessandra Cesano DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Yu Xia DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Jeffrey T. Huber DIRECTOR ELECTIONS ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. COMPENSATION ISSUER 1337.250000 294300.000000 FOR 1337.250000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 Election of Directors: Pierre Legault DIRECTOR ELECTIONS ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 Election of Directors: Michael A. Metzger DIRECTOR ELECTIONS ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 1990.750000 0.000000 FOR 1990.750000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc A. Stapley DIRECTOR ELECTIONS ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 1872.780000 0.000000 FOR 1872.780000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 Elect Bettina M. Cockroft DIRECTOR ELECTIONS ISSUER 2565.590000 0.000000 FOR 2565.590000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 Elect Douglas E. Love DIRECTOR ELECTIONS ISSUER 2565.590000 0.000000 FOR 2565.590000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2565.590000 0.000000 FOR 2565.590000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2565.590000 0.000000 FOR 2565.590000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 2565.590000 0.000000 FOR 2565.590000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Nicole Lambert DIRECTOR ELECTIONS ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2046.690000 0.000000 FOR 2046.690000 FOR S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 1083.110000 0.000000 FOR 1083.110000 FOR S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 Elect Teresa Marie Bitetti DIRECTOR ELECTIONS ISSUER 1083.110000 0.000000 FOR 1083.110000 FOR S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1083.110000 0.000000 FOR 1083.110000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Amy E. McKee DIRECTOR ELECTIONS ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 4487.920000 0.000000 FOR 4487.920000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Fred E. Cohen DIRECTOR ELECTIONS ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect John W. Hanna DIRECTOR ELECTIONS ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1190.950000 0.000000 ONE YEAR 1190.950000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 1190.950000 0.000000 FOR 1190.950000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D DIRECTOR ELECTIONS ISSUER 1318.590000 0.000000 FOR 1318.590000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D DIRECTOR ELECTIONS ISSUER 1318.590000 0.000000 FOR 1318.590000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1318.590000 0.000000 FOR 1318.590000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1318.590000 0.000000 FOR 1318.590000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Adsett DIRECTOR ELECTIONS ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders. AUDIT-RELATED ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares. COMPENSATION ISSUER 1903.930000 0.000000 FOR 1903.930000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Elect Brady Stewart DIRECTOR ELECTIONS ISSUER 1115.890000 0.000000 FOR 1115.890000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Elect Vikram Malik DIRECTOR ELECTIONS ISSUER 1115.890000 0.000000 FOR 1115.890000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1115.890000 0.000000 FOR 1115.890000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1115.890000 0.000000 FOR 1115.890000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Richard J. Barry DIRECTOR ELECTIONS ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Pierre Gravier DIRECTOR ELECTIONS ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Claude Nicaise, M.D. DIRECTOR ELECTIONS ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To approve Amendment No. 2 to the Company's 2018 Omnibus Incentive Plan, which, among other things, increases the authorized number of shares issuable thereunder by 4,000,000 shares (from 5,000,000 to 9,000,000 authorized shares). COMPENSATION ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1072.710000 0.000000 FOR 1072.710000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Ross Fubini DIRECTOR ELECTIONS ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Christian Henry DIRECTOR ELECTIONS ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Sri Kosuri DIRECTOR ELECTIONS ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Harry E. Sloan DIRECTOR ELECTIONS ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 817.950000 0.000000 FOR 817.950000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Craig Collard DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Tom Cusack DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Craig Johnson DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Michael Kaseta DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Adam Morgan DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Christian Waage DIRECTOR ELECTIONS ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares COMPENSATION ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To amend the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares COMPENSATION ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To ratify, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan SHAREHOLDER RIGHTS AND DEFENSES ISSUER 3234.320000 0.000000 FOR 3234.320000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Andrew Dudum DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Kofi Amoo-Gottfried DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Deborah M. Autor DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Delos Cosgrove DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Anja L. Manuel DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Christopher D. Payne DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Andrea Perez DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Kare Schultz DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect David B. Wells DIRECTOR ELECTIONS ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1534.140000 398400.000000 FOR 1534.140000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders. Natasha Hernday DIRECTOR ELECTIONS ISSUER 932.670000 0.000000 FOR 932.670000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders. Eric Dobmeier DIRECTOR ELECTIONS ISSUER 932.670000 0.000000 FOR 932.670000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 932.670000 0.000000 FOR 932.670000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 932.670000 0.000000 FOR 932.670000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Charles N. Mills DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Jacob Best DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect James M. Boyle DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Richard A. Galanti DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Patrick J. Healy DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Andrew J. Mills DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Stephen H. Wise DIRECTOR ELECTIONS ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4985.430000 0.000000 ONE YEAR 4985.430000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 4985.430000 0.000000 FOR 4985.430000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Ellen Hukkelhoven DIRECTOR ELECTIONS ISSUER 1058.940000 0.000000 FOR 1058.940000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Nicole Seligman DIRECTOR ELECTIONS ISSUER 1058.940000 0.000000 FOR 1058.940000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Debra YU DIRECTOR ELECTIONS ISSUER 1058.940000 0.000000 FOR 1058.940000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1058.940000 0.000000 FOR 1058.940000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. DIRECTOR ELECTIONS ISSUER 733.750000 0.000000 FOR 733.750000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. DIRECTOR ELECTIONS ISSUER 733.750000 0.000000 FOR 733.750000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. DIRECTOR ELECTIONS ISSUER 733.750000 0.000000 FOR 733.750000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 733.750000 0.000000 FOR 733.750000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Rowan Chapman DIRECTOR ELECTIONS ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Herm Rosenman DIRECTOR ELECTIONS ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Jonathan Sheena DIRECTOR ELECTIONS ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Eric H. Rubin DIRECTOR ELECTIONS ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3105.180000 0.000000 ONE YEAR 3105.180000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 3105.180000 0.000000 FOR 3105.180000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Elect Kirsten Castillo DIRECTOR ELECTIONS ISSUER 7567.860000 0.000000 FOR 7567.860000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Elect Satish Chandran DIRECTOR ELECTIONS ISSUER 7567.860000 0.000000 FOR 7567.860000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 7567.860000 0.000000 FOR 7567.860000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 7567.860000 0.000000 FOR 7567.860000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the preferred frequency with which future advisory votes on the compensation of Ocugen's named executive officers should be held. SECTION 14A SAY-ON-PAY VOTES ISSUER 7567.860000 0.000000 ONE YEAR 7567.860000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Bernard Coulie, M.D., Ph.D., M.B.A. DIRECTOR ELECTIONS ISSUER 1208.950000 0.000000 FOR 1208.950000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Gayle Crowell DIRECTOR ELECTIONS ISSUER 1208.950000 0.000000 FOR 1208.950000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Steve Krognes, M.B.A. DIRECTOR ELECTIONS ISSUER 1208.950000 0.000000 FOR 1208.950000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1208.950000 0.000000 FOR 1208.950000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1208.950000 0.000000 FOR 1208.950000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Maria Sainz DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 133.510000 46700.000000 FOR 133.510000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Laurence N. Charney DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Yann Echelard DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Daniel Hume DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Sagar Lonial DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Michael S. Weiss DIRECTOR ELECTIONS ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3517.790000 0.000000 FOR 3517.790000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Robert S. Epstein, M.D., M.S. DIRECTOR ELECTIONS ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Karin Jooss, Ph.D. DIRECTOR ELECTIONS ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 2310.480000 0.000000 FOR 2310.480000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Evert Schimmelpennink DIRECTOR ELECTIONS ISSUER 3.300000 34600.000000 FOR 3.300000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Jeff George DIRECTOR ELECTIONS ISSUER 3.300000 34600.000000 FOR 3.300000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Shelley Thunen DIRECTOR ELECTIONS ISSUER 3.300000 34600.000000 FOR 3.300000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3.300000 34600.000000 FOR 3.300000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2406.410000 0.000000 FOR 2406.410000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah Gray DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. Mitchell DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O Connor DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. Pakianathan DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E Winningham DIRECTOR ELECTIONS ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 817.430000 0.000000 FOR 817.430000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 904.080000 0.000000 FOR 904.080000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. William Fairey DIRECTOR ELECTIONS ISSUER 904.080000 0.000000 FOR 904.080000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Timothy Walbert DIRECTOR ELECTIONS ISSUER 904.080000 0.000000 FOR 904.080000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 904.080000 0.000000 FOR 904.080000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 904.080000 0.000000 FOR 904.080000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Robert Ades DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Jon Giacomin DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Michele Korfin DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Gilberto Quintero DIRECTOR ELECTIONS ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 1820.630000 0.000000 FOR 1820.630000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Olivier Brandicourt DIRECTOR ELECTIONS ISSUER 2828.780000 0.000000 FOR 2828.780000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Halley E. Gilbert DIRECTOR ELECTIONS ISSUER 2828.780000 0.000000 FOR 2828.780000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Grant E. Pickering DIRECTOR ELECTIONS ISSUER 2828.780000 0.000000 FOR 2828.780000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2828.780000 0.000000 FOR 2828.780000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2828.780000 0.000000 FOR 2828.780000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Robert B. Bazemore Jr. DIRECTOR ELECTIONS ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Muna Bhanji DIRECTOR ELECTIONS ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay") SECTION 14A SAY-ON-PAY VOTES ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years SECTION 14A SAY-ON-PAY VOTES ISSUER 6007.340000 0.000000 ONE YEAR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. COMPENSATION ISSUER 6007.340000 0.000000 FOR 6007.340000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Elect Nadim Ahmed DIRECTOR ELECTIONS ISSUER 705.830000 0.000000 FOR 705.830000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Elect Stephen W. Webster DIRECTOR ELECTIONS ISSUER 705.830000 0.000000 FOR 705.830000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 705.830000 0.000000 FOR 705.830000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 705.830000 0.000000 FOR 705.830000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 Elect Vina M. Leite DIRECTOR ELECTIONS ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 Elect James M. Travers DIRECTOR ELECTIONS ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve a series of six alternative amendments to the Company's Second Amended and Restated Certificate of Incorporation to effect (I) a reverse stock split of the Company's common stock at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 (each, a "Reverse Stock Split"), with such ratio and the time of the Reverse Stock Split as determined in the sole discretion of the Company's Board of Directors at a later date, and (II) a proportionate reduction in the number of authorized shares of the Company's common stock and preferred stock by a corresponding ratio. CAPITAL STRUCTURE ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2077.420000 0.000000 FOR 2077.420000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Wendy Barnes DIRECTOR ELECTIONS ISSUER 2065.700000 0.000000 FOR 2065.700000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Ronald E. Bruehlman DIRECTOR ELECTIONS ISSUER 2065.700000 0.000000 FOR 2065.700000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Gregory K. Mondre DIRECTOR ELECTIONS ISSUER 2065.700000 0.000000 FOR 2065.700000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2065.700000 0.000000 FOR 2065.700000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2065.700000 0.000000 FOR 2065.700000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 1897.340000 0.000000 FOR 1897.340000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. DIRECTOR ELECTIONS ISSUER 1897.340000 0.000000 FOR 1897.340000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. DIRECTOR ELECTIONS ISSUER 1897.340000 0.000000 FOR 1897.340000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1897.340000 0.000000 FOR 1897.340000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 1897.340000 0.000000 FOR 1897.340000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Mark G. Currie DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Alexander J. Denner DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Jon R. Duane DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Marla L. Kessler DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Thomas A. McCourt DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Julie H. McHugh DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Jay P. Shepard DIRECTOR ELECTIONS ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. COMPENSATION ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 3540.480000 0.000000 FOR 3540.480000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: David Johnson DIRECTOR ELECTIONS ISSUER 1465.690000 0.000000 FOR 1465.690000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: Katie Rielly-Gauvin DIRECTOR ELECTIONS ISSUER 1465.690000 0.000000 FOR 1465.690000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: Ramandeep Singh DIRECTOR ELECTIONS ISSUER 1465.690000 0.000000 FOR 1465.690000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. AUDIT-RELATED ISSUER 1465.690000 0.000000 FOR 1465.690000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1465.690000 0.000000 FOR 1465.690000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 960.890000 0.000000 FOR 960.890000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Ron Squarer DIRECTOR ELECTIONS ISSUER 960.890000 0.000000 FOR 960.890000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 960.890000 0.000000 FOR 960.890000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 960.890000 0.000000 FOR 960.890000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Brian Blaser DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Kenneth F. Buechler DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect John R. Chiminski DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Edward L. Michael DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Mary Lake Polan DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Kenneth J. Widder DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 1633.730000 0.000000 FOR 1633.730000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. William J. Link, Ph.D. DIRECTOR ELECTIONS ISSUER 842.820000 0.000000 FOR 842.820000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. Robert Warner DIRECTOR ELECTIONS ISSUER 842.820000 0.000000 FOR 842.820000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 842.820000 0.000000 FOR 842.820000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 842.820000 0.000000 FOR 842.820000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 842.820000 0.000000 FOR 842.820000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Raymond J. Deshaies DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Barbara Klencke DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Todd E. Simpson DIRECTOR ELECTIONS ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares. COMPENSATION ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1186.830000 0.000000 FOR 1186.830000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 1206.690000 0.000000 FOR 1206.690000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Elect Jan Skvarka DIRECTOR ELECTIONS ISSUER 1206.690000 0.000000 FOR 1206.690000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1206.690000 0.000000 FOR 1206.690000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1206.690000 0.000000 FOR 1206.690000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Nancy Miller-Rich DIRECTOR ELECTIONS ISSUER 1024.300000 0.000000 FOR 1024.300000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 1024.300000 0.000000 FOR 1024.300000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Shawn Cline Tomasello, MBA DIRECTOR ELECTIONS ISSUER 1024.300000 0.000000 FOR 1024.300000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1024.300000 0.000000 FOR 1024.300000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1024.300000 0.000000 FOR 1024.300000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect Adrian Adams DIRECTOR ELECTIONS ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect Michael Rogers DIRECTOR ELECTIONS ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect LeAnne M. Zumwalt DIRECTOR ELECTIONS ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval of an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and to increase the number of authorized shares of common stock from 350,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6022.260000 0.000000 ONE YEAR 6022.260000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 6022.260000 0.000000 FOR 6022.260000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Elizabeth A. Garofalo DIRECTOR ELECTIONS ISSUER 1752.180000 0.000000 FOR 1752.180000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Errol B. De Souza DIRECTOR ELECTIONS ISSUER 1752.180000 0.000000 FOR 1752.180000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Kristine Yaffe DIRECTOR ELECTIONS ISSUER 1752.180000 0.000000 FOR 1752.180000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1752.180000 0.000000 FOR 1752.180000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1752.180000 0.000000 FOR 1752.180000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Matthew P. Young DIRECTOR ELECTIONS ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares. CAPITAL STRUCTURE ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 3864.960000 0.000000 FOR 3864.960000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3864.960000 0.000000 ONE YEAR 3864.960000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 Elect Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 2335.130000 0.000000 FOR 2335.130000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 Elect Elliott Levy DIRECTOR ELECTIONS ISSUER 2335.130000 0.000000 FOR 2335.130000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2335.130000 0.000000 FOR 2335.130000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2335.130000 0.000000 FOR 2335.130000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Election of Class II Directors: Ian Clark DIRECTOR ELECTIONS ISSUER 2692.050000 0.000000 FOR 2692.050000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Election of Class II Directors: Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 2692.050000 0.000000 FOR 2692.050000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc. 's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2692.050000 0.000000 FOR 2692.050000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2692.050000 0.000000 FOR 2692.050000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2692.050000 0.000000 ONE YEAR 2692.050000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Julian Baker DIRECTOR ELECTIONS ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Daniel Brennan DIRECTOR ELECTIONS ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: James Daly DIRECTOR ELECTIONS ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 367.080000 0.000000 FOR 367.080000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Sean P. Bohen DIRECTOR ELECTIONS ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Scott Garland DIRECTOR ELECTIONS ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Yi Larson DIRECTOR ELECTIONS ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Andrew S. Rappaport DIRECTOR ELECTIONS ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's in dependent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 935.200000 0.000000 FOR 935.200000 FOR S000004450 OmniAb, Inc. 68218J103 06/17/2026 Election of Directors: Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 2137.080000 0.000000 FOR 2137.080000 FOR S000004450 OmniAb, Inc. 68218J103 06/17/2026 Election of Directors: Jennifer Cochran, Ph.D. DIRECTOR ELECTIONS ISSUER 2137.080000 0.000000 FOR 2137.080000 FOR S000004450 OmniAb, Inc. 68218J103 06/17/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm AUDIT-RELATED ISSUER 2137.080000 0.000000 FOR 2137.080000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Dinesh V. Patel DIRECTOR ELECTIONS ISSUER 1237.210000 0.000000 FOR 1237.210000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Lewis T. Williams DIRECTOR ELECTIONS ISSUER 1237.210000 0.000000 FOR 1237.210000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1237.210000 0.000000 FOR 1237.210000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1237.210000 0.000000 FOR 1237.210000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 1237.210000 0.000000 FOR 1237.210000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Elect Najat Khan DIRECTOR ELECTIONS ISSUER 431.640000 1272095.000000 FOR 431.640000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Elect Franziska Michor DIRECTOR ELECTIONS ISSUER 431.640000 1272095.000000 FOR 431.640000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 431.640000 1272095.000000 FOR 431.640000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 431.640000 1272095.000000 FOR 431.640000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Michael Egholm DIRECTOR ELECTIONS ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Thomas Carey DIRECTOR ELECTIONS ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Eli Casdin DIRECTOR ELECTIONS ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve an amendment to our Amended and Restated 2017 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares. COMPENSATION ISSUER 6215.150000 0.000000 FOR 6215.150000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew Wallach DIRECTOR ELECTIONS ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 3745.570000 0.000000 FOR 3745.570000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Gregory Belinfanti DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Terence J. Connors DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Bradley J. Coppens DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Suzanne M. Foster DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Ted Lundberg DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Kenneth A. Samet DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Susan T. Weaver DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect David Williams III DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Dale B. Wolf DIRECTOR ELECTIONS ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2377.430000 0.000000 FOR 2377.430000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian Goff DIRECTOR ELECTIONS ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia Smith DIRECTOR ELECTIONS ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. COMPENSATION ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1349.050000 0.000000 FOR 1349.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Deborah Messemer DIRECTOR ELECTIONS ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Vicki Sato, Ph.D. DIRECTOR ELECTIONS ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Owen Witte, M.D. DIRECTOR ELECTIONS ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5959.300000 0.000000 ONE YEAR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 5959.300000 0.000000 FOR 5959.300000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 508.510000 0.000000 FOR 508.510000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect John A. Hohneker DIRECTOR ELECTIONS ISSUER 508.510000 0.000000 FOR 508.510000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect Stuart Lutzker DIRECTOR ELECTIONS ISSUER 508.510000 0.000000 FOR 508.510000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 508.510000 0.000000 FOR 508.510000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Jerome M. Adams DIRECTOR ELECTIONS ISSUER 1289.250000 0.000000 FOR 1289.250000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Howard H. Berman DIRECTOR ELECTIONS ISSUER 1289.250000 0.000000 FOR 1289.250000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Barbara G. Duncan DIRECTOR ELECTIONS ISSUER 1289.250000 0.000000 FOR 1289.250000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1289.250000 0.000000 FOR 1289.250000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 1289.250000 0.000000 FOR 1289.250000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Joseph Devivo DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Jonathan M. Rothberg DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Caroll H. Neubauer DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Erica G. Schwartz DIRECTOR ELECTIONS ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4910.500000 0.000000 FOR 4910.500000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 2141.620000 0.000000 FOR 2141.620000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 2141.620000 0.000000 FOR 2141.620000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 2141.620000 0.000000 FOR 2141.620000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2141.620000 0.000000 FOR 2141.620000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 2141.620000 0.000000 FOR 2141.620000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 599.850000 0.000000 FOR 599.850000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 599.850000 0.000000 FOR 599.850000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 599.850000 0.000000 FOR 599.850000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 599.850000 0.000000 FOR 599.850000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 599.850000 0.000000 FOR 599.850000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Goran A. Ando DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Jay S. Duker DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect John B. Landis DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Wendy F. DiCicco DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Karen Zaderej DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Stuart Duty DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Fred Hassan DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Reginald J. Sanders DIRECTOR ELECTIONS ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares. COMPENSATION ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1803.790000 0.000000 FOR 1803.790000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Elect Katherine Stueland DIRECTOR ELECTIONS ISSUER 485.840000 0.000000 FOR 485.840000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 485.840000 0.000000 FOR 485.840000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 485.840000 0.000000 FOR 485.840000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 485.840000 0.000000 ONE YEAR 485.840000 FOR S000004450 GRAIL, Inc. 384747101 06/18/2026 Elect Sarah Krevans DIRECTOR ELECTIONS ISSUER 864.160000 0.000000 FOR 864.160000 FOR S000004450 GRAIL, Inc. 384747101 06/18/2026 Elect Steven C. Mizell DIRECTOR ELECTIONS ISSUER 864.160000 0.000000 FOR 864.160000 FOR S000004450 GRAIL, Inc. 384747101 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 864.160000 0.000000 FOR 864.160000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Mark L. Baum DIRECTOR ELECTIONS ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Adrienne Graves DIRECTOR ELECTIONS ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 766.880000 0.000000 FOR 766.880000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D. DIRECTOR ELECTIONS ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares. COMPENSATION ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock. COMPENSATION ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3419.200000 0.000000 FOR 3419.200000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Thomas J. Cable DIRECTOR ELECTIONS ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Peter A. Demopulos, M.D. DIRECTOR ELECTIONS ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Diana T. Perkinson, M.D. DIRECTOR ELECTIONS ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Approval of advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1683.100000 0.000000 FOR 1683.100000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 To approve the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 10104.570000 0.000000 FOR 10104.570000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Jacob M. Chacko, M.D DIRECTOR ELECTIONS ISSUER 1044.600000 0.000000 FOR 1044.600000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Mardi C. Dier DIRECTOR ELECTIONS ISSUER 1044.600000 0.000000 FOR 1044.600000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1044.600000 0.000000 FOR 1044.600000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 1044.600000 0.000000 FOR 1044.600000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1044.600000 0.000000 FOR 1044.600000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1044.600000 0.000000 ONE YEAR 1044.600000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Arani Bose DIRECTOR ELECTIONS ISSUER 919.770000 0.000000 FOR 919.770000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Bridget O'Rourke DIRECTOR ELECTIONS ISSUER 919.770000 0.000000 FOR 919.770000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Surbhi Sarna DIRECTOR ELECTIONS ISSUER 919.770000 0.000000 FOR 919.770000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 919.770000 0.000000 FOR 919.770000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 919.770000 0.000000 FOR 919.770000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 4200.640000 0.000000 FOR 4200.640000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Alexis A. Borisy DIRECTOR ELECTIONS ISSUER 4019.180000 0.000000 FOR 4019.180000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Mark A. Goldsmith DIRECTOR ELECTIONS ISSUER 4019.180000 0.000000 FOR 4019.180000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 4019.180000 0.000000 FOR 4019.180000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 4019.180000 0.000000 FOR 4019.180000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Neal C. Bradsher DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Wei Jiang DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Richard T. LeBuhn DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Louis E. Silverman DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Christopher M. Wang DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Lilian Zhou DIRECTOR ELECTIONS ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Approve an amendment to the Company's Amended and Restated Omnibus Equity Incentive Plan, as amended. COMPENSATION ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Ratify the appointment of the Company's independent registered public accounting firm for fiscal 2026 AUDIT-RELATED ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 785.490000 0.000000 FOR 785.490000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson DIRECTOR ELECTIONS ISSUER 1656.120000 0.000000 FOR 1656.120000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III DIRECTOR ELECTIONS ISSUER 1656.120000 0.000000 FOR 1656.120000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1656.120000 0.000000 FOR 1656.120000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1656.120000 0.000000 FOR 1656.120000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. COMPENSATION ISSUER 1656.120000 0.000000 FOR 1656.120000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect James C. Momtazee DIRECTOR ELECTIONS ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect Frank McCormick DIRECTOR ELECTIONS ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect Hannah A. Valantine DIRECTOR ELECTIONS ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3591.290000 0.000000 ONE YEAR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 3591.290000 0.000000 FOR 3591.290000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Joshua Hausman DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Nikolas W. Stengle DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Denise W. Warren DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: C. Christian Winkle DIRECTOR ELECTIONS ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 5671.580000 0.000000 FOR 5671.580000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Richard A. Friesner DIRECTOR ELECTIONS ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Rosana Kapeller-Libermann DIRECTOR ELECTIONS ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Gary Sender DIRECTOR ELECTIONS ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1621.650000 0.000000 FOR 1621.650000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Stuart Holden, M.D. DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Leana S. Wen, M.D., M.Sc. DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman DIRECTOR ELECTIONS ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve the amendment and restatement of the Artides of Association of the Company to, among other things, tie ellgibility for shareholder proposals to the requirements under the Israeli Companies Law. CORPORATE GOVERNANCE ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve an amendment to the Company's Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors' and officers' insurance. COMPENSATION ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000 shares. COMPENSATION ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2027 annual meeting of shareholders. AUDIT-RELATED ISSUER 1128.680000 0.000000 FOR 1128.680000 FOR S000004450 WAVE Life Sciences Ltd. Y95308105 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. CORPORATE GOVERNANCE ISSUER 3101.870000 0.000000 FOR 3101.870000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Michael D. Dale DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Amy M. Wendell DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect William Burke DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect John H. Johnson DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Alan Levine DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Paul G. Thomas DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Joseph Tyndall DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Kathy Weiler DIRECTOR ELECTIONS ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1150.800000 0.000000 FOR 1150.800000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Janet M. Dillione DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Gregory Duncan DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Alan W. Dunton DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Myron Kaplan DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Steven Lefkowitz DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Robert A. Stewart DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Joseph Todisco DIRECTOR ELECTIONS ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve the ratification of the Certificate of Designation Amendments (as defined in the Proxy Statement). CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve amendments to our Charter to make technical changes. CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the extent permitted by Delaware law and provided that no changes are made to the terms of common stock. CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to designate the exclusive forums in which certain claims relating to the Company may be brought. CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to limit certain officers' personal liability for monetary damages for breaches of the duty of care, as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. CORPORATE GOVERNANCE ISSUER 832.250000 121997.000000 FOR 832.250000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Roger Susi DIRECTOR ELECTIONS ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Monty Allen DIRECTOR ELECTIONS ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Joe Kiani DIRECTOR ELECTIONS ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect James B. Hawkins DIRECTOR ELECTIONS ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 207.780000 0.000000 FOR 207.780000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 167.630000 144300.000000 FOR 167.630000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 167.630000 144300.000000 FOR 167.630000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 167.630000 144300.000000 FOR 167.630000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 167.630000 144300.000000 FOR 167.630000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 167.630000 144300.000000 FOR 167.630000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167.630000 144300.000000 ONE YEAR 167.630000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 Elect Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 1523.380000 0.000000 FOR 1523.380000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 Elect Randy Teel DIRECTOR ELECTIONS ISSUER 1523.380000 0.000000 FOR 1523.380000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1523.380000 0.000000 FOR 1523.380000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1523.380000 0.000000 FOR 1523.380000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks DIRECTOR ELECTIONS ISSUER 1055.730000 0.000000 FOR 1055.730000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz DIRECTOR ELECTIONS ISSUER 1055.730000 0.000000 FOR 1055.730000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill DIRECTOR ELECTIONS ISSUER 1055.730000 0.000000 FOR 1055.730000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1055.730000 0.000000 FOR 1055.730000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1055.730000 0.000000 FOR 1055.730000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Bruce Booth DIRECTOR ELECTIONS ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Nello Mainolfi DIRECTOR ELECTIONS ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect John M. Maraganore DIRECTOR ELECTIONS ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Elena Ridloff DIRECTOR ELECTIONS ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1339.750000 0.000000 FOR 1339.750000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 Elect Chaim Indig DIRECTOR ELECTIONS ISSUER 1734.500000 0.000000 FOR 1734.500000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 Elect Jon Kessler DIRECTOR ELECTIONS ISSUER 1734.500000 0.000000 FOR 1734.500000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 1734.500000 0.000000 FOR 1734.500000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1734.500000 0.000000 FOR 1734.500000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Elect David W.J. McGirr DIRECTOR ELECTIONS ISSUER 1587.880000 0.000000 FOR 1587.880000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Elect David P. Meeker DIRECTOR ELECTIONS ISSUER 1587.880000 0.000000 FOR 1587.880000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1587.880000 0.000000 FOR 1587.880000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 1587.880000 0.000000 FOR 1587.880000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1877.560000 0.000000 FOR 1877.560000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 2533.410000 0.000000 FOR 2533.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno DIRECTOR ELECTIONS ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg DIRECTOR ELECTIONS ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison DIRECTOR ELECTIONS ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 891.410000 0.000000 FOR 891.410000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 4773.980000 0.000000 FOR 4773.980000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 4773.980000 0.000000 FOR 4773.980000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 4773.980000 0.000000 FOR 4773.980000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 4773.980000 0.000000 FOR 4773.980000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub") and the Company, and approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 3340.600000 0.000000 FOR 3340.600000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 3340.600000 0.000000 FOR 3340.600000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 3340.600000 0.000000 FOR 3340.600000 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Shalini Sharp, M.B.A. DIRECTOR ELECTIONS ISSUER 319.770000 0.000000 FOR 319.770000 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Jake Simson, Ph.D. DIRECTOR ELECTIONS ISSUER 319.770000 0.000000 FOR 319.770000 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 319.770000 0.000000 FOR 319.770000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1175.410000 0.000000 FOR 1175.410000 FOR S000004450 Alumis Inc. 022307102 06/30/2026 Elect James B. Tananbaum DIRECTOR ELECTIONS ISSUER 1908.450000 0.000000 FOR 1908.450000 FOR S000004450 Alumis Inc. 022307102 06/30/2026 Elect Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 1908.450000 0.000000 FOR 1908.450000 FOR S000004450 Alumis Inc. 022307102 06/30/2026 Elect Zhengbin Yao DIRECTOR ELECTIONS ISSUER 1908.450000 0.000000 FOR 1908.450000 FOR S000004450 Alumis Inc. 022307102 06/30/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1908.450000 0.000000 FOR 1908.450000 FOR S000004450 agilon health, inc. 00857U107 03/17/2026 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); and CAPITAL STRUCTURE ISSUER 1851.920000 0.000000 FOR 1851.920000 FOR S000004450 agilon health, inc. 00857U107 03/17/2026 Approval of the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Amendment Proposal. CORPORATE GOVERNANCE ISSUER 1851.920000 0.000000 FOR 1851.920000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Colleen E. Jay DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 AGAINST 920.730000 AGAINST S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Barbara A. Carbone DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Lawrence E. Kurzius DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Cynthia L. Lucchese DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 AGAINST 920.730000 AGAINST S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Teresa S. Madden DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Maria Rivas, M.D. DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 AGAINST 920.730000 AGAINST S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Walter M Rosebrough, Jr. DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Robert S. Weiss DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Election of Directors: Albert G. White III DIRECTOR ELECTIONS ISSUER 920.730000 0.000000 FOR 920.730000 FOR S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2026. AUDIT-RELATED ISSUER 920.730000 0.000000 AGAINST 920.730000 AGAINST S000004450 The Cooper Companies, Inc. 216648501 04/07/2026 Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920.730000 0.000000 AGAINST 920.730000 AGAINST S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Jerome Durso DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect John M. Gill DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Philip L. Hodges DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 WITHHOLD 710.360000 AGAINST S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Diane Jorkasky DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Teri Lawver DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Wayne Pisano DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Mitchel B. Sayare DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Klaus O. Schafer DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Elect Catherine Angell Sohn DIRECTOR ELECTIONS ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 710.360000 0.000000 AGAINST 710.360000 AGAINST S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to increase the number of authorized shares of the Company's common stock. CAPITAL STRUCTURE ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Vote to approve an amendment to the Company's 2019 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock reserved under the Company's 2019 Employee Stock Purchase Plan COMPENSATION ISSUER 710.360000 0.000000 FOR 710.360000 FOR S000004450 Altimmune, Inc. 02155H200 04/16/2026 Approve the authorization to adjourn the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the proposals. CORPORATE GOVERNANCE ISSUER 710.360000 0.000000 AGAINST 710.360000 AGAINST S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Frank A. D Amelio DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 AGAINST 768.930000 AGAINST S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 768.930000 0.000000 AGAINST 768.930000 AGAINST S000004450 Humana Inc. 444859102 04/16/2026 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The approval of the Humana Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 768.930000 0.000000 FOR 768.930000 FOR S000004450 Humana Inc. 444859102 04/16/2026 The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. COMPENSATION SECURITY HOLDER 768.930000 0.000000 FOR 768.930000 AGAINST S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Gary D. Blackford DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): William P. Burke DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): James L. Cunniff DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Lisa Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 WITHHOLD 281.500000 AGAINST S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Indrani L. Franchini DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Patrick J. O'Leary DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): David C. Pacitti DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Election of Directors (to serve until the 2027 Annual Meeting): Dr. Julie Shimer DIRECTOR ELECTIONS ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 281.500000 0.000000 AGAINST 281.500000 AGAINST S000004450 Avanos Medical, Inc. 05350V106 04/21/2026 Approval of an amendment to the Company's 2021 Long Term Incentive Plan to allow for the issuance of awards thereunder to the Company's outside directors. COMPENSATION ISSUER 281.500000 0.000000 FOR 281.500000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Nominees: Melinda Litherland DIRECTOR ELECTIONS ISSUER 113.780000 0.000000 AGAINST 113.780000 AGAINST S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Nominees: Arnold A. Pinkston DIRECTOR ELECTIONS ISSUER 113.780000 0.000000 AGAINST 113.780000 AGAINST S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Proposal to ratify the selection of KPMG LLP to serve as the Company's independent auditors. AUDIT-RELATED ISSUER 113.780000 0.000000 FOR 113.780000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 113.780000 0.000000 FOR 113.780000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Approval of the Amended Bio-Rad Laboratories, Inc. 2017 Incentive Award Plan. COMPENSATION ISSUER 113.780000 0.000000 FOR 113.780000 FOR S000004450 Bio-Rad Laboratories, Inc. 090572207 04/21/2026 Stockholder proposal regarding dual class capital structure. CAPITAL STRUCTURE SECURITY HOLDER 113.780000 0.000000 FOR 113.780000 AGAINST S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: David M. Cordani DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Brian C. Evanko DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Eric J. Foss DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Neesha Hathi DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Michael J. Hennigan DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: George Kurian DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Kathleen M. Mazzarella DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Philip O. Ozuah DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Kimberly A. Ross DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Eric C. Wiseman DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Election of Directors: Donna F. Zarcone DIRECTOR ELECTIONS ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1625.190000 0.000000 FOR 1625.190000 FOR S000004450 The Cigna Group 125523100 04/22/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 1625.190000 0.000000 AGAINST 1625.190000 AGAINST S000004450 The Cigna Group 125523100 04/22/2026 Shareholder Proposal - Shareholder Right to Act by Written Consent SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1625.190000 0.000000 FOR 1625.190000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 FOR 997.290000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 FOR 997.290000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 FOR 997.290000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 997.290000 0.000000 FOR 997.290000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 To ratify the appointment of Ernst & Young LLP as our Independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 997.290000 0.000000 AGAINST 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 997.290000 0.000000 FOR 997.290000 FOR S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 997.290000 0.000000 FOR 997.290000 AGAINST S000004450 HCA Healthcare, Inc. 40412C101 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding shareholders' right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 997.290000 0.000000 AGAINST 997.290000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Ari Bousbib DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Carol J. Burt DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: John G. Danhakl DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: James A. Fasano DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 AGAINST 1035.100000 AGAINST S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 AGAINST 1035.100000 AGAINST S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: William G. Kaelin Jr., M.D. DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Election of Directors: Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 1035.100000 0.000000 AGAINST 1035.100000 AGAINST S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1035.100000 0.000000 AGAINST 1035.100000 AGAINST S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 Approve the adoption of the IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan. COMPENSATION ISSUER 1035.100000 0.000000 FOR 1035.100000 FOR S000004450 IQVIA Holdings Inc. 46266C105 04/23/2026 If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. CORPORATE GOVERNANCE SECURITY HOLDER 1035.100000 0.000000 FOR 1035.100000 AGAINST S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 AGAINST 14607.910000 AGAINST S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: John G. Morikis DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 14607.910000 0.000000 FOR 14607.910000 FOR S000004450 Johnson & Johnson 478160104 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 14607.910000 0.000000 AGAINST 14607.910000 AGAINST S000004450 Johnson & Johnson 478160104 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 14607.910000 0.000000 FOR 14607.910000 AGAINST S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 AGAINST 35140.750000 AGAINST S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 35140.750000 0.000000 AGAINST 35140.750000 AGAINST S000004450 Pfizer Inc. 717081103 04/23/2026 Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026 COMPENSATION ISSUER 35140.750000 0.000000 FOR 35140.750000 FOR S000004450 Pfizer Inc. 717081103 04/23/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 35140.750000 0.000000 AGAINST 35140.750000 AGAINST S000004450 Pfizer Inc. 717081103 04/23/2026 Adopt an Independent Chair Policy CORPORATE GOVERNANCE SECURITY HOLDER 35140.750000 0.000000 FOR 35140.750000 AGAINST S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Parvinderjit S. Khanuja DIRECTOR ELECTIONS ISSUER 714.500000 0.000000 FOR 714.500000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Robert A. Ortenzio DIRECTOR ELECTIONS ISSUER 714.500000 0.000000 AGAINST 714.500000 AGAINST S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Election of Class II Directors: Daniel J. Thomas DIRECTOR ELECTIONS ISSUER 714.500000 0.000000 FOR 714.500000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on the Compensation of Our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 714.500000 0.000000 FOR 714.500000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 714.500000 0.000000 AGAINST 714.500000 AGAINST S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Amendment to the Company's Amended and Restated Certificate of Incorporation to phase out the classified structure of the Board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 714.500000 0.000000 FOR 714.500000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 714.500000 0.000000 ABSTAIN 714.500000 AGAINST S000004450 Select Medical Holdings Corporation 81619Q105 04/23/2026 Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 714.500000 0.000000 FOR 714.500000 AGAINST S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. G. O Grady DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Election of Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Abbott Laboratories 002824100 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 10757.250000 0.000000 FOR 10757.250000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan DIRECTOR ELECTIONS ISSUER 840.080000 0.000000 FOR 840.080000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 840.080000 0.000000 AGAINST 840.080000 AGAINST S000004450 Biohaven Ltd. G1110E107 04/28/2026 Election of Director for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin DIRECTOR ELECTIONS ISSUER 840.080000 0.000000 FOR 840.080000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026. AUDIT-RELATED ISSUER 840.080000 0.000000 FOR 840.080000 FOR S000004450 Biohaven Ltd. G1110E107 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 840.080000 0.000000 AGAINST 840.080000 AGAINST S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Peter Barrett, PhD DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Samuel R. Chapin DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michael A. Klobuchar DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michelle McMurry-Heath, MD, PhD DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Alexis P. Michas DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Prahlad R. Singh, PhD DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Michel Vounatsos DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Frank Witney, PhD DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To elect ten nominees for director for terms of one year each: Pascale Witz DIRECTOR ELECTIONS ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED ISSUER 731.210000 0.000000 AGAINST 731.210000 AGAINST S000004450 Revvity, Inc. 714046109 04/28/2026 To approve, by non-binding advisory vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To approve an amendment to Revvity's Amended and Restated By-Laws to Allow Shareholders Owning 25% of Our Stock to Call a Special Meeting. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 731.210000 0.000000 FOR 731.210000 FOR S000004450 Revvity, Inc. 714046109 04/28/2026 To approve the shareholder proposal regarding Executives to Retain Significant Stock. COMPENSATION SECURITY HOLDER 731.210000 0.000000 FOR 731.210000 AGAINST S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Anthony Colaluca, Jr. DIRECTOR ELECTIONS ISSUER 38.800000 0.000000 WITHHOLD 38.800000 AGAINST S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Michael S. Klein DIRECTOR ELECTIONS ISSUER 38.800000 0.000000 WITHHOLD 38.800000 AGAINST S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Allen R. Thorpe DIRECTOR ELECTIONS ISSUER 38.800000 0.000000 FOR 38.800000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Elect Dale A. White DIRECTOR ELECTIONS ISSUER 38.800000 0.000000 FOR 38.800000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 38.800000 0.000000 FOR 38.800000 FOR S000004450 Claritev Corporation 62548M209 04/29/2026 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 38.800000 0.000000 AGAINST 38.800000 AGAINST S000004450 Claritev Corporation 62548M209 04/29/2026 Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 38.800000 0.000000 FOR 38.800000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Sujata Dayal DIRECTOR ELECTIONS ISSUER 357.260000 0.000000 FOR 357.260000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: John Fowler, Jr. DIRECTOR ELECTIONS ISSUER 357.260000 0.000000 FOR 357.260000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Zsolt Harsanyi, Ph.D. DIRECTOR ELECTIONS ISSUER 357.260000 0.000000 WITHHOLD 357.260000 AGAINST S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 Election of Class II Director to hold office for a term expiring at our 2029 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Joseph Papa DIRECTOR ELECTIONS ISSUER 357.260000 0.000000 WITHHOLD 357.260000 AGAINST S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 357.260000 0.000000 AGAINST 357.260000 AGAINST S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To hold, on an advisory basis, a vote to approve the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 357.260000 0.000000 FOR 357.260000 FOR S000004450 Emergent BioSolutions Inc. 29089Q105 04/29/2026 To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. COMPENSATION ISSUER 357.260000 0.000000 FOR 357.260000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Robert L. Zerbe DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 WITHHOLD 340.160000 AGAINST S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Alan L. Rubino DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 FOR 340.160000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Heidi Hagen DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 WITHHOLD 340.160000 AGAINST S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Kevin McLaughlin DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 FOR 340.160000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Paul Kevin Wotton DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 FOR 340.160000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Dominick C. Colangelo DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 FOR 340.160000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 Elect Lisa Wright DIRECTOR ELECTIONS ISSUER 340.160000 0.000000 FOR 340.160000 FOR S000004450 Vericel Corporation 92346J108 04/29/2026 To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 340.160000 0.000000 AGAINST 340.160000 AGAINST S000004450 Vericel Corporation 92346J108 04/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 340.160000 0.000000 AGAINST 340.160000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Susan E Morano DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 AGAINST 9992.560000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Catherine R. Smith DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 AGAINST 9992.560000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 9992.560000 0.000000 AGAINST 9992.560000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 9992.560000 0.000000 FOR 9992.560000 FOR S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 9992.560000 0.000000 AGAINST 9992.560000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 9992.560000 0.000000 ABSTAIN 9992.560000 AGAINST S000004450 Boston Scientific Corporation 101137107 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 9992.560000 0.000000 FOR 9992.560000 AGAINST S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Vipin Gopal DIRECTOR ELECTIONS ISSUER 747.830000 0.000000 FOR 747.830000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: William Newton DIRECTOR ELECTIONS ISSUER 747.830000 0.000000 FOR 747.830000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. Watkins DIRECTOR ELECTIONS ISSUER 747.830000 0.000000 FOR 747.830000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Hold a non-binding advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 747.830000 0.000000 FOR 747.830000 FOR S000004450 Concentra Group Holdings Parent, Inc. 20603L102 04/30/2026 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 747.830000 0.000000 FOR 747.830000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jacqueline K. Barton, Ph.D DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Jeffrey A. Bluestone, Ph.D DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Ted W. Love, M.D DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Harish Manwani DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified. Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 8362.880000 0.000000 AGAINST 8362.880000 AGAINST S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 8362.880000 0.000000 FOR 8362.880000 FOR S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 8362.880000 0.000000 FOR 8362.880000 AGAINST S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 8362.880000 0.000000 FOR 8362.880000 AGAINST S000004450 Gilead Sciences, Inc. 375558103 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 8362.880000 0.000000 AGAINST 8362.880000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Gary L. Ellis DIRECTOR ELECTIONS ISSUER 180.360000 0.000000 WITHHOLD 180.360000 AGAINST S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Georgia Melenikiotou DIRECTOR ELECTIONS ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Elect Dana G. Mead, Jr. DIRECTOR ELECTIONS ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 180.360000 0.000000 ONE YEAR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. COMPENSATION ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Inspire Medical Systems, Inc. 457730109 04/30/2026 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. CORPORATE GOVERNANCE ISSUER 180.360000 0.000000 FOR 180.360000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2284.550000 0.000000 FOR 2284.550000 FOR S000004450 Intuitive Surgical, Inc. 46120E602 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 2284.550000 0.000000 AGAINST 2284.550000 AGAINST S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Ms. Minnie Baylor-Henry DIRECTOR ELECTIONS ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Mr. Heinz Mausli DIRECTOR ELECTIONS ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Ms. Julie McHugh DIRECTOR ELECTIONS ISSUER 446.300000 0.000000 AGAINST 446.300000 AGAINST S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 Election of Class II Directors to our Board of Directors: Dr. Phuong Khanh (P.K.) Morrow DIRECTOR ELECTIONS ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval, on an advisory basis, of the compensation paid to our named executive officers (commonly referred to as "say on pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval, on an advisory basis, of the frequency of holding future "say on pay" votes. SECTION 14A SAY-ON-PAY VOTES ISSUER 446.300000 0.000000 ONE YEAR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval of an amendment to our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The approval of the Lantheus Holdings, Inc. Amended and Restated 2026 Equity Incentive Plan. COMPENSATION ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lantheus Holdings, Inc. 516544103 04/30/2026 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 446.300000 0.000000 FOR 446.300000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Samuel L. Barker DIRECTOR ELECTIONS ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Christopher J. Sobecki DIRECTOR ELECTIONS ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Elect Judith L. Swain DIRECTOR ELECTIONS ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Ratification and approval of the Company's Seventh Amended and Restated Certificate of Incorporation CAPITAL STRUCTURE ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Approval of the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Approval of the Company's 2026 Non-Employee Directors Equity Incentive Plan COMPENSATION ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1228.410000 0.000000 FOR 1228.410000 FOR S000004450 Lexicon Pharmaceuticals, Inc. 528872302 04/30/2026 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1228.410000 0.000000 AGAINST 1228.410000 AGAINST S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 AGAINST 883.550000 AGAINST S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 AGAINST 883.550000 AGAINST S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Donal O Connor DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 Election of Director to serve until the 2027 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor. AUDIT-RELATED ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To provide advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To provide approval of the 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To renew the Board's authority to issue shares under Irish law. CAPITAL STRUCTURE ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 Perrigo Company plc G97822103 04/30/2026 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law. CAPITAL STRUCTURE ISSUER 883.550000 0.000000 FOR 883.550000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Jorge A. Caballero DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Teri G. Fontenot DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Cary S. Grace DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: James H. Hinton DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Celia P. Huber DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Daphne E. Jones DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of Directors: Eric P. Palmer DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 Election of directors Sylvia D. Trent-Adams DIRECTOR ELECTIONS ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To approve, by non-binding advisory vote, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 248.020000 0.000000 AGAINST 248.020000 AGAINST S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To ratify the appointment of KPMG LLP to be our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 248.020000 0.000000 AGAINST 248.020000 AGAINST S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 To approve Amendment No. 1 to the AMN Healthcare 2025 Equity Plan. COMPENSATION ISSUER 248.020000 0.000000 FOR 248.020000 FOR S000004450 AMN Healthcare Services, Inc. 001744101 05/01/2026 A shareholder proposal entitled: "Independent Board Chairman." CORPORATE GOVERNANCE SECURITY HOLDER 248.020000 0.000000 AGAINST 248.020000 FOR S000004450 Masimo Corporation 574795100 05/01/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated February 16, 2026, by and among Masimo Corporation ("Masimo"), Danaher Corporation ("Danaher"), and Mobius Merger Sub, Inc., a wholly owned subsidiary of Danaher ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Masimo, with Masimo surviving the merger as a wholly owned subsidiary of Danaher (the "Merger" and such proposal, the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 319.320000 0.000000 FOR 319.320000 FOR S000004450 Masimo Corporation 574795100 05/01/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 319.320000 0.000000 FOR 319.320000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 4972.310000 0.000000 AGAINST 4972.310000 AGAINST S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 4972.310000 0.000000 AGAINST 4972.310000 AGAINST S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 4972.310000 0.000000 FOR 4972.310000 FOR S000004450 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 4972.310000 0.000000 FOR 4972.310000 AGAINST S000004450 Eli Lilly and Company 532457108 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 4972.310000 0.000000 FOR 4972.310000 AGAINST S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Mark A. DiPaolo, Esq. DIRECTOR ELECTIONS ISSUER 482.290000 0.000000 AGAINST 482.290000 AGAINST S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Pavel Raifeld DIRECTOR ELECTIONS ISSUER 482.290000 0.000000 FOR 482.290000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Jules Haimovitz DIRECTOR ELECTIONS ISSUER 482.290000 0.000000 AGAINST 482.290000 AGAINST S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Sarah J. Schlesinger, M.D. DIRECTOR ELECTIONS ISSUER 482.290000 0.000000 AGAINST 482.290000 AGAINST S000004450 Innoviva, Inc. 45781M101 05/04/2026 Election of Director to serve until the 2027 Annual Meeting of Stockholders: Derek A. Small DIRECTOR ELECTIONS ISSUER 482.290000 0.000000 FOR 482.290000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Approval of a non-binding advisory resolution regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 482.290000 0.000000 FOR 482.290000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 482.290000 0.000000 FOR 482.290000 FOR S000004450 Innoviva, Inc. 45781M101 05/04/2026 Approval of the 2026 Equity Incentive Plan. COMPENSATION ISSUER 482.290000 0.000000 FOR 482.290000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Mark A. Buthman DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: William F. Feehery DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Robert F. Friel DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Eric M. Green DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Janet B. Haugen DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Molly E. Joseph DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Deborah L. V. Keller DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 AGAINST 459.740000 AGAINST S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Myla P. Lai-Goldman DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Douglas A. Michels DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Election of Directors: Paolo Pucci DIRECTOR ELECTIONS ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 459.740000 0.000000 FOR 459.740000 FOR S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 459.740000 0.000000 AGAINST 459.740000 AGAINST S000004450 West Pharmaceutical Services, Inc. 955306105 05/04/2026 Shareholder proposal regarding an independent Board Chair policy. CORPORATE GOVERNANCE SECURITY HOLDER 459.740000 0.000000 FOR 459.740000 AGAINST S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: William A. Ampofo II DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Jeffrey A. Craig DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Andrew P. Hider DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Michael R. McDonnell DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Patricia B. Morrison DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Brent Shafer DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: Amy A. Wendell DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Election of Directors: David S. Wilkes, M.D. DIRECTOR ELECTIONS ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Advisory Vote to Approve Named Executive Officer Compensation for 2025 SECTION 14A SAY-ON-PAY VOTES ISSUER 3508.770000 0.000000 AGAINST 3508.770000 AGAINST S000004450 Baxter International Inc. 071813109 05/05/2026 Ratification of Appointment of Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 3508.770000 0.000000 AGAINST 3508.770000 AGAINST S000004450 Baxter International Inc. 071813109 05/05/2026 Approval of the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan COMPENSATION ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Baxter International Inc. 071813109 05/05/2026 Approval of Amendment to the Baxter International Inc. Amended and Restated Certificate of Incorporation to Amend Board Size CORPORATE GOVERNANCE ISSUER 3508.770000 0.000000 FOR 3508.770000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 AGAINST 13901.030000 AGAINST S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 13901.030000 0.000000 FOR 13901.030000 FOR S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 13901.030000 0.000000 AGAINST 13901.030000 AGAINST S000004450 Bristol-Myers Squibb Company 110122108 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 13901.030000 0.000000 FOR 13901.030000 AGAINST S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Nancy C. Andrews DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 AGAINST 330.040000 AGAINST S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Steven Barg DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Abraham Ceesay DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 AGAINST 330.040000 AGAINST S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Mark Enyedy DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: James C. Foster DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Birgit Girshick DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Paul Graves DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Reshema Kemps-Polanco DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: George Llado DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Martin Mackay DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Craig B. Thompson DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Election of Directors: Virginia Wilson DIRECTOR ELECTIONS ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Advisory approval of 2025 executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 2026 Long-Term Incentive Plan. COMPENSATION ISSUER 330.040000 0.000000 FOR 330.040000 FOR S000004450 Charles River Laboratories International, Inc. 159864107 05/05/2026 Ratification of PricewaterhouseCoopers LLC as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 330.040000 0.000000 AGAINST 330.040000 AGAINST S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 AGAINST 4285.010000 AGAINST S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 4285.010000 0.000000 AGAINST 4285.010000 AGAINST S000004450 Danaher Corporation 235851102 05/05/2026 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Danaher Corporation 235851102 05/05/2026 To approve the Company's Amended and Restated Omnibus Incentive Plan. COMPENSATION ISSUER 4285.010000 0.000000 FOR 4285.010000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: John Ackerman DIRECTOR ELECTIONS ISSUER 135.690000 0.000000 FOR 135.690000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified: Randall Lewis DIRECTOR ELECTIONS ISSUER 135.690000 0.000000 WITHHOLD 135.690000 AGAINST S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 135.690000 0.000000 FOR 135.690000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To approve, on a non-binding advisory basis, the frequency of the Company's future advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 135.690000 0.000000 ONE YEAR 135.690000 FOR S000004450 Guardian Pharmacy Services, Inc. 40145W101 05/05/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 135.690000 0.000000 FOR 135.690000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 Election of Class I Directors: Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 800.110000 0.000000 FOR 800.110000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 Election of Class I Directors: Matthew L. Posard DIRECTOR ELECTIONS ISSUER 800.110000 0.000000 AGAINST 800.110000 AGAINST S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 800.110000 0.000000 FOR 800.110000 FOR S000004450 Halozyme Therapeutics, Inc. 40637H109 05/05/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 800.110000 0.000000 AGAINST 800.110000 AGAINST S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Michael J. Fucci DIRECTOR ELECTIONS ISSUER 596.110000 0.000000 AGAINST 596.110000 AGAINST S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Patrice A. Harris DIRECTOR ELECTIONS ISSUER 596.110000 0.000000 FOR 596.110000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Election of Directors: Daniel J. Cancelmi DIRECTOR ELECTIONS ISSUER 596.110000 0.000000 FOR 596.110000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. COMPENSATION ISSUER 596.110000 0.000000 FOR 596.110000 FOR S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 596.110000 0.000000 AGAINST 596.110000 AGAINST S000004450 Acadia Healthcare Company, Inc. 00404A109 05/06/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 596.110000 0.000000 AGAINST 596.110000 AGAINST S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Deb Autor DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: J. Kevin Buchi DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Jeff George DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: John Kiely DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Paul Meister DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 AGAINST 1075.110000 AGAINST S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Ted Nark DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Chintu Patel DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Chirag Patel DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Gautam Patel DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Election of Directors: Shlomo Yanai DIRECTOR ELECTIONS ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Amneal Pharmaceuticals, Inc. 03168L105 05/06/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026. AUDIT-RELATED ISSUER 1075.110000 0.000000 FOR 1075.110000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Sandra Horning, M.D. DIRECTOR ELECTIONS ISSUER 2064.840000 0.000000 FOR 2064.840000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal. Abbas Hussain DIRECTOR ELECTIONS ISSUER 2064.840000 0.000000 FOR 2064.840000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2064.840000 0.000000 AGAINST 2064.840000 AGAINST S000004450 Moderna, Inc. 60770K107 05/06/2026 To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2064.840000 0.000000 ONE YEAR 2064.840000 FOR S000004450 Moderna, Inc. 60770K107 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2064.840000 0.000000 FOR 2064.840000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Steven J. Orlando DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Ronna E. Romney DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 AGAINST 349.770000 AGAINST S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Francis S. Soistman DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Dale B. Wolf DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 AGAINST 349.770000 AGAINST S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To elect ten directors to hold office until the 2027 Annual Meeting. Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 349.770000 0.000000 AGAINST 349.770000 AGAINST S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 349.770000 0.000000 AGAINST 349.770000 AGAINST S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve an amendment to the Company's 2025 Equity Incentive Plan to increase the number of shares available for issuance under such plan. COMPENSATION ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Molina Healthcare, Inc. 60855R100 05/06/2026 To consider and approve an amendment to the Company's Certificate of Incorporation to permit stockholders to call special stockholders meetings. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 349.770000 0.000000 FOR 349.770000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To approve and adopt the Merger Agreement. EXTRAORDINARY TRANSACTIONS ISSUER 257.890000 0.000000 FOR 257.890000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 257.890000 0.000000 FOR 257.890000 FOR S000004450 Penumbra, Inc. 70975L107 05/06/2026 To adjourn or postpone the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment or postponement, there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to the accompanying proxy statement/prospectus is timely provided to Penumbra Stockholders. CORPORATE GOVERNANCE ISSUER 257.890000 0.000000 FOR 257.890000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 AGAINST 2340.450000 AGAINST S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Election of Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Stryker Corporation 863667101 05/06/2026 Ratification of appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 2340.450000 0.000000 AGAINST 2340.450000 AGAINST S000004450 Stryker Corporation 863667101 05/06/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2340.450000 0.000000 FOR 2340.450000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect William W. Burke DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Valerie Asbury DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Sheri Dodd DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Raymond Huggenberger DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Laura G. King DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Andrea A. Pearson DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Brent Shafer DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect Carmen Volkart DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Elect B. Vindell Washington DIRECTOR ELECTIONS ISSUER 151.620000 0.000000 WITHHOLD 151.620000 AGAINST S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Approve, on an advisory basis, the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Tactile Systems Technology, Inc. 87357P100 05/06/2026 Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. CORPORATE GOVERNANCE ISSUER 151.620000 0.000000 FOR 151.620000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Simon Dingemans DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Emmanuel Ligner DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Lucier DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 AGAINST 4648.240000 AGAINST S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Dame Louise Makin DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Joseph Massaro DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Sanjeev Mehra DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Mala Murthy DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Michael Severino DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Election of Directors: Gregory Summe DIRECTOR ELECTIONS ISSUER 4648.240000 0.000000 AGAINST 4648.240000 AGAINST S000004450 Avantor, Inc. 05352A100 05/07/2026 Advisory Approval of Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 4648.240000 0.000000 ONE YEAR 4648.240000 FOR S000004450 Avantor, Inc. 05352A100 05/07/2026 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026 AUDIT-RELATED ISSUER 4648.240000 0.000000 FOR 4648.240000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 AGAINST 3944.770000 AGAINST S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 AGAINST 3944.770000 AGAINST S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 AGAINST 3944.770000 AGAINST S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 AGAINST 3944.770000 AGAINST S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Election of Directors: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 3944.770000 0.000000 AGAINST 3944.770000 AGAINST S000004450 Edwards Lifesciences Corporation 28176E108 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 3944.770000 0.000000 FOR 3944.770000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Greg D. Carmichael DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 AGAINST 684.300000 AGAINST S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Edward M. Christie III DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Cain A. Hayes DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Joan E. Herman DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 AGAINST 684.300000 AGAINST S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Leslye G. Katz DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Kevin J. O'Connor DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Christopher R. Reidy DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Nancy M. Schlichting DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Mark J. Tarr DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Election of Directors: Terrance Williams DIRECTOR ELECTIONS ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 Encompass Health Corporation 29261A100 05/07/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 684.300000 0.000000 AGAINST 684.300000 AGAINST S000004450 Encompass Health Corporation 29261A100 05/07/2026 An advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 684.300000 0.000000 FOR 684.300000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: H. Lawrence Culp, Jr. DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Rodney F. Hochman DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Catherine Lesjak DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 AGAINST 3098.580000 AGAINST S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Anne T. Madden DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: William J. Stromberg DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Election of Directors: Phoebe L. Yang DIRECTOR ELECTIONS ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Approval of our named executive officers' compensation in an advisory vote. SECTION 14A SAY-ON-PAY VOTES ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 GE HealthCare Technologies Inc. 36266G107 05/07/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3098.580000 0.000000 FOR 3098.580000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 AGAINST 452.620000 AGAINST S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 Election of Director to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade DIRECTOR ELECTIONS ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026. AUDIT-RELATED ISSUER 452.620000 0.000000 AGAINST 452.620000 AGAINST S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Integra LifeSciences Holdings Corporation 457985208 05/07/2026 To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan. COMPENSATION ISSUER 452.620000 0.000000 FOR 452.620000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Roland Diggelmann DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Domitille Doat-Le Bigot DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 AGAINST 138.900000 AGAINST S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Elisha W. Finney DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Pablo Perversi DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Thomas P. Salice DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 AGAINST 138.900000 AGAINST S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Brian Shepherd DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Wolfgang Wienand DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Election of Directors: Ingrid Zhang DIRECTOR ELECTIONS ISSUER 138.900000 0.000000 AGAINST 138.900000 AGAINST S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Ratification of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 138.900000 0.000000 AGAINST 138.900000 AGAINST S000004450 Mettler-Toledo International Inc. 592688105 05/07/2026 Advisory Vote to Approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 138.900000 0.000000 FOR 138.900000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; Emil E. Hassan DIRECTOR ELECTIONS ISSUER 90.260000 0.000000 AGAINST 90.260000 AGAINST S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; Lisa Piercey, M.D. DIRECTOR ELECTIONS ISSUER 90.260000 0.000000 FOR 90.260000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 The re-election of directors to hold office for a three (3) year term and until their successors have been duly elected and qualified; William A. Adams DIRECTOR ELECTIONS ISSUER 90.260000 0.000000 FOR 90.260000 FOR S000004450 National HealthCare Corporation 635906100 05/07/2026 To consider an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 90.260000 0.000000 FOR 90.260000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Laura A. Linynsky DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Thomas A. McEachin DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 AGAINST 583.230000 AGAINST S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Kurt D. Newman DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Mark S. Ordan DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Michael A. Rucker DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr. DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Shirley A. Weis DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: Sylvia J. Young DIRECTOR ELECTIONS ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2026 fiscal year AUDIT-RELATED ISSUER 583.230000 0.000000 AGAINST 583.230000 AGAINST S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Conduct an advisory vote regarding the compensation of our named executive officers for the 2025 fiscal year SECTION 14A SAY-ON-PAY VOTES ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 Pediatrix Medical Group, Inc. 58502B106 05/07/2026 Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan COMPENSATION ISSUER 583.230000 0.000000 FOR 583.230000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Election of Class II directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Say on pay - an advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting SHAREHOLDER RIGHTS AND DEFENSES ISSUER 12019.350000 0.000000 FOR 12019.350000 FOR S000004450 AbbVie Inc. 00287Y109 05/08/2026 Stockholder proposal - to adopt a policy to require an independent chair CORPORATE GOVERNANCE SECURITY HOLDER 12019.350000 0.000000 FOR 12019.350000 AGAINST S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: James Boylan DIRECTOR ELECTIONS ISSUER 109.210000 0.000000 FOR 109.210000 FOR S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To elect the two Class II director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Patrick G. Enright DIRECTOR ELECTIONS ISSUER 109.210000 0.000000 FOR 109.210000 FOR S000004450 Zenas BioPharma, Inc. 98937L105 05/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 109.210000 0.000000 FOR 109.210000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Thomas F. Ackerman DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 WITHHOLD 268.380000 AGAINST S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Daniel J. Bevevino DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Marna P. Borgstrom DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect James W. Bullock DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Jeffrey H. Burbank DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 WITHHOLD 268.380000 AGAINST S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Elizabeth A. Hoff DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect J. Patrick Mackin DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Jon W. Salveson DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 Elect Anthony B. Semedo DIRECTOR ELECTIONS ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Artivion, Inc. 228903100 05/12/2026 To ratify the preliminary approval of Ernst & Young LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 268.380000 0.000000 FOR 268.380000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Jessica L. Blume DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 AGAINST 3350.870000 AGAINST S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Kenneth A. Burdick DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Christopher J. Coughlin DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: H. James Dallas DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Frederick H. Eppinger DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Monte E. Ford DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Sarah M. London DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Election of Directors: Kenneth Y. Tanji DIRECTOR ELECTIONS ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3350.870000 0.000000 FOR 3350.870000 FOR S000004450 Centene Corporation 15135B101 05/12/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 3350.870000 0.000000 AGAINST 3350.870000 AGAINST S000004450 Centene Corporation 15135B101 05/12/2026 Stockholder proposal regarding an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 3350.870000 0.000000 AGAINST 3350.870000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 AGAINST 852.190000 AGAINST S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Kevin J. Hammons DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 AGAINST 852.190000 AGAINST S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 852.190000 0.000000 FOR 852.190000 FOR S000004450 Community Health Systems, Inc. 203668108 05/12/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 852.190000 0.000000 AGAINST 852.190000 AGAINST S000004450 Enhabit, Inc. 29332G102 05/12/2026 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 22, 2026, by and among Enhabit, Inc. ("Enhabit"), Anchor Parent, LLC, a Delaware limited liability company ("Parent"), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Enhabit, with Enhabit surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). EXTRAORDINARY TRANSACTIONS ISSUER 348.630000 0.000000 FOR 348.630000 FOR S000004450 Enhabit, Inc. 29332G102 05/12/2026 Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 348.630000 0.000000 FOR 348.630000 FOR S000004450 Enhabit, Inc. 29332G102 05/12/2026 Approval of the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes virtually or by proxy to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE ISSUER 348.630000 0.000000 FOR 348.630000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Daniel M. Junius DIRECTOR ELECTIONS ISSUER 534.800000 0.000000 AGAINST 534.800000 AGAINST S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Lawrence D. Kingsley DIRECTOR ELECTIONS ISSUER 534.800000 0.000000 FOR 534.800000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Election of Director: Sophie V. Vandebroek, PhD DIRECTOR ELECTIONS ISSUER 534.800000 0.000000 AGAINST 534.800000 AGAINST S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 534.800000 0.000000 AGAINST 534.800000 AGAINST S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 534.800000 0.000000 FOR 534.800000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Amend Certificate of Incorporation to Declassify the Board (Proposal Four). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 534.800000 0.000000 FOR 534.800000 FOR S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting (Proposal Five). SHAREHOLDER RIGHTS AND DEFENSES ISSUER 534.800000 0.000000 ABSTAIN 534.800000 AGAINST S000004450 IDEXX Laboratories, Inc. 45168D104 05/12/2026 Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 534.800000 0.000000 FOR 534.800000 AGAINST S000004450 Personalis, Inc. 71535D106 05/12/2026 Election of Directors: Olivia K. Bloom DIRECTOR ELECTIONS ISSUER 361.720000 0.000000 WITHHOLD 361.720000 AGAINST S000004450 Personalis, Inc. 71535D106 05/12/2026 Election of Directors: Woodrow A. Myers, Jr., M.D. DIRECTOR ELECTIONS ISSUER 361.720000 0.000000 WITHHOLD 361.720000 AGAINST S000004450 Personalis, Inc. 71535D106 05/12/2026 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 361.720000 0.000000 FOR 361.720000 FOR S000004450 Personalis, Inc. 71535D106 05/12/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 361.720000 0.000000 FOR 361.720000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Gail K. Boudreaux DIRECTOR ELECTIONS ISSUER 1483.880000 0.000000 FOR 1483.880000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Robert L. Dixon, Jr. DIRECTOR ELECTIONS ISSUER 1483.880000 0.000000 FOR 1483.880000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Election of Directors: Deanna D. Strable DIRECTOR ELECTIONS ISSUER 1483.880000 0.000000 FOR 1483.880000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1483.880000 0.000000 FOR 1483.880000 FOR S000004450 Elevance Health, Inc. 036752103 05/13/2026 Ratification of Ernst & Young LLP as Auditors for 2026. AUDIT-RELATED ISSUER 1483.880000 0.000000 AGAINST 1483.880000 AGAINST S000004450 Elevance Health, Inc. 036752103 05/13/2026 Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. OTHER SOCIAL ISSUES SECURITY HOLDER 1483.880000 0.000000 FOR 1483.880000 AGAINST S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Mr. Barry M. Smith DIRECTOR ELECTIONS ISSUER 399.950000 0.000000 AGAINST 399.950000 AGAINST S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Swati B. Abbott DIRECTOR ELECTIONS ISSUER 399.950000 0.000000 FOR 399.950000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS I DIRECTOR FOR A THREE-YEAR TERM: Ms. Suzanne D. Snapper DIRECTOR ELECTIONS ISSUER 399.950000 0.000000 AGAINST 399.950000 AGAINST S000004450 Ensign Group, Inc. 29358P101 05/13/2026 ELECTION OF CLASS II DIRECTOR FOR AN INITIAL ONE-YEAR TERM: Ms. Marivic Uychiat Pison DIRECTOR ELECTIONS ISSUER 399.950000 0.000000 FOR 399.950000 FOR S000004450 Ensign Group, Inc. 29358P101 05/13/2026 Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 399.950000 0.000000 AGAINST 399.950000 AGAINST S000004450 Ensign Group, Inc. 29358P101 05/13/2026 Approval, on an advisory basis, of our named executive officers compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 399.950000 0.000000 FOR 399.950000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Vivek Jain DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect David C. Greenberg DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Elisha W. Finney DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 WITHHOLD 162.460000 AGAINST S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect David F. Hoffmeister DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Donald M. Abbey DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Laurie Hernandez DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 Elect Kolleen T. Kennedy DIRECTOR ELECTIONS ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt astockholder right to call special meetings at an ownership threshold of 25%. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 162.460000 0.000000 ABSTAIN 162.460000 AGAINST S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 162.460000 0.000000 FOR 162.460000 FOR S000004450 ICU Medical, Inc. 44930G107 05/13/2026 To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 162.460000 0.000000 FOR 162.460000 AGAINST S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Dr. David Wheadon DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 AGAINST 731.860000 AGAINST S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Joe Ciaffoni DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Dr. Keith Humphreys DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Tony Kingsley DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Daniel Ninivaggi DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 AGAINST 731.860000 AGAINST S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Barbara Ryan DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Mark Stejbach DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 Election of Director: Juliet Thompson DIRECTOR ELECTIONS ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 731.860000 0.000000 ONE YEAR 731.860000 FOR S000004450 Indivior Pharmaceuticals, Inc. 45579U109 05/13/2026 To ratify the appointment of PricewaterhouseCoopers LLP (US) as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 731.860000 0.000000 FOR 731.860000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 Elect Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 1437.930000 0.000000 WITHHOLD 1437.930000 AGAINST S000004450 Insmed Incorporated 457669307 05/13/2026 Elect Clarissa Desjardins DIRECTOR ELECTIONS ISSUER 1437.930000 0.000000 FOR 1437.930000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1437.930000 0.000000 FOR 1437.930000 FOR S000004450 Insmed Incorporated 457669307 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1437.930000 0.000000 AGAINST 1437.930000 AGAINST S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Martha G. Aronson (three (3) year term) DIRECTOR ELECTIONS ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term) DIRECTOR ELECTIONS ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term) DIRECTOR ELECTIONS ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Scott R. Ward (three (3) year term) DIRECTOR ELECTIONS ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Approval of the Merit Medical Systems, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 409.720000 0.000000 FOR 409.720000 FOR S000004450 Merit Medical Systems, Inc. 589889104 05/13/2026 Ratification of the Audit Committee's appointment of Deloitte & Touche LLP to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 409.720000 0.000000 AGAINST 409.720000 AGAINST S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Lloyd A. Carney DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 AGAINST 1699.350000 AGAINST S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Election of Directors: Suketu Upadhyay DIRECTOR ELECTIONS ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1699.350000 0.000000 AGAINST 1699.350000 AGAINST S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 1699.350000 0.000000 FOR 1699.350000 FOR S000004450 Vertex Pharmaceuticals Incorporated 92532F100 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 1699.350000 0.000000 FOR 1699.350000 AGAINST S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 AGAINST 426.050000 AGAINST S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 AGAINST 426.050000 AGAINST S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 426.050000 0.000000 AGAINST 426.050000 AGAINST S000004450 Accendra Health, Inc. 690732102 05/14/2026 Non-Binding advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Accendra Health, Inc. 690732102 05/14/2026 Approval of the Accenda Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 426.050000 0.000000 FOR 426.050000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Richard E. Buller DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect David F. Dalvey DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Leo T. Furcht DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 WITHHOLD 141.690000 AGAINST S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Lance G. Laing DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Polly A. Murphy DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Richard J. Nigon DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 WITHHOLD 141.690000 AGAINST S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Charles Romp DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 Elect Brian F. Sullivan DIRECTOR ELECTIONS ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To ratify the appointment of Boulay PLLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 141.690000 0.000000 FOR 141.690000 FOR S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 141.690000 0.000000 AGAINST 141.690000 AGAINST S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve the Celcuity Inc. 2026 Stock Incentive Plan. COMPENSATION ISSUER 141.690000 0.000000 AGAINST 141.690000 AGAINST S000004450 Celcuity Inc. 15102K100 05/14/2026 To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 141.690000 0.000000 AGAINST 141.690000 AGAINST S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Arjun Bedi DIRECTOR ELECTIONS ISSUER 830.920000 0.000000 FOR 830.920000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Stephen M. McLean DIRECTOR ELECTIONS ISSUER 830.920000 0.000000 WITHHOLD 830.920000 AGAINST S000004450 Certara, Inc. 15687V109 05/14/2026 Elect Jon Resnick DIRECTOR ELECTIONS ISSUER 830.920000 0.000000 FOR 830.920000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 Ratification of the selection of RSM US LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 830.920000 0.000000 FOR 830.920000 FOR S000004450 Certara, Inc. 15687V109 05/14/2026 A non-binding advisory vote to approve the compensation of our named executive officers for the most recently completed fiscal year. SECTION 14A SAY-ON-PAY VOTES ISSUER 830.920000 0.000000 FOR 830.920000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D. DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 AGAINST 219.950000 AGAINST S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D. DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Election of directors to hold office until the 2027 Annual Meeting: Gino Santini DIRECTOR ELECTIONS ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 Collegium Pharmaceutical, Inc. 19459J104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 219.950000 0.000000 FOR 219.950000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 AGAINST 8503.060000 AGAINST S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 8503.060000 0.000000 FOR 8503.060000 FOR S000004450 CVS Health Corporation 126650100 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 8503.060000 0.000000 AGAINST 8503.060000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Ming Hsieh DIRECTOR ELECTIONS ISSUER 137.320000 0.000000 FOR 137.320000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Linda Dong DIRECTOR ELECTIONS ISSUER 137.320000 0.000000 FOR 137.320000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Michael Nohaile, Ph.D. DIRECTOR ELECTIONS ISSUER 137.320000 0.000000 WITHHOLD 137.320000 AGAINST S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 Election of Directors: Regina Groves DIRECTOR ELECTIONS ISSUER 137.320000 0.000000 FOR 137.320000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 137.320000 0.000000 FOR 137.320000 FOR S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 137.320000 0.000000 AGAINST 137.320000 AGAINST S000004450 Fulgent Genetics, Inc. 359664109 05/14/2026 To approve the Fulgent Genetics, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 137.320000 0.000000 FOR 137.320000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Geno Germano DIRECTOR ELECTIONS ISSUER 292.420000 0.000000 FOR 292.420000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Troy Ignelzi DIRECTOR ELECTIONS ISSUER 292.420000 0.000000 WITHHOLD 292.420000 AGAINST S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Ron Philip DIRECTOR ELECTIONS ISSUER 292.420000 0.000000 WITHHOLD 292.420000 AGAINST S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Elect Andreas Wicki DIRECTOR ELECTIONS ISSUER 292.420000 0.000000 FOR 292.420000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 292.420000 0.000000 FOR 292.420000 FOR S000004450 Harmony Biosciences Holdings, Inc. 413197104 05/14/2026 Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules. SECTION 14A SAY-ON-PAY VOTES ISSUER 292.420000 0.000000 FOR 292.420000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company. Shane M. Cooke DIRECTOR ELECTIONS ISSUER 294.700000 0.000000 AGAINST 294.700000 AGAINST S000004450 Prothena Corporation plc G72800108 05/14/2026 To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company. Dennis J. Selkoe DIRECTOR ELECTIONS ISSUER 294.700000 0.000000 FOR 294.700000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To ratify, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year 2026, and to authorize, in a binding vote, the Company's Board of Directors, through its Audit Committee, to approve the remuneration of that auditor. AUDIT-RELATED ISSUER 294.700000 0.000000 FOR 294.700000 FOR S000004450 Prothena Corporation plc G72800108 05/14/2026 To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 294.700000 0.000000 AGAINST 294.700000 AGAINST S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Olivier Loeillot DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Karen A. Dawes DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Nicolas M. Barthelemy DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Carrie Eglinton Manner DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Konstantin Konstantinov, Ph.D. DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Martin D. Madaus, D.V.M., Ph.D. DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 AGAINST 357.890000 AGAINST S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Rohin Mhatre, Ph.D. DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Glenn P. Muir DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Election of Directors: Margaret A. Pax DIRECTOR ELECTIONS ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 Repligen Corporation 759916109 05/14/2026 Ratification of the selection of Ernst & Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 357.890000 0.000000 AGAINST 357.890000 AGAINST S000004450 Repligen Corporation 759916109 05/14/2026 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 357.890000 0.000000 FOR 357.890000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: Christopher R. Christensen DIRECTOR ELECTIONS ISSUER 236.670000 0.000000 FOR 236.670000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: Brent J. Guerisoli DIRECTOR ELECTIONS ISSUER 236.670000 0.000000 FOR 236.670000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Election of Directors: John G. Nackel, Ph.D. DIRECTOR ELECTIONS ISSUER 236.670000 0.000000 FOR 236.670000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2026. AUDIT-RELATED ISSUER 236.670000 0.000000 FOR 236.670000 FOR S000004450 The Pennant Group, Inc. 70805E109 05/14/2026 Advisory approval of the Company's named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 236.670000 0.000000 AGAINST 236.670000 AGAINST S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Emil D. Kakkis, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 601.800000 0.000000 FOR 601.800000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Shehnaaz Suliman, M.D. DIRECTOR ELECTIONS ISSUER 601.800000 0.000000 WITHHOLD 601.800000 AGAINST S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Election of Directors: Daniel G. Welch DIRECTOR ELECTIONS ISSUER 601.800000 0.000000 FOR 601.800000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Approval of the Third Amended and Restated 2023 Incentive Plan. COMPENSATION ISSUER 601.800000 0.000000 FOR 601.800000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 601.800000 0.000000 FOR 601.800000 FOR S000004450 Ultragenyx Pharmaceutical Inc. 90400D108 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 601.800000 0.000000 FOR 601.800000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Elect Krish S. Krishnan DIRECTOR ELECTIONS ISSUER 151.130000 0.000000 WITHHOLD 151.130000 AGAINST S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Elect Christopher Mason DIRECTOR ELECTIONS ISSUER 151.130000 0.000000 FOR 151.130000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 151.130000 0.000000 FOR 151.130000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 151.130000 0.000000 FOR 151.130000 FOR S000004450 Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the Company's Non-Employee Director Compensation Policy. COMPENSATION ISSUER 151.130000 0.000000 AGAINST 151.130000 AGAINST S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Brian T. Carley DIRECTOR ELECTIONS ISSUER 155.000000 0.000000 WITHHOLD 155.000000 AGAINST S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Femida H. Gwadry-Sridhar DIRECTOR ELECTIONS ISSUER 155.000000 0.000000 FOR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Robert O. Kraft DIRECTOR ELECTIONS ISSUER 155.000000 0.000000 WITHHOLD 155.000000 AGAINST S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect August J. Troendle DIRECTOR ELECTIONS ISSUER 155.000000 0.000000 FOR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Elect Dani S. Zander DIRECTOR ELECTIONS ISSUER 155.000000 0.000000 FOR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 155.000000 0.000000 AGAINST 155.000000 AGAINST S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 155.000000 0.000000 FOR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 155.000000 0.000000 ONE YEAR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove supermajority voting requirements. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 155.000000 0.000000 FOR 155.000000 FOR S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 To approve an amendment to the Company's Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 155.000000 0.000000 ABSTAIN 155.000000 AGAINST S000004450 Medpace Holdings, Inc. 58506Q109 05/15/2026 Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 155.000000 0.000000 FOR 155.000000 AGAINST S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Arthur T. Sands DIRECTOR ELECTIONS ISSUER 523.070000 0.000000 FOR 523.070000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Roger D. Dansey DIRECTOR ELECTIONS ISSUER 523.070000 0.000000 FOR 523.070000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Elect Paul M. Silva DIRECTOR ELECTIONS ISSUER 523.070000 0.000000 WITHHOLD 523.070000 AGAINST S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026. AUDIT-RELATED ISSUER 523.070000 0.000000 FOR 523.070000 FOR S000004450 Nurix Therapeutics, Inc. 67080M103 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 523.070000 0.000000 FOR 523.070000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Charles Kummeth DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 AGAINST 1248.890000 AGAINST S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jeffrey Hawkins DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Paula Dowdy DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Ruth Fattori DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Amir Jafri DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jack Kenny DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Brigid A. Makes DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Scott Mendel DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 AGAINST 1248.890000 AGAINST S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Kevin Rakin DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To elect ten directors to serve one-year terms expiring in 2027 Jonathan M. Rothberg, Ph.D. DIRECTOR ELECTIONS ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Quantum-Si incorporated 74765K105 05/15/2026 To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 1248.890000 0.000000 FOR 1248.890000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Carlos Alban DIRECTOR ELECTIONS ISSUER 1078.180000 0.000000 FOR 1078.180000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 1078.180000 0.000000 AGAINST 1078.180000 AGAINST S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Shirley Edwards DIRECTOR ELECTIONS ISSUER 1078.180000 0.000000 FOR 1078.180000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Election of Directors: Dr. Bernard A. Harris Jr. DIRECTOR ELECTIONS ISSUER 1078.180000 0.000000 FOR 1078.180000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1078.180000 0.000000 FOR 1078.180000 FOR S000004450 Solventum Corporation 83444M101 05/15/2026 Ratification of the appointment of PwC as Solventum's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1078.180000 0.000000 FOR 1078.180000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Candace H. Duncan DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Gretchen R. Haggerty DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Andrew A. Krakauer DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Neena M. Patil DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Stuart A. Randle DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Jaewon Ryu DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Election of Directors: Michael J. Tokich DIRECTOR ELECTIONS ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Approval, on an advisory basis, of Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 305.610000 0.000000 FOR 305.610000 FOR S000004450 Teleflex Incorporated 879369106 05/15/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 305.610000 0.000000 AGAINST 305.610000 AGAINST S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: W. Don Cornwell DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Frank D'Amelio DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: JoEllen Lyons Dillon DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 AGAINST 7955.320000 AGAINST S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Elisha Finney DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Leo Groothuis DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Melina Higgins DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: James M. Kilts DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Richard Mark DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Mark Parrish DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Michael Severino DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: David Simmons DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Scott A. Smith DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Election of 13 director nominees, each to hold office until the 2027 annual meeting of shareholders: Rogerio Vivaldi Coelho DIRECTOR ELECTIONS ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Approval of, on a non-binding advisory basis, the 2025 compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 7955.320000 0.000000 FOR 7955.320000 FOR S000004450 Viatris Inc. 92556V106 05/15/2026 Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 7955.320000 0.000000 AGAINST 7955.320000 AGAINST S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Michael H. Carrel DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Regina E. Groves DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: B. Kristine Johnson DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Shlomo Nachman DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Karen N. Prange DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Deborah H. Telman DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 AGAINST 346.920000 AGAINST S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Sven A. Wehrwein DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Robert S. White DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 AGAINST 346.920000 AGAINST S000004450 AtriCure, Inc. 04963C209 05/18/2026 Election of Directors: Maggie Yuen DIRECTOR ELECTIONS ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 346.920000 0.000000 AGAINST 346.920000 AGAINST S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. COMPENSATION ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Proposal to approve an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000. COMPENSATION ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 AtriCure, Inc. 04963C209 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 346.920000 0.000000 FOR 346.920000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Kevin J. McNamara DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Ron DeLyons DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Patrick P. Grace DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 AGAINST 98.140000 AGAINST S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Christopher J. Heaney DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Thomas C. Hutton DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Andrea R. Lindell DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: Eileen P. McCarthy DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: John M. Mount, Jr. DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Election of directors: George J. Walsh III DIRECTOR ELECTIONS ISSUER 98.140000 0.000000 FOR 98.140000 FOR S000004450 Chemed Corporation 16359R103 05/18/2026 Ratification of Audit Committee's selection of PricewaterhouseCoopers LLP as independent accountants for 2026. AUDIT-RELATED ISSUER 98.140000 0.000000 AGAINST 98.140000 AGAINST S000004450 Chemed Corporation 16359R103 05/18/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 98.140000 0.000000 AGAINST 98.140000 AGAINST S000004450 CONMED Corporation 207410101 05/18/2026 Elect Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect David Bronson DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect LaVerne Council DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Charles M. Farkas DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 WITHHOLD 216.720000 AGAINST S000004450 CONMED Corporation 207410101 05/18/2026 Elect Mark Kaye DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Kim Kelderman DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Elect Barbara J. Schwarzentraub DIRECTOR ELECTIONS ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 216.720000 0.000000 FOR 216.720000 FOR S000004450 CONMED Corporation 207410101 05/18/2026 Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 216.720000 0.000000 AGAINST 216.720000 AGAINST S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3721.310000 0.000000 FOR 3721.310000 FOR S000004450 Amgen Inc. 031162100 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3721.310000 0.000000 AGAINST 3721.310000 AGAINST S000004450 Amgen Inc. 031162100 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 3721.310000 0.000000 FOR 3721.310000 AGAINST S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Liam J. Kelly DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Angela S. Lalor DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Damien McDonald DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Philip A. Okala DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Christine Ortiz DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: A. Clayton Perfall DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Brady Shirley DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Rajiv Vinnakota DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 AGAINST 395.730000 AGAINST S000004450 Enovis Corporation 194014502 05/19/2026 Election of Directors: Sharon Wienbar DIRECTOR ELECTIONS ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 395.730000 0.000000 AGAINST 395.730000 AGAINST S000004450 Enovis Corporation 194014502 05/19/2026 To approve on an advisory basis the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Enovis Corporation 194014502 05/19/2026 To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan. COMPENSATION ISSUER 395.730000 0.000000 FOR 395.730000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Wendy Carruthers DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 WITHHOLD 1140.080000 AGAINST S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 WITHHOLD 1140.080000 AGAINST S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Vivek Jain DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Paul Keel DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect J. Andrew Pierce DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Daniel A. Raskas DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 Elect Christine A. Tsingos DIRECTOR ELECTIONS ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1140.080000 0.000000 FOR 1140.080000 FOR S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To approve on an advisory basis Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1140.080000 0.000000 AGAINST 1140.080000 AGAINST S000004450 Envista Holdings Corporation 29415F104 05/19/2026 To hold an advisory vote relating to the frequency of future stockholder(s) advisory votes on Envista's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1140.080000 0.000000 ONE YEAR 1140.080000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Scott Koenig, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 356.970000 0.000000 FOR 356.970000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Federica O'Brien DIRECTOR ELECTIONS ISSUER 356.970000 0.000000 FOR 356.970000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To elect three Class I directors listed in the proxy materials to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Eric Risser DIRECTOR ELECTIONS ISSUER 356.970000 0.000000 FOR 356.970000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst &Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 356.970000 0.000000 AGAINST 356.970000 AGAINST S000004450 MacroGenics, Inc. 556099109 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials. SECTION 14A SAY-ON-PAY VOTES ISSUER 356.970000 0.000000 FOR 356.970000 FOR S000004450 MacroGenics, Inc. 556099109 05/19/2026 To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. COMPENSATION ISSUER 356.970000 0.000000 FOR 356.970000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer DIRECTOR ELECTIONS ISSUER 310.840000 0.000000 FOR 310.840000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim DIRECTOR ELECTIONS ISSUER 310.840000 0.000000 WITHHOLD 310.840000 AGAINST S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick DIRECTOR ELECTIONS ISSUER 310.840000 0.000000 WITHHOLD 310.840000 AGAINST S000004450 Omnicell, Inc. 68213N109 05/19/2026 Say on Pay - An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 310.840000 0.000000 FOR 310.840000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. COMPENSATION ISSUER 310.840000 0.000000 FOR 310.840000 FOR S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates. CORPORATE GOVERNANCE ISSUER 310.840000 0.000000 AGAINST 310.840000 AGAINST S000004450 Omnicell, Inc. 68213N109 05/19/2026 Proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 310.840000 0.000000 FOR 310.840000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta DIRECTOR ELECTIONS ISSUER 324.460000 0.000000 FOR 324.460000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder DIRECTOR ELECTIONS ISSUER 324.460000 0.000000 FOR 324.460000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 Election of class I Director to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse DIRECTOR ELECTIONS ISSUER 324.460000 0.000000 WITHHOLD 324.460000 AGAINST S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 324.460000 0.000000 FOR 324.460000 FOR S000004450 Phathom Pharmaceuticals, Inc. 71722W107 05/19/2026 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 324.460000 0.000000 AGAINST 324.460000 AGAINST S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Roy D. Baynes DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 WITHHOLD 589.120000 AGAINST S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Suzanne Bruhn DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Timothy Coughlin DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Eric Dube DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Gary Lyons DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 WITHHOLD 589.120000 AGAINST S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Jeffrey Meckler DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 WITHHOLD 589.120000 AGAINST S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect John Orwin DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Sandra Poole DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Ron Squarer DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 Elect Ruth Williams-Brinkley DIRECTOR ELECTIONS ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 589.120000 0.000000 ONE YEAR 589.120000 FOR S000004450 Travere Therapeutics Inc. 89422G107 05/19/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 589.120000 0.000000 FOR 589.120000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Lance Berry DIRECTOR ELECTIONS ISSUER 350.100000 0.000000 FOR 350.100000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Elizabeth Hanna DIRECTOR ELECTIONS ISSUER 350.100000 0.000000 WITHHOLD 350.100000 AGAINST S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Elect Jane E. Kiernan DIRECTOR ELECTIONS ISSUER 350.100000 0.000000 FOR 350.100000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 350.100000 0.000000 FOR 350.100000 FOR S000004450 Treace Medical Concepts, Inc. 89455T109 05/19/2026 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31. 2026. AUDIT-RELATED ISSUER 350.100000 0.000000 FOR 350.100000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Christopher J. Reading DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Bernard A. Harris, Jr. DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Kathleen A. Gilmartin DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Reginald E. Swanson DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Anne B. Motsenbocker DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 WITHHOLD 106.380000 AGAINST S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Michael G. Mayrsohn DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Elect Peter F. Minan DIRECTOR ELECTIONS ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Advisory vote to approve the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 106.380000 0.000000 FOR 106.380000 FOR S000004450 U.S. Physical Therapy, Inc. 90337L108 05/19/2026 Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 106.380000 0.000000 AGAINST 106.380000 AGAINST S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 Elect J. Matthew Singleton DIRECTOR ELECTIONS ISSUER 741.220000 0.000000 WITHHOLD 741.220000 AGAINST S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 Elect S. Kathy Rouan DIRECTOR ELECTIONS ISSUER 741.220000 0.000000 WITHHOLD 741.220000 AGAINST S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 To ratify the selection of CBIZ CPAS P.C. as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 741.220000 0.000000 FOR 741.220000 FOR S000004450 Viking Therapeutics, Inc. 92686J106 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 741.220000 0.000000 AGAINST 741.220000 AGAINST S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Kevin T. Conroy DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Kevin J. Dallas DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Joseph M. Hogan DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Joseph Lacob DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 AGAINST 473.300000 AGAINST S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: C. Raymond Larkin, Jr. DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 AGAINST 473.300000 AGAINST S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Anne M. Myong DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Mojdeh Poul DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Andrea L. Saia DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Susan E. Siegel DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Election of Directors: Britt Vitalone DIRECTOR ELECTIONS ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Align Technology, Inc. 016255101 05/20/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 473.300000 0.000000 AGAINST 473.300000 AGAINST S000004450 Align Technology, Inc. 016255101 05/20/2026 Ratification Of Appointment Of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 473.300000 0.000000 AGAINST 473.300000 AGAINST S000004450 Align Technology, Inc. 016255101 05/20/2026 Ratification of Special Meeting Provision in our Bylaws SHAREHOLDER RIGHTS AND DEFENSES ISSUER 473.300000 0.000000 FOR 473.300000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Shane M. Cooke DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard B. Gaynor, M.D. DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Cato T. Laurencin, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy S. Lurker DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 AGAINST 1069.970000 AGAINST S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Companys 2027 annual general meeting of shareholders: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Richard F. Pops DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Nancy L. Snyderman, M.D. DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Frank Anders Wilson DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 Election of Directors to serve a one-year term until the Company's 2027 annual general meeting of shareholders: Christopher I. Wright, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. AUDIT-RELATED ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. COMPENSATION ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To renew Board authority to allot and issue shares under Irish law. CAPITAL STRUCTURE ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alkermes plc G01767105 05/20/2026 To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. CAPITAL STRUCTURE ISSUER 1069.970000 0.000000 FOR 1069.970000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle DIRECTOR ELECTIONS ISSUER 920.230000 0.000000 FOR 920.230000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. DIRECTOR ELECTIONS ISSUER 920.230000 0.000000 FOR 920.230000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 Election of Class I Directors of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 920.230000 0.000000 FOR 920.230000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 920.230000 0.000000 FOR 920.230000 FOR S000004450 Alnylam Pharmaceuticals, Inc. 02043Q107 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 920.230000 0.000000 AGAINST 920.230000 AGAINST S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Mark Sotir DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 WITHHOLD 197.650000 AGAINST S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Martin J. Bonick DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Peter Bulgarelli DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Peter C.B. Bynoe DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 WITHHOLD 197.650000 AGAINST S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Suzanne Campion DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Robert A. Demichiei DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect William M. Goodyear DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Ellen Havdala DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Edmondo Robinson DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Rahul Sen DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 WITHHOLD 197.650000 AGAINST S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Elect Robert Webb DIRECTOR ELECTIONS ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Approval, on a non-binding advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 197.650000 0.000000 FOR 197.650000 FOR S000004450 Ardent Health, Inc. 03980N107 05/20/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 197.650000 0.000000 AGAINST 197.650000 AGAINST S000004450 Geron Corporation 374163103 05/20/2026 Elect Susan M. Molineaux DIRECTOR ELECTIONS ISSUER 3328.800000 0.000000 WITHHOLD 3328.800000 AGAINST S000004450 Geron Corporation 374163103 05/20/2026 Elect Patricia S. Andrews DIRECTOR ELECTIONS ISSUER 3328.800000 0.000000 FOR 3328.800000 FOR S000004450 Geron Corporation 374163103 05/20/2026 Elect Constantine Chinoporos DIRECTOR ELECTIONS ISSUER 3328.800000 0.000000 FOR 3328.800000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the Proxy Statement. COMPENSATION ISSUER 3328.800000 0.000000 FOR 3328.800000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3328.800000 0.000000 FOR 3328.800000 FOR S000004450 Geron Corporation 374163103 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3328.800000 0.000000 AGAINST 3328.800000 AGAINST S000004450 Insulet Corporation 45784P101 05/20/2026 Elect Luciana Borio DIRECTOR ELECTIONS ISSUER 487.950000 0.000000 FOR 487.950000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 Elect Michael R. Minogue DIRECTOR ELECTIONS ISSUER 487.950000 0.000000 FOR 487.950000 FOR S000004450 Insulet Corporation 45784P101 05/20/2026 Elect TImothy C. Stonesifer DIRECTOR ELECTIONS ISSUER 487.950000 0.000000 WITHHOLD 487.950000 AGAINST S000004450 Insulet Corporation 45784P101 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 487.950000 0.000000 AGAINST 487.950000 AGAINST S000004450 Insulet Corporation 45784P101 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 487.950000 0.000000 FOR 487.950000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Sheila Antrum DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Cheryl C. Capps DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Michael J. Coyle DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Flanagan DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. James F. Hinrichs DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 WITHHOLD 245.510000 AGAINST S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Alvin (Tyrone) Jeffers DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Aaron Kapito DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Payman Khales DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. M. Craig Maxwell DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 WITHHOLD 245.510000 AGAINST S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Filippo Passerini DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To elect 11 directors for a one-year term or until their successors have been duly elected and qualified. Donald J. Spence DIRECTOR ELECTIONS ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2026. AUDIT-RELATED ISSUER 245.510000 0.000000 AGAINST 245.510000 AGAINST S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To approve, in an advisory non-binding vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 Integer Holdings Corporation 45826H109 05/20/2026 To approve the Integer Holdings Corporation 2026 Omnibus Incentive Plan. COMPENSATION ISSUER 245.510000 0.000000 FOR 245.510000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect James S. Shannon DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 WITHHOLD 2021.790000 AGAINST S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Michael E. Castagna DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Steven B. Binder DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Ronald J. Consiglio DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Michael A. Friedman DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Jennifer Grancio DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 WITHHOLD 2021.790000 AGAINST S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Anthony Hooper DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Sabrina Kay DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 Elect Christine Mundkur DIRECTOR ELECTIONS ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 2021.790000 0.000000 FOR 2021.790000 FOR S000004450 MannKind Corporation 56400P706 05/20/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2021.790000 0.000000 AGAINST 2021.790000 AGAINST S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Elizabeth D. Bierbower DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Eric K. Brandt DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Natasha Deckmann DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Harry M. Jansen Kraemer, Jr. DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 WITHHOLD 1099.950000 AGAINST S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect R. Carter Pate DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect John C. Rademacher DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Timothy P. Sullivan DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 Elect Norman L. Wright DIRECTOR ELECTIONS ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Option Care Health, Inc. 68404L201 05/20/2026 To approve, on a non-binding advisory basis, our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1099.950000 0.000000 FOR 1099.950000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Nancy Cocozza DIRECTOR ELECTIONS ISSUER 683.630000 0.000000 FOR 683.630000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: David King DIRECTOR ELECTIONS ISSUER 683.630000 0.000000 WITHHOLD 683.630000 AGAINST S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 Election of Class I Director to the Board of Directors to serve until our 2029 annual meeting and until their respective successors have been duly elected and qualified: Francis Soistman DIRECTOR ELECTIONS ISSUER 683.630000 0.000000 FOR 683.630000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). SECTION 14A SAY-ON-PAY VOTES ISSUER 683.630000 0.000000 FOR 683.630000 FOR S000004450 Privia Health Group, Inc. 74276R102 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 683.630000 0.000000 FOR 683.630000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Robert B. Carter DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors James E. Davis DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Luis A. Diaz, Jr., M.D. DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Tracey C. Doi DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Vicky B. Gregg DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Wright L. Lassiter, III DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy L. Main DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Denise M. Morrison DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Gary M. Pfeiffer DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 AGAINST 772.030000 AGAINST S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy M. Ring DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 AGAINST 772.030000 AGAINST S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Election of Directors Timothy C. Wentworth DIRECTOR ELECTIONS ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 772.030000 0.000000 FOR 772.030000 FOR S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Ratification of the appointment of our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 772.030000 0.000000 AGAINST 772.030000 AGAINST S000004450 Quest Diagnostics Incorporated 74834L100 05/20/2026 Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 772.030000 0.000000 FOR 772.030000 AGAINST S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Peter Fong, Ph.D. DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 WITHHOLD 563.290000 AGAINST S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Carsten Boess DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 WITHHOLD 563.290000 AGAINST S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Mikael Dolsten, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 WITHHOLD 563.290000 AGAINST S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Fady Malik, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Gaurav Shah, M.D. DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; David P. Southwell DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 WITHHOLD 563.290000 AGAINST S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; Roderick Wong, M.D. DIRECTOR ELECTIONS ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The ratification of the appointment of Eisner Amper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 A non-binding, advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Rocket Pharmaceuticals, Inc. 77313F106 05/20/2026 The approval of the proposed stock option exchange program COMPENSATION ISSUER 563.290000 0.000000 FOR 563.290000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 AGAINST 470.280000 AGAINST S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 AGAINST 470.280000 AGAINST S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey DIRECTOR ELECTIONS ISSUER 470.280000 0.000000 AGAINST 470.280000 AGAINST S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan. COMPENSATION ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL"). CORPORATE GOVERNANCE ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL. CORPORATE GOVERNANCE ISSUER 470.280000 0.000000 AGAINST 470.280000 AGAINST S000004450 Tandem Diabetes Care, Inc. 875372203 05/20/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 470.280000 0.000000 FOR 470.280000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 AGAINST 2606.830000 AGAINST S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 2606.830000 0.000000 FOR 2606.830000 FOR S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2606.830000 0.000000 AGAINST 2606.830000 AGAINST S000004450 Thermo Fisher Scientific Inc. 883556102 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 2606.830000 0.000000 AGAINST 2606.830000 AGAINST S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Waleed H. Hassanein, M.D. DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: James R. Tobin DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 AGAINST 225.940000 AGAINST S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Edward M. Basile DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 AGAINST 225.940000 AGAINST S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Thomas J. Gunderson DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Edwin M. Kania, Jr. DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Stephanie Lovell DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: Merilee Raines DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 Election of Directors: David Weill, M.D. DIRECTOR ELECTIONS ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 225.940000 0.000000 FOR 225.940000 FOR S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. COMPENSATION ISSUER 225.940000 0.000000 AGAINST 225.940000 AGAINST S000004450 Transmedics Group, Inc., 89377M109 05/20/2026 To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 225.940000 0.000000 AGAINST 225.940000 AGAINST S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Election of Director: Nina Chen-Langenmayr DIRECTOR ELECTIONS ISSUER 383.390000 0.000000 FOR 383.390000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Proposal to conduct an advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 383.390000 0.000000 FOR 383.390000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 383.390000 0.000000 FOR 383.390000 FOR S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. CORPORATE GOVERNANCE SECURITY HOLDER 383.390000 0.000000 FOR 383.390000 AGAINST S000004450 Universal Health Services, Inc. 913903100 05/20/2026 Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 383.390000 0.000000 FOR 383.390000 AGAINST S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 AGAINST 3054.540000 AGAINST S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Election of Directors: Stephanie Tilenius DIRECTOR ELECTIONS ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Advisory vote to approve the frequency of future advisory votes on our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3054.540000 0.000000 ONE YEAR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 3054.540000 0.000000 FOR 3054.540000 FOR S000004450 Zoetis Inc. 98978V103 05/20/2026 Shareholder proposal to permit shareholder action by written consent. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 3054.540000 0.000000 FOR 3054.540000 AGAINST S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Thomas J. Haughey DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 AGAINST 125.170000 AGAINST S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Nikhil Lalwani DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Matthew J. Leonard, R.Ph. DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Antonio R. Pera DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Muthusamy Shanmugam DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Renee P. Tannenbaum, Pharm.D. DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 AGAINST 125.170000 AGAINST S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the frequency of future advisory votes to approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 125.170000 0.000000 ONE YEAR 125.170000 FOR S000004450 ANI Pharmaceuticals, Inc. 00182C103 05/21/2026 To approve the Amended and Restated 2022 Stock Incentive Plan. COMPENSATION ISSUER 125.170000 0.000000 FOR 125.170000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Olivia F. Kirtley DIRECTOR ELECTIONS ISSUER 1002.330000 0.000000 WITHHOLD 1002.330000 AGAINST S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Max C. Lin DIRECTOR ELECTIONS ISSUER 1002.330000 0.000000 FOR 1002.330000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Election of Class II directors: Steve Miller DIRECTOR ELECTIONS ISSUER 1002.330000 0.000000 WITHHOLD 1002.330000 AGAINST S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Ratification of the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 1002.330000 0.000000 FOR 1002.330000 FOR S000004450 BrightSpring Health Services, Inc. 10950A106 05/21/2026 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1002.330000 0.000000 FOR 1002.330000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Jack Phillips DIRECTOR ELECTIONS ISSUER 745.800000 0.000000 FOR 745.800000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Hermann F. Requardt DIRECTOR ELECTIONS ISSUER 745.800000 0.000000 FOR 745.800000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Elect Laura A. Francis DIRECTOR ELECTIONS ISSUER 745.800000 0.000000 FOR 745.800000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Approval on an advisory basis of the 2025 compensation of our named executive officers, as discussed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 745.800000 0.000000 FOR 745.800000 FOR S000004450 Bruker Corporation 116794108 05/21/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 745.800000 0.000000 FOR 745.800000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Gregg Alton DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 WITHHOLD 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: G. Leonard Baker, Jr. DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 WITHHOLD 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Joseph K. Belanoff, M.D. DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 FOR 751.010000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: David L. Mahoney DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 FOR 751.010000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Joshua M. Murray DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 FOR 751.010000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Kimberly Park DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 WITHHOLD 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: Daniel N. Swisher, Jr. DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 FOR 751.010000 FOR S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 Election of Directors: James N. Wilson DIRECTOR ELECTIONS ISSUER 751.010000 0.000000 WITHHOLD 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 751.010000 0.000000 AGAINST 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 751.010000 0.000000 AGAINST 751.010000 AGAINST S000004450 Corcept Therapeutics Incorporated 218352102 05/21/2026 To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. COMPENSATION ISSUER 751.010000 0.000000 AGAINST 751.010000 AGAINST S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Sujay Kango DIRECTOR ELECTIONS ISSUER 243.340000 0.000000 FOR 243.340000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge DIRECTOR ELECTIONS ISSUER 243.340000 0.000000 WITHHOLD 243.340000 AGAINST S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Jonathan Violin, Ph.D. DIRECTOR ELECTIONS ISSUER 243.340000 0.000000 FOR 243.340000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To approve, on an advisory basis, the compensation paid to our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 243.340000 0.000000 FOR 243.340000 FOR S000004450 Dianthus Therapeutics, Inc. 252828108 05/21/2026 To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 243.340000 0.000000 FOR 243.340000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kapila Anand DIRECTOR ELECTIONS ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Paul Herendeen DIRECTOR ELECTIONS ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Michael Harrington DIRECTOR ELECTIONS ISSUER 3449.620000 0.000000 AGAINST 3449.620000 AGAINST S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Lawrence Kurzius DIRECTOR ELECTIONS ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Election of two Class I director nominees and three Class II director nominees: Kirk McDonald DIRECTOR ELECTIONS ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Elanco Animal Health Incorporated 28414H103 05/21/2026 Advisory vote on the compensation of the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3449.620000 0.000000 FOR 3449.620000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Mohamad Ali DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 AGAINST 735.690000 AGAINST S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: William K. "Dan" Daniel DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Deborah Derby DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 AGAINST 735.690000 AGAINST S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Carole T. Faig DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Kurt P. Kuehn DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Philip A. Laskawy DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 AGAINST 735.690000 AGAINST S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Max Lin DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 AGAINST 735.690000 AGAINST S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Frederick M. Lowery DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Anne H. Margulies DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Election of Incumbent Directors: Reed V. Tuckson, M.D., FACP DIRECTOR ELECTIONS ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 735.690000 0.000000 FOR 735.690000 FOR S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026. AUDIT-RELATED ISSUER 735.690000 0.000000 AGAINST 735.690000 AGAINST S000004450 Henry Schein, Inc. 806407102 05/21/2026 Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 735.690000 0.000000 FOR 735.690000 AGAINST S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Caroline D. Dorsa DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. David P. King DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Keith A. Meister DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Anna Richo DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 AGAINST 1059.580000 AGAINST S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Philip W. Schiller DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Susan E. Siegel DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Jacob Thaysen, Ph.D. DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 Election of Directors. Scott B. Ullem DIRECTOR ELECTIONS ISSUER 1059.580000 0.000000 FOR 1059.580000 FOR S000004450 Illumina, Inc. 452327109 05/21/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 1059.580000 0.000000 AGAINST 1059.580000 AGAINST S000004450 Illumina, Inc. 452327109 05/21/2026 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1059.580000 0.000000 AGAINST 1059.580000 AGAINST S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kerrii B. Anderson DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Victor Bulto DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Jeffrey A. Davis DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Richelle P. Parham DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: John H. Sampson, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Election of the members of the Company's Board of Directors: Kathryn E. Wengel DIRECTOR ELECTIONS ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 To approve, by non-binding vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Labcorp Holdings Inc. 504922105 05/21/2026 Ratification of the appointment of Deloitte and Touche LLP as Labcorp Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 574.750000 0.000000 FOR 574.750000 FOR S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 316.530000 0.000000 WITHHOLD 316.530000 AGAINST S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. DIRECTOR ELECTIONS ISSUER 316.530000 0.000000 WITHHOLD 316.530000 AGAINST S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Daphne Karydas DIRECTOR ELECTIONS ISSUER 316.530000 0.000000 WITHHOLD 316.530000 AGAINST S000004450 Mineralys Therapeutics, Inc. 603170101 05/21/2026 Ratify the appointment of Ernst & Young LLP as Mineralys Therapeutics, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 316.530000 0.000000 FOR 316.530000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 AGAINST 900.830000 AGAINST S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Marjorie C. Green DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 AGAINST 900.830000 AGAINST S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Michael A. Kelly DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: John P. Kenny DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: David B. Perez DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Felicia Williams DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Election of the directors named in the proxy statement as set forth below: Anthony P. Zook DIRECTOR ELECTIONS ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 900.830000 0.000000 AGAINST 900.830000 AGAINST S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Neogenomics, Inc. 64049M209 05/21/2026 Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 900.830000 0.000000 FOR 900.830000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Elect Robert B. Bazemore Jr. DIRECTOR ELECTIONS ISSUER 1544.510000 0.000000 WITHHOLD 1544.510000 AGAINST S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Elect Robert Mashal DIRECTOR ELECTIONS ISSUER 1544.510000 0.000000 FOR 1544.510000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1544.510000 0.000000 FOR 1544.510000 FOR S000004450 Nuvation Bio Inc. 67080N101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1544.510000 0.000000 FOR 1544.510000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Lloyd Dean DIRECTOR ELECTIONS ISSUER 566.550000 0.000000 WITHHOLD 566.550000 AGAINST S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Kevin Gordon DIRECTOR ELECTIONS ISSUER 566.550000 0.000000 WITHHOLD 566.550000 AGAINST S000004450 Progyny, Inc. 74340E103 05/21/2026 Election of Directors: Cheryl Scott DIRECTOR ELECTIONS ISSUER 566.550000 0.000000 FOR 566.550000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Ratification of the selection of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 566.550000 0.000000 FOR 566.550000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 566.550000 0.000000 FOR 566.550000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate certain supermajority voting requirements SHAREHOLDER RIGHTS AND DEFENSES ISSUER 566.550000 0.000000 FOR 566.550000 FOR S000004450 Progyny, Inc. 74340E103 05/21/2026 Approval of the amendment to the company's certificate of incorporation to eliminate the default supermajority voting requirement concerning certain business combinations SHAREHOLDER RIGHTS AND DEFENSES ISSUER 566.550000 0.000000 FOR 566.550000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Sean L. Cunningham DIRECTOR ELECTIONS ISSUER 1498.850000 0.000000 WITHHOLD 1498.850000 AGAINST S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Richard G. Kyle DIRECTOR ELECTIONS ISSUER 1498.850000 0.000000 FOR 1498.850000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Vincent K. Petrella DIRECTOR ELECTIONS ISSUER 1498.850000 0.000000 FOR 1498.850000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Elect the four following Class III director nominees to serve until the 2029 Annual Meeting of Stockholders: Christopher A. Simon DIRECTOR ELECTIONS ISSUER 1498.850000 0.000000 FOR 1498.850000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1498.850000 0.000000 FOR 1498.850000 FOR S000004450 Sotera Health Company 83601L102 05/21/2026 Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1498.850000 0.000000 FOR 1498.850000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Charles Divita, III DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Sandra L. Fenwick DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Catherine A. Jacobson DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 AGAINST 1227.670000 AGAINST S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Kenneth H. Paulus DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 AGAINST 1227.670000 AGAINST S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Susan R. Salka DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: David L. Shedlarz DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Mark Douglas Smith, M.D., MBA DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: Michael S. Smith DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Elect nine directors, each for a term of one year: David B. Snow, Jr. DIRECTOR ELECTIONS ISSUER 1227.670000 0.000000 AGAINST 1227.670000 AGAINST S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Teladoc Health, Inc. 87918A105 05/21/2026 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1227.670000 0.000000 FOR 1227.670000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Peter Barris DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Eric D. Belcher DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 WITHHOLD 644.180000 AGAINST S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect David R. Epstein DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Wayne A.I. Frederick DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Scott Gottlieb DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 WITHHOLD 644.180000 AGAINST S000004450 Tempus AI, Inc. 88023B103 05/21/2026 Elect Nadja Y. West DIRECTOR ELECTIONS ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 644.180000 0.000000 FOR 644.180000 FOR S000004450 Tempus AI, Inc. 88023B103 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 644.180000 0.000000 ONE YEAR 644.180000 AGAINST S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect Michael M. Morrissey DIRECTOR ELECTIONS ISSUER 265.690000 0.000000 WITHHOLD 265.690000 AGAINST S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect Patrick G. Enright DIRECTOR ELECTIONS ISSUER 265.690000 0.000000 FOR 265.690000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 Elect James R. Meyers DIRECTOR ELECTIONS ISSUER 265.690000 0.000000 FOR 265.690000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 265.690000 0.000000 FOR 265.690000 FOR S000004450 Vera Therapeutics, Inc. 92337R101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 265.690000 0.000000 FOR 265.690000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Michael P. Bailey DIRECTOR ELECTIONS ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Brian Stuglik DIRECTOR ELECTIONS ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 Elect Karin Tollefson DIRECTOR ELECTIONS ISSUER 298.410000 0.000000 WITHHOLD 298.410000 AGAINST S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2021 Equity Incentive Plan. COMPENSATION ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve the adoption of the Company's Amended and Restated 2018 Employee Stock Purchase Plan. COMPENSATION ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Verastem, Inc. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 298.410000 0.000000 FOR 298.410000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dr. Flemming Ornskov, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 AGAINST 682.270000 AGAINST S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Linda Baddour DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Udit Batra, Ph.D. DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Dan Brennan DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Richard Fearon DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Claire M. Fraser, Ph.D. DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Pearl S. Huang, Ph.D. DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Wei Jiang DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Heather Knight DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Christopher A. Kuebler DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To elect directors to serve for the ensuing year and until their successors are elected: Mark Vergnano DIRECTOR ELECTIONS ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 Waters Corporation 941848103 05/21/2026 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 682.270000 0.000000 AGAINST 682.270000 AGAINST S000004450 Waters Corporation 941848103 05/21/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 682.270000 0.000000 FOR 682.270000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Owen Hughes DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 WITHHOLD 67.130000 AGAINST S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Heather L. Franklin DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Natasha A. Hernday DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Barbara Kosacz DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Joseph M. Limber DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 WITHHOLD 67.130000 AGAINST S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Elect Matthew D. Perry DIRECTOR ELECTIONS ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of an amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan. COMPENSATION ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of the 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 XOMA Royalty Corporation 98419J206 05/21/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 67.130000 0.000000 FOR 67.130000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Filippo "Peter" Caldini DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Ann Custin DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Leslie Gillin DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 AGAINST 1.500000 AGAINST S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Nicholas Lewin DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Edward Schutter DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To elect six directors to serve for a one-year term: Bryan Slotkin DIRECTOR ELECTIONS ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Establishment Labs Holdings Inc. G31249108 05/22/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1.500000 0.000000 FOR 1.500000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Betsy J. Bernard DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Michael J. Farrell DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Robert A. Hagemann DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Arthur J. Higgins DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Maria Teresa Hilado DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 AGAINST 1381.030000 AGAINST S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Syed Jafry DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Devdatt Kurdikar DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 AGAINST 1381.030000 AGAINST S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Louis A. Shapiro DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Election of Directors: Ivan Tornos DIRECTOR ELECTIONS ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1381.030000 0.000000 AGAINST 1381.030000 AGAINST S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Approve, on a non-binding advisory basis, named executive officer compensation " Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1381.030000 0.000000 FOR 1381.030000 FOR S000004450 Zimmer Biomet Holdings, Inc. 98956P102 05/22/2026 Shareholder proposal on Independent Board Chairman. CORPORATE GOVERNANCE SECURITY HOLDER 1381.030000 0.000000 FOR 1381.030000 AGAINST S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Lindsay Androski DIRECTOR ELECTIONS ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Robert A. Beardsley DIRECTOR ELECTIONS ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Joseph Bishop DIRECTOR ELECTIONS ISSUER 999.100000 0.000000 WITHHOLD 999.100000 AGAINST S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Matthew Gline DIRECTOR ELECTIONS ISSUER 999.100000 0.000000 WITHHOLD 999.100000 AGAINST S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 Elect Roger Sawhney DIRECTOR ELECTIONS ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve the adoption of the Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan. COMPENSATION ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Arbutus Biopharma Corporation 03879J100 05/26/2026 To approve the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 999.100000 0.000000 FOR 999.100000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Mary C. Beckerle, Ph.D. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: S. Gail Eckhardt, M.D. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Maria C. Freire, Ph.D. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 AGAINST 1780.540000 AGAINST S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Tomas J. Heyman DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: David E. Johnson DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Michael M. Morrissey, Ph.D. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Robert L. Oliver Jr. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Stelios Papadopoulos, Ph.D. DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 AGAINST 1780.540000 AGAINST S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: George Poste, DVM, Ph.D., FRS DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Julie Anne Smith DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To elect the eleven nominees for director named in the accompanying Proxy Statement to hold office until the next Annual Meeting of Stockholders: Jack L. Wyszomierski DIRECTOR ELECTIONS ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Exelixis' independent registered public accounting firm for the fiscal year ending January 1, 2027. AUDIT-RELATED ISSUER 1780.540000 0.000000 AGAINST 1780.540000 AGAINST S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To amend and restate the Exelixis, Inc. 2017 Equity Incentive Plan to, among other things, increase the number of shares authorized for issuance by 2,000,000 shares. COMPENSATION ISSUER 1780.540000 0.000000 FOR 1780.540000 FOR S000004450 Exelixis, Inc. 30161Q104 05/26/2026 To approve, on an advisory basis, the compensation of Exelixis' named executive officers, as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1780.540000 0.000000 AGAINST 1780.540000 AGAINST S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Bernd Brust DIRECTOR ELECTIONS ISSUER 751.520000 0.000000 FOR 751.520000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 751.520000 0.000000 WITHHOLD 751.520000 AGAINST S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 Election of Director for 3-year term expiring in 2029: Luke Marker DIRECTOR ELECTIONS ISSUER 751.520000 0.000000 FOR 751.520000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 To ratify the appointment of Deloitte & Touche LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 751.520000 0.000000 FOR 751.520000 FOR S000004450 Maravai LifeSciences Holdings, Inc. 56600D107 05/26/2026 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 751.520000 0.000000 AGAINST 751.520000 AGAINST S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Patrick F. Russo DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 17202.610000 0.000000 FOR 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 17202.610000 0.000000 AGAINST 17202.610000 AGAINST S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 17202.610000 0.000000 AGAINST 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 17202.610000 0.000000 AGAINST 17202.610000 FOR S000004450 Merck & Co., Inc. 58933Y105 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 17202.610000 0.000000 FOR 17202.610000 AGAINST S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Robert More, MBA DIRECTOR ELECTIONS ISSUER 821.830000 0.000000 FOR 821.830000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Janet Napolitano, J.D. DIRECTOR ELECTIONS ISSUER 821.830000 0.000000 WITHHOLD 821.830000 AGAINST S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To elect the following three nominees for director to hold office until the 2029 Annual Meeting of Stockholders, and until their successor is duly elected and qualified, or until their earlier death, resignation or removal: Elliott Sigal, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 821.830000 0.000000 FOR 821.830000 FOR S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 821.830000 0.000000 AGAINST 821.830000 AGAINST S000004450 Vir Biotechnology, Inc. 92764N102 05/26/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 821.830000 0.000000 FOR 821.830000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. DIRECTOR ELECTIONS ISSUER 812.980000 0.000000 FOR 812.980000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Wendell Wierenga, Ph.D. DIRECTOR ELECTIONS ISSUER 812.980000 0.000000 WITHHOLD 812.980000 AGAINST S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 Election of Class I Directors for terms expiring in 2029: Nancy J. Wysenski DIRECTOR ELECTIONS ISSUER 812.980000 0.000000 FOR 812.980000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance thereunder by 1,000,000 shares of common stock. COMPENSATION ISSUER 812.980000 0.000000 FOR 812.980000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 812.980000 0.000000 FOR 812.980000 FOR S000004450 Cytokinetics, Incorporated 23282W605 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 812.980000 0.000000 FOR 812.980000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Steven Altman DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 AGAINST 2736.040000 AGAINST S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Dr. Euan Ashley DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 AGAINST 2736.040000 AGAINST S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 AGAINST 2736.040000 AGAINST S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Richard Collins DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 AGAINST 2736.040000 AGAINST S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Mark Foletta DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Bridgette Heller DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Jacob Leach DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Rick Osterloh DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To elect twelve nominees for director, each to hold office until our 2027 annual meeting of stockholders: Kevin Sayer DIRECTOR ELECTIONS ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To ratify the selection by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2736.040000 0.000000 FOR 2736.040000 FOR S000004450 DexCom, Inc. 252131107 05/27/2026 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 2736.040000 0.000000 AGAINST 2736.040000 AGAINST S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Cathleen Noel Bairey Merz DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Quentin Blackford DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Bruce G. Bodaken DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 WITHHOLD 225.860000 AGAINST S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Karen L. Ling DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Kevin C. O'Boyle DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Jason Patten DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Abhijit Y. Talwalkar DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 WITHHOLD 225.860000 AGAINST S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 Elect Brian Yoor DIRECTOR ELECTIONS ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve the adoption of our 2026 Equity Incentive Plan. COMPENSATION ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision. CORPORATE GOVERNANCE ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 225.860000 0.000000 FOR 225.860000 FOR S000004450 iRhythm Holdings, Inc. 450056106 05/27/2026 To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 225.860000 0.000000 AGAINST 225.860000 AGAINST S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Paul Berns DIRECTOR ELECTIONS ISSUER 439.600000 0.000000 FOR 439.600000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Matthew Fust DIRECTOR ELECTIONS ISSUER 439.600000 0.000000 FOR 439.600000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: David Piacquad DIRECTOR ELECTIONS ISSUER 439.600000 0.000000 FOR 439.600000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of Emst & Young LLP, as the independent registered public accounting firm and independent auditor of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 439.600000 0.000000 FOR 439.600000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 439.600000 0.000000 FOR 439.600000 FOR S000004450 Neumora Therapeutics, Inc. 640979100 05/27/2026 Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 439.600000 0.000000 ONE YEAR 439.600000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 696.940000 0.000000 FOR 696.940000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Gary Lyons DIRECTOR ELECTIONS ISSUER 696.940000 0.000000 FOR 696.940000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Elect Johanna Mercier DIRECTOR ELECTIONS ISSUER 696.940000 0.000000 WITHHOLD 696.940000 AGAINST S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 Advisory vote on the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 696.940000 0.000000 FOR 696.940000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION ISSUER 696.940000 0.000000 FOR 696.940000 FOR S000004450 Neurocrine Biosciences, Inc. 64125C109 05/27/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 696.940000 0.000000 AGAINST 696.940000 AGAINST S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Lori A. Woods DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 WITHHOLD 680.210000 AGAINST S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Heidi Henson DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 FOR 680.210000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Robert Froman Williamson III DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 FOR 680.210000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Frank Morich DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 WITHHOLD 680.210000 AGAINST S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Johan (Thijs) Spoor DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 FOR 680.210000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 Elect Maya Martinez-Davis DIRECTOR ELECTIONS ISSUER 680.210000 0.000000 FOR 680.210000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 680.210000 0.000000 FOR 680.210000 FOR S000004450 Perspective Therapeutics, Inc. 46489V302 05/27/2026 To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 680.210000 0.000000 ONE YEAR 680.210000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 344.610000 0.000000 FOR 344.610000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Cameron Turtle DIRECTOR ELECTIONS ISSUER 344.610000 0.000000 FOR 344.610000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 Elect Laurie D. Stelzer DIRECTOR ELECTIONS ISSUER 344.610000 0.000000 WITHHOLD 344.610000 AGAINST S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 344.610000 0.000000 AGAINST 344.610000 AGAINST S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 344.610000 0.000000 FOR 344.610000 FOR S000004450 Spyre Therapeutics, Inc. 00773J202 05/27/2026 To approve the Company's amended and restated 2016 Employee Stock Purchase Plan. COMPENSATION ISSUER 344.610000 0.000000 FOR 344.610000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Saumya Sutaria DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: J. Robert Kerrey DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Vineeta Agarwala DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Roy Blunt DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Richard W. Fisher DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Meghan M. FitzGerald DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Cecil D. Haney DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Christopher S. Lynch DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Richard J. Mark DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Tammy Romo DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 AGAINST 618.560000 AGAINST S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 618.560000 0.000000 AGAINST 618.560000 AGAINST S000004450 Tenet Healthcare Corporation 88033G407 05/27/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 618.560000 0.000000 FOR 618.560000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Ellen Goldberg DIRECTOR ELECTIONS ISSUER 204.100000 0.000000 FOR 204.100000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Miles D. Harrison DIRECTOR ELECTIONS ISSUER 204.100000 0.000000 FOR 204.100000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 Elect Tiffany P. Olson DIRECTOR ELECTIONS ISSUER 204.100000 0.000000 WITHHOLD 204.100000 AGAINST S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To ratify the selection of KPMG LLP by the Audit Committee of our Board of Directors as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 204.100000 0.000000 FOR 204.100000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 204.100000 0.000000 FOR 204.100000 FOR S000004450 Castle Biosciences, Inc. 14843C105 05/28/2026 To approve our non-employee director compensation policy. COMPENSATION ISSUER 204.100000 0.000000 FOR 204.100000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 Election of Class I Directors: J. Martin Carroll DIRECTOR ELECTIONS ISSUER 1668.720000 0.000000 WITHHOLD 1668.720000 AGAINST S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 Election of Class I Directors: Sheldon L. Koenig DIRECTOR ELECTIONS ISSUER 1668.720000 0.000000 FOR 1668.720000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To approve the non-binding advisory resolution on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1668.720000 0.000000 AGAINST 1668.720000 AGAINST S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1668.720000 0.000000 FOR 1668.720000 FOR S000004450 Esperion Therapeutics, Inc. 29664W105 05/28/2026 To approve an amendment to the Esperion Therapeutics, Inc. 2022 Stock Option and Incentive Plan. COMPENSATION ISSUER 1668.720000 0.000000 FOR 1668.720000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Elect Denice M. Torres DIRECTOR ELECTIONS ISSUER 404.960000 0.000000 WITHHOLD 404.960000 AGAINST S000004450 Glaukos Corporation 377322102 05/28/2026 Elect Aimee S. Weisner DIRECTOR ELECTIONS ISSUER 404.960000 0.000000 FOR 404.960000 FOR S000004450 Glaukos Corporation 377322102 05/28/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 404.960000 0.000000 AGAINST 404.960000 AGAINST S000004450 Glaukos Corporation 377322102 05/28/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 404.960000 0.000000 AGAINST 404.960000 AGAINST S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir DIRECTOR ELECTIONS ISSUER 163.240000 0.000000 WITHHOLD 163.240000 AGAINST S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Jeffrey L. McLaren DIRECTOR ELECTIONS ISSUER 163.240000 0.000000 FOR 163.240000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick DIRECTOR ELECTIONS ISSUER 163.240000 0.000000 FOR 163.240000 FOR S000004450 HealthStream, Inc. 42222N103 05/28/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 163.240000 0.000000 AGAINST 163.240000 AGAINST S000004450 HealthStream, Inc. 42222N103 05/28/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as described in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 163.240000 0.000000 FOR 163.240000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable DIRECTOR ELECTIONS ISSUER 94.200000 0.000000 FOR 94.200000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS ISSUER 94.200000 0.000000 FOR 94.200000 FOR S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More DIRECTOR ELECTIONS ISSUER 94.200000 0.000000 WITHHOLD 94.200000 AGAINST S000004450 Tyra Biosciences, Inc. 90240B106 05/28/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 94.200000 0.000000 FOR 94.200000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: James M. Daly DIRECTOR ELECTIONS ISSUER 954.150000 0.000000 FOR 954.150000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 954.150000 0.000000 FOR 954.150000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To elect the Board's three nominees for Class I director to hold office until the Company's 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Adora Ndu DIRECTOR ELECTIONS ISSUER 954.150000 0.000000 WITHHOLD 954.150000 AGAINST S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 954.150000 0.000000 FOR 954.150000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 954.150000 0.000000 FOR 954.150000 FOR S000004450 ACADIA Pharmaceuticals Inc. 004225108 05/29/2026 To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. COMPENSATION ISSUER 954.150000 0.000000 FOR 954.150000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Rodney D. Windley DIRECTOR ELECTIONS ISSUER 371.310000 0.000000 WITHHOLD 371.310000 AGAINST S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Sam Weil DIRECTOR ELECTIONS ISSUER 371.310000 0.000000 FOR 371.310000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 Election of Class II director to serve a three-year term expiring at the 2029 Annual Meeting of the Company's stockholders: Steven E. Rodgers DIRECTOR ELECTIONS ISSUER 371.310000 0.000000 FOR 371.310000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 2, 2027. AUDIT-RELATED ISSUER 371.310000 0.000000 FOR 371.310000 FOR S000004450 Aveanna Healthcare Holdings Inc 05356F105 05/29/2026 To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 371.310000 0.000000 FOR 371.310000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar DIRECTOR ELECTIONS ISSUER 257.290000 0.000000 AGAINST 257.290000 AGAINST S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole DIRECTOR ELECTIONS ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart DIRECTOR ELECTIONS ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders. AUDIT-RELATED ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To receive the Company's UK statutory annual accounts and report for the period ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025. COMPENSATION ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve the Company's UK Statutory Directors' Remuneration Policy. COMPENSATION ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 Kiniksa Pharmaceuticals International, plc G52694109 05/29/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 257.290000 0.000000 FOR 257.290000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Jean Bennett DIRECTOR ELECTIONS ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Argeris N. Karabelas DIRECTOR ELECTIONS ISSUER 298.070000 0.000000 WITHHOLD 298.070000 AGAINST S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Elect Daniel Tasse DIRECTOR ELECTIONS ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To approve a stock option exchange for our non-executive employees. COMPENSATION ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 REGENXBIO Inc. 75901B107 05/29/2026 To approve a stock option exchange for our executive employees. COMPENSATION ISSUER 298.070000 0.000000 FOR 298.070000 FOR S000004450 Talkspace, Inc. 87427V103 05/29/2026 To adopt the Agreement and Plan of Merger, dated as of March 9, 2026, by and among Talkspace, Inc., a Delaware corporation (the "Company"), Universal Health Services, Inc., a Delaware corporation ("UHS"), UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of UHS ("Merger Sub"), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the "merger"), with the Company continuing as the surviving corporation in the merger as an indirect wholly owned subsidiary of UHS. EXTRAORDINARY TRANSACTIONS ISSUER 1121.820000 0.000000 FOR 1121.820000 FOR S000004450 Talkspace, Inc. 87427V103 05/29/2026 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers of the Company in connection with the consummation of the merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 1121.820000 0.000000 AGAINST 1121.820000 AGAINST S000004450 Talkspace, Inc. 87427V103 05/29/2026 To approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. CORPORATE GOVERNANCE ISSUER 1121.820000 0.000000 FOR 1121.820000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: David Gaugh DIRECTOR ELECTIONS ISSUER 260.420000 0.000000 FOR 260.420000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: William J. Peters DIRECTOR ELECTIONS ISSUER 260.420000 0.000000 AGAINST 260.420000 AGAINST S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi DIRECTOR ELECTIONS ISSUER 260.420000 0.000000 AGAINST 260.420000 AGAINST S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 260.420000 0.000000 AGAINST 260.420000 AGAINST S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 260.420000 0.000000 FOR 260.420000 FOR S000004450 Amphastar Pharmaceuticals, Inc. 03209R103 06/01/2026 To approve, on an advisory basis, the frequency of future stockholder advisory votes on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 260.420000 0.000000 ONE YEAR 260.420000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 Elect Sean P. Nolan DIRECTOR ELECTIONS ISSUER 1062.250000 0.000000 WITHHOLD 1062.250000 AGAINST S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 Elect Laura Sepp-Lorenzino DIRECTOR ELECTIONS ISSUER 1062.250000 0.000000 FOR 1062.250000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1062.250000 0.000000 FOR 1062.250000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1062.250000 0.000000 FOR 1062.250000 FOR S000004450 Taysha Gene Therapies, Inc. 877619106 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1062.250000 0.000000 ONE YEAR 1062.250000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Charles Baker DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 AGAINST 6377.770000 AGAINST S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Timothy Flynn DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Paul Garcia DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Kristen Gil DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Stephen Hemsley DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. F. William McNabb III DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Election of Directors. John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 6377.770000 0.000000 FOR 6377.770000 FOR S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 6377.770000 0.000000 AGAINST 6377.770000 AGAINST S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 6377.770000 0.000000 AGAINST 6377.770000 AGAINST S000004450 UnitedHealth Group Incorporated 91324P102 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 6377.770000 0.000000 FOR 6377.770000 AGAINST S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Robert A. Demichiei DIRECTOR ELECTIONS ISSUER 819.140000 0.000000 FOR 819.140000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect John P. Driscoll DIRECTOR ELECTIONS ISSUER 819.140000 0.000000 WITHHOLD 819.140000 AGAINST S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Paul G. Moskowitz DIRECTOR ELECTIONS ISSUER 819.140000 0.000000 FOR 819.140000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Elect Lauren Young DIRECTOR ELECTIONS ISSUER 819.140000 0.000000 FOR 819.140000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 819.140000 0.000000 FOR 819.140000 FOR S000004450 Waystar Holding Corp. 946784105 06/01/2026 Indicate, on a non-binding advisory basis, the frequency of future advisory votes to approve the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 819.140000 0.000000 ONE YEAR 819.140000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Alison C. Finger DIRECTOR ELECTIONS ISSUER 1852.570000 0.000000 WITHHOLD 1852.570000 AGAINST S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To elect the following Class I directors for a term expiring at the 2029 Annual Meeting of Stockholders or until their successors are duly elected and qualified. Eduardo Rene Salas DIRECTOR ELECTIONS ISSUER 1852.570000 0.000000 FOR 1852.570000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1852.570000 0.000000 FOR 1852.570000 FOR S000004450 ADMA Biologics, Inc. 000899104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1852.570000 0.000000 FOR 1852.570000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Diana Mckenzie DIRECTOR ELECTIONS ISSUER 101.530000 0.000000 FOR 101.530000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Karen McLoughlin DIRECTOR ELECTIONS ISSUER 101.530000 0.000000 AGAINST 101.530000 AGAINST S000004450 agilon health, inc. 00857U206 06/02/2026 Election of Class II Directors: Ronald Williams DIRECTOR ELECTIONS ISSUER 101.530000 0.000000 AGAINST 101.530000 AGAINST S000004450 agilon health, inc. 00857U206 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 101.530000 0.000000 FOR 101.530000 FOR S000004450 agilon health, inc. 00857U206 06/02/2026 Approval, by advisory vote, of the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 101.530000 0.000000 AGAINST 101.530000 AGAINST S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Elizabeth M. Anderson DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Barbara W. Bodem DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Ian T. Clark DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 AGAINST 1302.440000 AGAINST S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Athena Countouriotis DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Willard Dere DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Mark J. Enyedy DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 AGAINST 1302.440000 AGAINST S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Alexander Hardy DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Maykin Ho DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Robert J. Hombach DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 Election of Directors: Timothy P. Walbert DIRECTOR ELECTIONS ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1302.440000 0.000000 AGAINST 1302.440000 AGAINST S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1302.440000 0.000000 AGAINST 1302.440000 AGAINST S000004450 BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan, as amended. COMPENSATION ISSUER 1302.440000 0.000000 FOR 1302.440000 FOR S000004450 CeriBell, Inc. 15678C102 06/02/2026 Election of Directors: Josef Parvizi, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 130.260000 0.000000 FOR 130.260000 FOR S000004450 CeriBell, Inc. 15678C102 06/02/2026 Election of Directors: Rebecca Robertson DIRECTOR ELECTIONS ISSUER 130.260000 0.000000 WITHHOLD 130.260000 AGAINST S000004450 CeriBell, Inc. 15678C102 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 130.260000 0.000000 FOR 130.260000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 Elect William M. Greenman DIRECTOR ELECTIONS ISSUER 1557.120000 0.000000 WITHHOLD 1557.120000 AGAINST S000004450 Cerus Corporation 157085101 06/02/2026 Elect Ann Lucena DIRECTOR ELECTIONS ISSUER 1557.120000 0.000000 FOR 1557.120000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION ISSUER 1557.120000 0.000000 FOR 1557.120000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1557.120000 0.000000 FOR 1557.120000 FOR S000004450 Cerus Corporation 157085101 06/02/2026 The ratification of the selection by the Audit Committee of the Board of Directors of Emst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1557.120000 0.000000 AGAINST 1557.120000 AGAINST S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Michael J. Barber DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: James D. Forbes DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Brian T. Gladden DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Betsy D. Holden DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 AGAINST 1423.890000 AGAINST S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Clyde R. Hosein DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Gregory T. Lucier DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Brian P. McKeon DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Daniel T. Scavilla DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Leslie F. Varon DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Janet S. Vergis DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Election of Directors: Donald J. Zurbay DIRECTOR ELECTIONS ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Approval, by non-binding vote, of the Company's executive compensation for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1423.890000 0.000000 AGAINST 1423.890000 AGAINST S000004450 DENTSPLY SIRONA Inc. 24906P109 06/02/2026 Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. COMPENSATION ISSUER 1423.890000 0.000000 FOR 1423.890000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Charles A. Bancroft DIRECTOR ELECTIONS ISSUER 206.790000 0.000000 WITHHOLD 206.790000 AGAINST S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Bassil I. Dahiyat, Ph.D. DIRECTOR ELECTIONS ISSUER 206.790000 0.000000 FOR 206.790000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Elect three Class II directors nominated by our board and named in this proxy statement. Taiyin Yang, Ph.D. DIRECTOR ELECTIONS ISSUER 206.790000 0.000000 FOR 206.790000 FOR S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 206.790000 0.000000 AGAINST 206.790000 AGAINST S000004450 Kodiak Sciences Inc. 50015M109 06/02/2026 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 206.790000 0.000000 FOR 206.790000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 Election of Director: David B. Roberts DIRECTOR ELECTIONS ISSUER 153.690000 0.000000 FOR 153.690000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 Election of Director: John A. Roush DIRECTOR ELECTIONS ISSUER 153.690000 0.000000 FOR 153.690000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 153.690000 0.000000 FOR 153.690000 FOR S000004450 LeMaitre Vascular, Inc. 525558201 06/02/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 153.690000 0.000000 FOR 153.690000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: David Bourdon DIRECTOR ELECTIONS ISSUER 1392.620000 0.000000 FOR 1392.620000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Election of Director to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D. DIRECTOR ELECTIONS ISSUER 1392.620000 0.000000 FOR 1392.620000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Ratification of the appointment of PricewaterhouseCoopers LLP ('PwC') as our independent registered public accounting firm for the year ended December 31, 2026. AUDIT-RELATED ISSUER 1392.620000 0.000000 FOR 1392.620000 FOR S000004450 LifeStance Health Group, Inc. 53228F101 06/02/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1392.620000 0.000000 FOR 1392.620000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025. CORPORATE GOVERNANCE ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. John W. Smither until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. Janneke van der Kamp until the 2030 annual general meeting DIRECTOR ELECTIONS ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to issue ordinary shares (or rights to subscribe for ordinary shares) in the Company's capital. CAPITAL STRUCTURE ISSUER 439.930000 0.000000 AGAINST 439.930000 AGAINST S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Extension of authorization for the Board of Directors to limit or exclude pre-emption rights. CAPITAL STRUCTURE ISSUER 439.930000 0.000000 AGAINST 439.930000 AGAINST S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 439.930000 0.000000 FOR 439.930000 FOR S000004450 NewAmsterdam Pharma Company N.V. N62509109 06/02/2026 Non-binding, advisory vote to approve the 2025 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 439.930000 0.000000 AGAINST 439.930000 AGAINST S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 Elect Lawrence Klein DIRECTOR ELECTIONS ISSUER 154.950000 0.000000 FOR 154.950000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 Elect Chris Martin DIRECTOR ELECTIONS ISSUER 154.950000 0.000000 FOR 154.950000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Oruka Therapeutics, Inc. for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 154.950000 0.000000 FOR 154.950000 FOR S000004450 Oruka Therapeutics, Inc. 687604108 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154.950000 0.000000 FOR 154.950000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jessica Chutter DIRECTOR ELECTIONS ISSUER 577.190000 0.000000 FOR 577.190000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Matthew B. Klein DIRECTOR ELECTIONS ISSUER 577.190000 0.000000 FOR 577.190000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Stephanie S. Okey DIRECTOR ELECTIONS ISSUER 577.190000 0.000000 WITHHOLD 577.190000 AGAINST S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Elect Jerome B. Zeldis DIRECTOR ELECTIONS ISSUER 577.190000 0.000000 FOR 577.190000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 577.190000 0.000000 FOR 577.190000 FOR S000004450 PTC Therapeutics, Inc. 69366J200 06/02/2026 Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 577.190000 0.000000 FOR 577.190000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Howard G. Berger DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect A. Gregory Sorensen DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Laura P. Jacobs DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 WITHHOLD 467.950000 AGAINST S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Lawrence L. Levitt DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect Gregory E. Spurlock DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 Elect David L. Swartz DIRECTOR ELECTIONS ISSUER 467.950000 0.000000 WITHHOLD 467.950000 AGAINST S000004450 Radnet, Inc. 750491102 06/02/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 An advisory vote to approve the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Radnet, Inc. 750491102 06/02/2026 The approval of an amendment and restatement to the Company's Equity Incentive Plan. COMPENSATION ISSUER 467.950000 0.000000 FOR 467.950000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas Kiselak DIRECTOR ELECTIONS ISSUER 464.600000 0.000000 WITHHOLD 464.600000 AGAINST S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Jennifer K. Moses DIRECTOR ELECTIONS ISSUER 464.600000 0.000000 WITHHOLD 464.600000 AGAINST S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 464.600000 0.000000 FOR 464.600000 FOR S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 464.600000 0.000000 AGAINST 464.600000 AGAINST S000004450 Viridian Therapeutics, Inc. 92790C104 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 464.600000 0.000000 ONE YEAR 464.600000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Kevin Tang DIRECTOR ELECTIONS ISSUER 898.840000 0.000000 FOR 898.840000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Jeffrey A. Bailey DIRECTOR ELECTIONS ISSUER 898.840000 0.000000 WITHHOLD 898.840000 AGAINST S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Kathy Goetz DIRECTOR ELECTIONS ISSUER 898.840000 0.000000 FOR 898.840000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Craig Johnson DIRECTOR ELECTIONS ISSUER 898.840000 0.000000 WITHHOLD 898.840000 AGAINST S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Election of Directors: Tina S. Nova DIRECTOR ELECTIONS ISSUER 898.840000 0.000000 FOR 898.840000 FOR S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed. AUDIT-RELATED ISSUER 898.840000 0.000000 WITHHOLD 898.840000 AGAINST S000004450 Aurinia Pharmaceuticals Inc. 05156V102 06/03/2026 Advisory Resolution on Executive Compensation: To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular. SECTION 14A SAY-ON-PAY VOTES ISSUER 898.840000 0.000000 FOR 898.840000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Evans DIRECTOR ELECTIONS ISSUER 650.400000 0.000000 FOR 650.400000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 650.400000 0.000000 FOR 650.400000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Election of the following nominees as Class III directors for three-year terms ending at our Annual Meeting of Stockholders to be held in 2029: Christi Shaw DIRECTOR ELECTIONS ISSUER 650.400000 0.000000 FOR 650.400000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 650.400000 0.000000 FOR 650.400000 FOR S000004450 Beam Therapeutics Inc. 07373V105 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 650.400000 0.000000 FOR 650.400000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect William A. Hawkins DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect John A. Bartholdson DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Patrick J. Beyer DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Robert E. Claypoole DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Philip G. Cowdy DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Ajay Dhankar DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Mary Kay Ladone DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Michelle McMurry-Heath DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Guido J. Neels DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Guy P. Nohra DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Susan M. Stalnecker DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 WITHHOLD 285.570000 AGAINST S000004450 Bioventus Inc. 09075A108 06/03/2026 Elect Martin P. Sutter DIRECTOR ELECTIONS ISSUER 285.570000 0.000000 WITHHOLD 285.570000 AGAINST S000004450 Bioventus Inc. 09075A108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 285.570000 0.000000 FOR 285.570000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect Jennifer E. Cook DIRECTOR ELECTIONS ISSUER 1103.200000 0.000000 WITHHOLD 1103.200000 AGAINST S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 1103.200000 0.000000 FOR 1103.200000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Elect Ryan J. Watts DIRECTOR ELECTIONS ISSUER 1103.200000 0.000000 FOR 1103.200000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1103.200000 0.000000 FOR 1103.200000 FOR S000004450 Denali Therapeutics Inc 24823R105 06/03/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1103.200000 0.000000 FOR 1103.200000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas DIRECTOR ELECTIONS ISSUER 902.840000 0.000000 FOR 902.840000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil DIRECTOR ELECTIONS ISSUER 902.840000 0.000000 WITHHOLD 902.840000 AGAINST S000004450 Globus Medical, Inc. 379577208 06/03/2026 Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000. COMPENSATION ISSUER 902.840000 0.000000 AGAINST 902.840000 AGAINST S000004450 Globus Medical, Inc. 379577208 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 902.840000 0.000000 FOR 902.840000 FOR S000004450 Globus Medical, Inc. 379577208 06/03/2026 Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 902.840000 0.000000 FOR 902.840000 FOR S000004450 Hinge Health, Inc. 433313103 06/03/2026 Elect Teddie Wardi DIRECTOR ELECTIONS ISSUER 140.080000 0.000000 WITHHOLD 140.080000 AGAINST S000004450 Hinge Health, Inc. 433313103 06/03/2026 Elect Tyler Sloat DIRECTOR ELECTIONS ISSUER 140.080000 0.000000 FOR 140.080000 FOR S000004450 Hinge Health, Inc. 433313103 06/03/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 140.080000 0.000000 FOR 140.080000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To elect the two (2) nominees for Class IIl director named below to hold office until the 2029 Annual Meeting of Stockholders. Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 117.330000 0.000000 WITHHOLD 117.330000 AGAINST S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To elect the two (2) nominees for Class IIl director named below to hold office until the 2029 Annual Meeting of Stockholders. Charles Newton DIRECTOR ELECTIONS ISSUER 117.330000 0.000000 FOR 117.330000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 117.330000 0.000000 FOR 117.330000 FOR S000004450 Keros Therapeutics, Inc. 492327101 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 117.330000 0.000000 FOR 117.330000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Asaf Danziger DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: William Doyle DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 AGAINST 757.340000 AGAINST S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Jeryl Hilleman DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: David Hung DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Frank Leonard DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Kinyip Gabriel Leung DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 AGAINST 757.340000 AGAINST S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Martin Madden DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Allyson Ocean DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Timothy Scannell DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: Kristin Stafford DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 Election of Directors: William Vernon DIRECTOR ELECTIONS ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 NovoCure Limited G6674U108 06/03/2026 The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 757.340000 0.000000 AGAINST 757.340000 AGAINST S000004450 NovoCure Limited G6674U108 06/03/2026 A non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 757.340000 0.000000 AGAINST 757.340000 AGAINST S000004450 NovoCure Limited G6674U108 06/03/2026 The approval of our amended and restated 2024 Omnibus Incentive Plan. COMPENSATION ISSUER 757.340000 0.000000 FOR 757.340000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. John D. Bertrand DIRECTOR ELECTIONS ISSUER 499.710000 0.000000 AGAINST 499.710000 AGAINST S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. Steven K. Boyd DIRECTOR ELECTIONS ISSUER 499.710000 0.000000 FOR 499.710000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To elect three (3) Class Directors to serve for a term expiring at the Company's Annual Meeting of Stockholders In 2029. Robert W. McMahon DIRECTOR ELECTIONS ISSUER 499.710000 0.000000 AGAINST 499.710000 AGAINST S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 499.710000 0.000000 FOR 499.710000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 499.710000 0.000000 FOR 499.710000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. COMPENSATION ISSUER 499.710000 0.000000 FOR 499.710000 FOR S000004450 OraSure Technologies, Inc. 68554V108 06/03/2026 To approve an amendment to the Company's Certificate of Incorporation to declassify the Company's Board of Directors and add certain clarifying changes. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 499.710000 0.000000 FOR 499.710000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: William Ericson DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 AGAINST 1830.080000 AGAINST S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Christian O. Henry DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 AGAINST 1830.080000 AGAINST S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: John F. Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 AGAINST 1830.080000 AGAINST S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Kathy Ordonez DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 Election of Directors: Christopher M. Smith DIRECTOR ELECTIONS ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Pacific Biosciences of California, Inc. 69404D108 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 1830.080000 0.000000 FOR 1830.080000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Clare Kahn DIRECTOR ELECTIONS ISSUER 284.820000 0.000000 FOR 284.820000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Adrian R. Krainer DIRECTOR ELECTIONS ISSUER 284.820000 0.000000 WITHHOLD 284.820000 AGAINST S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 Elect Julie Anne Smith DIRECTOR ELECTIONS ISSUER 284.820000 0.000000 FOR 284.820000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 284.820000 0.000000 FOR 284.820000 FOR S000004450 Stoke Therapeutics, Inc 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 284.820000 0.000000 FOR 284.820000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders. Nominee: Michael Heffernan DIRECTOR ELECTIONS ISSUER 606.700000 0.000000 FOR 606.700000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 606.700000 0.000000 FOR 606.700000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 606.700000 0.000000 FOR 606.700000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval of the Trevi Therapeutics, Inc. Amended and Restated 2019 Stock Incentive Plan. COMPENSATION ISSUER 606.700000 0.000000 FOR 606.700000 FOR S000004450 Trevi Therapeutics, Inc. 89532M101 06/03/2026 Approval of an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 606.700000 0.000000 FOR 606.700000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Serge Saxonov DIRECTOR ELECTIONS ISSUER 815.520000 0.000000 FOR 815.520000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 815.520000 0.000000 FOR 815.520000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Election of Class I Directors to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal: John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 815.520000 0.000000 AGAINST 815.520000 AGAINST S000004450 10x Genomics, Inc. 88025U109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 815.520000 0.000000 FOR 815.520000 FOR S000004450 10x Genomics, Inc. 88025U109 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 815.520000 0.000000 FOR 815.520000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jody Bilney DIRECTOR ELECTIONS ISSUER 1202.630000 0.000000 FOR 1202.630000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: David Hodgson DIRECTOR ELECTIONS ISSUER 1202.630000 0.000000 WITHHOLD 1202.630000 AGAINST S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Election of Directors: Jacqueline Kosecoff DIRECTOR ELECTIONS ISSUER 1202.630000 0.000000 FOR 1202.630000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026 AUDIT-RELATED ISSUER 1202.630000 0.000000 FOR 1202.630000 FOR S000004450 Alignment Healthcare, Inc. 01625V104 06/04/2026 Approval, on a non-binding, advisory basis, of the compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1202.630000 0.000000 FOR 1202.630000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. DIRECTOR ELECTIONS ISSUER 524.430000 0.000000 WITHHOLD 524.430000 AGAINST S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Paul Fonteyne DIRECTOR ELECTIONS ISSUER 524.430000 0.000000 FOR 524.430000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 524.430000 0.000000 FOR 524.430000 FOR S000004450 Amylyx Pharmaceuticals, Inc. 03237H101 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 524.430000 0.000000 FOR 524.430000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Christina Rossi DIRECTOR ELECTIONS ISSUER 304.930000 0.000000 FOR 304.930000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr. DIRECTOR ELECTIONS ISSUER 304.930000 0.000000 WITHHOLD 304.930000 AGAINST S000004450 CG Oncology, Inc. 156944100 06/04/2026 To ratify the appointment by the Audit Committee of the Board of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 304.930000 0.000000 FOR 304.930000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 304.930000 0.000000 FOR 304.930000 FOR S000004450 CG Oncology, Inc. 156944100 06/04/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 304.930000 0.000000 ONE YEAR 304.930000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Pamela M. Arway DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Barbara J. Desoer DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Gregory J. Moore, MD, PhD DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Dennis W. Pullin DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Adam H. Schechter DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Wendy L. Schoppert DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 DaVita Inc. 23918K108 06/04/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 307.910000 0.000000 AGAINST 307.910000 AGAINST S000004450 DaVita Inc. 23918K108 06/04/2026 To ratify the appolntment of KPMG LLP as our Independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 307.910000 0.000000 AGAINST 307.910000 AGAINST S000004450 DaVita Inc. 23918K108 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 307.910000 0.000000 FOR 307.910000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Sastry Chilukuri DIRECTOR ELECTIONS ISSUER 302.560000 0.000000 WITHHOLD 302.560000 AGAINST S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Chris Egan DIRECTOR ELECTIONS ISSUER 302.560000 0.000000 FOR 302.560000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To elect the three Class II directors of Definitive Healtcare Corp. named below, each to serve a three-year term expiring at the 2029 annual meeting of stockholders and until such director's successor is duly elected and qualified, or until such director's earlier death, resignation or removal: Samuel A. Hamood DIRECTOR ELECTIONS ISSUER 302.560000 0.000000 FOR 302.560000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 302.560000 0.000000 FOR 302.560000 FOR S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To approve an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan (the "2021 Plan"), to increase the number of shares of Class A Common Stock, par value $0.001 per share that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. COMPENSATION ISSUER 302.560000 0.000000 AGAINST 302.560000 AGAINST S000004450 Definitive Healthcare Corp. 24477E103 06/04/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 302.560000 0.000000 AGAINST 302.560000 AGAINST S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Laura A. Brege DIRECTOR ELECTIONS ISSUER 421.060000 0.000000 WITHHOLD 421.060000 AGAINST S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Badreddin Edris DIRECTOR ELECTIONS ISSUER 421.060000 0.000000 FOR 421.060000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Elect Jonathan Root DIRECTOR ELECTIONS ISSUER 421.060000 0.000000 WITHHOLD 421.060000 AGAINST S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 421.060000 0.000000 FOR 421.060000 FOR S000004450 Edgewise Therapeutics, Inc. 28036F105 06/04/2026 Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 421.060000 0.000000 FOR 421.060000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Toyin Ajayi, MD DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Craig Barbarosh DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Seth Blackley DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Russell Glass DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Peter Grua DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Shawn Guertin DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Richard Jelinek DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 AGAINST 747.370000 AGAINST S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Kim Keck DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 AGAINST 747.370000 AGAINST S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Jill Smith DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Election of Directors: Brendan Springstubb DIRECTOR ELECTIONS ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to approve the compensation of our named executive officers for 2025 on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Evolent Health, Inc. 30050B101 06/04/2026 Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 747.370000 0.000000 FOR 747.370000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Election of Class II Directors: Russell Cox DIRECTOR ELECTIONS ISSUER 1512.870000 0.000000 WITHHOLD 1512.870000 AGAINST S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Election of Class II Directors: Faheem Hasnain DIRECTOR ELECTIONS ISSUER 1512.870000 0.000000 WITHHOLD 1512.870000 AGAINST S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1512.870000 0.000000 FOR 1512.870000 FOR S000004450 Gossamer Bio, Inc. 38341P102 06/04/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1512.870000 0.000000 AGAINST 1512.870000 AGAINST S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Spencer R. Berthelsen DIRECTOR ELECTIONS ISSUER 1098.360000 0.000000 AGAINST 1098.360000 AGAINST S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 Election of Directors Nominees Joan E. Herman DIRECTOR ELECTIONS ISSUER 1098.360000 0.000000 FOR 1098.360000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1098.360000 0.000000 FOR 1098.360000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. COMPENSATION ISSUER 1098.360000 0.000000 FOR 1098.360000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan. COMPENSATION ISSUER 1098.360000 0.000000 FOR 1098.360000 FOR S000004450 Ionis Pharmaceuticals, Inc. 462222100 06/04/2026 To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year. AUDIT-RELATED ISSUER 1098.360000 0.000000 AGAINST 1098.360000 AGAINST S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Diane Parks DIRECTOR ELECTIONS ISSUER 525.780000 0.000000 WITHHOLD 525.780000 AGAINST S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Mary T. Szela DIRECTOR ELECTIONS ISSUER 525.780000 0.000000 WITHHOLD 525.780000 AGAINST S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Election of three Class III directors for three-year terms: Michael J. Vasconcelles, M.D. DIRECTOR ELECTIONS ISSUER 525.780000 0.000000 FOR 525.780000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 525.780000 0.000000 FOR 525.780000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 525.780000 0.000000 FOR 525.780000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 525.780000 0.000000 ONE YEAR 525.780000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval of an amendment to our Amended and Restated 2014 Equity Incentive Plan. COMPENSATION ISSUER 525.780000 0.000000 FOR 525.780000 FOR S000004450 Kura Oncology, Inc. 50127T109 06/04/2026 Approval of an amendment to our 2015 Employee Stock Purchase Plan. COMPENSATION ISSUER 525.780000 0.000000 FOR 525.780000 FOR S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 177.770000 0.000000 WITHHOLD 177.770000 AGAINST S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Election of Class II Director to serve until the Company's 2029 Annual Meeting of Stockholders and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers DIRECTOR ELECTIONS ISSUER 177.770000 0.000000 WITHHOLD 177.770000 AGAINST S000004450 MBX Biosciences, Inc. 55287L101 06/04/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 177.770000 0.000000 FOR 177.770000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Election of the Class I director nominee to serve until the 2029 Annual General Meeting of Shareholders and until his successor is duly elected and qualified. Spike Loy DIRECTOR ELECTIONS ISSUER 251.420000 0.000000 WITHHOLD 251.420000 AGAINST S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 251.420000 0.000000 FOR 251.420000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 251.420000 0.000000 FOR 251.420000 FOR S000004450 MoonLake Immunotherapeutics 61559X104 06/04/2026 Approval of an amendment and restatement of the Company's 2022 Equity Incentive Plan. COMPENSATION ISSUER 251.420000 0.000000 FOR 251.420000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Rashmi Kumar DIRECTOR ELECTIONS ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 Election of three Class III Directors to serve until the 2029 Annual Meeting of Stockholders: Lee N. Newcomer, M.D. DIRECTOR ELECTIONS ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 716.350000 0.000000 AGAINST 716.350000 AGAINST S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve the proposed amendment to the Amended and Restated 2012 Employee Stock Purchase Plan. COMPENSATION ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Myriad Genetics, Inc. 62855J104 06/04/2026 To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 716.350000 0.000000 FOR 716.350000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 Election of Director: Howard W. Robin DIRECTOR ELECTIONS ISSUER 172.400000 0.000000 FOR 172.400000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. COMPENSATION ISSUER 172.400000 0.000000 FOR 172.400000 FOR S000004450 Nektar Therapeutics 640268306 06/04/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 172.400000 0.000000 AGAINST 172.400000 AGAINST S000004450 Nektar Therapeutics 640268306 06/04/2026 To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). SECTION 14A SAY-ON-PAY VOTES ISSUER 172.400000 0.000000 FOR 172.400000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD DIRECTOR ELECTIONS ISSUER 124.550000 0.000000 WITHHOLD 124.550000 AGAINST S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Kelly Fischer DIRECTOR ELECTIONS ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 Election of Director to serve until the 2029 annual meeting of our stockholders: Harald Ruf DIRECTOR ELECTIONS ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve an amendment to the 2024 Incentive Award Plan. COMPENSATION ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 OrthoPediatrics Corp. 68752L100 06/04/2026 To approve, on an advisory basis, the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 124.550000 0.000000 FOR 124.550000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Hans E. Bishop DIRECTOR ELECTIONS ISSUER 1242.310000 0.000000 WITHHOLD 1242.310000 AGAINST S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Robert Nelsen DIRECTOR ELECTIONS ISSUER 1242.310000 0.000000 FOR 1242.310000 FOR S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified: Alise S. Reicin, M.D. DIRECTOR ELECTIONS ISSUER 1242.310000 0.000000 WITHHOLD 1242.310000 AGAINST S000004450 Sana Biotechnology, Inc. 799566104 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1242.310000 0.000000 FOR 1242.310000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Hans Wigzell, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 774.030000 0.000000 AGAINST 774.030000 AGAINST S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Kathryn J. Boor, Ph.D. DIRECTOR ELECTIONS ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Michael Chambers DIRECTOR ELECTIONS ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 To elect, as Class I directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified or their earlier death, resignation or removal, the following director nominees: Deirdre Connelly DIRECTOR ELECTIONS ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Advisory vote to approve, on a non-binding basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 774.030000 0.000000 AGAINST 774.030000 AGAINST S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Approve the Company's 2026 Equity Incentive Plan COMPENSATION ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Approve the Company's 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 774.030000 0.000000 FOR 774.030000 FOR S000004450 Sarepta Therapeutics, Inc. 803607100 06/04/2026 Ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2026 AUDIT-RELATED ISSUER 774.030000 0.000000 AGAINST 774.030000 AGAINST S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Matthew Pauls DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 AGAINST 492.660000 AGAINST S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Nevan Elam DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 AGAINST 492.660000 AGAINST S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Richard J. Hawkins DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: Joseph S. McCracken DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 AGAINST 492.660000 AGAINST S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: David A. Ramsay DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 AGAINST 492.660000 AGAINST S000004450 Savara Inc. 805111101 06/04/2026 To elect six directors to hold office until the next Annual Meeting of Stockholders: An van Es-Johansson DIRECTOR ELECTIONS ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 300,000,000 to 600,000,000. CAPITAL STRUCTURE ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve the amendment of the Savara Inc. 2024 Omnibus Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 18,900,000. COMPENSATION ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Savara Inc. 805111101 06/04/2026 To approve, on an advisory basis, the compensation of our named executives. SECTION 14A SAY-ON-PAY VOTES ISSUER 492.660000 0.000000 FOR 492.660000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect David Hallal DIRECTOR ELECTIONS ISSUER 499.750000 0.000000 WITHHOLD 499.750000 AGAINST S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Kristina M. Burow DIRECTOR ELECTIONS ISSUER 499.750000 0.000000 FOR 499.750000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Michael Gilman DIRECTOR ELECTIONS ISSUER 499.750000 0.000000 FOR 499.750000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 Elect Katie Peng DIRECTOR ELECTIONS ISSUER 499.750000 0.000000 FOR 499.750000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 499.750000 0.000000 FOR 499.750000 FOR S000004450 Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 499.750000 0.000000 AGAINST 499.750000 AGAINST S000004450 SI-BONE, Inc. 825704109 06/04/2026 Election of Directors: Jeffrey W. Dunn DIRECTOR ELECTIONS ISSUER 291.800000 0.000000 WITHHOLD 291.800000 AGAINST S000004450 SI-BONE, Inc. 825704109 06/04/2026 Election of Directors: John G. Freund, M.D. DIRECTOR ELECTIONS ISSUER 291.800000 0.000000 WITHHOLD 291.800000 AGAINST S000004450 SI-BONE, Inc. 825704109 06/04/2026 To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as SI-BONE, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 291.800000 0.000000 FOR 291.800000 FOR S000004450 SI-BONE, Inc. 825704109 06/04/2026 Advisory vote to approve executive compensation "Say-on-Pay". SECTION 14A SAY-ON-PAY VOTES ISSUER 291.800000 0.000000 FOR 291.800000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Malte Peters, M.D. DIRECTOR ELECTIONS ISSUER 320.230000 0.000000 FOR 320.230000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Kanishka Pothula DIRECTOR ELECTIONS ISSUER 320.230000 0.000000 WITHHOLD 320.230000 AGAINST S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 Election of Class II Director: Mace Rothenberg, M.D. DIRECTOR ELECTIONS ISSUER 320.230000 0.000000 WITHHOLD 320.230000 AGAINST S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 320.230000 0.000000 FOR 320.230000 FOR S000004450 Tango Therapeutics, Inc. 87583X109 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 320.230000 0.000000 FOR 320.230000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect R. Jeffrey Bailly DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 WITHHOLD 58.570000 AGAINST S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Thomas Oberdorf DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 FOR 58.570000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Marc Kozin DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 FOR 58.570000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Daniel C. Croteau DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 WITHHOLD 58.570000 AGAINST S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Cynthia L. Feldmann DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 WITHHOLD 58.570000 AGAINST S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Joseph John Hassett DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 FOR 58.570000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 Elect Symeria Hudson DIRECTOR ELECTIONS ISSUER 58.570000 0.000000 FOR 58.570000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 To vote on a non-binding advisory resolution to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 58.570000 0.000000 FOR 58.570000 FOR S000004450 UFP Technologies, Inc. 902673102 06/04/2026 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 58.570000 0.000000 AGAINST 58.570000 AGAINST S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Richard W. Dugan DIRECTOR ELECTIONS ISSUER 456.580000 0.000000 AGAINST 456.580000 AGAINST S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Charles C. Duncan DIRECTOR ELECTIONS ISSUER 456.580000 0.000000 FOR 456.580000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To elect three Class II Directors: Anne Sempowski Ward DIRECTOR ELECTIONS ISSUER 456.580000 0.000000 FOR 456.580000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 456.580000 0.000000 AGAINST 456.580000 AGAINST S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 456.580000 0.000000 FOR 456.580000 FOR S000004450 Vanda Pharmaceuticals Inc. 921659108 06/04/2026 To approve an amendment to the Company's amended and restated 2016 Equity Incentive Plan, as amended to increase the aggregate number of shares authorized for issuance thereunder. COMPENSATION ISSUER 456.580000 0.000000 FOR 456.580000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn Halkuff DIRECTOR ELECTIONS ISSUER 1331.930000 0.000000 FOR 1331.930000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John Johnson DIRECTOR ELECTIONS ISSUER 1331.930000 0.000000 WITHHOLD 1331.930000 AGAINST S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1331.930000 0.000000 FOR 1331.930000 FOR S000004450 Xeris Biopharma Holdings, Inc. 98422E103 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1331.930000 0.000000 FOR 1331.930000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Robert Hershberg, PhD, MD DIRECTOR ELECTIONS ISSUER 814.060000 0.000000 FOR 814.060000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Katey Owen, PhD DIRECTOR ELECTIONS ISSUER 814.060000 0.000000 FOR 814.060000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 814.060000 0.000000 FOR 814.060000 FOR S000004450 Adaptive Biotechnologies Corporation 00650F109 06/05/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 814.060000 0.000000 FOR 814.060000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Peter C. Farrell DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Joseph E. Payne DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect James Barlow DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 WITHHOLD 213.270000 AGAINST S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Edward W. Holmes DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 WITHHOLD 213.270000 AGAINST S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Magda Marquet DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Jing L. Marantz DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect John H. Markels DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Elect Moncef Slaoui DIRECTOR ELECTIONS ISSUER 213.270000 0.000000 WITHHOLD 213.270000 AGAINST S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcturus Therapeutics Holdings Inc. 03969T109 06/05/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 213.270000 0.000000 FOR 213.270000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. Heron DIRECTOR ELECTIONS ISSUER 857.400000 0.000000 FOR 857.400000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Neha Krishnamohan DIRECTOR ELECTIONS ISSUER 857.400000 0.000000 FOR 857.400000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Todd Franklin Watanabe DIRECTOR ELECTIONS ISSUER 857.400000 0.000000 FOR 857.400000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 857.400000 0.000000 FOR 857.400000 FOR S000004450 Arcutis Biotherapeutics, Inc. 03969K108 06/05/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 857.400000 0.000000 FOR 857.400000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 Elect Mark E. Saad DIRECTOR ELECTIONS ISSUER 281.600000 0.000000 WITHHOLD 281.600000 AGAINST S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 Elect Susan Mahony DIRECTOR ELECTIONS ISSUER 281.600000 0.000000 FOR 281.600000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 281.600000 0.000000 FOR 281.600000 FOR S000004450 Axsome Therapeutics, Inc. 05464T104 06/05/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 281.600000 0.000000 FOR 281.600000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Linda Baddour DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 WITHHOLD 338.940000 AGAINST S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Daniel M. Hancock DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Robert J. Hariri DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Ram M. Jagannath DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Ramkumar Mandalam DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 Elect Jerrell W. Shelton DIRECTOR ELECTIONS ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2026. AUDIT-RELATED ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Cryoport, Inc. 229050307 06/05/2026 To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; and COMPENSATION ISSUER 338.940000 0.000000 FOR 338.940000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner DIRECTOR ELECTIONS ISSUER 820.940000 0.000000 WITHHOLD 820.940000 AGAINST S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Brian Posner DIRECTOR ELECTIONS ISSUER 820.940000 0.000000 FOR 820.940000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 Election of Class III directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes DIRECTOR ELECTIONS ISSUER 820.940000 0.000000 WITHHOLD 820.940000 AGAINST S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 820.940000 0.000000 FOR 820.940000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares. CAPITAL STRUCTURE ISSUER 820.940000 0.000000 FOR 820.940000 FOR S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation. CORPORATE GOVERNANCE ISSUER 820.940000 0.000000 AGAINST 820.940000 AGAINST S000004450 Dyne Therapeutics, Inc. 26818M108 06/05/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 820.940000 0.000000 FOR 820.940000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Jason M. Aryeh DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 WITHHOLD 161.110000 AGAINST S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Todd C. Davis DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 WITHHOLD 161.110000 AGAINST S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Nancy Ryan Gray DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Jason Haas DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect John W. Kozarich DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect John L. LaMattina DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Stephen L. Sabba DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Elect Martine Zimmermann DIRECTOR ELECTIONS ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Ratification of Ernst & Young LLP as Ligand's independent registered accounting firm AUDIT-RELATED ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Approval, on an advisory basis, of the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Ligand Pharmaceuticals Incorporated 53220K504 06/05/2026 Approval of an amendment and restatement of Ligand's 2002 Stock Incentive Plan COMPENSATION ISSUER 161.110000 0.000000 FOR 161.110000 FOR S000004450 Prime Medicine Inc 74168J101 06/05/2026 Elect Michael A. Kelly DIRECTOR ELECTIONS ISSUER 713.520000 0.000000 WITHHOLD 713.520000 AGAINST S000004450 Prime Medicine Inc 74168J101 06/05/2026 Elect David P. Schenkein DIRECTOR ELECTIONS ISSUER 713.520000 0.000000 WITHHOLD 713.520000 AGAINST S000004450 Prime Medicine Inc 74168J101 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 713.520000 0.000000 FOR 713.520000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Devin O'Reilly DIRECTOR ELECTIONS ISSUER 600.460000 0.000000 WITHHOLD 600.460000 AGAINST S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Brent Turner DIRECTOR ELECTIONS ISSUER 600.460000 0.000000 WITHHOLD 600.460000 AGAINST S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Election of Class II Directors: Laura L. Forese, M.D. DIRECTOR ELECTIONS ISSUER 600.460000 0.000000 FOR 600.460000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 600.460000 0.000000 FOR 600.460000 FOR S000004450 Surgery Partners, Inc. 86881A100 06/05/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 600.460000 0.000000 FOR 600.460000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. Baker DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 AGAINST 1344.480000 AGAINST S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jean-Jacques Bienaime DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 AGAINST 1344.480000 AGAINST S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Otis W. Brawley DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 FOR 1344.480000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Paul J. Clancy DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 AGAINST 1344.480000 AGAINST S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Jacqualyn A. Fouse DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 AGAINST 1344.480000 AGAINST S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Edmund P. Harrigan DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 FOR 1344.480000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Katherine A. High DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 FOR 1344.480000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: William J. Meury DIRECTOR ELECTIONS ISSUER 1344.480000 0.000000 FOR 1344.480000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1344.480000 0.000000 FOR 1344.480000 FOR S000004450 Incyte Corporation 45337C102 06/08/2026 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1344.480000 0.000000 AGAINST 1344.480000 AGAINST S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 Election of Class III Director: Todd C. Brady, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 415.710000 0.000000 FOR 415.710000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 415.710000 0.000000 FOR 415.710000 FOR S000004450 Aldeyra Therapeutics, Inc. 01438T106 06/09/2026 To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 415.710000 0.000000 AGAINST 415.710000 AGAINST S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Mark C. McKenna DIRECTOR ELECTIONS ISSUER 308.510000 0.000000 WITHHOLD 308.510000 AGAINST S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect Jennifer Fox DIRECTOR ELECTIONS ISSUER 308.510000 0.000000 WITHHOLD 308.510000 AGAINST S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Elect William Jones, Jr. DIRECTOR ELECTIONS ISSUER 308.510000 0.000000 FOR 308.510000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 308.510000 0.000000 FOR 308.510000 FOR S000004450 Apogee Therapeutics, Inc. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 308.510000 0.000000 FOR 308.510000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher J. Bowden DIRECTOR ELECTIONS ISSUER 223.080000 0.000000 FOR 223.080000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng DIRECTOR ELECTIONS ISSUER 223.080000 0.000000 FOR 223.080000 FOR S000004450 Bicara Therapeutics Inc. 055477103 06/09/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 223.080000 0.000000 FOR 223.080000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd B. Minor DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 AGAINST 1220.840000 AGAINST S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher DIRECTOR ELECTIONS ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Biogen Inc. 09062X103 06/09/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1220.840000 0.000000 AGAINST 1220.840000 AGAINST S000004450 Biogen Inc. 09062X103 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1220.840000 0.000000 FOR 1220.840000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Chris Cain DIRECTOR ELECTIONS ISSUER 674.600000 0.000000 FOR 674.600000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Arlene M. Morris DIRECTOR ELECTIONS ISSUER 674.600000 0.000000 WITHHOLD 674.600000 AGAINST S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Elect Todd Shegog DIRECTOR ELECTIONS ISSUER 674.600000 0.000000 WITHHOLD 674.600000 AGAINST S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 674.600000 0.000000 FOR 674.600000 FOR S000004450 Cogent Biosciences, Inc. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 674.600000 0.000000 AGAINST 674.600000 AGAINST S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 Election of Directors: Richard A. Fair DIRECTOR ELECTIONS ISSUER 260.860000 0.000000 FOR 260.860000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Lori Kunkel, M.D. DIRECTOR ELECTIONS ISSUER 260.860000 0.000000 FOR 260.860000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 260.860000 0.000000 FOR 260.860000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE ISSUER 260.860000 0.000000 FOR 260.860000 FOR S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 260.860000 0.000000 AGAINST 260.860000 AGAINST S000004450 Enliven Therapeutics, Inc. 29337E102 06/09/2026 To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 260.860000 0.000000 ONE YEAR 260.860000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: Anshul Thakral DIRECTOR ELECTIONS ISSUER 743.740000 0.000000 FOR 743.740000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: Peter M. Neupert DIRECTOR ELECTIONS ISSUER 743.740000 0.000000 AGAINST 743.740000 AGAINST S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Election of Directors: William J. Sharbaugh DIRECTOR ELECTIONS ISSUER 743.740000 0.000000 FOR 743.740000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 743.740000 0.000000 FOR 743.740000 FOR S000004450 Fortrea Holdings Inc. 34965K107 06/09/2026 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 743.740000 0.000000 FOR 743.740000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect John P. Bamforth DIRECTOR ELECTIONS ISSUER 102.350000 0.000000 WITHHOLD 102.350000 AGAINST S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect Keith Anthony Jones DIRECTOR ELECTIONS ISSUER 102.350000 0.000000 FOR 102.350000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Elect Kathleen G. Sebelius DIRECTOR ELECTIONS ISSUER 102.350000 0.000000 WITHHOLD 102.350000 AGAINST S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 102.350000 0.000000 FOR 102.350000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to Humacyte, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 102.350000 0.000000 ONE YEAR 102.350000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP by the Board of Directors as Humacyte, Inc.'s independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 102.350000 0.000000 FOR 102.350000 FOR S000004450 Humacyte, Inc. 44486Q103 06/09/2026 Approval of an amendment to Humacyte, Inc.'s Second Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 350,000,000 shares to 550,000,000 shares. CAPITAL STRUCTURE ISSUER 102.350000 0.000000 FOR 102.350000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Patrick Soon-Shiong, M.D. DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 WITHHOLD 887.230000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Richard Adcock DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Michael D. Blaszyk DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 WITHHOLD 887.230000 AGAINST S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Wesley Clark DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Linda Maxwell, M.D. DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Christobel Selecky DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Barry J. Simon, M.D. DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 Election of Directors: Bruce Wendel DIRECTOR ELECTIONS ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 ImmunityBio, Inc. 45256X103 06/09/2026 To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 887.230000 0.000000 FOR 887.230000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. James Boylan DIRECTOR ELECTIONS ISSUER 769.170000 0.000000 WITHHOLD 769.170000 AGAINST S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Sandra M. Swain, M.D. DIRECTOR ELECTIONS ISSUER 769.170000 0.000000 FOR 769.170000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal. Philip Wagenheim DIRECTOR ELECTIONS ISSUER 769.170000 0.000000 FOR 769.170000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 769.170000 0.000000 FOR 769.170000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 769.170000 0.000000 FOR 769.170000 FOR S000004450 Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 769.170000 0.000000 ONE YEAR 769.170000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 875.440000 0.000000 FOR 875.440000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Brian Goff DIRECTOR ELECTIONS ISSUER 875.440000 0.000000 FOR 875.440000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 875.440000 0.000000 AGAINST 875.440000 AGAINST S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 875.440000 0.000000 FOR 875.440000 FOR S000004450 Intellia Therapeutics, Inc. 45826J105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 875.440000 0.000000 AGAINST 875.440000 AGAINST S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Carrie S. Cox DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 AGAINST 2087.360000 AGAINST S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Robert Essner DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 AGAINST 2087.360000 AGAINST S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Alan Ezekowitz, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Helene Gayle, M.D. DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Rochelle B. Lazarus DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Deborah Leone DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Philip Ozuah, M.D., Ph. D. DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Cynthia M. Patton DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Election of Directors: Shalini Sharp DIRECTOR ELECTIONS ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Approve, on a non-binding advisory basis, the compensation of Organon's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan. COMPENSATION ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Organon & Co. 68622V106 06/09/2026 Ratify the appointment of PricewaterhouseCoopers LLP as Organon's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 2087.360000 0.000000 FOR 2087.360000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Oliver Benton "Ben" Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA Nominees: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Samit Hirawat DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees opposed by DOMA: Tom Wiggans DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Ratification of the appointment of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of the Amended and Restated 2011 Stock Incentive Plan COMPENSATION ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of the Amended and Restated 2014 Employee Stock Purchase Plan COMPENSATION ISSUER 341.200000 0.000000 Takenoaction 341.200000 NONE S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Christopher J. Christie DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Samit Hirawat DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Company Nominees: Thomas Wiggans DIRECTOR ELECTIONS ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Oliver Benton Curtis III DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 WITHHOLD 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Eric de Armas DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 WITHHOLD 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 DOMA nominees opposed by the Company: Christopher Dennis DIRECTOR ELECTIONS SECURITY HOLDER 341.200000 0.000000 WITHHOLD 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of our Amended and Restated 2011 Stock Incentive Plan. COMPENSATION ISSUER 341.200000 0.000000 AGAINST 341.200000 AGAINST S000004450 Pacira BioSciences, Inc. 695127100 06/09/2026 Approval of our Amended and Restated 2014 Employee Stock Purchase Plan. COMPENSATION ISSUER 341.200000 0.000000 FOR 341.200000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai DIRECTOR ELECTIONS ISSUER 445.370000 0.000000 FOR 445.370000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Mary Garrett DIRECTOR ELECTIONS ISSUER 445.370000 0.000000 WITHHOLD 445.370000 AGAINST S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Election of Class II Directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Frederic Moll, M.D. DIRECTOR ELECTIONS ISSUER 445.370000 0.000000 FOR 445.370000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 445.370000 0.000000 FOR 445.370000 FOR S000004450 PROCEPT BioRobotics Corporation 74276L105 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 445.370000 0.000000 AGAINST 445.370000 AGAINST S000004450 Quanterix Corporation 74766Q101 06/09/2026 Election of Directors: William P. Donnelly DIRECTOR ELECTIONS ISSUER 335.570000 0.000000 AGAINST 335.570000 AGAINST S000004450 Quanterix Corporation 74766Q101 06/09/2026 Election of Directors: Ivana Magovcevic-Liebisch, Ph.D., J.D. DIRECTOR ELECTIONS ISSUER 335.570000 0.000000 FOR 335.570000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 335.570000 0.000000 FOR 335.570000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To ratify, on an advisory basis, the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 335.570000 0.000000 FOR 335.570000 FOR S000004450 Quanterix Corporation 74766Q101 06/09/2026 To approve the amendment and restatement of the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. COMPENSATION ISSUER 335.570000 0.000000 AGAINST 335.570000 AGAINST S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director'searlier death, resignation or removal: Douglas S. Ingram DIRECTOR ELECTIONS ISSUER 977.140000 0.000000 FOR 977.140000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director'searlier death, resignation or removal: Claire Mazumdar, Ph.D. DIRECTOR ELECTIONS ISSUER 977.140000 0.000000 WITHHOLD 977.140000 AGAINST S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To consider and act upon an advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 977.140000 0.000000 FOR 977.140000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 977.140000 0.000000 FOR 977.140000 FOR S000004450 Relay Therapeutics, Inc. 75943R102 06/09/2026 To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 300,000,000 to 450,000,000. CAPITAL STRUCTURE ISSUER 977.140000 0.000000 FOR 977.140000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Jaymie A. Durnan DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 WITHHOLD 353.090000 AGAINST S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Harold Ford, Jr. DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect John M. Keane DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Joseph W. Marshall, III DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 WITHHOLD 353.090000 AGAINST S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Gary J. Nabel DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Julian Nemirovsky DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Diem Nguyen DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 WITHHOLD 353.090000 AGAINST S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 Elect Holly L. Phillips DIRECTOR ELECTIONS ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of SIGA Technologies, Inc. for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 353.090000 0.000000 AGAINST 353.090000 AGAINST S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To approve the compensation of the named executive officers on a non-binding advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 SIGA Technologies, Inc. 826917106 06/09/2026 To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. COMPENSATION ISSUER 353.090000 0.000000 FOR 353.090000 FOR S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 Elect H. Edward Fleming, Jr. DIRECTOR ELECTIONS ISSUER 194.880000 0.000000 WITHHOLD 194.880000 AGAINST S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 Elect Liam Ratcliffe DIRECTOR ELECTIONS ISSUER 194.880000 0.000000 FOR 194.880000 FOR S000004450 Upstream Bio, Inc. 91678A107 06/09/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Upstream's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 194.880000 0.000000 FOR 194.880000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 Elect Michael Earley DIRECTOR ELECTIONS ISSUER 154.600000 0.000000 WITHHOLD 154.600000 AGAINST S000004450 Addus HomeCare Corporation 006739106 06/10/2026 Elect Veronica Hill-Milbourne DIRECTOR ELECTIONS ISSUER 154.600000 0.000000 FOR 154.600000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditor for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 154.600000 0.000000 FOR 154.600000 FOR S000004450 Addus HomeCare Corporation 006739106 06/10/2026 To approve, on an advisory, non-binding basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 154.600000 0.000000 FOR 154.600000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Mortimer Berkowitz III DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 WITHHOLD 963.120000 AGAINST S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Quentin Blackford DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 WITHHOLD 963.120000 AGAINST S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: David Demski DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Karen K. McGinnis DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 WITHHOLD 963.120000 AGAINST S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Patrick S. Miles DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: David R. Pelizzon DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 Election of Directors: Keith Valentine DIRECTOR ELECTIONS ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Equity Incentive Plan COMPENSATION ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 Alphatec Holdings, Inc. 02081G201 06/10/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 963.120000 0.000000 FOR 963.120000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Daniel Curran DIRECTOR ELECTIONS ISSUER 262.320000 0.000000 FOR 262.320000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Rekha Hemrajani DIRECTOR ELECTIONS ISSUER 262.320000 0.000000 FOR 262.320000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Elect Chris Takimoto DIRECTOR ELECTIONS ISSUER 262.320000 0.000000 FOR 262.320000 FOR S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 262.320000 0.000000 AGAINST 262.320000 AGAINST S000004450 ALX Oncology Holdings Inc. 00166B105 06/10/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 262.320000 0.000000 FOR 262.320000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Kenneth Sim DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 WITHHOLD 361.220000 AGAINST S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Thomas S. Lam DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect John Chiang DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Weili Dai DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Linda Dong DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect J. Lorraine Estradas DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 WITHHOLD 361.220000 AGAINST S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Mitchell W. Kitayama DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 WITHHOLD 361.220000 AGAINST S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect Matthew Mazdyasni DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 Elect David G. Schmidt DIRECTOR ELECTIONS ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Astrana Health, Inc. 03763A207 06/10/2026 To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. COMPENSATION ISSUER 361.220000 0.000000 FOR 361.220000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Demetrios L. Kouzoukas DIRECTOR ELECTIONS ISSUER 3428.220000 0.000000 FOR 3428.220000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Andrew Toy DIRECTOR ELECTIONS ISSUER 3428.220000 0.000000 FOR 3428.220000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Elect Thomas L. Tran DIRECTOR ELECTIONS ISSUER 3428.220000 0.000000 WITHHOLD 3428.220000 AGAINST S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 3428.220000 0.000000 FOR 3428.220000 FOR S000004450 Clover Health Investments, Corp. 18914F103 06/10/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 3428.220000 0.000000 FOR 3428.220000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Vera Imper DIRECTOR ELECTIONS ISSUER 871.390000 0.000000 WITHHOLD 871.390000 AGAINST S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Glenn P. Muir DIRECTOR ELECTIONS ISSUER 871.390000 0.000000 FOR 871.390000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 Elect Ming Yan DIRECTOR ELECTIONS ISSUER 871.390000 0.000000 FOR 871.390000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 871.390000 0.000000 FOR 871.390000 FOR S000004450 Cytek Biosciences, Inc. 23285D109 06/10/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 871.390000 0.000000 FOR 871.390000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Election of Directors: Peter S. Kim, Ph.D. DIRECTOR ELECTIONS ISSUER 153.570000 0.000000 FOR 153.570000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Election of Directors: Bernhardt Zeiher, M.D. DIRECTOR ELECTIONS ISSUER 153.570000 0.000000 FOR 153.570000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 153.570000 0.000000 FOR 153.570000 FOR S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. COMPENSATION ISSUER 153.570000 0.000000 AGAINST 153.570000 AGAINST S000004450 Entrada Therapeutics, Inc. 29384C108 06/10/2026 Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. COMPENSATION ISSUER 153.570000 0.000000 AGAINST 153.570000 AGAINST S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Iain D. Dukes DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 WITHHOLD 2470.260000 AGAINST S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Athena Countouriotis DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Ryan Maynard DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 WITHHOLD 2470.260000 AGAINST S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Wayne P. Rothbaum DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Frederick G. Vogt DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 Elect Michael Weiser DIRECTOR ELECTIONS ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the frequency of future votes on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2470.260000 0.000000 ONE YEAR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,000,000 shares COMPENSATION ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an amendment to our Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 500,000,000 shares to 650,000,000 shares CAPITAL STRUCTURE ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 6. CORPORATE GOVERNANCE ISSUER 2470.260000 0.000000 FOR 2470.260000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Election of Class I director, nominated by our board of directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham DIRECTOR ELECTIONS ISSUER 58.540000 0.000000 FOR 58.540000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Election of Class I director, nominated by our board of directors, to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers DIRECTOR ELECTIONS ISSUER 58.540000 0.000000 FOR 58.540000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 58.540000 0.000000 FOR 58.540000 FOR S000004450 Korro Bio, Inc. 500946108 06/10/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 58.540000 0.000000 FOR 58.540000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): J. Christopher Barry DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Francesco Bianchi DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): William Kozy DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 AGAINST 439.630000 AGAINST S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Jette Nygaard-Andersen DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Susan Podlogar DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Brooke Story DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Peter Wilver DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To elect, by separate resolution, each of the following eleven (11) directors for a term expiring at the AGM to be held in 2027 ("2027 AGM"): Donald Zurbay DIRECTOR ELECTIONS ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("U.S. Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of PS10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered, or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Special Resolution: Subject to the passing of resolution 4 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 4, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of PS10,985,296, provided that: (A) (unless previously revoked, varied, or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this power replaces (except for any power conferred by resolution 4) all subsisting authorities previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered, or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, for the purposes of section 694 of the Companies Act, the terms of the proposed share repurchase contracts set out in Appendix A and Appendix B of this proxy statement (the "Share Repurchase Contracts") and to authorize the Company to enter into a Share Repurchase Contract with any of the Approved Counterparties (as defined in this proxy statement) provided that: (A) the maximum aggregate number of Ordinary Shares that may be purchased pursuant to the Share Repurchase Contracts shall not exceed 10% of the total issued Ordinary Shares of the Company as at 5:00 pm Eastern Time on April 13, 2026 as adjusted on a proportionate basis to take into account any consolidation or division of shares from time to time; and (B) (unless previously revoked, varied, or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the Company may enter into any Share Repurchase Contract with any of the Approved Counterparties under this authority prior to its expiry and may purchase Ordinary Shares pursuant to any such Share Repurchase Contract. CAPITAL STRUCTURE ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the year ended December 31, 2025. COMPENSATION ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2025, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2026. CORPORATE GOVERNANCE ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 LivaNova PLC G5509L101 06/10/2026 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 439.630000 0.000000 FOR 439.630000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: Richard Klausner, M.D. DIRECTOR ELECTIONS ISSUER 61.680000 0.000000 FOR 61.680000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: Otis Brawley, M.D. DIRECTOR ELECTIONS ISSUER 61.680000 0.000000 FOR 61.680000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Election of Class II Directors: William Rieflin DIRECTOR ELECTIONS ISSUER 61.680000 0.000000 FOR 61.680000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 61.680000 0.000000 FOR 61.680000 FOR S000004450 Lyell Immunopharma, Inc. 55083R203 06/10/2026 Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 61.680000 0.000000 FOR 61.680000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Joseph H. Capper DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: James L. Bierman DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 AGAINST 953.810000 AGAINST S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: William A. Hawkins, III DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: K. Todd Newton DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Tiffany Olson DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Dorothy Puhy DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Election of Directors: Martin P. Sutter DIRECTOR ELECTIONS ISSUER 953.810000 0.000000 AGAINST 953.810000 AGAINST S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Advisory approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 MiMedx Group, Inc. 602496101 06/10/2026 Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 953.810000 0.000000 FOR 953.810000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 Elect Pravin U. Dugel DIRECTOR ELECTIONS ISSUER 1289.720000 0.000000 FOR 1289.720000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 Elect Merilee Raines DIRECTOR ELECTIONS ISSUER 1289.720000 0.000000 WITHHOLD 1289.720000 AGAINST S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve an advisory vote on named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1289.720000 0.000000 AGAINST 1289.720000 AGAINST S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1289.720000 0.000000 ONE YEAR 1289.720000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To approve an amendment to the Ocular Therapeutix, Inc. 2021 Stock Incentive Plan, as amended, to increase the number of shares of common stock issuable thereunder by 10,000,000 shares. COMPENSATION ISSUER 1289.720000 0.000000 FOR 1289.720000 FOR S000004450 Ocular Therapeutix, Inc. 67576A100 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Ocular Therapeutix's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1289.720000 0.000000 FOR 1289.720000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Alan L. Bazaar DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Wayne C. Burris DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Massimo Calafiore DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Vickie L. Capps DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Michael M. Finegan DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Jason M. Hannon DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: John B. Henneman, III DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 AGAINST 252.830000 AGAINST S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Charles R. Kummeth DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Shweta S. Maniar DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Election of Directors: Michael E. Paolucci DIRECTOR ELECTIONS ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Advisory and Non-Binding Vote to Approve Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. AUDIT-RELATED ISSUER 252.830000 0.000000 AGAINST 252.830000 AGAINST S000004450 Orthofix Medical Inc. 68752M108 06/10/2026 Approval of Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan. COMPENSATION ISSUER 252.830000 0.000000 FOR 252.830000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 377.180000 0.000000 WITHHOLD 377.180000 AGAINST S000004450 PACS Group, Inc. 69380Q107 06/10/2026 Elect Mark Hancock DIRECTOR ELECTIONS ISSUER 377.180000 0.000000 FOR 377.180000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 377.180000 0.000000 FOR 377.180000 FOR S000004450 PACS Group, Inc. 69380Q107 06/10/2026 To approve, on an advisory (non binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 377.180000 0.000000 FOR 377.180000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: George M. Jenkins DIRECTOR ELECTIONS ISSUER 78.420000 0.000000 WITHHOLD 78.420000 AGAINST S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. Davis DIRECTOR ELECTIONS ISSUER 78.420000 0.000000 WITHHOLD 78.420000 AGAINST S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Election of three director nominees to serve as Class III directors whose term will expire in 2029: John Doux, M.D. DIRECTOR ELECTIONS ISSUER 78.420000 0.000000 FOR 78.420000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Ratification of the appointment of Ernst & Young as the Company's independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 78.420000 0.000000 FOR 78.420000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 78.420000 0.000000 FOR 78.420000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval, on an advisory basis, of the preferred frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 78.420000 0.000000 ONE YEAR 78.420000 FOR S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. COMPENSATION ISSUER 78.420000 0.000000 AGAINST 78.420000 AGAINST S000004450 Palvella Therapeutics, Inc. 697947109 06/10/2026 Approval of an adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal 5. CORPORATE GOVERNANCE ISSUER 78.420000 0.000000 AGAINST 78.420000 AGAINST S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden DIRECTOR ELECTIONS ISSUER 190.070000 0.000000 WITHHOLD 190.070000 AGAINST S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio Souza DIRECTOR ELECTIONS ISSUER 190.070000 0.000000 FOR 190.070000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young DIRECTOR ELECTIONS ISSUER 190.070000 0.000000 WITHHOLD 190.070000 AGAINST S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 190.070000 0.000000 FOR 190.070000 FOR S000004450 Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 190.070000 0.000000 FOR 190.070000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 229.600000 0.000000 FOR 229.600000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect Robert J. Perez DIRECTOR ELECTIONS ISSUER 229.600000 0.000000 WITHHOLD 229.600000 AGAINST S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 Elect Raymond Sanchez DIRECTOR ELECTIONS ISSUER 229.600000 0.000000 FOR 229.600000 FOR S000004450 Rapport Therapeutics, Inc. 75383L102 06/10/2026 To ratify the appointment of PricewaterhouseCoopers LLP as Rapport's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 229.600000 0.000000 FOR 229.600000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Robert W. Duggan DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 FOR 455.960000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Mahkam Zanganeh DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 FOR 455.960000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 WITHHOLD 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Kenneth A. Clark DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 WITHHOLD 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Robert T. Booth DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 WITHHOLD 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Alessandra Cesano DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 WITHHOLD 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Yu Xia DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 FOR 455.960000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Mostafa Ronaghi DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 FOR 455.960000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Elect Jeffrey T. Huber DIRECTOR ELECTIONS ISSUER 455.960000 0.000000 WITHHOLD 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 455.960000 0.000000 FOR 455.960000 FOR S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 455.960000 0.000000 AGAINST 455.960000 AGAINST S000004450 Summit Therapeutics Inc. 86627T108 06/10/2026 Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. COMPENSATION ISSUER 455.960000 0.000000 AGAINST 455.960000 AGAINST S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 Election of Directors: Pierre Legault DIRECTOR ELECTIONS ISSUER 681.630000 0.000000 WITHHOLD 681.630000 AGAINST S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 Election of Directors: Michael A. Metzger DIRECTOR ELECTIONS ISSUER 681.630000 0.000000 FOR 681.630000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 681.630000 0.000000 FOR 681.630000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 681.630000 0.000000 FOR 681.630000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 681.630000 0.000000 FOR 681.630000 FOR S000004450 Syndax Pharmaceuticals, Inc. 87164F105 06/10/2026 To approve the Syndax Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 681.630000 0.000000 FOR 681.630000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 AGAINST 638.560000 AGAINST S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc A. Stapley DIRECTOR ELECTIONS ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Veracyte, Inc. 92337F107 06/10/2026 The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. COMPENSATION ISSUER 638.560000 0.000000 FOR 638.560000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 Elect Bettina M. Cockroft DIRECTOR ELECTIONS ISSUER 956.300000 0.000000 FOR 956.300000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 Elect Douglas E. Love DIRECTOR ELECTIONS ISSUER 956.300000 0.000000 FOR 956.300000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 956.300000 0.000000 FOR 956.300000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 956.300000 0.000000 FOR 956.300000 FOR S000004450 Annexon, Inc. 03589W102 06/11/2026 To approve an amendment to the Company's amended and restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 956.300000 0.000000 FOR 956.300000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Dietmar Berger, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 705.580000 0.000000 WITHHOLD 705.580000 AGAINST S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: David Lacey, M.D. DIRECTOR ELECTIONS ISSUER 705.580000 0.000000 FOR 705.580000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Nicole Lambert DIRECTOR ELECTIONS ISSUER 705.580000 0.000000 FOR 705.580000 FOR S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 Election of Directors: Johanna Mercier DIRECTOR ELECTIONS ISSUER 705.580000 0.000000 WITHHOLD 705.580000 AGAINST S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 705.580000 0.000000 AGAINST 705.580000 AGAINST S000004450 Arcus Biosciences, Inc. 03969F109 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 705.580000 0.000000 AGAINST 705.580000 AGAINST S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 369.300000 0.000000 WITHHOLD 369.300000 AGAINST S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 Elect Teresa Marie Bitetti DIRECTOR ELECTIONS ISSUER 369.300000 0.000000 FOR 369.300000 FOR S000004450 Aura Biosciences, Inc. 05153U107 06/11/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 369.300000 0.000000 FOR 369.300000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Theresa M. Heggie DIRECTOR ELECTIONS ISSUER 1672.830000 0.000000 FOR 1672.830000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Amy E. McKee DIRECTOR ELECTIONS ISSUER 1672.830000 0.000000 FOR 1672.830000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 Elect Jon P. Stonehouse DIRECTOR ELECTIONS ISSUER 1672.830000 0.000000 FOR 1672.830000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026. AUDIT-RELATED ISSUER 1672.830000 0.000000 AGAINST 1672.830000 AGAINST S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1672.830000 0.000000 FOR 1672.830000 FOR S000004450 BioCryst Pharmaceuticals, Inc. 09058V103 06/11/2026 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. COMPENSATION ISSUER 1672.830000 0.000000 FOR 1672.830000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Fred E. Cohen DIRECTOR ELECTIONS ISSUER 406.070000 0.000000 FOR 406.070000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect R. Bryan Riggsbee DIRECTOR ELECTIONS ISSUER 406.070000 0.000000 WITHHOLD 406.070000 AGAINST S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Suresh Gunasekaran DIRECTOR ELECTIONS ISSUER 406.070000 0.000000 FOR 406.070000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect Michael D. Goldberg DIRECTOR ELECTIONS ISSUER 406.070000 0.000000 WITHHOLD 406.070000 AGAINST S000004450 CareDx, Inc. 14167L103 06/11/2026 Elect John W. Hanna DIRECTOR ELECTIONS ISSUER 406.070000 0.000000 FOR 406.070000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 406.070000 0.000000 FOR 406.070000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 406.070000 0.000000 AGAINST 406.070000 AGAINST S000004450 CareDx, Inc. 14167L103 06/11/2026 To vote, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 406.070000 0.000000 ONE YEAR 406.070000 FOR S000004450 CareDx, Inc. 14167L103 06/11/2026 Approval of an amendment to the 2024 Equity Incentive Plan. COMPENSATION ISSUER 406.070000 0.000000 FOR 406.070000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Richard A. Miller, M.D DIRECTOR ELECTIONS ISSUER 454.570000 0.000000 WITHHOLD 454.570000 AGAINST S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To elect two Class I Directors with terms to expire at the 2029 annual meeting of stockholders: Linda S. Grais, M.D. J.D DIRECTOR ELECTIONS ISSUER 454.570000 0.000000 FOR 454.570000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 454.570000 0.000000 FOR 454.570000 FOR S000004450 Corvus Pharmaceuticals, Inc. 221015100 06/11/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 454.570000 0.000000 FOR 454.570000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Robert Barrow DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Suzanne Bruhn, Ph.D. DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Crystal, M.D. DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: David Gryska DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 WITHHOLD 649.180000 AGAINST S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Andreas Krebs DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Carol A. Vallone DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 WITHHOLD 649.180000 AGAINST S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 Election of Directors to hold office until the 2027 annual general meeting of shareholders: Roger Adsett DIRECTOR ELECTIONS ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 To appoint KPMG LLP as independent registered public accounting firm (auditor) for the Company until the 2027 annual general meeting of shareholders. AUDIT-RELATED ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Definium Therapeutics, Inc. 24477V105 06/11/2026 To consider, and if deemed advisable, approve the amendment to the Definium Therapeutics, Inc. 2025 Equity Incentive Plan (the "2025 Equity Incentive Plan") to increase the number of common shares available for issuance under the 2025 Equity Incentive Plan by 5,000,000 common shares. COMPENSATION ISSUER 649.180000 0.000000 FOR 649.180000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Elect Brady Stewart DIRECTOR ELECTIONS ISSUER 385.880000 0.000000 FOR 385.880000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Elect Vikram Malik DIRECTOR ELECTIONS ISSUER 385.880000 0.000000 WITHHOLD 385.880000 AGAINST S000004450 Evolus, Inc. 30052C107 06/11/2026 Ratification of the appointment of Ernst & Young LLP as Evolus' independent auditor for the year ending December 31, 2026. AUDIT-RELATED ISSUER 385.880000 0.000000 FOR 385.880000 FOR S000004450 Evolus, Inc. 30052C107 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 385.880000 0.000000 FOR 385.880000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Richard J. Barry DIRECTOR ELECTIONS ISSUER 367.290000 0.000000 FOR 367.290000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Pierre Gravier DIRECTOR ELECTIONS ISSUER 367.290000 0.000000 FOR 367.290000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To elect or re-elect three Class II Directors to serve for three-year terms and until their successors are duly elected and qualified: Claude Nicaise, M.D. DIRECTOR ELECTIONS ISSUER 367.290000 0.000000 FOR 367.290000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To approve Amendment No. 2 to the Company's 2018 Omnibus Incentive Plan, which, among other things, increases the authorized number of shares issuable thereunder by 4,000,000 shares (from 5,000,000 to 9,000,000 authorized shares). COMPENSATION ISSUER 367.290000 0.000000 FOR 367.290000 FOR S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 367.290000 0.000000 AGAINST 367.290000 AGAINST S000004450 Filana Therapeutics, Inc. 14817C107 06/11/2026 To approve, by a non-binding advisory vote, 2025 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 367.290000 0.000000 AGAINST 367.290000 AGAINST S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Ross Fubini DIRECTOR ELECTIONS ISSUER 278.890000 0.000000 FOR 278.890000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Christian Henry DIRECTOR ELECTIONS ISSUER 278.890000 0.000000 AGAINST 278.890000 AGAINST S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Sri Kosuri DIRECTOR ELECTIONS ISSUER 278.890000 0.000000 AGAINST 278.890000 AGAINST S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Election of Directors: Harry E. Sloan DIRECTOR ELECTIONS ISSUER 278.890000 0.000000 AGAINST 278.890000 AGAINST S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 278.890000 0.000000 FOR 278.890000 FOR S000004450 Ginkgo Bioworks Holdings, Inc. 37611X209 06/11/2026 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 278.890000 0.000000 FOR 278.890000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Craig Collard DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Tom Cusack DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Craig Johnson DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 AGAINST 1118.450000 AGAINST S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Michael Kaseta DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Adam Morgan DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 AGAINST 1118.450000 AGAINST S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To elect seven director nominees named in the enclosed Proxy Statement to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. Christian Waage DIRECTOR ELECTIONS ISSUER 1118.450000 0.000000 AGAINST 1118.450000 AGAINST S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1118.450000 0.000000 AGAINST 1118.450000 AGAINST S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 1118.450000 0.000000 AGAINST 1118.450000 AGAINST S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares COMPENSATION ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To amend the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10,000,000 shares COMPENSATION ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Heron Therapeutics, Inc. 427746102 06/11/2026 To ratify, on a nonbinding advisory basis, the adoption of the Tax Benefits Preservation Plan SHAREHOLDER RIGHTS AND DEFENSES ISSUER 1118.450000 0.000000 FOR 1118.450000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Andrew Dudum DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Kofi Amoo-Gottfried DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Deborah M. Autor DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Delos Cosgrove DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Anja L. Manuel DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Christopher D. Payne DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Andrea Perez DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect Kare Schultz DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Elect David B. Wells DIRECTOR ELECTIONS ISSUER 523.090000 0.000000 WITHHOLD 523.090000 AGAINST S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 523.090000 0.000000 FOR 523.090000 FOR S000004450 Hims & Hers Health, Inc. 433000106 06/11/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 523.090000 0.000000 AGAINST 523.090000 AGAINST S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders. Natasha Hernday DIRECTOR ELECTIONS ISSUER 319.910000 0.000000 FOR 319.910000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To elect the two nominees for Class II director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders. Eric Dobmeier DIRECTOR ELECTIONS ISSUER 319.910000 0.000000 FOR 319.910000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 319.910000 0.000000 FOR 319.910000 FOR S000004450 Janux Therapeutics, Inc. 47103J105 06/11/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 319.910000 0.000000 AGAINST 319.910000 AGAINST S000004450 Medline Inc. 58507V107 06/11/2026 Elect Charles N. Mills DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Joseph P. Baratta DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Jacob Best DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 WITHHOLD 1858.270000 AGAINST S000004450 Medline Inc. 58507V107 06/11/2026 Elect Todd M. Bluedorn DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect James M. Boyle DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Richard A. Galanti DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Patrick J. Healy DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Andrew J. Mills DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Robert R. Schmidt DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 WITHHOLD 1858.270000 AGAINST S000004450 Medline Inc. 58507V107 06/11/2026 Elect Anushka M. Sunder DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 WITHHOLD 1858.270000 AGAINST S000004450 Medline Inc. 58507V107 06/11/2026 Elect Thomas W. Sweet DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Elect Stephen H. Wise DIRECTOR ELECTIONS ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1858.270000 0.000000 ONE YEAR 1858.270000 FOR S000004450 Medline Inc. 58507V107 06/11/2026 Ratification of the Selection of Ernst & Young LLP as Our Independent Auditor for Fiscal Year 2026. AUDIT-RELATED ISSUER 1858.270000 0.000000 FOR 1858.270000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Ellen Hukkelhoven DIRECTOR ELECTIONS ISSUER 362.580000 0.000000 FOR 362.580000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Nicole Seligman DIRECTOR ELECTIONS ISSUER 362.580000 0.000000 FOR 362.580000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 Elect Debra YU DIRECTOR ELECTIONS ISSUER 362.580000 0.000000 FOR 362.580000 FOR S000004450 MeiraGTx Holdings plc G59665102 06/11/2026 To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 362.580000 0.000000 FOR 362.580000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. DIRECTOR ELECTIONS ISSUER 252.950000 0.000000 WITHHOLD 252.950000 AGAINST S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. DIRECTOR ELECTIONS ISSUER 252.950000 0.000000 FOR 252.950000 FOR S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. DIRECTOR ELECTIONS ISSUER 252.950000 0.000000 WITHHOLD 252.950000 AGAINST S000004450 Monte Rosa Therapeutics, Inc. 61225M102 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 252.950000 0.000000 FOR 252.950000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Rowan Chapman DIRECTOR ELECTIONS ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Herm Rosenman DIRECTOR ELECTIONS ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Jonathan Sheena DIRECTOR ELECTIONS ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 Elect Eric H. Rubin DIRECTOR ELECTIONS ISSUER 1058.760000 0.000000 WITHHOLD 1058.760000 AGAINST S000004450 Natera, Inc. 632307104 06/11/2026 To ratify the appointment of Ernst & Young LLP as Natera, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1058.760000 0.000000 ONE YEAR 1058.760000 FOR S000004450 Natera, Inc. 632307104 06/11/2026 To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 1058.760000 0.000000 FOR 1058.760000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Elect Kirsten Castillo DIRECTOR ELECTIONS ISSUER 2591.220000 0.000000 WITHHOLD 2591.220000 AGAINST S000004450 Ocugen, Inc. 67577C105 06/11/2026 Elect Satish Chandran DIRECTOR ELECTIONS ISSUER 2591.220000 0.000000 FOR 2591.220000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 2591.220000 0.000000 FOR 2591.220000 FOR S000004450 Ocugen, Inc. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2591.220000 0.000000 AGAINST 2591.220000 AGAINST S000004450 Ocugen, Inc. 67577C105 06/11/2026 Approval, on a non-binding advisory basis, of the preferred frequency with which future advisory votes on the compensation of Ocugen's named executive officers should be held. SECTION 14A SAY-ON-PAY VOTES ISSUER 2591.220000 0.000000 ONE YEAR 2591.220000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Bernard Coulie, M.D., Ph.D., M.B.A. DIRECTOR ELECTIONS ISSUER 412.210000 0.000000 FOR 412.210000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Gayle Crowell DIRECTOR ELECTIONS ISSUER 412.210000 0.000000 FOR 412.210000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To elect three class IIl directors named in the proxy statement to our Board of Directors: Steve Krognes, M.B.A. DIRECTOR ELECTIONS ISSUER 412.210000 0.000000 FOR 412.210000 FOR S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 412.210000 0.000000 AGAINST 412.210000 AGAINST S000004450 Pliant Therapeutics, Inc. 729139105 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 412.210000 0.000000 FOR 412.210000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Robert W. Duggan DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 AGAINST 43.850000 AGAINST S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Maria Sainz DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Manmeet S. Soni DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 AGAINST 43.850000 AGAINST S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Darrin R. Uecker DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Richard A. van den Broek DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 Election of Directors: Mahkam Zanganeh, D.D.S. DIRECTOR ELECTIONS ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 Pulse Biosciences, Inc. 74587B101 06/11/2026 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 43.850000 0.000000 FOR 43.850000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Laurence N. Charney DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Yann Echelard DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Kenneth Hoberman DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Daniel Hume DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Sagar Lonial DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 Elect Michael S. Weiss DIRECTOR ELECTIONS ISSUER 1216.470000 0.000000 WITHHOLD 1216.470000 AGAINST S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 1216.470000 0.000000 FOR 1216.470000 FOR S000004450 TG Therapeutics, Inc. 88322Q108 06/11/2026 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1216.470000 0.000000 AGAINST 1216.470000 AGAINST S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Robert S. Epstein, M.D., M.S. DIRECTOR ELECTIONS ISSUER 787.800000 0.000000 WITHHOLD 787.800000 AGAINST S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Karin Jooss, Ph.D. DIRECTOR ELECTIONS ISSUER 787.800000 0.000000 FOR 787.800000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 Election of Class I Directors: Laura J. Hamill DIRECTOR ELECTIONS ISSUER 787.800000 0.000000 FOR 787.800000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 787.800000 0.000000 FOR 787.800000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 787.800000 0.000000 FOR 787.800000 FOR S000004450 Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION ISSUER 787.800000 0.000000 FOR 787.800000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Evert Schimmelpennink DIRECTOR ELECTIONS ISSUER 1.140000 0.000000 FOR 1.140000 FOR S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Jeff George DIRECTOR ELECTIONS ISSUER 1.140000 0.000000 WITHHOLD 1.140000 AGAINST S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 Election of Class II Director to hold office until our 2029 annual meeting of stockholders, until their respective successors are elected and qualified: Shelley Thunen DIRECTOR ELECTIONS ISSUER 1.140000 0.000000 WITHHOLD 1.140000 AGAINST S000004450 LENZ Therapeutics, Inc. 52635N103 06/12/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1.140000 0.000000 FOR 1.140000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 832.150000 0.000000 AGAINST 832.150000 AGAINST S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 832.150000 0.000000 FOR 832.150000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 832.150000 0.000000 FOR 832.150000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 832.150000 0.000000 FOR 832.150000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 832.150000 0.000000 FOR 832.150000 FOR S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 832.150000 0.000000 AGAINST 832.150000 AGAINST S000004450 Regeneron Pharmaceuticals, Inc. 75886F107 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 832.150000 0.000000 FOR 832.150000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Laurie Smaldone Alsup DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Susannah Gray DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 AGAINST 304.690000 AGAINST S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Dean J. Mitchell DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Donal O Connor DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 AGAINST 304.690000 AGAINST S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Deepika R. Pakianathan DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Election of Director to serve as members of the board of directors until the annual general meeting held in 2027 and until their successors are duly elected and qualified: Rick E Winningham DIRECTOR ELECTIONS ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Ratify the appointment of Ernst & Young LLP as Theravance Biopharma, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Theravance Biopharma, Inc. G8807B106 06/12/2026 Approve the non-binding advisory resolution regarding the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 304.690000 0.000000 FOR 304.690000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Lon Cardon, Ph.D., FMedSci DIRECTOR ELECTIONS ISSUER 314.950000 0.000000 FOR 314.950000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. William Fairey DIRECTOR ELECTIONS ISSUER 314.950000 0.000000 FOR 314.950000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Timothy Walbert DIRECTOR ELECTIONS ISSUER 314.950000 0.000000 WITHHOLD 314.950000 AGAINST S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 314.950000 0.000000 FOR 314.950000 FOR S000004450 Mirum Pharmaceuticals, Inc. 604749101 06/15/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 314.950000 0.000000 FOR 314.950000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Robert Ades DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Michael J. Driscoll DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Prathyusha Duraibabu DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Jon Giacomin DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 WITHHOLD 598.020000 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Michele Korfin DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Arthur S. Leibowitz DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 WITHHOLD 598.020000 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Glenn H. Nussdorf DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 WITHHOLD 598.020000 AGAINST S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Elect Gilberto Quintero DIRECTOR ELECTIONS ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 598.020000 0.000000 FOR 598.020000 FOR S000004450 Organogenesis Holdings Inc. 68621F102 06/15/2026 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2026. AUDIT-RELATED ISSUER 598.020000 0.000000 AGAINST 598.020000 AGAINST S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Olivier Brandicourt DIRECTOR ELECTIONS ISSUER 985.470000 0.000000 FOR 985.470000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Halley E. Gilbert DIRECTOR ELECTIONS ISSUER 985.470000 0.000000 WITHHOLD 985.470000 AGAINST S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Elect Grant E. Pickering DIRECTOR ELECTIONS ISSUER 985.470000 0.000000 FOR 985.470000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 985.470000 0.000000 FOR 985.470000 FOR S000004450 Vaxcyte, Inc. 92243G108 06/15/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 985.470000 0.000000 AGAINST 985.470000 AGAINST S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Robert B. Bazemore Jr. DIRECTOR ELECTIONS ISSUER 2036.510000 0.000000 FOR 2036.510000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Muna Bhanji DIRECTOR ELECTIONS ISSUER 2036.510000 0.000000 FOR 2036.510000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 Elect Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 2036.510000 0.000000 WITHHOLD 2036.510000 AGAINST S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay") SECTION 14A SAY-ON-PAY VOTES ISSUER 2036.510000 0.000000 FOR 2036.510000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years SECTION 14A SAY-ON-PAY VOTES ISSUER 2036.510000 0.000000 ONE YEAR 2036.510000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 2036.510000 0.000000 FOR 2036.510000 FOR S000004450 Ardelyx, Inc. 039697107 06/16/2026 To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. COMPENSATION ISSUER 2036.510000 0.000000 FOR 2036.510000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Elect Nadim Ahmed DIRECTOR ELECTIONS ISSUER 245.890000 0.000000 FOR 245.890000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Elect Stephen W. Webster DIRECTOR ELECTIONS ISSUER 245.890000 0.000000 WITHHOLD 245.890000 AGAINST S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Proposal to ratify the appointment of KPMG LLP as Cullinan Therapeutics' independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 245.890000 0.000000 FOR 245.890000 FOR S000004450 Cullinan Therapeutics, Inc. 230031106 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 245.890000 0.000000 FOR 245.890000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 Elect Vina M. Leite DIRECTOR ELECTIONS ISSUER 723.710000 0.000000 WITHHOLD 723.710000 AGAINST S000004450 DocGo Inc. 256086109 06/16/2026 Elect James M. Travers DIRECTOR ELECTIONS ISSUER 723.710000 0.000000 WITHHOLD 723.710000 AGAINST S000004450 DocGo Inc. 256086109 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 723.710000 0.000000 AGAINST 723.710000 AGAINST S000004450 DocGo Inc. 256086109 06/16/2026 To approve a series of six alternative amendments to the Company's Second Amended and Restated Certificate of Incorporation to effect (I) a reverse stock split of the Company's common stock at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 (each, a "Reverse Stock Split"), with such ratio and the time of the Reverse Stock Split as determined in the sole discretion of the Company's Board of Directors at a later date, and (II) a proportionate reduction in the number of authorized shares of the Company's common stock and preferred stock by a corresponding ratio. CAPITAL STRUCTURE ISSUER 723.710000 0.000000 FOR 723.710000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation regarding the waiver of corporate opportunities. CORPORATE GOVERNANCE ISSUER 723.710000 0.000000 FOR 723.710000 FOR S000004450 DocGo Inc. 256086109 06/16/2026 To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 723.710000 0.000000 AGAINST 723.710000 AGAINST S000004450 DocGo Inc. 256086109 06/16/2026 Ratification of the appointment of Urish Popeck & Co., LLC as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 723.710000 0.000000 FOR 723.710000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Wendy Barnes DIRECTOR ELECTIONS ISSUER 719.630000 0.000000 FOR 719.630000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Ronald E. Bruehlman DIRECTOR ELECTIONS ISSUER 719.630000 0.000000 FOR 719.630000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Elect Gregory K. Mondre DIRECTOR ELECTIONS ISSUER 719.630000 0.000000 FOR 719.630000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 719.630000 0.000000 FOR 719.630000 FOR S000004450 GoodRx Holdings, Inc. 38246G108 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 719.630000 0.000000 AGAINST 719.630000 AGAINST S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata DIRECTOR ELECTIONS ISSUER 660.980000 0.000000 FOR 660.980000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. DIRECTOR ELECTIONS ISSUER 660.980000 0.000000 WITHHOLD 660.980000 AGAINST S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. DIRECTOR ELECTIONS ISSUER 660.980000 0.000000 FOR 660.980000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To ratify the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 660.980000 0.000000 FOR 660.980000 FOR S000004450 IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 660.980000 0.000000 FOR 660.980000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Mark G. Currie DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Alexander J. Denner DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 WITHHOLD 1212.250000 AGAINST S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Jon R. Duane DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Marla L. Kessler DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Thomas A. McCourt DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Julie H. McHugh DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 WITHHOLD 1212.250000 AGAINST S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Catherine Moukheibir DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Elect Jay P. Shepard DIRECTOR ELECTIONS ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Approval, by non-binding advisory vote, of the compensation paid to the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Approval of an amendment to Ironwood Pharmaceuticals, Inc. Amended and Restated 2019 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 10,000,000 shares. COMPENSATION ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Ironwood Pharmaceuticals, Inc. 46333X108 06/16/2026 Ratification of the selection of KPMG LLP as Ironwood Pharmaceuticals, Inc.'s independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 1212.250000 0.000000 FOR 1212.250000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: David Johnson DIRECTOR ELECTIONS ISSUER 510.600000 0.000000 FOR 510.600000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: Katie Rielly-Gauvin DIRECTOR ELECTIONS ISSUER 510.600000 0.000000 FOR 510.600000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 Election of Directors: Ramandeep Singh DIRECTOR ELECTIONS ISSUER 510.600000 0.000000 WITHHOLD 510.600000 AGAINST S000004450 Liquidia Corporation 53635D202 06/16/2026 To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. AUDIT-RELATED ISSUER 510.600000 0.000000 FOR 510.600000 FOR S000004450 Liquidia Corporation 53635D202 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 510.600000 0.000000 FOR 510.600000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Michael L. Meyers, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 334.750000 0.000000 FOR 334.750000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 Election of the following nominees as Class Il directors: Ron Squarer DIRECTOR ELECTIONS ISSUER 334.750000 0.000000 FOR 334.750000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 334.750000 0.000000 FOR 334.750000 FOR S000004450 Nuvalent, Inc. 670703107 06/16/2026 To ratify the appointment of KPMG LLP as Nuvalent, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 334.750000 0.000000 FOR 334.750000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Brian Blaser DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Kenneth F. Buechler DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 WITHHOLD 569.140000 AGAINST S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect John R. Chiminski DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Evelyn S. Dilsaver DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect R. Scott Huennekens DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Edward L. Michael DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Mary Lake Polan DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Ann D. Rhoads DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Kenneth J. Widder DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 WITHHOLD 569.140000 AGAINST S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Elect Joseph D. Wilkins Jr. DIRECTOR ELECTIONS ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 569.140000 0.000000 AGAINST 569.140000 AGAINST S000004450 QuidelOrtho Corporation 219798105 06/16/2026 Ratification of the selection of KPMG LLP as QuidelOrtho's independent registered public accounting firm for the fiscal year ending January 3, 2027. AUDIT-RELATED ISSUER 569.140000 0.000000 FOR 569.140000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. William J. Link, Ph.D. DIRECTOR ELECTIONS ISSUER 288.580000 0.000000 FOR 288.580000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. Robert Warner DIRECTOR ELECTIONS ISSUER 288.580000 0.000000 WITHHOLD 288.580000 AGAINST S000004450 RxSight, Inc. 78349D107 06/16/2026 To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. Shweta Singh Maniar DIRECTOR ELECTIONS ISSUER 288.580000 0.000000 FOR 288.580000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 288.580000 0.000000 FOR 288.580000 FOR S000004450 RxSight, Inc. 78349D107 06/16/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 288.580000 0.000000 FOR 288.580000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Bassil I. Dahiyat DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Raymond J. Deshaies DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Ellen G. Feigal DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Kevin C. Gorman DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Kurt A. Gustafson DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 WITHHOLD 407.080000 AGAINST S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Barbara Klencke DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 WITHHOLD 407.080000 AGAINST S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: A. Bruce Montgomery DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Richard J. Ranieri DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Election of Directors: Todd E. Simpson DIRECTOR ELECTIONS ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Ratification of selection by the Audit Committee of the Board of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares. COMPENSATION ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Xencor, Inc. 98401F105 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 407.080000 0.000000 FOR 407.080000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Elect David M. Johnson DIRECTOR ELECTIONS ISSUER 420.370000 0.000000 WITHHOLD 420.370000 AGAINST S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Elect Jan Skvarka DIRECTOR ELECTIONS ISSUER 420.370000 0.000000 FOR 420.370000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 420.370000 0.000000 FOR 420.370000 FOR S000004450 Zentalis Pharmaceuticals, Inc. 98943L107 06/16/2026 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 420.370000 0.000000 AGAINST 420.370000 AGAINST S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Nancy Miller-Rich DIRECTOR ELECTIONS ISSUER 356.840000 0.000000 FOR 356.840000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. John F. Milligan, Ph.D. DIRECTOR ELECTIONS ISSUER 356.840000 0.000000 WITHHOLD 356.840000 AGAINST S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Election of three Class III directors: to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Shawn Cline Tomasello, MBA DIRECTOR ELECTIONS ISSUER 356.840000 0.000000 WITHHOLD 356.840000 AGAINST S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Ratification of the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 356.840000 0.000000 FOR 356.840000 FOR S000004450 4D Molecular Therapeutics, Inc. 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 356.840000 0.000000 FOR 356.840000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect Adrian Adams DIRECTOR ELECTIONS ISSUER 2097.980000 0.000000 WITHHOLD 2097.980000 AGAINST S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect Michael Rogers DIRECTOR ELECTIONS ISSUER 2097.980000 0.000000 FOR 2097.980000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Elect LeAnne M. Zumwalt DIRECTOR ELECTIONS ISSUER 2097.980000 0.000000 WITHHOLD 2097.980000 AGAINST S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval of an amendment to the Company's Ninth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of capital stock from 375,000,000 to 525,000,000 and to increase the number of authorized shares of common stock from 350,000,000 to 500,000,000. CAPITAL STRUCTURE ISSUER 2097.980000 0.000000 FOR 2097.980000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2097.980000 0.000000 FOR 2097.980000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Approval, on an advisory basis, of the frequency of the advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2097.980000 0.000000 ONE YEAR 2097.980000 FOR S000004450 Akebia Therapeutics, Inc. 00972D105 06/17/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2097.980000 0.000000 FOR 2097.980000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Elizabeth A. Garofalo DIRECTOR ELECTIONS ISSUER 610.410000 0.000000 FOR 610.410000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Errol B. De Souza DIRECTOR ELECTIONS ISSUER 610.410000 0.000000 FOR 610.410000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Elect Kristine Yaffe DIRECTOR ELECTIONS ISSUER 610.410000 0.000000 WITHHOLD 610.410000 AGAINST S000004450 Alector, Inc. 014442107 06/17/2026 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 610.410000 0.000000 FOR 610.410000 FOR S000004450 Alector, Inc. 014442107 06/17/2026 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 610.410000 0.000000 FOR 610.410000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Matthew P. Young DIRECTOR ELECTIONS ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To elect two directors with terms to expire at the 2029 Annual Meeting of Stockholders; Elaine V. Jones, Ph.D. DIRECTOR ELECTIONS ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares. CAPITAL STRUCTURE ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan. COMPENSATION ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve an amendment to our Amended and Restated Employee Stock Purchase Plan. COMPENSATION ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 1346.440000 0.000000 FOR 1346.440000 FOR S000004450 CytomX Therapeutics, Inc. 23284F105 06/17/2026 To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1346.440000 0.000000 ONE YEAR 1346.440000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 Elect Bernadette Connaughton DIRECTOR ELECTIONS ISSUER 813.490000 0.000000 WITHHOLD 813.490000 AGAINST S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 Elect Elliott Levy DIRECTOR ELECTIONS ISSUER 813.490000 0.000000 FOR 813.490000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 813.490000 0.000000 FOR 813.490000 FOR S000004450 Editas Medicine, Inc. 28106W103 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 813.490000 0.000000 FOR 813.490000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Election of Class II Directors: Ian Clark DIRECTOR ELECTIONS ISSUER 937.830000 0.000000 WITHHOLD 937.830000 AGAINST S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Election of Class II Directors: Manuel Hidalgo Medina DIRECTOR ELECTIONS ISSUER 937.830000 0.000000 FOR 937.830000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc. 's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 937.830000 0.000000 FOR 937.830000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 937.830000 0.000000 FOR 937.830000 FOR S000004450 Guardant Health, Inc. 40131M109 06/17/2026 Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 937.830000 0.000000 ONE YEAR 937.830000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Julian Baker DIRECTOR ELECTIONS ISSUER 123.840000 0.000000 WITHHOLD 123.840000 AGAINST S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: Daniel Brennan DIRECTOR ELECTIONS ISSUER 123.840000 0.000000 WITHHOLD 123.840000 AGAINST S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Re-election of Class I directors: James Daly DIRECTOR ELECTIONS ISSUER 123.840000 0.000000 FOR 123.840000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 123.840000 0.000000 FOR 123.840000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 123.840000 0.000000 FOR 123.840000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Stock Plan COMPENSATION ISSUER 123.840000 0.000000 FOR 123.840000 FOR S000004450 Madrigal Pharmaceuticals, Inc. 558868105 06/17/2026 Approval of Madrigal Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan COMPENSATION ISSUER 123.840000 0.000000 FOR 123.840000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Sean P. Bohen DIRECTOR ELECTIONS ISSUER 315.500000 0.000000 FOR 315.500000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Scott Garland DIRECTOR ELECTIONS ISSUER 315.500000 0.000000 FOR 315.500000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Yi Larson DIRECTOR ELECTIONS ISSUER 315.500000 0.000000 WITHHOLD 315.500000 AGAINST S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Elect Andrew S. Rappaport DIRECTOR ELECTIONS ISSUER 315.500000 0.000000 FOR 315.500000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 315.500000 0.000000 FOR 315.500000 FOR S000004450 Olema Pharmaceuticals, Inc. 68062P106 06/17/2026 Ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's in dependent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 315.500000 0.000000 FOR 315.500000 FOR S000004450 OmniAb, Inc. 68218J103 06/17/2026 Election of Directors: Matthew W. Foehr DIRECTOR ELECTIONS ISSUER 720.970000 0.000000 FOR 720.970000 FOR S000004450 OmniAb, Inc. 68218J103 06/17/2026 Election of Directors: Jennifer Cochran, Ph.D. DIRECTOR ELECTIONS ISSUER 720.970000 0.000000 WITHHOLD 720.970000 AGAINST S000004450 OmniAb, Inc. 68218J103 06/17/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm AUDIT-RELATED ISSUER 720.970000 0.000000 FOR 720.970000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Dinesh V. Patel DIRECTOR ELECTIONS ISSUER 419.420000 0.000000 FOR 419.420000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 Elect Lewis T. Williams DIRECTOR ELECTIONS ISSUER 419.420000 0.000000 FOR 419.420000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 419.420000 0.000000 FOR 419.420000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 419.420000 0.000000 FOR 419.420000 FOR S000004450 Protagonist Therapeutics, Inc. 74366E102 06/17/2026 To approve the adoption of the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 419.420000 0.000000 FOR 419.420000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Elect Najat Khan DIRECTOR ELECTIONS ISSUER 147.790000 0.000000 FOR 147.790000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Elect Franziska Michor DIRECTOR ELECTIONS ISSUER 147.790000 0.000000 FOR 147.790000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 147.790000 0.000000 FOR 147.790000 FOR S000004450 Recursion Pharmaceuticals, Inc. 75629V104 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 147.790000 0.000000 FOR 147.790000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Michael Egholm DIRECTOR ELECTIONS ISSUER 2089.060000 0.000000 FOR 2089.060000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Thomas Carey DIRECTOR ELECTIONS ISSUER 2089.060000 0.000000 WITHHOLD 2089.060000 AGAINST S000004450 Standard BioTools Inc. 34385P108 06/17/2026 Elect Eli Casdin DIRECTOR ELECTIONS ISSUER 2089.060000 0.000000 FOR 2089.060000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2089.060000 0.000000 AGAINST 2089.060000 AGAINST S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 2089.060000 0.000000 FOR 2089.060000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. COMPENSATION ISSUER 2089.060000 0.000000 FOR 2089.060000 FOR S000004450 Standard BioTools Inc. 34385P108 06/17/2026 To approve an amendment to our Amended and Restated 2017 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,200,000 shares. COMPENSATION ISSUER 2089.060000 0.000000 FOR 2089.060000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Tim Cabral DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mark Carges DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Peter P. Gassner DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 AGAINST 1304.850000 AGAINST S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Priscilla Hung DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Marshall Mohr DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Gordon Ritter DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 AGAINST 1304.850000 AGAINST S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Paul Sekhri DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 Veeva Systems Inc. 922475108 06/17/2026 To elect the following to serve as directors until the annual meeting to be held in 2027 or until their successors are duly elected and qualified: Matthew Wallach DIRECTOR ELECTIONS ISSUER 1304.850000 0.000000 AGAINST 1304.850000 AGAINST S000004450 Veeva Systems Inc. 922475108 06/17/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 1304.850000 0.000000 FOR 1304.850000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Gregory Belinfanti DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Terence J. Connors DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Bradley J. Coppens DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Suzanne M. Foster DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 WITHHOLD 799.110000 AGAINST S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Ted Lundberg DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 WITHHOLD 799.110000 AGAINST S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Kenneth A. Samet DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Susan T. Weaver DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect David Williams III DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Elect Dale B. Wolf DIRECTOR ELECTIONS ISSUER 799.110000 0.000000 WITHHOLD 799.110000 AGAINST S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Ratification of Appointment of KPMG LLP - To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 AdaptHealth Corp. 00653Q102 06/18/2026 Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 799.110000 0.000000 FOR 799.110000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. DIRECTOR ELECTIONS ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Brian Goff DIRECTOR ELECTIONS ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Cynthia Smith DIRECTOR ELECTIONS ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. COMPENSATION ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Agios Pharmaceuticals, Inc. 00847X104 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 461.910000 0.000000 FOR 461.910000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Deborah Messemer DIRECTOR ELECTIONS ISSUER 2076.050000 0.000000 FOR 2076.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Vicki Sato, Ph.D. DIRECTOR ELECTIONS ISSUER 2076.050000 0.000000 FOR 2076.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 Election of Directors: Owen Witte, M.D. DIRECTOR ELECTIONS ISSUER 2076.050000 0.000000 WITHHOLD 2076.050000 AGAINST S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 2076.050000 0.000000 FOR 2076.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2076.050000 0.000000 ONE YEAR 2076.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE ISSUER 2076.050000 0.000000 FOR 2076.050000 FOR S000004450 Allogene Therapeutics, Inc. 019770106 06/18/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 2076.050000 0.000000 FOR 2076.050000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect James I. Healy DIRECTOR ELECTIONS ISSUER 174.110000 0.000000 WITHHOLD 174.110000 AGAINST S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect John A. Hohneker DIRECTOR ELECTIONS ISSUER 174.110000 0.000000 WITHHOLD 174.110000 AGAINST S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 Elect Stuart Lutzker DIRECTOR ELECTIONS ISSUER 174.110000 0.000000 FOR 174.110000 FOR S000004450 ArriVent BioPharma, Inc. 04272N102 06/18/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 174.110000 0.000000 FOR 174.110000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Jerome M. Adams DIRECTOR ELECTIONS ISSUER 433.350000 0.000000 WITHHOLD 433.350000 AGAINST S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Howard H. Berman DIRECTOR ELECTIONS ISSUER 433.350000 0.000000 FOR 433.350000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Elect Barbara G. Duncan DIRECTOR ELECTIONS ISSUER 433.350000 0.000000 WITHHOLD 433.350000 AGAINST S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 433.350000 0.000000 FOR 433.350000 FOR S000004450 Atea Pharmaceuticals, Inc. 04683R106 06/18/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 433.350000 0.000000 AGAINST 433.350000 AGAINST S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Joseph Devivo DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Jonathan M. Rothberg DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Caroll H. Neubauer DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Elazer Edelman, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: S. Louise Phanstiel DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 AGAINST 1681.350000 AGAINST S000004450 Butterfly Network, Inc. 124155102 06/18/2026 Election of Directors: Erica G. Schwartz DIRECTOR ELECTIONS ISSUER 1681.350000 0.000000 AGAINST 1681.350000 AGAINST S000004450 Butterfly Network, Inc. 124155102 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1681.350000 0.000000 FOR 1681.350000 FOR S000004450 Butterfly Network, Inc. 124155102 06/18/2026 To approve by a non-binding advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1681.350000 0.000000 AGAINST 1681.350000 AGAINST S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren Deardorf DIRECTOR ELECTIONS ISSUER 746.080000 0.000000 FOR 746.080000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Weston Nichols, Ph.D. DIRECTOR ELECTIONS ISSUER 746.080000 0.000000 FOR 746.080000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S. DIRECTOR ELECTIONS ISSUER 746.080000 0.000000 WITHHOLD 746.080000 AGAINST S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 746.080000 0.000000 FOR 746.080000 FOR S000004450 Crinetics Pharmaceuticals, Inc. 22663K107 06/18/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 746.080000 0.000000 FOR 746.080000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: Donald Nicholson, Ph.D. DIRECTOR ELECTIONS ISSUER 203.350000 0.000000 WITHHOLD 203.350000 AGAINST S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: John Quisel, J.D., Ph.D. DIRECTOR ELECTIONS ISSUER 203.350000 0.000000 FOR 203.350000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To elect each of the following Class III nominees to the Board of Directors as set forth below: William White, M.P.P., J.D. DIRECTOR ELECTIONS ISSUER 203.350000 0.000000 WITHHOLD 203.350000 AGAINST S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 203.350000 0.000000 FOR 203.350000 FOR S000004450 Disc Medicine, Inc. 254604101 06/18/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 203.350000 0.000000 FOR 203.350000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Goran A. Ando DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 WITHHOLD 617.620000 AGAINST S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Jay S. Duker DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect John B. Landis DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Wendy F. DiCicco DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Karen Zaderej DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Stuart Duty DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Fred Hassan DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 Elect Reginald J. Sanders DIRECTOR ELECTIONS ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 To approve Amendment No. 3 to the EyePoint, Inc. 2023 Long-Term Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,900,000 shares. COMPENSATION ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 EyePoint, Inc. 30233G209 06/18/2026 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 617.620000 0.000000 AGAINST 617.620000 AGAINST S000004450 EyePoint, Inc. 30233G209 06/18/2026 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 617.620000 0.000000 FOR 617.620000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Elect Katherine Stueland DIRECTOR ELECTIONS ISSUER 169.250000 0.000000 FOR 169.250000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 169.250000 0.000000 FOR 169.250000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 169.250000 0.000000 FOR 169.250000 FOR S000004450 GeneDx Holdings Corp. 81663L200 06/18/2026 Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 169.250000 0.000000 ONE YEAR 169.250000 FOR S000004450 GRAIL, Inc. 384747101 06/18/2026 Elect Sarah Krevans DIRECTOR ELECTIONS ISSUER 292.950000 0.000000 WITHHOLD 292.950000 AGAINST S000004450 GRAIL, Inc. 384747101 06/18/2026 Elect Steven C. Mizell DIRECTOR ELECTIONS ISSUER 292.950000 0.000000 WITHHOLD 292.950000 AGAINST S000004450 GRAIL, Inc. 384747101 06/18/2026 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 292.950000 0.000000 FOR 292.950000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Mark L. Baum DIRECTOR ELECTIONS ISSUER 262.580000 0.000000 FOR 262.580000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Adrienne Graves DIRECTOR ELECTIONS ISSUER 262.580000 0.000000 FOR 262.580000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Lauren P. Silvernail DIRECTOR ELECTIONS ISSUER 262.580000 0.000000 WITHHOLD 262.580000 AGAINST S000004450 Harrow, Inc. 415858109 06/18/2026 Elect Perry J. Sternberg DIRECTOR ELECTIONS ISSUER 262.580000 0.000000 FOR 262.580000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 262.580000 0.000000 FOR 262.580000 FOR S000004450 Harrow, Inc. 415858109 06/18/2026 Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 262.580000 0.000000 FOR 262.580000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs DIRECTOR ELECTIONS ISSUER 1153.510000 0.000000 FOR 1153.510000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D. DIRECTOR ELECTIONS ISSUER 1153.510000 0.000000 AGAINST 1153.510000 AGAINST S000004450 Novavax, Inc. 670002401 06/18/2026 Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers DIRECTOR ELECTIONS ISSUER 1153.510000 0.000000 FOR 1153.510000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 The approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1153.510000 0.000000 FOR 1153.510000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, to increase the number of shares of Common Stock available for issuance thereunder by 9,400,000 shares. COMPENSATION ISSUER 1153.510000 0.000000 FOR 1153.510000 FOR S000004450 Novavax, Inc. 670002401 06/18/2026 Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock. COMPENSATION ISSUER 1153.510000 0.000000 AGAINST 1153.510000 AGAINST S000004450 Novavax, Inc. 670002401 06/18/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1153.510000 0.000000 FOR 1153.510000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Thomas J. Cable DIRECTOR ELECTIONS ISSUER 577.310000 0.000000 AGAINST 577.310000 AGAINST S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Peter A. Demopulos, M.D. DIRECTOR ELECTIONS ISSUER 577.310000 0.000000 FOR 577.310000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Election of Directors: Diana T. Perkinson, M.D. DIRECTOR ELECTIONS ISSUER 577.310000 0.000000 FOR 577.310000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Approval of advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 577.310000 0.000000 FOR 577.310000 FOR S000004450 Omeros Corporation 682143102 06/18/2026 Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. COMPENSATION ISSUER 577.310000 0.000000 AGAINST 577.310000 AGAINST S000004450 Omeros Corporation 682143102 06/18/2026 Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 577.310000 0.000000 AGAINST 577.310000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 AGAINST 3520.140000 AGAINST S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Subbarao V. Uppaluri, Ph.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 Election of Director for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 To approve the Company's 2026 Equity Incentive Plan. COMPENSATION ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 Opko Health, Inc. 68375N103 06/18/2026 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 3520.140000 0.000000 FOR 3520.140000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Jacob M. Chacko, M.D DIRECTOR ELECTIONS ISSUER 363.910000 0.000000 FOR 363.910000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. Mardi C. Dier DIRECTOR ELECTIONS ISSUER 363.910000 0.000000 WITHHOLD 363.910000 AGAINST S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 363.910000 0.000000 FOR 363.910000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. COMPENSATION ISSUER 363.910000 0.000000 AGAINST 363.910000 AGAINST S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 363.910000 0.000000 FOR 363.910000 FOR S000004450 ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 363.910000 0.000000 ONE YEAR 363.910000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Arani Bose DIRECTOR ELECTIONS ISSUER 311.800000 0.000000 FOR 311.800000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Bridget O'Rourke DIRECTOR ELECTIONS ISSUER 311.800000 0.000000 WITHHOLD 311.800000 AGAINST S000004450 Penumbra, Inc. 70975L107 06/18/2026 Elect Surbhi Sarna DIRECTOR ELECTIONS ISSUER 311.800000 0.000000 WITHHOLD 311.800000 AGAINST S000004450 Penumbra, Inc. 70975L107 06/18/2026 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 311.800000 0.000000 FOR 311.800000 FOR S000004450 Penumbra, Inc. 70975L107 06/18/2026 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 311.800000 0.000000 FOR 311.800000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 AGAINST 1440.820000 AGAINST S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 AGAINST 1440.820000 AGAINST S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 AGAINST 1440.820000 AGAINST S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Precigen, Inc. 74017N105 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 1440.820000 0.000000 FOR 1440.820000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Alexis A. Borisy DIRECTOR ELECTIONS ISSUER 1355.930000 0.000000 WITHHOLD 1355.930000 AGAINST S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 Elect Mark A. Goldsmith DIRECTOR ELECTIONS ISSUER 1355.930000 0.000000 FOR 1355.930000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1355.930000 0.000000 FOR 1355.930000 FOR S000004450 Revolution Medicines, Inc. 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1355.930000 0.000000 FOR 1355.930000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Neal C. Bradsher DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 WITHHOLD 273.640000 AGAINST S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Arthur C. Butcher DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 WITHHOLD 273.640000 AGAINST S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Wei Jiang DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Richard T. LeBuhn DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Louis E. Silverman DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Christopher M. Wang DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Elect Lilian Zhou DIRECTOR ELECTIONS ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Approve an amendment to the Company's Amended and Restated Omnibus Equity Incentive Plan, as amended. COMPENSATION ISSUER 273.640000 0.000000 FOR 273.640000 FOR S000004450 STAAR Surgical Company 852312305 06/18/2026 Ratify the appointment of the Company's independent registered public accounting firm for fiscal 2026 AUDIT-RELATED ISSUER 273.640000 0.000000 AGAINST 273.640000 AGAINST S000004450 STAAR Surgical Company 852312305 06/18/2026 Approve on a non-binding advisory basis the compensation of the Company's named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 273.640000 0.000000 AGAINST 273.640000 AGAINST S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson DIRECTOR ELECTIONS ISSUER 549.170000 0.000000 WITHHOLD 549.170000 AGAINST S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III DIRECTOR ELECTIONS ISSUER 549.170000 0.000000 WITHHOLD 549.170000 AGAINST S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To approve, on a non-binding basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 549.170000 0.000000 FOR 549.170000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 549.170000 0.000000 FOR 549.170000 FOR S000004450 Supernus Pharmaceuticals, Inc. 868459108 06/18/2026 To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan. COMPENSATION ISSUER 549.170000 0.000000 FOR 549.170000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect James C. Momtazee DIRECTOR ELECTIONS ISSUER 1211.570000 0.000000 FOR 1211.570000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect Frank McCormick DIRECTOR ELECTIONS ISSUER 1211.570000 0.000000 WITHHOLD 1211.570000 AGAINST S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 Elect Hannah A. Valantine DIRECTOR ELECTIONS ISSUER 1211.570000 0.000000 WITHHOLD 1211.570000 AGAINST S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1211.570000 0.000000 FOR 1211.570000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1211.570000 0.000000 ONE YEAR 1211.570000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1211.570000 0.000000 FOR 1211.570000 FOR S000004450 BridgeBio Pharma, Inc. 10806X102 06/22/2026 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. COMPENSATION ISSUER 1211.570000 0.000000 FOR 1211.570000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Claudia N. Drayton DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Mark Fioravanti DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Victoria L. Freed DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 AGAINST 1906.360000 AGAINST S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Joshua Hausman DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Elizabeth B. Mace DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Nikolas W. Stengle DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Denise W. Warren DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 AGAINST 1906.360000 AGAINST S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: Lee S. Wielansky DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Election of Directors: C. Christian Winkle DIRECTOR ELECTIONS ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Advisory approval of named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 1906.360000 0.000000 FOR 1906.360000 FOR S000004450 Brookdale Senior Living Inc. 112463104 06/22/2026 Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 1906.360000 0.000000 AGAINST 1906.360000 AGAINST S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Richard A. Friesner DIRECTOR ELECTIONS ISSUER 547.090000 0.000000 FOR 547.090000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Rosana Kapeller-Libermann DIRECTOR ELECTIONS ISSUER 547.090000 0.000000 FOR 547.090000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Election of each of the following Class III directors to serve until the 2029 Annual Meeting: Gary Sender DIRECTOR ELECTIONS ISSUER 547.090000 0.000000 AGAINST 547.090000 AGAINST S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 547.090000 0.000000 FOR 547.090000 FOR S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Approval of an amendment to the Schrodinger, Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 3,000,000 shares. COMPENSATION ISSUER 547.090000 0.000000 AGAINST 547.090000 AGAINST S000004450 Schrodinger, Inc. 80810D103 06/22/2026 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 547.090000 0.000000 FOR 547.090000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 AGAINST 374.270000 AGAINST S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Elizabeth Barrett DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Cynthia M. Butitta DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Stuart Holden, M.D. DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: James A. Robinson, Jr. DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Leana S. Wen, M.D., M.Sc. DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 AGAINST 374.270000 AGAINST S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Daniel G. Wildman DIRECTOR ELECTIONS ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve the amendment and restatement of the Artides of Association of the Company to, among other things, tie ellgibility for shareholder proposals to the requirements under the Israeli Companies Law. CORPORATE GOVERNANCE ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve an amendment to the Company's Amended and Restated Non-Employee Director and Officer Compensation Policy in relation to directors' and officers' insurance. COMPENSATION ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 1,000,000 shares. COMPENSATION ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 UroGen Pharma Ltd. M96088105 06/22/2026 To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's auditor until the Company's 2027 annual meeting of shareholders. AUDIT-RELATED ISSUER 374.270000 0.000000 FOR 374.270000 FOR S000004450 WAVE Life Sciences Ltd. Y95308105 06/22/2026 To approve the scheme of arrangement under Singapore law among Wave Life Sciences Ltd., a public company limited by shares incorporated under the laws of the Republic of Singapore ("Wave-Singapore"), the shareholders of Wave-Singapore and Wave Life Sciences, Inc., a Delaware corporation, subject to approval of the High Court of the Republic of Singapore, as set forth in Wave-Singapore's notice of, and proxy statement relating to, the Special Meeting of Wave-Singapore shareholders. CORPORATE GOVERNANCE ISSUER 1041.700000 0.000000 FOR 1041.700000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Michael D. Dale DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Amy M. Wendell DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect William Burke DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect John H. Johnson DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Alan Levine DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Paul G. Thomas DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 WITHHOLD 386.810000 AGAINST S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Joseph Tyndall DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 Elect Kathy Weiler DIRECTOR ELECTIONS ISSUER 386.810000 0.000000 WITHHOLD 386.810000 AGAINST S000004450 Axogen, Inc. 05463X106 06/23/2026 To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 Axogen, Inc. 05463X106 06/23/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 386.810000 0.000000 FOR 386.810000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Janet M. Dillione DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Gregory Duncan DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Alan W. Dunton DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 WITHHOLD 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Myron Kaplan DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 WITHHOLD 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Steven Lefkowitz DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 WITHHOLD 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Robert A. Stewart DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 Elect Joseph Todisco DIRECTOR ELECTIONS ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve on a non-binding advisory basis the compensation of our named executive officers for 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve the ratification of the Certificate of Designation Amendments (as defined in the Proxy Statement). CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve amendments to our Charter to make technical changes. CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 FOR 279.740000 FOR S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to update the approval process for amendments relating solely to the terms of one or more series of preferred stock by permitting such amendments to be approved by the holders of the applicable series, without a separate vote of common stockholders, to the extent permitted by Delaware law and provided that no changes are made to the terms of common stock. CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 AGAINST 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to designate the exclusive forums in which certain claims relating to the Company may be brought. CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 AGAINST 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve an amendment to our Charter to limit certain officers' personal liability for monetary damages for breaches of the duty of care, as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 AGAINST 279.740000 AGAINST S000004450 CorMedix Inc. 21900C308 06/23/2026 To approve the adjournment of the 2026 Annual Meeting to a later date or dates, if necessary, to permit further solicitation and voting of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No.s 4, 5, 6, 7 or 8. CORPORATE GOVERNANCE ISSUER 279.740000 0.000000 AGAINST 279.740000 AGAINST S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Roger Susi DIRECTOR ELECTIONS ISSUER 69.840000 0.000000 FOR 69.840000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Monty Allen DIRECTOR ELECTIONS ISSUER 69.840000 0.000000 WITHHOLD 69.840000 AGAINST S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Joe Kiani DIRECTOR ELECTIONS ISSUER 69.840000 0.000000 FOR 69.840000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect Hilda Scharen-Guivel DIRECTOR ELECTIONS ISSUER 69.840000 0.000000 FOR 69.840000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 Elect James B. Hawkins DIRECTOR ELECTIONS ISSUER 69.840000 0.000000 WITHHOLD 69.840000 AGAINST S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 69.840000 0.000000 FOR 69.840000 FOR S000004450 IRADIMED CORPORATION 46266A109 06/23/2026 To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 69.840000 0.000000 FOR 69.840000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Saqib Islam, J.D. DIRECTOR ELECTIONS ISSUER 56.290000 0.000000 FOR 56.290000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Phillip Schneider DIRECTOR ELECTIONS ISSUER 56.290000 0.000000 WITHHOLD 56.290000 AGAINST S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To elect our Board of Directors' three nominees for Class III director named in the accompanying proxy statement to serve for three-year terms until the 2029 Annual Meeting of Stockholders: Laura Shawver, Ph.D. DIRECTOR ELECTIONS ISSUER 56.290000 0.000000 WITHHOLD 56.290000 AGAINST S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 56.290000 0.000000 FOR 56.290000 FOR S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 56.290000 0.000000 AGAINST 56.290000 AGAINST S000004450 ARS Pharmaceuticals, Inc. 82835W108 06/24/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 56.290000 0.000000 ONE YEAR 56.290000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 Elect Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 511.590000 0.000000 FOR 511.590000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 Elect Randy Teel DIRECTOR ELECTIONS ISSUER 511.590000 0.000000 FOR 511.590000 FOR S000004450 Arvinas, Inc. 04335A105 06/24/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 511.590000 0.000000 AGAINST 511.590000 AGAINST S000004450 Arvinas, Inc. 04335A105 06/24/2026 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 511.590000 0.000000 FOR 511.590000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks DIRECTOR ELECTIONS ISSUER 354.540000 0.000000 FOR 354.540000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz DIRECTOR ELECTIONS ISSUER 354.540000 0.000000 FOR 354.540000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill DIRECTOR ELECTIONS ISSUER 354.540000 0.000000 FOR 354.540000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 A non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 354.540000 0.000000 FOR 354.540000 FOR S000004450 Fulcrum Therapeutics, Inc. 359616109 06/24/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 354.540000 0.000000 FOR 354.540000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Bruce Booth DIRECTOR ELECTIONS ISSUER 449.930000 0.000000 FOR 449.930000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Nello Mainolfi DIRECTOR ELECTIONS ISSUER 449.930000 0.000000 FOR 449.930000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect John M. Maraganore DIRECTOR ELECTIONS ISSUER 449.930000 0.000000 FOR 449.930000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 Elect Elena Ridloff DIRECTOR ELECTIONS ISSUER 449.930000 0.000000 WITHHOLD 449.930000 AGAINST S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers; and SECTION 14A SAY-ON-PAY VOTES ISSUER 449.930000 0.000000 FOR 449.930000 FOR S000004450 Kymera Therapeutics, Inc. 501575104 06/24/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 449.930000 0.000000 FOR 449.930000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 Elect Chaim Indig DIRECTOR ELECTIONS ISSUER 578.760000 0.000000 FOR 578.760000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 Elect Jon Kessler DIRECTOR ELECTIONS ISSUER 578.760000 0.000000 WITHHOLD 578.760000 AGAINST S000004450 Phreesia, Inc. 71944F106 06/24/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 578.760000 0.000000 FOR 578.760000 FOR S000004450 Phreesia, Inc. 71944F106 06/24/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 578.760000 0.000000 FOR 578.760000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Elect David W.J. McGirr DIRECTOR ELECTIONS ISSUER 533.260000 0.000000 WITHHOLD 533.260000 AGAINST S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Elect David P. Meeker DIRECTOR ELECTIONS ISSUER 533.260000 0.000000 WITHHOLD 533.260000 AGAINST S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 533.260000 0.000000 FOR 533.260000 FOR S000004450 Rhythm Pharmaceuticals, Inc. 76243J105 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 533.260000 0.000000 FOR 533.260000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Harry H. Penner, Jr. DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 AGAINST 630.540000 AGAINST S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Anthony S. Marucci DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Keith L. Brownlie DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 AGAINST 630.540000 AGAINST S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Cheryl L. Cohen DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Herbert J. Conrad DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Rita I. Jain, M.D. DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: James J. Marino DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Garry A. Neil, M.D. DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 Election of Directors: Denice Torres DIRECTOR ELECTIONS ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 3,400,000 shares to 12,900,000 shares and a clarification regarding the tax withholding provisions applicable to awards under the 2021 Incentive Plan. COMPENSATION ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 630.540000 0.000000 FOR 630.540000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert Selander DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 AGAINST 832.520000 AGAINST S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott Cutler DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D. DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian Dillon DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn Dilsaver DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William Gassen DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowan DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 AGAINST 832.520000 AGAINST S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh Natarajan DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart Parker DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle Wellborn DIRECTOR ELECTIONS ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. AUDIT-RELATED ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. COMPENSATION ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 HealthEquity, Inc. 42226A107 06/25/2026 To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. COMPENSATION ISSUER 832.520000 0.000000 FOR 832.520000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy Yarno DIRECTOR ELECTIONS ISSUER 299.360000 0.000000 FOR 299.360000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew Goldberg DIRECTOR ELECTIONS ISSUER 299.360000 0.000000 WITHHOLD 299.360000 AGAINST S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott Morrison DIRECTOR ELECTIONS ISSUER 299.360000 0.000000 WITHHOLD 299.360000 AGAINST S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: David E.I. Pyott DIRECTOR ELECTIONS ISSUER 299.360000 0.000000 FOR 299.360000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 299.360000 0.000000 FOR 299.360000 FOR S000004450 Tarsus Pharmaceuticals, Inc. 87650L103 06/25/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 299.360000 0.000000 FOR 299.360000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin DIRECTOR ELECTIONS ISSUER 1603.240000 0.000000 WITHHOLD 1603.240000 AGAINST S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. DIRECTOR ELECTIONS ISSUER 1603.240000 0.000000 FOR 1603.240000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. DIRECTOR ELECTIONS ISSUER 1603.240000 0.000000 FOR 1603.240000 FOR S000004450 Erasca, Inc. 29479A108 06/26/2026 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 AUDIT-RELATED ISSUER 1603.240000 0.000000 FOR 1603.240000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub") and the Company, and approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Merger Sub with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 1093.470000 0.000000 FOR 1093.470000 FOR S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES ISSUER 1093.470000 0.000000 AGAINST 1093.470000 AGAINST S000004450 Select Medical Holdings Corporation 81619Q105 06/26/2026 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE ISSUER 1093.470000 0.000000 FOR 1093.470000 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Shalini Sharp, M.B.A. DIRECTOR ELECTIONS ISSUER 106.040000 0.000000 WITHHOLD 106.040000 AGAINST S000004450 Septerna, Inc. 81734D104 06/26/2026 Election of Directors: Jake Simson, Ph.D. DIRECTOR ELECTIONS ISSUER 106.040000 0.000000 FOR 106.040000 FOR S000004450 Septerna, Inc. 81734D104 06/26/2026 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 106.040000 0.000000 FOR 106.040000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 AGAINST 386.080000 AGAINST S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 AGAINST 386.080000 AGAINST S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 386.080000 0.000000 FOR 386.080000 FOR S000004450 United Therapeutics Corporation 91307C102 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 386.080000 0.000000 AGAINST 386.080000 AGAINST S000004450 Alumis Inc. 022307102 06/30/2026 Elect James B. Tananbaum DIRECTOR ELECTIONS ISSUER 629.690000 0.000000 WITHHOLD 629.690000 AGAINST S000004450 Alumis Inc. 022307102 06/30/2026 Elect Lynn A. Tetrault DIRECTOR ELECTIONS ISSUER 629.690000 0.000000 FOR 629.690000 FOR S000004450 Alumis Inc. 022307102 06/30/2026 Elect Zhengbin Yao DIRECTOR ELECTIONS ISSUER 629.690000 0.000000 WITHHOLD 629.690000 AGAINST S000004450 Alumis Inc. 022307102 06/30/2026 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the Company's fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 629.690000 0.000000 FOR 629.690000 FOR S000004450